TI,AU,DO,YR,Title Screen,Abstract Screen,Data Screen,Data Extracted,,,,
electronic and other new media technology interventions for hiv care and prevention: a systematic review,Maloney KM,10.1002/jia2.25439,2020,review,,0,,,,,
evolution of experimental design and research techniques in hiv-1 reservoir studies: a systematic review,De-Scheerder M-A,10.24875/AIDSRev.M20000028,2020,review,,0,,,,,
hiv-1 maturation: lessons learned from inhibitors [review],Kleinpeter AB,10.3390/v12090940,2020,review,,0,,,,,
hiv-1 subtype frequency in northeast brazil: a systematic review and meta-analysis,da Costa CP,10.1002/jmv.25842,2020,review,,0,,,,,
human immunodeficiency virus infection and diverse physical health outcomes: an umbrella review of meta-analyses of observational studies,Grabovac I,10.1093/cid/ciz539,2020,review,,0,,,,,
impact of male circumcision on risk of hiv infection in men in a changing epidemic context - systematic review and meta-analysis,Farley TMM,10.1002/jia2.25490,2020,review,,0,,,,,
initial manifestation of parotid extra-medullary myeloma in an hiv positive patient on anti-retroviral therapy: a case report and review of the literature,Maharaj S,10.3892/br.2020.1335,2020,review,,0,,,,,
minding the gap in hiv host genetics: opportunities and challenges [review],Gingras SN,10.1007/s00439-020-02177-9,2020,review,,0,,,,,
recent advances in natural anti-hiv triterpenoids and analogs [review],Wu HF,10.1002/med.21708,2020,review,,0,,,,,
sensor sensibility-hiv-1 and the innate immune response [review],Yin X,10.3390/cells9010254,2020,review,,0,,,,,
single-cell technologies applied to hiv-1 research: reaching maturity [review],Sannier G,10.3389/fmicb.2020.00297,2020,review,,0,,,,,
"structure, function, and inhibitor targeting of hiv-1 nef-effector kinase complexes [review]",Staudt RP,10.1074/jbc.REV120.012317,2020,review,,0,,,,,
the role of torsin aaa+ proteins in preserving nuclear envelope integrity and safeguarding against disease [review],Rampello AJ,10.3390/biom10030468,2020,review,,0,,,,,
understanding the mechanisms driving the spread of subtype c hiv-1 [review],Gartner MJ,10.1016/j.ebiom.2020.102682,2020,review,,0,,,,,
a review of hiv testing strategies among msm (2005-2015): changes and continuities due to the biomedicalization of responses to aids,Monteiro,10.1080/17441692.2018.1545038,2019,review,,0,,,,,
a review of telehealth innovations for hiv pre-exposure prophylaxis (prep),Touger R,10.1007/s11904-019-00430-z,2019,review,,0,,,,,
challenges to the performance of current hiv diagnostic assays and the need for centralized specimen archives: a review of the consortium for the evaluation and performance of hiv incidence assays (cephia) repository,Facente SN,10.12688/gatesopenres.12903.1,2019,review,,0,,,,,
effect of fc receptor genetic diversity on hiv-1 disease pathogenesis [review],Geraghty DE,10.3389/fimmu.2019.00970,2019,review,,0,,,,,
experiences of hiv-infected adults and healthcare providers with healthcare delivery practices that influence engagement in us primary healthcare settings: a qualitative systematic review,Norberg A,10.11124/JBISRIR-2017-003756,2019,review,,0,,,,,
hiv-1 antibodies in prevention of transmission [review],Barin F,10.1097/COH.0000000000000553,2019,review,,0,,,,,
"human dendritic cell subsets, ontogeny, and impact on hiv infection [review]",Rhodes JW,10.3389/fimmu.2019.01088,2019,review,,0,,,,,
nanoparticle vaccines for inducing hiv-1 neutralizing antibodies [review],Brinkkemper M,10.3390/vaccines7030076,2019,review,,0,,,,,
nanotechnology approaches to eradicating hiv reservoirs [review],Cao S,10.1016/j.ejpb.2018.06.002,2019,review,,0,,,,,
phylogenetic inference for the study of within-host hiv-1 dynamics and persistence on antiretroviral therapy [review],Capoferri AA,10.1016/S2352-3018(19)30051-7,2019,review,,0,,,,,
phylogenetics in hiv transmission: taking within-host diversity into account [review],Leitner T,10.1097/COH.0000000000000536,2019,review,,0,,,,,
prescription drug diversion among people living with hiv: a systematic scoping review,Chibi B,10.1016/j.puhe.2019.07.017,2019,review,,0,,,,,
psychological interventions for alcohol use disorders in people living with hiv/aids: a systematic review,Madhombiro M,10.1186/s13643-019-1176-4,2019,review,,0,,,,,
recent levels and trends in hiv incidence rates among adolescent girls and young women in ten high-prevalence african countries: a systematic review and meta-analysis,Birdthistle I,10.1016/S2214-109X%2819%2930410-3,2019,review,,0,,,,,
the linkage between amphetamine-type stimulants and hiv sexual transmission risk behaviors (trbs): a systematic review,Muflih S,10.5530/srp.2019.1s.16,2019,review,,0,,,,,
the theory of masculinity in studies on hiv a systematic review,Jacques-Avino C,10.1080/17441692.2018.1493133,2019,review,,0,,,,,
a global review of hiv self-testing: themes and implications,Stevens DR,10.1007/s10461-017-1707-8,2018,review,,0,,,,,
adherence to antiretroviral therapy for hiv/aids in latin america and the caribbean: systematic review and meta-analysis: systematic,Costa JDM,10.1002/jia2.25066,2018,review,,0,,,,,
crispr/cas9 genome editing to disable the latent hiv-1 provirus [review],Panfil AR,10.3389/fmicb.2018.03107,2018,review,,0,,,,,
current insights into anti-hiv drug discovery and development: a review of recent patent literature (2014-2017),Zuo X,10.1080/13543776.2018.1438410,2018,review,,0,,,,,
"cytomegalovirus retinitis in hiv-negative patients - associated conditions, clinical presentation, diagnostic methods and treatment strategy [review]",Shapira Y,10.1111/aos.13553,2018,review,,0,,,,,
defining and surveying key populations at risk of hiv infection: towards a unified approach to eligibility criteria for respondent-driven sampling hiv biobehavioral surveys [review],Hakim AJ,10.1177/0956462418763882,2018,review,,0,,,,,
engineering multi-specific antibodies against hiv-1 [review],Padte NN,10.1186/s12977-018-0439-9,2018,review,,0,,,,,
essential two-component systems regulating cell envelope functions: opportunities for novel antibiotic therapies [review],Cardona ST,10.1007/s00232-017-9995-5,2018,review,,0,,,,,
hiv outcomes among migrants from low-income and middle-income countries living in high-income countries: a review of recent evidence [review],Ross J,10.1097/QCO.0000000000000415,2018,review,,0,,,,,
hiv pre-exposure prophylaxis in south east asia: a focused review on present situation,To KW,10.1016/j.ijid.2018.10.027,2018,review,,0,,,,,
"integrating cardiovascular diseases, hypertension, and diabetes with hiv services: a systematic review",Haldane V,10.1080/09540121.2017.1344350,2018,review,,0,,,,,
measuring replication competent hiv-1: advances and challenges in defining the latent reservoir [review],Wang Z,10.1186/s12977-018-0404-7,2018,review,,0,,,,,
"multi-envelope hiv-1 vaccine development: two targeted immune pathways, one desired protective outcome [review]",Hurwitz JL,10.1089/vim.2017.0144,2018,review,,0,,,,,
phylogenetic analysis as a forensic tool in hiv transmission investigations [review],Abecasis AB,10.1097/QAD.0000000000001728,2018,review,,0,,,,,
physical activity correlates in people living with hiv/aids: a systematic review of 45 studies,Vancampfort D,10.1080/09638288.2017.1306587,2018,review,,0,,,,,
polyreactive antibodies in anti-hiv-1 responses [review],Liao H,10.2174/1566524018666180720165406,2018,review,,0,,,,,
preventive and therapeutic features of broadly neutralising monoclonal antibodies against hiv-1 [review],Jaworski JP,10.1016/S2352-3018(18)30174-7,2018,review,,0,,,,,
recent progress in understanding hiv reservoirs [review],Kuo HH,10.1097/COH.0000000000000441,2018,review,,0,,,,,
risky behaviours and their correlates among adolescents living with hiv in sub-saharan africa: a systematic review,Zgambo M,10.1186/s12978-018-0614-4,2018,review,,0,,,,,
"scaling up hiv self-testing in sub-saharan africa: a review of technology, policy and evidence",Indravudh PP,10.1097/QCO.0000000000000426,2018,review,,0,,,,,
single-molecule techniques to quantify and genetically characterise persistent hiv [review],Wang XQ,10.1186/s12977-017-0386-x,2018,review,,0,,,,,
supervised physical activity and improved functional capacity among adults living with hiv: a systematic review,Voigt N,10.1016/j.jana.2018.05.001,2018,review,,0,,,,,
the impact of hiv-1 within-host evolution on transmission dynamics [review],Theys K,10.1016/j.coviro.2017.12.001,2018,review,,0,,,,,
[molecular mechanisms of hiv-1 genetic diversity] [review] [russian],Sosin DV,10.7868/S0026898417030156,2017,review,,0,,,,,
a systematic review of emergency department based hiv testing and linkage to care initiatives in low resource settings,Hansoti B,10.1371/journal.pone.0187443,2017,review,,0,,,,,
an analysis of the extent of social inclusion and equity consideration in malawi's national hiv and aids policy review process,Chinyama MJ,10.15171/ijhpm.2017.87,2017,review,,0,,,,,
defining hiv-1 transmission clusters based on sequence data [review],Hassan AS,10.1097/QAD.0000000000001470,2017,review,,0,,,,,
development of an anti-hiv vaccine eliciting broadly neutralizing antibodies [review],Ahmed Y,10.1186/s12981-017-0178-3,2017,review,,0,,,,,
development of an hiv vaccine using a vesicular stomatitis virus vector expressing designer hiv-1 envelope glycoproteins to enhance humoral responses [review],Racine T,10.1186/s12981-017-0179-2,2017,review,,0,,,,,
dropout from physical activity interventions in people living with hiv: a systematic review and meta-analysis,Vancampfort D,10.1080/09540121.2016.1248347,2017,review,,0,,,,,
effectiveness of progressive resistive exercise (pre) in the context of hiv: systematic review and meta-analysis using the cochrane collaboration protocol,O'Brien KK,10.1186/s12879-017-2342-8,2017,review,,0,,,,,
geographic distribution and temporal trends of hiv-1 subtypes through heterosexual transmission in china: a systematic review and meta-analysis,Xiao P,10.3390/ijerph14070830,2017,review,,0,,,,,
harmonizing community-based health worker programs for hiv: a narrative review and analytic framework,De Neve J-W,10.1186/s12960-017-0219-y,2017,review,,0,,,,,
health systems facilitators and barriers to the integration of hiv and chronic disease services: a systematic review,Watt N,10.1093/heapol/czw149,2017,review,,0,,,,,
how can we use phylogenetics to facilitate clinical case finding and partner notification in hiv? lessons from a systematic review of its use in stigmatised infectious diseases,Mulka L,10.1111/hiv.12513,2017,review,,0,,,,,
how hiv-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design [review],Pancera M,10.1097/COH.0000000000000360,2017,review,,0,,,,,
human immunodeficiency virus-negative plasmablastic lymphoma: a case report and literature review,Lin L,10.1097/MD.0000000000006171,2017,review,,0,,,,,
integration of sexually transmitted infection (sti) services into hiv care and treatment services for women living with hiv: a systematic review,Kennedy CE,10.1136/bmjopen-2016-015310,2017,review,,0,,,,,
interventions and approaches to integrating hiv and mental health services: a systematic review,Chuah FLH,10.1093/heapol/czw169,2017,review,,0,,,,,
making sense of multifunctional proteins: human immunodeficiency virus type 1 accessory and regulatory proteins and connections to transcription [review],Faust TB,10.1146/annurev-virology-101416-041654,2017,review,,0,,,,,
mechanisms of hiv-1 control [review],Soliman M,10.1007/s11904-017-0357-9,2017,review,,0,,,,,
on the whereabouts of hiv-1 cellular entry and its fusion ports [review],Jakobsdottir GM,10.1016/j.molmed.2017.08.005,2017,review,,0,,,,,
phospholipases: at the crossroads of the immune system and the pathogenesis of hiv-1 infection [review],Cecchetti S,10.1189/jlb.3RU0316-148RR,2017,review,,0,,,,,
"sexual activity, sexual function, and sexual satisfaction among women living with hiv: a feminist scoping review of 20 years of global epidemiological research",Carter A,,2017,review,,0,,,,,
systems serology: profiling vaccine induced humoral immunity against hiv [review],Chung AW,10.1186/s12977-017-0380-3,2017,review,,0,,,,,
underutilisation of routinely collected data in the hiv programme in zambia: a review of quantitatively analysed peer-reviewed articles,Munthali T,10.1186/s12961-017-0221-9,2017,review,,0,,,,,
use of direct oral anticoagulants for treatment of atrial fibrillation in patients with hiv: a review,West,10.1097/COH.0000000000000412,2017,review,,0,,,,,
virus-host gene interactions define hiv-1 disease progression [review],Monaco DC,10.1007/82_2017_33,2017,review,,0,,,,,
a step forward understanding hiv-1 diversity [review],Smyth RP,10.1186/s12977-016-0259-8,2016,review,,0,,,,,
cardiorespiratory fitness levels and moderators in people with hiv: a systematic review and meta-analysis,Vancampfort D,10.1016/j.ypmed.2016.10.001,2016,review,,0,,,,,
effectiveness of aerobic exercise for adults living with hiv: systematic review and meta-analysis using the cochrane collaboration protocol,O'Brien KK,10.1186/s12879-016-1478-2,2016,review,,0,,,,,
enhancing hiv prevention among young men who have sex with men: a systematic review of hiv behavioral interventions for young gay and bisexual men (special issue: hiv prevention among diverse young msm),Hergenrather,10.1521/aeap.2016.28.3.252,2016,review,,0,,,,,
exosomes in human immunodeficiency virus type i pathogenesis: threat or opportunity? [review],Teow SY,10.1155/2016/9852494,2016,review,,0,,,,,
hiv-1 drug resistance and resistance testing [review],Clutter DS,10.1016/j.meegid.2016.08.031,2016,review,,0,,,,,
hiv-1 subtype b: traces of a pandemic [review],Junqueira DM,10.1016/j.virol.2016.05.003,2016,review,,0,,,,,
hiv-host interactions: implications for vaccine design [review],Haynes BF,10.1016/j.chom.2016.02.002,2016,review,,0,,,,,
improving engagement in the hiv care cascade: a systematic review of interventions involving people living with hiv/aids as peers,Genberg BL,10.1007/s10461-016-1307-z,2016,review,,0,,,,,
"interventions to prevent sexually transmitted infections, including hiv, among young people in low- and middle-income countries: a systematic review of the published and gray literature (special issue: what works? systematic assessments of sexual and reproductive interventions for young people in low- and middle-income countries)",Kalamar,10.1016/j.jadohealth.2016.05.020,2016,review,,0,,,,,
lessons from acute hiv infection [review],Robb ML,,2016,review,,0,,,,,
molecular epidemiology of hiv-1 infection in europe: an overview [review],Beloukas A,10.1016/j.meegid.2016.06.033,2016,review,,0,,,,,
release of soluble ligands for the activating nkg2d receptor: one more immune evasion strategy evolved by hiv-1 ? [review],Giuliani E,,2016,review,,0,,,,,
the early bird catches the worm--can evolution teach us lessons in fighting hiv? [review],Schaller T,,2016,review,,0,,,,,
the role genes encoding of killer cell immunoglobulin-like receptors (kirs) and their ligands in susceptibility to and progression of hiv infection [review],Blachowicz O,10.5604/17322693.1227771,2016,review,,0,,,,,
[identification and characterization of hiv-1 transmitted /founder viruses] [review] [chinese],Zhao JY,10.16288/j.yczz.14-452,2015,review,,0,,,,,
cd4+ t cell counts in initiation of antiretroviral therapy in hiv infected asymptomatic individuals; controversies and inconsistencies [review],Maina EK,10.1016/j.imlet.2015.10.005,2015,review,,0,,,,,
cell walls and the convergent evolution of the viral envelope [review],Buchmann JP,10.1128/MMBR.00017-15,2015,review,,0,,,,,
effectiveness of aerobic exercise for adults living with hiv: a cochrane collaboration systematic review update,O'Brien KK,,2015,review,,0,,,,,
hiv and sti testing in older adults: an integrative review [review],Tillman JL,10.1111/jocn.12797,2015,review,,0,,,,,
hiv-1 gp120 as a therapeutic target: navigating a moving labyrinth [review],Acharya P,10.1517/14728222.2015.1010513,2015,review,,0,,,,,
"hiv-1 group o origin, evolution, pathogenesis, and treatment: unraveling the complexity of an outlier 25 years later [review]",Bush S,,2015,review,,0,,,,,
hiv-1 nef: a master manipulator of the membrane trafficking machinery mediating immune evasion [review],Pawlak EN,10.1016/j.bbagen.2015.01.003,2015,review,,0,,,,,
"hiv-1 rnas: sense and antisense, large mrnas and small sirnas and mirnas [review]",Harwig A,10.1097/COH.0000000000000135,2015,review,,0,,,,,
integrating antiretroviral strategies for human immunodeficiency virus prevention: post- and pre-exposure prophylaxis and early treatment [review],Grant RM,10.1093/ofid/ofv126,2015,review,,0,,,,,
potential predictors for serofast state after treatment among hiv-negative persons with syphilis in china: a systematic review and meta-analysis,Qin JiaBi,,2015,review,,0,,,,,
review: influence of art on hiv genetics,Simonetti,10.1097/COH.0000000000000120,2015,review,,0,,,,,
role of hla adaptation in hiv evolution [review],Kloverpris HN,10.3389/fimmu.2015.00665,2015,review,,0,,,,,
social media and hiv: a systematic review of uses of social media in hiv communication,Taggart T,10.2196/jmir.4387,2015,review,,0,,,,,
the evolution of hiv-1 interactions with coreceptors and mannose c-type lectin receptors [review],Borggren M,10.1016/bs.pmbts.2014.10.004,2015,review,,0,,,,,
the hiv-1 entry process: a stoichiometric view [review],Brandenberg OF,10.1016/j.tim.2015.09.003,2015,review,,0,,,,,
work environments and hiv prevention: a qualitative review and meta-synthesis of sex worker narratives,Goldenberg,,2015,review,,0,,,,,
a fitness bottleneck in hiv-1 transmission,Joseph SB,10.1126/science.1257425,2014,review,,0,,,,,
"a systematic review of income generation interventions, including microfinance and vocational skills training, for hiv prevention",Kennedy CE,10.1080/09540121.2013.845287,2014,review,,0,,,,,
"a systematic review of stigma-reducing interventions for diasporic black, african and caribbean women living with hiv in canada",Aden M,,2014,review,,0,,,,,
antibody b cell responses in hiv-1 infection [review],Mouquet H,10.1016/j.it.2014.08.007,2014,review,,0,,,,,
antiretroviral therapy for initial human immunodeficiency virus/aids treatment: critical appraisal of the evidence from over 100 randomized trials and 400 systematic reviews and meta-analyses [review],Kanters S,10.1111/1469-0691.12475,2014,review,,0,,,,,
cardiovascular disease in patients with chronic human immunodeficiency virus infection [review],Escarcega RO,10.1016/j.ijcard.2014.04.155,2014,review,,0,,,,,
challenges in the design of a t cell vaccine in the context of hiv-1 diversity [review],Tongo M,10.3390/v6103968,2014,review,,0,,,,,
deep sequencing of hiv: clinical and research applications [review],Chabria SB,10.1146/annurev-genom-091212-153406,2014,review,,0,,,,,
development of broadly neutralizing antibodies from autologous neutralizing antibody responses in hiv infection [review],Derdeyn CA,10.1097/COH.0000000000000057,2014,review,,0,,,,,
drug resistance in non-b subtype hiv-1: impact of hiv-1 reverse transcriptase inhibitors [review],Singh K,10.3390/v6093535,2014,review,,0,,,,,
drug resistance in the hiv-1-infected paediatric population worldwide: a systematic review,Sanchez PR,10.1093/jac/dku104,2014,review,,0,,,,,
drug resistance in the hiv-1-infected paediatric population worldwide: a systematic review [review],Rojas Sanchez P,10.1093/jac/dku104,2014,review,,0,,,,,
hiv pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research,Escudero DJ,10.7448/IAS.17.1.18899,2014,review,,0,,,,,
hiv/aids health care challenges for cross-country migrants in low- and middle-income countries: a scoping review,Suphanchaimat R,10.2147/HIV.S56277,2014,review,,0,,,,,
innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following hiv infection [review],Nguyen PV,10.1038/cmi.2014.41,2014,review,,0,,,,,
intimate partner violence and hiv infection among women: a systematic review and meta-analysis,Li Y,10.7448/IAS.17.1.18845,2014,review,,0,,,,,
molecular tools for studying hiv transmission in sexual networks [review],Grabowski MK,10.1097/COH.0000000000000040,2014,review,,0,,,,,
novel hiv-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011-2014),Li X,10.1517/13543776.2014.964685,2014,review,,0,,,,,
role of biomedical and behavioral interventions and their evidence in prevention of hiv infection: a literature review,Chattu,10.4103/2230-8598.144057,2014,review,,0,,,,,
structural and community-level interventions for increasing condom use to prevent the transmission of hiv and other sexually transmitted infections [review],Moreno R,10.1002/14651858.CD003363.pub3,2014,review,,0,,,,,
the influence of delivery vectors on hiv vaccine efficacy [review],Ondondo BO,10.3389/fmicb.2014.00439,2014,review,,0,,,,,
the role of fc receptors in hiv infection and vaccine efficacy [review],Cocklin SL,10.1097/COH.0000000000000051,2014,review,,0,,,,,
what is health communication and how does it affect the hiv/aids continuum of care? a brief primer and case study from new york city [review],Storey D,10.1097/QAI.0000000000000243,2014,review,,0,,,,,
[elite controllers and the mechanisms behind spontaneous control of hiv] [review] [hebrew],Shasha D,,2013,review,,0,,,,,
a review of referrals and interventions within a specialist hiv outpatient physiotherapy service,Brown D,10.1111/hiv.12027,2013,review,,0,,,,,
current status of hiv-1 diversity and drug resistance monitoring in the former ussr [review],Bobkova M,,2013,review,,0,,,,,
current trends of hiv recombination worldwide [review],Lau KA,10.4081/idr.2013.s1.e4,2013,review,,0,,,,,
electrospun fibers for vaginal anti-hiv drug delivery [review],Blakney AK,10.1016/j.antiviral.2013.09.022,2013,review,,0,,,,,
genetic diversity of human immunodeficiency virus type 1 in democratic republic of congo: a review of available data,Kamangu EN,10.1136/sextrans-2013-051184.0720,2013,review,,0,,,,,
genetic diversity of human immunodeficiency virus type 1 in the democratic republic of congo: a review of available data,Erick,,2013,review,,0,,,,,
hiv-1 associated topoisomerase iibeta kinase: a potential pharmacological target for viral replication [review],Ponraj K,,2013,review,,0,,,,,
mobile phone applications for the care and prevention of hiv and other sexually transmitted diseases: a review,Muessig KE,10.2196/jmir.2301,2013,review,,0,,,,,
mobile phone applications for the care and prevention of hiv and other sexually transmitted diseases: a review [review],Muessig KE,10.2196/jmir.2301,2013,review,,0,,,,,
"paleovirology of 'syncytins', retroviral env genes exapted for a role in placentation [review]",Lavialle C,10.1098/rstb.2012.0507,2013,review,,0,,,,,
pathogenesis of hiv infection [review],Naif HM,10.4081/idr.2013.s1.e6,2013,review,,0,,,,,
role of glycosphingolipids in dendritic cell-mediated hiv-1 trans-infection [review],Puryear WB,10.1007/978-1-4614-4433-6_5,2013,review,,0,,,,,
supervised and unsupervised self-testing for hiv in high- and low-risk populations: a systematic review,Pant Pai N,10.1371/journal.pmed.1001414,2013,review,,0,,,,,
"systematic review examining differences in hiv, sexually transmitted infections and health-related harms between migrant and non-migrant female sex workers",Platt L,10.1136/sextrans-2012-050491,2013,review,,0,,,,,
the increasing prevalence of hiv-1 subtype c in southern brazil and its dispersion through the continent (special issue: 2013 reviews issue),Graf,10.1016/j.virol.2012.08.048,2013,review,,0,,,,,
the role of neutralizing antibodies in prevention of hiv-1 infection: what can we learn from the mother-to-child transmission context? [review],Braibant M,10.1186/1742-4690-10-103,2013,review,,0,,,,,
use of digital media technology for primary prevention of stis/hiv in adolescents and young adults: a systematic review of the literature,Chavez NR,10.1016/j.jadohealth.2012.10.199,2013,review,,0,,,,,
are subtype differences important in hiv drug resistance? [review],Lessells RJ,10.1016/j.coviro.2012.08.006,2012,review,,0,,,,,
cocaine and hiv-1 interplay in cns: cellular and molecular mechanisms [review],Buch S,,2012,review,,0,,,,,
community strategies that improve care and retention along the prevention of mother-to-child transmission of hiv cascade: a review,Marcos Y,,2012,review,,0,,,,,
from promoting to inhibiting: diverse roles of helicases in hiv-1 replication [review],Lorgeoux RP,10.1186/1742-4690-9-79,2012,review,,0,,,,,
hiv compartmentalization: a review on a clinically important phenomenon,Blackard,10.2174/157016212799937245,2012,review,,0,,,,,
"hiv types, groups, subtypes and recombinant forms: errors in replication, selection pressure and quasispecies [review]",Eberle J,10.1159/000331993,2012,review,,0,,,,,
hiv-related stigma within communities of gay men: a literature review,Smit PJ,10.1080/09540121.2011.613910,2012,review,,0,,,,,
host genes important to hiv replication and evolution [review],Telenti A,10.1101/cshperspect.a007203,2012,review,,0,,,,,
labor migration and hiv risk: a systematic review of the literature,Weine SM,10.1007/s10461-012-0183-4,2012,review,,0,,,,,
mechanism of hiv antiretroviral drugs progress toward drug resistance [review],Ammaranond P,10.1111/j.1472-8206.2011.01009.x,2012,review,,0,,,,,
microbicides: topical prevention against hiv [review],Shattock RJ,10.1101/cshperspect.a007385,2012,review,,0,,,,,
neutralizing antibodies and control of hiv: moves and countermoves [review],Hessell AJ,10.1007/s11904-011-0105-5,2012,review,,0,,,,,
on hiv diversity [review],Ndung'u T,10.1097/QAD.0b013e32835461b5,2012,review,,0,,,,,
opioids in the management of hiv-related pain [review],Krashin DL,,2012,review,,0,,,,,
osteoporosis and vitamin d deficiency in hiv-infected patients: genetic and classical factors compared to the hiv-associated ones - review,Bander D,10.1016/j.hivar.2011.11.001,2012,review,,0,,,,,
pharmacy nonprescription syringe distribution and hiv/aids: a review,Janulis P,10.1331/JAPhA.2012.11136,2012,review,,0,,,,,
physical activity: do patients infected with hiv practice? how much? a systematic review,Schuelter-Trevisol F,10.2174/157016212802429794,2012,review,,0,,,,,
review: a critical evaluation of arguments opposing male circumcision for hiv prevention in developed countries,Morris BJ,10.1080/09540121.2012.661836,2012,review,,0,,,,,
t cell virological synapses and hiv-1 pathogenesis [review],Chen BK,10.1007/s12026-012-8320-8,2012,review,,0,,,,,
the antibody response against hiv-1 [review],Overbaugh J,10.1101/cshperspect.a007039,2012,review,,0,,,,,
the hiv epidemic: high-income countries [review],Vermund SH,10.1101/cshperspect.a007195,2012,review,,0,,,,,
the molecular basis of hiv entry [review],Klasse PJ,10.1111/j.1462-5822.2012.01812.x,2012,review,,0,,,,,
the role of vif oligomerization and rna chaperone activity in hiv-1 replication [review],Batisse J,10.1016/j.virusres.2012.06.018,2012,review,,0,,,,,
update on hiv-1 diversity in africa: a decade in review [review],Lihana RW,,2012,review,,0,,,,,
aerobic exercise interventions for adults living with hiv/aids: an update of a cochrane collaboration systematic review,O'Brien KK,,2011,review,,0,,,,,
beyond plasma membrane targeting: role of the ma domain of gag in retroviral genome encapsidation [review],Parent LJ,10.1016/j.jmb.2011.04.072,2011,review,,0,,,,,
beyond the abc in hiv/aids prevention: a systematic literature review of sexual education programs for young people,Estrada-Montoya JH,10.1136/sextrans-2011-050108.279,2011,review,,0,,,,,
cellular kinases incorporated into hiv-1 particles: passive or active passengers? [review],Giroud C,10.1186/1742-4690-8-71,2011,review,,0,,,,,
diverse interactions of retroviral gag proteins with rnas [review],Rein A,10.1016/j.tibs.2011.04.001,2011,review,,0,,,,,
epidemiology of hiv infection in the united states: implications for linkage to care [review],Moore RD,10.1093/cid/ciq044,2011,review,,0,,,,,
facilitating hiv disclosure across diverse settings: a review,Obermeyer CM,10.2105/AJPH.2010.300102,2011,review,,0,,,,,
hiv and depression--a systematic review of interventions,Sherr L,,2011,review,,0,,,,,
hiv care for geographically mobile populations [review],Taylor BS,10.1002/msj.20255,2011,review,,0,,,,,
hiv envelope: challenges and opportunities for development of entry inhibitors [review],Caffrey M,10.1016/j.tim.2011.02.001,2011,review,,0,,,,,
hiv infection and sti in the trans population: a critical review,Giami A,10.1016/j.respe.2011.02.102,2011,review,,0,,,,,
"hiv-1 envelope, integrins and co-receptor use in mucosal transmission of hiv [review]",Cicala C,10.1186/1479-5876-9-S1-S2,2011,review,,0,,,,,
hiv-1 molecular epidemiology evidence and transmission patterns in the middle east and north africa [review],Mumtaz G,10.1136/sti.2010.043711,2011,review,,0,,,,,
hiv-1 viral diversity and its implications for viral load testing: review of current platforms [review],Luft LM,10.1016/j.ijid.2011.05.013,2011,review,,0,,,,,
hiv/sti prevention interventions targeting fsws in china: a systematic literature review,Hong Y,10.1080/09540121.2011.554526,2011,review,,0,,,,,
linkage to care for hiv-infected heterosexual men in the united states [review],Zaller ND,10.1093/cid/ciq046,2011,review,,0,,,,,
optimized methods for imaging membrane nanotubes between t cells and trafficking of hiv-1 [review],Sowinski S,10.1016/j.ymeth.2010.04.002,2011,review,,0,,,,,
promoting african american women and sexual assertiveness in reducing hiv/aids: an analytical review of the research literature [review],Kennedy BR,,2011,review,,0,,,,,
review of hiv and other sexually transmitted infections among female sex workers in china,Poon AN,10.1080/09540121.2011.554519,2011,review,,0,,,,,
review of hiv and other sexually transmitted infections among female sex workers in china (special issue: women and hiv in china),Poon,10.1080/09540121.2011.554519,2011,review,,0,,,,,
reviewing the history of hiv-1: spread of subtype b in the americas,Junqueira DM,10.1371/journal.pone.0027489,2011,review,,0,,,,,
"substance abuse, violence, and hiv in women: a literature review of the syndemic",Meyer JP,10.1089/jwh.2010.2328,2011,review,,0,,,,,
the role of hiv replicative fitness in perinatal transmission of hiv [review],Chen XQ,10.1007/s12250-011-3180-2,2011,review,,0,,,,,
the status of the hiv epidemic in lebanondsystematic review and synthesis,Mumtaz G,10.1136/sextrans-2011-050108.15,2011,review,,0,,,,,
tits and bits of hiv tat protein [review],Johri MK,10.1517/14712598.2011.546339,2011,review,,0,,,,,
transgenders and hiv: a literature review of hiv risk behaviours and prevalence rates,Butt S,10.1136/sextrans-2011-050108.351,2011,review,,0,,,,,
what do we know about older adults and hiv? a review of social and behavioral literature,Sankar A,10.1080/09540121.2011.564115,2011,review,,0,,,,,
alternative splicing: regulation of hiv-1 multiplication as a target for therapeutic action [review] [50 refs],Tazi J,10.1111/j.1742-4658.2009.07522.x,2010,review,,0,,,,,
behavioural interventions for hiv positive prevention in developing countries: a systematic review and meta-analysis,Kennedy,10.2471/BLT.09.068213,2010,review,,0,,,,,
modulation of hiv-1 virulence via the host glucocorticoid receptor: towards further understanding the molecular mechanisms of hiv-1 pathogenesis [review] [126 refs],Hapgood JP,10.1007/s00705-010-0678-0,2010,review,,0,,,,,
"non-nucleoside reverse transcriptase inhibitors (nnrtis), their discovery, development, and use in the treatment of hiv-1 infection: a review of the last 20 years (1989-2009)",de Bethune M-P,10.1016/j.antiviral.2009.09.008,2010,review,,0,,,,,
the expanding epidemics of hiv type 1 among men who have sex with men in low-and middle-income countries: diversity and consistency,Beyrer C,10.1093/epirev/mxq011,2010,review,,0,,,,,
the multiple facets of hiv attachment to dendritic cell lectins [review],Tsegaye TS,10.1111/j.1462-5822.2010.01519.x,2010,review,,0,,,,,
toward an antibody-based hiv-1 vaccine [review] [110 refs],Hoxie JA,10.1146/annurev.med.60.042507.164323,2010,review,,0,,,,,
viral evolution and escape during acute hiv-1 infection [review] [50 refs],Boutwell CL,10.1086/655653,2010,review,,0,,,,,
[hiv genetic diversity and its consequences] [review] [47 refs] [french],Roquebert B,10.1016/j.patbio.2008.04.004,2009,review,,0,,,,,
an african perspective on mucosal immunity and hiv-1 [review] [194 refs],Pala P,10.1038/mi.2009.23,2009,review,,0,,,,,
can data from hiv voluntary counselling and testing be used to assess the impact of public health interventions? a literature review,Guy RJ,10.1258/ijsa.2009.009005,2009,review,,0,,,,,
genetic determinants of hiv-1 infection and progression to aids: immune response genes [review] [50 refs],Kaur G,10.1111/j.1399-0039.2009.01337.x,2009,review,,0,,,,,
global hiv-1 molecular epidemiology with special reference to genetic analysis of hiv-1 subtypes circulating in north india: functional and pathogenic implications of genetic variation [review] [37 refs],Neogi U,,2009,review,,0,,,,,
hiv molecular epidemiology: transmission and adaptation to human populations [review] [44 refs],Woodman Z,10.1097/COH.0b013e32832c0672,2009,review,,0,,,,,
hiv-1 resistance to first- and second-generation non-nucleoside reverse transcriptase inhibitors [review] [54 refs],Ghosn J,,2009,review,,0,,,,,
modeling sequence evolution in acute hiv-1 infection [review],Lee HY,10.1016/j.jtbi.2009.07.038,2009,review,,0,,,,,
molecular pathology of neuro-aids (cns-hiv) [review],Crews L,10.3390/ijms10031045,2009,review,,0,,,,,
the capsid protein of human immunodeficiency virus: intersubunit interactions during virus assembly [review] [61 refs],Mateu MG,10.1111/j.1742-4658.2009.07313.x,2009,review,,0,,,,,
the mental health of people living with hiv/aids in africa: a systematic review,Brandt R,10.2989/AJAR.2009.8.2.1.853,2009,review,,0,,,,,
the remarkable frequency of human immunodeficiency virus type 1 genetic recombination [review] [368 refs],Onafuwa-Nuga A,10.1128/MMBR.00012-09,2009,review,,0,,,,,
critical issues in mucosal immunity for hiv-1 vaccine development [review] [85 refs],Haynes BF,10.1016/j.jaci.2008.03.036,2008,review,,0,,,,,
hiv-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo [review] [190 refs],Martinez-Picado J,10.1016/j.virusres.2007.12.021,2008,review,,0,,,,,
hiv-1 vaccine development: tackling virus diversity with a multi-envelope cocktail [review] [85 refs],Hurwitz JL,,2008,review,,0,,,,,
implications of recombination for hiv diversity [review] [70 refs],Ramirez BC,10.1016/j.virusres.2008.01.007,2008,review,,0,,,,,
strand transfer events during hiv-1 reverse transcription [review] [168 refs],Basu VP,10.1016/j.virusres.2007.12.017,2008,review,,0,,,,,
a review of std/hiv preventive interventions for adolescents: sustaining effects using an ecological approach,DiClemente RJ,10.1093/jpepsy/jsm056,2007,review,,0,,,,,
centralized hiv-1 envelope immunogens and neutralizing antibodies [review] [57 refs],Gao F,,2007,review,,0,,,,,
clade specific neutralising vaccines for hiv: an appropriate target? [review] [92 refs],McKnight A,,2007,review,,0,,,,,
hiv epidemiology update and transmission factors: risks and risk contexts--16th international aids conference epidemiology plenary [review] [60 refs],Beyrer C,,2007,review,,0,,,,,
impact of human immunodeficiency virus (hiv) subtypes on hiv-associated neurological disease [review] [141 refs],Liner KJ 2nd,,2007,review,,0,,,,,
predictors of disease progression in hiv infection: a review,Langford SE,,2007,review,,0,,,,,
prevalence and determinants of transmitted antiretroviral drug resistance in hiv-1 infection [review] [109 refs],Booth CL,,2007,review,,0,,,,,
the impact of viral and host elements on hiv fitness and disease progression [review] [73 refs],Henry KR,,2007,review,,0,,,,,
[finding the traces of the hiv selection] [review] [60 refs] [spanish],Espinosa E,,2006,review,,0,,,,,
[hiv-1 diversity: a tool for studying the pandemic] [review] [85 refs] [portuguese],Pinto ME,,2006,review,,0,,,,,
a decade in review: building on the experiences of past adolescent sti/hiv interventions to optimise future prevention efforts,Sales JM,10.1136/sti.2005.018002,2006,review,,0,,,,,
clinical implications of hiv drug resistance to nucleoside and nucleotide reverse transcriptase inhibitors [review] [61 refs],Geretti AM,,2006,review,,0,,,,,
evolutionary dynamics of hiv-1 and the control of aids [review] [122 refs],Mullins JI,,2006,review,,0,,,,,
fitness constraints on immune escape from hiv: implications of envelope as a target for both hiv-specific t cells and antibody [review] [83 refs],Peut V,,2006,review,,0,,,,,
hiv evolutionary dynamics within and among hosts [review] [129 refs],Lemey P,,2006,review,,0,,,,,
hiv transmission and primary drug resistance [review] [47 refs],Turner D,,2006,review,,0,,,,,
impact of hiv-1 pol diversity on drug resistance and its clinical implications [review] [112 refs],Kantor R,,2006,review,,0,,,,,
novel drug resistance mutations in hiv: recognition and clinical relevance [review] [83 refs],Perno CF,,2006,review,,0,,,,,
[vaccine for human immunodeficiency virus (hiv)--relevance of these days] [review] [17 refs] [lithuanian],Laiskonis A,,2005,review,,0,,,,,
application of the polyvalent approach to hiv-1 vaccine development [review] [143 refs],Hurwitz JL,,2005,review,,0,,,,,
"enfuvirtide, the first fusion inhibitor to treat hiv infection [review] [71 refs]",Poveda E,,2005,review,,0,,,,,
hiv vaccines: brief review and discussion of future directions,Slobod KS,10.1586/14760584.4.3.305,2005,review,,0,,,,,
hiv-1 envelope evolution and vaccine efficacy [review] [123 refs],Mosier DE,,2005,review,,0,,,,,
human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant? [review] [262 refs],van Marle G,,2005,review,,0,,,,,
molecular epidemiology of hiv [review] [81 refs],Kandathil AJ,,2005,review,,0,,,,,
reversion of immune escape hiv variants upon transmission: insights into effective viral immunity [review] [24 refs],Kent SJ,,2005,review,,0,,,,,
clinical development of microbicides for the prevention of hiv infection [review] [200 refs],D'Cruz OJ,,2004,review,,0,,,,,
foundations for a phase iii human immunodeficiency virus vaccine trial: a decade of thai-us army collaborative research [review] [70 refs],Brown AE,,2004,review,,0,,,,,
molecular epidemiology of hiv: tracking aids pandemic [review] [60 refs],TakebE Y,,2004,review,,0,,,,,
rationale for maintenance of the m184v resistance mutation in human immunodeficiency virus type 1 reverse transcriptase in treatment experienced patients [review] [48 refs],Turner D,,2004,review,,0,,,,,
the causes and consequences of hiv evolution,Rambaut,10.1038/nrg1246,2004,review,,0,,,,,
vaccines and vaccine strategies against hiv [review] [114 refs],Stratov I,,2004,review,,0,,,,,
evolution and diversity of hiv-1 in africa - a review,Papathanasopoulos,10.1023/A:1023435429841,2003,review,,0,,,,,
progress in the development of an hiv vaccine [review] [45 refs],Tramont EC,,2003,review,,0,,,,,
regulation of hiv-1 gene transcription: from lymphocytes to microglial cells [review] [200 refs],Rohr O,,2003,review,,0,,,,,
travel and the spread of hiv-1 genetic variants [review] [78 refs],Perrin L,,2003,review,,0,,,,,
a protocol for the analytical aspects of a systematic review of hiv prevention research,Johnson WD,10.1097/00042560-200207011-00007,2002,review,,0,,,,,
cd8+ t-cell immunity to hiv infection [review] [162 refs],Piazza P,,2002,review,,0,,,,,
chemokines as natural hiv antagonists [review] [127 refs],Verani A,,2002,review,,0,,,,,
hiv and drug misuse in the edinburgh cohort [review] [48 refs],Bell JE,,2002,review,,0,,,,,
hiv-1 genotypic and phenotypic resistance [review] [60 refs],Hanna GJ,,2002,review,,0,,,,,
mathematical models of hiv pathogenesis and treatment [review] [42 refs],Wodarz D,,2002,review,,0,,,,,
bitter-sweet symphony: defining the role of dendritic cell gp120 receptors in hiv infection [review] [70 refs],Turville SG,,2001,review,,0,,,,,
design of antiretroviral clinical trials for hiv-1 infected pregnant women and their newborn infants [review] [27 refs],Rodman JH,,2001,review,,0,,,,,
harm reduction theories and strategies for control of human immunodeficiency virus: a review of the literature [review] [110 refs],Hilton BA,,2001,review,,0,,,,,
hiv risk in adolescents with severe mental illness: literature review,Smith MD,10.1016/S1054-139X%2801%2900265-8,2001,review,,0,,,,,
mutational patterns in the hiv genome and cross-resistance following nucleoside and nucleotide analogue drug exposure [review] [147 refs],Miller V,,2001,review,,0,,,,,
testing for hiv-1 drug resistance [review] [65 refs],Hanna GJ,,2001,review,,0,,,,,
recent studies on natural products as anti-hiv agents [review] [104 refs],Jung M,,2000,review,,0,,,,,
significance of hiv-1 genetic subtypes [review] [78 refs],Alaeus A,,2000,review,,0,,,,,
the effect of genetic variation in chemokines and their receptors on hiv transmission and progression to aids [review] [132 refs],O'Brien SJ,,2000,review,,0,,,,,
"the natural history, current status, and future trends of hiv infection [review] [40 refs]",Lears MK,,2000,review,,0,,,,,
transmission and prevalence of hiv resistance among treatment-naive subjects [review] [50 refs],Little SJ,,2000,review,,0,,,,,
[genetic diversity of hiv infection worldwide and its consequences] [review] [44 refs] [french],Peeters M,,1999,review,,0,,,,,
clinical progress and the future of hiv exceptionalism [review] [45 refs],Bayer R,,1999,review,,0,,,,,
genetic determinants of hiv-1 infection and its manifestations [review] [62 refs],Kaslow RA,,1999,review,,0,,,,,
human immunodeficiency virus-associated pericardial effusion: report of 40 cases and review of the literature,Chen Y,10.1016/S0002-8703(99)70500-4,1999,review,,0,,,,,
long-distance truck drivers' sexual cultures and attempts to reduce hiv risk behaviour amongst them: a review of the african and asian literature,Marck,,1999,review,,0,,,,,
studies of human immunodeficiency virus type 1 mucosal viral shedding and transmission in kenya,Overbaugh J,10.1086/314792,1999,review,,0,,,,,
whom does partner notification for hiv infection serve in san francisco? a review of counseling and testing data from 1995-1997,White E,10.1023/A:1025452426937,1999,review,,0,,,,,
association of non-acquired immunodeficiency syndrome-defining cancers with human immunodeficiency virus infection [review] [19 refs],Rabkin CS,,1998,review,,0,,,,,
hiv vaccine development: a subtype e-specific strategy [review] [30 refs],Brown AE,,1998,review,,0,,,,,
host and viral factors influencing heterosexual hiv transmission [review] [86 refs],Miller CJ,,1998,review,,0,,,,,
testing for hiv infection in time: scientific reasons [review] [88 refs],Koblet H,,1998,review,,0,,,,,
new mechanisms of viral persistence in primary human immunodeficiency virus (hiv) infection [review] [26 refs],Soudeyns H,,1997,review,,0,,,,,
libraries of human rhinovirus-based hiv vaccines generated using random systematic mutagenesis [review] [29 refs],Resnick DA,,1994,review,,0,,,,,
pathogenicity and diversity of hiv and implications for clinical management: a review,Saag MS,,1994,review,,0,,,,,
the association between lack of male circumcision and risk for hiv infection: a review of the epidemiological data,Moses S,,1994,review,,0,,,,,
the macrophage and hiv-1 [review] [187 refs],Ho WZ,,1994,review,,0,,,,,
the molecular epidemiology of hiv in asia [review] [156 refs],Weniger BG,,1994,review,,0,,,,,
hiv infection in children: a challenge to dental practice [review] [50 refs],Sote EO,,1993,review,,0,,,,,
perinatal transmission of human immunodeficiency virus-1 infection and maternal immunization strategies for prevention [review] [94 refs],Ukwu HN,,1992,review,,0,,,,,
pulmonary hypertension and human immunodeficiency virus infection; two reports and a review of the literature,Polos PG,10.1378/chest.101.2.474,1992,review,,0,,,,,
the host immune response may be responsible for selection of envelope and precore/core variants of hbv [review] [43 refs],Thomas HC,,1992,review,,0,,,,,
[ten years ahead in infectious diseases : aids/ hiv towards stopping transmission] [french],Struvay S,,2020,publication language,,0,,,,,
"analysis on characteristics of hiv-1 molecular networks in men who have sex with men in kunming, 2016-2018 [chinese]",Li SY,10.3760/cma.j.cn112338-20190916-00676,2020,publication language,,0,,,,,
"characteristics of hiv-1 genotype and drug resistance among men who have sex with men in kunming, 2018 [chinese]",Dai J,10.3760/cma.j.cn112338-20191107-00792,2020,publication language,,0,,,,,
"characteristics of subtypes and transmission of hiv-1 infected persons among student msm in zhejiang province, 2013-2015 [chinese]",Ding XB,10.3760/cma.j.cn112338-20190809-00586,2020,publication language,,0,,,,,
epidemiological characteristics and primary drug resistance of elderly hiv/aids population in longgang district of shenzhen [chinese],Zhou JianMing,10.13604/j.cnki.46-1064/r.2020.01.10,2020,publication language,,0,,,,,
"genetic characteristics and drug resistance of hiv strains isolated in taiyuan, shanxi, 2016-2017 [chinese]",Lin Mei,10.3784/j.issn.1003-9961.2020.02.013,2020,publication language,,0,,,,,
infections with human immunodeficiency virus among children in germany 1999-2016 [german],Marcus U,10.1007/s00112-020-00865-4,2020,publication language,,0,,,,,
"[epidemiological characteristics of molecular transmission cluster among reported hiv/aids cases in jiaxing city, zhejiang province, 2017] [chinese]",Luo MY,10.3760/cma.j.issn.0254-6450.2019.02.015,2019,publication language,,0,,,,,
[postmortem molecular epidemiology of hiv-1 strains isolated in turkey] [turkish],Ziyade N,10.5578/mb.68681,2019,publication language,,0,,,,,
analysis of the nearly full-length genome of a novel hiv-1 crf01_ae/b/c recombinant strain isolated in yunnan province [chinese],Liu J,10.3760/cma.j.issn.0254-5101.2019.08.007,2019,publication language,,0,,,,,
"central nervous system compartmentalization of hiv, an interesting model of viral evolution: from theory to clinical implications [french]",Stefic K,10.1684/vir.2019.0801,2019,publication language,,0,,,,,
"characteristics and dynamics of hiv-1 subtype distribution among injected drug users in guangzhou, 2008-2015 [chinese]",Yuteng Z,10.3760/cma.j.issn.0254-6450.2019.12.023,2019,publication language,,0,,,,,
correlation of results analysis drug resistance of human immunodeficiency virus among patients with virological failure by next-generation sequencing and traditional population sequencing [russian],Kirichenko AA,10.20953/1729-9225-2019-2-12-19,2019,publication language,,0,,,,,
"epidemiological characteristics of molecular transmission cluster among reported hiv/aids cases in jiaxing city, zhejiang province, 2017 [chinese]",Luo M,10.3760/cma.j.issn.0254-6450.2019.02.015,2019,publication language,,0,,,,,
hiv infection and social behavior characteristics of men who have sex with men in different places to find sexual partners of mianyang [chinese],Wang Yi,,2019,publication language,,0,,,,,
hiv-1 genotypes and drug resistance among intravenous drug users in nanning [chinese],Wang Liang,,2019,publication language,,0,,,,,
increase in frequency of repeat hiv testing among men who have sex with men in france between 2017 and 2019 results from the rapport au sexe survey [french],Duchesne,,2019,publication language,,0,,,,,
study on pol genetic characteristics and protein structure of hiv-1/aids before antiretroviral treatment patients in nanning [chinese],Pei JianXin,,2019,publication language,,0,,,,,
"subtypes and transmission characteristics of hiv-1 in men who have sex with men in lishui, zhejiang [chinese]",Ye Ling,,2019,publication language,,0,,,,,
"""we live on the tightrope"": the experience of health professionals working with hiv/aids in a remote area of northeast brazil [portuguese]",Tavares,,2018,publication language,,0,,,,,
"[characteristic and dynamic of hiv-1 subtype distribution in men who have sex with men in guangzhou, 2008-2015] [chinese]",Han ZG,10.3760/cma.j.issn.0254-6450.2018.01.014,2018,publication language,,0,,,,,
[mutation frequencies in hiv-1 genome in regions containing efficient rnai targets as calculated from ultra-deep sequencing data] [russian],Kretova OV,10.7868/S0026898418030084,2018,publication language,,0,,,,,
analysis of plasma viral envelope genes and neutralization characteristics of a chronically hiv-1 infected patient with broadly neutralization activity [chinese],Zhang Dai,,2018,publication language,,0,,,,,
analysis on birth weight of 228 neonates born by hiv-infected pregnant women [chinese],Li Zheng,,2018,publication language,,0,,,,,
"characteristic and dynamic of hiv-1 subtype distribution in men who have sex with men in guangzhou, 2008-2015 [chinese]",Han Z,10.3760/cma.j.issn.0254-6450.2018.01.014,2018,publication language,,0,,,,,
from evidence to action: challenges for the brazilian unified national health system in offering pre-exposure prophylaxis (prep) for hiv to persons with the greatest vulnerability [portuguese],Zucchi,,2018,publication language,,0,,,,,
"hiv gene subtypes of newly reported hiv/aids cases in dehong dai and jingpo autonomous prefecture of yunnan province, 2016 [chinese]",Duan X,10.3760/cma.j.issn.0254-6450.2018.05.027,2018,publication language,,0,,,,,
hiv-1 genotyping analysis among newly diagnosed men who have sex with men in harbin city of china [chinese],Zhang Lin,,2018,publication language,,0,,,,,
mutation frequencies in hiv-1 genome in regions containing efficient rnai targets as calculated from ultra-deep sequencing data [russian],Kretova OV,10.7868/S0026898418030084,2018,publication language,,0,,,,,
mutation frequencies in rnai targets in hiv-1 genomes obtained from blood plasma of patients receiving anti-retroviral therapy [russian],Kretova OV,10.1134/S0026898418040110,2018,publication language,,0,,,,,
[comparison of different methods in dealing with hiv viral load data with diversified missing value mechanism on hiv positive msm] [chinese],Jiang Z,10.3760/cma.j.issn.0254-6450.2017.11.025,2017,publication language,,0,,,,,
"[distribution of hiv-1 subtypes among foreign patients, in guangzhou, between 2008 and 2010, and in 2015] [chinese]",Han ZG,10.3760/cma.j.issn.0254-6450.2017.06.023,2017,publication language,,0,,,,,
"[hiv-1 drug resistance transmission threshold survey in dehong prefecture of yunnan province, 2015] [chinese]",Chen M,10.3760/cma.j.issn.0254-6450.2017.07.022,2017,publication language,,0,,,,,
[molecular epidemiological analysis of hiv-1 variants circulating in russia in 1987-2015] [russian],Lapovok IA,10.17116/terarkh2017891144-49,2017,publication language,,0,,,,,
"[molecular epidemiology and transmission of hiv-1 infection in zhejiang province, 2015] [chinese]",Yang JZ,10.3760/cma.j.issn.0254-6450.2017.11.023,2017,publication language,,0,,,,,
"[study on hiv-1 subtype among elderly male clients and female sex workers of low-cost venues in guangxi zhuang autonomous region, china] [chinese]",Deng YQ,10.3760/cma.j.issn.0254-6450.2017.03.010,2017,publication language,,0,,,,,
"analysis on hiv-1 subtypes and transmission clusters in newly reported hiv/aids cases in yiwu, zhejiang province, 2016 [chinese]",Zhang J,10.3760/cma.j.issn.0254-6450.2017.12.021,2017,publication language,,0,,,,,
comparison of different methods in dealing with hiv viral load data with diversified missing value mechanism on hiv positive msm [chinese],Jiang Z,10.3760/cma.j.issn.0254-6450.2017.11.025,2017,publication language,,0,,,,,
"distribution of hiv-1 subtypes among foreign patients, in guangzhou, between 2008 and 2010, and in 2015 [chinese]",Han Z,10.3760/cma.j.issn.0254-6450.2017.06.023,2017,publication language,,0,,,,,
"hiv-1 drug resistance transmission threshold survey in dehong prefecture of yunnan province, 2015 [chinese]",Chen M,10.3760/cma.j.issn.0254-6450.2017.07.022,2017,publication language,,0,,,,,
investigation on drug resistance threshold of newly found hiv infected persons in shaanxi [chinese],Ren Qiang,,2017,publication language,,0,,,,,
"molecular epidemiology and transmission of hiv-1 infection in zhejiang province, 2015 [chinese]",Yang J,10.3760/cma.j.issn.0254-6450.2017.11.023,2017,publication language,,0,,,,,
molecular mechanisms of hiv-1 genetic diversity [russian],Sosin DV,10.7868/S0026898417030156,2017,publication language,,0,,,,,
neutralization phenotype of the env-pseudoviruses from an hiv-1 infected individual with broadly neutralizing activity [chinese],Zou Sen,,2017,publication language,,0,,,,,
"sti co-infections at hiv diagnosis, france, 2012-2016 (journee mondiale du sida, 1er decembre 2017) [french]",Lot,,2017,publication language,,0,,,,,
"study on hiv-1 subtype among elderly male clients and female sex workers of low-cost venues in guangxi zhuang autonomous region, china [chinese]",Deng Y,10.3760/cma.j.issn.0254-6450.2017.03.010,2017,publication language,,0,,,,,
"[correlativity of subtype b viral transmission among elderly hiv-1 infected individuals in yongding district, zhangjiajie city, hunan province] [chinese]",Wu YQ,10.3760/cma.j.issn.0254-6450.2016.12.016,2016,publication language,,0,,,,,
"[distribution of subtypes of pol gene in hiv-1 epidemic strains in guangxi zhuang autonomous region, 2010- 2012] [chinese]",Wang H,10.3760/cma.j.issn.0253-9624.2016.01.014,2016,publication language,,0,,,,,
"[molecular epidemiology and transmission of hiv in tianjin, 2015] [chinese]",Zheng MN,10.3760/cma.j.issn.0254-6450.2016.08.018,2016,publication language,,0,,,,,
"analysis of factors about late diagnosis of hiv/aids cases in qinnan district, qinzhou, 2011-2015 [chinese]",Shen Ping,,2016,publication language,,0,,,,,
"characteristics of very recent hiv infections and transmission networks based on data from the mandatory notification system, france 2012-2014 (journee mondiale du sida, 1er decembre 2016) [french]",Capsec,,2016,publication language,,0,,,,,
comparative analysis of the perceptions of hiv/aids by gay and bisexual colombian men with and without migratory experience [spanish],Restrepo-Pineda,10.15446/rsap.v18n1.41974,2016,publication language,,0,,,,,
concurrent training on immunity and physical fitness in hiv/aids patients [portuguese],Lazzarotto,10.1590/1517-869220162202152915,2016,publication language,,0,,,,,
constraints on molecular evolution of hiv-1 drug resistance related genes from protein structure [chinese],Guan Q,10.3760/cma.j.issn.0254-5101.2016.06.001,2016,publication language,,0,,,,,
"correlativity of subtype b viral transmission among elderly hiv-1 infected individuals in yongding district, zhangjiajie city, hunan province [chinese]",Wu Y,10.3760/cma.j.issn.0254-6450.2016.12.016,2016,publication language,,0,,,,,
"distribution of subtypes of pol gene in hiv-1 epidemic strains in guangxi zhuang autonomous region, 2010- 2012 [chinese]",Wang H,10.3760/cma.j.issn.0253-9624.2016.01.014,2016,publication language,,0,,,,,
drug resistance threshold survey of hiv-1 in sichuan in 2014 [chinese],Su Ling,,2016,publication language,,0,,,,,
"molecular epidemiology and transmission of hiv in tianjin, 2015 [chinese]",Zheng M,10.3760/cma.j.issn.0254-6450.2016.08.018,2016,publication language,,0,,,,,
molecular transmission networks of human immunodeficiency virus-1 crf01_ae strains in china [chinese],Li X,10.3760/cma.j.issn.0254-5101.2016.05.001,2016,publication language,,0,,,,,
near full-length genomic sequence analysis of an hiv-1 01_ae/07_bc unique recombinant form virus [chinese],Huang XuHe,,2016,publication language,,0,,,,,
somatotype and body image in people living with hiv/aids [portuguese],Medeiros,10.1590/1517-869220162201137961,2016,publication language,,0,,,,,
variability of nef sequences from newly diagnosed hiv-1 crf01_ae infections in harbin city of china [chinese],Cao LiJun,,2016,publication language,,0,,,,,
[analysis on gene sequence of hiv isolated from men who have sex with men in beijing] [chinese],Gui T,,2015,publication language,,0,,,,,
analysis on gene sequence of hiv isolated from men who have sex with men in beijing [chinese],Tao G,10.3760/cma.j.issn.0254-6450.2015.09.017,2015,publication language,,0,,,,,
analysis on hiv-1 genetics and threshold of drug resistance in dehong prefecture of yunnan province in 2013 [chinese],Ma Y,,2015,publication language,,0,,,,,
"characteristics of hiv transmission through heterosexual contact in china, 2008-2014 [chinese]",Liyan W,10.3760/cma.j.issn.0254-6450.2015.12.002,2015,publication language,,0,,,,,
"community testing with hiv rapid diagnosis tests (rdt) in france over a period of three years, 2012-2014 [french]",Sarr,,2015,publication language,,0,,,,,
"hiv-1 subtype diversity and transmission clusters among men having sex with men who recently got hiv-l infection,in zhejiang province [chinese]",Zhang J,10.3760/cma.j.issn.0254-6450.2015.01.015,2015,publication language,,0,,,,,
identification and characterization of hiv-1 transmitted /founder viruses [chinese],Jianyuan Z,10.16288/j.yczz.14-452,2015,publication language,,0,,,,,
study of mycoplasma pirum infection and related factors among male hiv/aids patients [chinese],Chen L,10.3760/cma.j.issn.0254-6450.2015.08.012,2015,publication language,,0,,,,,
[research on construction of sheep lung adenomas virus pegfp-c1/exjsrv-env and induction of malignant transformation in nih3t3] [chinese],Zhang YF,,2014,publication language,,0,,,,,
[sensitivity of the cobas ampliscreen tm hiv-1 test v15 for hiv-1 detection] [spanish],Gomez LP,10.1016/S0325-7541(14)70072-0,2014,publication language,,0,,,,,
contact tracing of a possible case of hiv sexual transmission by using miseq platform [chinese],Zhao Q,,2014,publication language,,0,,,,,
hiv-1 subtype distribution determined by phylogenetic analysis of pol gene sequences and automated subtyping tools among hiv-1 isolates from the aegian region of turkey [turkish],BiiCeroglu SU,10.5578/mb.7609,2014,publication language,,0,,,,,
neonatal outcomes of prevention of vertical hiv transmission; 15 years of experience in a non-university hiv centre [dutch],Veen,,2014,publication language,,0,,,,,
physical training on the risk of ischemic heart disease in hiv/aids subjects on haart [portuguese],Lazzarotto,10.1590/1517-86922014200302064,2014,publication language,,0,,,,,
sensitivity of the cobas ampliscreentm hiv-1 test v15 for hiv-1 detection [spanish],Gomez LP,,2014,publication language,,0,,,,,
study on hiv-1 related genetics and threshold on drug resistance in dehong prefecture of yunnan province in 2012 [chinese],Chen M,,2014,publication language,,0,,,,,
systematic review of hiv prevalence and its influencing factors among domestic and international long-distance truck drivers [chinese],Zhao JiuHua,,2014,publication language,,0,,,,,
the analyses of hiv-1 quasispecies in hiv-infected subjects by the application of single genome amplification assay [chinese],Qin Y,,2014,publication language,,0,,,,,
trends in the distribution of hiv/aids infection in europe and in bulgaria for the period 1986-2011 [bulgarian],Doycheva,,2014,publication language,,0,,,,,
[detection of resistance mutations in proviral dna in hiv-1 infection] [spanish],Delgado R,10.1016/S0213-005X(13)70112-5,2013,publication language,,0,,,,,
[elite controllers and the mechanisms behind spontaneous control of hiv] [hebrew],Shasha D,,2013,publication language,,0,,,,,
[genetic characteristics of viral quasispecies of hiv-1 crf07_bc among intravenous drug users] [chinese],Xin RL,,2013,publication language,,0,,,,,
[molecular epidemiological characteristics of hiv-1 b'/c strains in beijing] [chinese],Ye JR,,2013,publication language,,0,,,,,
[molecular epidemiological study on hiv/aids under the follow-up program in zhejiang province in 2009] [chinese],Zhang JF,,2013,publication language,,0,,,,,
[molecular investigation of a possible case of hiv transmission after a blood transfusion] [chinese],Shi LL,,2013,publication language,,0,,,,,
analysis of the test results on hiv antibody among specific populations in xining between 2009 and 2011 [chinese],Wu JianYing,,2013,publication language,,0,,,,,
detection of resistance mutations in proviral dna in hiv-1 infection [spanish],Delgado R,10.1016/S0213-005X%2813%2970112-5,2013,publication language,,0,,,,,
genetic characteristics of viral quasispecies of hiv-1 crf07_bc among intravenous drug users [chinese],Xin RuoLei,,2013,publication language,,0,,,,,
genotyping analysis of hiv-1 strains isolated from newly-identified patients prior to antiviral treatment in harbin of china [chinese],Li Hang,,2013,publication language,,0,,,,,
hiv disclosure in polygamous settings in senegal (special issue: disclosure in times of art: a relational analysis of social practices) [french],Sow,,2013,publication language,,0,,,,,
hiv subtype diversity and primary resistance to antiretroviral drugs in newly diagnosed hiv-infected persons from croatia in 2013 [croatian],Grgic I,,2013,publication language,,0,,,,,
immunological and virological characteristics and performance in the variables flexibility (flex) and abdominal resistence (ea) strength of adolescents hiv/aids under highly active antirretroviral therapy [portuguese],Santos,10.1590/S1517-86922013000100008,2013,publication language,,0,,,,,
molecular epidemiological characteristics of hiv-1 b'/c strains in beijing [chinese],Ye J-R,10.3760/cma.j.issn.0376-2491.2013.29.015,2013,publication language,,0,,,,,
"prokaryotic expression, purification and preparation of polyclonal antibody of extracellular domain of autographa californica multiple nucleopolyhedrovirus envelope protein gp64 [chinese]",Wang B,,2013,publication language,,0,,,,,
the impact of thymidine analogue resistance mutations on the level of drug resistance and replicative capacity of hiv-1 subtype b' viruses [chinese],Zhou Qian,,2013,publication language,,0,,,,,
[analysis of the polymorphism of the genome region of hiv-1 encoding the fusion protein] [russian],Vasil'ev AV,,2012,publication language,,0,,,,,
[comparison between different gene and near full-length genome on the phylogenetic analyses of hiv-1 subtype b' in china] [chinese],Li Z,,2012,publication language,,0,,,,,
"[distribution of hiv-1 subtypes among different populations in dehong prefecture, yunnan province, in 2011] [chinese]",Chen M,,2012,publication language,,0,,,,,
"[men who have sex with men and its relationship with hiv-1 strains prevailing in the paid blood donors from zhengzhou city, henan] [chinese]",Wang Z,,2012,publication language,,0,,,,,
[molecular characteristics of hiv-1 crf01_ae strains in zhejiang province in 2009] [chinese],Pan X,,2012,publication language,,0,,,,,
[mutation of drug resistant gene in hiv/aids patients with antiretroviral therapy in shandong province in 2011] [chinese],Sun X,,2012,publication language,,0,,,,,
[subtype and sequence analysis of the gag genes for hiv-1 strains isolated in hubei province] [chinese],Chu XG,,2012,publication language,,0,,,,,
[the primary hiv drug resistance in partial region of henan province] [chinese],Xue XJ,,2012,publication language,,0,,,,,
comparison between different gene and near full-length genome on the phylogenetic analyses of hiv-1 subtype b' in china [chinese],Li Zhe,,2012,publication language,,0,,,,,
health services accessibility of people living with hiv/aids (pha) in shanghai [chinese],Wang Hui,,2012,publication language,,0,,,,,
study on variation in the env gene v3 loop of crf01_ae strains of hiv-1 during 2002 to 2009 in shenzhen [chinese],Liu Jia,,2012,publication language,,0,,,,,
"subtype and sequence analysis of gag gene of hiv-1 among men who have sex with men in zhengzhou, henan province [chinese]",Song Dan,,2012,publication language,,0,,,,,
[distribution of hiv-1 subtype and its relationship with hiv/aids epidemic in guizhou province] [chinese],Sun XG,,2011,publication language,,0,,,,,
[epidemic trend and evolution of hiv-1 crf01_ae strains isolated from 1992 through 2008 in shenzhen district] [chinese],Yu W,,2011,publication language,,0,,,,,
[relationship between strain subtypes and transmission of hiv infection within marriage-based immigrant women in rural area of zhejiang province] [chinese],Pan XH,,2011,publication language,,0,,,,,
human immunodeficiency virus type 1 divergent variants [french],Plantier J-C,10.1016/j.antinf.2011.03.009,2011,publication language,,0,,,,,
influencing factors of the need for hiv test among drug addicts in pudong new area of shanghai city [chinese],Huang Xing,,2011,publication language,,0,,,,,
status and demand on hiv/aids control among men who have sex with men in main districts of chongqing [chinese],Zeng Huan,10.3724/SP.J.1008.2011.00494,2011,publication language,,0,,,,,
the role of neutralizing antibodies in type 1 human immunodeficiency virus (hiv-1) infection [french],Braibant M,10.1684/vir.2011.0381,2011,publication language,,0,,,,,
[genetic characteristics of hiv-1 crf01_ae strains circulating in beijing] [chinese],Ye JR,,2010,publication language,,0,,,,,
[specific diagnosis and follow-up of hiv-1 group o infection: res-o data] [french],Depatureaux A,10.1016/j.medmal.2010.04.011,2010,publication language,,0,,,,,
[subtype and transmission of hiv strain in both hiv infected spouses in zhejiang province] [chinese],Pan XH,,2010,publication language,,0,,,,,
advances in the study of anti-hiv natural compounds derived from traditional chinese medicines [chinese],Zhang X,,2010,publication language,,0,,,,,
genetic characteristics of hiv-1 crf01_ae strains circulating in beijing [chinese],Ye J-R,,2010,publication language,,0,,,,,
hiv-1 reverse transcriptase: role of the connection domain and rnase h in antiretroviral resistance [french],Roquebert B,10.1684/vir.2010.0290,2010,publication language,,0,,,,,
preliminary report of hiv and toxoplasma gondii occurrence in pregnant women from mozambique [portuguese],Sitoe SPBL,10.1590/S0036-46652010000600002,2010,publication language,,0,,,,,
specific diagnosis and follow-up of hiv-1 group o infection: res-o data [french],Depatureaux A,10.1016/j.medmal.2010.04.011,2010,publication language,,0,,,,,
status of sentinel monitoring of hiv/aids in hebei province [chinese],Li BaoJun,,2010,publication language,,0,,,,,
[genetic analysis of the complete env genes of hiv-1 from paid blood donors in henan province] [chinese],Feng X,,2009,publication language,,0,,,,,
"[genetic characteristics of hiv-1 crf01_ae strains in four provinces, southern china] [chinese]",Cheng CL,,2009,publication language,,0,,,,,
[hiv-1 drug-resistance profiles of treated aids patients in liaoning: genetic characteristics and prevalence] [chinese],Wu SH,,2009,publication language,,0,,,,,
[study on herpes simplex virus 2 infection and risky sexual behavior among hiv-infected patients in a county of yunnan province] [chinese],Fu ZH,,2009,publication language,,0,,,,,
[subtype and sequence analysis of gag genes among hiv-1 strains circulating in beijing during 2007] [chinese],Ye JR,,2009,publication language,,0,,,,,
diversity and prevalence of antiretroviral genotypic resistance mutations among hiv-1-infected children [portuguese],Almeida,10.2223/JPED.1877,2009,publication language,,0,,,,,
genetic analysis of the complete env genes of hiv-1 from paid blood donors in henan province [chinese],Feng X,,2009,publication language,,0,,,,,
"genetic characteristics of hiv-1 crf01_ae strains in four provinces, southern china [chinese]",Cheng CL,,2009,publication language,,0,,,,,
"genetic diversity of human immunodeficiency virus in the americas, with emphasis on the venezuelan epidemics [spanish]",Rangel,,2009,publication language,,0,,,,,
genetic diversity of human immunodeficiency virus type-1 (hiv-1) in infected women from a northeast city of brazil [portuguese],Santos ES,,2009,publication language,,0,,,,,
hiv genetic diversity and its consequences [french],Roquebert,10.1016/j.patbio.2008.04.004,2009,publication language,,0,,,,,
prokaryotic expression and purification of microcystis viridis lectin protein against hiv [chinese],Li Y-Q,,2009,publication language,,0,,,,,
subtype and sequence analysis of gag genes among hiv-1 strains circulating in beijing during 2007 [chinese],Ye JR,,2009,publication language,,0,,,,,
[molecular characteristics of hiv-1 crf01 _ ae strains in zhejiang province] [chinese],Yao YP,,2008,publication language,,0,,,,,
"[subtype of hiv-1 strains: an epidemic study of 1157 samples in henan province, china] [chinese]",Zhao F,,2008,publication language,,0,,,,,
[the analysis of human immunodeficiency virus-1 subtypes in yunnan province] [chinese],Ma YL,,2008,publication language,,0,,,,,
global hiv epidemiology and current migration [spanish],Gascon Brustenga J,10.1157/13123261,2008,publication language,,0,,,,,
"intimate partner sexual violence among men and women in urban brazil, 2005 (comportamento sexual e percepcoes sobre hiv/aids no brasil, 1998 e 2005) [portuguese]",Schraiber,10.1590/S0034-89102008000800015,2008,publication language,,0,,,,,
molecular characteristics of hiv-1 crf01 _ ae strains in zhejiang province [chinese],Yao YP,,2008,publication language,,0,,,,,
tasks in medical management of hiv-infected child for general practitioner [polish],Czerniakb T,,2008,publication language,,0,,,,,
the analysis of human immunodeficiency virus-1 subtypes in yunnan province [chinese],Ma YL,,2008,publication language,,0,,,,,
[hiv-1 molecular epidemiological survey of drug users in jiangxi province] [chinese],Yi ZQ,,2007,publication language,,0,,,,,
[subtype and sequence analysis of gag and env genes among hiv-1 strains circulating in beijing residents during 2006] [chinese],Ye JR,,2007,publication language,,0,,,,,
construction and immunogenicity of multiple-epitope dna vaccine against hiv [chinese],Li Z,,2007,publication language,,0,,,,,
hiv-1 molecular epidemiological survey of drug users in jiangxi province [chinese],Yi ZQ,,2007,publication language,,0,,,,,
oral candidal carriage and biotyping of candida species in hiv positive patients [chinese],Deng HJ,,2007,publication language,,0,,,,,
study on gag-pol region characteristics of hiv-1 strains epidemic in liaoning province [chinese],Han X-X,,2007,publication language,,0,,,,,
subtype and sequence analysis of gag and env genes among hiv-1 strains circulating in beijing residents during 2006 [chinese],Ye JR,,2007,publication language,,0,,,,,
survey of infectious status of hiv and syphilis in male track divers in 2005-2006 [chinese],Cai YiBiao,,2007,publication language,,0,,,,,
the activities and role of the gay community center 'akta' in hiv prevention within the gay community in tokyo (special issue: how should we promote the latest aids countermeasures in japan?) [japanese],Ichikawa,,2007,publication language,,0,,,,,
"analysis of proxemic communication with hiv/aids patients [portuguese, english]",Galvao MTG,10.1590/S0104-11692006000400004,2006,publication language,,0,,,,,
finding the traces of the hiv selection [spanish],Espinosa E,,2006,publication language,,0,,,,,
hiv resistance to non-nucleoside reverse transcriptase inhibitors [french],Delaugerre C,10.1684/vir.2006.0008,2006,publication language,,0,,,,,
hiv-1 diversity: a tool for studying the pandemic [portuguese],Pinto ME,,2006,publication language,,0,,,,,
human immunodeficiency virus type 1 strains epidemic in shenzhen [chinese],Feng T-J,,2006,publication language,,0,,,,,
problems and limits of art in the hiv treatment center [german],Eger J,,2006,publication language,,0,,,,,
"sexualities and hiv/aids vulnerability in china, an anthropological perspective [french]",Micollier E,10.1016/j.sexol.2006.06.006,2006,publication language,,0,,,,,
the hiv epidemiology in province of modena: use of two different sources of data [italian],Cmoni L,,2006,publication language,,0,,,,,
[identification of signature amino acids in the env v3-v4 and flanking regions of human immunodeficiency virus type 1 predominant strains in china] [chinese],Liang H,,2005,publication language,,0,,,,,
analysis on quasispecies of hiv-1 env gene by single clone per pcr [korean],Han NY,,2005,publication language,,0,,,,,
hiv diversity: the need for surveillance [french],Barin F,,2005,publication language,,0,,,,,
identification of signature amino acids in the env v3-v4 and flanking regions of human immunodeficiency virus type 1 predominant strains in china [chinese],Liang H,,2005,publication language,,0,,,,,
the roles of protein kinase c in hiv replication and drugs discovery [chinese],Zhang G-H,,2005,publication language,,0,,,,,
vaccine for human immunodeficiency virus (hiv)--relevance of these days [lithuanian],Laiskonis A,,2005,publication language,,0,,,,,
[cloning and characterization of a full-length hiv-1 genome of a prevalent subtype b-thai strain in henan province] [chinese],Feng FM,,2004,publication language,,0,,,,,
[distribution of recombinant human immunodeficiency virus type-1 crf01_ae strains in china and its sequence variations in the env v3-c3 region] [chinese],Xing H,,2004,publication language,,0,,,,,
[sequence analysis of gag-pol gene of hiv-1 b/c recombinant viruses in china] [chinese],Guan Q,,2004,publication language,,0,,,,,
[study on the distribution of human immunodeficiency virus-1 subtypes in different regions of china and mother-to-child transmission] [chinese],Li GH,,2004,publication language,,0,,,,,
cloning and characterization of a full-length hiv-1 genome of a prevalent subtype b-thai strain in henan province [chinese],Feng FM,,2004,publication language,,0,,,,,
distribution of recombinant human immunodeficiency virus type-1 crf01_ae strains in china and its sequence variations in the env v3-c3 region [chinese],Xing H,,2004,publication language,,0,,,,,
sequence analysis of gag-pol gene of hiv-1 b/c recombinant viruses in china [chinese],Guan Q,,2004,publication language,,0,,,,,
sequence variation of hiv and bioinformatics [japanese],Yamaguchi-Kabata Y,10.2222/jsv.54.33,2004,publication language,,0,,,,,
study on the distribution of human immunodeficiency virus-1 subtypes in different regions of china and mother-to-child transmission [chinese],Li GH,,2004,publication language,,0,,,,,
[sequence variation in the env v3-v4 region of hiv type 1 predominant subtype b and c strains circulating in china] [chinese],Liang H,,2003,publication language,,0,,,,,
[study on the evolutionary pressure on the env gene of the human immunodeficiency virus type 1 crf01-ae strains circulating in china] [chinese],Liang H,,2003,publication language,,0,,,,,
impact of antiretroviral therapy on the magnitude of the hiv/aids epidemic in brazil: various scenarios [portuguese],Barbosa,10.1590/S0102-311X2003000200020,2003,publication language,,0,,,,,
sequence variation in the env v3-v4 region of hiv type 1 predominant subtype b and c strains circulating in china [chinese],Liang H,,2003,publication language,,0,,,,,
study on the evolutionary pressure on the env gene of the human immunodeficiency virus type 1 crf01-ae strains circulating in china [chinese],Liang H,,2003,publication language,,0,,,,,
[from the apprehension of sexually transmissible diseases to the prevention of hiv] [french],Deniaud F,,2002,publication language,,0,,,,,
[identification of new mutant sites and 894c deletion variant genotyping of hiv-1 coreceptor ccr5 in indigenous chinese populations] [chinese],Liu M,,2002,publication language,,0,,,,,
[molecular genetic characteristics of hiv-1 in russia] [russian],Bobkov AF,,2002,publication language,,0,,,,,
"cloning and sequence analysis of envelope glycoprotein e1 gene of rubella virus, jr23 strain [chinese]",Wang Z,,2002,publication language,,0,,,,,
from the apprehension of sexually transmissible diseases to the prevention of hiv [french],Deniaud F,,2002,publication language,,0,,,,,
identification of new mutant sites and 894c deletion variant genotyping of hiv-1 coreceptor ccr5 in indigenous chinese populations [chinese],Liu M,,2002,publication language,,0,,,,,
molecular genetic characteristics of hiv-1 in russia [russian],Bobkov AF,,2002,publication language,,0,,,,,
recommendations for non-occupational postexposure prophylaxis for hiv [spanish],Almeda J,,2002,publication language,,0,,,,,
"vulnerability to hiv and aids of short distance truck drivers stationed, brazil (prevencao do hiv em contexto de vulnerabilidade social) [portuguese]",Villarinho,10.1590/S0034-89102002000500009,2002,publication language,,0,,,,,
[analysis of hiv-1 seropositive individual infected with different subtypes] [chinese],Feng T,,2001,publication language,,0,,,,,
aids and hiv infection in brazil: a multifaceted epidemic [portuguese],Brito AM,,2001,publication language,,0,,,,,
analysis of hiv-1 seropositive individual infected with different subtypes [chinese],Feng T,,2001,publication language,,0,,,,,
study on hiv dna of epidemic hiv-1 strains [chinese],Xu X,,2001,publication language,,0,,,,,
[hiv-1 group n in cameroon and apparent viruses in the chimpanzee] [french],Mauclere P,,2000,publication language,,0,,,,,
hiv-1 group n in cameroon and apparent viruses in the chimpanzee [french],Mauclere P,,2000,publication language,,0,,,,,
national sentinel surveillance of hiv infection in china from 1995 to 1998 [chinese],Anonymous,,2000,publication language,,0,,,,,
[a recombinant hiv-1 strain causing an epidemic among injection drug addicts in kaliningrad] [russian],Korovina GI,,1999,publication language,,0,,,,,
[identification and characterization of hiv-1 subtype d strain in china] [chinese],Xing H,,1999,publication language,,0,,,,,
"[molecular epidemiology of the human immunodeficiency virus type 1 in santiago, chile] [spanish]",Perez C,,1999,publication language,,0,,,,,
[sequence analysis of human immunodeficiency virus type 1 tat gene among the long-term hiv infected non-progressoris in yunnan province] [chinese],Zhao F,,1999,publication language,,0,,,,,
genetic diversity of hiv infection worldwide and its consequences [french],Peeters M,,1999,publication language,,0,,,,,
identification and characterization of hiv-1 subtype d strain in china [chinese],Xing H,,1999,publication language,,0,,,,,
"molecular epidemiology of the human immunodeficiency virus type 1 in santiago, chile [spanish]",Perez C,,1999,publication language,,0,,,,,
sequence analysis of human immunodeficiency virus type 1 tat gene among the long-term hiv infected non-progressoris in yunnan province [chinese],Zhao F,,1999,publication language,,0,,,,,
[subtype and sequence analysis of the c2-v3 region of gp120 genes among hiv-1 strains in sichuan province] [chinese],Qin G,,1998,publication language,,0,,,,,
host factors in hiv infection [french],Champagne P,10.4267/10608/1001,1998,publication language,,0,,,,,
subtype and sequence analysis of the c2-v3 region of gp120 genes among hiv-1 strains in sichuan province [chinese],Qin G,,1998,publication language,,0,,,,,
"the hiv epidemic in burkina faso : current status and level of aids knowledge in population, 1994-1995 [french]",Meda,,1998,publication language,,0,,,,,
[serotypes of the human immunodeficiency virus type 1 in madrid] [spanish],Soriano V,,1997,publication language,,0,,,,,
[subtype and sequence analysis of the c2-v3 region of gp120 genes among human immunodeficiency virus infected idus in ruili epidemic area of yunnan province of china] [chinese],Guan Y,,1997,publication language,,0,,,,,
molecular epidemiology of candida infections in hiv infected mothers and their children [german],Ruhnke M,,1997,publication language,,0,,,,,
serotypes of the human immunodeficiency virus type 1 in madrid [spanish],Soriano V,,1997,publication language,,0,,,,,
subtype and sequence analysis of the c2-v3 region of gp120 genes among human immunodeficiency virus infected idus in ruili epidemic area of yunnan province of china [chinese],Guan Y,,1997,publication language,,0,,,,,
[modification of tobacco mosaic virus envelope protein using trinitrobenzenesulfonic acid] [russian],Abou-Ed M,,1996,publication language,,0,,,,,
[the identification of the genetic subtypes of hiv-1 circulating on the territory of russia] [russian],Leinikki P,,1996,publication language,,0,,,,,
modification of tobacco mosaic virus envelope protein using trinitrobenzenesulfonic acid [russian],Abou-Ed M,,1996,publication language,,0,,,,,
the identification of the genetic subtypes of hiv-1 circulating on the territory of russia [russian],Leinikki P,,1996,publication language,,0,,,,,
[detection of hiv virus antibodies in saliva] [czech],Bruckova M,,1995,publication language,,0,,,,,
"aids/hiv related knowledge, attitude and behavior of acupuncture therapists in aichi prefecture [japanese]",Hirose K,,1995,publication language,,0,,,,,
detection of hiv virus antibodies in saliva [czech],Bruckova M,,1995,publication language,,0,,,,,
[multicenter french cohort of adults with hiv infection description and course after 4 years of follow-up seroco] [french],Bucquet D,,1994,publication language,,0,,,,,
prospective follow-up of hiv-infected adults four-year report of the multicentric french cohort [french],Bucquet D,,1994,publication language,,0,,,,,
geographic disparities of hiv and aids infection in south saharan africans [french],Amat-Roze J-M,10.1016/0277-9536%2893%2990214-O,1993,publication language,,0,,,,,
hiv seropositivity and fitness to fly in aviation personnel of the federal german armed forces [german],Stocker UR,,1992,publication language,,0,,,,,
hiv-specific cytotoxic effector cells [french],Riviere Y,,1990,publication language,,0,,,,,
an hiv-infected patient with an extraordinary rash,Dillon,,1989,pre 1990,,0,,,,,
biologic and molecular characterization of producer and nonproducer clones from hut-78 cells infected with a patient hiv isolate,Federico M,,1989,pre 1990,,0,,,,,
generation of hybrid human immunodeficiency virus by homologous recombination,Srinivasan A,,1989,pre 1990,,0,,,,,
hiv and dentistry [french],Szpirglas H,10.1016/S0399-077X%2889%2980094-0,1989,pre 1990,,0,,,,,
hiv and pediatry [french],Berhouet M,10.1016/S0399-077X%2889%2980091-5,1989,pre 1990,,0,,,,,
human immunodeficiency virus 1 predominance of a group-specific neutralizing epitope that persists despite genetic variation,Berkower I,,1989,pre 1990,,0,,,,,
infection of brain cells by diverse human immunodeficiency virus isolates: role of cd4 as receptor,Weber J,,1989,pre 1990,,0,,,,,
low prevalence of hiv infection in djibouti: has the aids epidemic come to a stop at the horn of africa?,Fox,10.1016/0035-9203(89)90726-8,1989,pre 1990,,0,,,,,
"pathogenesis of congenital infection with three diverse viruses: varicella-zoster virus, human parvovirus, and human immunodeficiency virus",Grose C,,1989,pre 1990,,0,,,,,
"pathogenesis of congenital infection with three diverse viruses: varicella-zoster virus, human parvovirus, and human immunodeficiency virus [review] [68 refs]",Grose C,,1989,pre 1990,,0,,,,,
patterns of nucleotide substitutions and implications for the immunological diversity of human immunodeficiency virus,Shimizu N,,1989,pre 1990,,0,,,,,
the diversity of n-linked oligosaccharides on human immunodeficiency virus,Anonymous,,1989,pre 1990,,0,,,,,
"thymidine kinase, ca 15-3 and beta2-microglobulin in patients infected with human immunodeficiency virus [german]",Bauer R,,1989,pre 1990,,0,,,,,
biologically diverse molecular variants within a single hiv-1 isolate,Fisher AG,,1988,pre 1990,,0,,,,,
carbohydrate structures of the human-immunodeficiency-virus (hiv) recombinant envelope glycoprotein gp120 produced in chinese-hamster ovary cells,Mizuochi T,,1988,pre 1990,,0,,,,,
isotypic restriction of the antibody response to human immunodeficiency virus,Khalife J,,1988,pre 1990,,0,,,,,
rapid latex agglutination assay using recombinant envelope polypeptide for the detection of antibody to the hiv,Quinn TC,,1988,pre 1990,,0,,,,,
structural characterization by chromatographic profiling of the oligosaccharides of human immunodeficiency virus (hiv) recombinant envelope glycoprotein gp120 produced in chinese hamster ovary cells,Mizuochi T,,1988,pre 1990,,0,,,,,
the neurobiology of human immunodeficiency virus infections [review] [63 refs],Johnson RT,,1988,pre 1990,,0,,,,,
type-restricted neutralization of molecular clones of human immunodeficiency virus,Looney DJ,,1988,pre 1990,,0,,,,,
"clonal selection of human immunodeficiency virus (hiv): serological differences in the envelope antigens of the cloned viruses and hiv prototypes (htlv-iii b, lav, and arv)",Harada S,,1987,pre 1990,,0,,,,,
computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions,Modrow S,,1987,pre 1990,,0,,,,,
genomic diversity of zairian hiv isolates: biological characteristics and clinical manifestation of hiv infection,Laure F,,1987,pre 1990,,0,,,,,
heterogeneity of human immunodeficiency virus cell-associated antigens and demonstration of virus type specificities of human antibody responses,Cloyd MW,,1987,pre 1990,,0,,,,,
hiv env glycoprotein shares a cross-reacting epitope with a surface protein present on activated human monocytes and involved in antigen presentation,Beretta A,,1987,pre 1990,,0,,,,,
human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins,Ho DD,,1987,pre 1990,,0,,,,,
monoclonal antibodies to gp110 and gp41 of human immunodeficiency virus,Gosting LH,,1987,pre 1990,,0,,,,,
the expert's examination of anti-hiv-positive persons by the health authorities [german],Kathke,,1986,pre 1990,,0,,,,,
genomic diversity of the acquired immune deficiency syndrome virus htlv-iii: different viruses exhibit greatest divergence in their envelope genes,Hahn BH,,1985,pre 1990,,0,,,,,
monoclonal antibodies against murine leukemia viruses: identification of six antigenic determinants on the p15(e) and gp70 envelope proteins,Lostrom ME,10.1016/0042-6822%2879%2990557-9,1979,pre 1990,,0,,,,,
location of envelope specific and sarcoma specific oligonucleotides on rna of schmidt-ruppin rous sarcoma virus,Wang LH,10.1073/pnas.73.2.447,1976,pre 1990,,0,,,,,
diversity of envelope antigens on murine type c rna viruses,Aoki T,10.1093/jnci/52.4.1189,1974,pre 1990,,0,,,,,
source identification of hiv-1 transmission in three lawsuits using ultra-deep pyrosequencing and phylogenetic analysis,Li W-Y,10.1016/j.jmii.2019.12.002,2020,pass,other transmission,0,,,,,
evaluation of phylogenetic methods for inferring the direction of hiv transmission: hptn 052,Zhang Y,10.1093/cid/ciz1247,2020,pass,other transmission,0,,,,,
phylogenetic methods inconsistently predict the direction of hiv transmission among heterosexual pairs in the hptn 052 cohort,Rose R,10.1093/infdis/jiy734,2019,pass,other transmission,0,,,,,
accidental father-to-son hiv-1 transmission during the seroconversion period,Ezeonwumelu I,10.1089/AID.2018.0060,2018,pass,other transmission,0,,,,,
"phylogenetic and phenotypic properties of hiv-1 variants of different subtypes, in mother to child transmission",Caridha,,2013,pass,thesis,0,,,,,
genetic aspects of hiv-1 evolution and transmission,Berry,,2008,pass,thesis,0,,,,,
in vitro replicative fitness of early transmitted founder hiv-1 variants and sensitivity to interferon alpha,Ashokkumar M,10.1038/s41598-020-59596-x,2020,pass,T/F phenotype,0,,,,,
accumulated mutations by 6 months of infection collectively render transmitted/founder hiv-1 significantly less fit,Wang C,10.1016/j.jinf.2019.12.001,2020,pass,T/F phenotype,0,,,,,
hiv-1 envelope glycoprotein amino acids signatures associated with clade b transmitted/founder and recent viruses,Kafando A,10.3390/v11111012,2019,pass,T/F phenotype,0,,,,,
hiv-1 dna sequence diversity and evolution during acute subtype c infection,Lee,10.1038/s41467-019-10659-2,2019,pass,T/F phenotype,0,,,,,
infant transmitted/founder hiv-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma,Kumar A,10.1371/journal.ppat.1006944,2018,pass,T/F phenotype,0,,,,,
molecular characteristics of the envelope of vertically transmitted hiv-1 strains from infants with hiv infection,Ashokkumar M,10.1089/AID.2016.0260,2017,pass,T/F phenotype,0,,,,,
differentiating founder and chronic hiv envelope sequences,Murray JM,10.1371/journal.pone.0171572,2017,pass,T/F phenotype,0,,,,,
resistance of transmitted founder hiv-1 to ifitm-mediated restriction,Foster TL,10.1016/j.chom.2016.08.006,2016,pass,T/F phenotype,0,,,,,
features of recently transmitted hiv-1 clade c viruses that impact antibody recognition: implications for active and passive immunization,Rademeyer C,10.1371/journal.ppat.1005742,2016,pass,T/F phenotype,0,,,,,
single genome amplification and standard bulk pcr yield hiv-1 envelope products with similar genotypic and phenotypic characteristics,Etemad B,10.1016/j.jviromet.2015.01.006,2015,pass,T/F phenotype,0,,,,,
characterization of hiv-1 envelopes in acutely and chronically infected injection drug users,Etemad B,10.1186/s12977-014-0106-8,2014,pass,T/F phenotype,0,,,,,
generation and characterization of an hiv-1 subtype c transmitted and early founder virus consensus sequence,Killick M,10.1089/aid.2014.0042,2014,pass,T/F phenotype,0,,,,,
using an epidemiological model for phylogenetic inference reveals density dependence in hiv transmission,Leventhal GE,10.1093/molbev/mst172,2014,pass,T/F phenotype,0,,,,,
antibody light-chain-restricted recognition of the site of immune pressure in the rv144 hiv-1 vaccine trial is phylogenetically conserved,Wiehe K,10.1016/j.immuni.2014.11.014,2014,pass,T/F phenotype,0,,,,,
glycosylation in hiv transmission,Arthos J,10.1097/01.qai.0000429224.84630.26,2013,pass,T/F phenotype,0,,,,,
characterization of host-cell line specific glycosylation profiles of early transmitted/founder hiv-1 gp120 envelope proteins,Go EP,10.1021/pr300870t,2013,pass,T/F phenotype,0,,,,,
co-evolution of a broadly neutralizing hiv-1 antibody and founder virus,Liao HX,10.1038/nature12053,2013,pass,T/F phenotype,0,,,,,
"hiv-1 maternal and infant variants show similar sensitivity to broadly neutralizing antibodies, but sensitivity varies by subtype",Mabuka J,10.1097/QAD.0b013e32835faba5,2013,pass,T/F phenotype,0,,,,,
frequency and predictors of hiv-1 co-receptor switch in treatment naive patients,Mortier V,10.1371/journal.pone.0080259,2013,pass,T/F phenotype,0,,,,,
transmitted/founder and chronic hiv-1 envelope proteins are distinguished by differential utilization of ccr5,Parker ZF,10.1128/JVI.02964-12,2013,pass,T/F phenotype,0,,,,,
generation of transmitted/founder hiv-1 infectious molecular clones and characterization of their replication capacity in cd4 t lymphocytes and monocyte-derived macrophages,Ochsenbauer C,10.1128/JVI.06157-11,2012,pass,T/F phenotype,0,,,,,
transmitted/founder and chronic subtype c hiv-1 use cd4 and ccr5 receptors with equal efficiency and are not inhibited by blocking the integrin alpha4beta7,Parrish NF,10.1371/journal.ppat.1002686,2012,pass,T/F phenotype,0,,,,,
impact of immune escape mutations on hiv-1 fitness in the context of the cognate transmitted/founder genome,Song H,10.1186/1742-4690-9-89,2012,pass,T/F phenotype,0,,,,,
enrichment of intersubtype hiv-1 recombinants in a dual infection system using hiv-1 strain-specific sirnas,Gao Y,10.1186/1742-4690-8-5,2011,pass,T/F phenotype,0,,,,,
phenotypic and immunologic comparison of clade b transmitted/founder and chronic hiv-1 envelope glycoproteins,Wilen CB,10.1128/JVI.00736-11,2011,pass,T/F phenotype,0,,,,,
highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype c hiv-1 env clones from india,Kulkarni SS,10.1016/j.virol.2008.12.032,2009,pass,T/F phenotype,0,,,,,
drastic fitness loss in human immunodeficiency virus type 1 upon serial bottleneck events,Yuste E,10.1128/JVI.73.4.2745-2751.1999,1999,pass,T/F phenotype,0,,,,,
father-to-mother-to-infant transmission of hiv-1: clonally transmitted isolate of infant mutates more rapidly than that of the mother and rapidly loses reactivity with neutralizing antibody,Okamoto Y,10.1111/j.1348-0421.1997.tb01178.x,1997,pass,T/F phenotype,0,,,,,
multiple-infection and recombination in hiv-1 within a longitudinal cohort of women,Templeton AR,10.1186/1742-4690-6-54,2009,pass,superinfection,0,,,,,
"frequency of hiv type 1 dual infection and hiv diversity: analysis of low- and high-risk populations in mbeya region, tanzania",Herbinger K-H,10.1089/aid.2006.22.599,2006,pass,superinfection,0,,,,,
estimating the mutational fitness effects distribution during early hiv infection,Bons E,10.1093/ve/vey029,2018,pass,simulation,0,,,,,
a single variant sequencing method for sensitive and quantitative detection of hiv-1 minority variants,Sidhu G,10.1038/s41598-020-65085-y,2020,pass,sequencing tech,0,,,,,
hiv-1 phylogenetics and vaccines,Rolland M,10.1097/COH.0000000000000545,2019,pass,review,0,,,,,
immunologic basis for long hcdr3s in broadly neutralizing antibodies against hiv-1,Yu L,10.3389/fimmu.2014.00250,2014,pass,review,0,,,,,
the intra-host evolutionary and population dynamics of human immunodeficiency virus type 1: a phylogenetic perspective,Salemi M,10.4081/idr.2013.s1.e3,2013,pass,review,0,,,,,
induction of innate immunity in control of mucosal transmission of hiv,Wang Y,10.1097/COH.0b013e3283499df7,2011,pass,review,0,,,,,
advances in basic science understanding of mother-to-child hiv-1 transmission,Walter J,10.1097/COH.0b013e3282f50bb2,2008,pass,review,0,,,,,
identifying hiv-1 dual infections,van der Kuyl AC,10.1186/1742-4690-4-67,2007,pass,review,0,,,,,
"(c2) saliva, breast milk, and mucosal fluids in hiv transmission",Page-Shafer K,10.1177/154407370601900127,2006,pass,review,0,,,,,
"hiv diversity, molecular epidemiology, and the role of recombination",Kijak GH,10.1007/s11908-005-0051-8,2005,pass,review,0,,,,,
maternal-fetal transmission of human immunodeficiency virus,Ahmad N,10.1007/BF02253703,1996,pass,review,0,,,,,
disparate impact on cd4 t cell count by two distinct hiv-1 phylogenetic clusters from the same clade,Song H,10.1073/pnas.1814714116,2019,pass,receptor tropsim,0,,,,,
genetic characterization of hiv-1 subtype g envelope sequences by single genome analysis,Rene Ghislain E,10.1186/1742-4690-9-S2-P152,2012,pass,poster,0,,,,,
dynamics and frequency of gag transmitted polymorphisms in zambia,Schaefer M,10.1186/1742-4690-9-S2-P156,2012,pass,poster,0,,,,,
deep sequencing reveals an association between hiv-1 subtype c mutations in gp41 mper epitopes and mother-to-child transmission,Yin L,10.1186/1742-4690-9-S2-P154,2012,pass,poster,0,,,,,
phylogenetic cluster analysis identifies virological and behavioral drivers of hiv transmission in msm,Bachmann N,10.1093/cid/ciaa411,2020,pass,other transmission study,0,,,,,
phylogenetic and demographic characterization of directed hiv-1 transmission using deep sequences from high-risk and general population cohorts/groups in uganda,Bbosa N,10.3390/v12030331,2020,pass,other transmission study,0,,,,,
a short-term assessment of nascent hiv-1 transmission clusters among newly diagnosed individuals using envelope sequence-based phylogenetic analyses,Kafando A,10.1089/AID.2019.0142,2019,pass,other transmission study,0,,,,,
inferring hiv-1 transmission networks and sources of epidemic spread in africa with deep-sequence phylogenetic analysis,Ratmann O,10.1038/s41467-019-09139-4,2019,pass,other transmission study,0,,,,,
transmission dynamics of hiv-1 subtype b strains in indonesia,Ueda S,10.1038/s41598-019-50491-8,2019,pass,other transmission study,0,,,,,
exploring hiv-1 transmission dynamics by combining phylogenetic analysis and infection timing,Verhofstede C,10.3390/v11121096,2019,pass,other transmission study,0,,,,,
"hiv-1 genotype diversity and distribution characteristics among heterosexually transmitted population in jiangsu province, china",Xiao P,10.1186/s12985-019-1162-4,2019,pass,other transmission study,0,,,,,
detection of hiv transmission clusters from phylogenetic trees using a multi-state birth-death model,Barido-Sottani J,10.1098/rsif.2018.0512,2018,pass,other transmission study,0,,,,,
integration of contact tracing and phylogenetics in an investigation of acute hiv infection,Dennis AM,10.1097/OLQ.0000000000000726,2018,pass,other transmission study,0,,,,,
"high hiv-1 prevalence and viral diversity among entry-exit populations at frontier ports of china, 2012-2016: a cross-sectional molecular epidemiology study",Wang H,10.1016/j.meegid.2018.08.003,2018,pass,other transmission study,0,,,,,
genomic characterization and molecular evolution analysis of subtype b and bf recombinant hiv-1 strains among argentinean men who have sex with men reveal a complex scenario,Cevallos CG,10.1371/journal.pone.0189705,2017,pass,other transmission study,0,,,,,
"hiv-1 molecular epidemiology among newly diagnosed hiv-1 individuals in hebei, a low hiv prevalence province in china",Lu X,10.1371/journal.pone.0171481,2017,pass,other transmission study,0,,,,,
molecular epidemiology identifies hiv transmission networks associated with younger age and heterosexual exposure among korean individuals,Chin BS,10.1002/jmv.24523,2016,pass,other transmission study,0,,,,,
assessment of overlap of phylogenetic transmission clusters and communities in simple sexual contact networks: applications to hiv-1,Villandre L,10.1371/journal.pone.0148459,2016,pass,other transmission study,0,,,,,
"molecular linkage tracing of hiv-1 transmission events in seroconcordant couples in guangxi province, southeastern china",Wang NiDan,10.1186/s40064-016-3578-2,2016,pass,other transmission study,0,,,,,
molecular epidemiology and transmission dynamics of recent and long-term hiv-1 infections in rural western kenya,Zeh C,10.1371/journal.pone.0147436,2016,pass,other transmission study,0,,,,,
phylogenetic investigation of a statewide hiv-1 epidemic reveals ongoing and active transmission networks among men who have sex with men,Chan PA,10.1097/QAI.0000000000000786,2015,pass,other transmission study,0,,,,,
combining the estimated date of hiv infection with a phylogenetic cluster study to better understand hiv spread: application in a paris neighbourhood,Robineau O,10.1371/journal.pone.0135367,2015,pass,other transmission study,0,,,,,
phylogenetic analyses reveal hiv-1 infections between men misclassified as heterosexual transmissions,Hue S,10.1097/QAD.0000000000000383,2014,pass,other transmission study,0,,,,,
molecular epidemiology of hiv in a cohort of men having sex with men from istanbul,Alpsar D,10.1007/s00430-012-0285-7,2013,pass,other transmission study,0,,,,,
molecular evolution of the hiv-1 thai epidemic between the time of rv144 immunogen selection to the execution of the vaccine efficacy trial,Kijak GH,10.1128/JVI.03070-12,2013,pass,other transmission study,0,,,,,
dynamics and molecular evolution of hiv-1 strains in sicily among antiretroviral naive patients,Tramuto F,10.1016/j.meegid.2013.02.012,2013,pass,other transmission study,0,,,,,
"multiple introductions of hiv into men who have sex with men were found in zhengzhou city, china",Li Lin,10.1089/aid.2011.0379,2012,pass,other transmission study,0,,,,,
"associations between phylogenetic clustering and hla profile among hiv-infected individuals in san diego, california",Mehta SR,10.1093/infdis/jis231,2012,pass,other transmission study,0,,,,,
molecular epidemiology of recent hiv-1 infections in southern poland,Smolen-Dzirba J,10.1002/jmv.23395,2012,pass,other transmission study,0,,,,,
simple epidemiological dynamics explain phylogenetic clustering of hiv from patients with recent infection,Volz EM,10.1371/journal.pcbi.1002552,2012,pass,other transmission study,0,,,,,
combining epidemiological and genetic networks signifies the importance of early treatment in hiv-1 transmission,Zarrabi N,10.1371/journal.pone.0046156,2012,pass,other transmission study,0,,,,,
a comparison of four sampling methods among men having sex with men in china: implications for hiv/std surveillance and prevention,Guo Y,10.1080/09540121.2011.565029,2011,pass,other transmission study,0,,,,,
"determinants of hiv-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach",Fisher M,10.1097/QAD.0b013e32833ac9e6,2010,pass,other transmission study,0,,,,,
molecular epidemiology of hiv type 1 in newly diagnosed patients in southern spain,McConnell MJ,10.1089/aid.2008.0051,2008,pass,other transmission study,0,,,,,
"a hiv-1 heterosexual transmission chain in guangzhou, china: a molecular epidemiological study",Han Z,10.1186/1743-422X-6-148,2009,pass,other transmission study,0,,,,,
"evidence for a ""founder effect"" among hiv-infected injection drug users (idus) in pakistan",Rai MA,10.1186/1471-2334-10-7,2009,pass,other transmission study,0,,,,,
the epidemic origin and molecular properties of b': a founder strain of the hiv-1 transmission in asia,Deng X,10.1097/QAD.0b013e32830f4c62,2008,pass,other transmission study,0,,,,,
molecular and phylogenetic analysis of hiv-1 variants circulating among injecting drug users in mashhad-iran,Naderi HR,10.1186/1750-9378-1-4,2006,pass,other transmission study,0,,,,,
"phylogenetic analysis of the p24-p7 region of the human immunodeficiency virus type 1 gag gene to determine subtype distribution among female sex workers in calcutta, india",Sengupta S,10.1128/JCM.43.11.5787-5791.2005,2005,pass,other transmission study,0,,,,,
hiv type 1 sequence diversity and dual infections in kenya,Steain MC,10.1089/aid.2005.21.882,2005,pass,other transmission study,0,,,,,
"characterization of hiv type 1 heterosexual transmission in yunnan, china",Yu X-F,10.1089/088922203322588422,2003,pass,other transmission study,0,,,,,
molecular epidemiology of human immunodeficiency virus type 1 transmission in a heterosexual cohort of discordant couples in zambia,Trask SA,10.1128/jvi.76.1.397-405.2002,2002,pass,other transmission study,0,,,,,
presence of multiple hiv type 1 subtypes among mothers and children in japan,Hara T,10.1089/08892220151126706,2001,pass,other transmission study,0,,,,,
phylogenetic analysis of multiple heterosexual transmission events involving subtype b of hiv type 1,Hayman A,10.1089/088922201750236960,2001,pass,other transmission study,0,,,,,
genetic evidence of multiple transmissions of hiv type subtype f within romania from adult blood donors to children,Op De Coul E,10.1089/088922200309205,2000,pass,other transmission study,0,,,,,
analysis of the v3 loop sequences from 10 hiv type 1-infected aids patients from paraguay,Cabello A,10.1089/aid.1995.11.1135,1995,pass,other transmission study,0,,,,,
comparison of major and minor viral snps identified through single template sequencing and pyrosequencing in acute hiv-1 infection,Iyer S,10.1371/journal.pone.0135903,2015,pass,pass,uses previous results,,,,,no new results
fitness-balanced escape determines resolution of dynamic founder virus escape processes in hiv-1 infection,Sunshine JE,10.1128/JVI.01876-15,2015,pass,pass,T/F phenotype,,,,,no quantification
how does mother-to-child transmission of hiv differ among african populations? lessons from mbl2 genetic variation in zimbabweans,Mhandire K,10.1089/omi.2013.0131,2014,pass,pass,T/F phenotype,,,,,no quantification
frequency of occurrence of hiv-1 dual infection in a belgian msm population,Hebberecht,10.1371/journal.pone.0195679,2018,pass,pass,superinfection,,,,,superinfection
high frequency of hiv-1 infections with multiple hiv-1 strains in men having sex with men (msm) in senegal,Leye N,10.1016/j.meegid.2013.09.002,2013,pass,pass,superinfection,,,,,superinfection
"a novel multiregion hybridization assay reveals high frequency of dual inter-subtype infections among hiv-positive individuals in cameroon, west central africa",Vidal N,10.1016/j.meegid.2012.11.017,2013,pass,pass,superinfection,,,,,superinfection
longitudinal quasispecies analysis of viral variants in hiv type 1 dually infected individuals highlights the importance of sequence identity in viral recombination,Powell RL,10.1089/aid.2009.0174,2010,pass,pass,superinfection,,,,,superinfection
dual hiv-1 infection associated with rapid disease progression,Gottlieb GS,10.1016/S0140-6736(04)15596-7,2004,pass,pass,superinfection,,,,,antiretroviral
evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype b in an acute seroconvertor,Zhu T,10.1128/JVI.69.2.1324-1327.1995,1995,pass,pass,superinfection,,,,,review
genetic analyses of hiv-1 strains transmitted from mother to child in northern vietnam,Phan CT,10.1089/AID.2014.0335,2015,pass,pass,subject CART,,,,,superinfection
longitudinal population analysis of dual infection with recombination in two strains of hiv type 1 subtype b in an individual from a phase 3 hiv vaccine efficacy trial,Jobes,10.1089/aid.2006.22.968,2006,pass,pass,subject CART,,,,,no new results
genetic analysis of human immunodeficiency virus type 1 envelope v3 region isolates from mothers and infants after perinatal transmission,Ahmad N,10.1128/JVI.69.2.1001-1012.1995,1995,pass,pass,subject CART,,,,,no quantification
"viral sequence analysis from hiv-infected mothers and infants: molecular evolution, diversity, and risk factors for mother-to-child transmission",Bulterys PL,10.1016/j.clp.2010.08.003,2010,pass,pass,review,,,,,no quantification
identification of modifiable factors that affect the genetic diversity of the transmitted hiv-1 population,Sagar M,10.1097/00002030-200403050-00005,2004,pass,pass,post-hoc analysis of previous results,,,,,pass
hiv-1 gag genetic variation in a single acutely infected participant defined by high-resolution deep sequencing,Al-Mawsawi,10.1089/aid.2014.0097,2014,pass,pass,population level,,,,,pass
"hiv type 1 molecular epidemiology in pol and gp41 genes among naive patients from mato grosso do sul state, central western brazil",da Silveira AA,10.1089/aid.2011.0128,2012,pass,pass,population level,,,,,pass
hiv-1 variants are archived throughout infection and persist in the reservoir,Brooks K,10.1371/journal.ppat.1008378,2020,pass,pass,pass,1,,,,pass
the genetic diversity of hiv-1 quasispecies within primary infected individuals,Liu Y,10.1089/AID.2019.0242,2020,pass,pass,pass,1,,,,pass
hiv-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naive recently infected individuals,Leda AR,10.1016/j.virol.2019.11.006,2020,pass,pass,pass,1,,,,pass
triple hiv-1 infection is associated with faster cd4+ t-cell decline,Zhang Y,10.3389/fmicb.2020.00021,2020,pass,pass,pass,1,,,,pass
"infection with multiple hiv-1 founder variants is associated with lower viral replicative capacity, faster cd4+ t cell decline and increased immune activation during acute infection",Macharia GN,10.1371/journal.ppat.1008853,2020,pass,pass,pass,1,,,,pass
"maternal broadly neutralizing antibodies can select for neutralization-resistant, infant-transmitted/founder hiv variants",Martinez DR,10.1128/mBio.00176-20,2020,pass,pass,pass,1,,,,pass
molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in hiv-1 infected adults in east africa and thailand,Rolland M,10.1371/journal.ppat.1008179,2020,pass,pass,pass,1,,,,pass
number of hiv-1 founder variants is determined by the recency of the source partner infection,Villabona-Arenas CJ,10.1126/science.aba5443,2020,pass,pass,pass,1,,,,pass
"phylogenetic analysis of human immunodeficiency virus from people who inject drugs in indonesia, ukraine, and vietnam: hptn 074",Sivay MV,10.1093/cid/ciz1081,2019,pass,pass,pass,1,,,,pass
caution is needed in interpreting hiv transmission chains by ultradeep sequencing,Todesco E,10.1097/QAD.0000000000002105,2019,pass,pass,pass,1,,,,pass
deep sequencing reveals central nervous system compartmentalization in multiple transmitted/founder virus acute hiv-1 infection,Tovanabutra S,10.3390/cells8080902,2019,pass,pass,pass,1,,,,pass
a non-parametric analytic framework for within-host viral phylogenies and a test for hiv-1 founder multiplicity,Lewitus E,10.1093/ve/vez044,2019,pass,pass,pass,1,,,,pass
unique phenotypic characteristics of recently transmitted hiv-1 subtype c envelope glycoprotein gp120: use of cxcr6 coreceptor by transmitted founder viruses,Ashokkumar M,10.1128/JVI.00063-18,2018,pass,pass,pass,1,,,,pass
characterization of the transmitted virus in an ongoing hiv-1 epidemic driven by injecting drug use,Dukhovlinova E,10.1089/AID.2017.0313,2018,pass,pass,pass,1,,,,pass
tracking hiv-1 recombination to resolve its contribution to hiv-1 evolution in natural infection,Song H,10.1038/s41467-018-04217-5,2018,pass,pass,pass,1,,,,pass
phylogenetic patterns recover known hiv epidemiological relationships and reveal common transmission of multiple variants,Leitner T,10.1038/s41564-018-0204-9,2018,pass,pass,pass,1,,,,pass
sieve analysis of breakthrough hiv-1 sequences in hvtn 505 identifies vaccine pressure targeting the cd4 binding site of env-gp120,deCamp AC,10.1371/journal.pone.0185959,2017,pass,pass,pass,1,,,,pass
resistance to type 1 interferons is a major determinant of hiv-1 transmission fitness,Iyer SS,10.1073/pnas.1620144114,2017,pass,pass,pass,1,,,,pass
rare hiv-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection,Kijak GH,10.1371/journal.ppat.1006510,2017,pass,pass,pass,1,,,,pass
characterizing the multiplicity of hiv founder variants during sexual transmission among msm,Chaillon A,10.1093/ve/vew012,2016,pass,pass,pass,1,,,,pass
spmm: estimating infection duration of multivariant hiv-1 infections,Love TM,10.1093/bioinformatics/btv749,2016,pass,pass,pass,1,,,,pass
deciphering multiplicity of hiv-1c infection: transmission of closely related multiple viral lineages,Novitsky V,10.1371/journal.pone.0166746,2016,pass,pass,pass,1,,,,pass
tracing hiv-1 transmission: envelope traits of hiv-1 transmitter and recipient pairs,Oberle CS,10.1186/s12977-016-0299-0,2016,pass,pass,pass,1,,,,pass
enhancement of viral escape in hiv-1 nef by step vaccination,Park SY,10.1097/QAD.0000000000001202,2016,pass,pass,pass,1,,,,pass
use of dried blood spots to elucidate full-length transmitted/founder hiv-1 genomes,Salazar-Gonzalez JF,10.20411/pai.v1i1.116,2016,pass,pass,pass,1,,,,pass
transmission of multiple hiv-1 subtype c transmitted/founder viruses into the same recipients was not determined by modest phenotypic differences,Song H,10.1038/srep38130,2016,pass,pass,pass,1,,,,pass
"diversification in the hiv-1 envelope hyper-variable domains v2, v4, and v5 and higher probability of transmitted/founder envelope glycosylation favor the development of heterologous neutralization breadth",Smith SA,10.1371/journal.ppat.1005989,2016,pass,pass,pass,1,,,,pass
differences in the selection bottleneck between modes of sexual transmission influence the genetic composition of the hiv-1 founder virus,Tully DC,10.1371/journal.ppat.1005619,2016,pass,pass,pass,1,,,,pass
comprehensive characterization of the transmitted/founder env genes from a single msm cohort in china,Chen Y,10.1097/QAI.0000000000000649,2015,pass,pass,pass,1,,,,pass
heterosexual transmission of subtype c hiv-1 selects consensus-like variants without increased replicative capacity or interferon-alpha resistance,Deymier MJ,10.1371/journal.ppat.1005154,2015,pass,pass,pass,1,,,,pass
high frequency of transmitted hiv-1 gag hla class i-driven immune escape variants but minimal immune selection over the first year of clade c infection,Gounder K,10.1371/journal.pone.0119886,2015,pass,pass,pass,1,,,,pass
hiv-1 infections with multiple founders are associated with higher viral loads than infections with single founders,Janes H,10.1038/nm.3932,2015,pass,pass,pass,1,,,,pass
differential evolution of a cxcr4-using hiv-1 strain in ccr5wt/wt and ccr532/32 hosts revealed by longitudinal deep sequencing and phylogenetic reconstruction,Le AQ,10.1038/srep17607,2015,pass,pass,pass,1,,,,pass
population genomics of intrapatient hiv-1 evolution,Zanini F,10.7554/eLife.11282,2015,pass,pass,pass,1,,,,pass
evidence of long-lived founder virus in mother-to-child hiv transmission,Danaviah S,10.1371/journal.pone.0120389,2015,pass,pass,pass,1,,,,pass
low multiplicity of hiv-1 infection and no vaccine enhancement in vax003 injection drug users,Sterrett S,10.1093/ofid/ofu056,2014,pass,pass,pass,1,,,,pass
estimating the timing of mother-to-child transmission of the human immunodeficiency virus type 1 using a viral molecular evolution model,Chaillon A,10.1371/journal.pone.0090421,2014,pass,pass,pass,1,,,,pass
incidence and prevalence of intrasubtype hiv-1 dual infection in at-risk men in the united states,Wagner,10.1093/infdis/jit633,2014,pass,pass,pass,1,,,,pass
"molecular identification, cloning and characterization of transmitted/founder hiv-1 subtype a, d and a/d infectious molecular clones",Baalwa J,10.1016/j.virol.2012.10.009,2013,pass,pass,pass,1,,,,pass
sexually-transmitted/founder hiv-1 cannot be directly predicted from plasma or pbmc-derived viral quasispecies in the transmitting partner,Frange P,10.1371/journal.pone.0069144,2013,pass,pass,pass,1,,,,pass
whole genome deep sequencing of hiv-1 reveals the impact of early minor variants upon immune recognition during acute infection,Henn MR,10.1371/journal.ppat.1002529,2012,pass,pass,pass,1,,,,pass
hiv-1 subtypes and recombinants in northern tanzania: distribution of viral quasispecies,Kiwelu IE,10.1371/journal.pone.0047605,2012,pass,pass,pass,1,,,,pass
"viral diversity and diversification of major non-structural genes vif, vpr, vpu, tat exon 1 and rev exon 1 during primary hiv-1 subtype c infection",Rossenkhan R,10.1371/journal.pone.0035491,2012,pass,pass,pass,1,,,,pass
central nervous system compartmentalization of hiv-1 subtype c variants early and late in infection in young children,Sturdevant CB,10.1371/journal.ppat.1003094,2012,pass,pass,pass,1,,,,pass
hiv-1 dual infection is associated with faster cd4+ t-cell decline in a cohort of men with primary hiv infection,Cornelissen M,10.1093/cid/cir849,2012,pass,pass,pass,1,,,,pass
role of donor genital tract hiv-1 diversity in the transmission bottleneck,Boeras DI,10.1073/pnas.1103764108,2011,pass,pass,pass,1,,,,pass
significantly longer envelope v2 loops are characteristic of heterosexually transmitted subtype b hiv-1 in trinidad,Collins-Fairclough AM,10.1371/journal.pone.0019995,2011,pass,pass,pass,1,,,,pass
demographic processes affect hiv-1 evolution in primary infection before the onset of selective processes,Herbeck JT,10.1128/JVI.02697-10,2011,pass,pass,pass,1,,,,pass
genotypic and functional properties of early infant hiv-1 envelopes,Kishko M,10.1186/1742-4690-8-67,2011,pass,pass,pass,1,,,,pass
defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms,Nofemela A,10.1016/j.virol.2010.12.027,2011,pass,pass,pass,1,,,,pass
transmission of single and multiple viral variants in primary hiv-1 subtype c infection,Novitsky V,10.1371/journal.pone.0016714,2011,pass,pass,pass,1,,,,pass
characterization of human immunodeficiency virus type 1 (hiv-1) diversity and tropism in 145 patients with primary hiv-1 infection,Rieder P,10.1093/cid/cir725,2011,pass,pass,pass,1,,,,pass
genetic impact of vaccination on breakthrough hiv-1 sequences from the step trial,Rolland M,10.1038/nm.2316,2011,pass,pass,pass,1,,,,pass
"time-measured phylogenies of gag, pol and env sequence data reveal the direction and time interval of hiv-1 transmission",Rachinger A,10.1097/QAD.0b013e3283467020,2011,pass,pass,pass,1,,,,pass
wide variation in the multiplicity of hiv-1 infection among injection drug users,Bar KJ,10.1128/JVI.00077-10,2010,pass,pass,pass,1,,,,pass
transmission of single hiv-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing,Fischer W,10.1371/journal.pone.0012303,2010,pass,pass,pass,1,,,,pass
high multiplicity infection by hiv-1 in men who have sex with men,Li H,10.1371/journal.ppat.1000890,2010,pass,pass,pass,1,,,,pass
"a substantial transmission bottleneck among newly and recently hiv-1-infected injection drug users in st petersburg, russia",Masharsky AE,10.1086/652702,2010,pass,pass,pass,1,,,,pass
restricted genetic diversity of hiv-1 subtype c envelope glycoprotein from perinatally infected zambian infants,Zhang H,10.1371/journal.pone.0009294,2010,pass,pass,pass,1,,,,pass
quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype c reveals a non-poisson distribution of transmitted variants,Abrahams MR,10.1128/JVI.02132-08,2009,pass,pass,pass,1,,,,pass
inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype a and c hiv-1,Haaland RE,10.1371/journal.ppat.1000274,2009,pass,pass,pass,1,,,,pass
human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals,Kearney M,10.1128/JVI.01960-08,2009,pass,pass,pass,1,,,,pass
evolution of proviral gp120 over the first year of hiv-1 subtype c infection,Novitsky V,10.1016/j.virol.2008.09.017,2009,pass,pass,pass,1,,,,pass
"genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early hiv-1 infection",Salazar-Gonzalez JF,10.1084/jem.20090378,2009,pass,pass,pass,1,,,,pass
hiv-1 variation before seroconversion in men who have sex with men: analysis of acute/early hiv infection in the multicenter aids cohort study,Gottlieb GS,10.1086/529206,2008,pass,pass,pass,1,,,,pass
identification and characterization of transmitted and early founder virus envelopes in primary hiv-1 infection,Keele BF,10.1073/pnas.0802203105,2008,pass,pass,pass,1,,,,pass
the molecular epidemiology of hiv-1 envelope diversity during hiv-1 subtype c vertical transmission in malawian mother-infant pairs,Kwiek JJ,10.1097/QAD.0b013e3282f51ea0,2008,pass,pass,pass,1,,,,pass
deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing,Salazar-Gonzalez JF,10.1128/JVI.02660-07,2008,pass,pass,pass,1,,,,pass
diversity in hiv-1 envelope v1-v3 sequences early in infection reflects sequence diversity throughout the hiv-1 genome but does not predict the extent of sequence diversity during chronic infection,Sagar M,10.1089/aid.2006.22.430,2006,pass,pass,pass,1,,,,pass
envelope-constrained neutralization-sensitive hiv-1 after heterosexual transmission,Derdeyn CA,10.1126/science.1093137,2004,pass,pass,pass,1,,,,pass
multiple v1/v2 env variants are frequently present during primary infection with human immunodeficiency virus type 1,Ritola K,10.1128/JVI.78.20.11208-11218.2004,2004,pass,pass,pass,1,,,,pass
human immunodeficiency virus type 1 (hiv-1) diversity at time of infection is not restricted to certain risk groups or specific hiv-1 subtypes,Sagar M,10.1128/JVI.78.13.7279-7283.2004,2004,pass,pass,pass,1,,,,pass
in-utero transmission of quasispecies among human immunodeficiency virus type 1 genotypes,Renjifo B,10.1016/s0042-6822(02)00066-1,2003,pass,pass,pass,1,,,,pass
infection with multiple human immunodeficiency virus type 1 variants is associated with faster disease progression,Sagar M,10.1128/jvi.77.23.12921-12926.2003,2003,pass,pass,pass,1,,,,pass
diversity of the human immunodeficiency virus type 1 (hiv-1) env sequence after vertical transmission in mother-child pairs infected with hiv-1 subtype a,Verhofstede C,10.1128/jvi.77.5.3050-3057.2003,2003,pass,pass,pass,1,,,,pass
homogeneous quasispecies in 16 out of 17 individuals during very early hiv-1 primary infection,Delwart E,10.1097/00002030-200201250-00007,2002,pass,pass,pass,1,,,,pass
virus population homogenization following acute human immunodeficiency virus type 1 infection,Learn GH,10.1128/jvi.76.23.11953-11959.2002,2002,pass,pass,pass,1,,,,pass
the selection and evolution of viral quasispecies in hiv-1 infected children,Nowak P,10.1046/j.1464-2662.2001.00097.x,2002,pass,pass,pass,1,,,,pass
"perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum",Dickover RE,10.1128/JVI.75.5.2194-2203.2001,2001,pass,pass,pass,1,,,,pass
gender differences in hiv-1 diversity at time of infection,Long EM,10.1038/71563,2000,pass,pass,pass,1,,,,pass
analysis of human immunodeficiency virus type 1 env and gag sequence variants derived from a mother and two vertically infected children provides evidence for the transmission of multiple sequence variants,Wade CM,10.1099/0022-1317-79-5-1055,1998,pass,pass,pass,1,,,,pass
analysis of envelope sequence variants suggests multiple mechanisms of mother-to-child transmission of human immunodeficiency virus type 1,Briant L,10.1128/JVI.69.6.3778-3788.1995,1995,pass,pass,pass,1,,,,no quantification
diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1,Poss M,10.1128/JVI.69.12.8118-8122.1995,1995,pass,pass,pass,1,,,,no quantification
selective transmission of human immunodeficiency virus type-1 variants from mothers to infants,Wolinsky SM,10.1126/science.1546316,1992,pass,pass,pass,1,,,,no quantification
"hiv type 1 variants transmitted to women in kenya require the ccr5 coreceptor for entry, regardless of the genetic complexity of the infecting virus",Long EM,10.1089/088922202753747914,2002,pass,pass,pass,,,,,no quantification
deep-profiling identifies selection of non-synonymous amino acid substitutions in hiv-1 envelope during early infection,Ashokkumar M,10.1089/AID.2020.0143,2020,pass,pass,no quantification,,,,,no quantification
combining viral genetics and statistical modeling to improve hiv-1 time-of-infection estimation towards enhanced vaccine efficacy assessment,Rossenkhan R,10.3390/v11070607,2019,pass,pass,no quantification,,,,,no quantification
deep sequence analysis of hiv adaptation following vertical transmission reveals the impact of immune pressure on the evolution of hiv,Currenti J,10.1371/journal.ppat.1008177,2019,pass,pass,no quantification,,,,,no quantification
next-generation sequencing of hiv-1 single genome amplicons,Kijak GH,10.1016/j.bdq.2019.01.002,2019,pass,pass,no quantification,,,,,no quantification
hiv surveillance combining an assay for identification of very recent infection and phylogenetic analyses on dried spots,Brand D,10.1097/QAD.0000000000001325,2017,pass,pass,no quantification,,,,,no quantification
"generation and characterization of hiv-1 transmitted and founder virus consensus sequence from intravenous drug users in xinjiang, china",Li F,10.1089/AID.2016.0316,2017,pass,pass,no quantification,,,,,no quantification
forensic application of phylogenetic analyses - exploration of suspected hiv-1 transmission case,Siljic M,10.1016/j.fsigen.2016.12.006,2017,pass,pass,no quantification,,,,,no quantification
"transmitted/founder hiv-1 subtype c viruses show distinctive signature patterns in vif, vpr, and vpu that are under subsequent immune pressure during early infection",Rossenkhan R,10.1089/aid.2015.0330,2016,pass,pass,no quantification,,,,,no quantification
the combination of phylogenetic analysis with epidemiological and serological data to track hiv-1 transmission in a sexual transmission case,Chen M,10.1371/journal.pone.0119989,2015,pass,pass,no quantification,,,,,no quantification
comprehensive sieve analysis of breakthrough hiv-1 sequences in the rv144 vaccine efficacy trial,Edlefsen PT,10.1371/journal.pcbi.1003973,2015,pass,pass,no quantification,,,,,no quantification
disentangling the impact of within-host evolution and transmission dynamics on the tempo of hiv-1 evolution,Vrancken B,10.1097/QAD.0000000000000731,2015,pass,pass,no quantification,,,,,no quantification
estimating hiv-1 transmission routes for patients with unknown risk histories by viral sequence phylogenetic analyses,Wei M,10.1097/QAI.0000000000000735,2015,pass,pass,no quantification,,,,,no quantification
selection bias at the heterosexual hiv-1 transmission bottleneck,Carlson JM,10.1126/science.1254031,2014,pass,pass,no quantification,,,,,no quantification
homogenous hiv-1 subtype b quasispecies in brazilian men and women recently infected via heterosexual transmission,Gouveia NL,10.1007/s11262-014-1048-x,2014,pass,pass,no quantification,,,,,no quantification
"single genome amplification of proviral hiv-1 dna from dried blood spot specimens collected during early infant screening programs in lusaka, zambia",Seu L,10.1016/j.jviromet.2014.03.001,2014,pass,pass,no quantification,,,,,no quantification
"identification of human immunodeficiency virus-1 (hiv-1) transmission from a 29-year-old daughter to her mother in shanghai, china",Shao J,10.1007/s00705-012-1421-9,2013,pass,pass,no quantification,,,,,no quantification
hiv-1 env c2-v4 diversification in a slow-progressor infant reveals a flat but rugged fitness landscape,Smith SA,10.1371/journal.pone.0063094,2013,pass,pass,no quantification,,,,,no quantification
"molecular epidemiology of early and acute hiv type 1 infections in the united states navy and marine corps, 2005-2010",Heipertz RA Jr,10.1089/AID.2013.0087,2013,pass,pass,no quantification,,,,,no quantification
"molecular epidemiology of hiv-1 transmission in a cohort of hiv-1 concordant heterosexual couples from dakar, senegal",Jennes W,10.1371/journal.pone.0037402,2012,pass,pass,no quantification,,,,,no quantification
reconstructing the dynamics of hiv evolution within hosts from serial deep sequence data,Poon AF,10.1371/journal.pcbi.1002753,2012,pass,pass,no quantification,,,,,no quantification
a gp41-based heteroduplex mobility assay provides rapid and accurate assessment of intrasubtype epidemiological linkage in hiv type 1 heterosexual transmission pairs,Manigart O,10.1089/AID.2012.0023,2012,pass,pass,no quantification,,,,,no quantification
phylogenetic analysis consistent with a clinical history of sexual transmission of hiv-1 from a single donor reveals transmission of highly distinct variants,English S,10.1186/1742-4690-8-54,2011,pass,pass,no quantification,,,,,no quantification
recurrent signature patterns in hiv-1 b clade envelope glycoproteins associated with either early or chronic infections,Gnanakaran S,10.1371/journal.ppat.1002209,2011,pass,pass,no quantification,,,,,no quantification
molecular epidemiological analysis of paired pol/env sequences from portuguese hiv type 1 patients,Abecasis AB,10.1089/aid.2010.0312,2011,pass,pass,no quantification,,,,,no quantification
phylogenetic analysis of full-length pol gene from korean hemophiliacs and plasma donors infected with korean subclade b of hiv type 1,Cho YK,10.1089/AID.2010.0174,2011,pass,pass,no quantification,,,,,no quantification
"molecular epidemiological analysis of env and pol sequences in newly diagnosed hiv type 1-infected, untreated patients in hungary",Mezei M,10.1089/AID.2011.0077,2011,pass,pass,no quantification,,,,,no quantification
detection of a rare hiv type 1 strain crf16-a2d in bangladesh,Safiullah Sarker M,10.1089/aid.2010.0209,2011,pass,pass,no quantification,,,,,no quantification
structure of hiv-1 quasi-species as early indicator for switches of co-receptor tropism,Dybowski JN,10.1186/1742-6405-7-41,2010,pass,pass,no quantification,,,,,no quantification
comparison of methods to detect hiv dual infection,Pacold,10.1089/aid.2010.0042,2010,pass,pass,no quantification,,,,,no quantification
sequence evolution of hiv-1 following mother-to-child transmission,Ryland EG,10.1128/JVI.01617-10,2010,pass,pass,no quantification,,,,,no quantification
diversity of hiv type 1 long terminal repeat (ltr) sequences following mother-to-child transmission in north india,Neogi U,10.1089/aid.2010.0128,2010,pass,pass,no quantification,,,,,no quantification
selection of hiv variants with signature genotypic characteristics during heterosexual transmission,Sagar M,10.1086/596557,2009,pass,pass,no quantification,,,,,no quantification
comparison of bayesian and maximum-likelihood phylogenetic approaches in two legal cases involving accusations of transmission of hiv,Kaye M,10.1089/aid.2008.0306,2009,pass,pass,no quantification,,,,,no quantification
env length and n-linked glycosylation following transmission of human immunodeficiency virus type 1 subtype b viruses,Liu Y,10.1016/j.virol.2008.01.029,2008,pass,pass,no quantification,,,,,no quantification
genetic characterization of hiv type 1 long terminal repeat following vertical transmission,Mehta R,10.1089/aid.2007.0234,2008,pass,pass,no quantification,,,,,no quantification
utility of the heteroduplex assay (hda) as a simple and cost-effective tool for the identification of hiv type 1 dual infections in resource-limited settings,Powell RLR,10.1089/aid.2007.0162,2008,pass,pass,no quantification,,,,,no quantification
hiv-1 genetic diversity and compartmentalization in mother/infant pairs infected with crf01_ae,Tovanabutra S,10.1097/QAD.0b013e32810c8cf3,2007,pass,pass,no quantification,,,,,no quantification
cloning and characterization of functional subtype a hiv1-1 envelope variants transmitted through breastfeeding,Rainwater SMJ,10.2174/157016207780076986,2007,pass,pass,no quantification,,,,,no quantification
population genetic estimation of the loss of genetic diversity during horizontal transmission of hiv-1,Edwards CT,10.1186/1471-2148-6-28,2006,pass,pass,no quantification,,,,,modelling review
passive sexual transmission of human immunodeficiency virus type 1 variants and adaptation in new hosts,Frater AJ,10.1128/JVI.02014-05,2006,pass,pass,no quantification,,,,,modelling
characterization of hiv-1 envelope gp41 genetic diversity and functional domains following perinatal transmission,Ramakrishnan R,10.1186/1742-4690-3-42,2006,pass,pass,no quantification,,,,,modelling
molecular characterization of the hiv-1 gag nucleocapsid gene associated with vertical transmission,Wellensiek BP,10.1186/1742-4690-3-21,2006,pass,pass,no quantification,,,,,modelling
identification of hiv type 1 group n infections in a husband and wife in cameroon: viral genome sequences provide evidence for horizontal transmission,Yamaguchi J,10.1089/aid.2006.22.83,2006,pass,pass,no quantification,,,,,intrahost evolution
conservation of functional domains and limited heterogeneity of hiv-i reverse transcriptase gene following vertical transmission,Sundaravaradan V,10.1186/1742-4690-2-36,2005,pass,pass,no quantification,,,,,intrahost evolution
heterosexual transmission of multiple highly conserved viral variants in hiv-1 subtype c-infected seronegative women,Rademeyer C,10.1097/00002030-200410210-00019,2004,pass,pass,no quantification,,,,,intrahost evolution
genetic and phylogenetic analyses of hiv-1 corroborate the transmission link hypothesis,Pistello M,10.1016/j.jcv.2003.08.008,2004,pass,pass,no quantification,,,,,no quantification
epidemiological and molecular evidence of two events of father-to-child hiv type 1 horizontal transmission,Ceballos A,10.1089/0889222041725154,2004,pass,pass,no quantification,,,,,intrahost evolution
hiv-1 superinfections in a cohort of commercial sex workers in burkina faso as assessed by an autologous heteroduplex mobility procedure,Manigart O,10.1097/01.aids.0000131333.30548.db,2004,pass,pass,no quantification,,,,,chronic infection
molecular investigation of transmission of human immunodeficiency virus type 1 in a criminal case,Machuca R,10.1128/CDLI.8.5.884-890.2001,2001,pass,pass,no quantification,,,,,no quantification
characterization of hiv type 1 tat sequences associated with perinatal transmission,Husain M,10.1089/088922201750237040,2001,pass,pass,no quantification,,,,,no quantification
diversity of the hiv-1 long terminal repeat following mother-to-child transmission,Blackard JT,10.1006/viro.2000.0466,2000,pass,pass,no quantification,,,,,antiretrovirals
the molecular clock of hiv-1 unveiled through analysis of a known transmission history,Leitner T,10.1073/pnas.96.19.10752,1999,pass,pass,no quantification,,,,,*
"selection of appropriate hiv-1 genomic regions for single-strand conformation polymorphism analysis of the diversity, modification, and transmission of hiv-1 quasispecies",Lin HJ,10.1097/00042560-199808150-00001,1998,pass,pass,no quantification,,,,,*
molecular analyses of human immunodeficiency virus type 1 v3 region quasispecies derived from plasma and peripheral blood mononuclear cells of the first long-term-nonprogressing mother and child pair,Wang Bin,10.1086/516489,1997,pass,pass,no quantification,,,,,*
accurate reconstruction of a known hiv-1 transmission history by phylogenetic tree analysis,Leitner T,10.1073/pnas.93.20.10864,1996,pass,pass,no quantification,,,,,*
elucidation of an hiv-1 transmission from mother to child in west africa by sequence analysis,Kasper P,10.1016/s0934-8840(96)80107-1,1996,pass,pass,no quantification,,,,,*
intraspecific phylogenetics: support for dental transmission of human immunodeficiency virus,Crandall KA,10.1128/JVI.69.4.2351-2356.1995,1995,pass,pass,no quantification,,,,,*
human immunodeficiency virus type 1 evolution in vivo tracked by dna heteroduplex mobility assays,Delwart EL,10.1128/JVI.68.10.6672-6683.1994,1994,pass,pass,no quantification,,,,,*
genomic human immunodeficiency virus type 1 rna variation in mother and child following intra-uterine virus transmission,Mulder-Kampinga GA,10.1099/0022-1317-74-9-1747,1993,pass,pass,no quantification,,,,,*
selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection,Zhang LQ,10.1128/JVI.67.6.3345-3356.1993,1993,pass,pass,no quantification,,,,,*
diversification of hiv-1 strains after infection from a unique source,Kasper P,10.1089/aid.1993.9.153,1993,pass,pass,no quantification,,,,,*
hiv-1 genomic rna diversification following sexual and parenteral virus transmission,Wolfs TF,10.1016/0042-6822(92)90685-I,1992,pass,pass,no quantification,,,,,*
modeling sequence evolution in acute hiv-1 infection,Lee HY,10.1016/j.jtbi.2009.07.038,2009,pass,pass,modelling review,,,,,*
donor-recipient identification in para- and poly-phyletic trees under alternative hiv-1 transmission hypotheses using approximate bayesian computation,Romero-Severson EO,10.1534/genetics.117.300284,2017,pass,pass,modelling,,,,,*
an evaluation of phylogenetic methods for reconstructing transmitted hiv variants using longitudinal clonal hiv sequence data,McCloskey RM,10.1128/JVI.00483-14,2014,pass,pass,modelling,,,,,*
hiv-1 transmission during early infection in men who have sex with men: a phylodynamic analysis,Volz EM,10.1371/journal.pmed.1001568,2013,pass,pass,modelling,,,,,*
deep sequencing reveals compartmentalized hiv-1 in the semen of men with and without sexually transmitted infection-associated urethritis,Council OD,10.1128/JVI.00151-20,2020,pass,pass,intrahost evolution,,,,,*
hiv-1 tropism dynamics and phylogenetic analysis from longitudinal ultra-deep sequencing data of ccr5- and cxcr4-using variants,Sede MM,10.1371/journal.pone.0102857,2014,pass,pass,intrahost evolution,,,,,*
limited heterogeneity of hiv type 1 in infected mothers correlates with lack of vertical transmission,Matala E,10.1089/088922200750006001,2000,pass,pass,intrahost evolution,,,,,*
genital tract human immunodeficiency virus type 1 (hiv-1) shedding and inflammation and hiv-1 env diversity in perinatal hiv-1 transmission,Panther LA,10.1086/315230,2000,pass,pass,intrahost evolution,,,,,*
slower evolution of human immunodeficiency virus type 1 quasispecies during progression to aids,Delwart EL,10.1128/JVI.71.10.7498-7508.1997,1997,pass,pass,intrahost evolution,,,,,*
"high frequency of hiv-1 dual infections among hiv-positive individuals in cameroon, west central africa",Powell RL,10.1097/QAI.0b013e31818d5a40,2009,pass,pass,chronic infection,,,,,*
phylogenetic approach reveals that virus genotype largely determines hiv set-point viral load,Alizon S,10.1371/journal.ppat.1001123,2010,pass,other transmission study,0,,,,,
transmission of hiv-1 from an obstetrician to a patient during a caesarean section,Mallolas J,10.1097/01.aids.0000199831.02854.b2,2006,pass,other transmission study,0,,,,,
influence of human immunodeficiency virus type 1 subtype on mother-to-child transmission,Tapia,10.1099/vir.0.18754-0,2003,pass,other transmission,0,,,,,
common genetic arrangements among human immunodeficiency virus type 1 subtype a and d recombinant genomes vertically transmitted in tanzania,Koulinska IN,10.1089/088922202760265614,2002,pass,other transmission,0,,,,,
exposure to hiv-1 during delivery and mother-to-child transmission,Gaillard P,10.1097/00002030-200010200-00015,2000,pass,other transmission,0,,,,,
nosocomial hiv-transmission in an outpatient clinic detected by epidemiological and phylogenetic analyses,Katzenstein TL,10.1097/00002030-199909100-00018,1999,pass,other transmission,0,,,,,
variants from the diverse virus population identified at seroconversion of a clade a human immunodeficiency virus type 1-infected woman have distinct biological properties,Poss M,10.1128/JVI.73.7.5255-5264.1999,1999,pass,other transmission,0,,,,,
evolution and biological characterization of human immunodeficiency virus type 1 subtype e gp120 v3 sequences following horizontal and vertical virus transmission in a single family,Sato H,10.1128/JVI.73.5.3551-3559.1999,1999,pass,other transmission,0,,,,,
genetically related human immunodeficiency virus type 1 in three adults of a family with no identified risk factor for intrafamilial transmission,Belec L,10.1128/JVI.72.7.5831-5839.1998,1998,pass,other transmission,0,,,,,
molecular evidence for nosocomial transmission of human immunodeficiency virus from a surgeon to one of his patients,Blanchard A,10.1128/JVI.72.5.4537-4540.1998,1998,pass,other transmission,0,,,,,
conservation of an intact vif gene of human immunodeficiency virus type 1 during maternal-fetal transmission,Yedavalli VR,10.1128/JVI.72.2.1092-1102.1998,1998,pass,other transmission,0,,,,,
maintenance of an intact human immunodeficiency virus type 1 vpr gene following mother-to-infant transmission,Yedavalli VR,10.1128/JVI.72.8.6937-6943.1998,1998,pass,other transmission,0,,,,,
"longitudinal studies of viral sequence, viral phenotype, and immunologic parameters of human immunodeficiency virus type 1 infection in perinatally infected twins with discordant disease courses",Hutto C,10.1128/JVI.70.6.3589-3598.1996,1996,pass,other transmission,0,,,,,
sequence distances between env genes of hiv-1 from individuals infected from the same source: implications for the investigation of possible transmission events,Arnold C,10.1006/viro.1995.1391,1995,pass,other transmission,0,,,,,
genomic structure of an attenuated quasi species of hiv-1 from a blood transfusion donor and recipients,Deacon NJ,10.1126/science.270.5238.988,1995,pass,other transmission,0,,,,,
the genetic diversification of the hiv type 1 gag p17 gene in patients infected from a common source,Kasper P,10.1089/aid.1995.11.1197,1995,pass,other transmission,0,,,,,
hiv type 1 v3 sequence diversity in contact-traced swedish couples at the time of sexual transmission,Furuta Y,10.1089/aid.1994.10.1187,1994,pass,other transmission,0,,,,,
evolution of sequence divergence among human immunodeficiency virus type 1 isolates derived from a blood donor and a recipient,McNearney T,10.1203/00006450-199301000-00008,1993,pass,other transmission,0,,,,,
phylogenetic analysis of population-based and deep sequencing data to identify coevolving sites in the nef gene of hiv-1,Poon AF,10.1093/molbev/msp289,2010,pass,other phylogenetics,0,,,,,
an evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in hiv-1,Kosakovsky Pond SL,10.1371/journal.pcbi.1000581,2009,pass,other phylogenetic,0,,,,,
hla footprints on human immunodeficiency virus type 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering,Matthews PC,10.1128/JVI.02017-08,2009,pass,other phylogenetic,0,,,,,
"diversity of risk of mother-to-child hiv-1 transmission according to feeding practices, cd4 cell count, and haemoglobin concentration in a south african cohort",Tournoud M,10.1111/j.1365-3156.2008.02004.x,2008,pass,other,0,,,,,
evidence of genetic variability of human immunodeficiency virus type 1 in plasma and cervicovaginal lavage in ethiopian women seeking care for sexually transmitted infections,Adal M,10.1089/aid.2005.21.649,2005,pass,other,0,,,,,
viral fitness costs and benefits of disrupting the host cell actin cytoskeleton in mucosal hiv-infection,Mempel T,10.1097/01.qai.0000557988.95699.8e,2019,pass,NR,0,,,,,
deep sequencing of hiv-1 variants from paired plasma and cerebrospinal fluid during primary hiv infection,Gega A,,2015,pass,NR,0,,,,,
differences in envelope glycan content of hiv-1 clones influences transmission fitness,Klein K,,2015,pass,NR,0,,,,,
differential intrahost hiv-1 evolution revealed by ancestral phylogenetic reconstruction in a rare case of transmission of cxcr4-using hiv,Le AQ,,2015,pass,NR,0,,,,,
a stochastic model for hiv transmission under alertness using exponentiated exponential distribution,Kannan,,2013,pass,NR,0,,,,,
high diversity in reverse transcriptase drug resistance mutations relative to envelope variants in early-acute hiv transmission,Lipscomb JT,,2013,pass,NR,0,,,,,
reconstructing transmitted hiv genotypes by phylogenetic analysis of serial samples,McCloskey RM,,2013,pass,NR,0,,,,,
distinguishing features of transmitted/founder hiv-1,Parrish NF,,2013,pass,NR,0,,,,,
"identification of full-length transmitted hiv-1 genomes reveals extraordinary dynamics and precise molecular pathways of early virus diversification, adaptation and immune evasion",Shaw GM,,2009,pass,NR,0,,,,,
maternal and viral factors in vertical transmission of hiv-1 subtype e,Sutthent R,,1997,pass,NR,0,,,,,
metagenomic sequencing of hiv-1 in the blood and female genital tract reveals little quasispecies diversity during acute infection,Piantadosi A,10.1128/JVI.00804-18,2019,pass,no quantification,0,,,,,
"diversity of hiv-1 genetic subtypes in france, in the context of mother-to-child transmission",Chaix M-L,10.1097/00002030-200002180-00018,2000,pass,NA,0,,,,,
link between the numbers of particles and variants founding new hiv-1 infections depends on the timing of transmission,Thompson RN,10.1093/ve/vey038,2019,pass,modelling study,0,,,,,
effects of replicative fitness on competing hiv strains,Chirove F,10.1016/j.biosystems.2013.04.001,2013,pass,modelling,0,,,,,
new insights into the evolutionary rate of hiv-1 at the within-host and epidemiological levels,Lythgoe KA,10.1098/rspb.2012.0595,2012,pass,modelling,0,,,,,
fitness costs and diversity of the cytotoxic t lymphocyte (ctl) response determine the rate of ctl escape during acute and chronic phases of hiv infection,Ganusov VV,10.1128/JVI.00655-11,2011,pass,modelling,0,,,,,
dynamic correlation between intrahost hiv-1 quasispecies evolution and disease progression,Lee HY,10.1371/journal.pcbi.1000240,2008,pass,modelling,0,,,,,
the genital tract and rectal microbiomes: their role in hiv susceptibility and prevention in women,Abdool Karim SS,10.1002/jia2.25300,2019,pass,microbiome,0,,,,,
altered vaginal microbiota are associated with perinatal mother-to-child transmission of hiv in african women from burkina faso,Frank DN,10.1097/QAI.0b013e31824e4bdb,2012,pass,microbiome,0,,,,,
compartmentalization of surface envelope glycoprotein of human immunodeficiency virus type 1 during acute and chronic infection,Zhang L,10.1128/jvi.76.18.9465-9473.2002,2002,pass,intrahost evolution,0,,,,,
consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection,Shankarappa R,10.1128/JVI.73.12.10489-10502.1999,1999,pass,intrahost evolution,0,,,,,
analysis of hiv-1 env gene sequences reveals evidence for a low effective number in the viral population,Brown AJ,10.1073/pnas.94.5.1862,1997,pass,intrahost evolution,0,,,,,
convergent evolution within the v3 loop domain of human immunodeficiency virus type 1 in association with disease progression,Strunnikova N,10.1128/JVI.69.12.7548-7558.1995,1995,pass,intrahost evolution,0,,,,,
full-length genome sequencing of hiv type 1 group o viruses isolated from a heterosexual transmission cluster in senegal,Kane CT,10.1089/088922201316912817,2001,pass,group O,0,,,,,
key positions of hiv-1 env and signatures of vaccine efficacy show gradual reduction of population founder effects at the clade and regional levels,Han C,10.1128/mBio.00126-20,2020,pass,global bottlenecks,0,,,,,
erratum: publisher correction: in vitro replicative fitness of early transmitted founder hiv-1 variants and sensitivity to interferon alpha (scientific reports (2020) 10 1 (2747)),Ashokkumar M,10.1038/s41598-020-68818-1,2020,pass,erratum,0,,,,,
publisher correction: in vitro replicative fitness of early transmitted founder hiv-1 variants and sensitivity to interferon alpha,Ashokkumar M,10.1038/s41598-020-68818-1,2020,pass,erratum,0,,,,,
phenotypic properties influencing hiv-1 transmission fitness,Klein K,10.7448/IAS.18.5.20350,2015,pass,erratum,0,,,,,
within-host evolution of x4 hiv-1 in a rare transmission pair revealed by phylogenetic reconstruction of deep-sequence data,Le A,10.7448/IAS.18.5.20420,2015,pass,erratum,0,,,,,
incident cases characterization and deep sequencing provide new insight into multiplicity of infection and hiv evolution in very early acute infection,Kijak G,10.1186/1742-4690-9-S2-P143,2012,pass,erratum,0,,,,,
virus genetic variability involvement in transmissibility of hiv-1 immune activation and disease progression,Khouri R,10.2217/fvl.15.96,2015,pass,editorial,0,,,,,
low-frequency nnrti-resistant hiv-1 variants and relationship to mutational load in antiretroviral-naive subjects,Gupta S,10.3390/v6093428,2014,pass,drug resistance,0,,,,,
"hiv-1 transmission patterns in antiretroviral therapy-naive, hiv-infected north americans based on phylogenetic analysis by population level and ultra-deep dna sequencing",Ross LL,10.1371/journal.pone.0089611,2014,pass,drug resistance,0,,,,,
ultra-deep sequencing of hiv-1 reverse transcriptase before start of an nnrti-based regimen in treatment-naive patients,Messiaen,10.1016/j.virol.2012.01.002,2012,pass,drug resistance,0,,,,,
sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated brazilian individuals,Brindeiro R,10.1128/AAC.43.7.1674,1999,pass,drug resistance,0,,,,,
deep sequence analysis of hiv adaptation following vertical transmission: importance of human leucocyte antigen-driven selection on the evolution of hiv,Gaudieri S,10.1002/jia2.25327,2019,pass,conference,0,,,,,
differential infection of cultured peripheral and cns cells by distinct transmitted/founder hiv-1 infectious molecular clones (imc),Balinang J,10.1089/aid.2018.5000.abstracts,2018,pass,conference,0,,,,,
transmission of unique intersubtype hiv-1 recombinants predominate in both single and multiple variant infections in uganda,Balinda SN,10.1089/aid.2018.5000.abstracts,2018,pass,conference,0,,,,,
"the virtue of simplicity: the vaginal microbiome, genital inflammation and hiv risk",Kwon D,10.1111/aji.12981,2018,pass,conference,0,,,,,
infection with multiple transmitted/founder (tf) hiv-1 viruses impacts peak vl and hiv-1 pathogenesis,Macharia G,10.1089/aid.2018.5000.abstracts,2018,pass,conference,0,,,,,
molecular epidemiological of hiv-1 virus among blood donors in malaysia,Ab Halim M,10.1111/vox.12530,2017,pass,conference,0,,,,,
splicing in a panel of hiv-1 transmitted/founder viruses,Emery A,,2017,pass,conference,0,,,,,
exponential growth of hiv dependent on burst size breakthrough of the allee threshold,Hataye JM,,2017,pass,conference,0,,,,,
deep sequencing reveals rare cns compartmentalization in acute hiv-1 infection,Sirijatuphat R,,2017,pass,conference,0,,,,,
type 1 interferon resistance is a hallmark of mucosally transmitted hiv-1,Bibollet-Ruche F,,2016,pass,conference,0,,,,,
sieve pressure toward the cd4 binding site of env in hvtn 505 breakthrough infections,DeCamp AC,10.1089/aid.2016.5000.abstracts,2016,pass,conference,0,,,,,
"hiv-1 subtype c transmitted/founder variants do not downregulate hla-i, cd4 or cd62l differently than non-transmitted donor variants",Ende Z,10.1089/aid.2016.5000.abstracts,2016,pass,conference,0,,,,,
early events in hiv-1 infection: new insight from the rv217 early capture acute infection cohort,Kijak G,10.1089/aid.2016.5000.abstracts,2016,pass,conference,0,,,,,
assessing hiv transmission networks in a thai cohort with acute hiv infection,Kroon E,,2016,pass,conference,0,,,,,
the transmission bottleneck of hiv-1 in idus of china xinjiang,Li F,10.1089/aid.2016.5000.abstracts,2016,pass,conference,0,,,,,
transmission of multiple hiv-1 founder viruses and high frequency of unique recombinant forms among msm in kenya,Macharia G,10.1089/aid.2016.5000.abstracts,2016,pass,conference,0,,,,,
characterizing viral evolution and bnab specificities in two subjects infected with closely related founder strains of hiv,Newman RM,10.1089/aid.2016.5000.abstracts,2016,pass,conference,0,,,,,
a mother-to-child hiv-1 transmission bottleneck? a new understanding of the selection biases underlying successful perinatal infection,Noble C,10.7448/IAS.19.8.21487,2016,pass,conference,0,,,,,
molecular characterization of vertically transmitted hiv-1 among children born to hiv-1 seropositive mothers in northern tanzania,Nyombi BM,10.1186/s12879-016-1466-6,2016,pass,conference,0,,,,,
effectiveness of broadly neutralizing antibodies against drug resistant and transmitter/founder hiv strains,Scott Y,10.1089/aid.2016.5000.abstracts,2016,pass,conference,0,,,,,
infant peripartum transmitted-founder hiv-1 variants are resistant to autologous maternal plasma neutralization,Smith CEP,10.1089/aid.2016.5000.abstracts,2016,pass,conference,0,,,,,
"phylogenetic analysis of hiv full genomes in london, uk: initial results from iconic",Yebra G,,2016,pass,conference,0,,,,,
"hiv transmission in male serodiscordant couples in australia, thailand and brazil",Bavinton BR,10.1136/sextrans-2015-052270.189,2015,pass,conference,0,,,,,
hiv-1/m+o dual infections and hiv-mo recombinants in france from 2004 to 2014,Cappy P,,2015,pass,conference,0,,,,,
hiv transmission linkage among seroconverting partners in hiv-discordant relationships in kenya,Chohan BH,,2015,pass,conference,0,,,,,
in vitro replication and interferon-alpha resistance of transmitted hiv-1 variants,Ende Z,,2015,pass,conference,0,,,,,
"genital immunology, the microbiota and hiv transmission",Kaul R,10.1136/sextrans-2015-052270.62,2015,pass,conference,0,,,,,
evaluation of hiv-1 clones for unique properties associated with transmission,Klein K,,2015,pass,conference,0,,,,,
phenotypic characterization of transmitted/founder virus in hiv-1 transmission pairs,Oberle CS,,2015,pass,conference,0,,,,,
hvtn505 breakthrough sequences show hiv vaccine-associated differences in env-gp120,Rolland M,,2015,pass,conference,0,,,,,
characterizing the ifnalpha resistance of transmitted founder hiv-1,Iyer SS,,2014,pass,conference,0,,,,,
molecular epidemiology analysis of hiv-1 circulating strain without receiving antiviral therapy,Wang F,10.1007/s12072-013-9429-0,2013,pass,conference,0,,,,,
"high prevalence of hiv-1 intersubtypes multiple infections in the metropolitan region of sao paulo, brazil",Nunes ERM,10.7448/IAS.15.5.18438,2012,pass,conference,0,,,,,
"using phylogenetic analysis to identify hiv transmission channels among persons newly diagnosed with hiv-1 infection in los angeles county, 2009-2010",Sey K,10.7448/IAS.15.5.18438,2012,pass,conference,0,,,,,
hiv-1 populations that persist in plasma after long-term suppressive art are more closely related to ancestral sequences than are pre-therapy populations,Kearney M,,2011,pass,conference,0,,,,,
evolution of hiv-1 transmitted/founder viruses results in the formation of epitopes for later broadly cross-neutralizing antibodies,Moore PL,10.1089/aid.2011.1502,2011,pass,conference,0,,,,,
early selective pressures acting on the hiv-1 subtype c transmitted whole genome in five individuals with differing disease progression profiles,Abrahams M,10.1089/aid.2010.9998,2010,pass,conference,0,,,,,
quantifying factors determining the rate of ctl escape and reversion during acute and chronic phases of hiv infection,Ganusov VV,10.1089/aid.2010.9998,2010,pass,conference,0,,,,,
ultra-deep sequencing during acute hiv infection reveals complex adaptive changes to host selection pressures,Henn M,10.1089/aid.2010.9998,2010,pass,conference,0,,,,,
molecular identification of transmitted/founder viruses by single genome amplification following percutaneous occupational exposure to hiv-1,Li H,10.1089/aid.2010.9998,2010,pass,conference,0,,,,,
genotypic prediction of hiv-1 coreceptor usage based on single genome analysis of proviral dna,Martinez-Prats L,,2010,pass,conference,0,,,,,
evolution of the same hiv-1 transmitted/founder virus in two hosts,Pavlicek JW,10.1089/aid.2010.9998,2010,pass,conference,0,,,,,
detecting selective sweeps in hiv-1 within patients by phylogenetic analysis of next-generation sequencing data,Poon AF,,2010,pass,conference,0,,,,,
hiv-1 acute infection: evidence of selection?,Rolland M,10.1089/aid.2010.9998,2010,pass,conference,0,,,,,
short communication: nucleotide variation and positively selected sites in hiv type 1 reverse transcriptase among heterosexual transmission pairs,Shanmugasundaram U,10.1089/aid.2010.0003,2010,pass,conference,0,,,,,
nucleotide variation and positively selected sites in hiv type 1 reverse transcriptase among heterosexual transmission pairs,Uma Shanmugasundaram,10.1089/aid.2010.0003,2010,pass,conference,0,,,,,
molecular evolution of hiv-1 subtype a transmitted/founder viruses in response to cytotoxic t-cell and neutralizing antibodies after transmission,Yue L,10.1089/aid.2010.9998,2010,pass,conference,0,,,,,
molecular epidemiology of hiv-1 transmission in heterosexual pairs,Chkhartishvili N,10.1111/j.1468-1293.2009.00792.x,2009,pass,conference,0,,,,,
"hiv transmission amongst msm: association with antiretroviral therapy, infection stage, viraemia and sexually transmitted infections (sti) in a longitudinal phylogenetic study",Fisher M,10.1111/j.1468-1293.2009.00705.x,2009,pass,conference,0,,,,,
phylogenetic relatedness of hiv-1 donor and recipient populations,Wertheim JO,10.1093/infdis/jit021,2013,pass,editorial,0,,,,,
compartmentalization of hiv-1 within the female genital tract is due to monotypic and low-diversity variants not distinct viral populations,Bull M,10.1371/journal.pone.0007122,2009,pass,chronic individuals,0,,,,,
evaluation of dried blood spots with a multiplex assay for measuring recent hiv-1 infection,Curtis KA,10.1371/journal.pone.0107153,2014,pass,assay eval,0,,,,,
biological and genetic characterization of hiv type 1 subtype b and nonsubtype b transmitted viruses: usefulness for vaccine candidate assessment,Cuevas,10.1089/aid.2010.0018,2010,pass,assay eval,0,,,,,
comparison of standard pcr/cloning to single genome sequencing for analysis of hiv-1 populations,Jordan MR,10.1016/j.jviromet.2010.04.030,2010,pass,assay eval,0,,,,,
primary isolates of human immunodeficiency virus type 1 are usually dominated by the major variants found in blood,Voronin Y,10.1128/JVI.01035-07,2007,pass,assay eval,0,,,,,
rapid molecular epidemiology of human immunodeficiency virus transmission,Delwart EL,10.1089/aid.1995.11.1081,1995,pass,assay eval,0,,,,,
novel bimodular dna aptamers with guanosine quadruplexes inhibit phylogenetically diverse hiv-1 reverse transcriptases,Michalowski D,10.1093/nar/gkn891,2008,NR,-,0,,,,,
"""a dream come true"": perspectives on long-acting injectable antiretroviral therapy among female sex workers living with hiv from the dominican republic and tanzania",Kerrigan D,10.1371/journal.pone.0234666,2020,NR,,0,,,,,
#testathome: implementing 2 phases of a hiv self-testing program through community-based organization partnerships in new york city,Hubbard SJ,10.1097/OLQ.0000000000001151,2020,NR,,0,,,,,
163 moving the needle forward: what factors are associated with engagement of at-risk young black and latinx transgender women and men who have sex with men into a behavioral hiv intervention?,Villalona S,10.1016/j.jadohealth.2019.11.166,2020,NR,,0,,,,,
"identification of a novel hiv-1 unique crf01_ae/c recombinant in yan'an city, shaanxi province",Cheng SW,10.1089/AID.2020.0174,2020,NR,,0,,,,,
near full-length genomic characterization of a novel hiv-1 circulating recombinant form (crf106_cpx) identified among heterosexuals in china,Zhou J,10.1089/AID.2020.0101,2020,NR,,0,,,,,
a dual-app nucleoside probe reports g-quadruplex formation and ligand binding in the long terminal repeat of hiv-1 proviral genome,Sontakke VA,10.1016/j.bmcl.2020.127345,2020,NR,,0,,,,,
a geographic hotspot and emerging transmission cluster of the hiv-1 epidemic among older adults in a rural area of eastern china,Fan Q,10.1089/AID.2019.0293,2020,NR,,0,,,,,
"a high-throughput hiv-1 drug screening platform, based on lentiviral vectors and compatible with biosafety level-1",Ellinger B,10.3390/v12050580,2020,NR,,0,,,,,
sequence and functional variation in the hiv-1 rev regulatory axis,Jackson PEH,10.2174/1570162X18666200106112842,2020,NR,,0,,,,,
genetic variability of the u5 and downstream sequence of major hiv-1 subtypes and circulating recombinant forms,Mbondji-Wonje C,10.1038/s41598-020-70083-1,2020,NR,,0,,,,,
a new cell line for assessing hiv-1 antibody dependent cellular cytotoxicity against a broad range of variants,Thomas AS,10.1016/j.jim.2020.112766,2020,NR,,0,,,,,
a comprehensive genomics solution for hiv surveillance and clinical monitoring in low income settings,Bonsall D,10.1128/JCM.00382-20,2020,NR,,0,,,,,
racial differences in dermatologic conditions associated with hiv: a cross-sectional study of 4679 patients in an urban tertiary care center,Bender AM,10.1016/j.jaad.2019.08.072,2020,NR,,0,,,,,
the hiv-1 accessory protein vpu downregulates peroxisome biogenesis,Xu Z,10.1128/mBio.03395-19,2020,NR,,0,,,,,
a zika virus envelope mutation preceding the 2015 epidemic enhances virulence and fitness for transmission,Shan C,10.1073/pnas.2005722117,2020,NR,,0,,,,,
acceptability of routine point-of-care early infant diagnosis in eight african countries: findings from a qualitative assessment of clinical and laboratory personnel (special issue: closer to home: evidence for use of point-of-care nucleic acid testing for early infant diagnosis of hiv and beyond),Bianchi,10.1097/QAI.0000000000002372,2020,NR,,0,,,,,
accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-b subtype hiv-1 strains from patients failing raltegravir in uganda,Ndashimye E,10.1093/jac/dkaa355,2020,NR,,0,,,,,
"identification of a novel hiv-1 crf55_01b/b recombinant isolate in guangxi, china",Liang B,10.1089/AID.2019.0222,2020,NR,,0,,,,,
"adherence to antiretroviral therapy among hiv-positive pregnant women on followup at mizan tepi university teaching and tepi general hospitals, southwest ethiopia",Aferu T,10.1177/2150132720902561,2020,NR,,0,,,,,
a cross-sectional evaluation of hiv testing practices among women in the rural dominican republic,Montgomery MC,10.1186/s12905-020-0891-2,2020,NR,,0,,,,,
hiv-1 unique recombinant forms identified in slovenia and their characterization by near full-length genome sequencing,Lunar MM,10.3390/v12010063,2020,NR,,0,,,,,
"a cross-sectional study to characterize local hiv-1 dynamics in washington, dc using next-generation sequencing",Gibson KM,10.1038/s41598-020-58410-y,2020,NR,,0,,,,,
hiv-1 central nervous system compartmentalization and cytokine interplay in non-subtype b hiv-1 infections in nigeria and malawi,Adewumi OM,10.1089/AID.2019.0245,2020,NR,,0,,,,,
genetic clustering analysis for hiv infection among msm in nigeria: implications for intervention,Li Y,10.1097/QAD.0000000000002409,2020,NR,,0,,,,,
interferon lambda rs368234815 deltag/deltag is associated with higher cd4+:cd8+ t-cell ratio in treated hiv-1 infection,Freitas IT,10.1186/s12981-020-00269-0,2020,NR,,0,,,,,
premature stop codon at residue 101 within hiv-1 rev does not influence viral replication of clade bc but severely reduces viral fitness of clade b,Wang Z,10.1007/s12250-019-00179-0,2020,NR,,0,,,,,
altered-specificity mutants of the hiv rev arginine-rich motif-rre iib interaction,Raad NG,10.1002/jmr.2833,2020,NR,,0,,,,,
adeno-associated viral vector mediated expression of broadly- neutralizing antibodies against hiv-hitting a fast-moving target,Sherpa C,10.2174/1570162X18666200210121339,2020,NR,,0,,,,,
a near full-length hiv-1 genome from 1966 recovered from formalin-fixed paraffin-embedded tissue,Gryseels S,10.1073/pnas.1913682117,2020,NR,,0,,,,,
a de novo approach to inferring within-host fitness effects during untreated hiv-1 infection,Illingworth CJR,10.1371/journal.ppat.1008171,2020,NR,,0,,,,,
a novel alignment-free method for hiv-1 subtype classification,He L,10.1016/j.meegid.2019.104080,2020,NR,,0,,,,,
natural presence of v179e and rising prevalence of e138g in hiv-1 reverse transcriptase in crf55_01b viruses,Liu Y,10.1016/j.meegid.2019.104098,2020,NR,,0,,,,,
an hiv vaccine targeting the v2 region of the hiv envelope induces a highly durable polyfunctional fc-mediated antibody response in rhesus macaques,Powell RL,10.1128/JVI.01175-20,2020,NR,,0,,,,,
diverse effects of interferon alpha on the establishment and reversal of hiv latency,Van der Sluis RM,10.1371/journal.ppat.1008151,2020,NR,,0,,,,,
cross-reactive cd8 t-cell responses elicited by adenovirus type 5-based hiv-1 vaccines contributed to early viral evolution in vaccine recipients who became infected,Boppana S,10.1128/JVI.01632-19,2020,NR,,0,,,,,
a universal car-nk cell targeting various epitopes of hiv-1 gp160,Lim RM,10.1021/acschembio.0c00537,2020,NR,,0,,,,,
arthropod bite-like eruption as rare presentation of secondary syphilis in an hiv-infected patient,Chen CY,10.4103/ijd.IJD_522_18,2020,NR,,0,,,,,
"belief, covariates, and impact of the ""undetectable = untransmittable"" message among people living with hiv in australia",Huntingdon B,10.1089/apc.2019.0300,2020,NR,,0,,,,,
blood and lymph node dissemination of clonal genome-intact human immunodeficiency virus 1 dna sequences during suppressive antiretroviral therapy,Kuo HH,10.1093/infdis/jiaa137,2020,NR,,0,,,,,
blood bacterial profiles associated with hiv infection and immune recovery,Serrano-Villar S,10.1093/infdis/jiaa379,2020,NR,,0,,,,,
bridging the digital divide among racial and ethnic minority men who have sex with men to reduce substance use and hiv risk: mixed methods feasibility study,Hsiang E,10.2196/15282,2020,NR,,0,,,,,
broaching the topic of hiv self-testing with potential sexual partners among men and transgender women who have sex with men in new york and puerto rico,Lentz C,10.1007/s10461-020-02851-z,2020,NR,,0,,,,,
determination of rna structural diversity and its role in hiv-1 rna splicing,Tomezsko PJ,10.1038/s41586-020-2253-5,2020,NR,,0,,,,,
characterization of human respiratory syncytial virus (rsv) isolated from hiv-exposed-uninfected and hiv-unexposed infants in south africa during 2015-2017,Liu H,10.1111/irv.12727,2020,NR,,0,,,,,
characterization of subtypes and transmitted drug resistance strains of hiv among beijing residents between 2001-2016,Ye J,10.1371/journal.pone.0230779,2020,NR,,0,,,,,
characterizing social cohesion and gender identity as risk determinants of hiv among cisgender men who have sex with men and transgender women in cote d'ivoire,Moran,10.1016/j.annepidem.2019.11.003,2020,NR,,0,,,,,
choosing the right program for the identification of hiv-1 transmission networks from nucleotide sequences sampled from different populations,Bbosa N,10.1089/AID.2020.0033,2020,NR,,0,,,,,
challenges for accessing and maintaining good quality of hiv care among men who have sex with men living with hiv in china: a qualitative study with key stakeholders,Li ChunYan,10.1080/09540121.2020.1739210,2020,NR,,0,,,,,
comparison of hiv drug resistance profiles across hiv-1 subtypes a and d for patients receiving a tenofovir-based and zidovudine-based first line regimens in uganda,Ayitewala A,10.1186/s12981-020-0258-7,2020,NR,,0,,,,,
composition of gut microbiota of children and adolescents with perinatal human immunodeficiency virus infection taking antiretroviral therapy in zimbabwe,Flygel TT,10.1093/infdis/jiz473,2020,NR,,0,,,,,
characterization of co-formulated high-concentration broadly neutralizing anti-hiv-1 monoclonal antibodies for subcutaneous administration,Sharma VK,10.3390/antib9030036,2020,NR,,0,,,,,
consensus document on enhancing medication adherence in patients with the human immunodeficiency virus receiving antiretroviral therapy,Morillo-Verdugo R,10.7399/fh.11441,2020,NR,,0,,,,,
characterization of hiv-1 diversity in various compartments at the time of primary infection by ultradeep sequencing,Gaube G,10.1038/s41598-020-59234-6,2020,NR,,0,,,,,
"context, types, and consequences of violence across the life course: a qualitative study of the lived experiences of transgender women living with hiv",Lacombe-Duncan A,10.1177/0886260520935093,2020,NR,,0,,,,,
contribution of transgender sex workers to the complexity of the hiv-1 epidemic in the metropolitan area of milan,Lai A,10.1136/sextrans-2019-054103,2020,NR,,0,,,,,
"characterizing the latent hiv-1 reservoir in patients with viremia suppressed on cart: progress, challenges, and opportunities",Rausch JW,10.2174/1570162X18666191231105438,2020,NR,,0,,,,,
chemical profiling of hiv-1 capsid-targeting antiviral pf74,Wang L,10.1016/j.ejmech.2020.112427,2020,NR,,0,,,,,
cxcr4-using hiv strains predominate in naive and central memory cd4+ t cells in people living with hiv on antiretroviral therapy: implications for how latency is established and maintained,Roche M,10.1128/JVI.01736-19,2020,NR,,0,,,,,
demographic differences in people living with hiv according to recruitment sources: comparison between health-care systems and social media networks,Hsiao Y-H,10.1080/09540121.2019.1668524,2020,NR,,0,,,,,
"development of a new comprehensive hiv-1 genotypic drug resistance assay for all commercially available reverse transcriptase, protease and integrase inhibitors in patients infected with group m hiv-1 strains",Chrysostomou,10.1016/j.meegid.2020.104243,2020,NR,,0,,,,,
compartmentalization and clonal amplification of hiv-1 in the male genital tract characterized using next-generation sequencing,Kariuki SM,10.1128/JVI.00229-20,2020,NR,,0,,,,,
different and diverse anaerobic microbiota were seen in women living with hiv with unsuppressed hiv viral load and in women with recurrent bacterial vaginosis: a cohort study,Elwood C,10.1111/1471-0528.15930,2020,NR,,0,,,,,
direct binding of polymeric gbp1 to lps disrupts bacterial cell envelope functions,Kutsch M,10.15252/embj.2020104926,2020,NR,,0,,,,,
diversity and function of maternal hiv-1-specific antibodies at the time of vertical transmission,Doepker LE,10.1128/JVI.01594-19,2020,NR,,0,,,,,
drug-resistance mutation frequency of sga-derived hiv-1 polymerase genomes in the csf and plasma of hiv-1-infected individuals under non-suppressive therapy,St Bernard L,10.1128/JVI.01824-19,2020,NR,,0,,,,,
dynamics of hiv dna reservoir seeding in a cohort of superinfected kenyan women,Pankau MD,10.1371/journal.ppat.1008286,2020,NR,,0,,,,,
earlier treatment initiation is associated with a decreased number of hiv-1 subtype a1 transmissions in greece,Kostaki EG,10.1136/sextrans-2020-054509,2020,NR,,0,,,,,
effect of a nutritional intervention on the intestinal microbiota of vertically hiv-infected children: the pediabiota study,Sainz T,10.3390/nu12072112,2020,NR,,0,,,,,
effect of synaptic cell-to-cell transmission and recombination on the evolution of double mutants in hiv,Kreger J,10.1098/rsif.2019.0832,2020,NR,,0,,,,,
defective hiv-1 envelope gene promotes the evolution of the infectious strain through recombination in vitro,Wei H,10.1186/s12879-020-05288-w,2020,NR,,0,,,,,
effectiveness of a mobile antiretroviral pharmacy and hiv care intervention on the continuum of hiv care in rural uganda,Bajunirwe F,10.1080/09540121.2020.1753006,2020,NR,,0,,,,,
deficient uracil base excision repair leads to persistent dump in hiv proviruses during infection of monocytes and macrophages,Meshesha M,10.1371/journal.pone.0235012,2020,NR,,0,,,,,
ending the hiv epidemic in the usa: an economic modelling study in six cities,Nosyk B,10.1016/S2352-3018%2820%2930033-3,2020,NR,,0,,,,,
engineering antibody-based molecules for hiv treatment and cure,Tuyishime M,10.1097/COH.0000000000000640,2020,NR,,0,,,,,
factors associated with human immunodeficiency virus infections linked in genetic clusters but disconnected in partner tracing,Pasquale DK,10.1097/OLQ.0000000000001094,2020,NR,,0,,,,,
enrichment of the airway microbiome in people living with hiv with potential pathogenic bacteria despite antiretroviral therapy,Rofael SAD,10.1016/j.eclinm.2020.100427,2020,NR,,0,,,,,
env diversity-dependent protection of the attenuated equine infectious anaemia virus vaccine,Lin Y,10.1080/22221751.2020.1773323,2020,NR,,0,,,,,
ethnically diverse urban transmission networks of neisseria gonorrhoeae without evidence of hiv serosorting,Dave,10.1136/sextrans-2019-054025,2020,NR,,0,,,,,
evaluation of hiv-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors,Scutari R,10.1016/j.jgar.2019.07.015,2020,NR,,0,,,,,
"genetic diversity of human immunodeficiency virus type 1 in asymptomatic blood donors in islamabad, pakistan",Waheed U,10.1055/s-0040-1716593,2020,NR,,0,,,,,
evidence for hiv-1 cure after ccr5delta32/delta32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report,Gupta RK,10.1016/S2352-3018(20)30069-2,2020,NR,,0,,,,,
distinct viral reservoirs in individuals with spontaneous control of hiv-1,Jiang C,10.1038/s41586-020-2651-8,2020,NR,,0,,,,,
evolutionary remodelling of the cell envelope in bacteria of the planctomycetes phylum,Mahajan M,10.1093/gbe/evaa159,2020,NR,,0,,,,,
exploring the potency of currently used drugs against hiv-1 protease of subtype d variant by using multiscale simulations,Sk MF,10.1080/07391102.2020.1724196,2020,NR,,0,,,,,
"first detection of a circulating recombinant form of hiv-1 crf01_ae/08_bc (crf105_0108) with drug-resistant mutations in sichuan, china",Dong A,10.1089/AID.2020.0034,2020,NR,,0,,,,,
fulminant central nervous system varicella-zoster virus infection unexpectedly diagnosed by metagenomic next-generation sequencing in an hiv-infected patient: a case report,Fang M,10.1186/s12879-020-4872-8,2020,NR,,0,,,,,
hiv-1 genotype is independently associated with immunodeficiency progression among chinese men who have sex with men: an observational cohort study,Liang Y,10.1111/hiv.12823,2020,NR,,0,,,,,
"efficacy and impact of digital hiv care navigation in young people living with hiv in san francisco, california: prospective study",Arayasirikul S,10.2196/18597,2020,NR,,0,,,,,
"gender-related factors that influence uptake of hiv services in women who inject drugs: a community based qualitative study in st petersburg, russia",King EJ,10.1016/S2214-109X%2820%2930152-2,2020,NR,,0,,,,,
genetic and epigenetic regulation of natural resistance to hiv-1 infection: new approaches to unveil the hesn secret,Fenizia C,10.1080/1744666X.2020.1732820,2020,NR,,0,,,,,
envelope characteristics in individuals who developed neutralizing antibodies targeting different epitopes in hiv-1 subtype c infection,Ndlovu B,10.1016/j.virol.2020.03.003,2020,NR,,0,,,,,
"genetic diversity and drug resistance of hiv-1 crf55_01b in guangdong, china",Yu GuoLong,10.2174/1570162X18666200415140652,2020,NR,,0,,,,,
genetic diversity of hiv in seminal plasma remains higher than in blood after short-term antiretroviral therapy,Lopez Zuniga,10.1136/sextrans-2020-054439,2020,NR,,0,,,,,
"genetic diversity, compartmentalization, and age of hiv proviruses persisting in cd4+ t cell subsets during long-term combination antiretroviral therapy",Jones BR,10.1128/JVI.01786-19,2020,NR,,0,,,,,
genetic transmission networks of hiv-1 crf07_bc strain among hiv-1 infections with virologic failure of art in a minority area of china: a population-based study,Yuan D,10.1186/s12879-020-05347-2,2020,NR,,0,,,,,
"genomic characterization of a novel hiv type 1 strain originating from crf07_bc and crf01_ae by heterosexual transmission in the lingshan prefecture of guangxi province, china",Jiang J,10.1089/aid.2019.0182,2020,NR,,0,,,,,
geographic distribution of hiv transmission networks in the united states,Board AR,10.1097/QAI.0000000000002448,2020,NR,,0,,,,,
high frequency of new recombinant forms in hiv-1 transmission networks demonstrated by full genome sequencing,Hebberecht L,10.1016/j.meegid.2020.104365,2020,NR,,0,,,,,
"high prevalence of hiv-1 drug resistance and dynamics of transmission among high-risk populations in port-au-prince, haiti",Jean Louis F,10.1097/QAI.0000000000002475,2020,NR,,0,,,,,
"hiv risk profile and its socio-demographic correlates among long-distance truckers in west bengal, india: evidence from national hiv sentinel surveillance 2017",Biswas S,10.4103/ijph.IJPH_98_20,2020,NR,,0,,,,,
hiv rna rebound in seminal plasma after antiretroviral treatment interruption,Gianella S,10.1128/JVI.00415-20,2020,NR,,0,,,,,
evaluation of an emergency department and hospital-based data exchange to improve hiv care engagement and viral suppression,Avoundjian,10.1097/OLQ.0000000000001195,2020,NR,,0,,,,,
intersectional stigmas and hiv-related outcomes among a cohort of key populations enrolled in stigma mitigation interventions in senegal,Lyons CE,10.1097/QAD.0000000000002641,2020,NR,,0,,,,,
conformational landscape of non-b variants of hiv-1 protease: a pulsed epr study,Tran TT,10.1016/j.bbrc.2020.08.030,2020,NR,,0,,,,,
identification of a deep intronic polr3a variant causing inclusion of a pseudoexon derived from an alu element in pol iii-related leukodystrophy,Hiraide T,10.1038/s10038-020-0786-y,2020,NR,,0,,,,,
sialylation and fucosylation modulate inflammasome-activating eif2 signaling and microbial translocation during hiv infection,Giron LB,10.1038/s41385-020-0279-5,2020,NR,,0,,,,,
"identification of a novel hiv-1 unique crf01_ae/c recombinant in yan`an city, shaanxi province",Cheng S-W,10.1089/AID.2020.0174,2020,NR,,0,,,,,
hiv postexposure prophylaxis during covid-19,Junejo M,10.1016/S2352-3018%2820%2930146-6,2020,NR,,0,,,,,
exploiting b cell receptor analyses to inform on hiv-1 vaccination strategies,Kreer C,10.3390/vaccines8010013,2020,NR,,0,,,,,
exploring the association between mobility and access to hiv services among female sex workers in zimbabwe,Davey C,10.1007/s10461-019-02559-9,2020,NR,,0,,,,,
medical personnel knowledge and stigmatic attitude toward hiv patients in a high-income country,Shahar E,10.1080/09540121.2020.1734172,2020,NR,,0,,,,,
genetic adjuvants in replicating single-cycle adenovirus vectors amplify systemic and mucosal immune responses against hiv-1 envelope,Matchett WE,10.3390/vaccines8010064,2020,NR,,0,,,,,
hiv-1 drug resistance in art-naive individuals in myanmar,Ye M,10.2147/IDR.S246462,2020,NR,,0,,,,,
near full-length genomic characterization of a novel hiv-1 circulating recombinant form (crf106_cpx) identifified among heterosexuals in china,Zhou J,10.1089/AID.2020.0101,2020,NR,,0,,,,,
positive and negative emotional expression measured from a single written essay about trauma predicts survival 17 years later in people living with hiv,Ironson G,10.1016/j.jpsychores.2020.110166,2020,NR,,0,,,,,
hiv-1 gag mutations alone are sufficient to reduce darunavir susceptibility during virological failure to boosted pi therapy,Blanch-Lombarte O,10.1093/jac/dkaa228,2020,NR,,0,,,,,
adeno-associated viral vector mediated expression of broadly neutralizing antibodies against hiv-hitting a fast-moving target,Sherpa C,10.2174/1570162X18666200210121339,2020,NR,,0,,,,,
"regulation of the er stress response by the ion channel activity of the infectious bronchitis coronavirus envelope protein modulates virion release, apoptosis, viral fitness, and pathogenesis",Li S,10.3389/fmicb.2019.03022,2020,NR,,0,,,,,
"identification of a novel hiv-1 crf55-01b/b recombinant isolate in guangxi, china",Liang B,10.1089/aid.2019.0222,2020,NR,,0,,,,,
"hiv-1 genetic diversity and high prevalence of pretreatment drug resistance in tianjin, china",Zeng R,10.1089/AID.2020.0056,2020,NR,,0,,,,,
"hiv-1 genetic diversity and transmitted drug resistance among newly diagnosed hiv-1 individuals in jiangmen, china",Guan X,10.1002/jmv.25741,2020,NR,,0,,,,,
hiv-1 genetic diversity and transmitted drug resistance mutations in female sex workers from a brazilian municipality in the amazon region,da Costa LM,10.1089/AID.2019.0243,2020,NR,,0,,,,,
hiv-related stigma among health-care workers in the mena region,Ballouz T,10.1016/S2352-3018%2819%2930401-1,2020,NR,,0,,,,,
global mapping of interventions to improve the quality of life of people living with hiv/aids: implications for priority settings,Tran BX,10.24875/AIDSRev.20000135,2020,NR,,0,,,,,
factors associated with loss-to-follow-up of hiv-positive mothers and their infants enrolled in hiv care clinic: a qualitative study,Mpinganjira S,10.1186/s12889-020-8373-x,2020,NR,,0,,,,,
a randomized controlled efficacy trial of an mhealth hiv prevention intervention for sexual minority young men: mypeeps mobile study protocol,Kuhns LM,10.1186/s12889-020-8180-4,2020,NR,,0,,,,,
hiv pre-exposure prophylaxis for female sex workers: ensuring women's family planning needs are not left behind,Bowring AL,10.1002/jia2.25442,2020,NR,,0,,,,,
"genome sequence of a novel hiv-1 circulating recombinant form (crf103-01b) identified from hebei province, china",Zhou J,10.1089/aid.2019.0196,2020,NR,,0,,,,,
hiv-1 molecular epidemiology and drug resistance-associated mutations among treatment-naive blood donors in china,Zhao J,10.1038/s41598-020-64463-w,2020,NR,,0,,,,,
"hiv-1 genetic diversity and recombinant forms among men who have sex with men at a sentinel surveillance site in xi'an city, china",Chang W,10.1016/j.meegid.2020.104257,2020,NR,,0,,,,,
the impact of localized implementation: determining the cost-effectiveness of hiv prevention and care interventions across six united states cities,Krebs E,10.1097/QAD.0000000000002455,2020,NR,,0,,,,,
defective hiv-1 proviruses produce viral proteins,Imamichi H,10.1073/pnas.1917876117,2020,NR,,0,,,,,
hiv-1 phylodynamic analysis among people who inject drugs in pakistan correlates with trends in illicit opioid trade,Cholette F,10.1371/journal.pone.0237560,2020,NR,,0,,,,,
"five waves of an online hiv self-test giveaway in new york city, 2015 to 2018",Edelstein,10.1097/OLQ.0000000000001144,2020,NR,,0,,,,,
food insecurity among people living with hiv/aids on art follower at public hospitals of western ethiopia,Adugna Oluma,10.1155/2020/8825453,2020,NR,,0,,,,,
"persistence with hiv preexposure prophylaxis in the united states, 2012-2017",Huang Y-LA,10.1093/cid/ciaa037,2020,NR,,0,,,,,
hiv-1 pseudoviruses constructed in china regulatory laboratory,Nie J,10.1080/22221751.2019.1702479,2020,NR,,0,,,,,
full-length title: dramatic hiv dna degradation associated with spontaneous hiv suppression and disease-free outcome in a young seropositive woman following her infection,Colson P,10.1038/s41598-020-58969-6,2020,NR,,0,,,,,
"hiv-1 sub-subtype a6: settings for normalised identification and molecular epidemiology in the southern federal district, russia",Schlosser M,10.3390/v12040475,2020,NR,,0,,,,,
"hiv-1 subtype distribution and diversity over 18 years in rakai, uganda",Lamers SL,10.1089/aid.2020.0062,2020,NR,,0,,,,,
"hiv-1 subtype variability and transmitted drug resistance in a culturally diverse population in western sydney, new south wales, australia",Richardson D,10.1071/SH20013,2020,NR,,0,,,,,
hiv-drlink: a tool for reporting linked hiv-1 drug resistance mutations in large single-genome datasets using the stanford hiv database,Shao W,10.1089/AID.2020.0109,2020,NR,,0,,,,,
host cell factors stimulate hiv-1 transcription by antagonizing substrate-binding function of siah1 ubiquitin ligase to stabilize transcription elongation factor ell2,Wu J,10.1093/nar/gkaa461,2020,NR,,0,,,,,
how follow-up counselling increases linkage to care among hiv-positive persons identified through home-based hiv counselling and testing: a qualitative study in uganda,Bukenya,,2020,NR,,0,,,,,
induction of identical igg hiv-1 envelope epitope recognition patterns after initial hivis-dna/mva-cmdr immunization and a late mva-cmdr boost,Joachim A,10.3389/fimmu.2020.00719,2020,NR,,0,,,,,
human immunodeficiency virus infection is associated with preterm delivery independent of vaginal microbiota in pregnant african women,Gudza-Mugabe M,10.1093/infdis/jiz584,2020,NR,,0,,,,,
hemagglutinating virus of japan envelope (hvj-e)-guided gene transfer to the intestinal epithelium,Imajo M,10.1007/978-1-0716-0747-3_19,2020,NR,,0,,,,,
human papillomavirus infection and cervical dysplasia in hiv-positive women potential role of the vaginal microbiota,Wijgert,10.1097/QAD.0000000000002381,2020,NR,,0,,,,,
human papillomavirus infection and cervical dysplasia in hiv-positive women: potential role of the vaginal microbiota,Van De Wijgert JHHM,10.1097/QAD.0000000000002381,2020,NR,,0,,,,,
"high hiv burden and recent transmission chains in rural forest areas in southern cameroon, where ancestors of hiv-1 have been identified in ape populations",Edoul G,10.1016/j.meegid.2020.104358,2020,NR,,0,,,,,
high levels of genetically intact hiv in hla-dr+ memory t cells indicates their value for reservoir studies,Horsburgh BA,10.1097/QAD.0000000000002465,2020,NR,,0,,,,,
high-risk sexual practices contribute to hiv-1 double infection among men who have sex with men in madrid,Casado C,10.1089/AID.2020.0068,2020,NR,,0,,,,,
identification of gp120 polymorphisms in hiv-1 b subtype potentially associated with resistance to fostemsavir,Bouba Y,10.1093/jac/dkaa073,2020,NR,,0,,,,,
hiv genetic diversity - superpower of a formidable virus,Sherpa C,10.2174/1570162X1802200311104204,2020,NR,,0,,,,,
impact of antiretroviral therapy duration on hiv-1 infection of t cells within anatomic sites,Lee E,10.1128/JVI.01270-19,2020,NR,,0,,,,,
impact of suboptimal apobec3g neutralization on the emergence of hiv drug resistance in humanized mice,Hernandez MM,10.1128/JVI.01543-19,2020,NR,,0,,,,,
leveraging crowdsourcing for human immunodeficiency virus testing posters: a visual content analysis and cognitive responses among chinese men who have sex with men,Smith MK,10.1097/OLQ.0000000000001213,2020,NR,,0,,,,,
hiv vaccine delayed boosting increases env variable region 2-specific antibody effector functions,Easterhoff D,10.1172/jci.insight.131437,2020,NR,,0,,,,,
hiv vpr modulates the host dna damage response at two independent steps to damage dna and repress double-strand dna break repair,Li D,10.1128/mBio.00940-20,2020,NR,,0,,,,,
indigenous traditional knowledge of medicinal plants used by herbalists in treating opportunistic infections among people living with hiv/aids in uganda,Anywar,10.1016/j.jep.2019.112205,2020,NR,,0,,,,,
hiv-1 pol gene diversity and molecular dating of subtype c from sri lanka,Patil A,10.1371/journal.pone.0234133,2020,NR,,0,,,,,
intact hiv proviruses persist in children seven to nine years after initiation of antiretroviral therapy in the first year of life,Katusiime MG,10.1128/JVI.01519-19,2020,NR,,0,,,,,
interrogating the recognition landscape of a conserved hiv-specific tcr reveals distinct bacterial peptide cross-reactivity,Mendoza JL,10.7554/eLife.58128,2020,NR,,0,,,,,
it all dials back to safety': a qualitative study of social and economic vulnerabilities among transgender women participating in hiv research in the usa,Reisner SL,10.1136/bmjopen-2019-029852,2020,NR,,0,,,,,
lack of association between amino acid sequences of the bovine leukemia virus envelope and varying stages of infection in dairy cattle,Ceron Tellez F,10.1016/j.virusres.2020.197866,2020,NR,,0,,,,,
learning robust multilabel sample specific distances for identifying hiv-1 drug resistance,Brand L,10.1089/cmb.2019.0329,2020,NR,,0,,,,,
level of adherence to antiretroviral therapy and its determinants among people living with hiv/aids accessing services at tertiary hospital -art centre,Sameeksha,,2020,NR,,0,,,,,
how can hiv/sti testing services be more accessible and acceptable for gender and sexually diverse young people? a brief report exploring young people's perspectives in queensland,Heard E,10.1002/hpja.263,2020,NR,,0,,,,,
hsf1 inhibition attenuates hiv-1 latency reversal mediated by several candidate lras in vitro and ex vivo,Timmons A,10.1073/pnas.1916290117,2020,NR,,0,,,,,
i want the heart of fierceness to arise within us': maintaining public space to promote hiv-related health with house ball community members in an era of gentrification,Wong,10.1080/13691058.2019.1606281,2020,NR,,0,,,,,
long-acting rilpivirine (rpv) preexposure prophylaxis does not inhibit vaginal transmission of rpv-resistant hiv-1 or select for high-frequency drug resistance in humanized mice,Melody K,10.1128/JVI.01912-19,2020,NR,,0,,,,,
longitudinal antibody responses in people who inject drugs infected with similar human immunodeficiency virus strains,Redd AD,10.1093/infdis/jiz503,2020,NR,,0,,,,,
"identification of adolescent girls and young women for targeted hiv prevention: a new risk scoring tool in kwazulu natal, south africa",Ayton SG,10.1038/s41598-020-69842-x,2020,NR,,0,,,,,
"loss to follow-up and associated maternal factors among hiv-exposed infants at the mbarara regional referral hospital, uganda: a retrospective study",Ankunda R,10.1186/s12879-020-04964-1,2020,NR,,0,,,,,
mapping of hiv-1c transmission networks reveals extensive spread of viral lineages across villages in botswana treatment-as-prevention trial,Novitsky V,10.1093/infdis/jiaa276,2020,NR,,0,,,,,
maternal hiv infection alters antimicrobial immunity in exposed and uninfected infants,Marchant,10.1097/INF.0000000000002614,2020,NR,,0,,,,,
persistence of vaccine-elicited immune response up to 14 years post-hiv gp120-neftat/as01b vaccination,Van Der Meeren O,10.1016/j.vaccine.2019.12.058,2020,NR,,0,,,,,
maximizing response rates to ads for free at-home hiv testing on a men-for-men geosocial sexual networking app: lessons learned and implications for researchers and providers,Grov,10.1177/1090198119893692,2020,NR,,0,,,,,
implementing 2 phases of a hiv self-testing program through community-based organization partnerships in new york city,Hubbard,10.1097/OLQ.0000000000001151,2020,NR,,0,,,,,
improving inpatient provider-initiated hiv testing and counseling in sierra leone,Kassa G,10.1371/journal.pone.0236358,2020,NR,,0,,,,,
incident infection in high-priority hiv molecular transmission clusters in the united states,Wertheim JO,10.1097/QAD.0000000000002531,2020,NR,,0,,,,,
incorporation of information diffusion model for enhancing analyses in hiv molecular surveillance,Kwan TH,10.1080/22221751.2020.1718554,2020,NR,,0,,,,,
induction of neutralizing responses against autologous virus in maternal hiv vaccine trials,Hompe ED,10.1128/mSphere.00254-20,2020,NR,,0,,,,,
moderate rate of transmitted resistance mutations to antiretrovirals and genetic diversity in newly hiv-1 patients diagnosed in benin,Tchiakpe E,10.1186/s13104-020-05151-w,2020,NR,,0,,,,,
intra-host dynamics and co-receptor usage of hiv-1 quasi-species in vertically infected patients with phenotypic switch,Fernandez MF,10.1016/j.meegid.2019.104066,2020,NR,,0,,,,,
molecular epidemiology of the hiv-1 subtype b sub-epidemic in bulgaria,Alexiev I,10.3390/v12040441,2020,NR,,0,,,,,
"molecular epidemiology reveals low genetic diversity among cryptococcus neoformans isolates from people living with hiv in lima, peru, during the pre-haart era",van de Wiele N,10.3390/pathogens9080665,2020,NR,,0,,,,,
"longitudinal within-host evolution of hiv nef-mediated cd4, hla and serinc5 downregulation activity: a case study",Sudderuddin H,10.1186/s12977-019-0510-1,2020,NR,,0,,,,,
multi response genetic optimization for the estimation of decreased median drug resistance to nnrtis in hiv,Bai A,10.1186/s12879-020-05038-y,2020,NR,,0,,,,,
maintaining hiv care during the covid-19 pandemic,Jiang H,10.1016/S2352-3018%2820%2930105-3,2020,NR,,0,,,,,
mapping polyclonal antibody responses in non-human primates vaccinated with hiv env trimer subunit vaccines,Nogal B,10.1016/j.celrep.2020.02.061,2020,NR,,0,,,,,
natural polymorphisms in hiv-1 crf01_ae strain and profile of acquired drug resistance mutations in a long-term combination treatment cohort in northeastern china,Sun Z,10.1186/s12879-020-4808-3,2020,NR,,0,,,,,
natural presence of the v179d and k103r/v179d mutations associated with resistance to nonnucleoside reverse transcriptase inhibitors in hiv-1 crf65_cpx strains,Liu Y,10.1186/s12879-020-05007-5,2020,NR,,0,,,,,
mexican hiv-1 protease sequence diversity,Hernandez-Sanchez PG,10.1089/AID.2019.0201,2020,NR,,0,,,,,
minding the gap in hiv host genetics: opportunities and challenges,Gingras SN,10.1007/s00439-020-02177-9,2020,NR,,0,,,,,
"near real-time identification of recent hiv transmissions, transmitted drug resistance mutations, and transmission networks by mpid-ngs in north carolina",Zhou S,10.1093/infdis/jiaa417,2020,NR,,0,,,,,
new strategy for identifying potential natural hiv-1 non-nucleoside reverse transcriptase inhibitors against drug-resistance: an in silico study,Wang Y,10.1080/07391102.2019.1656673,2020,NR,,0,,,,,
"multiple hiv-1 genotypes circulating among college students in nanjing, china",Li W,10.1089/aid.2019.0288,2020,NR,,0,,,,,
mutation of ccr5 delta 32 in umbilical cord blood samples: future potential for hiv-1 cure,Kedage VV,10.7860/JCDR/2020/43618.13727,2020,NR,,0,,,,,
mxb sensitivity of hiv-1 is determined by a highly variable and dynamic capsid surface,Miles RJ,10.7554/eLife.56910,2020,NR,,0,,,,,
neutralization breadth and potency of single-chain variable fragments derived from broadly neutralizing antibodies targeting multiple epitopes on the hiv-1 envelope,van Dorsten RT,10.1128/JVI.01533-19,2020,NR,,0,,,,,
neutralizing antibody vrc01 failed to select for hiv-1 mutations upon viral rebound,Cale EM,10.1172/JCI134395,2020,NR,,0,,,,,
new directions for the consideration of hiv: heterogeneity and the cognition of time,Tan M,10.1002/cad.20327,2020,NR,,0,,,,,
perceptions of people living with hiv in the united states on alternatives to oral daily antiretroviral therapy (special issue on hiv cure research),Dube,10.1089/aid.2019.0175,2020,NR,,0,,,,,
perinatal exposure of rats to the hiv drug efavirenz affects medial prefrontal cortex cytoarchitecture,Garcia LP,10.1016/j.bcp.2020.114050,2020,NR,,0,,,,,
persistence of hiv transmission clusters among people who inject drugs,Rose R,10.1097/QAD.0000000000002662,2020,NR,,0,,,,,
novel hiv-1 capsid-targeting small molecules of the pf74 binding site,Wang L,10.1016/j.ejmech.2020.112626,2020,NR,,0,,,,,
pervasive and non-random recombination in near full-length hiv genomes from uganda,Grant HE,10.1093/ve/veaa004,2020,NR,,0,,,,,
"nutritional status and dietary diversity of school-age children living with hiv: a cross-sectional study in phnom penh, cambodia",Yasuoka J,10.1186/s12889-020-09238-8,2020,NR,,0,,,,,
pharmacophore model and atom-based 3d quantitative structure activity relationship (qsar) of human immunodeficiency virus-1 (hiv-1) capsid assembly inhibitors,Bhole RP,10.1080/07391102.2020.1715258,2020,NR,,0,,,,,
sensor sensibility-hiv-1 and the innate immune response,Yin X,10.3390/cells9010254,2020,NR,,0,,,,,
structure of super-potent antibody cap256-vrc2625 in complex with hiv-1 envelope reveals a combined mode of trimer-apex recognition,Gorman J,10.1016/j.celrep.2020.03.052,2020,NR,,0,,,,,
phylogenetic clustering networks among heterosexual migrants with new hiv diagnoses post-migration in australia,Sacks-Davis R,10.1371/journal.pone.0237469,2020,NR,,0,,,,,
perceptions and determinants of healthy eating for people with hiv in the dominican republic who experience food insecurity,Wallace DD,10.1017/S1368980020002694,2020,NR,,0,,,,,
"phylogenomic analysis of neisseria gonorrhoeae transmission to assess sexual mixing and hiv transmission risk in england: a cross-sectional, observational, whole-genome sequencing study",Town K,10.1016/S1473-3099%2819%2930610-3,2020,NR,,0,,,,,
pharmacological activation of the circadian component rev-erb inhibits hiv-1 replication,Borrmann H,10.1038/s41598-020-70170-3,2020,NR,,0,,,,,
phyloanatomic characterization of the distinct t cell and monocyte contributions to the peripheral blood hiv population within the host,RifeMagalis B,10.1093/ve/veaa005,2020,NR,,0,,,,,
phylodynamic analysis complements partner services by identifying acute and unreported hiv transmission,Campbell EM,10.3390/v12020145,2020,NR,,0,,,,,
"phylodynamic analysis of hiv-1 subtypes b, c and crf 02_ag in senegal",Nascimento FF,10.1016/j.epidem.2019.100376,2020,NR,,0,,,,,
pin50 non-sexual risk behaviors are associated with increased odds of hiv testing: results from the 2017 brfss,Yelverton V,10.1016/j.jval.2020.04.518,2020,NR,,0,,,,,
pooled resistance analyses of darunavir once-daily regimens and formulations across 10 clinical studies of treatment-naive and treatment-experienced patients with human immunodeficiency virus-1 infection,Lathouwers E,10.1080/25787489.2020.1794439,2020,NR,,0,,,,,
population-specific profiling of ccl3l1 copy number of the three major ethnic groups in malaysia and the implication on hiv susceptibility,Mohamad Isa II,10.1016/j.gene.2020.144821,2020,NR,,0,,,,,
placental growth disorders and perinatal adverse outcomes in brazilian hiv-infected pregnant women,Dos Reis HLB,10.1371/journal.pone.0231938,2020,NR,,0,,,,,
potential of metformin to modify the gut microbiota and prevent inflammation in nondiabetic people with hiv,Isnard S,10.1158/1538-7445.MVC2020-PR04,2020,NR,,0,,,,,
pre-treatment drug resistance and hiv-1 genetic diversity in the rural and urban settings of northwest-cameroon,Fokam J,10.1371/journal.pone.0235958,2020,NR,,0,,,,,
positive health check evaluation: a type 1 hybrid design randomized trial to decrease hiv viral loads in patients seen in hiv primary care,Lewis MA,10.1016/j.cct.2020.106097,2020,NR,,0,,,,,
potent inhibition of hiv replication in primary human cells by novel synthetic polyketides inspired by aureothin,Herrmann A,10.1038/s41598-020-57843-9,2020,NR,,0,,,,,
"pretreatment hiv drug resistance in adults initiating antiretroviral therapy in china, 2017",Kang R-H,10.1186/s40249-020-00668-5,2020,NR,,0,,,,,
"prevalence and determinants of virological failure, genetic diversity and drug resistance among people living with hiv in a minority area in china: a population-based study",Yuan D,10.1186/s12879-020-05124-1,2020,NR,,0,,,,,
prevalence of torque viruses in hiv-infected and non-hiv-infected nigerian subjects: analysis of near-full-length genome sequences,Elesinnla AR,10.1007/s00705-020-04538-1,2020,NR,,0,,,,,
"prevalence of hiv-1 drug-resistance genotypes among unique recombinant forms from yunnan province, china in 2016-2017",Deng X,10.1089/aid.2019.0041,2020,NR,,0,,,,,
prevention and treatment of shivad8 infection in rhesus macaques by a potent d-peptide hiv entry inhibitor,Nishimura Y,10.1073/pnas.2009700117,2020,NR,,0,,,,,
purifying selection in human immunodeficiency virus-1 pol gene in perinatally human immunodeficiency virus-1-infected children harboring discordant immunological response and virological nonresponse to long-term antiretroviral therapy,Mboumba Bouassa RS,10.14740/jocmr4157,2020,NR,,0,,,,,
"quantifying hiv transmission flow between high-prevalence hotspots and surrounding communities: a population-based study in rakai, uganda",Ratmann O,10.1016/S2352-3018(19)30378-9,2020,NR,,0,,,,,
randomized controlled trial protocol for project bridge: a telephone-administered motivational interviewing intervention targeting risky sexual behavior in older people living with hiv,Kahler J,10.1016/j.cct.2020.106047,2020,NR,,0,,,,,
"reducing undernutrition through counseling on diversified food intake among adult people living with hiv on haart, northern ethiopia",Tedla,10.1155/2020/9858619,2020,NR,,0,,,,,
"syndemic theory, structural violence and hiv among african-americans",Godley,10.1097/COH.0000000000000634,2020,NR,,0,,,,,
recent hiv infection among men who have sex with men and transgender women in tijuana,Skaathun B,10.11606/s1518-8787.2020054002179,2020,NR,,0,,,,,
restriction of hiv-1 escape by a highly broad and potent neutralizing antibody,Schommers P,10.1016/j.cell.2020.01.010,2020,NR,,0,,,,,
"rising hiv seroconversion rates & associated risks among employees of organization 'x': a case control study, pakistan, 2017",Mansoor E,10.12669/pjms.36.6.1735,2020,NR,,0,,,,,
"recombination analysis of near full-length hiv-1 sequences and the identification of a potential new circulating recombinant form from rakai, uganda",Capoferri AA,10.1089/aid.2019.0150,2020,NR,,0,,,,,
recreational use of hiv antiretroviral medication and implications for hiv pre-exposure prophylaxis and treatment,Kuo C,10.1007/s10461-020-02821-5,2020,NR,,0,,,,,
the lipid membrane of hiv-1 stabilizes the viral envelope glycoproteins and modulates their sensitivity to antibody neutralization,Salimi H,10.1074/jbc.RA119.009481,2020,NR,,0,,,,,
relationship stigma and hiv risk behavior among cisgender men partnered with transgender women: the moderating role of sexual identity (special section: social and behavioral science with gay and bisexual men in the era of biomedical prevention),Gamarel,10.1007/s10508-019-1446-1,2020,NR,,0,,,,,
seminal plasma-derived extracellular-vesicle fractions from hiv-infected men exhibit unique microrna signatures and induce a proinflammatory response in cells isolated from the female reproductive tract,Marques de Menezes EG,10.1128/JVI.00525-20,2020,NR,,0,,,,,
single-cell tcr sequencing reveals phenotypically diverse clonally expanded cells harboring inducible hiv proviruses during art,Gantner P,10.1038/s41467-020-17898-8,2020,NR,,0,,,,,
single-cell technologies applied to hiv-1 research: reaching maturity,Sannier G,10.3389/fmicb.2020.00297,2020,NR,,0,,,,,
smartphone-based measurement of executive function in older adults with and without hiv,Moore RC,10.1093/arclin/acz084,2020,NR,,0,,,,,
stabilized diverse hiv-1 envelope trimers for vaccine design,Wang Q,10.1080/22221751.2020.1745093,2020,NR,,0,,,,,
"standards, equality and safety in mohs micrographic surgery for patients living with hiv",Alani A,10.1111/ced.14367,2020,NR,,0,,,,,
seroprevalence and determinants of human immunodeficiency virus infection among women of reproductive age in mozambique: a multilevel analysis,Ekholuenetale M,10.1007/s40121-020-00336-z,2020,NR,,0,,,,,
seroprevalence of hiv among blood donors,Puttegowda A,10.1186/s12879-020-05038-y,2020,NR,,0,,,,,
shared and cell type-specific adaptation strategies of gag and env yield high titer bovine foamy virus variants,Bao Q,10.1016/j.meegid.2020.104287,2020,NR,,0,,,,,
sympathetic function and markers of inflammation in well-controlled hiv,Robinson-Papp J,10.1016/j.bbih.2020.100112,2020,NR,,0,,,,,
targeting the n332-supersite of the hiv-1 envelope for vaccine design,Moyo T,10.1080/14728222.2020.1752183,2020,NR,,0,,,,,
signatures of oral microbiome in hiv-infected individuals with oral kaposi's sarcoma and cell-associated kshv dna,Gruffaz M,10.1371/journal.ppat.1008114,2020,NR,,0,,,,,
simulating system dynamics of the hiv care continuum to achieve treatment as prevention,Weeks MR,10.1371/journal.pone.0230568,2020,NR,,0,,,,,
social and behavioral health responses to covid-19: lessons learned from four decades of an hiv pandemic,Eaton LA,10.1007/s10865-020-00157-y,2020,NR,,0,,,,,
"social representations of the prevention of heterosexual transmission of hiv among young africans from five countries, 1997-2014",Winskell K,10.1371/journal.pone.0227878,2020,NR,,0,,,,,
"spatial characteristics of men who have sex with men and transgender women attending hiv voluntary counselling and testing in bangkok, thailand, 2005-2015",Weiss,10.4081/gh.2020.790,2020,NR,,0,,,,,
subordinate effect of -21 m hla-b dimorphism on nk cell repertoire diversity and function in hiv-1 infected individuals of african origin,Cubero,10.3389/fimmu.2020.00156,2020,NR,,0,,,,,
successful recruitment of a multi-site international randomized placebo-controlled trial in people with hiv with attention to diversity of race and ethnicity: critical role of central coordination,Fitch KV,10.1080/25787489.2020.1733794,2020,NR,,0,,,,,
"surveillance of hiv-1 primary infections in france from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?",Visseaux B,10.1093/jac/dkz404,2020,NR,,0,,,,,
syphilis infection does not affect immunodeficiency progression in hiv-infected men who have sex with men in china,Huang LiPing,10.1177/0956462419860618,2020,NR,,0,,,,,
"temporal changes in hiv transmission patterns among young men who have sex with men, united states, 2009-2016",Panneer N,10.1097/QAI.0000000000002305,2020,NR,,0,,,,,
"the central role of nondisclosed men who have sex with men in human immunodeficiency virus-1 transmission networks in guangzhou, china",Yan H,10.1093/ofid/ofaa154,2020,NR,,0,,,,,
"the characteristics of pretreatment hiv-1 drug resistance in western yunnan, china",Chen M,10.1017/S095026882000093X,2020,NR,,0,,,,,
the development and cognitive testing of the positive outcomes hiv prom: a brief novel patient-reported outcome measure for adults living with hiv,Bristowe K,10.1186/s12955-020-01462-5,2020,NR,,0,,,,,
the dose response: perceptions of people living with hiv in the united states on alternatives to oral daily antiretroviral therapy,Dube K,10.1089/aid.2019.0175,2020,NR,,0,,,,,
the e3 ubiquitin-protein ligase cullin 3 regulates hiv-1 transcription,Langer S,10.3390/cells9092010,2020,NR,,0,,,,,
the emerging of crf01_ae: a clinical story and future hiv/aids situation in thailand,Winichakoon P,10.2174/1570162X18666200129160723,2020,NR,,0,,,,,
the role of sex work laws and stigmas in increasing hiv risks among sex workers,Lyons,10.1038/s41467-020-14593-6,2020,NR,,0,,,,,
the frequency of defective genes in vif and vpr genes in 20 hemophiliacs is associated with korean red ginseng and highly active antiretroviral therapy: the impact of lethal mutations in vif and vpr genes on hiv-1 evolution,Cho YK,10.1016/j.jgr.2020.03.003,2020,NR,,0,,,,,
genetic clustering analysis for hiv infection among msm in nigeria implications for intervention,Li YuRuo,10.1097/QAD.0000000000002409,2020,NR,,0,,,,,
adeno-associated viral vector mediated expression of broadly-neutralizing antibodies against hiv-hitting a fast-moving target,Chringma,10.2174/1570162X18666200210121339,2020,NR,,0,,,,,
"the genetic diversity of hiv-1 within antiretroviral-naive outpatients in ganzhou, china",Xie YN,10.1089/AID.2020.0168,2020,NR,,0,,,,,
the late domain of prototype foamy virus gag facilitates autophagic clearance of stress granules by promoting amphisome formation,Zheng Y,10.1128/JVI.01719-19,2020,NR,,0,,,,,
the impact of hiv-1 subtypes on virologic and immunologic treatment outcomes at the lagos university teaching hospital: a longitudinal evaluation,Ogbenna AA,10.1371/journal.pone.0238027,2020,NR,,0,,,,,
the impact of human immunodeficiency virus infection on gut microbiota alpha-diversity: an individual-level meta-analysis,Tuddenham SA,10.1093/cid/ciz258,2020,NR,,0,,,,,
the impact of socioeconomic factors on the healthcare costs of people living with hiv in turkey,Ozdemir HO,10.1186/s12889-020-08469-z,2020,NR,,0,,,,,
the neurologic phenotype of south african patients with hiv-associated neurocognitive impairment,Anderson SG,10.1212/CPJ.0000000000000687,2020,NR,,0,,,,,
the length of lipoteichoic acid polymers controls staphylococcus aureus cell size and envelope integrity,Hesser AR,10.1128/JB.00149-20,2020,NR,,0,,,,,
three lessons for the covid-19 response from pandemic hiv,Hargreaves J,10.1016/S2352-3018%2820%2930110-7,2020,NR,,0,,,,,
the seafood musculus senhousei shows anti-influenza a virus activity by targeting virion envelope lipids,Chen D,10.1016/j.bcp.2020.113982,2020,NR,,0,,,,,
transforming growth factor-beta promotes the function of hiv-specific cxcr5+cd8 t cells,Yang H-G,10.1111/1348-0421.12789,2020,NR,,0,,,,,
topical tenofovir pre-exposure prophylaxis and mucosal hiv-specific fc-mediated antibody activities in women,Fisher KL,10.3389/fimmu.2020.01274,2020,NR,,0,,,,,
tracing the transmission dynamics of hiv-1 crf55_01b,Zai J,10.1038/s41598-020-61870-x,2020,NR,,0,,,,,
understanding the mechanisms driving the spread of subtype c hiv-1,Gartner MJ,10.1016/j.ebiom.2020.102682,2020,NR,,0,,,,,
transmitted drug resistance in newly diagnosed and treatment-naive hiv type 1-infected patients in hungary,Ay E,10.1016/j.jgar.2019.07.014,2020,NR,,0,,,,,
use of drug-level testing and single-genome sequencing to unravel a case of hiv seroconversion on prep,Spinelli MA,10.1093/cid/ciaa1011,2020,NR,,0,,,,,
"variability in hiv-1 integrase gene and 3'-polypurine tract sequences in cameroon clinical isolates, and implications for integrase inhibitors efficacy",Acharya A,10.3390/ijms21051553,2020,NR,,0,,,,,
very high hiv incidence and associated risk factors in a longitudinal cohort study of diverse adolescent and young adult men who have sex with men and transgender women,Mustanski B,10.1007/s10461-019-02766-4,2020,NR,,0,,,,,
"week 48 resistance analyses of the once-daily, single-tablet regimen darunavir/cobicistat/emtricitabine/tenofovir alafenamide (d/c/f/taf) in adults living with hiv-1 from the phase iii randomized amber and emerald trials",Lathouwers E,10.1089/AID.2019.0111,2020,NR,,0,,,,,
"""in zimbabwe there is nothing for us"": sex work and vulnerability of hiv infection among male sex workers in zimbabwe",Qiao S,10.1080/09540121.2019.1574334,2019,NR,,0,,,,,
"""self-testing sounds more private, rather than going to the clinic and everybody will find out"": facilitators and barriers regarding hiv testing among men who purchase sex in bali, indonesia",Wulandari,10.1371/journal.pone.0214987,2019,NR,,0,,,,,
(q)sar models of hiv-1 protein inhibition by drug-like compounds,Stolbov LA,10.3390/molecules25010087,2019,NR,,0,,,,,
"a 28-year history of hiv-1 drug resistance and transmission in washington, dc",Gibson KM,10.3389/fmicb.2019.00369,2019,NR,,0,,,,,
"a descriptive analysis of the role of a whatsapp clinical discussion group as a forum for continuing medical education in the management of complicated hiv and tb clinical cases in a group of doctors in the eastern cape, south africa",Woods J,10.4102/sajhivmed.v20i1.982,2019,NR,,0,,,,,
hiv-1 genetic diversity to estimate time of infection and infer adherence to pre-exposure prophylaxis,Council OD,10.1097/QAD.0000000000002390,2019,NR,,0,,,,,
"a colonial legacy of hiv/aids, ntd, and sti super-syndemics: eugenicist foreign aid and intertwined health burdens in nigeria",Maju M,10.1080/17441692.2019.1582683,2019,NR,,0,,,,,
a community-based participatory approach to understanding hiv/aids in the ethiopian community,Oliphant,10.1080/19371918.2019.1635944,2019,NR,,0,,,,,
a retrospective molecular study of cryptosporidium species and genotypes in hiv-infected patients from thailand,Sannella AR,10.1186/s13071-019-3348-4,2019,NR,,0,,,,,
"epigenetics, n-myrystoyltransferase-1 and casein kinase-2-alpha modulates the increased replication of hiv-1 crf02_ag, compared to subtype-b viruses",Bhargavan B,10.1038/s41598-019-47069-9,2019,NR,,0,,,,,
a viral genome wide association study and genotypic resistance testing in patients failing first line antiretroviral therapy in the first large countrywide ethiopian hiv cohort,Telele NF,10.1186/s12879-019-4196-8,2019,NR,,0,,,,,
a creative pathway to a meaningful life: an existential expressive arts group therapy for people living with hiv in hong kong,Kwong M-K,10.1016/j.aip.2019.05.004,2019,NR,,0,,,,,
hiv infected t cells can proliferate in vivo without inducing expression of the integrated provirus,Musick A,10.3389/fmicb.2019.02204,2019,NR,,0,,,,,
hiv-1 genetic diversity to estimate time of infection and infer adherence to preexposure prophylaxis,Council OD,10.1097/QAD.0000000000002390,2019,NR,,0,,,,,
a highly unusual v1 region of env in an elite controller of hiv infection,Silver ZA,10.1128/JVI.00094-19,2019,NR,,0,,,,,
isolation of specific human recombinant antibodies against glycoprotein 41 of hiv,Aghaei Afshar MJ,,2019,NR,,0,,,,,
hiv-1 envelope glycoproteins isolated from viremic non-progressor individuals are fully functional and cytopathic,Cabrera-Rodriguez R,10.1038/s41598-019-42075-3,2019,NR,,0,,,,,
correction: whole genome sequencing of extreme phenotypes identifies variants in cd101 and ube2v1 associated with increased risk of sexually acquired hiv-1,Mackelprang RD,10.1371/journal.ppat.1007588,2019,NR,,0,,,,,
"another near full-length sequence of an hiv-1 crf01_ae/crf07_bc recombinant virus from a man who has sex with men in tianjin, china",Zhou Z,10.1089/AID.2019.0071,2019,NR,,0,,,,,
"genomic characterization of a novel hiv-1 second-generation recombinant form (crf01_ae/b) from men who have sex with men in guangxi zhuang autonomous region, china",Li K,10.1089/AID.2019.0149,2019,NR,,0,,,,,
the relationship between physical activity and cardiorespiratory fitness among people living with human immunodeficiency virus throughout the life span,Webel AR,10.1097/JCN.0000000000000589,2019,NR,,0,,,,,
measurement error and variant-calling in deep illumina sequencing of hiv,Howison M,10.1093/bioinformatics/bty919,2019,NR,,0,,,,,
an evolutionary insight into a growing hiv subtype a epidemic in serbia,Siljic M,10.1111/hiv.12815,2019,NR,,0,,,,,
multiple-strain infections of human cytomegalovirus with high genomic diversity are common in breast milk from human immunodeficiency virus-infected women in zambia,Suarez NM,10.1093/infdis/jiz209,2019,NR,,0,,,,,
"rhabdo-immunodeficiency virus, a murine model of acute hiv-1 infection",Liberatore RA,10.7554/eLife.49875,2019,NR,,0,,,,,
a vibrio cholerae bola-like protein is required for proper cell shape and cell envelope integrity,Fleurie A,10.1128/mBio.00790-19,2019,NR,,0,,,,,
"development of a versatile, near full genome amplification and sequencing approach for a broad variety of hiv-1 group m variants",Banin AN,10.3390/v11040317,2019,NR,,0,,,,,
"characterization of a new hiv-1 crf01_ae/b recombinant virus form among men who have sex with men in shanghai, china",Ou W,10.1089/AID.2018.0197,2019,NR,,0,,,,,
"homogenous hiv-1 subtype b from the brazilian amazon with infrequent diverse bf1 recombinants, subtypes f1 and c among blood donors",Crispim MAE,10.1371/journal.pone.0221151,2019,NR,,0,,,,,
an outbreak of hiv infection among people who inject drugs linked to injection of propofol in taiwan,Huang Y-C,10.1371/journal.pone.0210210,2019,NR,,0,,,,,
"comparative performance of the biocentric generic viral load, roche cap/ctm v15, roche cap/ctm v20 and m2000 abbott assays for quantifying hiv-1 b and non-b strains: underestimation of some crf02 strains",Avettand-Fenoel V,10.1016/j.jcv.2018.12.002,2019,NR,,0,,,,,
"genetic characterization and recombinant history of a novel hiv-1 circulating recombinant form (crf101_01b) identified in yunnan, china",Zhang C,10.1016/j.meegid.2019.04.024,2019,NR,,0,,,,,
"identification of two novel hiv-1 second-generation recombinant forms (crf01_ae/07_bc) in shaanxi, china",Zhang M,10.1089/AID.2018.0137,2019,NR,,0,,,,,
"analysis of hiv-1 diversity, primary drug resistance and transmission networks in croatia",Oroz M,10.1038/s41598-019-53520-8,2019,NR,,0,,,,,
increased predominance of hiv-1 crf01_ae and its recombinants in the philippines,Chen Y,10.1099/jgv.0.001198,2019,NR,,0,,,,,
determining 3'-termini and sequences of nascent single-stranded viral dna molecules during hiv-1 reverse transcription in infected cells,Pollpeter D,10.3791/58715,2019,NR,,0,,,,,
ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of hiv vaccine immunogens,Mesa KA,10.1371/journal.pone.0213409,2019,NR,,0,,,,,
acceptability of cell and gene therapy for curing hiv infection among people living with hiv in the northwestern united states: a qualitative study,Dube K,10.1089/AID.2019.0021,2019,NR,,0,,,,,
clade c hiv-1 envelope vaccination regimens differ in their ability to elicit antibodies with moderate neutralization breadth against genetically diverse tier 2 hiv-1 envelope variants,Burton S,10.1128/JVI.01846-18,2019,NR,,0,,,,,
applications of hiv genetic networks in mexico: implications for prevention,Avila-Rios S,10.1002/jia2.25327,2019,NR,,0,,,,,
"assessing the role of transmission chains in the spread of hiv-1 among men who have sex with men in quebec, canada",Villandre L,10.1371/journal.pone.0213366,2019,NR,,0,,,,,
age-related factors influence hiv testing within subpopulations: a cross-sectional survey of msm within the celtic nations,Dalrymple J,10.1136/sextrans-2018-053935,2019,NR,,0,,,,,
association between impaired valpha72+cd161++cd8+ (mait) and valpha72+cd161-cd8+ t-cell populations and gut dysbiosis in chronically hiv-and/or hcv-infected patients,Merlini E,10.3389/fmicb.2019.01972,2019,NR,,0,,,,,
"association between single-nucleotide polymorphisms in hla alleles and human immunodeficiency virus type 1 viral load in demographically diverse, antiretroviral therapy-naive participants from the strategic timing of antiretroviral treatment trial",Ekenberg C,10.1093/infdis/jiz294,2019,NR,,0,,,,,
aging with hiv,Guaraldi,10.1007/s11904-019-00464-3,2019,NR,,0,,,,,
"associations between cannabis use, sexual behavior, and sexually transmitted infections/human immunodeficiency virus in a cohort of young men who have sex with men",Gorbach PM,10.1097/OLQ.0000000000000919,2019,NR,,0,,,,,
phase angle is associated with the physical fitness of hiv-infected children and adolescents,Martins PC,10.1111/sms.13419,2019,NR,,0,,,,,
association between hiv/aids knowledge and stigma towards people living with hiv/aids in botswana,Letshwenyo-Maruatona SB,10.2989/16085906.2018.1552879,2019,NR,,0,,,,,
conformational diversity in the intrinsically disordered hiv-1 tat protein induced by zinc and ph,Kunihara T,10.1016/j.bbrc.2018.12.126,2019,NR,,0,,,,,
"authentic and successful community engagement for sti/hiv prevention, screening and treatment in rural and urban settings",Rhodes S,10.1136/sextrans-2019-sti.95,2019,NR,,0,,,,,
amino acid prevalence of hiv-1 pol mutations by direct polymerase chain reaction and single genome sequencing,Tzou PL,10.1089/AID.2018.0289,2019,NR,,0,,,,,
"beyond ""purposeful and planned"": varied trajectories of healthcare transition from pediatric to adult-oriented care among youth living with hiv",Hussen SA,10.1080/09540121.2018.1488029,2019,NR,,0,,,,,
an update on the status of hiv/stis in iusti's five regions,Ndowa F,10.1136/sextrans-2019-sti.81,2019,NR,,0,,,,,
analysis of the tcr repertoire in hiv-exposed but uninfected infants,Gabriel B,10.1038/s41598-019-48434-4,2019,NR,,0,,,,,
bridging of neisseria gonorrhoeae lineages across sexual networks in the hiv pre-exposure prophylaxis era,Williamson DA,10.1038/s41467-019-12053-4,2019,NR,,0,,,,,
antibody lineages with vaccine-induced antigen-binding hotspots develop broad hiv neutralization,Kong R,10.1016/j.cell.2019.06.030,2019,NR,,0,,,,,
antibody neutralization and its determinants in hiv-1 infected patients from portugal: implications for vaccine design and efficacy,Marcelino R,10.1080/07853890.2018.1561831,2019,NR,,0,,,,,
candida spp determination and th1/th2 mixed cytokine profile in oral samples from hiv+ patients with chronic periodontitis,Lomeli-Martinez SM,10.3389/fimmu.2019.01465,2019,NR,,0,,,,,
capture of a hyena-specific retroviral envelope gene with placental expression associated in evolution with the unique emergence among carnivorans of hemochorial placentation in hyaenidae,Funk M,10.1128/JVI.01811-18,2019,NR,,0,,,,,
characterization of a novel hiv-1 circulating recombinant form (crf80-0107) among men who have sex with men in china,Zhang Y,10.1089/aid.2018.0226,2019,NR,,0,,,,,
cd161+ cd4+ t cells harbor clonally expanded replication-competent hiv-1 in antiretroviral therapy-suppressed individuals,Li X,10.1128/mBio.02121-19,2019,NR,,0,,,,,
cellular ip6 levels limit hiv production while viruses that cannot efficiently package ip6 are attenuated for infection and replication,Mallery DL,10.1016/j.celrep.2019.11.050,2019,NR,,0,,,,,
characteristics of plasmablast repertoire in chronically hiv-infected individuals for immunoglobulin h and l chain profiled by single-cell analysis,Liao H,10.3389/fimmu.2019.03163,2019,NR,,0,,,,,
assessment of genetic diversity of htlv-1 orf-i sequences collected from patients with different clinical profiles (special issue on hiv prevention science),Borba,10.1089/aid.2019.0127,2019,NR,,0,,,,,
awareness and uptake of layered hiv prevention programming for young women: analysis of population-based surveys in three dreams settings in kenya and south africa,Gourlay A,10.1186/s12889-019-7766-1,2019,NR,,0,,,,,
characteristics of hiv-1 pretreatment drug resistance and its impact on combined antiretroviral therapy in beijing,Xin R,10.1136/sextrans-2019-sti.310,2019,NR,,0,,,,,
barriers to access hiv-healthcare services for women living with hiv in mexico,Ramirez Rodriguez I,10.1002/jia2.25263,2019,NR,,0,,,,,
characterization of gut microbiota composition in hiv-infected patients with metabolic syndrome,Villanueva-Millan MJ,10.1007/s13105-019-00673-9,2019,NR,,0,,,,,
beyond the barefoot doctors: using community health workers to translate hiv research to service,Young B,10.1007/s10461-019-02636-z,2019,NR,,0,,,,,
characterization of intact proviruses in blood and lymph node from hiv-infected individuals undergoing analytical treatment interruption,Vibholm LK,10.1128/JVI.01920-18,2019,NR,,0,,,,,
characterization of new recombinant forms of hiv-1 from the comunitat valenciana (spain) by phylogenetic incongruence,Beamud B,10.3389/fmicb.2019.01006,2019,NR,,0,,,,,
clinical relevance of immune non-response among virally suppressed adults living with hiv in africa and the united states,Noiman A,10.1093/ofid/ofz360.2193,2019,NR,,0,,,,,
characterization of resistance to a potent d-peptide hiv entry inhibitor,Smith AR,10.1186/s12977-019-0489-7,2019,NR,,0,,,,,
"identification of two novel hiv-1 second-generation recombinant forms (crf01-ae/07-bc) in shaanxi, china",Zhang M,10.1089/aid.2018.0137,2019,NR,,0,,,,,
cascade analysis: an adaptable implementation strategy across hiv and non-hiv delivery platforms,Wagner AD,10.1097/QAI.0000000000002220,2019,NR,,0,,,,,
conformational differences between functional human immunodeficiency virus envelope glycoprotein trimers and stabilized soluble trimers,Castillo-Menendez LR,10.1128/JVI.01709-18,2019,NR,,0,,,,,
ccl2 mobilizes alix to facilitate gag-p6 mediated hiv-1 virion release,Ajasin DO,10.7554/eLife.35546,2019,NR,,0,,,,,
cd4 occupancy triggers sequential pre-fusion conformational states of the hiv-1 envelope trimer with relevance for broadly neutralizing antibody activity,Ivan B,10.1371/journal.pbio.3000114,2019,NR,,0,,,,,
cd4/cd8 ratio is a better indicator of acute phase inflammation than absolute cd4 count during virally suppressed hiv infection,Rousseau R,,2019,NR,,0,,,,,
comparative dna methylomic analyses reveal potential origins of novel epigenetic biomarkers of insulin resistance in monocytes from virally suppressed hiv-infected adults,Dye CK,10.1186/s13148-019-0694-1,2019,NR,,0,,,,,
"central nervous system compartmentalization of hiv, an interesting model of viral evolution: from theory to clinical implications",Stefic K,10.1684/vir.2019.0801,2019,NR,,0,,,,,
characteristics of envelope genes in a chinese chronically hiv-1 infected patient with broadly neutralizing activity,Zhang D,10.3389/fmicb.2019.01096,2019,NR,,0,,,,,
comparisons of human immunodeficiency virus type 1 envelope variants in blood and genital fluids near the time of male-to-female transmission,Williams-Wietzikoski CA,10.1128/JVI.01769-18,2019,NR,,0,,,,,
composition of gut microbiota of children and adolescents with perinatal hiv infection taking antiretroviral therapy,Flaegstad T,10.1080/2331205X.2019.1694205,2019,NR,,0,,,,,
characterization of a large cluster of hiv-1 a1 infections detected in portugal and connected to several western european countries,Araujo PMM,10.1038/s41598-019-43420-2,2019,NR,,0,,,,,
characterization of apobec3 variation in a population of hiv-1 infected individuals in northern south africa,Matume ND,10.1186/s12881-018-0740-4,2019,NR,,0,,,,,
computer-mediated communication to facilitate synchronous online focus group discussions: feasibility study for qualitative hiv research among transgender women across the united states,Wirtz AL,10.2196/12569,2019,NR,,0,,,,,
concomitant enhancement of hiv-1 replication potential and neutralization-resistance in concert with three adaptive mutations in env v1/c2/c4 domains,Doi N,10.3389/fmicb.2019.00002,2019,NR,,0,,,,,
characterization of eiav env quasispecies during long-term passage in vitro: gradual loss of pathogenicity,Liu C,10.3390/v11040380,2019,NR,,0,,,,,
"characterization of four nearly full-length genomic sequences of hiv-1 subtype g identified in guangdong province, china",Li T,10.1089/AID.2019.0025,2019,NR,,0,,,,,
characterization of hiv-1 genotype specific antigens for the detection of recent and long-term hiv-1 infection in china,Cai Q,10.1016/j.virusres.2019.02.010,2019,NR,,0,,,,,
contraceptive-induced changes in genital tract hiv-1 cellular targets and microbiota among women enrolled in the echo trial,Jaspan H,10.1002/jia2.25327,2019,NR,,0,,,,,
"cotrimoxazole prophylaxis treatment adherence and associated factors among human immunodeficiency virus (hiv) exposed children in public hospitals in ilubabor zone, southwest ethiopia, 2018",Nigatu D,10.2174/1874944501912010184,2019,NR,,0,,,,,
cotrimoxazole reduces systemic inflammation in hiv infection by altering the gut microbiome and immune activation,Bourke CD,10.1126/scitranslmed.aav0537,2019,NR,,0,,,,,
cryptococcus genetic diversity and mixed infections in ivorian hiv patients: a follow up study,Kassi FK,10.1371/journal.pntd.0007812,2019,NR,,0,,,,,
clinical outcomes and experiences of trans people accessing hiv care in england,Kirwan P,10.1111/hiv.12738,2019,NR,,0,,,,,
combined hiv-1 sequence and integration site analysis informs viral dynamics and allows reconstruction of replicating viral ancestors,Patro SC,10.1073/pnas.1910334116,2019,NR,,0,,,,,
"identification of three hiv-1 unique (b/c) recombinant forms in shaanxi, china",Zhang M,10.1089/aid.2019.0108,2019,NR,,0,,,,,
"detection of hiv transmission hotspots in british columbia, canada: a novel framework for the prioritization and allocation of treatment and prevention resources",McLaughlin A,10.1016/j.ebiom.2019.09.026,2019,NR,,0,,,,,
comparability of pulse wave velocity in children and adolescents living with hiv,Mellin J,,2019,NR,,0,,,,,
detection of human immunodeficiency virus type 1 phylogenetic clusters with multidrug resistance mutations among 2011 to 2017 blood donors from the highly endemic northern brazilian amazon,Esashika Crispim MA,10.1111/trf.15347,2019,NR,,0,,,,,
detection of pretreatment minority hiv-1 reverse transcriptase inhibitor-resistant variants by ultra-deep sequencing has a limited impact on virological outcomes,Su B,10.1093/jac/dky561,2019,NR,,0,,,,,
comparison of two distinct house ball communities involved in an hiv prevention study: baseline data from the posse project,Hosek,,2019,NR,,0,,,,,
development of the r263k mutation to dolutegravir in an hiv-1 subtype d virus harboring 3 class-drug resistance,Ahmed N,10.1093/ofid/ofy329,2019,NR,,0,,,,,
compartmentalization of subtype a17 of small ruminant lentiviruses between blood and colostrum in infected goats is not exclusively associated to the env gene,Olech M,10.3390/v11030270,2019,NR,,0,,,,,
"identification of three hiv-1 unique (b/c) recombinant forms in shaanxi, china (special issue on hiv prevention science)",Zhang MengYan,10.1089/aid.2019.0108,2019,NR,,0,,,,,
comprehensive profiling of hiv antibody evolution,Eshleman SH,10.1016/j.celrep.2019.03.097,2019,NR,,0,,,,,
distinct gut microbiota profile in antiretroviral therapy-treated perinatally hiv-infected patients associated with cardiac and inflammatory biomarkers,Sessa L,10.1097/QAD.0000000000002131,2019,NR,,0,,,,,
distribution and phylogeny of erythrocytic necrosis virus (env) in salmon suggests marine origin,Pagowski VA,10.3390/v11040358,2019,NR,,0,,,,,
conformational engineering of hiv-1 env based on mutational tolerance in the cd4 and pg16 bound states,Heredia JD,10.1128/JVI.00219-19,2019,NR,,0,,,,,
conformational plasticity in the hiv-1 fusion peptide facilitates recognition by broadly neutralizing antibodies,Yuan M,10.1016/j.chom.2019.04.011,2019,NR,,0,,,,,
constrained mutational sampling of amino acids in hiv-1 protease evolution,Boucher JI,10.1093/molbev/msz022,2019,NR,,0,,,,,
construction and analysis of v3 glycopeptide antigens for hiv-1 vaccine design,Zhang R,,2019,NR,,0,,,,,
diversity of vaginal microbiota in sub-saharan africa and its effects on hiv transmission and prevention,Bayigga L,10.1016/j.ajog.2018.10.014,2019,NR,,0,,,,,
"diversity, stigma, and social integration among older adults with hiv",Brennan-Ing M,10.1007/s41999-018-0142-3,2019,NR,,0,,,,,
docking-based 3d-qsar and pharmacophore studies on diarylpyrimidines as non-nucleoside inhibitors of hiv-1 reverse transcriptase,Liu G,10.1007/s11030-018-9860-1,2019,NR,,0,,,,,
draft genome sequence analysis of a high carbapenem-resistant klebsiella quasipneumoniae subsp quasipneumoniae strain isolated from an hiv-positive patient with pneumonia,Gao JY,10.1016/j.jgar.2019.09.004,2019,NR,,0,,,,,
"drawing from the theory of planned behaviour to examine pre-exposure prophylaxis uptake intentions among heterosexuals in high hiv prevalence neighbourhoods in philadelphia, pennsylvania, usa: an observational study",Roth A,10.1071/SH18081,2019,NR,,0,,,,,
drug susceptibility and replication capacity of a rare hiv-1 subtype c protease hinge region variant,Zondagh J,10.3851/IMP3308,2019,NR,,0,,,,,
"earlier initiation of antiretroviral treatment coincides with an initial control of the hiv-1 sub-subtype f1 outbreak among men-having-sex-with-men in flanders, belgium",Vinken L,10.3389/fmicb.2019.00613,2019,NR,,0,,,,,
effect of daily consumption of extra virgin olive oil on the lipid profile and microbiota of hiv-infected patients over 50 years of age,Olalla J,10.1097/MD.0000000000017528,2019,NR,,0,,,,,
effect of multiple intervention models on uptake of hiv testing services and sexual behaviour among residents of military cantonments in south-east nigeria,Azuogu BN,10.2989/16085906.2019.1586738,2019,NR,,0,,,,,
defining characteristics of genital health in south african adolescent girls and young women at high risk for hiv infection,Dabee S,10.1371/journal.pone.0213975,2019,NR,,0,,,,,
"effects of antiretroviral therapy and hiv exposure in utero on adverse pregnancy and infant outcomes: a prospective cohort study in guangzhou, china",Hu F,10.3967/bes2019.092,2019,NR,,0,,,,,
design and in vitro delivery of hiv-1 multi-epitope dna and peptide constructs using novel cell-penetrating peptides,Davoodi S,10.1007/s10529-019-02734-x,2019,NR,,0,,,,,
design features of a guideline implementation tool designed to increase awareness of a clinical practice guide to hiv rehabilitation: a qualitative process evaluation,Salbach NM,10.1111/jep.13070,2019,NR,,0,,,,,
"emergence of clonal nontypeable haemophilus influenzae in hiv+ black men who have sex with men (msm) in metro atlanta, 2017-18",Collins LF,10.1136/jim-2018-000974.545,2019,NR,,0,,,,,
"development and validation of hiv-assist, an online, educational, clinical decision support tool to guide patient-centered arv regimen selection",Maddali MV,10.1097/QAI.0000000000002118,2019,NR,,0,,,,,
evolution of interdisciplinary landscapes of hiv/acquired immune deficiency syndromes studies from 1983 to 2017: results from the global analysis for policy in research (gapresearch),Tran BX,,2019,NR,,0,,,,,
"epidemiological changes of acute/recent human immunodeficiency virus type 1 infection in barcelona, spain (1997-2015): a prospective cohort study",Nicolas D,10.1016/j.cmi.2018.10.021,2019,NR,,0,,,,,
lipid based nutrient supplements during pregnancy may improve foetal growth in hiv infected women - a cohort study,Nkhoma,10.1371/journal.pone.0215760,2019,NR,,0,,,,,
metabolic plasticity of hiv-specific cd8+ t cells is associated with enhanced antiviral potential and natural control of hiv-1 infection,Angin M,10.1038/s42255-019-0081-4,2019,NR,,0,,,,,
different forms of household wealth are associated with opposing risks for hiv infection in east africa,Hadley,10.1016/j.worlddev.2018.09.015,2019,NR,,0,,,,,
evidence for a recombinant origin of hiv-1 group m from genomic variation,Olabode AS,10.1093/ve/vey039,2019,NR,,0,,,,,
diverse folding pathways of hiv-1 protease monomer on a rugged energy landscape,Yoo J,10.1016/j.bpj.2019.09.015,2019,NR,,0,,,,,
diverse large hiv-1 non-subtype b clusters are spreading among men who have sex with men in spain,Delgado E,10.3389/fmicb.2019.00655,2019,NR,,0,,,,,
"diversity and characterization of hiv-1 subtypes in the united states, 2008-2016",Kline RL,10.1016/j.annepidem.2019.02.010,2019,NR,,0,,,,,
evolution of the envelope glycoprotein of hiv-1 clade b toward higher infectious properties over the course of the epidemic,Bouvin-Pley M,10.1128/JVI.01171-18,2019,NR,,0,,,,,
evolution of the hiv-1 rev response element during natural infection reveals nucleotide changes that correlate with altered structure and increased activity over time,Sherpa C,10.1128/JVI.02102-18,2019,NR,,0,,,,,
exploring evolutionary and transmission dynamics of hiv epidemic in serbia: bridging socio-demographic with phylogenetic approach,Jovanovic L,10.3389/fmicb.2019.00287,2019,NR,,0,,,,,
does hiv infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and alzheimer's disease?,Fulop T,10.1007/s13365-019-00732-3,2019,NR,,0,,,,,
factors influencing hiv-1 phylogenetic clustering,Junqueira DM,10.1097/COH.0000000000000540,2019,NR,,0,,,,,
driving factors in amiloride recognition of hiv rna targets,Patwardhan NN,10.1039/c9ob01702j,2019,NR,,0,,,,,
"flux nz': an online national cohort investigating hiv, sti and drug-related practices among new zealand gay and bisexual men",Saxton P,10.1136/sextrans-2019-sti.631,2019,NR,,0,,,,,
hiv subtype and nef-mediated immune evasion function correlate with viral reservoir size in early-treated individuals,Omondi FH,10.1128/JVI.01832-18,2019,NR,,0,,,,,
effect of fc receptor genetic diversity on hiv-1 disease pathogenesis,Geraghty DE,10.3389/fimmu.2019.00970,2019,NR,,0,,,,,
"effects of cd4 binding on conformational dynamics, molecular motions, and thermodynamics of hiv-1 gp120",Li Y,10.3390/ijms20020260,2019,NR,,0,,,,,
effects of short-term cash and food incentives on food insecurity and nutrition among hiv-infected adults in tanzania,Fahey CA,10.1097/QAD.0000000000002056,2019,NR,,0,,,,,
gender disparities in traumatic life experiences and antiretroviral therapy adherence among people living with hiv in south carolina,Brown MJ,10.1007/s10461-019-02440-9,2019,NR,,0,,,,,
"engineering and characterising a novel, highly potent bispecific antibody imab-cap256 that targets hiv-1",Moshoette T,10.1186/s12977-019-0493-y,2019,NR,,0,,,,,
human immunodeficiency virus (hiv) infection and use of illicit substances promote secretion of semen exosomes that enhance monocyte adhesion and induce actin reorganization and chemotactic migration,Lyu Y,10.3390/cells8091027,2019,NR,,0,,,,,
"human immunodeficiency virus type 1 ((hiv-1) subtypes in the northwest region, cameroon",Abongwa LE,10.1186/s12985-019-1209-6,2019,NR,,0,,,,,
"genetic diversity and drug resistance of hiv-1 among infected pregnant women newly diagnosed in luanda, angola",Sebastiao CS,10.1371/journal.pone.0225251,2019,NR,,0,,,,,
"human immunodeficiency virus type 1 (hiv-1) subtypes in the northwest region, cameroon",Abongwa,10.1186/s12985-019-1209-6,2019,NR,,0,,,,,
"genetic diversity and transmitted drug resistance in hiv-1 infected pregnant women newly diagnosed in luanda, angola",Sebastiao CS,10.1093/trstmh/trz090,2019,NR,,0,,,,,
estimating hiv-1 genetic diversity in brazil through next-generation sequencing,Alves BM,10.3389/fmicb.2019.00749,2019,NR,,0,,,,,
genotypic and mechanistic characterization of subtype-specific hiv adaptation to host cellular immunity,Kinloch NN,10.1128/JVI.01502-18,2019,NR,,0,,,,,
heterogeneous hiv-1 reactivation patterns of disulfiram and combined disulfiram+romidepsin treatments,Kula A,10.1097/QAI.0000000000001958,2019,NR,,0,,,,,
high hiv prevalence and associated risk factors among transgender women in china: a cross-sectional survey,Yan H,10.1002/jia2.25417,2019,NR,,0,,,,,
"high levels of syndemics and their association with adherence, viral non-suppression, and biobehavioral transmission risk in miami, a us city with an hiv/aids epidemic",Glynn TR,10.1007/s10461-019-02619-0,2019,NR,,0,,,,,
hiv copd: exploring the role of host recognition and response to the lung microbiome in pulmonary disease,Dunlap DG,,2019,NR,,0,,,,,
hiv diversity and genetic compartmentalization in blood and testes during suppressive antiretroviral therapy,Miller RL,10.1128/JVI.00755-19,2019,NR,,0,,,,,
hiv drug resistance among naive hiv-infected patients in iran,Farrokhi M,10.4103/jrms.JRMS_689_18,2019,NR,,0,,,,,
hiv genotyping and phylogenetic analysis in the system of virological monitoring of hiv infection,Peksheva OY,10.17691/stm2019.11.4.17,2019,NR,,0,,,,,
"hiv incidence among men who have sex with men and transgender women in tijuana, mexico",Skaathun B,10.1002/jia2.25327,2019,NR,,0,,,,,
hiv increases hbv replication through exosome induction and mx1 regulation,Lin W,,2019,NR,,0,,,,,
"human immunodeficiency virus-1 diversity in the moscow region, russia: phylodynamics of the most common subtypes",Lebedev A,10.3389/fmicb.2019.00320,2019,NR,,0,,,,,
human immunodeficiency virus-associated neurocognitive impairment in diverse resource-limited settings,Robertson KR,10.1093/cid/ciy767,2019,NR,,0,,,,,
hiv transmission links between past and newly diagnosed infections: a molecular epidemiology study,Kwan TH,10.1016/S0140-6736%2819%2932340-2,2019,NR,,0,,,,,
"hiv transmission networks among transgender women in los angeles county, ca, usa: a phylogenetic analysis of surveillance data",Ragonnet-Cronin M,10.1016/S2352-3018(18)30359-X,2019,NR,,0,,,,,
evidence for both intermittent and persistent compartmentalization of hiv-1 in the female genital tract,Mabvakure BM,10.1128/JVI.00311-19,2019,NR,,0,,,,,
immune correlates of disease progression in linked hiv-1 infection,Tuen M,10.3389/fimmu.2019.01062,2019,NR,,0,,,,,
"hiv vertical transmission in rio de janeiro, brazil - does the distance matter?",Hofer CB,10.1080/09540121.2018.1515466,2019,NR,,0,,,,,
hiv-1 balances the fitness costs and benefits of disrupting the host cell actin cytoskeleton early after mucosal transmission,Usmani SM,10.1016/j.chom.2018.12.008,2019,NR,,0,,,,,
hiv-1 diversity and antiretroviral resistance among bulgarian citizens infected abroad and foreigners registered with hiv/aids in bulgaria from 2012 to 2017 (preliminary analysis),Alexiev I,10.1111/hiv.12815,2019,NR,,0,,,,,
"income inequality, hiv stigma, and preventing hiv disease progression in rural communities",Kalichman S,10.1007/s11121-019-01013-5,2019,NR,,0,,,,,
full length tat 101 is themost frequently sequenced length variant in hiv-1-infected patient samples within the drexel medicine cares cohort and lanl,Mele AR,10.1007/s13365-019-00807-1,2019,NR,,0,,,,,
hiv-1 drug resistance before initiation or re-initiation of first-line art in eight regions of mexico: a sub-nationally representative survey,Avila-Rios,10.1093/jac/dky512,2019,NR,,0,,,,,
hiv-1 envelope glycan composition as a key determinant of efficient virus transmission via dc-sign and resistance to inhibitory lectins,Jan M,10.1016/j.isci.2019.10.030,2019,NR,,0,,,,,
"exploring the use of fact-based and story-based learning materials for hiv/sti prevention and sexual health promotion with south asian women in toronto, canada",Wong JP-H,10.1093/her/cyy042,2019,NR,,0,,,,,
analysis of the latent reservoir of a patient infected with hiv under prep by single full-length hiv-1 amplification,Damagnez M,10.1111/hiv.12815,2019,NR,,0,,,,,
"identification of an hiv-1 bc intersubtype recombinant form, which is circulating in spain",Canada Garcia JE,10.1111/hiv.12815,2019,NR,,0,,,,,
cd161 expression identifies a subset of cd4+t cells that promote clonal expansion of latent hiv-1 in art-suppressed individuals,Li X,10.1002/eji.201970400,2019,NR,,0,,,,,
"hiv-1 molecular epidemiology, transmission clusters and transmitted drug resistance mutations in central brazil",Tanaka TSO,10.3389/fmicb.2019.00020,2019,NR,,0,,,,,
hiv-1 molecular transmission clusters in nine european countries and canada: association with demographic and clinical factors,Paraskevis D,10.1186/s12916-018-1241-1,2019,NR,,0,,,,,
fierce selection and interference in b-cell repertoire response to chronic hiv-1,Nourmohammad A,10.1093/molbev/msz143,2019,NR,,0,,,,,
disparities in cardiovascular disease prevention among persons living with hiv in the united states military natural history study,Larson DT,10.1093/ofid/ofz360.409,2019,NR,,0,,,,,
population structure and implications on the genetic architecture of hiv-1 phenotypes within southern africa,Thami PK,10.3389/fgene.2019.00905,2019,NR,,0,,,,,
"challenges in optimizing preexposure prophylaxis development, engagement, and access for hiv prevention",Scully EP,10.1172/JCI134389,2019,NR,,0,,,,,
predicting cognitive performance from physical activity and fitness in adolescents and young adults in botswana relative to hiv status,Malete L,10.1038/s41598-019-55925-x,2019,NR,,0,,,,,
hiv pre-exposure prophylaxis for adolescent girls and young women in africa: from efficacy trials to delivery,Celum CL,10.1002/jia2.25298,2019,NR,,0,,,,,
postfusion structure of human-infecting bourbon virus envelope glycoprotein,Bai C,10.1016/j.jsb.2019.08.005,2019,NR,,0,,,,,
"frustrated patients, frustrated providers: a comprehensive integrated conceptual model to explain why patients delay, decline, or discontinue hiv medication and strategies to boost sustained hiv viral suppression in populations at-risk",Gwadz M,10.1002/jia2.25327,2019,NR,,0,,,,,
"characterization of a new hiv-1 crf01-ae/b recombinant virus form among men who have sex with men in shanghai, china",Ou W,10.1089/aid.2018.0197,2019,NR,,0,,,,,
"identification of a novel hiv type 1 crf01-ae/crf07-bc recombinant virus in men who have sex with men in guangxi, china",Liu W,10.1089/aid.2018.0157,2019,NR,,0,,,,,
next-generation hiv pre-exposure prophylaxis preferences among men who have sex with men taking daily oral pre-exposure prophylaxis,Ellison J,10.1089/apc.2019.0093,2019,NR,,0,,,,,
"frailty is an independent risk factor for mortality, cardiovascular disease, bone disease, and diabetes among aging adults with human immunodeficiency virus",Kelly SG,10.1093/cid/ciy1101,2019,NR,,0,,,,,
"genomic characterization of a novel hiv-1 second-generation recombinant form (crf01-ae/b) from men who have sex with men in guangxi zhuang autonomous region, china",Li K,10.1089/aid.2019.0149,2019,NR,,0,,,,,
hiv testing in a large community health center serving a multi-cultural patient population: a qualitative study of providers,James AJ,10.1080/09540121.2019.1612016,2019,NR,,0,,,,,
gathering trauma narratives: a qualitative study on the impact of traumas on people living with hiv (plwh),Pierson D,10.1093/ofid/ofz360.1179,2019,NR,,0,,,,,
conformational changes in hiv-1 reverse transcriptase that facilitate its maturation,Slack RL,10.1016/j.str.2019.08.004,2019,NR,,0,,,,,
"another near full-length sequence of an hiv-1 crf01-ae/crf07-bc recombinant virus from a man who has sex with men in tianjin, china",Zhou Z,10.1089/aid.2019.0071,2019,NR,,0,,,,,
"hiv-1 subtype diversity, drug resistance, and genetic transmission networks in men who have sex with men with virologic failure in antiretroviral therapy in sichuan, china, 2011 to 2017",Yuan D,10.1097/MD.0000000000017585,2019,NR,,0,,,,,
gch1 haplotypes and cardiovascular risk in hiv,Slaven JE,10.1097/QAD.0000000000002263,2019,NR,,0,,,,,
genetic analysis of the full-length gag gene from the earliest korean subclade b of hiv-1: an outbreak among korean hemophiliacs,Cho YK,10.3390/v11060545,2019,NR,,0,,,,,
"characterization of a novel hiv-1 crf01-ae/crf07-bc recombinant virus form in guizhou, china",Wu L,10.1089/aid.2019.0010,2019,NR,,0,,,,,
"genomic characterization of a novel hiv-1 second-generation recombinant form (crf01-ae/07-bc) from a married man who has sex with men in zhejiang, china",Sun J,10.1089/aid.2018.0271,2019,NR,,0,,,,,
identification of new hiv-1 circulating recombinant forms crf81-cpx and crf99-bf1 in central western brazil and of unique bf1 recombinant forms,Reis MNG,10.3389/fmicb.2019.00097,2019,NR,,0,,,,,
the lipoprotein nlpe is a cpx sensor that serves as a sentinel for protein sorting and folding defects in the escherichia coli envelope,Delhaye A,10.1128/JB.00611-18,2019,NR,,0,,,,,
"hiv prevalence, spatial distribution and risk factors for hiv infection in the kenyan fishing communities of lake victoria",Kwena ZA,10.1371/journal.pone.0214360,2019,NR,,0,,,,,
"near full-length genomic characterization of hiv-1 crf01-ae/b recombinant strains identified in hebei, china",Huang Q,10.1089/aid.2018.0130,2019,NR,,0,,,,,
"impact of counseling in knowledge, attitude and practice and association of nutritional status with cd4 count and opportunistic infections of hiv patients of udupi, india",Pokharel P,10.1016/j.clnesp.2018.11.001,2019,NR,,0,,,,,
"correction: whole genome sequencing of extreme phenotypes identifies variants in cd101 and ube2v1 associated with increased risk of sexually acquired hiv-1 (plos pathogens, (2017), 13, 11, (e1006703), 101371/journalppat1006703)",Anonymous,10.1371/journal.ppat.1007588,2019,NR,,0,,,,,
hiv-1 vif triggers cell cycle arrest by degrading cellular ppp2r5 phospho-regulators,Salamango DJ,10.1016/j.celrep.2019.09.057,2019,NR,,0,,,,,
different hiv transcriptional profiles in memory cd4+ t cells subsets during art,Ruiz MJ,10.1002/jia2.25327,2019,NR,,0,,,,,
"ascent: phase 2a, randomized, double-blind, placebo controlled study evaluating safety and immunogenicity of two hiv-1 prophylactic vaccine regimens comprising ad26mos4hiv and either clade c gp140 or bivalent gp140",Stieh DJ,10.1002/jia2.25327,2019,NR,,0,,,,,
engaging culturally and linguistically diverse populations in hiv/sti services: challenges and opportunities,Sawleshwarkar S,10.1136/sextrans-2019-sti.84,2019,NR,,0,,,,,
the hiv-1 antisense protein asp is a structural protein of the viral envelope,Affram Y,,2019,NR,,0,,,,,
849 racial differences in the presentation of dermatologic conditions in patients with hiv,Bender AM,10.1016/j.jid.2019.03.925,2019,NR,,0,,,,,
correction: whole genome sequencing of extreme phenotypes identifies variants in cd101 and ube2v1 associated with increased risk of sexually acquired hiv-1 (plos pathog (2017) 13: 11 (e1006703) doi: 101371/journalppat1006703),MacKelprang RD,10.1371/journal.ppat.1007588,2019,NR,,0,,,,,
highly mutable linker regions regulate hiv-1 rev function and stability,Jayaraman B,10.1038/s41598-019-41582-7,2019,NR,,0,,,,,
hivfird: a tool for detection of resistance to fusion inhibitor drugs in hiv-1 sequences,Barreto Vasconcelos AL,10.1089/aid.2019.0116,2019,NR,,0,,,,,
hla-b*57 carriage in a post-treatment viral load controller from an hiv-1 therapeutic vaccine clinical trial,Ananworanich J,10.1016/j.humimm.2019.07.120,2019,NR,,0,,,,,
hla-b*57:01 allele prevalence in treatment-naive hiv-infected patients from colombia,Martinez Buitrago E,10.1186/s12879-019-4415-3,2019,NR,,0,,,,,
genomic evidence for dissemination of mycobacterium marinum in an hiv patient with multifocal cutaneous disease,Chiang AD,10.1093/ofid/ofz360.307,2019,NR,,0,,,,,
genotypic characterization of hiv-1 subtype c in the central region of nepal (special issue on hiv prevention science),Oka,10.1089/aid.2019.0105,2019,NR,,0,,,,,
how are transgender women acquiring hiv? insights from phylogenetic transmission clusters in san francisco,Truong H-HM,10.1097/QAD.0000000000002318,2019,NR,,0,,,,,
human anti-hiv-1 gp120 monoclonal antibodies with neutralizing activity cloned from humanized mice infected with hiv-1,Gawron MA,10.4049/jimmunol.1801085,2019,NR,,0,,,,,
"human immunodeficiency virus (hiv)-1 transmission among persons with acute hiv-1 infection in malawi: demographic, behavioral, and phylogenetic relationships",Dennis AM,10.1093/cid/ciy1006,2019,NR,,0,,,,,
graphical analysis of hiv guidelines adherence finds system-wide anomalies in diagnostic testing,Hauser RG,10.1093/ofid/ofz360.1164,2019,NR,,0,,,,,
harnessing avidity: quantifying the entropic and energetic effects of linker length and rigidity for multivalent binding of antibodies to hiv-1,Einav T,10.1016/j.cels.2019.09.007,2019,NR,,0,,,,,
hcmv envelope glycoprotein diversity demystified,Foglierini M,10.3389/fmicb.2019.01005,2019,NR,,0,,,,,
healthcare needs beyond hiv in a changing nhs: participant exploration of positive voices data,Smithson K,10.1111/hiv.12739,2019,NR,,0,,,,,
human immunodeficiency virus type 1 rna detected in the central nervous system (cns) after years of suppressive antiretroviral therapy can originate from a replicating cns reservoir or clonally expanded cells,Joseph SB,10.1093/cid/ciy1066,2019,NR,,0,,,,,
hybrid nanocarriers incorporating mechanistically distinct drugs for lymphatic cd4+ t cell activation and hiv-1 latency reversal,Cao S,10.1126/sciadv.aav6322,2019,NR,,0,,,,,
higher genetic diversity and viral evolution in key regions of the envelope gene are associated with broader neutralizing antibody responses: a report of two chronic hiv infected cases,Shen S,10.7883/yoken.JJID.2018.336,2019,NR,,0,,,,,
higher viral loads and genetic diversities of hiv-1 in seminal compartments than in bloods of seven chinese men with msm who have early hiv-1 infection,Zhang L,10.1002/eji.201970400,2019,NR,,0,,,,,
"identification of hiv-1 transmission clusters in croatia, 2014-2017: evidence for the forward spread of hiv-1 resistant variants",Begovac J,10.1111/hiv.12815,2019,NR,,0,,,,,
"identity, stigma, and hiv risk among transgender women: a qualitative study in jiangsu province, china",Yan Z-H,10.1186/s40249-019-0606-9,2019,NR,,0,,,,,
impact of herpes simplex virus type 2 and human immunodeficiency virus dual infection on female genital tract mucosal immunity and the vaginal microbiome,Keller,10.1093/infdis/jiz203,2019,NR,,0,,,,,
hiv non-b subtypes in san francisco: migration but little local transmission,O'Keefe K,10.1136/sextrans-2019-sti.352,2019,NR,,0,,,,,
impact of pain on pulmonary function and respiratory symptoms in people living with hiv,Singhvi DG,,2019,NR,,0,,,,,
"hiv positive status disclosure and associated factor among hiv infected children in pediatric art clinics in gondar town public health facilities, north west ethiopia, 2018",Abegaz BF,10.1016/j.jiph.2019.05.018,2019,NR,,0,,,,,
hiv rebound is predominantly fueled by genetically identical viral expansions from diverse reservoirs,De Scheerder MA,10.1016/j.chom.2019.08.003,2019,NR,,0,,,,,
hiv transmission chains exhibit greater hla-b homogeneity than randomly expected,Nguyen H,10.1097/QAI.0000000000002077,2019,NR,,0,,,,,
hiv transmission patterns study by using genotyping fingerprinting method among the high risk groups of north-west india,Chauhan CK,10.1007/s13337-019-00523-8,2019,NR,,0,,,,,
in vitro validation of crispr-cas9 mediated targeting of transgene integration sites to excise hiv-1 sequences from hiv-1 tg rat,Luongo FP,10.1007/s11481-019-09847-0,2019,NR,,0,,,,,
"structural and binding insights into hiv-1 protease and p2-ligand interactions through molecular dynamics simulations, binding free energy and principal component analysis",Karnati KR,10.1016/j.jmgm.2019.07.008,2019,NR,,0,,,,,
in-depth sampling of high-risk populations to characterize hiv transmission epidemics among young msm using prep in france and quebec,Chaillon A,10.1093/ofid/ofz080,2019,NR,,0,,,,,
hiv-1 clusters and risk factors in blood donors found positive for hiv in france,Cappy P,10.1111/vox.12792,2019,NR,,0,,,,,
hiv-1 envelope glycoprotein at the interface of host restriction and virus evasion,Beitari S,10.3390/v11040311,2019,NR,,0,,,,,
hiv-1 genetic diversity and demographic characteristics in bulgaria,Billings E,10.1371/journal.pone.0217063,2019,NR,,0,,,,,
"informal transit, socio-spatial exclusion, and changing geographies of hiv/aids in urban malawi",Mkandawire P,10.2989/16085906.2019.1575884,2019,NR,,0,,,,,
infrequent hiv infection of circulating monocytes during antiretroviral therapy,Massanella M,10.1128/JVI.01174-19,2019,NR,,0,,,,,
hiv-1 neutralizing antibody signatures and application to epitope-targeted vaccine design,Bricault CA,10.1016/j.chom.2018.12.001,2019,NR,,0,,,,,
hiv-1 requires staufen1 to dissociate stress granules and to produce infectious viral particles,Rao S,10.1261/rna.069351.118,2019,NR,,0,,,,,
intact hiv-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy,Einkauf KB,10.1172/JCI124291,2019,NR,,0,,,,,
hiv-positive men as superheros,Ohayon M,10.1016/j.sexol.2019.05.006,2019,NR,,0,,,,,
is hiv prevention creating new biosocialities among gay men? treatment as prevention and pre-exposure prophylaxis in canada,Girard G,10.1111/1467-9566.12826,2019,NR,,0,,,,,
"isolation, identification, and phylogenetic analysis of potentially pathogenic free-living amoebae isolated from nasal and oral mucosa of hiv/aids patients in iran",Arab-Mazar Z,10.1007/s00436-019-06448-x,2019,NR,,0,,,,,
"human dendritic cell subsets, ontogeny, and impact on hiv infection",Rhodes JW,10.3389/fimmu.2019.01088,2019,NR,,0,,,,,
linked dual-class hiv resistance mutations are associated with treatment failure,Boltz VF,10.1172/jci.insight.130118,2019,NR,,0,,,,,
local epidemics gone viral: evolution and diffusion of the italian hiv-1 recombinant form crf60_bc,Lai A,10.3389/fmicb.2019.00769,2019,NR,,0,,,,,
humoral response to the hiv-1 envelope v2 region in a thai early acute infection cohort,Trinh HV,10.3390/cells8040365,2019,NR,,0,,,,,
i'm 51 but living in the body of a 65-year old': exploring the experiences and needs of those with hiv and multiple comorbidities,Duncan A,10.1111/hiv.12739,2019,NR,,0,,,,,
long-term evolution of transmitted cxcr4-using hiv-1 under effective antiretroviral therapy,Raymond S,10.1097/QAD.0000000000002295,2019,NR,,0,,,,,
identification of hiv gp41-specific antibodies that mediate killing of infected cells,Williams KL,10.1371/journal.ppat.1007572,2019,NR,,0,,,,,
national and international dimensions of human immunodeficiency virus-1 sequence clusters in a northern california clinical cohort,Rhee SY,10.1093/ofid/ofz135,2019,NR,,0,,,,,
new ellagitannins from geranium sanguineum and punica granatum: anti-hiv activity and immunosuppressive effect on dendritic cells,Zhernov YV,10.1111/all.13961,2019,NR,,0,,,,,
identifying integration sites of the hiv-1 genome with intact and aberrant ends through deep sequencing,Ode H,10.1016/j.jviromet.2019.03.004,2019,NR,,0,,,,,
identifying the postpartum needs of women living with hiv in the russian federation,King,,2019,NR,,0,,,,,
massively parallel profiling of hiv-1 resistance to the fusion inhibitor enfuvirtide,Dingens AS,10.3390/v11050439,2019,NR,,0,,,,,
maternal hiv infection alters the community composition and dynamics of the enteric microbiome of associated infants,Brown B,10.1002/jia2.25327,2019,NR,,0,,,,,
impact of hiv-1 diversity on its sensitivity to neutralization,Stefic K,10.3390/vaccines7030074,2019,NR,,0,,,,,
medroxyprogesterone acetate alters the vaginal microbiota and microenvironment in women and increases susceptibility to hiv-1 in humanized mice,Wessels JM,10.1242/dmm.039669,2019,NR,,0,,,,,
memory cd4 + t-cells expressing hla-dr contribute to hiv persistence during prolonged antiretroviral therapy,Lee E,10.3389/fmicb.2019.02214,2019,NR,,0,,,,,
"microbiota richness and diversity in a cohort of underweight hiv-positive children aged 24-72 months in cape town, south africa",Van Niekerk M,10.1111/hiv.12815,2019,NR,,0,,,,,
moderate prevalence of hiv-1 transmitted drug resistance mutations in southern brazil,Bahls LD,10.1186/s12981-019-0219-1,2019,NR,,0,,,,,
modulation of saliva microbiota through prebiotic intervention in hiv-infected individuals,Jimenez-Hernandez N,10.3390/nu11061346,2019,NR,,0,,,,,
molecular and geographic characterization of hiv-1 bf recombinant viruses,Souza JSM,10.1016/j.virusres.2019.197650,2019,NR,,0,,,,,
insights for implementation science from 2 multiphased studies with end-users of potential multipurpose prevention technology and hiv prevention products,Minnis AM,10.1097/QAI.0000000000002215,2019,NR,,0,,,,,
molecular characterization of hiv-1 minority subtypes in hong kong: a recent epidemic of crf07_bc among the men who have sex with men population,Leung KS,10.2174/1570162X17666190530081355,2019,NR,,0,,,,,
interaction of the host and viral genome and their influence on hiv disease,Tough RH,10.3389/fgene.2018.00720,2019,NR,,0,,,,,
molecular detection of candida species by restriction fragment length polymorphism (rflp) analysis of pcr from hiv infected persons,Sandhya Rani T,10.26452/ijrps.v10i3.1317,2019,NR,,0,,,,,
interplay between neuro hiv and binge exposure to alcohol,Chang SL,10.1111/acer.14060,2019,NR,,0,,,,,
isolated anti-cd4 monoclonal antibodies from an hiv-1 long term non-progressor display high potency against diverse hiv-1 subtypes,Kintu C,10.1002/eji.201970400,2019,NR,,0,,,,,
isolation and characterization of cross-neutralizing human anti-v3 single-chain variable fragments (scfvs) against hiv-1 from an antigen preselected phage library,Kumar R,10.1007/s12010-018-2862-8,2019,NR,,0,,,,,
"potential immune escape mutations under inferred selection pressure in hiv-1 strains circulating in medellin, colombia",Arcia D,10.1016/j.meegid.2018.07.001,2019,NR,,0,,,,,
molecular epidemiology of hiv-1 subtype g in the russian federation,Murzakova A,10.3390/v11040348,2019,NR,,0,,,,,
lc/ms analysis and deep sequencing reveal the accurate rna composition in the hiv-1 virion,Simonova A,10.1038/s41598-019-45079-1,2019,NR,,0,,,,,
"limited sustained local transmission of hiv-1 crf01_ae in new south wales, australia",Di Giallonardo F,10.3390/v11050482,2019,NR,,0,,,,,
love with hiv: a latent class analysis of sexual and intimate relationship experiences among women living with hiv in canada,Carter,,2019,NR,,0,,,,,
multilayered stigma and vulnerabilities for hiv infection and transmission: a qualitative study on male sex workers in zimbabwe,Tsang YukHa [Tsang,10.1177/1557988318823883,2019,NR,,0,,,,,
mapping the lineage relationship between cxcr5+ and cxcr5- cd4+ t cells in hiv-infected human lymph nodes,Del Alcazar D,10.1016/j.celrep.2019.08.037,2019,NR,,0,,,,,
multispecific anti-hiv duocar-t cells display broad in vitro antiviral activity and potent in vivo elimination of hiv-infected cells in a humanized mouse model,Anthony-Gonda K,10.1126/scitranslmed.aav5685,2019,NR,,0,,,,,
maximum diversity weighting for biomarkers with application in hiv-1 vaccine studies,He Z,10.1002/sim.8212,2019,NR,,0,,,,,
mutations and migration: molecular and epidemiological aspects of hiv-1 in sweden,Andersson,,2019,NR,,0,,,,,
meaningful involvement to design solutions for ensuring people living with hiv live well into older age,Hirono J,10.1111/hiv.12739,2019,NR,,0,,,,,
nanoencapsulation introduces long-acting phenomenon to tenofovir alafenamide and emtricitabine drug combination: a comparative pre-exposure prophylaxis efficacy study against hiv-1 vaginal transmission,Mandal S,10.1016/j.jconrel.2018.12.027,2019,NR,,0,,,,,
"neighborhood racial diversity, socioeconomic status, and perceptions of hiv-related discrimination and internalized hiv stigma among women living with hiv in the united states",Crockett,,2019,NR,,0,,,,,
"new hiv-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in france, 2013 to 2017",Wirden,,2019,NR,,0,,,,,
new subtype b containing hiv-1 circulating recombinant of sub-saharan africa origin in nigerian men who have sex with men,Billings E,10.1097/QAI.0000000000002076,2019,NR,,0,,,,,
modular hiv-1 capsid assemblies reveal diverse host-capsid recognition mechanisms,Summers BJ,10.1016/j.chom.2019.07.007,2019,NR,,0,,,,,
modulation of tcr-dependent nfat signaling is impaired in hiv-1 nef isolates from elite controllers,Jin SW,10.1016/j.virol.2019.02.008,2019,NR,,0,,,,,
molecular characterisation of hiv acquisition events in the partner study,Beloukas A,10.1111/hiv.12738,2019,NR,,0,,,,,
no clinical impact of cyp3a5 gene polymorphisms on the pharmacokinetics and/or efficacy of maraviroc in healthy volunteers and hiv-1-infected subjects,Vourvahis,10.1002/jcph.1306,2019,NR,,0,,,,,
molecular characteristic of hiv-1 crf01_ae in nanjing from 2015 to 2017,Li W,10.1016/j.meegid.2019.104038,2019,NR,,0,,,,,
no evidence of hiv-1 evolution in circulating reservoirs in children during more than six years of early suppressive antiretroviral therapy despite detectable levels of cell associated-hiv-rna,Moragas M,10.1002/jia2.25327,2019,NR,,0,,,,,
"novel clinical and dual infection by histoplasma capsulatum genotypes in hiv patients from northeastern, brazil",Damasceno LS,10.1038/s41598-019-48111-6,2019,NR,,0,,,,,
novel intersubunit interaction critical for hiv-1 core assembly defines a potentially targetable inhibitor binding pocket,Craveur P,10.1128/mBio.02858-18,2019,NR,,0,,,,,
"onward transmission of multiple hiv-1 unique recombinant forms among men who have sex with men in beijing, china",Liu Y,10.1097/QAI.0000000000001983,2019,NR,,0,,,,,
"multiple hiv-1 subtypes were found circulating in shijingshan district of beijing, china",Sun L,10.1089/aid.2018.0263,2019,NR,,0,,,,,
optimization of peptidic hiv-1 fusion inhibitor t20 by phage display,Chen G,10.1002/pro.3669,2019,NR,,0,,,,,
oral fecal microbiota transplantation increases gut microbiome diversity and alters the microbiome distribution in people with hiv,Utay NS,10.1093/ofid/ofz360.2195,2019,NR,,0,,,,,
n-acetyltransferase 2 enzyme genotype-phenotype discordances in both hiv-negative and hiv-positive nigerians,Kotila,,2019,NR,,0,,,,,
nanoparticle vaccines for inducing hiv-1 neutralizing antibodies,Brinkkemper M,10.3390/vaccines7030076,2019,NR,,0,,,,,
nanotechnology approaches to eradicating hiv reservoirs,Cao S,10.1016/j.ejpb.2018.06.002,2019,NR,,0,,,,,
pangea-hiv 2: phylogenetics and networks for generalised epidemics in africa,Abeler-Dorner,10.1097/COH.0000000000000542,2019,NR,,0,,,,,
patients infected with multi-class resistant hiv-1 and with viral suppression treated with no more than one active drug: comparison of historical resistance reports and drug resistance in proviral dna,Hoffmann C,10.1111/hiv.12815,2019,NR,,0,,,,,
neutralizing antibodies for hiv-1 prevention,Julg B,10.1097/COH.0000000000000556,2019,NR,,0,,,,,
new t- and b-lymphocytes production and t-cell receptor diversity in young adults perinatally infected by hiv,Properzi M,10.1111/hiv.12815,2019,NR,,0,,,,,
performance of hiv pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: results from the prep brasil study,Marins LMS,10.1371/journal.pone.0221281,2019,NR,,0,,,,,
nfpws: a web server for delineating broadly neutralizing antibody specificities from serum hiv-1 neutralization data,Raju N,10.1093/bioinformatics/btz097,2019,NR,,0,,,,,
"ongoing spread of hiv subtype a in tel aviv, israel",Turner D,10.1111/hiv.12815,2019,NR,,0,,,,,
phylogenetic analyses comparing hiv sequences from plasma at virologic failure to cervix versus blood sequences from antecedent antiretroviral therapy suppression,Bull ME,10.1089/AID.2018.0211,2019,NR,,0,,,,,
"optimizing enrollment methods: lessons learned from an mhealth, pilot hiv prevention randomized controlled trial with sexual minority men",Mitchell,10.1177/0956462419831854,2019,NR,,0,,,,,
"phylogenetic analysis highlights the role of older people in the transmission of hiv-1 in fuyang, anhui province, china",Wu J,10.1186/s12879-019-4187-9,2019,NR,,0,,,,,
"oral bacteriome of hiv-1-infected children from rio de janeiro, brazil: next-generation dna sequencing analysis",Goncalves LS,10.1111/jcpe.13176,2019,NR,,0,,,,,
"patient and provider perspectives on 30-day readmissions, preventability, and strategies for improving transitions of care for patients with hiv at a safety net hospital",Nijhawan,10.1177/2325958219827615,2019,NR,,0,,,,,
phylogenetic measures of indel rate variation among the hiv-1 group m subtypes,Palmer J,10.1093/ve/vez022,2019,NR,,0,,,,,
"phylopi: an affordable, purpose built phylogenetic pipeline for the hiv drug resistance testing facility",Bester PA,10.1371/journal.pone.0213241,2019,NR,,0,,,,,
pin150 analysis of treatment sequences from the french national sniiram database: case study of incident people living with hiv in 2013,Laurent M,10.1016/j.jval.2019.09.1390,2019,NR,,0,,,,,
physical activity and quality of life in people living with hiv,Martin,10.1080/09540121.2019.1576848,2019,NR,,0,,,,,
structure of the zebrafish galectin-1-l2 and model of its interaction with the infectious hematopoietic necrosis virus (ihnv) envelope glycoprotein,Ghosh A,10.1093/glycob/cwz015,2019,NR,,0,,,,,
"physician mistrust, medical system mistrust, and perceived discrimination: associations with hiv care engagement and viral load",Brincks AM,10.1007/s10461-019-02464-1,2019,NR,,0,,,,,
positive selection at key residues in the hiv envelope distinguishes broad and strain-specific plasma neutralizing antibodies,Mabvakure BM,10.1128/JVI.01685-18,2019,NR,,0,,,,,
prediction of hiv transmission cluster growth with statewide surveillance data,Billock RM,10.1097/QAI.0000000000001905,2019,NR,,0,,,,,
prediction of pd-l1 inhibition effects for hiv infected individuals,Zheltkova V,10.1371/journal.pcbi.1007401,2019,NR,,0,,,,,
"presence, persistence and effects of pre-treatment hiv-1 drug resistance variants detected using next generation sequencing: a retrospective longitudinal study from rural coastal kenya",Hassan AS,10.1371/journal.pone.0210559,2019,NR,,0,,,,,
slow delivery immunization enhances hiv neutralizing antibody and germinal center responses via modulation of immunodominance,Cirelli KM,10.1016/j.cell.2019.04.012,2019,NR,,0,,,,,
small rnas to treat human immunodeficiency virus type 1 infection by gene therapy,Goguen RP,10.1016/j.coviro.2019.04.003,2019,NR,,0,,,,,
presentation of hiv-1 envelope glycoprotein trimers on diverse nanoparticle platforms,Brouwer PJM,10.1097/COH.0000000000000549,2019,NR,,0,,,,,
prevalence and patterns of illicit drug use in people living with hiv in spain: a cross-sectional study,Fuster-RuizdeApodaca MJ,10.1371/journal.pone.0211252,2019,NR,,0,,,,,
prevalence and the role of ccr5delta32 heterozygosity in disease progression in hiv positive patients in the czech republic,Sacka L,,2019,NR,,0,,,,,
somatic hypermutation to counter a globally rare viral immunotype drove off-track antibodies in the cap256-vrc26 hiv-1 v2-directed bnab lineage,Sacks D,10.1371/journal.ppat.1008005,2019,NR,,0,,,,,
prevalence of non-b hiv-1 subtypes in north italy and analysis of transmission clusters based on sequence data analysis,Lorenzin G,10.3390/microorganisms8010036,2019,NR,,0,,,,,
principles governing establishment versus collapse of hiv-1 cellular spread,Hataye JM,10.1016/j.chom.2019.10.006,2019,NR,,0,,,,,
"rapid and complicated hiv genotype expansion among high-risk groups in guangdong province, china",Zhou P-P,10.1186/s12879-019-3788-7,2019,NR,,0,,,,,
rapid cd4 t-cell decline is associated with coreceptor switch among msm primarily infected with hiv-1 crf01-ae in northeast china,Cui H,10.1097/QAD.0000000000001981,2019,NR,,0,,,,,
psychological burden and the impact on engagement with care among ethnically diverse older women with hiv,Solomon D,10.1111/hiv.12738,2019,NR,,0,,,,,
strain-dependent activation and inhibition of human immunodeficiency virus entry by a specific pf-68742 stereoisomer,Zhao C,10.1128/JVI.01197-19,2019,NR,,0,,,,,
"qualitative analysis of the experiences of gay, bisexual and other men who have sex with men who use getcheckedonlinecom: a comprehensive internet-based diagnostic service for hiv and other stis",Knight RE,10.1136/sextrans-2018-053645,2019,NR,,0,,,,,
structure and immunogenicity of a stabilized hiv-1 envelope trimer based on a group-m consensus sequence,Sliepen K,10.1038/s41467-019-10262-5,2019,NR,,0,,,,,
real-time pcr assay for rapid differentiation of env-based genotypes of feline leukemia virus,Nakagawa S,10.14943/jjvr.67.1.103,2019,NR,,0,,,,,
representations of people living with hiv: influences on the late diagnosis of infection,Ribeiro LCS,10.1590/S1980-220X2018009703439,2019,NR,,0,,,,,
recent advances towards treatment of hiv: synthesis and sar studies,Shrivastava N,10.2174/1389557519666190312170158,2019,NR,,0,,,,,
role of male sex partners in hiv risk of adolescent girls and young women in mozambique,Chapman J,10.9745/GHSP-D-19-00117,2019,NR,,0,,,,,
reduction of hiv-1 reservoir size and diversity after 1 year of cart among brazilian individuals starting treatment during early stages of acute infection,Leite,10.3389/fmicb.2019.00145,2019,NR,,0,,,,,
self-dna sensing fuels hiv-1-associated inflammation,Heil M,10.1016/j.molmed.2019.06.004,2019,NR,,0,,,,,
resistance to the tat inhibitor didehydro-cortistatin a is mediated by heightened basal hiv-1 transcription,Mousseau G,10.1128/mBio.01750-18,2019,NR,,0,,,,,
sexual dimorphism in hiv-1 infection,Rechtien A,10.1007/s00281-018-0704-y,2019,NR,,0,,,,,
rites of resistance: sex workers' fight to maintain rights and pleasure in the centre of the response to hiv in brazil,Murray LR,10.1080/17441692.2018.1510020,2019,NR,,0,,,,,
single genome sequencing of near full-length hiv-1 rna using a limiting dilution approach,Hebberecht L,10.1016/j.jviromet.2019.113737,2019,NR,,0,,,,,
single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated hiv infection,Pardons M,10.1371/journal.ppat.1007619,2019,NR,,0,,,,,
sleep disturbances in hiv-infected patients associated with depression and high risk of obstructive sleep apnea,Gutierrez J,10.1177/2050312119842268,2019,NR,,0,,,,,
sensitivity to broadly neutralizing antibodies of recently transmitted hiv-1 clade crf02_ag viruses with a focus on evolution over time,Stefic K,10.1128/JVI.01492-18,2019,NR,,0,,,,,
systems serology for decoding infection and vaccine-induced antibody responses to hiv-1,Pittala S,10.1097/COH.0000000000000558,2019,NR,,0,,,,,
similar but different: using combined phylogenies of austria and switzerland reveals differences in transmission patterns of the local hiv-1 epidemics,Kusejko K,10.1111/hiv.12815,2019,NR,,0,,,,,
snappy: a snakemake pipeline for scalable hiv-1 subtyping by phylogenetic pairing,Araujo PMM,10.1093/ve/vez050,2019,NR,,0,,,,,
status of hiv-infected patients classified as lost to follow up from a large antiretroviral program in southwest nigeria,Balogun M,10.1371/journal.pone.0219903,2019,NR,,0,,,,,
strategies for improving mobile technology-based hiv prevention interventions with latino men who have sex with men and latina transgender women,Maccarthy S,10.1521/aeap.2019.31.5.407,2019,NR,,0,,,,,
the antibody response in hiv-1-infected donors,Richardson SI,10.1097/COH.0000000000000559,2019,NR,,0,,,,,
"structural variation of centromeric endogenous retroviruses in human populations and their impact on cutaneous t-cell lymphoma, sezary syndrome, and hiv infection",Kaplan MH,10.1186/s12920-019-0505-8,2019,NR,,0,,,,,
"tat basic domain: a ""swiss army knife"" of hiv-1 tat?",Kurnaeva MA,10.1002/rmv.2031,2019,NR,,0,,,,,
the breadth of hiv-1 neutralizing antibodies depends on the conservation of key sites in their epitopes,Bai H,10.1371/journal.pcbi.1007056,2019,NR,,0,,,,,
the changing epidemiological profile of hiv-1 subtype b epidemic in ukraine,Vasylyeva TI,10.1089/AID.2018.0167,2019,NR,,0,,,,,
the collision of public health interventions on hiv-1 spread in albania by molecular epidemiology,Enkelejda S,10.1111/hiv.12815,2019,NR,,0,,,,,
the first acanthamoeba keratitis case of non-contact lens wearer with hiv infection in thailand,Tananuvat N,10.3347/kjp.2019.57.5.505,2019,NR,,0,,,,,
the mutual orientation between v1/v2 and v3 is the structural determinant of hiv-1 gp120 conformational states and dynamics,Li Y,10.1080/07391102.2019.1604468,2019,NR,,0,,,,,
the evolution of endogenous retroviral envelope genes in bats and their potential contribution to host biology,Skirmuntt EC,10.1016/j.virusres.2019.197645,2019,NR,,0,,,,,
refused and referred-persistent stigma and discrimination against people living with hiv/aids in bihar: a qualitative study from india,Mohit Nair,10.1136/bmjopen-2019-033790,2019,NR,,0,,,,,
the impact of hiv-1 genetic diversity on crispr-cas9 antiviral activity and viral escape,Darcis G,10.3390/v11030255,2019,NR,,0,,,,,
"another near full-length sequence of an hiv-1 crf01_ae/crf07_bc recombinant virus from a man who has sex with men in tianjin, china (special issue on hiv prevention science)",Zhou ZeHua,10.1089/aid.2019.0071,2019,NR,,0,,,,,
"characterization of a novel hiv-1 crf01_ae/crf07_bc recombinant virus form in guizhou, china",Wu Li,,2019,NR,,0,,,,,
the inference of hiv-1 transmission direction between hiv-1 positive couples based on the sequences of hiv-1 quasi-species,Wu J,10.1186/s12879-019-4163-4,2019,NR,,0,,,,,
the replication-competent hiv-1 latent reservoir is primarily established near the time of therapy initiation,Abrahams MR,10.1126/scitranslmed.aaw5589,2019,NR,,0,,,,,
the prevalence and correlates of sexual arrangements in a national cohort of hiv-negative gay and bisexual men in the united states,Starks TJ,10.1007/s10508-018-1282-8,2019,NR,,0,,,,,
the unmet mental health needs of people living with hiv: participant exploration of the positive voices data,Smithson K,10.1111/hiv.12739,2019,NR,,0,,,,,
therapeutic vaccination refocuses t-cell responses towards conserved regions of hiv-1 in early treated individuals (bcn 01 study),Mothe B,10.1016/j.eclinm.2019.05.009,2019,NR,,0,,,,,
the role of civil society in the evolving hiv treatment programmes: lessons learned and recommendations,Hourcade Bellocq J,10.1002/jia2.25263,2019,NR,,0,,,,,
the role of gay-related stigma in hiv-risk behavior among sexual minority men in europe,Lelutiu-Weinberger C,10.1007/s10461-018-2306-z,2019,NR,,0,,,,,
the role of social support in the association between childhood trauma and depression among hiv-infected and hiv-uninfected individuals,Rodriguez VJ,10.1177/0956462418793736,2019,NR,,0,,,,,
the social context of hiv prevention and care among black men who have sex with men in three us cities: the neighborhoods and networks (n2) cohort study,Duncan DT,10.3390/ijerph16111922,2019,NR,,0,,,,,
transcontinental dissemination of the major hiv-1 crf01-ae lineages circulating in china,An M,10.1136/sextrans-2019-sti.313,2019,NR,,0,,,,,
"transmission linkages among persons with incident hiv-1 infection in north carolina, 2014 to 2018",Dennis A,10.1002/jia2.25327,2019,NR,,0,,,,,
tracing the impact of public health interventions on hiv-1 transmission in portugal using molecular epidemiology,Vasylyeva TI,10.1093/infdis/jiz085,2019,NR,,0,,,,,
"violence and mental health among gender-diverse individuals enrolled in a human immunodeficiency virus program in karnataka, south india",Thompson LH,10.1089/trgh.2018.0051,2019,NR,,0,,,,,
"two-year cross-sectional studies reveal that single, young msms in shenzhen, china are at high risk for hiv infection",Jia D,10.1186/s12985-019-1189-6,2019,NR,,0,,,,,
"understanding factors influencing linkage to hiv care in a rural setting, mbeya, tanzania: qualitative findings of a mixed methods study",Sanga ES,10.1186/s12889-019-6691-7,2019,NR,,0,,,,,
"transmission dynamics of hiv subtype a in tel aviv, israel: implications for hiv spread and eradication",Grossman Z,10.1093/ofid/ofz304,2019,NR,,0,,,,,
utility of whole-genome next-generation sequencing of plasma in identifying opportunistic infections in hiv/aids,Zhou Y,10.2174/1874613601913010007,2019,NR,,0,,,,,
"validation of a self-report adherence measurement tool among a multinational cohort of children living with hiv in kenya, south africa and thailand",Vreeman RC,10.1002/jia2.25304,2019,NR,,0,,,,,
viral characteristics associated with maintenance of elite neutralizing activity in chronically hiv-1 clade c-infected monozygotic pediatric twins,Mishra N,10.1128/JVI.00654-19,2019,NR,,0,,,,,
viral diversity based on next-generation sequencing of hiv-1 provides precise estimates of infection recency and time since infection,Carlisle LA,10.1093/infdis/jiz094,2019,NR,,0,,,,,
unbinding dynamics of non-nucleoside inhibitors from hiv-1 reverse transcriptase,Dodda LS,10.1021/acs.jpcb.8b10341,2019,NR,,0,,,,,
"vitamin d concentration during early pregnancy and adverse outcomes among hiv-negative women in dar-es-salaam, tanzania: a case-control study",Kalinjuma AV,10.3390/nu11122906,2019,NR,,0,,,,,
"why i can't, won't or don't test for hiv: insights from australian migrants born in sub-saharan africa, southeast asia and northeast asia",Gray,10.3390/ijerph16061034,2019,NR,,0,,,,,
"willingness to donate hair samples for research among people living with hiv/aids attending a tertiary health facility in ibadan, nigeria",Nwogu,10.1089/aid.2018.0242,2019,NR,,0,,,,,
viral suppression among hiv-infected methadone-maintained patients: the role of ongoing injection drug use and adherence to antiretroviral therapy (art),Shrestha R,,2019,NR,,0,,,,,
vitamin d and phenylbutyrate supplementation does not modulate gut derived immune activation in hiv-1,Missailidis C,10.3390/nu11071675,2019,NR,,0,,,,,
"women's encounters with venue-based hiv risk contexts in abuja, nigeria",Thompson L,10.1136/sextrans-2019-sti.773,2019,NR,,0,,,,,
virus envelope tissue factor promotes infection in mice,Sutherland MR,10.1111/jth.14389,2019,NR,,0,,,,,
zimbabwean secondary school guidance and counseling teachers teaching sexuality education in the hiv and aids education curriculum,Gudyanga E,10.1080/17290376.2019.1610485,2019,NR,,0,,,,,
young people who inject drugs in india have high hiv incidence and behavioural risk: a cross-sectional study,Ganapathi L,10.1002/jia2.25287,2019,NR,,0,,,,,
proviral quasispecies diversity is not associated with virologic breakthrough or cd4+ t cell loss in hiv-1 elite controllers,De Azevedo SSD,10.3389/fmicb.2019.00673,2019,NR,,0,,,,,
determining the origins of human immunodeficiency virus type 1 drug-resistant minority variants in people who are recently infected using phylogenetic reconstruction,Mbisa JL,10.1093/cid/ciy1048,2019,NR,,0,,,,,
a compositional transform reveals hiv exposure induced shifts in the fecal microbiota of nigerian infants,Brown B,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
a comprehensive analysis of the t and b lymphocytes repertoire shaped by hiv vaccines,Wang L,10.3389/fimmu.2018.02194,2018,NR,,0,,,,,
a novel amyloid designable scaffold and potential inhibitor inspired by gaiig of amyloid beta and the hiv-1 v3 loop,Kokotidou C,10.1002/1873-3468.13096,2018,NR,,0,,,,,
a small-molecule inhibitor of hiv-1 rev function detected by a diversity screen based on rre-rev interference,Prado S,10.1016/j.bcp.2018.07.040,2018,NR,,0,,,,,
acceptability and feasibility of dual hiv and syphilis point-of-care testing for early detection of infection among pregnant women in china: a prospective study,Wang Q,10.1136/bmjopen-2017-020717,2018,NR,,0,,,,,
"acquisition of tenofovir-susceptible, emtricitabine-resistant hiv despite high adherence to daily pre-exposure prophylaxis: a case report",Cohen SE,10.1016/S2352-3018(18)30288-1,2018,NR,,0,,,,,
"adult stakeholder guidance for improved hiv and other std prevention and screening with gay, bisexual and transgender youth",Cahill S,,2018,NR,,0,,,,,
"a high hiv-1 strain variability in london, uk, revealed by full-genome analysis: results from the iconic project",Yebra G,10.1371/journal.pone.0192081,2018,NR,,0,,,,,
a highly efficient and gmp compliant protocol to manufacture ccr5 edited cells to treat hiv infection,Romito M,10.1182/blood-2018-99-117116,2018,NR,,0,,,,,
adverse effects in children exposed to maternal hiv and antiretroviral therapy during pregnancy in brazil: a cohort study,Delicio,10.1186/s12978-018-0513-8,2018,NR,,0,,,,,
age-related differences in socio-demographic and behavioral determinants of hiv testing and counseling in hptn 043/nimh project accept,Salazar-Austin N,10.1007/s10461-017-1807-5,2018,NR,,0,,,,,
alterations in oral and gut microbiota in hiv-infected individuals related to pulmonary function,Yang L,,2018,NR,,0,,,,,
a newly developed b cell immunoglobulin phenotyping panel to facilitate more efficient hiv-1 antibody discovery,Nettey L,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
a neutralizing antibody recognizing primarily n-linked glycan targets the silent face of the hiv envelope,Zhou T,10.1016/j.immuni.2018.02.013,2018,NR,,0,,,,,
an outbreak of hiv amongst people who inject drugs: a phylogenetic analysis,Jackson C,,2018,NR,,0,,,,,
single-cell analysis of quiescent hiv infection reveals host transcriptional profiles that regulate proviral latency,Bradley T,10.1016/j.celrep.2018.09.020,2018,NR,,0,,,,,
analysis of drug resistance mutations in whole blood dna from hiv-1 infected patients by single genome and ultradeep sequencing analysis,Sotillo A,10.1016/j.jviromet.2018.06.020,2018,NR,,0,,,,,
display of the hiv envelope protein at the yeast cell surface for immunogen development,Mathew E,10.1371/journal.pone.0205756,2018,NR,,0,,,,,
within-patient mutation frequencies reveal fitness costs of cpg dinucleotides and drastic amino acid changes in hiv,Theys K,10.1371/journal.pgen.1007420,2018,NR,,0,,,,,
ultradeep single-molecule real-time sequencing of hiv envelope reveals complete compartmentalization of highly macrophage-tropic r5 proviral variants in brain and cxcr4-using variants in immune and peripheral tissues,Brese RL,10.1007/s13365-018-0633-5,2018,NR,,0,,,,,
distribution of cell envelope proteinases genes among polish strains of lactobacillus helveticus,Skrzypczak KW,10.21307/pjm-2018-026,2018,NR,,0,,,,,
dimethyl adenosine transferase (ksga) contributes to cell-envelope fitness in salmonella enteritidis,Chiok KL,10.1016/j.micres.2018.08.009,2018,NR,,0,,,,,
a universal approach to optimize the folding and stability of prefusion-closed hiv-1 envelope trimers,Rutten L,10.1016/j.celrep.2018.03.061,2018,NR,,0,,,,,
a5340: brief ati does not alter the size or composition of the latent hiv-1 reservoir,Bar KJ,,2018,NR,,0,,,,,
accuracy of hiv risk perceptions among episodic substance-using men who have sex with men,Hall GC,10.1007/s10461-017-1935-y,2018,NR,,0,,,,,
achieving scale rapidly in public health: applying business management principles to scale up an hiv prevention program in india,Sgaier SK,10.1016/j.hjdsi.2017.09.002,2018,NR,,0,,,,,
"antiretroviral potency of 4'-ethnyl-2'-fluoro-2'-deoxyadenosine, tenofovir alafenamide and second-generation nnrtis across diverse hiv-1 subtypes",Njenda DT,10.1093/jac/dky256,2018,NR,,0,,,,,
adaptive evolution of industrial lactococcus lactis under cell envelope stress provides phenotypic diversity,Lopez-Gonzalez MJ,10.3389/fmicb.2018.02654,2018,NR,,0,,,,,
natural apobec3c variants can elicit differential hiv-1 restriction activity,Anderson BD,10.1186/s12977-018-0459-5,2018,NR,,0,,,,,
assessment of transmitted hiv-1 drug resistance mutations using ultra- deep pyrosequencing in a turkish cohort,Sili U,10.2174/1570162X16666180910130112,2018,NR,,0,,,,,
ageing in patients with chronic hiv infection: impact of hypercoagulation,Kent SJ,10.1186/s12981-018-0211-1,2018,NR,,0,,,,,
association of diverse genotypes and phenotypes of immune cells and immunoglobulins with the course of hiv-1 infection,Li L,10.3389/fimmu.2018.02735,2018,NR,,0,,,,,
association of new hiv diagnoses within long-lived transmission clusters from malaga area (spain),Viciana Ramos I,10.1002/jia2.25187,2018,NR,,0,,,,,
attrition and hiv risk behaviors: a comparison of young men who have sex with men recruited from online and offline venues for an online hiv prevention program,Madkins K,10.1007/s10508-018-1253-0,2018,NR,,0,,,,,
altered composition and elevated diversity in the enteric virome of hiv exposed uninfected south african infants,Brown B,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
"back to the future: even in the art era, men coinfected with hiv and urethritis pose a potential transmission threat",Chen JS,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
bacterial vaginosis is associated with elevated genital inflammation and cellular activation in young african women at high risk for hiv infection,Dabee S,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
"characterization of the membrane-bound form of the chimeric, b/c recombinant hiv-1 env, lt5j4b12c",Das S,10.1099/jgv.0.001141,2018,NR,,0,,,,,
amplification of near full-length hiv-1 proviruses for next-generation sequencing,Hiener B,10.3791/58016,2018,NR,,0,,,,,
a new hiv-1 circulating recombinant form (crf98_cpx) between crf06_cpx and subtype b identified in southwestern france,Recordon-Pinson P,10.1089/AID.2018.0122,2018,NR,,0,,,,,
evaluation of different analysis pipelines for the detection of hiv-1 minority resistant variants,Perrier M,10.1371/journal.pone.0198334,2018,NR,,0,,,,,
ptap motif duplication in the p6 gag protein confers a replication advantage on hiv-1 subtype c,Sharma S,10.1074/jbc.M117.815829,2018,NR,,0,,,,,
"characterization of a new hiv-1 crf01_ae/crf07_bc recombinant virus in tianjin, china",Zhou Z,10.1089/AID.2018.0077,2018,NR,,0,,,,,
"identification of a novel hiv-1 b/c/crf01_ae recombinant isolate in guangxi, china",Wang C,10.1089/AID.2018.0070,2018,NR,,0,,,,,
"identification of a new hiv-1 circulating recombinant form crf65_cpx strain in jilin, china",Wang JY,10.1089/AID.2018.0086,2018,NR,,0,,,,,
the kat5-acetyl-histone4-brd4 axis silences hiv-1 transcription and promotes viral latency,Li Z,10.1371/journal.ppat.1007012,2018,NR,,0,,,,,
detection of numerous hiv-1/mo recombinants in france,De Oliveira F,10.1097/QAD.0000000000001814,2018,NR,,0,,,,,
bioinformatic data processing pipelines in support of next-generation sequencing-based hiv drug resistance testing: the winnipeg consensus,Ji H,10.1002/jia2.25193,2018,NR,,0,,,,,
allele-specific long-distance regulation dictates il-32 isoform switching and mediates susceptibility to hiv-1,Palstra RJ,10.1126/sciadv.1701729,2018,NR,,0,,,,,
kinetics of hiv-specific ctl responses plays a minimal role in determining hiv escape dynamics,Yang Y,10.3389/fimmu.2018.00140,2018,NR,,0,,,,,
signal peptide of hiv envelope protein impacts glycosylation and antigenicity of gp120,Yolitz J,10.1073/pnas.1722627115,2018,NR,,0,,,,,
full-length glycosylated gag of murine leukemia virus can associate with the viral envelope as a type i integral membrane protein,Renner TM,10.1128/JVI.01530-17,2018,NR,,0,,,,,
immunogenetic factors in early immune control of human immunodeficiency virus type 1 (hiv-1) infection: evaluation of hla class i amino acid variants in two african populations,Wiener HW,10.1016/j.humimm.2017.12.005,2018,NR,,0,,,,,
"identification of a novel hiv-1 unique recombinant form between b, crf01_ae and crf07_bc in men who have sex with men in guangxi, china",Kong D,10.1089/AID.2017.0259,2018,NR,,0,,,,,
epistastic interactions within the junin virus envelope glycoprotein complex provide an evolutionary barrier to reversion in the live-attenuated candid#1 vaccine,York J,10.1128/JVI.01682-17,2018,NR,,0,,,,,
comparison of measures of adherence to human immunodeficiency virus preexposure prophylaxis among adolescent and young men who have sex with men in the united states,Koss CA,10.1093/cid/cix755,2018,NR,,0,,,,,
assessing changes in hiv-related legal and policy environments: lessons learned from a multi-country evaluation,Ferguson L,10.1371/journal.pone.0192765,2018,NR,,0,,,,,
assessing strategies and capacity for gender integration in hiv biomedical research,Maple J,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
"association between hiv genotype, viral load and disease progression in a cohort of thai men who have sex with men with estimated dates of hiv infection",Leelawiwat W,10.1371/journal.pone.0201386,2018,NR,,0,,,,,
changes in intestinal microbiota in hiv-1-infected subjects following cart initiation: influence of cd4+ t cell count article,Ji Y,10.1038/s41426-018-0117-y,2018,NR,,0,,,,,
"characteristics of hiv infections, including genotypes and drug resistance mutations, in blood donors in the us",Custer B,10.1111/trf.14903,2018,NR,,0,,,,,
chimeric antigen receptors against hiv: bispecific cd4-based designs for enhanced breadth/potency and minimal immunogenicity,Hajduczki A,,2018,NR,,0,,,,,
"characteristics of hiv-1 molecular epidemiology in suzhou, china, from 2009 to 2014",Yuan Y,10.1007/s12250-018-0022-5,2018,NR,,0,,,,,
barriers and facilitators to seeking hiv services in chicago among young men who have sex with men: perspectives of hiv service providers,Beach LB,10.1089/apc.2018.0094,2018,NR,,0,,,,,
barriers to initiation of extended release naltrexone among hiv-infected adults with alcohol use disorders,Chokron Garneau H,10.1016/j.jsat.2017.05.004,2018,NR,,0,,,,,
"characterization of hiv-1 subtypes and transmitted drug resistance among treatment-naive hiv-infected individuals in zhejiang, china, 2014-2017",Xu Y,10.1007/s00705-018-3839-1,2018,NR,,0,,,,,
characterization of minority hiv-1 drug resistant variants in the united kingdom following the verification of a deep sequencing-based hiv-1 genotyping and tropism assay,Silver N,10.1186/s12981-018-0206-y,2018,NR,,0,,,,,
broadly neutralizing antibodies: what is needed to move from a rare event in hiv-1 infection to vaccine efficacy?,Subbaraman H,10.1186/s12977-018-0433-2,2018,NR,,0,,,,,
broadly neutralizing sera from long-term nonprogressors predominantly target envelope epitopes within the v3 glycan-dependent region,Gonzalez N,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
patterns of genomic site inheritance in hiv-1m inter-subtype recombinants delineate the most likely genomic sites of subtype-specific adaptation,Tongo M,10.1093/ve/vey015,2018,NR,,0,,,,,
case report: mechanisms of hiv elite control in two african women,Moosa Y,10.1186/s12879-018-2961-8,2018,NR,,0,,,,,
cd32-expressing cd4 t cells are phenotypically diverse and can contain proviral hiv dna,Martin GE,10.3389/fimmu.2018.00928,2018,NR,,0,,,,,
combination of hiv-1 antibodies 3bnc117 and 10-1074 delays viral rebound during treatment interruption,Mendoza P,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
"comparative sequence and structural analysis of indian orf viruses based on major envelope immuno-dominant protein (f1l), an homologue of pox viral p35/h3 protein",Yogisharadhya R,10.1016/j.gene.2018.04.026,2018,NR,,0,,,,,
"comparing self-reported demographic and sexual behavioral factors among men who have sex with men recruited through mechanical turk, qualtrics, and a hiv/sti clinic-based sample: implications for researchers and providers",Beymer MR,10.1007/s10508-016-0932-y,2018,NR,,0,,,,,
comparison of measures of adherence to hiv pre-exposure prophylaxis (prep) among men who have sex with men (msm) and transgender women (tgw): results from the prep brasil study,Marins LMS,10.1002/jia2.25148,2018,NR,,0,,,,,
complete genome sequence of an african swine fever virus (asfv pol/2015/podlaskie) determined directly from pig erythrocyte-associated nucleic acid,Olesen AS,10.1016/j.jviromet.2018.07.015,2018,NR,,0,,,,,
computational analysis of envelope glycoproteins from diverse geographical isolates of bovine leukemia virus identifies highly conserved peptide motifs,Pluta A,10.1186/s12977-017-0383-0,2018,NR,,0,,,,,
computational study of hiv gp120 as a target for polyanionic entry inhibitors: exploiting the v3 loop region,Hollingsworth LR,10.1371/journal.pone.0190658,2018,NR,,0,,,,,
characterization of broadly neutralizing antibody responses to hiv-1 in a cohort of long term non-progressors,Gonzalez N,10.1371/journal.pone.0193773,2018,NR,,0,,,,,
"hiv env: structure, function, and inhibition thereof",Kwong PD,,2018,NR,,0,,,,,
characterization of hiv-1 envelope genes in a long-term nonprogressor with broadly neutralizing activity,Zhang D,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
characterization of infectious hiv clones from the reservoir of patients,Nicolas A,10.1186/s12977-018-0436-z,2018,NR,,0,,,,,
characterizing env-specific monoclonal antibodies isolated from us and malawian hiv-infected non-transmitting and transmitting women,Martinez D,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
chemo-enzymatic synthesis of n-glycans for array development and hiv antibody profiling,Shivatare SS,10.3791/55855,2018,NR,,0,,,,,
circumstances surrounding high-risk sexual experiences among primary care patients living with and without hiv,Fredericksen RJ,10.1007/s11606-018-4675-4,2018,NR,,0,,,,,
day-level associations between substance use and hiv risk behavior among a diverse sample of transgender women,Millar BM,10.1089/trgh.2018.0032,2018,NR,,0,,,,,
decreased microbiome diversity in the hiv small airway epithelium,Xu S,10.1186/s12931-018-0835-7,2018,NR,,0,,,,,
clonal cd4+ t cells in the hiv-1 latent reservoir display a distinct gene profile upon reactivation,Cohn LB,10.1038/s41591-018-0017-7,2018,NR,,0,,,,,
clones of cd4 t cells with unique gene signature contribute to hiv-1 persistence,Cohn LB,,2018,NR,,0,,,,,
deep-sequencing analysis of the dynamics of hiv-1 quasiespecies in naive patients during a short exposure to maraviroc,Cascajero A,10.1128/JVI.00390-18,2018,NR,,0,,,,,
defining and characterizing the 'escapability' of potent broadly neutralizing antibodies against hiv in humanized mice,Deal C,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
"degree of housing instability shows independent ""dose-response"" with virologic suppression rates among people living with human immunodeficiency virus",Clemenzi-Allen A,10.1093/ofid/ofy035,2018,NR,,0,,,,,
collecting mobility data with gps methods to understand the hiv environmental riskscape among young black men who have sex with men: a multi-city feasibility study in the deep south,Duncan DT,10.1007/s10461-018-2163-9,2018,NR,,0,,,,,
hiv-tat can autocleave and form branching fibrillar structures,Popescu AP,10.1007/s11481-018-9786-5,2018,NR,,0,,,,,
detection of hiv transmitted drug resistance by next-generation sequencing in a crf01-ae predominant epidemic,Salvana EM,10.1093/ofid/ofy210.1115,2018,NR,,0,,,,,
comparative genetic variability in hiv-1 subtype c p24 gene in early age groups of infants,Sharma U,10.1007/s11262-018-1588-6,2018,NR,,0,,,,,
"comparison of detection limits of fourth- and fifth-generation combination hiv antigen-antibody, p24 antigen, and viral load assays on diverse hiv isolates",Stone M,10.1128/JCM.02045-17,2018,NR,,0,,,,,
comparison of the genotypic and phenotypic properties of hiv-1 standard subtype b and subtype b/b' env molecular clones derived from infections in china,Xie H,10.1038/s41426-018-0087-0,2018,NR,,0,,,,,
"dietary diversity and associated factors among hiv positive adults attending antiretroviral therapy clinics at hiwot fana and dilchora hospitals, eastern ethiopia",Weldegebreal F,10.2147/HIV.S138638,2018,NR,,0,,,,,
compartmentalized hiv-1 is found in the semen of men with and without urethritis,Council O,,2018,NR,,0,,,,,
identification of a structural element in hiv-1 gag required for virus particle assembly and maturation,Novikova M,10.1128/mBio.01567-18,2018,NR,,0,,,,,
complete functional mapping of infection- and vaccine-elicited antibodies against the fusion peptide of hiv,Dingens AS,10.1371/journal.ppat.1007159,2018,NR,,0,,,,,
distance to hiv care and treatment adherence: adjusting for socio-demographic and geographical heterogeneity,Amram O,10.1016/j.sste.2018.08.001,2018,NR,,0,,,,,
distinct hiv populations in csf and blood during active cryptococcal meningitis,Manion M,,2018,NR,,0,,,,,
distinct systemic microbiome and microbial translocation are associated with plasma level of anti-cd4 autoantibody in hiv infection,Xu W,10.1038/s41598-018-31116-y,2018,NR,,0,,,,,
"consumer, provider, and organizational leadership perspectives on integrated care for opioid use disorder and hiv: a community-engaged, qualitative study",Oldfield B,,2018,NR,,0,,,,,
dynamics of drug resistance-associated mutations in hiv-1 dna reverse transcriptase sequence during effective art,Nouchi A,10.1093/jac/dky130,2018,NR,,0,,,,,
defining and surveying key populations at risk of hiv infection: towards a unified approach to eligibility criteria for respondent-driven sampling hiv biobehavioral surveys,Hakim AJ,10.1177/0956462418763882,2018,NR,,0,,,,,
delineating hiv-1 evolutionary pathways associated with development of a broadly neutralizing antibody response,Joshi V,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
"effects of hiv, antiretroviral therapy and prebiotics on the active fraction of the gut microbiota",Deusch S,10.1097/QAD.0000000000001831,2018,NR,,0,,,,,
effects of social adversity and hiv on subcortical shape and neurocognitive function,Thames AD,10.1007/s11682-017-9676-0,2018,NR,,0,,,,,
"identification of a novel hiv-1 recombinant form (b/c) in men who have sex with men in shaanxi, china",Zhang M,10.1089/aid.2018.0003,2018,NR,,0,,,,,
enrichment of gut-derived fusobacterium is associated with suboptimal immune recovery in hiv-infected individuals,Lee SC,10.1038/s41598-018-32585-x,2018,NR,,0,,,,,
emergence of the transmitted resistance of hiv-1 to antiretroviral drugs in cuban patients during the period 2009-2016,Machado Zaldivar L,10.1002/jia2.25093,2018,NR,,0,,,,,
enhanced selection for hiv-1 transmitted/ founder viruses in blt humanized mice following intravaginal exposure,Claiborne D,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
development of broadly neutralizing antibodies in hiv-1 infected elite neutralizers,Landais E,10.1186/s12977-018-0443-0,2018,NR,,0,,,,,
"epidemiological surveillance of hiv-1 transmitted drug resistance among newly diagnosed individuals in shijiazhuang, northern china, 2014-2015",Wang X,10.1371/journal.pone.0198005,2018,NR,,0,,,,,
"dietary diversity and associated factors among hiv positive adult patients attending public health facilities in motta town, east gojjam zone, northwest ethiopia, 2017",Addisu Tesfaw,10.1155/2018/6135482,2018,NR,,0,,,,,
discordant hiv populations with discordant v3 tropism in csf and plasma: implications for establishing hiv reservoirs,Lange C,,2018,NR,,0,,,,,
evaluating the association of single-nucleotide polymorphisms with tenofovir exposure in a diverse prospective cohort of women living with hiv,Baxi SM,10.1038/tpj.2017.3,2018,NR,,0,,,,,
evaluation of the association between the concentrations of key vaginal bacteria and the increased risk of hiv acquisition in african women from five cohorts: a nested case-control study,McClelland,10.1016/S1473-3099(18)30058-6,2018,NR,,0,,,,,
"dissecting hiv virulence: heritability of setpoint viral load, cd4+ t-cell decline, and per-parasite pathogenicity",Bertels F,10.1093/molbev/msx246,2018,NR,,0,,,,,
distinct antibody profile associated with hiv controllers,Klingler J,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
"distinct, igg1-driven antibody response landscapes demarcate individuals with broadly hiv-1 neutralizing activity",Kadelka C,10.1084/jem.20180246,2018,NR,,0,,,,,
distinctive variation in the u3r region of the 5' long terminal repeat from diverse hiv-1 strains,Mbondji-Wonje C,10.1371/journal.pone.0195661,2018,NR,,0,,,,,
divergent members of a hiv-1 broadly neutralizing antibody lineage that share a common mode of recognition within the n332-glycan supersite,Kitchin D,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
evolution of hiv-1 within untreated individuals and at the population scale in uganda,Raghwani J,10.1371/journal.ppat.1007167,2018,NR,,0,,,,,
"diversity of hiv-1 in aquitaine, southwestern france, 2012-2016",Tumiotto C,10.1089/AID.2017.0298,2018,NR,,0,,,,,
genetic variation in cd101 alters immune signatures and risk of hiv acquisition,Richert-Spuhler LE,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
exploring the transmission dynamic of hiv-1 epidemic spread in serbia using birth-death skyline plot,Cirkovic V,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
dominant hiv dna populations present in different t-cell subsets before stem cell transplantation persist in tissues early after transplantation with ccr5delta32 stem cells,Wensing A,10.1002/jia2.25148,2018,NR,,0,,,,,
glycan masking focuses immune responses to the hiv-1 cd4-binding site and enhances elicitation of vrc01-class precursor antibodies,Duan H,10.1016/j.immuni.2018.07.005,2018,NR,,0,,,,,
harnessing post-translational modifications for next-generation hiv immunogens,Allen JD,10.1042/BST20170394,2018,NR,,0,,,,,
first report of a subtype b containing hiv-1 recombinant of sub-saharan africa origin,Kijak G,,2018,NR,,0,,,,,
first-line hiv treatment failure in non-b subtypes and recombinants in uganda,Poon A,,2018,NR,,0,,,,,
high-resolution definition of humoral immune response correlates of effective immunity against hiv,Alter G,10.15252/msb.20177881,2018,NR,,0,,,,,
fully-phased smrt hiv-pol sequencing unravels the complexity of viral quasispecies during treatment failure,Monaco D,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
hiv-1 immunogens and strategies to drive antibody responses towards neutralization breadth,Van Schooten J,10.1186/s12977-018-0457-7,2018,NR,,0,,,,,
hiv-1 vpu immune correlates in a narrow-source infection cohort: impact of adcc and kir-associated pressure,Rai MA,10.1093/ofid/ofy210.640,2018,NR,,0,,,,,
elicitation of moderate neutralization response associated with polyclonal antibodies among hiv-1 subtype c infected individuals from southern india,Nandagopal P,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
engineering enhanced hiv broadly neutralizing antibodies (ebnabs) with improved potency,Jardine J,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
engineering multi-specific antibodies against hiv-1,Padte NN,10.1186/s12977-018-0439-9,2018,NR,,0,,,,,
genome-wide characterization of endogenous retroviruses in bombyx mori reveals the relatives and activity of env genes,Feng M,10.3389/fmicb.2018.01732,2018,NR,,0,,,,,
growth of hiv-1 molecular transmission clusters in new york city,Wertheim JO,10.1093/infdis/jiy431,2018,NR,,0,,,,,
gut microbial diversity in hiv infection post combined antiretroviral therapy: a key target for prevention of cardiovascular disease,El-Far,10.1097/coh.0000000000000426,2018,NR,,0,,,,,
"gut microbiota and plasma metabolites associated with diabetes in women with, or at high risk for, hiv infection",Moon J-Y,10.1016/j.ebiom.2018.10.037,2018,NR,,0,,,,,
gut microbiota is associated with the immune response to hiv-1 envelope vaccination of newborn rhesus macaques,Ardeshir A,10.1111/jmp.12383,2018,NR,,0,,,,,
high levels of adaptation to host cellular immunity in a concentrated north american hiv epidemic,Kinloch NN,10.1002/jia2.25148,2018,NR,,0,,,,,
hiv as social and ecological experience,King B,10.1016/j.socscimed.2018.04.015,2018,NR,,0,,,,,
hiv drug resistance in adults receiving early vs delayed antiretroviral therapy: hptn 052,Palumbo PJ,10.1097/QAI.0000000000001623,2018,NR,,0,,,,,
hiv epidemic heterogeneity in zimbabwe: evidence from successive demographic and health surveys,Oseni Z,10.1017/S0021932017000657,2018,NR,,0,,,,,
"hiv genotyping and phylogenetics in the hptn 071 (popart) study: validation of a high-throughput sequencing assay for viral load quantification, genotyping, resistance testing and high-resolution transmission networking",Bonsall D,10.1002/jia2.25148,2018,NR,,0,,,,,
hiv infection in patients with sexually transmitted infections in zimbabwe - results from the zimbabwe sti etiology study,Kilmarx PH,10.1371/journal.pone.0198683,2018,NR,,0,,,,,
hiv persistence on antiretroviral therapy and barriers to a cure,Marsh Sung J,10.1007/978-981-13-0484-2_7,2018,NR,,0,,,,,
hiv prevention research & development funding trends 2016-2017: investing to end the epidemic as a public health threat,Riaz F,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
evaluating hiv knowledge questionnaires among men who have sex with men: a multi-study item response theory analysis,Janulis P,10.1007/s10508-016-0910-4,2018,NR,,0,,,,,
evaluating the accuracy and sensitivity of detecting minority hiv-1 populations by illumina next-generation sequencing,Kireev DE,10.1016/j.jviromet.2018.08.001,2018,NR,,0,,,,,
hiv subtype diversity across geography and transmission groups in maryland,German D,,2018,NR,,0,,,,,
evaluation capacity building-results and reflections across two years of a multisite empowerment evaluation in an hiv prevention context,Lindeman PT,10.1016/j.evalprogplan.2018.09.001,2018,NR,,0,,,,,
experiences using and organizing hiv self-testing,Qin Y,10.1097/QAD.0000000000001705,2018,NR,,0,,,,,
explosive mutation accumulation triggered by heterozygous human pol e proofreading-deficiency is driven by suppression of mismatch repair,Hodel KP,10.7554/eLife.32692,2018,NR,,0,,,,,
hiv-1 genetic diversity and drug resistance in haiti,Delva G,,2018,NR,,0,,,,,
"hiv-1 genetic diversity and resistance to antiretroviral drugs among pregnant women in ribeirao preto (sp), brazil cross-sectional study",Pimenta,10.1590/1516-3180.2017.0233011017,2018,NR,,0,,,,,
"hiv-1 genetic transmission networks among men who have sex with men in kunming, china",Chen M,10.1371/journal.pone.0196548,2018,NR,,0,,,,,
factors associated with the utilization of antenatal care and prevention of mother-to-child hiv transmission services in ethiopia: applying a count regression model,Zegeye EA,10.1186/s12905-018-0679-9,2018,NR,,0,,,,,
factors leading to the loss of natural elite control of hiv-1 infection,Pernas M,10.1128/JVI.01805-17,2018,NR,,0,,,,,
hiv-1 infection among crack cocaine users in a region far from the epicenter of the hiv epidemic in brazil: prevalence and molecular characteristics,Da Silva Franca DD,10.1371/journal.pone.0199606,2018,NR,,0,,,,,
first case of hiv-nat negative donation collected during eclipse phase since implementation of highly sensitive individual nat in france,Cappy P,10.1111/vox.12658,2018,NR,,0,,,,,
flexible but conserved: a new essential motif in the ctd of hiv-1 group m integrases,Kanja M,10.1186/s12977-018-0436-z,2018,NR,,0,,,,,
hiv-1 protease evolvability is affected by synonymous nucleotide recoding,Nevot M,10.1128/JVI.00777-18,2018,NR,,0,,,,,
full-length envelope analyzer (flea): a tool for longitudinal analysis of viral amplicons,Eren K,10.1371/journal.pcbi.1006498,2018,NR,,0,,,,,
in vitro exposure to prostratin but not bryostatin-1 improves natural killer cell functions including killing of cd4+ t cells harboring reactivated human immunodeficiency virus,Desimio MG,10.3389/fimmu.2018.01514,2018,NR,,0,,,,,
hiv-1 subtype diversity and international travel in romanian people who inject drugs,Jipa R,10.1002/jia2.25187,2018,NR,,0,,,,,
generating evidence for health policy in challenging settings: lessons learned from four prevention of mother-to-child transmission of hiv implementation research studies in nigeria,Sam-Agudu NA,10.1186/s12961-018-0309-x,2018,NR,,0,,,,,
"hiv-1 subtype diversity, transmission networks and transmitted drug resistance amongst acute and early infected msm populations from coastal kenya",Hassan AS,10.1371/journal.pone.0206177,2018,NR,,0,,,,,
"hiv-1 subtype diversity, transmitted drug resistance and phylogenetics in australia",Pinto AN,10.2217/fvl-2018-0031,2018,NR,,0,,,,,
hiv-1 transmission clustering and phylodynamics highlight the important role of young men who have sex with men (special issue on hiv prevention science),Dennis,10.1089/aid.2018.0039,2018,NR,,0,,,,,
hiv-1 transmission networks across cyprus (2010-2012),Kostrikis LG,10.1371/journal.pone.0195660,2018,NR,,0,,,,,
hiv-1 transmitted drug resistance in slovenia and its impact on predicted treatment effectiveness: 2011-2016 update,Lunar MM,10.1371/journal.pone.0196670,2018,NR,,0,,,,,
genetic characterization of the hiv-1 reservoir after vacc-4x and romidepsin therapy in hiv-1-infected individuals,Winckelmann A,10.1097/QAD.0000000000001861,2018,NR,,0,,,,,
hiv-1 whole-genome ngs analysis to characterize virus evolution following dendritic cell immunotherapy and analytical treatment interruption,Lungu C,,2018,NR,,0,,,,,
"hiv-genetic diversity and drug resistance transmission clusters in gondar, northern ethiopia, 2003-2013",Arimide DA,10.1371/journal.pone.0205446,2018,NR,,0,,,,,
hiv-trace (transmission cluster engine): a tool for large scale molecular epidemiology of hiv-1 and other rapidly evolving pathogens,Kosakovsky Pond SL,10.1093/molbev/msy016,2018,NR,,0,,,,,
essential two-component systems regulating cell envelope functions: opportunities for novel antibiotic therapies,Cardona ST,10.1007/s00232-017-9995-5,2018,NR,,0,,,,,
"identification of a novel hiv-1 unique recombinant form comprising crf01-ae, subtype b', and crf65-cpx among men who have sex with men in jilin, china",Lin Y-L,10.1089/aid.2018.0109,2018,NR,,0,,,,,
"characterization of a new hiv-1 crf01 ae/crf07 bc recombinant virus in tianjin, china",Zhou Z,10.1089/aid.2018.0077,2018,NR,,0,,,,,
"identification of a novel hiv-1 b/c/crf01-ae recombinant isolate in guangxi, china",Wang C,10.1089/aid.2018.0070,2018,NR,,0,,,,,
genome-scale analysis of evolutionary rate and selection in a fast-expanding spanish cluster of hiv-1 subtype f1,Patino-Galindo,10.1016/j.meegid.2018.09.008,2018,NR,,0,,,,,
"knowledge, practices, and barriers to hiv preexposure prophylaxis prescribing among washington state medical providers",Wood BR,10.1097/OLQ.0000000000000781,2018,NR,,0,,,,,
"characterization of a new hiv-1 crf01-ae/crf07-bc recombinant virus form among men who have sex with men in beijing, china",Jiao Y,10.1089/aid.2018.0049,2018,NR,,0,,,,,
samhd1 phosphorylation coordinates the anti-hiv-1 response by diverse interferons and tyrosine kinase inhibition,Szaniawski MA,10.1128/mBio.00819-18,2018,NR,,0,,,,,
continued propagation of the crf19_cpx variant among hiv-positive msm patients in spain,Perez-Parra S,10.1093/jac/dkx474,2018,NR,,0,,,,,
"characterization of a novel hiv-1 circulating recombinant form, crf01-ae/b'/c (crf96-cpx), in yunnan, china",Miao J,10.1089/aid.2017.0288,2018,NR,,0,,,,,
"identification of a novel hiv-1 unique recombinant form between b, crf01-ae and crf07-bc in men who have sex with men in guangxi, china",Kong D,10.1089/aid.2017.0259,2018,NR,,0,,,,,
a new hiv-1 circulating recombinant form (crf98-cpx) between crf06-cpx and subtype b identified in southwestern france,Recordon-Pinson P,10.1089/aid.2018.0122,2018,NR,,0,,,,,
guiding the humoral response against hiv-1 toward a mper adjacent region by immunization with a vlp-formulated antibody-selected envelope variant,Beltran-Pavez C,10.1371/journal.pone.0208345,2018,NR,,0,,,,,
the neutralizing antibody response to the hiv-1 env protein,Moore PL,10.2174/1570162X15666171124122044,2018,NR,,0,,,,,
inhibition of human immunodeficiency virus type 1 entry by a keggin polyoxometalate,Wang X,10.3390/v10050265,2018,NR,,0,,,,,
"6-arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited hiv reverse transcriptase-associated rnase h with antiviral activity",Wang L,10.1016/j.ejmech.2018.07.039,2018,NR,,0,,,,,
fulllength glycosylated gag of murine leukemia virus can associate with the viral envelope as a type i integral membrane protein,Renner TM,10.1128/JVI.01530-17,2018,NR,,0,,,,,
hematopoietic stem and progenitor cells are a distinct hiv reservoir that contributes to persistent viremia in suppressed patients,Zaikos TD,10.1016/j.celrep.2018.11.104,2018,NR,,0,,,,,
perceptions of intersectional stigma among diverse women living with hiv in the united states,Rice WS,10.1016/j.socscimed.2018.05.001,2018,NR,,0,,,,,
"structural barriers to hiv prevention among men who have sex with men (msm) in vietnam: diversity, stigma, and healthcare access",Philbin MM,10.1371/journal.pone.0195000,2018,NR,,0,,,,,
evolving models and ongoing challenges for hiv preexposure prophylaxis implementation in the united states,Mayer KH,10.1097/QAI.0000000000001579,2018,NR,,0,,,,,
publicly available internet content as a hiv/sti prevention intervention for urban youth,Whiteley LB,10.1007/s10935-018-0514-y,2018,NR,,0,,,,,
"human immunodeficiency virus, sexually transmitted disease awareness and condom usage among long-distance internal truck drivers in pune, india",Yadav AK,10.5114/hivar.2018.73978,2018,NR,,0,,,,,
"knowledge, attitude, willingness of hiv counseling and testing and factors associated with it, among long distant drivers in enugu, nigeria: an opportunity in reduction of hiv prevalence",Ijeoma A,10.4314/ahs.v18i4.30,2018,NR,,0,,,,,
acquisition of tdf-susceptible hiv despite high level adherence to daily tdf/ftc prep as measured by dried blood spot (dbs) and segmental hair analysis: a case report,Cohen SE,10.1093/ofid/ofy210.1131,2018,NR,,0,,,,,
hiv-1 isolates from west africa show higher fitness than to those from east africa,Farinre O,10.1186/s12977-018-0436-z,2018,NR,,0,,,,,
efficient serinc5 antagonism does not enhance hiv-1 replication and cytopathicity,Kmiec D,10.1186/s12977-018-0436-z,2018,NR,,0,,,,,
in depth hiv-1 transcriptome characterization using oxford nanopore minion sequencing,Quang NN,10.1186/s12977-018-0436-z,2018,NR,,0,,,,,
physical activity is associated with physical fitness in hiv+ women but not hiv+ men,Webel AR,,2018,NR,,0,,,,,
variants of hiv envelope glycoprotein with enhanced affinity for precursors to broadly neutralizing antibodies identified using yeast surface display,Mathew E,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
high prevalence of non-b hiv-1 subtypes in overseas sailors and prostitutes in korea,Cho Y-K,10.1089/aid.2017.0238,2018,NR,,0,,,,,
hiv-1 recombinant viruses from west africa display higher replication capacity compared to recombinants from east africa,Farinre O,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
interactions between young female sex workers and paying and nonpaying sexual partners in western kenya: implications for hiv prevention interventions,Omollo D,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
high-precision single-molecule characterization of the folding of an hiv rna hairpin by atomic force microscopy,Walder R,10.1021/acs.nanolett.8b02597,2018,NR,,0,,,,,
unique and expanded breadth estimate of cd8 t-cell responses to cohort-specific hiv-1 gag protein peptides,Michelo CM,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
optimizing murine vaccination regimens to elicit hiv-1 neutralizing responses targeting diverse fusion peptide sequences,Geng H,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
an escape mutation in the v2 region of the hiv envelope protein of a t/f virus guides vaccine design to elicit broadly reactive v2-directed antibodies,Jain S,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
monitoring the sensitivity to broadly neutralizing antibodies of early (t/f) hiv-1 variants of clade crf02-ag,Stefic K,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
identification of hiv-1 epitopes presented by the protective hla-c*12:02 allele using mass spectrometry analysis of single-allele transfectants,Chikata T,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
efficacy of mk-8591 against diverse hiv-1 subtypes and nrti-resistant clinical isolates,Grobler J,10.1002/jia2.25187,2018,NR,,0,,,,,
dysglycaemia is prevalent in hiv patients over 40 and may be detected using routine screening for cardiovascular risk,Mok J,10.1002/jia2.25187,2018,NR,,0,,,,,
higher sequence diversity in the vaginal tract than in blood at early hiv-1 infection,Klein K,10.1371/journal.ppat.1006754,2018,NR,,0,,,,,
killer cell immunoglobulin-like receptor 3dl1 variation modifies hla-b*57 protection against hiv-1,Martin MP,10.1172/JCI98463,2018,NR,,0,,,,,
"deep sequencing reveals viral evolution in gag within protective hla alleles b*57: 02, b*58: 01, and b*7 supertype individuals acutely infected with hiv-1 subtype c in durban, south africa",Gounder K,,2018,NR,,0,,,,,
hiite: hiv-1 incidence and infection time estimator,Park SY,10.1093/bioinformatics/bty073,2018,NR,,0,,,,,
adapting an alcohol screening and brief intervention for older adults living with hiv,Del Pino HE,10.1111/acer.13747,2018,NR,,0,,,,,
identifying clusters of recent and rapid hiv transmission through analysis of molecular surveillance data,Oster AM,10.1097/QAI.0000000000001856,2018,NR,,0,,,,,
"self-reported function and disability of people living with hiv and/or cancer during acute hospital admissions in the uk, using the world health organization disability assessment schedule (whodas) 20",Brown D,,2018,NR,,0,,,,,
proteomic and cytokine profiling of exosomes derived from the plasma of hiv patients and substance abusers,Kodidela S,10.1007/s11481-018-9786-5,2018,NR,,0,,,,,
ongoing hiv microepidemics in rural south africa: the need for flexible interventions,Coltart C,,2018,NR,,0,,,,,
chronic kidney disease risk factors and urine kidney injury markers in hiv+ persons,Muiru A,,2018,NR,,0,,,,,
transcriptional reprogramming in ccr5+ memory cd4+ t cells promotes hiv-1 latency,Shan L,,2018,NR,,0,,,,,
primer id sequencing to study the development of cxcr4-using hiv-1 variants,Zhou S,,2018,NR,,0,,,,,
hiv knowledge and use of health services among people from south-east asia and sub-saharan africa living in western australia,Gray C,10.1002/hpja.168,2018,NR,,0,,,,,
hiv molecular surveillance in chinese blood donors,Liu Z,10.1111/trf.14903,2018,NR,,0,,,,,
hiv population-level adaptation can rapidly diminish the impact of a partially effective vaccine,Herbeck JT,10.1016/j.vaccine.2017.12.004,2018,NR,,0,,,,,
impact of treatment interruption on hiv reservoirs and immunologic parameters,Clarridge K,,2018,NR,,0,,,,,
"impact of worker emigration on hiv epidemics in labour export areas: a molecular epidemiology investigation in guangyuan, china",Su L,10.1038/s41598-018-33996-6,2018,NR,,0,,,,,
hiv rebound driven by rare superspreading cd4+ t cell lineages,Hataye JM,,2018,NR,,0,,,,,
hiv receptor usage impacts sensitivity to v1-v3 loop broadly neutralizing antibodies,Registre L,,2018,NR,,0,,,,,
improving the accuracy and precision of estimated temporal trends in hiv incidence among msm populations by calibrating agent-based simulation models to phylogenetic tree data,Delva W,,2018,NR,,0,,,,,
individuals with hiv-1 subtype c infection and cryptococcal meningitis exhibit viral genetic intermixing of hiv-1 between plasma and cerebrospinal fluid and a high prevalence of cxcr4-using variants,Sojane K,10.1089/AID.2017.0209,2018,NR,,0,,,,,
induction and maturation of hiv-1 fusion peptidedirected broadly neutralizing antibodies in rhesus macaques by vaccination,Kwong PD,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
hiv-1 diversity among young women in rural south africa: hptn 068,Sivay MV,10.1371/journal.pone.0198999,2018,NR,,0,,,,,
"hiv-1 diversity in the moscow region, russia: phylodynamics of the most common subtypes",Lebedev A,10.1002/jia2.25187,2018,NR,,0,,,,,
hiv-1 envelope glycoproteins from diverse clades differentiate antibody responses and durability among vaccinees,Yates NL,10.1128/JVI.01843-17,2018,NR,,0,,,,,
influenza vaccination can broadly activate the hiv reservoir during antiretroviral therapy,Christensen-Quick A,10.1097/QAI.0000000000001829,2018,NR,,0,,,,,
hiv-1 proviral landscapes distinguish posttreatment controllers from noncontrollers,Sharaf R,10.1172/JCI120549,2018,NR,,0,,,,,
insights about minority hiv-1 strains in transmitted drug resistance mutation dynamics and disease progression,Leda AR,10.1093/jac/dky132,2018,NR,,0,,,,,
hiv-1 reservoir diversity and genetic compartmentalization in blood and testis,Ponte R,10.1002/jia2.25148,2018,NR,,0,,,,,
hiv-1 splicing suppression as a possible therapeutic target,Emery A,,2018,NR,,0,,,,,
hiv-1- specific iga monoclonal antibodies from an hiv-1 vaccinee mediate galactosylceramide blocking and phagocytosis,Wills S,10.1128/JVI.01552-17,2018,NR,,0,,,,,
hiv-1-specific iga monoclonal antibodies from an hiv-1 vaccinee mediate galactosylceramide blocking and phagocytosis,Wills S,10.1128/JVI.01552-17,2018,NR,,0,,,,,
"structural constraints at the trimer apex stabilize the hiv-1 envelope in a closed, antibody-protected conformation",Guzzo C,10.1128/mBio.00955-18,2018,NR,,0,,,,,
hiv-specific fc effector function early in infection predicts the development of broadly neutralizing antibodies,Richardson SI,10.1371/journal.ppat.1006987,2018,NR,,0,,,,,
"multi-envelope hiv-1 vaccine development: two targeted immune pathways, one desired protective outcome",Hurwitz JL,10.1089/vim.2017.0144,2018,NR,,0,,,,,
hla class i-mediated hiv-1 control in vietnamese infected with hiv-1 subtype a/e,Chikata T,10.1128/JVI.01749-17,2018,NR,,0,,,,,
"household food insecurity access scale and dietary diversity score as a proxy indicator of nutritional status among people living with hiv/aids, bahir dar, ethiopia, 2017",Hussein FM,10.1371/journal.pone.0199511,2018,NR,,0,,,,,
"linkage to care, mobility and retention of hiv-positive postpartum women in antiretroviral therapy services in south africa",Phillips TK,10.1002/jia2.25114,2018,NR,,0,,,,,
"linking science education and hiv using viral biology, epidemiology and science practices",Moreno NP,10.1177/0017896918783778,2018,NR,,0,,,,,
low prevalence of transmitted hiv-1 drug resistance detected by a dried blood spot (dbs)-based next-generation sequencing (ngs) method in newly diagnosed individuals in cameroon in the years 2015-16,Mbunkah HA,10.1093/jac/dky103,2018,NR,,0,,,,,
identification of macrophage reservoirs through tropism of hiv-1 envelopes,Machado V,,2018,NR,,0,,,,,
identification of near pan-neutralizing antibodies against hiv-1 by deconvolution of plasma humoral responses,Sajadi M,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
identification of novel hiv-1 latency-reversing agents from a library of marine natural products,Richard K,10.3390/v10070348,2018,NR,,0,,,,,
identifying msm-competent physicians in china: a national online cross-sectional survey among physicians who see male hiv/sti patients,Zhao P,10.1186/s12913-018-3781-7,2018,NR,,0,,,,,
identifying spatial variation along the hiv care continuum: the role of distance to care on retention and viral suppression,Terzian AS,10.1007/s10461-018-2103-8,2018,NR,,0,,,,,
"marginalization and community perception of hiv care, treatment, and support on mfangano island, kenya",Chang A,10.1353/cpr.2018.0032,2018,NR,,0,,,,,
impact of hiv-1 subtype c tat genetic variation and evolution on disease outcome,Mkhize ZZ,10.1186/s12977-018-0436-z,2018,NR,,0,,,,,
impact of mail order pharmacy use on viral suppression among hiv-infected patients,Choe J,10.1093/ofid/ofy210.1560,2018,NR,,0,,,,,
measuring hiv persistence on antiretroviral therapy,Horsburgh BA,10.1007/978-981-13-0484-2_11,2018,NR,,0,,,,,
incomplete inhibition of hiv infection results in more hiv infected lymph node cells by reducing cell death,Jackson L,10.7554/eLife.30134,2018,NR,,0,,,,,
increased breadth of hiv-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth,Chukwuma VU,10.1371/journal.pone.0209437,2018,NR,,0,,,,,
metabarcoding analysis of eukaryotic microbiota in the gut of hiv-infected patients,Hamad I,10.1371/journal.pone.0191913,2018,NR,,0,,,,,
induction and relationship of hiv envelopespecific b cells in the peripheral blood and bone marrow following vaccination in humans,Kobie J,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
"microsatellite length polymorphism for dna-based typing of candida albicans isolated from hiv positive patients in tehran, iran",Farahbakhsh E,10.5812/jjm.64041,2018,NR,,0,,,,,
inhibition of hiv-1 infection by gene editing of ccr5 and cxcr4 using crispr/cas9,Li S,,2018,NR,,0,,,,,
"molecular epidemiology of a primarily msm acute hiv-1 cohort in bangkok, thailand and connections within networks of transmission in asia",Chang D,10.1002/jia2.25204,2018,NR,,0,,,,,
molecular epidemiology of hiv-1 infection among men who have sex with men in taiwan from 2013 to 2015,Li W-Y,10.1371/journal.pone.0202622,2018,NR,,0,,,,,
structural effects on hiv risk among youth: a multi-level analysis,Miller RL,10.1007/s10461-018-2031-7,2018,NR,,0,,,,,
"molecular epidemiology of the hiv epidemic in three german metropolitan regions - cologne/bonn, munich and hannover, 1999-2016",Stecher M,10.1038/s41598-018-25004-8,2018,NR,,0,,,,,
lessons learned: key informant perspectives on successful implementation and administration of electronic tablet-based patient-reported outcome (pro) measures in routine hiv care,Fredericksen R,10.1007/s11136-018-1946-9,2018,NR,,0,,,,,
"molecular investigation of hiv-1 cross-group transmissions during an outbreak among people who inject drugs (2011-2014) in athens, greece",Paraskevis D,10.1016/j.meegid.2018.04.010,2018,NR,,0,,,,,
longing for hiv protection,Zanoni M,10.1038/s41564-018-0169-8,2018,NR,,0,,,,,
longitudinal analysis of proviral hiv-dna,Heger E,10.1002/jia2.25187,2018,NR,,0,,,,,
monotypic low-level hiv viremias during antiretroviral therapy are associated with disproportionate production of x4 virions and systemic immune activation,Bull ME,10.1097/QAD.0000000000001824,2018,NR,,0,,,,,
loss of t-cell multifunctionality and tcr-vbeta repertoire against epstein-barr virus is associated with worse prognosis and clinical parameters in hiv+ patients,Hernandez DM,10.3389/fimmu.2018.02291,2018,NR,,0,,,,,
lower pre-art intra-participant hiv-1 pol diversity may not be associated with virologic failure in adults,Kearney,10.1371/journal.pone.0190438,2018,NR,,0,,,,,
mapping mutational effects along the evolutionary landscape of hiv envelope,Haddox HK,10.7554/eLife.34420,2018,NR,,0,,,,,
measuring replication competent hiv-1: advances and challenges in defining the latent reservoir,Wang Z,10.1186/s12977-018-0404-7,2018,NR,,0,,,,,
near full-length genome characterization of hiv-1 subtypes among drug users in kenya,Zulu T,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
"new diagnoses of hiv among injecting drug users, new york city 2006-2016",Torian LV,,2018,NR,,0,,,,,
modulation of vaccine-induced cd4 t cell functional profiles by changes in components of hiv vaccine regimens in humans,Pissani F,10.1128/JVI.01143-18,2018,NR,,0,,,,,
next-generation sequencing provides an added value in determining drug resistance and viral tropism in cameroonian hiv-1 vertically infected children,Fokam J,10.1097/MD.0000000000010176,2018,NR,,0,,,,,
ngs combined with phylogenetic analysis to detect hiv-1 dual infection in romanian people who inject drugs,Popescu B,10.1016/j.micinf.2018.03.004,2018,NR,,0,,,,,
non-disclosed men who have sex with men in uk hiv transmission networks: phylogenetic analysis of surveillance data,Ragonnet-Cronin M,10.1016/S2352-3018%2818%2930062-6,2018,NR,,0,,,,,
multi-compartment dissemination of genome-intact hiv-1 reservoir clones,Lee GQ,,2018,NR,,0,,,,,
native hiv-1 env circulating during the development of breadth in human subjects elicits tier 2 heterologous neutralizing monoclonal antibodies in nhp,Hessell A,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
naturally occurring mutations in hiv-1 crf01-ae capsid affect viral sensitivity to restriction factors,Nakayama EE,10.1089/aid.2017.0212,2018,NR,,0,,,,,
origin and spread of hiv-1 subtype b among heterosexual individuals in bulgaria,Alexiev I,10.1089/AID.2017.0167,2018,NR,,0,,,,,
"outbreak of hiv infection linked to nosocomial transmission, china, 2016-2017",Pan X,10.3201/eid2412.180117,2018,NR,,0,,,,,
neutralizing activity of broadly neutralizing anti-hiv-1 antibodies against clade b clinical isolates produced in peripheral blood mononuclear cells,Cohen YZ,10.1128/JVI.01883-17,2018,NR,,0,,,,,
patterns of hcv transmission in hiv-infected and hiv-negative men having sex with men,Cotte L,10.1002/hep.30257,2018,NR,,0,,,,,
perceptions of reducing hiv-preventive behaviors among men who have sex with men living with hiv in japan,Matsutaka,10.4236/health.2018.1012130,2018,NR,,0,,,,,
novel paradigm for measuring hiv-1 reservoir allows quantitation of intact proviruses,Bruner K,,2018,NR,,0,,,,,
perspective: apobec mutagenesis in drug resistance and immune escape in hiv and cancer evolution,Venkatesan S,10.1093/annonc/mdy003,2018,NR,,0,,,,,
phenotypic properties of envelope glycoproteins of transmitted hiv-1 variants from patients belonging to transmission chains,Beretta M,10.1097/QAD.0000000000001906,2018,NR,,0,,,,,
optimizing hiv-1 virus test panels for effective detection of neutralization breadth,Kadelka C,,2018,NR,,0,,,,,
phylogenetic analysis of the belgian hiv-1 epidemic reveals that local transmission is almost exclusively driven by men having sex with men despite presence of large african migrant communities,Verhofstede C,10.1016/j.meegid.2018.03.002,2018,NR,,0,,,,,
phylogenetic and geographic separation in hiv-infected people in british columbia,McVea D,,2018,NR,,0,,,,,
"phylogenetic and temporal dynamics of human immunodeficiency virus type 1 crf01_ae and crf07_bc among recently infected antiretroviral therapy-naive men who have sex with men in jiangsu province, china, 2012 to 2015: a molecular epidemiology-based study",Yang Yue,10.1097/MD.0000000000009826,2018,NR,,0,,,,,
"phylogenetic and temporal dynamics of human immunodeficiency virus type 1 crf01-ae and crf07-bc among recently infected antiretroviral therapy-naive men who have sex with men in jiangsu province, china, 2012 to 2015: a molecular epidemiology-based study",Yang Y,10.1097/MD.0000000000009826,2018,NR,,0,,,,,
phylogenetic approach to recover integration dates of latent hiv sequences within-host,Jones BR,10.1073/pnas.1802028115,2018,NR,,0,,,,,
phylogenetic characterization of hiv transmission in belgium between 2013 and 2015,Dauwe K,,2018,NR,,0,,,,,
passive and active antibody studies in primates to inform hiv vaccines,Hessell AJ,10.1080/14760584.2018.1425619,2018,NR,,0,,,,,
"structure of the 30 kda hiv-1 rna dimerization signal by a hybrid cryo-em, nmr, and molecular dynamics approach",Zhang K,10.1016/j.str.2018.01.001,2018,NR,,0,,,,,
perceptions of poor-quality healthcare by people living with hiv and diabetes,Duncan A,,2018,NR,,0,,,,,
permissable risk: professional views on hiv disclosure circumstances,Phillips M,,2018,NR,,0,,,,,
phenotypic deficits in the hiv-1 envelope are associated with the maturation of a v2-directed broadly neutralizing antibody lineage,Reh L,10.1371/journal.ppat.1006825,2018,NR,,0,,,,,
"pockets of hiv non-infection within highly-infected risk networks in athens, greece",Williams LD,10.3389/fmicb.2018.01825,2018,NR,,0,,,,,
point-of-care hiv-1 genotypic resistance testing using melt-curve analysis,Clutter DS,,2018,NR,,0,,,,,
polyreactive antibodies in anti-hiv-1 responses,Liao H,10.2174/1566524018666180720165406,2018,NR,,0,,,,,
"pre-exposure prophylaxis knowledge and perceived effectiveness to prevent hiv among deaf gay, bisexual, and queer men",Biskupiak,10.1089/lgbt.2018.0102,2018,NR,,0,,,,,
postpartum mobility and transfer of care among hiv+ women on art in south africa,Phillips TK,,2018,NR,,0,,,,,
preconception use of cart by hiv-positive pregnant women increases the risk of infants being born small for gestational age,Snijdewind IJM,10.1371/journal.pone.0191389,2018,NR,,0,,,,,
predictive model for hiv transmission cluster growth in north carolina,Billock R,,2018,NR,,0,,,,,
"pressured hiv testing ""in the name of love"": a mixed methods analysis of pressured hiv testing among men who have sex with men in china",Ong JJ,10.1002/jia2.25098,2018,NR,,0,,,,,
"preterm delivery and small-for-gestation outcomes in hiv-infected pregnant women on antiretroviral therapy in rural south africa: results from a cohort study, 2010-2015",Chetty T,10.1371/journal.pone.0192805,2018,NR,,0,,,,,
"pretreatment hiv-1 drug resistance in transmission clusters of the cologne-bonn region, germany",Stecher M,10.1093/ofid/ofy210.1116,2018,NR,,0,,,,,
prevalence of and factors associated with the use of hiv serosorting and other biomedical prevention strategies among men who have sex with men in a us nationwide survey,Grov C,10.1007/s10461-018-2084-7,2018,NR,,0,,,,,
prevalence of broadly neutralizing antibody responses in hiv-1-infected injecting drug users,Euler Z,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
"prevalence of drug resistance mutations in protease, reverse transcriptase, and integrase genes of north central mexico hiv isolates",Hernandez-Sanchez PG,10.1089/AID.2017.0257,2018,NR,,0,,,,,
preventive and therapeutic features of broadly neutralising monoclonal antibodies against hiv-1,Jaworski JP,10.1016/S2352-3018%2818%2930174-7,2018,NR,,0,,,,,
"prevalence of hiv-1 pretreatment drug resistance among treatment naive pregnant women in bissau, guinea bissau",Wilhelmson S,10.1371/journal.pone.0206406,2018,NR,,0,,,,,
"project posse: health promotion, recruitment and engagement of the house/ball and kiki communities for hiv prevention",Castillo M,,2018,NR,,0,,,,,
protective' silence surrounding aids: reasons and implications of non-disclosure among pregnant women living with hiv in rio de janeiro (brazil),Monteiro S,10.1080/17441692.2016.1211163,2018,NR,,0,,,,,
pushing the envelope with rationally designed multi-nabs,Steinhardt JJ,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
quantifying the turnover of latent hiv: applications to anti-proliferative therapy,Gerold J,,2018,NR,,0,,,,,
quantitation of the latent hiv-1 reservoir from the sequence diversity in viral outgrowth assays,Poon AFY,10.1186/s12977-018-0426-1,2018,NR,,0,,,,,
proviral landscape in hiv-1 post-treatment controllers and non-controllers,Sharaf R,,2018,NR,,0,,,,,
"rapidly growing hiv transmission clusters in the united states, 2013-2016",France AM,,2018,NR,,0,,,,,
recent hiv infection is a major driver of incident cluster growth,Little S,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
recent progress in understanding hiv reservoirs,Kuo H-H,10.1097/COH.0000000000000441,2018,NR,,0,,,,,
strategies for recruiting women living with human immunodeficiency virus in community-based research: lessons from canada,Webster K,10.1353/cpr.2018.0003,2018,NR,,0,,,,,
quantifying the fitness cost of hiv-1 drug resistance mutations through phylodynamics,Kuhnert D,10.1371/journal.ppat.1006895,2018,NR,,0,,,,,
recombination is required for efficient hiv-1 replication,Rawson JM,10.1186/s12977-018-0436-z,2018,NR,,0,,,,,
reconstructing integration dates of latent hiv sequences within-host,Jones BR,,2018,NR,,0,,,,,
"study of prevalence of dermatophytes among human immunodeficiency virus/aids patients in shadan institute of medical sciences and teaching hospital and research centre, hyderabad, telangana, india",Ali SY,10.4103/ijstd.IJSTD_103_16,2018,NR,,0,,,,,
"relational concurrency, stages of infection, and the evolution of hiv set point viral load",Goodreau SM,10.1093/ve/vey032,2018,NR,,0,,,,,
relationship between latent and rebound viruses in a clinical trial of anti-hiv-1 antibody 3bnc117,Cohen YZ,10.1084/jem.20180936,2018,NR,,0,,,,,
rare hiv variants with linked dual-class resistance are associated with art failure,Boltz VF,,2018,NR,,0,,,,,
"relative sensitivities of 4th and 5th gen combo hiv ag/ab, p24 and viral load assays",Stone M,,2018,NR,,0,,,,,
recognition and elimination of hiv-1-infected cells by adcc-mediating mabs for prevention and treatment of hiv-1 infection,Tuyishime M,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
revealing hiv viral load patterns using unsupervised machine learning and cluster summarization,Farooq SA,10.12688/F1000RESEARCH.15591.1,2018,NR,,0,,,,,
risk indicators and effects of hypertension on hiv/aids disease progression among patients seen at kenyatta hospital hiv care center,Chepchirchir A,10.1080/09540121.2017.1384533,2018,NR,,0,,,,,
targeted selection of an improbable hiv-1 antibody mutation critical for broadly neutralizing reactivity with a designed immunogen,Wiehe K,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
reduced susceptibility to virip-based hiv-1 entry inhibitors has a high genetic barrier and severe fitness costs,Muller JA,10.1128/JVI.00733-18,2018,NR,,0,,,,,
"regional transmission pattern of hiv-1 non-crf01-ae strains circulating in hebei province, china",Lu X,10.1089/aid.2017.0166,2018,NR,,0,,,,,
relationship between intact hiv-1 proviruses in circulating cd4+ t cells and rebound viruses emerging during treatment interruption,Lu CL,10.1073/pnas.1813512115,2018,NR,,0,,,,,
resistance of major histocompatibility complex class b (mhc-b) to nef-mediated downregulation relative to that of mhc-a is conserved among primate lentiviruses and influences antiviral t cell responses in hiv-1-infected individuals,Mwimanzi F,10.1128/JVI.01409-17,2018,NR,,0,,,,,
sequencing hiv-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation,Johnson EL,10.1038/s41467-018-06424-6,2018,NR,,0,,,,,
risk of hiv transmission through condomless sex in msm couples with suppressive art: the partner2 study extended results in gay men,Rodger A,10.1002/jia2.25148,2018,NR,,0,,,,,
role of phylogenetic analysis in epidemiological case definitions during an outbreak of hiv-1 in people who inject drugs in ireland,Dunford L,,2018,NR,,0,,,,,
rpv la does not inhibit resistant hiv transmission or select significant resistance,Ambrose Z,,2018,NR,,0,,,,,
single-molecule techniques to quantify and genetically characterise persistent hiv,Wang XiaoQian,10.1186/s12977-017-0386-x,2018,NR,,0,,,,,
sivcol nef counteracts serinc5 by promoting its proteasomal degradation but does not efficiently enhance hiv-1 replication in human cd4+ t cells and lymphoid tissue,Kmiec D,10.1371/journal.ppat.1007269,2018,NR,,0,,,,,
"spending on health and hiv/aids: domestic health spending and development assistance in 188 countries, 1995-2015",Dieleman JL,10.1016/S0140-6736%2818%2930698-6,2018,NR,,0,,,,,
stakeholders' experiences of hiv patient engagement within the i-score patient-reported outcome study: benefits and challenges,Lessard D,10.1002/jia2.25187,2018,NR,,0,,,,,
sequencing and bioinformatics analysis of viral integration in the hiv-1 transgenic rats,Du W,10.1007/s11481-018-9786-5,2018,NR,,0,,,,,
stated and revealed preferences for hiv testing: can oral self-testing help to increase uptake amongst truck drivers in kenya?,Strauss M,10.1186/s12889-018-6122-1,2018,NR,,0,,,,,
sex differences in voluntary wheel running in the hiv-1 transgenic rat,Cranston MN,10.1007/s11481-018-9786-5,2018,NR,,0,,,,,
susceptibility to neutralization by broadly neutralizing antibodies generally correlates with infected cell binding for a panel of clade b hiv reactivated from latent reservoirs,Ren Y,10.1128/JVI.00895-18,2018,NR,,0,,,,,
targeting the hiv-1 spike and coreceptor with bi- and trispecific antibodies for single-component broad inhibition of entry,Khan SN,10.1128/JVI.00384-18,2018,NR,,0,,,,,
single cell analysis of hiv latency reveals diverse proviral and host cell behavior,Browne EP,,2018,NR,,0,,,,,
smrt sequencing of full-length pol amplicons to investigate hiv-1 drug resistance,Ita S,,2018,NR,,0,,,,,
socioeconomic correlates of dietary diversity and its association with adherence and psychosocial functioning of people living with hiv in rural zambia,Masa R,10.1177/0260106018761282,2018,NR,,0,,,,,
south-south collaboration on hiv/aids prevention and treatment research: when birds of a feather rarely flock together,Fonseca BPF,10.1186/s12992-018-0341-1,2018,NR,,0,,,,,
"spread of hiv-1 pre-treatment drug resistance in the cologne-bonn region, germany",Stecher M,,2018,NR,,0,,,,,
structure-based lead optimization to improve antiviral potency and admet properties of phenyl-1h-pyrrole-carboxamide entry inhibitors targeted to hiv-1 gp120,Curreli F,10.1016/j.ejmech.2018.04.062,2018,NR,,0,,,,,
study of single nucleotide polymorphisms associated with hiv-1 set-point viral load in antiretroviral therapy-naive hiv-positive participants of the start study,Ekenberg C,10.1093/ofid/ofy210.1117,2018,NR,,0,,,,,
"surging hiv-1 crf07_bc epidemic among recently infected men who have sex with men in fujian, china",Chen ZW,10.1002/jmv.25072,2018,NR,,0,,,,,
synaptic transmission may provide an evolutionary benefit to hiv through modulation of latency,Vargas-Garcia C,10.1016/j.jtbi.2018.07.030,2018,NR,,0,,,,,
tandem bispecific neutralizing antibodies inhibit hiv-1 infection in humanized mice,Niu M,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
tandem bispecific neutralizing antibody eliminates hiv-1 infection in humanized mice,Wu X,10.1172/JCI96764,2018,NR,,0,,,,,
targeting fallible men: communication strategies and moral issues in a pre-exposure prophylaxis trial (special issue: volunteers for hiv vaccine trials: a social science approach),Trachman,10.1097/qai.0000000000001806,2018,NR,,0,,,,,
targeting highly networked ctl epitopes as a mechanism of elite hiv-1 control,Gaiha GD,,2018,NR,,0,,,,,
the 1988 elista outbreak and the epidemiology of hiv subtype g in russia,Serova E,,2018,NR,,0,,,,,
"the association between olfactory functioning in aging african, american and caucasian men with hiv and cognitive functioning",Vance D,10.1016/j.eurpsy.2017.12.016,2018,NR,,0,,,,,
the birc5/ox40 pathway maintains survival of hiv-1-infected cd4 t cells,Kuo H-H,,2018,NR,,0,,,,,
the changing face of hiv care: expanding hiv training in an internal medicine residency program,Barakat LA,10.1097/ACM.0000000000002317,2018,NR,,0,,,,,
the changing landscape of hiv prevention in the united states: health department experiences and local adaptations in response to the national hiv/aids strategy and high-impact prevention approach,Fisher HH,10.1097/PHH.0000000000000575,2018,NR,,0,,,,,
the effect of a 12-week combinational exercise program on cd4 count and mental health among hiv infected women: a randomized control trial,Dianatinasab,10.1016/j.jesf.2018.02.001,2018,NR,,0,,,,,
"the effect of maternal hiv status and treatment duration on body composition of hiv-exposed and hiv-unexposed preterm, very and extremely low-birthweight infants",Strydom K,10.1080/20469047.2018.1466481,2018,NR,,0,,,,,
the effect of the mechanism and amount of missingness on phylodynamic inference of heterosexual hiv transmission networks,Niyukuri D,,2018,NR,,0,,,,,
the evolution of subtype b hiv-1 tat in the netherlands during 1985-2012,van der Kuyl AC,10.1016/j.virusres.2018.04.008,2018,NR,,0,,,,,
the importance of sex in the lives of women living with hiv: a critical quantitative analysis,Carter,10.1080/19317611.2018.1447527,2018,NR,,0,,,,,
"identification of a novel hiv-1 unique recombinant form comprising crf01_ae, subtype b', and crf65_cpx among men who have sex with men in jilin, china",Lin,10.1089/aid.2018.0109,2018,NR,,0,,,,,
"hiv-1 genetic diversity in recently diagnosed infections in moscow: predominance of afsu, frequent branching in clusters, and circulation of the iberian subtype g variant",Karamov,10.1089/aid.2018.0055,2018,NR,,0,,,,,
"genetic characterization of a novel hiv-1 crf01_ae/crf07_bc recombinant form among men who have sex with men in guangdong, china",Lan Yun,10.1007/s00705-018-3928-1,2018,NR,,0,,,,,
the hiv-1 reverse transcriptase a62v mutation influences replication fidelity and viral fitness in the context of multi-drug-resistant mutations,Maldonado JO,10.3390/v10070376,2018,NR,,0,,,,,
the hiv/aids epidemic in grenada,Chaudhry MR,10.1097/MD.0000000000010869,2018,NR,,0,,,,,
engaging united states black communities in hiv pre-exposure prophylaxis: analysis of a prep engagement cascade,Kwakwa,10.1016/j.jnma.2017.12.006,2018,NR,,0,,,,,
the identification of a micro-epidemic in a hyper-endemic hiv setting using molecular epidemiology,Coltart C,10.1002/jia2.25148,2018,NR,,0,,,,,
acceptability of an adapted hiv prevention intervention for native american adolescents,Lee,10.1521/aeap.2018.30.1.72,2018,NR,,0,,,,,
the influence of cervicovaginal microbiota on mucosal immunity and prophylaxis in the battle against hiv,Farcasanu M,10.1007/s11904-018-0380-5,2018,NR,,0,,,,,
the potential impact of risk compensation in response to an hiv vaccine: accelerated rates of viral adaptation and reduced cost-effectiveness,Peebles K,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
"the informal use of antiretroviral medications for hiv prevention by men who have sex with men in south florida: initiation, use practices, medications and motivations",Buttram,,2018,NR,,0,,,,,
the puzzle of hiv neutral and selective evolution,Leitner T,10.1093/molbev/msy089,2018,NR,,0,,,,,
the microbiome and hiv persistence: implications for viral remission and cure,Koay WLA,10.1097/COH.0000000000000434,2018,NR,,0,,,,,
the moral discourse of hiv providers within their organizational context: an ethnographic case study,Fix GM,10.1016/j.pec.2018.08.018,2018,NR,,0,,,,,
the transmission and evolution of hiv-1 quasispecies within one couple: a follow-up study based on next-generation sequencing,Yu F,10.1038/s41598-018-19783-3,2018,NR,,0,,,,,
the relationship between adverse neighborhood socioeconomic context and hiv continuum of care outcomes in a diverse hiv clinic cohort in the southern united states,Rebeiro PF,10.1080/09540121.2018.1465526,2018,NR,,0,,,,,
"time intervals in sequence sampling, not data modifications, have a major impact on estimates of hiv escape rates",Ganusov VV,10.3390/v10030099,2018,NR,,0,,,,,
using primer-id deep sequencing to detect recent human immunodeficiency virus type 1 infection,Dennis AM,10.1093/infdis/jiy426,2018,NR,,0,,,,,
the spleen is an hiv-1 sanctuary during combined antiretroviral therapy,Nolan DJ,10.1089/AID.2017.0254,2018,NR,,0,,,,,
utilizing computational machine learning tools to understand immunogenic breadth of hiv in the context of a cd8 t-cell mediated hiv response,Hare J,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
tracing hiv-1 evolution in a dually infected subject developing a broadly neutralizing antibody response,Newman R,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
the vaginal microbiome and acquisition of hiv infection,Klatt N,,2018,NR,,0,,,,,
toward an enhanced understanding of psychological resilience for hiv youth populations,Harrison S,10.1080/09540121.2018.1556384,2018,NR,,0,,,,,
transmission dynamics among participants initiating antiretroviral therapy upon diagnosis of early acute hiv-1 infection in thailand,Kroon E,10.1097/QAD.0000000000001956,2018,NR,,0,,,,,
universal target capture of hiv sequences from ngs libraries,Yamaguchi J,10.3389/fmicb.2018.02150,2018,NR,,0,,,,,
unravelling the complicated evolutionary and dissemination history of hiv-1m subtype a lineages,Tongo M,10.1093/ve/vey003,2018,NR,,0,,,,,
transmission of hiv-1 drug resistance mutations within partner-pairs: a cross-sectional study of a primary hiv infection cohort,Stekler JD,10.1371/journal.pmed.1002537,2018,NR,,0,,,,,
transmitted hla pre-adapted polymorphisms in the gag protein influences viral evolution in the new host,Monaco D,,2018,NR,,0,,,,,
vaccine-elicited cross-neutralizing hiv antibodies (bnabs) to two env sites of vulnerability following heterologous nfl trimer liposome prime: boosting,Dubrovskaya V,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
viral characteristics associated with the clinical nonprogressor phenotype are inherited by viruses from a cluster of hiv-1 elite controllers,Casado C,10.1128/mBio.02338-17,2018,NR,,0,,,,,
viral diversity is an obligate consideration in crispr/cas9 designs for targeting the hiv reservoir,Roychoudhury P,10.1186/s12915-018-0544-1,2018,NR,,0,,,,,
viral evolution in infant hiv infection,Hou M,,2018,NR,,0,,,,,
ultra-deep sequencing for hiv-1 minority drug resistance testing has a limited impact on virological outcomes,Su B,10.1089/aid.2018.5000.abstracts,2018,NR,,0,,,,,
"viral suppression and hiv transmission in serodiscordant male couples: an international, prospective, observational, cohort study",Prestage GP,10.1016/S2352-3018%2818%2930132-2,2018,NR,,0,,,,,
understanding how teen support line (tsl) is addressing the need for confidential and round-the-clock psychosocial support for adolescents living hiv (alhiv) in malawi,McKenney A,10.1542/peds.142.1_MeetingAbstract.547,2018,NR,,0,,,,,
understanding preferences for hiv care and treatment in zambia: evidence from a discrete choice experiment among patients who have been lost to follow-up,Zanolini A,10.1371/journal.pmed.1002636,2018,NR,,0,,,,,
using real-time phylodynamic analysis to assess and guide public health interventions in an hiv outbreak among people who inject drugs in scotland,Ragonnet-Cronin M,10.1002/jia2.25187,2018,NR,,0,,,,,
using the molecular epidemiology of hiv transmission in new south wales to inform public health response: assessing the representativeness of linked phylogenetic data,Pinto A,,2018,NR,,0,,,,,
visualisation of the human immunodeficiency virus type 1 cdna by click chemistry,De Wit F,10.1186/s12977-018-0436-z,2018,NR,,0,,,,,
women's hiv knowledge and condom use across diverse relationship types in the dominican republic and haiti,Erausquin,,2018,NR,,0,,,,,
virion-packaged pyruvate kinase muscle type 2 affects reverse transcription efficiency of human immunodeficiency virus type 1 by blocking virion recruitment of trnalys3,Mouree KR,10.1248/bpb.b17-00991,2018,NR,,0,,,,,
virologic suppression in response to antiretroviral therapy despite extensive resistance within hiv-1 reverse transcriptase after the first virologic failure,Oliveira MI,10.1186/s12879-018-3400-6,2018,NR,,0,,,,,
whole genome sequencing of neisseria gonorrhoeae reveals transmission clusters involving patients of mixed hiv serostatus,Peters J,10.1136/sextrans-2017-053198,2018,NR,,0,,,,,
different susceptibility to scd4 of acute and chronic hiv in a transmission cluster,Bouvin-Pley M,10.1186/s12977-018-0436-z,2018,NR,,0,,,,,
computational comparison of availability in ctl/gag epitopes among patients with acute and chronic hiv-1 infection,Damilano GD,10.1016/j.vaccine.2018.04.086,2018,NR,,0,,,,,
"""i can't go out"": mobility obstacles to women's access to hiv treatment in kpk, pakistan",Saeed A,10.1016/j.jana.2017.03.010,2017,NR,,0,,,,,
"""life at the river is a living hell: "" a qualitative study of trauma, mental health, substance use and hiv risk behavior among female fish traders from the kafue flatlands in zambia",Michalopoulos LTM,10.1186/s12905-017-0369-z,2017,NR,,0,,,,,
"a 2-hydroxyisoquinoline-1,3-dione active-site rnase h inhibitor binds in multiple modes to hiv-1 reverse transcriptase",Kirby KA,10.1128/AAC.01351-17,2017,NR,,0,,,,,
a latent class analysis of sexual and romantic relationships among hiv-positive and hiv-negative gay and bisexual men in vancouver,Carter A,10.3138/cjhs.262.A1,2017,NR,,0,,,,,
a comparison of the clinical presentation of hiv infected children with spastic diplegia to hiv uninfected children with spastic diplegia in a south african setting,Naik T,10.1080/21679169.2017.1381325,2017,NR,,0,,,,,
a national study of the molecular epidemiology of hiv-1 in,Castley A,10.1371/journal.pone.0170601,2017,NR,,0,,,,,
a national study of the molecular epidemiology of hiv-1 in australia 2005-2012,Castley,10.1371/journal.pone.0170601,2017,NR,,0,,,,,
a novel bromodomain inhibitor reverses hiv-1 latency through specific binding with brd4 to promote tat and p-tefb association,Liu S,10.3389/fmicb.2017.01035,2017,NR,,0,,,,,
a novel preventive strategy against hiv-1 infection: combinatorial use of inhibitors targeting the nucleocapsid and fusion proteins,Yang Y,10.1038/emi.2017.26,2017,NR,,0,,,,,
a participatory approach to improving retention in hiv treatment and care for newly diagnosed patients in a secondary health facility in sierra leone,Ameyan,10.4172/2155-6113.1000686,2017,NR,,0,,,,,
a phylogenetic analysis of human immunodeficiency virus type 1 sequences in kiev: findings among key populations,Fearnhill E,10.1093/cid/cix499,2017,NR,,0,,,,,
a tamb homolog is involved in maintenance of cell envelope integrity and stress resistance of deinococcus radiodurans,Yu J,10.1038/srep45929,2017,NR,,0,,,,,
a useful humanized mouse model for hiv-1 cure research,Chen Z,10.1007/s11481-017-9751-8,2017,NR,,0,,,,,
acceptability of lifelong treatment among hiv-positive pregnant and breastfeeding women (option b+) in selected health facilities in zimbabwe: a qualitative study,Chadambuka A,10.1186/s12889-017-4611-2,2017,NR,,0,,,,,
access to medical and mental health services across the hiv care continuum among young transgender women: a qualitative study,Dowshen N,10.1089/trgh.2016.0046,2017,NR,,0,,,,,
an endogenous retroviral envelope syncytin and its cognate receptor identified in the viviparous placental mabuya lizard,Cornelis G,10.1073/pnas.1714590114,2017,NR,,0,,,,,
an open-label cluster randomised trial to evaluate the effectiveness of a counselling intervention on linkage to care among hiv-infected patients in uganda: study design,Ruzagira E,10.1016/j.conctc.2016.12.003,2017,NR,,0,,,,,
a prediction model of pretreatment hiv rna levels in naive thai hiv-infected patients: an application for resource-limited settings,Pongpech N,10.1093/ofid/ofx163.1097,2017,NR,,0,,,,,
a proportion of latent hiv is missed by assaying only resting cd4 t cells,Cillo AR,,2017,NR,,0,,,,,
a retrospective study: the 10 most common cutaneous disorders in patients with hiv and aids,Nurul Hidayati A,10.1016/j.jaad.2017.04.117,2017,NR,,0,,,,,
a small fraction of proviruses in expanded clones express unspliced hiv rna in vivo,Musick A,,2017,NR,,0,,,,,
analysis of nearly full-genome hiv-1 sequences from uganda: results from pangea-hiv,Yebra G,,2017,NR,,0,,,,,
a strongly selected mutation in the hiv-1 genome is independent of t cell responses and neutralizing antibodies,Liu D,10.1186/s12977-017-0371-4,2017,NR,,0,,,,,
activation and inactivation of primary human immunodeficiency virus envelope glycoprotein trimers by cd4-mimetic compounds,Madani N,10.1128/JVI.01880-16,2017,NR,,0,,,,,
extracellular matrix proteins mediate hiv-1 gp120 interactions with alpha4beta7,Plotnik D,10.1128/JVI.01005-17,2017,NR,,0,,,,,
assessing the danger of self-sustained hiv epidemics in heterosexuals by population based phylogenetic cluster analysis,Turk T,10.7554/eLife.28721,2017,NR,,0,,,,,
antibodyomics: bioinformatics technologies for understanding b-cell immunity to hiv-1,Kwong PD,10.1111/imr.12480,2017,NR,,0,,,,,
whole genome sequencing of extreme phenotypes identifies variants in cd101 and ube2v1 associated with increased risk of sexually acquired hiv-1,Mackelprang RD,10.1371/journal.ppat.1006703,2017,NR,,0,,,,,
"association between adductor pollicis muscle thickness, anthropometric and immunological parameters in hiv-positive patients",Cortez AF,10.1016/j.clnesp.2016.09.004,2017,NR,,0,,,,,
association of hiv diversity and virologic outcomes in early antiretroviral treatment: hptn 052,Palumbo PJ,10.1371/journal.pone.0177281,2017,NR,,0,,,,,
effects of mutations on replicative fitness and major histocompatibility complex class i binding affinity are among the determinants underlying cytotoxic-t-lymphocyte escape of hiv-1 gag epitopes,Du Y,10.1128/mBio.01050-17,2017,NR,,0,,,,,
"associations of the vaginal microbiota with hiv infection, bacterial vaginosis, and demographic factors",Chehoud C,10.1097/QAD.0000000000001421,2017,NR,,0,,,,,
bacteria and bacterial envelope components enhance mammalian reovirus thermostability,Berger AK,10.1371/journal.ppat.1006768,2017,NR,,0,,,,,
an association between k65r and hiv-1 subtype c viruses in patients treated with multiple nrtis,Smit E,10.1093/jac/dkx091,2017,NR,,0,,,,,
birth weight and preterm delivery outcomes of perinatally vs nonperinatally human immunodeficiency virus-infected pregnant women in the united states: results from the phacs smartt study and impaact p1025 protocol,Jao J,10.1093/cid/cix488,2017,NR,,0,,,,,
blind dating: phylogenetic determination of latent hiv sequence ages within host,Jones BR,,2017,NR,,0,,,,,
analysis of variability in hiv-1 subtype a strains in russia suggests a combination of deep sequencing and multitarget rna interference for silencing of the virus,Kretova OV,10.1089/AID.2016.0088,2017,NR,,0,,,,,
novel gp64 envelope variants for improved delivery to human airway epithelial cells,Sinn PL,10.1038/gt.2017.78,2017,NR,,0,,,,,
hiv-1 epitopes presented by mhc class i types associated with superior immune containment of viremia have highly constrained fitness landscapes,Gorin AM,10.1371/journal.ppat.1006541,2017,NR,,0,,,,,
"characterization of a stable hiv-1 b/c recombinant, soluble, and trimeric envelope glycoprotein (env) highly resistant to cd4-induced conformational changes",Kumar R,10.1074/jbc.M117.803056,2017,NR,,0,,,,,
brief report: selection of hiv-1 variants with higher transmission potential by 1% tenofovir gel microbicide,Ngandu NK,10.1097/QAI.0000000000001458,2017,NR,,0,,,,,
antibody 10-1074 suppresses viremia in hiv-1-infected individuals,Caskey M,10.1038/nm.4268,2017,NR,,0,,,,,
increase in human immunodeficiency virus 1 diversity and detection of various subtypes and recombinants in north-eastern brazil,Lima K,10.1099/jmm.0.000447,2017,NR,,0,,,,,
single-cell analysis of hiv-1 transcriptional activity reveals expression of proviruses in expanded clones during art,Wiegand A,10.1073/pnas.1617961114,2017,NR,,0,,,,,
"characterization of a novel hiv-1 unique recombinant form between crf07_bc and crf55_01b in men who have sex with men in guangzhou, china",Wu Y,10.1371/journal.pone.0175770,2017,NR,,0,,,,,
"candida species diversity and antifungal susceptibility patterns in oral samples of hiv/aids patients in baja california, mexico",Clark-Ordonez I,10.1093/mmy/myw069,2017,NR,,0,,,,,
cross-neutralizing anti-hiv-1 human single chain variable fragments(scfvs) against cd4 binding site and n332 glycan identified from a recombinant phage library,Khan L,10.1038/srep45163,2017,NR,,0,,,,,
impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individuals,Weber J,10.1186/s12981-017-0144-0,2017,NR,,0,,,,,
a recombinant multi-epitope protein mep1 elicits efficient long-term immune responses against hiv-1 infection,Yang Y,10.1080/21645515.2017.1281488,2017,NR,,0,,,,,
inhibition of hiv-1 maturation via small-molecule targeting of the amino-terminal domain in the viral capsid protein,Wang W,10.1128/JVI.02155-16,2017,NR,,0,,,,,
care-seeking behaviors among hiv-infected adults in mozambique: barriers and facilitators to timely enrollment in hiv care and treatment,Magaco AJ,10.1186/s13756-017-0201-4,2017,NR,,0,,,,,
the tumour suppressor apc promotes hiv-1 assembly via interaction with gag precursor protein,Miyakawa K,10.1038/ncomms14259,2017,NR,,0,,,,,
carriage of extended-spectrum beta-lactamase-producing enterobacteriaceae in hiv-infected children in zimbabwe,Wilmore SMS,10.1099/jmm.0.000474,2017,NR,,0,,,,,
cd4 results with a bias larger than hundred cells per microliter can have a significant impact on the clinical decision during treatment initiation of hiv patients,Daneau G,10.1002/cyto.b.21366,2017,NR,,0,,,,,
channel-inactivating mutations and their revertant mutants in the envelope protein of infectious bronchitis virus,To J,10.1128/JVI.02158-16,2017,NR,,0,,,,,
accumulation of pol mutations selected by hla-b*52:01-c*12:02 protective haplotype-restricted cytotoxic t lymphocytes causes low plasma viral load due to low viral fitness of mutant viruses,Murakoshi H,10.1128/JVI.02082-16,2017,NR,,0,,,,,
genetic and phenotypic analyses of sequential vpu alleles from hiv-infected ifn-treated patients,Vanwalscappel B,10.1016/j.virol.2016.10.028,2017,NR,,0,,,,,
"identification of a novel hiv type 1 circulating recombinant form (crf86_bc) among heterosexuals in yunnan, china",Li Y,10.1089/AID.2016.0188,2017,NR,,0,,,,,
"assessment of nutritional status and associated factors among prisoners living with hiv/aids in kality prison, addis ababa, ethiopia",Tsebaot Kassa,10.4172/2155-6113.1000703,2017,NR,,0,,,,,
association between intimate partner violence & hiv/aids: exploring the pathways in indian context,Seema Patrikar,10.4103/ijmr.ijmr_1782_14,2017,NR,,0,,,,,
association between intimate partner violence & hiv/aidsl: exploring the pathways in indian context,Patrikar S,10.4103/ijmr.IJMR_1782_14,2017,NR,,0,,,,,
"associations between at-risk alcohol use, substance use, and smoking with lipohypertrophy and lipoatrophy among patients living with hiv",Noorhasan M,10.1089/aid.2015.0357,2017,NR,,0,,,,,
"characteristics of black men who have sex with men in baltimore, philadelphia, and washington, dc: geographic diversity in socio-demographics and hiv transmission risk (special issue: achieving greater hiv prevention impact through cdc's national hiv behavioral surveillance system)",German,10.1097/qai.0000000000001425,2017,NR,,0,,,,,
astrocytes resist hiv-1 fusion but engulf infected macrophage material,Russell RA,10.1016/j.celrep.2017.01.027,2017,NR,,0,,,,,
asymptomatic hiv-1 csf escape is uncommon and is not associated with neuronal damage,Joseph SB,,2017,NR,,0,,,,,
"characterization of hiv diversity, phylodynamics and drug resistance in washington, dc",Perez-Losada M,10.1371/journal.pone.0185644,2017,NR,,0,,,,,
evolutionary analysis of hiv-1 pol proteins reveals representative residues for viral subtype differentiation,Nagata S,10.3389/fmicb.2017.02151,2017,NR,,0,,,,,
within-epitope interactions can bias ctl escape estimation in early hiv infection,Garcia V,10.3389/fimmu.2017.00423,2017,NR,,0,,,,,
in vivo mutation rates and the landscape of fitness costs of hiv-1,Zanini F,10.1093/ve/vex003,2017,NR,,0,,,,,
effects of fitness training on physical fitness parameters and quality of life in human immunodeficiency virus-positive indian females,Patil R,10.4103/0253-7184.196886,2017,NR,,0,,,,,
cd4-binding site directed cross-neutralizing scfv monoclonals from hiv-1 subtype c infected indian children,Kumar S,10.3389/fimmu.2017.01568,2017,NR,,0,,,,,
comparative genomics of cryptococcus neoformans var grubii associated with meningitis in hiv infected and uninfected patients in vietnam,Day JN,10.1371/journal.pntd.0005628,2017,NR,,0,,,,,
comparison of hiv-1 drug-resistance genotyping by ultra-deep sequencing and sanger sequencing using clinical samples,Trabaud MA,10.1002/jmv.24872,2017,NR,,0,,,,,
"characteristics of hiv-infected us army soldiers linked in molecular transmission clusters, 2001-2012",Hakre S,10.1371/journal.pone.0182376,2017,NR,,0,,,,,
complex subtype diversity of hiv-1 among drug users in major kenyan cities,Gounder K,10.1089/AID.2016.0321,2017,NR,,0,,,,,
characterization of hiv-1 near full-length proviral genome quasispecies from patients with undetectable viral load undergoing first-line haart therapy,Alves BM,10.3390/v9120392,2017,NR,,0,,,,,
"characterization of new hiv infections among adults >=45 years-new york city, north carolina, san francisco, 2011-2013",Evans M,10.1093/ofid/ofxl62.036,2017,NR,,0,,,,,
correlates of drug resistance mutations in art-naive individuals with hiv infection,Porter SE,,2017,NR,,0,,,,,
"circulating microrna's as a diagnostic tool for hepatocellular carcinoma in a hyper endemic hiv setting, kwazulu-natal, south africa: a case control study protocol focusing on viral etiology",Sartorius K,10.1186/s12885-017-3915-z,2017,NR,,0,,,,,
"decreasing prevalence of transmitted drug resistance among art-naive hiv-1-infected patients in iceland, 1996-2012",Sallam,10.1080/20008686.2017.1328964,2017,NR,,0,,,,,
clonal expansion of genome-intact hiv-1 in functionally polarized th1 cd4+ t cells,Lee GQ,10.1172/JCI93289,2017,NR,,0,,,,,
cocaine enhances dc to t-cell hiv-1 transmission by activating dc-sign/larg/lsp1 complex and facilitating infectious synapse formation,Prasad A,10.1038/srep40648,2017,NR,,0,,,,,
coexistence of potent hiv-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller,Freund NT,10.1126/scitranslmed.aal2144,2017,NR,,0,,,,,
delineating cd4 dependency of hiv-1: adaptation to infect low level cd4 expressing target cells widens cellular tropism but severely impacts on envelope functionality,Beauparlant D,10.1371/journal.ppat.1006255,2017,NR,,0,,,,,
how hiv-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design,Pancera M,10.1097/COH.0000000000000360,2017,NR,,0,,,,,
communication between middle ses black women and healthcare providers about hiv testing,Fray NA,10.1016/j.jnma.2016.11.005,2017,NR,,0,,,,,
comparative evaluation of three fda-approved hiv ag/ab combination tests using a genetically diverse hiv panel and diagnostic specimens,Qiu X,10.1016/j.jcv.2017.05.005,2017,NR,,0,,,,,
determinants of hiv phylogenetic clustering in chicago among young black men who have sex with men from the uconnect cohort,Morgan E,10.1097/QAI.0000000000001379,2017,NR,,0,,,,,
determinants to antiretroviral treatment non-adherence among adult hiv/aids patients in northern ethiopia,Gebrezgabher BB,10.1186/s12981-017-0143-1,2017,NR,,0,,,,,
diagnosis and treatment of diffusible penicillium marneffei in human immunodeficiency virus-negative patients: a challenge for the physician,Chi XH,10.4103/ijmm.IJMM_15_418,2017,NR,,0,,,,,
disparities in hiv-1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populations,Todesco E,10.1111/hiv.12508,2017,NR,,0,,,,,
comprehensive assessment of alcohol consumption in persons living with hiv/aids (plwha),Ferguson TF,10.1111/acer.13391,2017,NR,,0,,,,,
disseminated penicillium marneffei infection with fungemia and intestinal perforation in an hiv-negative patient in a non-endemic region,He H,,2017,NR,,0,,,,,
comprehensive mapping of hiv-1 escape from a broadly neutralizing antibody,Dingens AS,10.1016/j.chom.2017.05.003,2017,NR,,0,,,,,
computational analysis of antibody dynamics identifies recent hiv-1 infection,Seaton KE,10.1172/jci.insight.94355,2017,NR,,0,,,,,
diffuse white matter signal abnormalities on magnetic resonance imaging are associated with human immunodeficiency virus type 1 viral escape in the central nervous system among patients with neurological symptoms,Kugathasan R,10.1093/cid/cix035,2017,NR,,0,,,,,
divergent hiv-1 strains (crf92_c2u and crf93_cpx) co-circulating in the democratic republic of the congo: phylogenetic insights on the early evolutionary history of subtype c,Villabona Arenas CJ,10.1093/ve/vex032,2017,NR,,0,,,,,
"drug resistance in antiretroviral-naive children newly diagnosed with hiv-1 in manaus, amazonas",Andrade SD,10.1093/jac/dkx025,2017,NR,,0,,,,,
"drug resistance mutation profiles of the drug-naive and first-line regimen-treated hiv-1-infected population of suzhou, china",Li T,10.1007/s12250-017-4002-y,2017,NR,,0,,,,,
drug resistance-related mutations t369v/i in the connection subdomain of hiv-1 reverse transcriptase severely impair viral fitness,Wang Z,10.1016/j.virusres.2017.03.002,2017,NR,,0,,,,,
echocardiographic characteristics of pulmonary arterial hypertension in children with horizontally transmitted hiv,Georgescu AM,10.17219/acem/62244,2017,NR,,0,,,,,
decoding noises in hiv computational genotyping,Jia M,10.1016/j.virol.2017.08.031,2017,NR,,0,,,,,
effect of alcohol consumption and psychosocial stressors on preterm and small-for-gestational-age births in hiv-infected women in south africa: a cohort study,Sania A,10.1136/bmjopen-2016-014293,2017,NR,,0,,,,,
demographic and contextual factors associated with hiv mortality in an african cohort in east africa and nigeria,Kibuuka H,,2017,NR,,0,,,,,
dendritic cell response to hiv-1 is controlled by differentiation programs in the cells and strain-specific properties of the virus,Nasi A,10.3389/fimmu.2017.00244,2017,NR,,0,,,,,
effects of patient load and travel distance on hiv transmission in rural china: implications for treatment as prevention,Smith MK,10.1371/journal.pone.0177976,2017,NR,,0,,,,,
"determinants of time from hiv infection to linkage-to-care in rural kwazulu-natal, south africa",Maheu-Giroux M,10.1097/QAD.0000000000001435,2017,NR,,0,,,,,
development and impact of the global plan (special issue: looking back and moving forward: the living legacy of the global plan towards the elimination of new hiv infections among children by 2015 and keeping their mothers alive),Haroz,,2017,NR,,0,,,,,
development of an anti-hiv vaccine eliciting broadly neutralizing antibodies,Ahmed Y,10.1186/s12981-017-0178-3,2017,NR,,0,,,,,
development of an hiv vaccine using a vesicular stomatitis virus vector expressing designer hiv-1 envelope glycoproteins to enhance humoral responses,Racine T,10.1186/s12981-017-0179-2,2017,NR,,0,,,,,
enhanced use of phylogenetic data to inform public health approaches to hiv among men who have sex with men,German D,10.1071/SH16056,2017,NR,,0,,,,,
escape from humoral immunity is associated with treatment failure in hiv-1-infected patients receiving long-term antiretroviral therapy,Ouyang Y,10.1038/s41598-017-05594-5,2017,NR,,0,,,,,
differential induction of anti-v3 crown antibodies with cradle- and ladle-binding modes in response to hiv-1 envelope vaccination,Balasubramanian P,10.1016/j.vaccine.2016.11.107,2017,NR,,0,,,,,
estimating the effect of completeness of hiv sequencing data on transmission networks,Dasgupta S,,2017,NR,,0,,,,,
"diminishing perceived threat of aids and increasing sexual risks of hiv among men who have sex with men, 1997-2015",Kalichman,10.1007/s10508-016-0934-9,2017,NR,,0,,,,,
evolution of hiv-1 resistance to the fusion inhibitor c34-cxcr4 and potential fitness costs in consideration of a phase 1 clinical trial,Leslie GJ,,2017,NR,,0,,,,,
expanding hiv-1 subtype b transmission networks among men who have sex with men in poland,Parczewski M,10.1371/journal.pone.0172473,2017,NR,,0,,,,,
dna vaccination by electroporation amplifies broadly cross-restricted public tcr clonotypes shared with hiv controllers,Mukhopadhyay M,10.4049/jimmunol.1700953,2017,NR,,0,,,,,
extending the minority stress model to incorporate hiv-positive gay and bisexual men's experiences: a longitudinal examination of mental health and sexual risk behavior,Rendina HJ,10.1007/s12160-016-9822-8,2017,NR,,0,,,,,
"a novel recombinant form of hiv-1 crf01_ae/crf07_bc identified by near full-length genome in shaanxi, china",Zhang M,10.1089/AID.2017.0186,2017,NR,,0,,,,,
domestic prevalence of substance use disorders in hiv care settings,Hartzler B,10.1016/j.drugalcdep.2016.08.237,2017,NR,,0,,,,,
dynamical properties and thresholds of an hiv model with super-infection,Malunguza NJ,10.1093/imammb/dqw014,2017,NR,,0,,,,,
effect of hiv infection on outcomes after surgical repair of genital fistula,Shephard SN,10.1002/ijgo.12233,2017,NR,,0,,,,,
hiv-1 cross-reactive primary virus neutralizing antibody response elicited by immunization in nonhuman primates,Wang Y,10.1128/JVI.00910-17,2017,NR,,0,,,,,
further characterization of the bifunctional hiv entry inhibitor scd4-fit45,Falkenhagen A,10.1016/j.omtn.2017.04.017,2017,NR,,0,,,,,
future technologies for monitoring hiv drug resistance and cure,Parikh UM,10.1097/COH.0000000000000344,2017,NR,,0,,,,,
"gag p2/nc and pol genetic diversity, polymorphism, and drug resistance mutations in hiv-1 crf02_ag- and non-crf02_ag-infected patients in yaounde, cameroon",Teto G,10.1038/s41598-017-14095-4,2017,NR,,0,,,,,
"gay men's perspectives on hiv prevention and treatment in berlin, germany: lessons for policy and prevention",Grov,10.1080/19317611.2016.1247758,2017,NR,,0,,,,,
genetic analyses of hiv env associated with uveitis in antiretroviral-naive individuals,Williams-Wietzikoski CA,10.1097/QAD.0000000000001550,2017,NR,,0,,,,,
engaging stakeholders into an electronic patient-reported outcome development study: on making an hiv-specific e-pro patient-centered,Engler K,10.1016/j.hlpt.2016.11.002,2017,NR,,0,,,,,
"a novel recombinant form of hiv-1 crf01-ae/crf07-bc identified by near full-length genome in shaanxi, china",Zhang M,10.1089/aid.2017.0186,2017,NR,,0,,,,,
ensuring community participation during program planning: lessons learned during the development of a hiv/sti program for young sexual and gender minorities,Bauermeister JA,10.1002/ajcp.12147,2017,NR,,0,,,,,
genetic characterization of human immunodeficiency virus type 1 transmission in the middle east and north africa,Sallam M,10.1016/j.heliyon.2017.e00352,2017,NR,,0,,,,,
epitope exposure on the outer face of the chikungunya virus envelope determines antibody neutralizing efficacy,Fong RH,,2017,NR,,0,,,,,
genetic diversity in envelope genes of contemporary us porcine reproductive and respiratory syndrome virus strains influences viral antigenicity,Chen Z,10.1016/j.rvsc.2017.07.027,2017,NR,,0,,,,,
genetic diversity of hiv-1 gene vif among treatment-naive brazilians,Villanova F,10.1089/AID.2016.0230,2017,NR,,0,,,,,
genetic variants in cyp2b6 and cyp2a6 explain interindividual variation in efavirenz plasma concentrations of hiv-infected children with diverse ethnic origin,Soeria-Atmadja S,10.1371/journal.pone.0181316,2017,NR,,0,,,,,
genital hiv shedding when antiretroviral therapy (art) suppresses plasma hiv rna,Bull ME,,2017,NR,,0,,,,,
genomic epidemiology of cryptococcus yeasts identifies adaptation to environmental niches underpinning infection across an african hiv/aids cohort,Vanhove M,10.1111/mec.13891,2017,NR,,0,,,,,
estimating the respective contributions of human and viral genetic variation to hiv control,Bartha I,10.1371/journal.pcbi.1005339,2017,NR,,0,,,,,
estimating time of hiv-1 infection from next-generation sequence diversity,Puller V,10.1371/journal.pcbi.1005775,2017,NR,,0,,,,,
"hemo, an ancestral endogenous retroviral envelope protein shed in the blood of pregnant women and expressed in pluripotent stem cells and tumors",Heidmann O,10.1073/pnas.1702204114,2017,NR,,0,,,,,
"heterologous prime-boost vaccination with dna and mva vaccines, expressing hiv-1 subtype c mosaic gag virus-like particles, is highly immunogenic in mice",Chapman R,10.1371/journal.pone.0173352,2017,NR,,0,,,,,
"high hiv-1 diversity and prevalence of transmitted drug resistance among antiretroviral-naive hiv-infected pregnant women from rio de janeiro, brazil",Delatorre E,10.1089/AID.2016.0159,2017,NR,,0,,,,,
high rates of transmission of drug-resistant hiv in aruba resulting in reduced susceptibility to the who recommended first-line regimen in nearly half of newly diagnosed hiv-infected patients,Hofstra LM,10.1093/cid/cix056,2017,NR,,0,,,,,
high-sequence diversity and rapid virus turnover contribute to higher rates of coreceptor switching in treatment-experienced subjects with hiv-1 viremia,Nedellec R,10.1089/AID.2016.0153,2017,NR,,0,,,,,
hiv antiretroviral resistance and transmission in mother-infant pairs enrolled in a large perinatal study,Yeganeh N,10.1093/ofid/ofxl62.039,2017,NR,,0,,,,,
estimation of stratified mark-specific proportional hazards models under two-phase sampling with application to hiv vaccine efficacy trials,Yang G,10.1007/s12561-016-9177-5,2017,NR,,0,,,,,
hiv prevalence and behavioral and psychosocial factors among transgender women and cisgender men who have sex with men in 8 african countries: a cross-sectional analysis,Poteat T,10.1371/journal.pmed.1002422,2017,NR,,0,,,,,
"hiv prevalence and phylogenetic characteristics among entry travelers in xishuangbanna prefecture, yunnan province, between 2003 and 2012",Wang B,10.1002/jmv.24740,2017,NR,,0,,,,,
hiv sequence diversity during the early phase of infection is associated with hiv dna reductions during antiretroviral therapy,Wang N,10.1002/jmv.24723,2017,NR,,0,,,,,
identification of human anti-hiv gp160 monoclonal antibodies that make effective immunotoxins,Pincus SH,10.1128/JVI.01955-16,2017,NR,,0,,,,,
evaluating the relative impact of state vocational rehabilitation and american job centers on contributing to the goals of the national hiv/aids strategy,Conyers L,10.3233/JVR-170890,2017,NR,,0,,,,,
"evaluation of risk factors in mtct among hiv-seropositive pregnant women in selected centers in akure, south western nigeria",Ebhodaghe BI,10.4103/1755-6783.205567,2017,NR,,0,,,,,
events in early hiv-1 infection that prime the development of heterologous neutralization breadth,Derdeyn C,,2017,NR,,0,,,,,
evidence of divergent amino acid usage in comparative analyses of r5- and x4-associated hiv-1 vpr sequences,Antell GC,10.1155/2017/4081585,2017,NR,,0,,,,,
evolution of b cell analysis and env trimer redesign,Karlsson Hedestam GB,10.1111/imr.12515,2017,NR,,0,,,,,
hiv-1 competition experiments in humanized mice show that apobec3h imposes selective pressure and promotes virus adaptation,Nakano Y,10.1371/journal.ppat.1006348,2017,NR,,0,,,,,
ex vivo activation of cd4+ t-cells from donors on suppressive art can lead to sustained production of infectious hiv-1 from a subset of infected cells,Bui JK,10.1371/journal.ppat.1006230,2017,NR,,0,,,,,
experiences along the hiv care continuum: perspectives of kenyan adolescents and caregivers,Luseno WK,10.2989/16085906.2017.1365089,2017,NR,,0,,,,,
exploring perceptions and practices of biomedical norms during exclusive breastfeeding among hiv-positive lactating mothers in mozambique,Cuinhane,10.4172/2155-6113.1000687,2017,NR,,0,,,,,
hiv-1 full-genome phylogenetics of generalized epidemics in sub-saharan africa: impact of missing nucleotide characters in next-generation sequences,Ratmann O,10.1089/AID.2017.0061,2017,NR,,0,,,,,
"hiv-1 genetic diversity and antiretroviral drug resistance among individuals from roraima state, northern brazil",Corado,10.1371/journal.pone.0173894,2017,NR,,0,,,,,
"hiv-1 genetic diversity and primary drug resistance mutations before large-scale access to antiretroviral therapy, republic of congo",Niama FR,10.1186/s13104-017-2550-8,2017,NR,,0,,,,,
"hiv-1 genetic diversity and transmitted drug resistance frequency among iranian treatment-naive, sexually infected individuals",Vahabpour R,10.1007/s00705-017-3228-1,2017,NR,,0,,,,,
factors associated with long turnaround time for early infant diagnosis of hiv in myanmar,Thiha S,10.1080/16549716.2017.1395657,2017,NR,,0,,,,,
peptide targeted by human antibodies associated with hiv vaccine-associated protection assumes a dynamic alpha-helical structure,Aiyegbo MS,10.1371/journal.pone.0170530,2017,NR,,0,,,,,
"hiv-1 infection and transmission networks of younger people in chicago, illinois, 2005-2011",Morgan E,10.1177/0033354916679988,2017,NR,,0,,,,,
hiv-1 persistence following extremely early initiation of antiretroviral therapy (art) during acute hiv-1 infection: an observational study,Henrich TJ,10.1371/journal.pmed.1002417,2017,NR,,0,,,,,
hiv-1 sequences in the epidemic suggest an alternative pathway for the generation of the long terminal repeats,Cappy P,10.1038/s41598-017-14135-z,2017,NR,,0,,,,,
hiv-1 strains belonging to large phylogenetic clusters show accelerated escape from integrase inhibitors in cell culture compared with viral isolates from singleton/small clusters,Brenner,10.1093/jac/dkx118,2017,NR,,0,,,,,
gene knockout shows that pml (trim19) does not restrict the early stages of hiv-1 infection in human cell lines,Masroori N,10.1128/mSphereDirect.00233-17,2017,NR,,0,,,,,
hiv-1 subtype diversity and prevalence of primary drug resistance in a single-center pediatric cohort in germany,Neubert J,10.1159/000477811,2017,NR,,0,,,,,
hiv-infected children in malawi have decreased performance on the 6-minute walk test with preserved cardiac mechanics regardless of antiretroviral treatment status,Sims Sanyahumbi AE,10.1097/INF.0000000000001540,2017,NR,,0,,,,,
glycans function as anchors for antibodies and help drive hiv broadly neutralizing antibody development,Andrabi R,10.1016/j.immuni.2017.08.006,2017,NR,,0,,,,,
glycosylation benchmark profile for hiv-1 envelope glycoprotein production based on eleven env trimers,Go EP,10.1128/JVI.02428-16,2017,NR,,0,,,,,
health communication and the hiv continuum of care,Vermund SH,10.1097/QAI.0000000000001211,2017,NR,,0,,,,,
hidden lineage complexity of glycan-dependent hiv-1 broadly neutralizing antibodies uncovered by digital panning and native-like gp140 trimer,He L,10.3389/fimmu.2017.01025,2017,NR,,0,,,,,
"high acceptability of rapid hiv self-testing among a diverse sample of msm from buenos aires, argentina",Pando,10.1371/journal.pone.0180361,2017,NR,,0,,,,,
"identification of a large, fast-expanding hiv-1 subtype b transmission cluster among msm in valencia, spain",Patino-Galindo JA,10.1371/journal.pone.0171062,2017,NR,,0,,,,,
higher viral load and genetic diversity of hiv-1 in seminal compartments than in blood of seven chinese men who have sex with men and have early hiv-1 infection,Jiao YM,10.1111/1348-0421.12488,2017,NR,,0,,,,,
"highlighting the crucial role of hangzhou in hiv-1 transmission among men who have sex with men in zhejiang, china",Zhang J,10.1038/s41598-017-14108-2,2017,NR,,0,,,,,
highly divergent patterns of genetic diversity and evolution in proviral quasispecies from hiv controllers,de Azevedo SSD,10.1186/s12977-017-0354-5,2017,NR,,0,,,,,
histidine 375 modulates cd4 binding in hiv-1 crf01_ae envelope glycoproteins,Zoubchenok D,10.1128/JVI.02151-16,2017,NR,,0,,,,,
"identification of rare hiv-1 group n, hbv ae, and htlv-3 strains in rural south cameroon",Rodgers MA,10.1016/j.virol.2017.01.008,2017,NR,,0,,,,,
identifying transmission clusters with cluster picker and hiv-trace,Rose R,10.1089/AID.2016.0205,2017,NR,,0,,,,,
hiv infection is an independent risk factor for decreased 6-minute walk test distance,Robertson TE,10.1164/ajrccm-conference.2017.B27,2017,NR,,0,,,,,
"the effects of prebiotics on microbial dysbiosis, butyrate production and immunity in hiv-infected subjects",Serrano-Villar S,10.1038/mi.2016.122,2017,NR,,0,,,,,
screening of primary gp120 immunogens to formulate the next generation polyvalent dna prime-protein boost hiv-1 vaccines,Wang S,10.1080/21645515.2017.1380137,2017,NR,,0,,,,,
"characterization of a novel hiv-1 second-generation recombinant form in men who have sex with men in beijing, china",Wang C,10.1089/aid.2017.0143,2017,NR,,0,,,,,
anti-lgbt and anti-immigrant structural stigma: an intersectional analysis of sexual minority men's hiv risk when migrating to or within europe,Pachankis JE,10.1097/QAI.0000000000001519,2017,NR,,0,,,,,
"a unique second-generation recombinant form of hiv-1 identified among men who have sex with men population in beijing, china",Li X,10.1089/aid.2017.0102,2017,NR,,0,,,,,
genetic variants of hiv type 1 in men who have sex with men in russia,Kazennova E,10.1089/aid.2017.0078,2017,NR,,0,,,,,
making sense of multifunctional proteins: human immunodeficiency virus type 1 accessory and regulatory proteins and connections to transcription,Faust TB,10.1146/annurev-virology-101416-041654,2017,NR,,0,,,,,
hiv testing intervention development among men who have sex with men in the developed world,Flowers P,10.1071/SH16081,2017,NR,,0,,,,,
"hiv risk, substance use, and personality characteristics among adults with history of serious mental illness (special issue: personality disorders and health)",Mainville,10.1080/08964289.2017.1301874,2017,NR,,0,,,,,
antigenicity-defined conformations of an extremely neutralization-resistant hiv-1 envelope spike,Cai Y,10.1073/pnas.1700634114,2017,NR,,0,,,,,
outcomes of a family-based hiv prevention intervention for substance using juvenile offenders,Tolou-Shams M,10.1016/j.jsat.2017.03.013,2017,NR,,0,,,,,
structure and topology around the cleavage site regulate post-translational cleavage of the hiv-1 gp160 signal peptide,Snapp EL,10.7554/eLife.26067,2017,NR,,0,,,,,
"identification of a novel hiv type 1 recombinant form (crf01-ae/crf07-bc) in men who have sex with men in zhejiang, china",Xu Y,10.1089/aid.2017.0001,2017,NR,,0,,,,,
attitudes towards exercise among substance using older adults living with hiv and chronic pain,Nguyen AL,10.1080/09540121.2017.1325437,2017,NR,,0,,,,,
"identification of a novel hiv type 1 circulating recombinant form (crf86-bc) among heterosexuals in yunnan, china",Li Y,10.1089/aid.2016.0188,2017,NR,,0,,,,,
hiv transmission dynamics among foreign-born persons in the united states,Valverde EE,10.1097/QAI.0000000000001541,2017,NR,,0,,,,,
hiv-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation,Gootenberg DB,10.1097/QCO.0000000000000341,2017,NR,,0,,,,,
"hiv transmission in tijuana, mexico: real-time identification of a new cluster",Chaillon A,,2017,NR,,0,,,,,
evaluation of a client-centered linkage intervention for patients newly diagnosed with hiv at an urban united states lgbt center: the linkage to care specialist project,Bendetson J,10.1089/apc.2017.0057,2017,NR,,0,,,,,
"different hiv-1 env frames: gp120 and asp (antisense protein) biosynthesis, and theirs co-variation tropic amino acid signatures in x4- and r5-viruses",Dimonte S,10.1002/jmv.24611,2017,NR,,0,,,,,
an hiv preexposure prophylaxis demonstration project and safety study for young msm,Hosek SG,10.1097/QAI.0000000000001179,2017,NR,,0,,,,,
insights from nmr spectroscopy into the conformational properties of man-9 and its recognition by two hiv binding proteins,Shahzad-ul-Hussan S,10.1002/cbic.201600665,2017,NR,,0,,,,,
offering pre-exposure prophylaxis for hiv prevention to pregnant and postpartum women: a clinical approach,Seidman DL,10.7448/IAS.20.2.21295,2017,NR,,0,,,,,
in women's eyes: key barriers to women's access to hiv treatment and a rights-based approach to their sustained well-being,Orza L,,2017,NR,,0,,,,,
brief report: medication sharing is rare among african hiv-1 serodiscordant couples enrolled in an efficacy trial of oral pre-exposure prophylaxis (prep) for hiv-1 prevention,Thomson KA,10.1097/QAI.0000000000001356,2017,NR,,0,,,,,
antibody gene transfer with adeno-associated viral vectors as a method for hiv prevention,Brady JM,10.1111/imr.12478,2017,NR,,0,,,,,
increased bacterial load in the small intestine but not lungs of hiv subjects,Yang J,10.1164/ajrccm-conference.2017.B21,2017,NR,,0,,,,,
regulation of subunit-specific germinal center b cell responses to the hiv-1 envelope glycoproteins by antibody-mediated feedback,Forsell MNE,10.3389/fimmu.2017.00738,2017,NR,,0,,,,,
increase in human immunodeficiency virus 1 diversity and detection of various subtypes and recombinants in northeastern brazil,Lima K,10.1099/jmm.0.000447,2017,NR,,0,,,,,
different expression of interferon-stimulated genes in response to hiv-1 infection in dendritic cells based on their maturation state,Calonge E,10.1128/JVI.01379-16,2017,NR,,0,,,,,
inhibition of hiv-1 maturation via small-molecule targeting of the aminoterminal domain in the viral capsid protein,Wang W,10.1128/JVI.02155-16,2017,NR,,0,,,,,
accumulation of pol mutations selected by hla-b*52: 01-c*12: 02 protective haplotype-restricted cytotoxic t lymphocytes causes low plasma viral load due to low viral fitness of mutant viruses,Murakoshi H,10.1128/JVI.02082-16,2017,NR,,0,,,,,
impact of genetic variations in hiv-1 tat on ltr-mediated transcription via tar rna interaction,Ronsard L,10.3389/fmicb.2017.00706,2017,NR,,0,,,,,
"defective hiv-1 proviruses are expressed and can be recognized by cytotoxic t lymphocytes, which shape the proviral landscape",Pollack RA,10.1016/j.chom.2017.03.008,2017,NR,,0,,,,,
"characterization of a novel hiv-1 unique recombinant form between crf07-bc and crf55-01b in men who have sex with men in guangzhou, china",Wu Y,10.1371/journal.pone.0175770,2017,NR,,0,,,,,
early infant diagnosis of hiv in myanmar: call for innovative interventions to improve uptake and reduce turnaround time,Thiha S,10.1080/16549716.2017.1319616,2017,NR,,0,,,,,
leveraging the us criminal justice system to access women for hiv interventions,Meyer JP,10.1007/s10461-017-1778-6,2017,NR,,0,,,,,
perceptions of brain health and cognition in older african americans and caucasians with hiv: a focus group study,Vance DE,10.1016/j.jana.2017.07.006,2017,NR,,0,,,,,
mixed-method quasi-experimental study of outcomes of a large-scale multilevel economic and food security intervention on hiv vulnerability in rural malawi,Weinhardt LS,10.1007/s10461-016-1455-1,2017,NR,,0,,,,,
cytotoxic t lymphocytes may shape the hiv-1 proviral landscape,Jones RB,,2017,NR,,0,,,,,
high-resolution mapping of an env epitope by comprehensive escape mutant selection,Dingens A,,2017,NR,,0,,,,,
inference of epistatic effects leading to entrenchment and drug resistance in hiv-1 protease,Flynn WF,10.1093/molbev/msx095,2017,NR,,0,,,,,
effect of exogenous interferon alpha on hiv viral populations in vivo,Bozzi G,,2017,NR,,0,,,,,
cxcr4 variants are neutralization-resistant compared to ccr5-using viruses in hiv-1b,Registre L,,2017,NR,,0,,,,,
hiv-1 epitope variability is associated with t cell receptor repertoire instability and breadth,Balamurugan A,10.1128/JVI.00771-17,2017,NR,,0,,,,,
"hiv-1 genetic diversity among incident infections in mbeya, tanzania",Billings E,10.1089/AID.2016.0111,2017,NR,,0,,,,,
hiv-1 escape from cd8+ cytotoxic t-lymphocytes defined at clonal resolution,Gorin A,,2017,NR,,0,,,,,
expression of unique and diverse hiv variants in cerebrospinal fluid during art,Johnson JA,,2017,NR,,0,,,,,
early cytoplasmic uncoating is necessary for infectivity of hiv-1,Mamede JI,,2017,NR,,0,,,,,
"artistic representations of hiv in northern ireland: how the arts can contribute to hiv awareness, prevention and stigma-reduction in a conservative environment",Campbell A,10.1136/sextrans-2017-053232.216,2017,NR,,0,,,,,
hiv-1 genetic diversity in northeastern brazil: high prevalence of non-b subtypes,Delatorre E,10.1089/AID.2017.0045,2017,NR,,0,,,,,
initial hiv diversity & neutralizing antibody development in people who inject drugs,Redd AD,,2017,NR,,0,,,,,
generation and characterization of anti-hiv-1 chuman recombinant monoclonals,Luthra K,10.1007/s12291-017-0733-7,2017,NR,,0,,,,,
hiv-1 persistent viremia is frequently followed by episodes of low-level viremia,Widera M,10.1007/s00430-017-0494-1,2017,NR,,0,,,,,
hiv prevention in primary care settings: facilitators and barriers associated with prescribing hiv pre-exposure prophylaxis (prep) in the united states,Patel VV,,2017,NR,,0,,,,,
clinico-pathological features of breast cancer patients; is it different in an hiv endemic sub saharan african country-botswana experience,Narasimhamurthy M,10.1038/labinvest.2016.162,2017,NR,,0,,,,,
hiv-1 sequences from early infection predict the age of the infection,Rolland M,,2017,NR,,0,,,,,
hiv-1 sub-subtype f1 outbreak among msm in belgium,Vinken L,10.1093/ve/vew036.020,2017,NR,,0,,,,,
internet-based hiv prevention with at-home sexually transmitted infection testing for young men having sex with men: study protocol of a randomized controlled trial of keep it up! 20,Mustanski B,10.2196/resprot.5740,2017,NR,,0,,,,,
hiv-1 subtypes circulating in constanta,Cernat R-C,10.1515/arsm-2017-0030,2017,NR,,0,,,,,
intestinal colonisation with extended-spectrum cephalosporin- and colistin-resistant enterobacteriaceae in hiv-positive individuals in switzerland: molecular features and risk factors,Joao P,10.1016/j.ijantimicag.2017.02.004,2017,NR,,0,,,,,
investigation of human immunodeficiency virus outbreaks among people who inject drugs: timely diagnosis and molecular surveillance are crucial,Paraskevis D,10.1093/infdis/jix308,2017,NR,,0,,,,,
hiv-specific cd8 t cell cross-reactivity following ad5-based vaccination is shaped by vaccine regimen and prior ad5 exposure,Boppana S,10.1093/ofid/ofx163.457,2017,NR,,0,,,,,
"is there a relationship between geographic distance and uptake of hiv testing services? a representative population-based study of chinese adults in guangzhou, china",Chen W,10.1371/journal.pone.0180801,2017,NR,,0,,,,,
lactobacillus-deficient cervicovaginal bacterial communities are associated with increased hiv acquisition in young south african women,Gosmann C,10.1016/j.immuni.2016.12.013,2017,NR,,0,,,,,
large cluster outbreaks sustain the hiv epidemic among msm in quebec,Brenner BG,10.1097/QAD.0000000000001383,2017,NR,,0,,,,,
human pegivirus-1 in the csf of patients with hiv-associated neurocognitive disorder (hand) may be derived from blood in highly viraemic patients,Hardie D,10.1016/j.jcv.2017.04.007,2017,NR,,0,,,,,
identification of a novel hiv-1-neutralizing antibody from a crf07_bc-infected chinese donor,Sun Y,10.18632/oncotarget.18594,2017,NR,,0,,,,,
identification of genetically intact hiv-1 proviruses in specific cd4+ t cells from effectively treated participants,Hiener B,10.1016/j.celrep.2017.09.081,2017,NR,,0,,,,,
mutation of the putative immunosuppressive domain of the retroviral envelope glycoprotein compromises infectivity,Eksmond U,10.1128/JVI.01152-17,2017,NR,,0,,,,,
"low rates of transmitted drug resistances among treatment-naive hiv-1-infected students in beijing, china",Hao M,10.1089/aid.2017.0053,2017,NR,,0,,,,,
identification of lras active in diverse primary t-cell models of hiv latency,Barnard R,,2017,NR,,0,,,,,
"lower genetic variability of hiv-1 and antiretroviral drug resistance in pregnant women from the state of para, brazil",Machado LF,10.1186/s12879-017-2392-y,2017,NR,,0,,,,,
identification of major routes of hiv transmission throughout mesoamerica,Chaillon A,10.1016/j.meegid.2017.06.021,2017,NR,,0,,,,,
identifying differentially coexpressed module during hiv disease progression: a multiobjective approach,Ray S,10.1038/s41598-017-00090-2,2017,NR,,0,,,,,
implementation of a multidisciplinary hiv interprofessional education project,Mak M,10.1016/j.japh.2017.04.011,2017,NR,,0,,,,,
improved hiv markers and decreased emergencyroom usage and hospital admission with initiation of a pilot specialty pharmacy at a southeastern ryan-white-funded clinic over a three year period,Nguyen ML,10.1093/ofid/ofx163.1048,2017,NR,,0,,,,,
phospholipases: at the crossroads of the immune system and the pathogenesis of hiv-1 infection,Cecchetti S,10.1189/jlb.3RU0316-148RR,2017,NR,,0,,,,,
in vitro functional assessment of natural hiv-1 group m vpu sequences using a universal priming approach,Rahimi A,10.1016/j.jviromet.2016.11.004,2017,NR,,0,,,,,
"medicinal plants and traditional treatment practices used in the management of hiv/aids clients in mpigi district, uganda",Nyamukuru A,10.1016/j.hermed.2016.10.001,2017,NR,,0,,,,,
"induction of a tier-1-like phenotype in diverse tier-2 isolates by agents that guide hiv-1 env to perturbation-sensitive, nonnative states",Johnson J,10.1128/JVI.00174-17,2017,NR,,0,,,,,
molecular and epidemiological characterization of hiv-1 subtypes among libyan patients,Daw MA,10.1186/s13104-017-2491-2,2017,NR,,0,,,,,
insights into the dynamics of hiv-1 transmission using whole genome deep sequencing,El Bouzidi K,10.1111/hiv.12513,2017,NR,,0,,,,,
molecular characteristics of hbv virus in patients with hiv/hbv combined infection,Wang T,,2017,NR,,0,,,,,
"integrating pmtct into maternal, newborn, and child health and related services: experiences from the global plan priority countries (special issue: looking back and moving forward: the living legacy of the global plan towards the elimination of new hiv infections among children by 2015 and keeping their mothers alive)",Kiragu,10.1097/qai.0000000000001323,2017,NR,,0,,,,,
"molecular epidemiology of hiv-1 in iceland: early introductions, transmission dynamics and recent outbreaks among injection drug users",Sallam M,10.1016/j.meegid.2017.01.004,2017,NR,,0,,,,,
molecular epidemiology of human immunodeficiency virus,Chin BumSik,10.3947/ic.2017.49.1.1,2017,NR,,0,,,,,
legal responses to hiv and aids: lessons from swaziland,Shongwe,10.2989/16085906.2017.1385495,2017,NR,,0,,,,,
molecular typing of human herpesvirus 8 among hiv positive in comparison to hiv-negative individuals in iran,Varmazyar S,10.1002/jmv.24644,2017,NR,,0,,,,,
longitudinal sequencing of hiv-1 infected patients with low-level viremia for years while on art shows no indications for genetic evolution of the virus,Vancoillie L,10.1016/j.virol.2017.07.010,2017,NR,,0,,,,,
monitoring of hiv drug resistance mutations in newly diagnosed patients in cyprus (2010-2012),Demetriades I,10.1093/ofid/ofx163.1066,2017,NR,,0,,,,,
multimethod longitudinal hiv drug resistance analysis in antiretroviral-therapy-naive patients,Nanfack AJ,10.1128/JCM.00634-17,2017,NR,,0,,,,,
multiple hiv-1/m + hiv-1/o dual infections and new hiv-1/mo inter-group recombinant forms detected in cameroon,De Oliveira F,10.1186/s12977-016-0324-3,2017,NR,,0,,,,,
"multiple introductions and onward transmission of hiv-1 subtype b strains in shanghai, china",Li X,10.1016/j.jinf.2017.05.009,2017,NR,,0,,,,,
rapid elicitation of broadly neutralizing antibodies to hiv by immunization in cows,Sok D,10.1038/nature23301,2017,NR,,0,,,,,
mechanisms of hiv-1 control,Soliman M,10.1007/s11904-017-0357-9,2017,NR,,0,,,,,
mining for pairs: shared clinic visit dates identify steady hiv-positive partnerships,Marzel A,10.1111/hiv.12507,2017,NR,,0,,,,,
no evidence of hiv replication in children on antiretroviral therapy,Van Zyl GU,10.1172/JCI94582,2017,NR,,0,,,,,
no substantial evidence for sexual transmission of minority hiv drug resistance mutations in men who have sex with men,Chaillon A,10.1128/JVI.00769-17,2017,NR,,0,,,,,
nuclear export signal masking regulates hiv-1 rev trafficking and viral rna nuclear export,Behrens RT,10.1128/JVI.02107-16,2017,NR,,0,,,,,
on the whereabouts of hiv-1 cellular entry and its fusion ports,Jakobsdottir GM,10.1016/j.molmed.2017.08.005,2017,NR,,0,,,,,
option b+ for prevention of vertical hiv transmission has no influence on adverse birth outcomes in a cross-sectional cohort in western uganda,Rempis EM,10.1186/s12884-017-1263-2,2017,NR,,0,,,,,
"origin, diffusion and evolution of hiv-1 group o viruses",Leoz M,10.1684/vir.2017.0705,2017,NR,,0,,,,,
neuroimaging abnormalities in clade c hiv are independent of tat genetic diversity,Paul RH,10.1007/s13365-016-0503-y,2017,NR,,0,,,,,
papulonodular secondary syphilis presenting as multiple distinct cutaneous lesions in an hiv-positive transgender woman,Navrazhina K,10.1159/000456065,2017,NR,,0,,,,,
"neurological manifestations, laboratory and neuroimaging features in hiv-infected patients",Chen H,10.17712/nsj.2017.4.20160606,2017,NR,,0,,,,,
"paucity of intact non-induced provirus with early, long-term antiretroviral therapy of perinatal hiv infection",Rainwater-Lovett K,10.1371/journal.pone.0170548,2017,NR,,0,,,,,
ngs analysis of hiv-1 group o rt residue 181c prevalence and evolution over time,Leoz M,,2017,NR,,0,,,,,
obstetric and perinatal outcomes in pregnant women with perinatally acquired hiv-infection -preliminary results,De Souza Osmundo G,10.1136/sextrans-2017-053264.193,2017,NR,,0,,,,,
occupational hiv infection in a research laboratory with unknown mode of transmission: a case report,Soria A,,2017,NR,,0,,,,,
phenotypic and phylogenetic relatedness of selected staphylococcus aureus strains cultured from hiv seropositive mothers and their neonate's pair,Ebhodaghe BI,10.4103/ATMPH.ATMPH_474_16,2017,NR,,0,,,,,
ongoing hiv replication during art reconsidered,Kearney MF,10.1093/ofid/ofx173,2017,NR,,0,,,,,
oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against lassa virus envelope glycoprotein,Galan-Navarro C,10.1016/j.virol.2017.09.013,2017,NR,,0,,,,,
pairwise diversity and tmrca as potential markers for hiv infection recency,Moyo S,10.1097/MD.0000000000006041,2017,NR,,0,,,,,
panels of hiv-1 subtype c env reference strains for standardized neutralization assessments,Hraber P,10.1128/JVI.00991-17,2017,NR,,0,,,,,
parent-offspring regression to estimate the heritability of an hiv-1 trait in a realistic setup,Bachmann N,10.1186/s12977-017-0356-3,2017,NR,,0,,,,,
"partial hiv c2v3 envelope sequence analysis reveals association of coreceptor tropism, envelope glycosylation and viral genotypic variability among kenyan patients on haart",Kitawi,10.1186/s12985-017-0703-y,2017,NR,,0,,,,,
phylogenetic characteristics of hiv-1 among travelers entering china from myanmar: a retrospective study,Zhang L,10.1002/jmv.24786,2017,NR,,0,,,,,
phylogenetic characterization of genes encoding for viral envelope glycoprotein (orf5) and nucleocapsid protein (orf7) of porcine reproductive & respiratory syndrome virus found in malaysia in 2013 and 2014,King SJ,10.1186/s12917-016-0933-z,2017,NR,,0,,,,,
phylogenetic evidence for underreporting of male-to-male sex among human immunodeficiency virus-infected donors in the netherlands and flanders,van de Laar TJ,10.1111/trf.14097,2017,NR,,0,,,,,
patterns and rates of viral evolution in hiv-1 subtype b infected females and males,Dapp MJ,10.1371/journal.pone.0182443,2017,NR,,0,,,,,
persistent circulation of highly divergent hiv-1m lineages in the congo basin region,Tongo M,,2017,NR,,0,,,,,
"plasma tenofovir levels to support adherence to tdf/ftc preexposure prophylaxis for hiv prevention in msm in los angeles, california",Landovitz RJ,10.1097/QAI.0000000000001538,2017,NR,,0,,,,,
physical function and inflammation in older hiv-infected men,McClintic H,,2017,NR,,0,,,,,
potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of hiv-1 infection,Gatanaga H,10.1097/QAD.0000000000001575,2017,NR,,0,,,,,
population growth and evolutionary history of hiv-1 b and f subtypes in the northeast brazil,De Lima KO,10.1136/sextrans-2017-053264.358,2017,NR,,0,,,,,
preferential targeting of conserved gag regions after vaccination with a heterologous dna primemodified vaccinia virus ankara boost hiv-1 vaccine regimen,Bauer A,10.1128/JVI.00730-17,2017,NR,,0,,,,,
pregnancy and neonatal outcomes among a cohort of hiv-infected women in a large italian teaching hospital: a 30-year retrospective study,Grignolo S,10.1017/S095026881700053X,2017,NR,,0,,,,,
prevalence and genotypes of gbv-c and its associations with hiv infection among persons who inject drugs in eastern europe,Jogeda,,2017,NR,,0,,,,,
prevalence of drug resistance among hiv-1 treatment-naive patients in greece during 2003-2015: transmitted drug resistance is due to onward transmissions,Paraskevis D,10.1016/j.meegid.2017.07.003,2017,NR,,0,,,,,
"prevalence of toxoplasma gondii infection in hiv-infected patients and food animals and direct genotyping of t gondii isolates, southern ghana",Pappoe F,10.1007/s00436-017-5442-x,2017,NR,,0,,,,,
prevalence of hiv at the kokoyo informal gold mining site: what lies behind the glitter of gold with regard to hiv epidemics in mali? a community-based approach (the anrs-12339 sanu gundo cross-sectional survey),Sagaon-Teyssier,10.1136/bmjopen-2017-016558,2017,NR,,0,,,,,
probing the compartmentalization of hiv-1 in the central nervous system through its neutralization properties,Stefic K,10.1371/journal.pone.0181680,2017,NR,,0,,,,,
prevalence of hiv-1 subtypes in slovenia with an emphasis on molecular and phylogenetic investigation of subtype a,Mlakar J,,2017,NR,,0,,,,,
progress and challenges in ending hiv and aids in australia,Holt M,10.1007/s10461-016-1642-0,2017,NR,,0,,,,,
proliferation of latently infected cd4+ t cells carrying replication-competent hiv-1: potential role in latent reservoir dynamics,Hosmane NN,10.1084/jem.20170193,2017,NR,,0,,,,,
proviruses with identical sequences comprise a large fraction of the replication-competent hiv reservoir,Bui JK,10.1371/journal.ppat.1006283,2017,NR,,0,,,,,
quantification of the latent hiv-1 reservoir using ultra deep sequencing and primer id in a viral outgrowth assay,Lee SookKyung,10.1097/qai.0000000000001187,2017,NR,,0,,,,,
"production of hiv-1 proteins from ""defective"" hiv-1 provirus",Imamichi H,,2017,NR,,0,,,,,
production of igg antibodies to pneumococcal polysaccharides is associated with expansion of icos+ circulating memory t follicular-helper cells which is impaired by hiv infection,Abudulai LN,10.1371/journal.pone.0176641,2017,NR,,0,,,,,
profiling the neutralizing antibody response in chronically hiv-1 crf07_bc-infected intravenous drug users naive to antiretroviral therapy,Hu X,10.1038/srep46308,2017,NR,,0,,,,,
"program implementation of option b+ at a president's emergency plan for aids relief-supported hiv clinic improves clinical indicators but not retention in care in mbarara, uganda",Miller K,10.1089/apc.2017.0034,2017,NR,,0,,,,,
promises and pitfalls of illumina sequencing for hiv resistance genotyping (special issue: deep sequencing in virology),Brumme,10.1016/j.virusres.2016.12.008,2017,NR,,0,,,,,
quaternary configuration of the functional cd4-binding site in the hiv-1 env trimer,Liu Q,,2017,NR,,0,,,,,
race/sex interactions and hiv testing among college students,McElrath K,10.1007/s40615-016-0208-1,2017,NR,,0,,,,,
"psychological distress, health protection, and sexual practices among young men who have sex with men: using social action theory to guide hiv prevention efforts",Holloway IW,10.1371/journal.pone.0184482,2017,NR,,0,,,,,
rates of viral suppression among hiv-positive women in rural north-central nigeria,Lee D,,2017,NR,,0,,,,,
re-establishing safer medical-circumcision-integrated initiation ceremonies for hiv prevention in a rural setting in papua new guinea a multi-method acceptability study,Manineng CM,10.1371/journal.pone.0187577,2017,NR,,0,,,,,
recent advances in understanding hiv evolution,Rowland-Jones S,10.12688/f1000research.10876.1,2017,NR,,0,,,,,
random amplification with next-generation sequencing to cover hiv and hcv full-length genomes,Cuypers L,10.1093/ve/vew036.017,2017,NR,,0,,,,,
relative risk for hiv in india - an estimate using conditional auto-regressive models with bayesian approach,Kandhasamy C,10.1016/j.sste.2017.01.001,2017,NR,,0,,,,,
systems serology: profiling vaccine induced humoral immunity against hiv,Chung AW,10.1186/s12977-017-0380-3,2017,NR,,0,,,,,
risk of preterm birth and small for gestational age infants: comparison between hiv-infected and uninfected women,Sibiude J,,2017,NR,,0,,,,,
"rectal microbiota among hiv-uninfected, untreated hiv, and treated hiv-infected in nigeria",Nowak RG,10.1097/QAD.0000000000001409,2017,NR,,0,,,,,
the hiv-1 envelope glycoprotein structure: nailing down a moving target,Ward AB,10.1111/imr.12507,2017,NR,,0,,,,,
regional challenges in the prevention of human immunodeficiency virus drug resistance,Godfrey C,10.1093/infdis/jix408,2017,NR,,0,,,,,
routine hiv testing in men who have sex with men: from risk to prevention,Redoschi,,2017,NR,,0,,,,,
seeking a cure for hiv-aids,Chang SL,10.1007/s11481-017-9751-8,2017,NR,,0,,,,,
sensitive next-generation sequencing method reveals deep genetic diversity of hiv-1 in the democratic republic of the congo,Rodgers MA,10.1128/JVI.01841-16,2017,NR,,0,,,,,
"revealing the molecular epidemiology of the cologne, germany, hiv epidemic",Stecher M,,2017,NR,,0,,,,,
rising prevalence of non-b hiv-1 subtypes in north carolina and evidence for local onward transmission,Dennis AM,10.1093/ve/vex013,2017,NR,,0,,,,,
sexual health knowledge and practices and sti/hiv prevalence among long-distance truck drivers in peru,Garcia PJ,10.1177/2050312117746308,2017,NR,,0,,,,,
short communication: potential risk of replication-competent virus in hiv-1 env-pseudotyped virus preparations,Bilska M,10.1089/AID.2016.0142,2017,NR,,0,,,,,
signature pattern analysis for the full-length env gene of the earliest korean subclade b of hiv-1: outbreak among korean hemophiliacs,Cho Y-K,10.1007/s11262-017-1477-4,2017,NR,,0,,,,,
silenced voices: experiences of women living with hiv in the uk who have experienced domestic abuse,Shentall L,10.1111/hiv.12513,2017,NR,,0,,,,,
romidepsin-induced hiv-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations,Winckelmann A,10.1097/QAD.0000000000001400,2017,NR,,0,,,,,
safer sex practices among newly diagnosed hiv-positive men who have sex with men in china: results from an ethnographic study,Li H,10.1080/17482631.2017.1335167,2017,NR,,0,,,,,
single-virus droplet microfluidics for high-throughput screening of neutralizing epitopes on hiv particles,Chaipan C,10.1016/j.chembiol.2017.05.009,2017,NR,,0,,,,,
six highly conserved targets of rnai revealed in hiv-1-infected patients from russia are also present in many hiv-1 strains worldwide,Kretova OV,10.1016/j.omtn.2017.07.010,2017,NR,,0,,,,,
space-time migration patterns and risk of hiv acquisition in rural south africa,Dobra,10.1097/QAD.0000000000001292,2017,NR,,0,,,,,
"stabilization of a soluble, native-like trimeric form of an efficiently cleaved indian hiv-1 clade c envelope glycoprotein",Ahmed S,10.1074/jbc.M117.776419,2017,NR,,0,,,,,
therapeutic immune recovery and reduction of cxcr4-tropic hiv-1,Bader J,10.1093/cid/ciw737,2017,NR,,0,,,,,
"sexual hiv risk among gay, bisexual and queer transgender men: findings from interviews in vancouver, canada",Rich,10.1080/13691058.2017.1299882,2017,NR,,0,,,,,
"successful control of a large outbreak of hiv infection associated with injection of cathinone derivatives in tel aviv, israel",Katchman E,10.1016/j.cmi.2016.11.009,2017,NR,,0,,,,,
surveillance of recent hiv infections among newly diagnosed hiv cases in germany between 2008 and 2014,Hofmann A,10.1186/s12879-017-2585-4,2017,NR,,0,,,,,
short communication: hiv patient systemic mitochondrial respiration improves with exercise,Kocher M,10.1089/aid.2016.0287,2017,NR,,0,,,,,
short communication: hiv-1 transmission networks across south korea,Ahn MY,10.1089/aid.2016.0212,2017,NR,,0,,,,,
t cell receptor repertoire in kenyan hiv exposed but uninfected infants at birth: evidence of in utero clonal expansions,Gabriel B,,2017,NR,,0,,,,,
skin coinfection by mycobacterium avium intracellulare and herpes virus in a patient infected with acquired human immunodeficiency virus case report and literature review,Bozo LRF,10.1016/j.jaad.2017.04.915,2017,NR,,0,,,,,
snapin promotes hiv-1 transmission from dendritic cells by dampening tlr8 signaling,Khatamzas E,10.15252/embj.201695364,2017,NR,,0,,,,,
social and genetic networks of hiv-1 transmission in new york city,Wertheim JO,10.1371/journal.ppat.1006000,2017,NR,,0,,,,,
socioeconomic position and ten-year survival and virologic outcomes in a ugandan hiv cohort receiving antiretroviral therapy,Flynn AG,10.1371/journal.pone.0189055,2017,NR,,0,,,,,
source of hiv-1 drug-resistant minority variants in people who are recently infected,Mbisa J,10.1111/hiv.12512,2017,NR,,0,,,,,
surveillance of hiv-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naive persons in rural western kenya,Onywera H,10.1371/journal.pone.0171124,2017,NR,,0,,,,,
"surveillance of hiv-1 transmitted drug resistance among drug-naive populations in rio de janeiro, brazil",Fernandez JCC,10.1136/sextrans-2017-053264.198,2017,NR,,0,,,,,
"the changes of positive selection within env gene of hiv-1 b', crf07_bc and crf08_bc from china over time",Li T,10.2174/1570162X13666161205122526,2017,NR,,0,,,,,
"the dimensions of food insecurity and malnutrition among people living with hiv in senegal, west africa",Benzekri NA,10.1080/09540121.2017.1338652,2017,NR,,0,,,,,
the effect of cryptococcal meningitis on the hiv reservoir in the cns,Manion M,,2017,NR,,0,,,,,
the emergence and spread of antimicrobial resistant neisseria gonorrhoeae in hiv positive men who have sex with men,Town K,10.1136/sextrans-2017-053264.68,2017,NR,,0,,,,,
the epidemic history of hiv-1 crf07_bc in hetian prefecture and the role of it on hiv spreading in china,Wu J,10.1089/AID.2016.0214,2017,NR,,0,,,,,
the hiv-exposed and uninfected child: what's to worry?,Thorne C,,2017,NR,,0,,,,,
the impact of an unknown hiv serostatus on inpatient mortality,Moodley Y,10.11604/pamj.2017.28.285.11860,2017,NR,,0,,,,,
the roles of 5 conserved lentiviral rna structures in hiv-1 replication,Liu Y,,2017,NR,,0,,,,,
the hiv genomic incidence assay meets frr and mdri performance standards,Park SY,,2017,NR,,0,,,,,
the influence of hiv infection on the age dependence of squamous cell carcinoma of the skin in south africa,Diffey BL,10.7196/SAMJ.2017.v107i2.10837,2017,NR,,0,,,,,
the human immunodeficiency virus endemic: maintaining disease transmission in at-risk urban areas,Rothenberg RB,10.1097/OLQ.0000000000000561,2017,NR,,0,,,,,
the majority of re-activatable latent hiv proviruses are genetically distinct with no evidence of ongoing evolution,Mok HP,10.1111/hiv.12513,2017,NR,,0,,,,,
differential potency and breadth of the same epitope-specific ctls to inhibit hiv-1 replication based on tcr usage,Tu Ting,10.4172/2155-6113.1000735,2017,NR,,0,,,,,
"the infection staging and profile of genotypic distribution and drug resistance mutation among the human immunodeficiency virus-1 infected blood donors from five chinese blood centers, 2012-2014",Zeng P,10.1371/journal.pone.0179328,2017,NR,,0,,,,,
diterpene from marine brown alga dictyota friabilis as a potential microbicide against hiv-1 in tissue explants,Stephens,10.1007/s10811-016-0925-1,2017,NR,,0,,,,,
identification of two new hiv-1 circulating recombinant forms (crf87_cpx and crf88_bc) from reported unique recombinant forms in asia,Hu YiHong,10.1089/aid.2016.0252,2017,NR,,0,,,,,
preferred physical characteristics of vaginal film microbicides for hiv prevention in pittsburgh women,Fan,10.1007/s10508-016-0816-1,2017,NR,,0,,,,,
the substitution rate of hiv-1 subtypes: a genomic approach,Patino-Galindo JA,10.1093/ve/vex029,2017,NR,,0,,,,,
the ptap sequence duplication in hiv-1 subtype c gag p6 in drug-naive subjects of india and south africa,Sharma S,10.1186/s12879-017-2184-4,2017,NR,,0,,,,,
the use of avatar counseling for hiv/aids health education: the examination of self-identity in avatar preferences,Canidate S,10.2196/jmir.6740,2017,NR,,0,,,,,
the second molecular epidemiological study of hiv infection in mongolia between 2010 and 2016,Jagdagsuren D,10.1371/journal.pone.0189605,2017,NR,,0,,,,,
transmission dynamics of hiv-1 drug resistance among treatment-naive individuals in greece: the added value of molecular epidemiology to public health,Paraskevis D,10.3390/genes8110322,2017,NR,,0,,,,,
"transmission networks and risk of hiv infection in kwazulu-natal, south africa: a community-wide phylogenetic study",de Oliveira T,10.1016/S2352-3018%2816%2930186-2,2017,NR,,0,,,,,
use of broadly neutralizing antibodies for hiv-1 prevention,Pegu A,10.1111/imr.12511,2017,NR,,0,,,,,
using primer id deep sequencing to identify recent hiv infection in north carolina,Zhou S,,2017,NR,,0,,,,,
variations in recruitment yield and characteristics of participants recruited across diverse internet platforms in an hiv testing study of young adult men-who-have-sex-with-men (ymsm),Merchant RC,10.1177/1557988317717383,2017,NR,,0,,,,,
ultra-deep sequencing analysis on hiv drug-resistance-associated mutations among hiv-infected individuals: first report from the philippines,SahBandar IN,10.1089/AID.2016.0151,2017,NR,,0,,,,,
ultradeep sequencing of b and non-b hiv-1 subtypes: viral diversity and drug resistance mutations before and after one month of antiretroviral therapy in naive patients,Epaulard,10.1016/j.jcv.2017.07.013,2017,NR,,0,,,,,
virus-host gene interactions define hiv-1 disease progression,Monaco DC,10.1007/82_2017_33,2017,NR,,0,,,,,
understanding hiv transmission and illness stigma: a relationship revisited in rural rwanda,Kang E,10.1521/aeap.2017.29.6.540,2017,NR,,0,,,,,
voices of citizen journalists on hiv and aids: implications for the next generation of researchers,Barnes,,2017,NR,,0,,,,,
viral evolution and innate immune responses during acute hiv-1 infection and their association with disease pathogenesis,Hassan AS,,2017,NR,,0,,,,,
use of whole genome deep sequencing to define emerging minority variants in virus envelope genes in herpesvirus treated with novel antimicrobial k21,Tweedy JG,10.1016/j.antiviral.2017.09.011,2017,NR,,0,,,,,
using participatory system dynamics modeling to examine the local hiv test and treatment care continuum in order to reduce community viral load,Weeks MR,10.1002/ajcp.12204,2017,NR,,0,,,,,
vaginal bacteria modify hiv tenofovir microbicide efficacy in african women,Klatt NR,10.1126/science.aai9383,2017,NR,,0,,,,,
vaginal microbiota in asymptomatic brazilian women with hiv,Figueiredo Facundo MK,10.12891/ceog3509.2017,2017,NR,,0,,,,,
when the reality of breastfeeding sets in: how hiv-infected mothers' perceptions about infant feeding messages change over time,Fox EL,,2017,NR,,0,,,,,
wide-ranging and unexpected consequences of altered pol ii catalytic activity in vivo,Malik I,10.1093/nar/gkx037,2017,NR,,0,,,,,
"virological response, hiv-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in n'djamena, chad: findings from a cross-sectional study",Adawaye C,10.1186/s13104-017-2893-1,2017,NR,,0,,,,,
week 48 resistance analysis of elvitegravir/cobicistat/emtricitabine/tenofovir df versus atazanavir + ritonavir + emtricitabine/tenofovir df in hiv-1 infected women (waves study gs-us-236-0128),Kulkarni R,10.1080/15284336.2017.1370059,2017,NR,,0,,,,,
well-positioned nucleosomes punctuate polycistronic pol ii transcription units and flank silent vsg gene arrays in trypanosoma brucei,Maree JP,10.1186/s13072-017-0121-9,2017,NR,,0,,,,,
workplace and hiv-related sexual behaviours and perceptions among female migrant workers: a study of mumbai city,Prashika,10.1136/sextrans-2017-053264.581,2017,NR,,0,,,,,
"""analyze locally & act locally"" - geographical prioritization of districts/blocks & strategic approach using hiv data triangulation in gujarat, india",Chavan Laxmikant,,2016,NR,,0,,,,,
"""let me help you help me"": church-based hiv prevention for young black men who have sex with men (special issue: hiv prevention among diverse young msm)",Powell,10.1521/aeap.2016.28.3.202,2016,NR,,0,,,,,
"""making it personal"": ideology, the arts, and shifting registers in health promotion (special issue: responsibility, intimacy and care: psychological and sociomedical aspects of aids/hiv july 13)",Ruthven,,2016,NR,,0,,,,,
"""poppers maculopathy"" in three hiv-positive patients",Finnerty F,10.1111/hiv.12393,2016,NR,,0,,,,,
1970s hiv-1 genomes reveal the early history of the north american hiv/aids epidemic,Worobey M,,2016,NR,,0,,,,,
1970s and 'patient 0' hiv-1 genomes illuminate early hiv/aids history in north america,Worobey M,10.1038/nature19827,2016,NR,,0,,,,,
a direct comparison of two densely sampled hiv epidemics: the uk and switzerland,Ragonnet-Cronin ML,10.1038/srep32251,2016,NR,,0,,,,,
a global research synthesis of hiv and sti biobehavioural risks in female-to-male transgender adults,Reisner SL,10.1080/17441692.2015.1134613,2016,NR,,0,,,,,
a longitudinal study on dynamics of plasma neutralising antibodies and its determinants in hiv-2 infected individuals,Ozkaya Sahin G,10.1016/j.jcv.2016.08.013,2016,NR,,0,,,,,
a comparison of younger and older men who have sex with men using data from jamaica aids support for life: characteristics associated with hiv status,Budhwani H,10.1177/0956462415594752,2016,NR,,0,,,,,
a comprehensive analysis of primer ids to study heterogeneous hiv-1 populations,Seifert D,10.1016/j.jmb.2015.12.012,2016,NR,,0,,,,,
"a study of potential hiv transmission hotspots among men who have sex with men and transgender women in lima, peru",Villaran M,10.7448/IAS.19.6.21264,2016,NR,,0,,,,,
a transmission-virulence evolutionary trade-off explains attenuation of hiv-1 in uganda,Blanquart F,10.7554/eLife.20492,2016,NR,,0,,,,,
accumulation of mxb/mx2-resistant hiv-1 capsid variants during expansion of the hiv-1 epidemic in human populations,Wei W,10.1016/j.ebiom.2016.04.020,2016,NR,,0,,,,,
"achieving the goals of the national hiv/aids strategy: declining hiv diagnoses, improving clinical outcomes, and diminishing racial/ethnic disparities in king county, wa (2004-2013)",Golden MR,10.1097/OLQ.0000000000000434,2016,NR,,0,,,,,
alarming increase of transmitted drug resistance to first-line hiv regimen in aruba,Hofstra LM,10.7448/IAS.19.2.21022,2016,NR,,0,,,,,
alterations in the fecal microbiota of patients with hiv-1 infection: an observational study in a chinese population,Ling ZongXin,,2016,NR,,0,,,,,
alternate routes of administration among prescription opioid misusers and associations with sexual hiv transmission risk behaviors,Buttram ME,10.1080/02791072.2016.1187319,2016,NR,,0,,,,,
a prominent site of antibody vulnerability on hiv envelope incorporates a motif associated with ccr5 binding and its camouflaging glycans,Sok D,10.1016/j.immuni.2016.06.026,2016,NR,,0,,,,,
a qualitative study of vulnerability to hiv infection: places and persons in urban settings of ethiopia,Mirgissa Kaba,,2016,NR,,0,,,,,
a step forward understanding hiv-1 diversity,Smyth RP,10.1186/s12977-016-0259-8,2016,NR,,0,,,,,
analysis of the env gene variability of the idu-a hiv-1 variant in the outbreak of the hiv infection epidemic in perm region of russia (1996-2011),Lebedev AV,,2016,NR,,0,,,,,
click labeling of unnatural sugars metabolically incorporated into viral envelope glycoproteins enables visualization of single particle fusion,Oum YH,10.1016/j.jviromet.2016.02.016,2016,NR,,0,,,,,
analysis of the humoral immune response against the envelope glycoprotein gc of schmallenberg virus reveals a domain located at the amino terminus targeted by mabs with neutralizing activity,Roman-Sosa G,10.1099/jgv.0.000377,2016,NR,,0,,,,,
antibody responses after analytic treatment interruption in human immunodeficiency virus-1-infected individuals on early initiated antiretroviral therapy,Stephenson KE,10.1093/ofid/ofw100,2016,NR,,0,,,,,
antiretroviral (hiv-1) activity of azulene derivatives,Peet J,10.1016/j.bmc.2016.02.038,2016,NR,,0,,,,,
antiretroviral medication adherence and amplified hiv transmission risk among sexually active hiv-infected individuals in three diverse international settings,Magidson JF,10.1007/s10461-015-1142-7,2016,NR,,0,,,,,
antiretroviral resistance after first-line antiretroviral therapy failure in diverse hiv-1 subtypes in the second-line study,Lam,,2016,NR,,0,,,,,
addressing the medical and support service needs of people living with hiv (plwh) through program collaboration and service integration (pcsi),Bernard,,2016,NR,,0,,,,,
art reduces cellular hiv rna but not the fraction of proviruses transcribing rna,Hong F,,2016,NR,,0,,,,,
assessing the spatial nonstationarity in relationship between local patterns of hiv infections and the covariates in south africa: a geographically weighted regression analysis,Wabiri N,10.1016/j.sste.2015.12.003,2016,NR,,0,,,,,
alcohol consumption patterns and hiv viral load suppression within the florida cohort: an important link in the hiv continuum of care,Cook RL,10.1111/acer.13084,2016,NR,,0,,,,,
bi-specific immunoadhesin fully protects humanized nsg mice challenged by hiv,Wu X,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
analysis of hiv diversity in hiv-infected black men who have sex with men (hptn 061),Chen I,10.1371/journal.pone.0167629,2016,NR,,0,,,,,
blt humanized mice recapitulate the preferential transmission of env n362 observed during heterosexual hiv infection,Tully DC,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
analysis of viral diversity in relation to the recency of hiv-1c infection in botswana,Moyo S,10.1371/journal.pone.0160649,2016,NR,,0,,,,,
brief report on ecological momentary assessment: everyday states predict hiv prevention behaviors,Cook,,2016,NR,,0,,,,,
"brief report: geographical variation in prevalence of cryptococcal antigenemia among hiv-infected, treatment-naive patients in nigeria: a multicenter cross-sectional study",Ezeanolue EE,10.1097/QAI.0000000000001048,2016,NR,,0,,,,,
brief report: hiv-1 evolution in breakthrough infections in a human trial of oral pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil fumarate,Ruone S,10.1097/QAI.0000000000000921,2016,NR,,0,,,,,
antibodies and acidic environment do not enhance hiv-1 transcytosis,Gonzalez OA,10.1093/infdis/jiw354,2016,NR,,0,,,,,
apobec3g and apobec3f act in concert to extinguish hiv-1 replication,Krisko JF,10.1128/JVI.03275-15,2016,NR,,0,,,,,
apolipoprotein e epsilon 4 genotype status is not associated with neuroimaging outcomes in a large cohort of hiv+ individuals,Cooley,10.1007/s13365-016-0434-7,2016,NR,,0,,,,,
apolipoprotein e epsilon4 genotype status is not associated with neuroimaging outcomes in a large cohort of hiv+ individuals,Cooley SA,,2016,NR,,0,,,,,
application of an ecological framework to examine barriers to the adoption of safer conception strategies by hiv-affected couples,Saleem HT,10.1080/09540121.2015.1074652,2016,NR,,0,,,,,
"cash, care and hiv community: social protection improves adolescent art adherence in south africa",Cluver L,10.7448/IAS.19.6.21264,2016,NR,,0,,,,,
art access-related barriers faced by hiv-positive persons linked to care in southern ghana: a mixed method study,Ankomah A,,2016,NR,,0,,,,,
fast dissemination of new hiv-1 crf02/a1 recombinants in pakistan,Chen Y,10.1371/journal.pone.0167839,2016,NR,,0,,,,,
cross-reactive potential of hiv-1 subtype c-infected indian individuals against multiple hiv-1 potential t cell epitope gag variants,Negi N,,2016,NR,,0,,,,,
studies in a murine model confirm the safety of griffithsin and advocate its further development as a microbicide targeting hiv-1 and other enveloped viruses,Kouokam JC,,2016,NR,,0,,,,,
increasing prevalence of k65k and k66k in hiv-1 subtype b reverse transcriptase,Telwatte S,,2016,NR,,0,,,,,
designed hiv-1 env molecules from multiple clades that display structural and antigenic characteristics of the mature prefusion hiv-1 env,Joyce MG,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
targeted hiv-1 latency reversal using crispr/cas9-derived transcriptional activator systems,Bialek JK,10.1371/journal.pone.0158294,2016,NR,,0,,,,,
changes in the vibrio harveyi cell envelope subproteome during permanence in cold seawater,Parada C,10.1007/s00248-016-0802-0,2016,NR,,0,,,,,
posttranscriptional m(6)a editing of hiv-1 mrnas enhances viral gene expression,Kennedy EM,10.1016/j.chom.2016.04.002,2016,NR,,0,,,,,
barriers to and facilitators of engagement in hiv care among adult ghanaian men who have sex with men (msm) living with hiv,Ogunbajo A,10.1097/01.olq.0000503358.65329.6f,2016,NR,,0,,,,,
functional characterization of vif proteins from hiv-1 infected patients with different apobec3g haplotypes,Reddy K,10.1097/QAD.0000000000001113,2016,NR,,0,,,,,
characteristics of transmitted drug-resistant hiv-1 in recently infected treatment-naive patients in japan,Hattori J,10.1097/QAI.0000000000000861,2016,NR,,0,,,,,
"bathhouse distribution of hiv self-testing kits reaches diverse, high-risk population",Woods,,2016,NR,,0,,,,,
characterization of hiv transmission in south-east austria,Hoenigl M,10.1371/journal.pone.0151478,2016,NR,,0,,,,,
"identification of an hiv-1 bg intersubtype recombinant form (crf73_bg), partially related to crf14_bg, which is circulating in portugal and spain",Fernandez-Garcia A,10.1371/journal.pone.0148549,2016,NR,,0,,,,,
"recombinant patterns of nine novel hiv-1 recombinant strains identified in hebei province, china",Lu X,10.1089/AID.2016.0005,2016,NR,,0,,,,,
biophysical characterization of small molecule antiviral-loaded nanolipogels for hiv-1 chemoprophylaxis and topical mucosal application,Ramanathan R,10.1016/j.actbio.2016.02.034,2016,NR,,0,,,,,
bispecific anti-hiv-1 antibodies with enhanced breadth and potency,Bournazos S,10.1016/j.cell.2016.04.050,2016,NR,,0,,,,,
rapid determination of hiv-1 mutant frequencies and mutation spectra using an mcherry/egfp dual-reporter viral vector,Rawson JM,10.1007/978-1-4939-3046-3_6,2016,NR,,0,,,,,
"the identification of a novel hiv-1 crf01_ae/b recombinant based on near full-length genomic analysis in yunnan province, china",Li J,10.1089/AID.2015.0245,2016,NR,,0,,,,,
effect of cytokines on siglec-1 and hiv-1 entry in monocyte-derived macrophages: the importance of hiv-1 envelope v1v2 region,Jobe O,10.1189/jlb.2A0815-361R,2016,NR,,0,,,,,
addressing risk and reluctance at the nexus of hiv and anal cancer screening,Ka'opua LS,10.1177/1524839915615611,2016,NR,,0,,,,,
"the effect of a community-based exercise program on inflammation, metabolic risk, and fitness levels among persons living with hiv/aids",Cutrono SE,10.1007/s10461-015-1245-1,2016,NR,,0,,,,,
broad activation of latent hiv-1 in vivo,Barton K,10.1038/ncomms12731,2016,NR,,0,,,,,
short communication: p21/cdkn1a expression shows broad interindividual diversity in a subset of hiv-1 elite controllers,de Pablo A,10.1089/AID.2015.0137,2016,NR,,0,,,,,
cellulitis-like symptoms manifested by bone metastasis of lung cancer in a patient living with human immunodeficiency virus,Kashima J,10.1177/0956462415606014,2016,NR,,0,,,,,
short communication: a recombinant variant with increased envelope entry efficiency emerged during early infection of an hiv-1 subtype c dual infected rapid progressor,Gordon K,10.1089/AID.2014.0100,2016,NR,,0,,,,,
"chasing the possible: are we there yet? innovations in testing to end the hiv epidemic in nsw, australia",Duck T,10.7448/IAS.19.6.21264,2016,NR,,0,,,,,
broadly neutralizing antibody responses in a large longitudinal sub-saharan hiv primary infection cohort,Landais E,10.1371/journal.ppat.1005369,2016,NR,,0,,,,,
buffering deleterious polymorphisms in the highly constrained c2 region of hiv-1 envelope by the flexible v3 domain,Gasser R,10.1186/s12977-016-0294-5,2016,NR,,0,,,,,
can a pill prevent hiv? negotiating the biomedicalisation of hiv prevention,Young I,10.1111/1467-9566.12372,2016,NR,,0,,,,,
can schools support hiv/aids-affected children? exploring the 'ethic of care' amongst rural zimbabwean teachers,Campbell C,10.1371/journal.pone.0146322,2016,NR,,0,,,,,
combined hiv-1 envelope systemic and mucosal immunization of lactating rhesus monkeys induces a robust immunoglobulin a isotype b cell response in breast milk,Nelson CS,10.1128/JVI.00335-16,2016,NR,,0,,,,,
conserved role of an n-linked glycan on the surface antigen of human immunodeficiency virus type 1 modulating virus sensitivity to broadly neutralizing antibodies against the receptor and coreceptor binding sites,Townsley S,10.1128/JVI.02321-15,2016,NR,,0,,,,,
community perceptions of repeat hiv-testing: experiences of the anrs 12249 treatment as prevention trial in rural south africa,Orne-Gliemann J,10.1080/09540121.2016.1164805,2016,NR,,0,,,,,
comparing three hiv-1 subtyping tools and a novel phylogenetic-based method,Switzer W,,2016,NR,,0,,,,,
coreceptor usage of chinese hiv-1 and impact of x4/dm transmission clusters among recently infected men who have sex with men,Li X,10.1097/MD.0000000000005017,2016,NR,,0,,,,,
characterization of the early antibody landscape in hiv-1 infected individuals who develop poor to elite levels of neutralization breadth,Smith SA,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
cryptococcus neoformans isolates from yaounde human immunodeficiency virus-infected patients exhibited intra-individual genetic diversity and variation in antifungal susceptibility profiles between isolates from the same patient,Kammalac Ngouana T,10.1099/jmm.0.000265,2016,NR,,0,,,,,
deep sequencing analysis of hiv-1 reverse transcriptase at baseline and time of failure in patients receiving rilpivirine in the phase iii studies echo and thrive,Van Eygen V,10.1002/jmv.24395,2016,NR,,0,,,,,
deep sequencing of hiv-1 rna and dna in newly diagnosed patients with baseline drug resistance showed no indications for hidden resistance and is biased by strong interference of hypermutation,Dauwe K,10.1128/JCM.00030-16,2016,NR,,0,,,,,
cns compartmentalization of hiv-1 and sensitivity to neutralizing antibodies,Stefic K,,2016,NR,,0,,,,,
"coalescent inference using serially sampled, high-throughput sequencing data from intrahost hiv infection",Dialdestoro K,10.1534/genetics.115.177931,2016,NR,,0,,,,,
defective hiv-1 proviruses produce novel protein-coding rna species in hiv-infected patients on combination antiretroviral therapy,Imamichi H,10.1073/pnas.1609057113,2016,NR,,0,,,,,
"design, synthesis and evaluation of small molecule cd4-mimics as entry inhibitors possessing broad spectrum anti-hiv-1 activity",Curreli F,10.1016/j.bmc.2016.09.057,2016,NR,,0,,,,,
"comparing abbott m2000 realtime hiv test and roche cobas ampliprep/cobas taqman hiv test, v20 in treated hiv-1 b and non-b subjects with low viraemia",Margariti A,10.1002/jmv.24369,2016,NR,,0,,,,,
development of a contemporary symptom diary for patients with hiv,Markowitz J,10.7448/IAS.19.8.21487,2016,NR,,0,,,,,
composition and antigenic effects of individual glycan sites of a trimeric hiv-1 envelope glycoprotein,Behrens A-J,10.1016/j.celrep.2016.02.058,2016,NR,,0,,,,,
"considering risk contexts in explaining the paradoxical hiv increase among female sex workers in mumbai and thane, india",Bandewar,,2016,NR,,0,,,,,
diversity and tropism of hiv-1 rebound virus populations in plasma level after treatment discontinuation,Bednar MM,10.1093/infdis/jiw172,2016,NR,,0,,,,,
diversity of hiv-1 proviral sequences during antiretroviral treatment from transmitted variants,Brooks K,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
in silico analysis of hiv-1 env-gp120 reveals structural bases for viral adaptation in growth-restrictive cells,Yokoyama M,10.3389/fmicb.2016.00110,2016,NR,,0,,,,,
construction and characterization of hiv type 1 crf07_bc infectious molecular clone from men who have sex with men,Jiang YL,10.1016/j.jviromet.2015.12.013,2016,NR,,0,,,,,
contemporary hiv vaccines: tissue resident t-cells and strategies to prevent mucosal infection,Tana H-X,,2016,NR,,0,,,,,
do we need to routinely re-screen heterosexual patients for hiv and syphilis when they reattend gum/srh clinics? (improving clinical practice and service delivery),Uthayakumar N,10.1136/sextrans-2016-052718.231,2016,NR,,0,,,,,
drift of the envelope glycoprotein of hiv-1 clade b towards higher infectious properties over the course of the epidemic,Bouvin-Pley M,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
correlates of hiv and sti testing among latino men who have sex with men in new york city,Spadafino JT,10.1080/09540121.2016.1147017,2016,NR,,0,,,,,
dynamic perturbations of the t-cell receptor repertoire in chronic hiv infection and following antiretroviral therapy,Heather JM,10.3389/fimmu.2015.00644,2016,NR,,0,,,,,
effect of advanced hiv infection on the respiratory microbiome,Twigg HL,10.1164/rccm.201509-1875OC,2016,NR,,0,,,,,
deep sequencing of the hiv-1 env gene reveals discrete x4 lineages and linkage disequilibrium between x4 and r5 viruses in the v1/v2 and v3 variable regions,Zhou S,10.1128/JVI.00441-16,2016,NR,,0,,,,,
effect of hiv-1 matrix protein p17 on natural killer cell mediated antibody-dependent cellular cytotoxicity,Carroll V,,2016,NR,,0,,,,,
defective proviruses rapidly accumulate during acute hiv-1 infection,Bruner KM,10.1038/nm.4156,2016,NR,,0,,,,,
efficient replication of a vpu containing sivagm construct in african green monkeys requires an hiv-1 nef gene,Joas S,10.1186/s12977-016-0294-5,2016,NR,,0,,,,,
effect of the maturation of neutralizing antibodies on human immunodeficiency virus (hiv) envelope evolution in hiv-infected subjects,Zhao J,10.1016/j.meegid.2015.12.012,2016,NR,,0,,,,,
developing an ethical indigenous research protocol: sowing seeds for the inclusion of indigenous peoples with hiv,Montalvo Pacahuala CDP,10.7448/IAS.19.6.21264,2016,NR,,0,,,,,
"development of a comprehensive measure of spatial access to hiv provider services, with application to atlanta, georgia",Dasgupta,,2016,NR,,0,,,,,
development of a large urban longitudinal hiv clinical cohort using a web-based platform to merge electronically and manually abstracted data from disparate medical record systems: technical challenges and innovative solutions,Greenberg AE,10.1093/jamia/ocv176,2016,NR,,0,,,,,
enhanced surveillance to study hiv-1 drug resistance among naive individuals in southern greece: the added value of molecular epidemiology to public health,Paraskevis D,10.7448/IAS.19.8.21487,2016,NR,,0,,,,,
developmental pathway of the mper-directed hiv-1-neutralizing antibody 10e8,Soto C,10.1371/journal.pone.0157409,2016,NR,,0,,,,,
equity in adherence to antiretroviral therapy among economically vulnerable adolescents living with hiv in uganda,Bermudez LG,10.1080/09540121.2016.1176681,2016,NR,,0,,,,,
differences in outbreak size for hiv-1 non-b subtypes amongst msm in the netherlands,Bezemer D,,2016,NR,,0,,,,,
estimation of the hiv-1 backward mutation rate from transmitted drug-resistant strains,Kitayimbwa JM,10.1016/j.tpb.2016.08.001,2016,NR,,0,,,,,
ethnicity and hiv epidemiology research in china,Pan SW,10.1016/S0140-6736%2816%2931541-0,2016,NR,,0,,,,,
evaluation of abbott architect human immunodeficiency virus (hiv) combo signal-to-cutoff ratio and ambiguous nucleotide frequency as markers of hiv infection duration,Porter SE,10.1093/ofid/ofw194.166,2016,NR,,0,,,,,
discovery of non-peptide small molecular cxcr4 antagonists as anti-hiv agents: recent advances and future opportunities,Zhang H,10.1016/j.ejmech.2016.02.051,2016,NR,,0,,,,,
"distance from care predicts in-hospital mortality in hiv-infected patients with severe sepsis from rural and semi-rural virginia, usa",Evans EE,10.1177/0956462415584489,2016,NR,,0,,,,,
distance to testing sites and its association with timing of hiv diagnosis,Cope,10.1080/09540121.2016.1191599,2016,NR,,0,,,,,
diversification of risk reduction strategies and reduced threat of hiv may explain increases in condomless sex,Kippax S,10.1097/QAD.0000000000001260,2016,NR,,0,,,,,
diversity in kir gene repertoire in hiv-1 exposed infected and uninfected infants: a study from india,Chavan VR,10.1002/jmv.24348,2016,NR,,0,,,,,
fecal bacterial microbiome diversity in chronic hiv-infected patients in china,Sun Y,10.1038/emi.2016.25,2016,NR,,0,,,,,
first evidence of transmission of an hiv-1 m/o intergroup recombinant virus,Ngoupo PA,10.1097/QAD.0000000000000880,2016,NR,,0,,,,,
early antibody lineage diversification and independent limb maturation lead to broad hiv-1 neutralization targeting the env high-mannose patch,MacLeod DT,10.1016/j.immuni.2016.04.016,2016,NR,,0,,,,,
educational technology to support active learning for hiv researchers and planners,Cockcroft A,10.1186/s12879-016-1466-6,2016,NR,,0,,,,,
effect of infusion of broadly neutralizing antibody vrc01 on hiv plasma rebound,Chun T-W,,2016,NR,,0,,,,,
hiv-1 env immunogen-elicited cross-reactive tier 2 virus neutralizing antibody response in non-human primates,Wang Y,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
hiv-1 gp140 epitope recognition is influenced by immunoglobulin dh gene segment sequence,Wang Y,10.1007/s00251-015-0890-x,2016,NR,,0,,,,,
hiv-1 nef impairs the formation of calcium membrane territories controlling the signaling nanoarchitecture at the immunological synapse,Silva JG,,2016,NR,,0,,,,,
gender differences in transmission of hiv-1 viral variants and their impact on early immune activation,El-Badry E,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
electrospun polymer nanofibers for longterm protection against hiv and hsv-2,Tyo KM,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
engineering broadly neutralizing antibodies for hiv prevention and therapy,Hua CK,10.1016/j.addr.2016.01.013,2016,NR,,0,,,,,
epitope-independent purification of nativelike envelope trimers from diverse hiv-1 isolates,Verkerke HP,10.1128/JVI.01351-16,2016,NR,,0,,,,,
genetic diversity and drug resistance profiles of human immunodeficiency virus type 1 (hiv-1) strains infecting pregnant women in the greater lisbon,Simoes C,10.1016/j.jcv.2016.08.182,2016,NR,,0,,,,,
genetic diversity and positive selection analysis of classical swine fever virus envelope protein gene e2 in east china under c-strain vaccination,Hu D,10.3389/fmicb.2016.00085,2016,NR,,0,,,,,
"genetic diversity and transmission networks of hiv-1 strains among men having sex with men (msm) in lome, togo",Konou AA,10.1016/j.meegid.2016.05.030,2016,NR,,0,,,,,
genetic diversity and transmitted drug resistance of hiv-1 subtypes in blood donors candidates in northern mozambique,Vubil,,2016,NR,,0,,,,,
"estimates of global, regional, and national incidence, prevalence, and mortality of hiv, 1980-2015: the global burden of disease study 2015",Wang H,10.1016/S2352-3018%2816%2930087-X,2016,NR,,0,,,,,
genetic diversity of hiv reveals the epidemiological role of high risk groups in nigeria,Volz E,,2016,NR,,0,,,,,
genome-wide association study of hiv whole genome sequences validated using drug resistance,Power RA,10.1371/journal.pone.0163746,2016,NR,,0,,,,,
"genome-wide screening of retroviral envelope genes in the nine-banded armadillo (dasypus novemcinctus, xenarthra) reveals an unfixed chimeric endogenous betaretrovirus using the asct2 receptor",Malicorne S,10.1128/JVI.00483-16,2016,NR,,0,,,,,
"genomic characterization of a novel hiv-1 second-generation recombinant form originated from crf01-ae and crf08-bc in dali prefecture of yunnan province, china",Li L,10.1089/aid.2015.0383,2016,NR,,0,,,,,
genotypic resistance tests sequences reveal the role of marginalized populations in hiv-1 transmission in switzerland,Shilaih M,10.1038/srep27580,2016,NR,,0,,,,,
"geographical variation in prevalence of cryptococcal antigenemia among hiv-infected, treatment-naive patients in nigeria: a multicenter cross-sectional study",Ezeanolue,10.1097/QAI.0000000000001048,2016,NR,,0,,,,,
"gut microbiome, hiv-exposure, and vaccine responses in south african infants",Viljoen K,10.1186/s12879-016-1466-6,2016,NR,,0,,,,,
gut microbiota associated with hiv infection is significantly enriched in bacteria tolerant to oxygen,Dubourg G,10.1136/bmjgast-2016-000080,2016,NR,,0,,,,,
gut microbiota linked to sexual preference and hiv infection,Noguera-Julian M,10.1016/j.ebiom.2016.01.032,2016,NR,,0,,,,,
hiv and syphilis,Mayer K,10.1016/j.ijid.2016.02.195,2016,NR,,0,,,,,
hiv care for latin american patients in london: recognising the diversity and complex needs of this minority ethnic group: a service evaluation,Hart MM,10.1136/sextrans-2016-052707,2016,NR,,0,,,,,
hiv dna is frequently present within pathologic tissues evaluated at autopsy from combined antiretroviral therapy-treated patients with undetectable viral loads,Lamers SL,10.1128/JVI.00674-16,2016,NR,,0,,,,,
hiv integration site analysis of cellular models of hiv latency with a probe-enriched next-generation sequencing assay,Sunshine S,10.1128/JVI.01617-15,2016,NR,,0,,,,,
hiv maintains an evolving and dispersed population in multiple tissues during suppressive combined antiretroviral therapy in individuals with cancer,Rose R,10.1128/JVI.00684-16,2016,NR,,0,,,,,
hiv migration between blood plasma and cellular subsets before and after hiv therapy,Choi JY,10.1002/jmv.24375,2016,NR,,0,,,,,
hiv neutralizing antibody sensitivity/ resistance signatures and applications,Korber B,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
"hiv phylodynamics in north carolina: detecting ""active"" clusters for intervention",Dennis AM,,2016,NR,,0,,,,,
"hiv phylogenetic analysis sheds light on transmission linkages in young women in high hiv burden districts in kwazulu-natal, south africa",De Oliveira T,10.7448/IAS.19.6.21264,2016,NR,,0,,,,,
hiv rna and proviral hiv dna can be detected in semen after 6 months of antiretroviral therapy although hiv rna is undetectable in blood,Du P,10.1111/1348-0421.12361,2016,NR,,0,,,,,
evaluating the contribution of apobec3g haplotypes on influencing hiv infection in a zimbabwean paediatric population,Mhandire K,10.7196/SAMJ.2016.v106i6.11013,2016,NR,,0,,,,,
immunisation practices in centres caring for children with perinatally acquired hiv: a call for harmonisation,Bamford A,10.1016/j.vaccine.2016.09.035,2016,NR,,0,,,,,
expansion of the e138a mutation in newly diagnosed hiv-infected patients in gran canaria,Chamizo F,10.1016/j.diagmicrobio.2016.06.014,2016,NR,,0,,,,,
hiv-1 drug resistance and genetic diversity in art-naive patients infected in 2013-2015 in kazakhstan,Dzissyuk N,10.7448/IAS.19.6.21264,2016,NR,,0,,,,,
"hiv-1 drug resistance by ultra-deep sequencing following short course zidovudine, single-dose nevirapine, and single-dose tenofovir with emtricitabine for prevention of mother-to-child transmission",Samuel R,,2016,NR,,0,,,,,
hiv-1 evolution in breakthrough infections in a human trial of oral pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil fumarate,Ruone S,10.1097/QAI.0000000000000921,2016,NR,,0,,,,,
hiv-1 evolutionary patterns associated with metastatic kaposi's sarcoma during aids,Lamers SL,10.1155/2016/4510483,2016,NR,,0,,,,,
extensive genetic diversity of hiv-1 in incident and prevalent infections among malaysian blood donors: multiple introductions of hiv-1 genotypes from highly prevalent countries,Chow WZ,10.1371/journal.pone.0161853,2016,NR,,0,,,,,
"hiv-1 genetic diversity and transmitted drug resistance in antiretroviral treatment-naive individuals from amapa state, northern brazil",Dos Anjos Silva L,10.1089/AID.2015.0280,2016,NR,,0,,,,,
factors are not the same for risk of stopping exclusive breast-feeding and introducing different types of liquids and solids in hiv-affected communities in ghana,Marquis GS,10.1017/S0007114516001707,2016,NR,,0,,,,,
factors associated with adherence to routine screening mammography in hiv-infected women,Weinstein ZM,10.1089/jwh.2015.5430,2016,NR,,0,,,,,
faster adaptation in smaller populations: counterintuitive evolution of hiv during childhood infection,Raghwani J,10.1371/journal.pcbi.1004694,2016,NR,,0,,,,,
feeding practices and nutritional status of hiv-exposed and hiv-unexposed infants in the western cape,Rossouw,,2016,NR,,0,,,,,
fertility options of hiv-positive women in south india,Frederick S,,2016,NR,,0,,,,,
first phase i human clinical trial of a killed whole-hiv-1 vaccine: demonstration of its safety and enhancement of anti-hiv antibody responses,Choi E,10.1186/s12977-016-0317-2,2016,NR,,0,,,,,
hiv-1 pol gene polymorphism and antiretroviral resistance mutations in treatment-naive adult patients in french guiana between 2006 and 2012,Darcissac E,10.1089/aid.2016.0048,2016,NR,,0,,,,,
hiv-1 resistance outcomes in seroconverters from the mtn-020/aspire dapivirine vaginal ring study,Parikh UM,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
hiv-1 resistance to neutralizing antibodies: determination of antibody concentrations leading to escape mutant evolution,Magnus C,10.1016/j.virusres.2015.10.009,2016,NR,,0,,,,,
formula: see text]the relative utility of three english language dominance measures in predicting the neuropsychological performance of hiv+ bilingual latino/a adults,Miranda C,10.1080/13854046.2016.1139185,2016,NR,,0,,,,,
fragments of the v1/v2 domain of hiv-1 glycoprotein 120 engineered for improved binding to the broadly neutralizing pg9 antibody,Morales JF,10.1016/j.molimm.2016.07.003,2016,NR,,0,,,,,
frequency and subtype of bk virus infection in iranian patients infected with hiv,Akhgari S,10.1007/s00430-015-0426-x,2016,NR,,0,,,,,
hiv-1 subtype c mosaic gag expressed by bcg and mva elicits persistent effector t cell responses in a prime-boost regimen in mice,Jongwe TI,10.1371/journal.pone.0159141,2016,NR,,0,,,,,
functional segregation of overlapping genes in hiv,Fernandes JD,10.1016/j.cell.2016.11.031,2016,NR,,0,,,,,
gender-specific issues for hiv-positive women: the regional perspective,Pineirua A,10.7448/IAS.19.2.21026,2016,NR,,0,,,,,
generation of long-lived bone marrow plasma cells secreting antibodies specific for the hiv-1 gp41 membrane-proximal external region in the absence of polyreactivity,Donius LR,10.1128/JVI.01089-16,2016,NR,,0,,,,,
genetic characterization of a panel of diverse hiv-1 isolates at seven international sites,Hora B,10.1371/journal.pone.0157340,2016,NR,,0,,,,,
hiv-1 transmission during recent infection and during treatment interruptions as major drivers of new infections in the swiss hiv cohort study,Marzel A,10.1093/cid/civ732,2016,NR,,0,,,,,
genetically determined ancestry is more informative than self-reported race in hiv-infected and -exposed children,Spector,10.1097/MD.0000000000004733,2016,NR,,0,,,,,
genetically determined ancestry is more informative than self-reported race in hiv-infected and-exposed children,Spector SA,10.1097/MD.0000000000004733,2016,NR,,0,,,,,
geriatric assessments and association with vacs index among hiv-infected older adults in san francisco,John,,2016,NR,,0,,,,,
induction of heterologous tier 2 hiv-1-neutralizing and cross-reactive v1/v2-specific antibodies in rabbits by prime-boost immunization,Townsley S,10.1128/JVI.00853-16,2016,NR,,0,,,,,
griffithsin-modified electrospun fibers as a delivery scaffold to prevent hiv infection,Grooms TN,10.1128/AAC.00956-16,2016,NR,,0,,,,,
influence of recombination on acquisition and reversion of immune escape and compensatory mutations in hiv-1,Nagaraja P,10.1016/j.epidem.2015.09.001,2016,NR,,0,,,,,
innate invariant nkt cell recognition of hiv-1-infected dendritic cells is an early detection mechanism targeted by viral immune evasion,Paquin-Proulx D,10.4049/jimmunol.1600556,2016,NR,,0,,,,,
high hiv-1 genetic diversity in patients from northern brazil,da Costa CM,10.1089/AID.2016.0044,2016,NR,,0,,,,,
human spd1-based hiv-1 gag-fusion dna vaccine induces high frequency of broadly reactive t cell responses in mice and rhesus macaques,Chen S,10.7448/IAS.19.6.21264,2016,NR,,0,,,,,
high sensitivity detection of hiv-1 using two genomic targets compared with single target pcr,Shah K,10.1002/jmv.24431,2016,NR,,0,,,,,
higher hiv-1 envelope sequence diversity in the vaginal tract than in blood at early stage of infection,Klein K,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
identity management and sense of belonging to gay community among young rural thai same-sex attracted men: implications for hiv prevention and treatment,Wijngaarden,10.1080/13691058.2015.1087595,2016,NR,,0,,,,,
hiv latency-reversing agents have diverse effects on natural killer cell function,Garrido C,,2016,NR,,0,,,,,
kir gene content diversity in a zimbabwean population: does kir2dl2 have a role in protection against human immunodeficiency virus infection?,Mhandire K,,2016,NR,,0,,,,,
"hiv prevention among diverse young msm: research needs, priorities, and opportunities",Rhodes SD,10.1521/aeap.2016.28.3.191,2016,NR,,0,,,,,
hiv prevention research and development funding trends 2000-2015: tracking investment flows from research to rollout of new prevention technologies,Donaldson E,10.7448/IAS.19.6.21264,2016,NR,,0,,,,,
hiv transmission dynamics,Pillay D,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
hiv whole-genome sequencing now: answering still-open questions,Metzner KJ,10.1128/JCM.03265-15,2016,NR,,0,,,,,
increasing role of young msm to hiv epidemic spread and renewal,Ratmann O,,2016,NR,,0,,,,,
hiv-1 adapts to replicate in cells expressing common marmoset apobec3g and bst2,Fernandez-Oliva A,10.1128/JVI.02431-15,2016,NR,,0,,,,,
independent lineages of hiv-1 multidrug resistance in children failing early art,Lange CM,,2016,NR,,0,,,,,
"hiv-1 genetic diversity and its distribution characteristics among newly diagnosed hiv-1 individuals in hebei province, china",Lu X,10.1186/s12981-015-0087-2,2016,NR,,0,,,,,
molecular clock of hiv-1 envelope genes under early immune selection,Park SY,10.1186/s12977-016-0269-6,2016,NR,,0,,,,,
hiv-1 genetic variation resulting in the development of new quasispecies continues to be encountered in the peripheral blood of well-suppressed patients,Dampier W,10.1371/journal.pone.0155382,2016,NR,,0,,,,,
hiv-1 laboratory contagion during recombination procedures with defective constructs,Alteri C,,2016,NR,,0,,,,,
developing family interventions for adolescent hiv prevention in south africa,Kuo C,10.1080/09540121.2016.1146396,2016,NR,,0,,,,,
"integrated prevention of mother-to-child hiv transmission services, antiretroviral therapy initiation, and maternal and infant retention in care in rural north-central nigeria: a cluster-randomised controlled trial",Aliyu MH,10.1016/S2352-3018%2816%2900018-7,2016,NR,,0,,,,,
transcriptional start site heterogeneity modulates the structure and function of the hiv-1 genome,Kharytonchyk S,10.1073/pnas.1616627113,2016,NR,,0,,,,,
increased cytomegalovirus secretion and risks of infant infection by breastfeeding duration from maternal human immunodeficiency virus positive compared to negative mothers in sub-saharan africa,Musonda KG,10.1093/jpids/piw015,2016,NR,,0,,,,,
maternal neutralization-resistant virus variants do not predict infant hiv infection risk,Milligan C,10.1128/mBio.02221-15,2016,NR,,0,,,,,
"near-full-length genome sequences of a novel hiv-1 circulating recombinant form, crf01-ae/b'/c (crf78-cpx), in yunnan, china",Song Y,10.1089/aid.2015.0351,2016,NR,,0,,,,,
multiscale systems-pharmacology pipeline to assess the prophylactic efficacy of nrtis against hiv-1,Duwal S,10.1002/psp4.12095,2016,NR,,0,,,,,
posttranscriptional m6a editing of hiv-1 mrnas enhances viral gene expression,Kennedy EM,10.1016/j.chom.2016.04.002,2016,NR,,0,,,,,
"cross-neutralizing antibodies in hiv-1 individuals infected by subtypes b, f1, c or the b/bbr variant in relation to the genetics and biochemical characteristics of the env gene",De Almeida DV,10.1371/journal.pone.0167690,2016,NR,,0,,,,,
hiv-1 subtype b: traces of a pandemic,Junqueira DM,10.1016/j.virol.2016.05.003,2016,NR,,0,,,,,
membrane bound indian clade c hiv-1 envelope antigen induces antibodies to diverse and conserved epitopes upon dna prime/protein boost in rabbits,Rangasamy SP,10.1016/j.vaccine.2016.03.062,2016,NR,,0,,,,,
"shutdown of hiv-1 transcription in t cells by nullbasic, a mutant tat protein",Jin H,10.1128/mBio.00518-16,2016,NR,,0,,,,,
distribution and time trends of hiv-1 variants in poland: characteristics of non-b clades and recombinant viruses,Parczewski M,10.1016/j.meegid.2016.02.001,2016,NR,,0,,,,,
"hiv-1 thai b strain has spread out of former plasma donors into general population through sexual contact in henan, china",Li L,10.1002/jmv.24383,2016,NR,,0,,,,,
"community cultural norms, stigma and disclosure to sexual partners among women living with hiv in thailand, brazil and zambia (hptn 063)",Ojikutu BO,10.1371/journal.pone.0153600,2016,NR,,0,,,,,
"the identification of a novel hiv-1 crf01-ae/b recombinant based on near full-length genomic analysis in yunnan province, china",Li L,10.1089/aid.2015.0245,2016,NR,,0,,,,,
hiv-1-specific chimeric antigen receptors based on broadly neutralizing antibodies,Ali A,10.1128/JVI.00805-16,2016,NR,,0,,,,,
high degree of hiv-1 group m (hiv-1m) genetic diversity within circulating recombinant forms: insight into the early events of hiv-1m evolution,Tongo M,10.1128/JVI.02302-15,2016,NR,,0,,,,,
"identification of an hiv-1 bg intersubtype recombinant form (crf73-bg), partially related to crf14-bg, which is circulating in portugal and spain",Fernandez-Garca A,10.1371/journal.pone.0148549,2016,NR,,0,,,,,
hiv-exposed children account for more than half of 24-month mortality in botswana,Zash R,,2016,NR,,0,,,,,
mutational analysis of hiv-1 viral protein u at ser52 and ser56 among the hiv-1 infected patients of manipur,Lakhikumar Sharma A,10.1016/j.hivar.2015.07.002,2016,NR,,0,,,,,
hiv-host interactions: implications for vaccine design,Haynes BF,10.1016/j.chom.2016.02.002,2016,NR,,0,,,,,
hiv/aids among african immigrants in the us: the need for disaggregating hiv surveillance data by country of birth,Koku EF,10.1353/hpu.2016.0128,2016,NR,,0,,,,,
influence of mutation and recombination on hiv-1 in vitro fitness recovery,Arenas M,10.1016/j.ympev.2015.09.001,2016,NR,,0,,,,,
a capsid-dependent integration program linking t cell activation to hiv-1 gene expression,Zhyvoloup A,10.1186/s12977-016-0294-5,2016,NR,,0,,,,,
an hiv pre-exposure prophylaxis demonstration project and safety study for adolescent msm aged 15-17 in the united states (atn 113),Hosek S,10.7448/IAS.19.6.21264,2016,NR,,0,,,,,
"knowledge, opinions, and experiences of stigma as a barrier to antiretroviral therapy adherence among hiv community volunteers and health care givers in an urban slum, in uganda",Mprah,10.4103/1755-6783.190180,2016,NR,,0,,,,,
allogeneic stem cell transplantation in hiv-1-infected individuals; the epistem consortium,Wensing AM,10.7448/IAS.19.6.21264,2016,NR,,0,,,,,
hla-associated polymorphisms of gag protein in hiv-1 b' infected chinese,Zou S,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
defining the fitness landscape of hiv-1 escape from cd8+ cytotoxic t-lymphocytes,Gorin A,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
high rates of hiv/stis with low prep uptake: baseline data from the posse project for black young msm in the chicago house/ball community,Hosek S,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
isolation of hiv specific monoclonal antibodies using a combined antigen-specific and b cell culture supernatant method,Lee A,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
yeast cell surface display of hiv envelope protein for vaccine development,Zhu H,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
"lifeskills: results from a full-scale, randomized controlled trial examining the efficacy of a group-based behavioural intervention for hiv prevention among young transgender women",Garofalo R,10.7448/IAS.19.6.21264,2016,NR,,0,,,,,
"genetic variants in dph5, prss37 and tas2r4 increase risk of hiv-1 acquisition among hiv-1 exposed uninfected africans",Emond MJ,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
rare variant association testing finds axl is associated with significantly decreased risk of sexually-acquired hiv-1,Emond MJ,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
autologous stem cell transplantation modulates t-cell receptor profiles in hiv-infected and-uninfected patients with non-hodgkin lymphoma,Bertoli D,,2016,NR,,0,,,,,
living conditions as a driving factor in persistent methicillin-resistant staphylococcus aureus colonization among hiv-infected youth,Vieira MTC,10.1097/INF.0000000000001246,2016,NR,,0,,,,,
"improved function, strength, quality of life and goal attainment in people living with hiv attending a specialist physiotherapy-led group rehabilitation intervention in the uk",Brown D,10.1111/hiv.12393,2016,NR,,0,,,,,
single cell transcriptome sequencing of human lymph node hiv-infected cd4 cells,Casazza JP,,2016,NR,,0,,,,,
evidence of hiv evolution in lymphatic and cancer tissues in art+ patients,Rose R,,2016,NR,,0,,,,,
long-lasting and rapid recall of memory responses induced by hiv-1 conserved element dna vaccine in rhesus macaques,Cai Y,10.1111/jmp.12245,2016,NR,,0,,,,,
long-term control of human immunodeficiency virus-1 replication despite extensive resistance to current antiretroviral regimens: clonal analysis of resistance mutations in proviral deoxyribonucleic acid,Stella-Ascariz N,10.1093/ofid/ofw041,2016,NR,,0,,,,,
longitudinal assessment of the vaginal microbiome with associated clinical predictors and hiv-1 shedding across the menstrual cycle in hiv-infected women on antiretroviral therapy,Carlson RD,10.1093/ofid/ofwl72.1783,2016,NR,,0,,,,,
longitudinal trends in western australian hiv-1 sequence diversity and viral transmission networks and their influence on clinical parameters: 2000 2014,Castley,10.1089/aid.2015.0206,2016,NR,,0,,,,,
"microglial gene expression is altered in hiv infection, even in the absence of detectable virus in brain",Ginsberg SD,10.1007/s13365-016-0478-8,2016,NR,,0,,,,,
hiv-1 vpr sequence variants associate specifically with co-linear genetic determinants of viral co-receptor phenotype,Antell G,10.1007/s13365-016-0478-8,2016,NR,,0,,,,,
relationship between medication synchronization and adherence in insured people living with hiv/aids,Ghassemi E,10.1016/j.japh.2016.03.014,2016,NR,,0,,,,,
low-frequency drug resistance in hiv-infected ugandans on antiretroviral treatment is associated with regimen failure,Kyeyune,10.1128/AAC.00038-16,2016,NR,,0,,,,,
identifying patterns of hiv-1 transmission among msm communities in japan for target selection of an active prevention programme,Shiino T,10.7448/IAS.19.6.21264,2016,NR,,0,,,,,
il-15 promotes activation and expansion of cd8+ t cells in hiv-1 infection,Younes S-A,10.1172/JCI85996,2016,NR,,0,,,,,
pathogenesis of hiv persistence: b-cell immune tolerance specific for the conformational antigenic determinants (bit-cad) of native trimeric envelope glycoprotein subunits (tegs),Vyas G,10.1002/eji.201670200,2016,NR,,0,,,,,
impact of aids education and training centers on the us hiv medical workforce,Khamarko,10.2105/AJPH.2016.303451,2016,NR,,0,,,,,
impact of pre-adapted hiv transmission,Carlson JM,10.1038/nm.4100,2016,NR,,0,,,,,
meaningful engagement of people living with hiv who use drugs: methodology for the design of a peer research associate (pra) hiring model,Closson K,10.1186/s12954-016-0116-z,2016,NR,,0,,,,,
"infant and young child feeding counseling, decision-making, and practices among hiv-infected women in malawi's option b+ prevention of mother-to-child transmission program: a mixed methods study",Flax VL,,2016,NR,,0,,,,,
model of socio-cultural dimensions involved in adherence to antiretroviral therapy for hiv/aids in public health care centers in chile,Stuardo Avila V,10.1080/09540121.2016.1179252,2016,NR,,0,,,,,
investigating hiv-1 envelope evolution in response to early neutralizing antibody pressure using next generation sequencing,Mielke D,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
"molecular epidemiology is becoming complex under the dynamic hiv prevalence: the perspective from harbin, china",Shao B,10.1002/jmv.24407,2016,NR,,0,,,,,
itaps/iavi: mentorship and training in scientific writing on hiv prevention research in low-and middle-income countries,Price M,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
key gp120 glycans pose roadblocks to the rapid development of vrc01-class antibodies in an hiv-1-infected chinese donor,Kong L,10.1016/j.immuni.2016.03.006,2016,NR,,0,,,,,
latent cell proliferation sustains the hiv reservoir on long-term art-a mathematical modeling study with implications for cure,Duke E,10.1093/ofid/ofw172.1238,2016,NR,,0,,,,,
molecular epidemiology reveals genetic diversity among 363 isolates of the cryptococcus neoformans and cryptococcus gattii species complex in 61 ivorian hiv-positive patients,Kassi,,2016,NR,,0,,,,,
lessons from acute hiv infection,Robb ML,10.1097/COH.0000000000000316,2016,NR,,0,,,,,
limited evidence for a bias toward consensus residues upon hiv-1 transmission,Rolland M,,2016,NR,,0,,,,,
limited evolution of a strain-specific antibody lineage targeting the c3 region of the hiv-1 envelope,Scheepers C,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
link4health: a cluster-randomized controlled trial evaluating the effectiveness of a combination strategy for linkage to and retention in hiv care in swaziland,McNairy M,10.7448/IAS.19.6.21264,2016,NR,,0,,,,,
more efficacious drugs lead to hard selective sweeps in hiv drug resistance evolution,Feder AF,,2016,NR,,0,,,,,
structure and quality of outpatient care for people living with an hiv infection,Engelhard,,2016,NR,,0,,,,,
multiple overimputation to address missing data and measurement error: application to hiv treatment during pregnancy and pregnancy outcomes,Bengtson,10.1097/EDE.0000000000000494,2016,NR,,0,,,,,
multivalent hiv-1 env-based pseudovirus vaccines elicit broad humoral immune response in human cd4 b cell transgenic mouse model,Bagaya B,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
meanings and vulnerability to hiv/aids among long-distance truck drivers in brazil,Magno,10.1590/s1518-8787.2016050006185,2016,NR,,0,,,,,
mutations related to antiretroviral resistance identified by ultra-deep sequencing in hiv-1 infected children under structured interruptions of haart,Vazquez-Guillen,10.1371/journal.pone.0147591,2016,NR,,0,,,,,
mechanisms of abrupt hiv disease progression in a cohort of previous elite and viremic hiv controllers,Rosas M,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
mechanisms of platelet-derived growth factor-bb in restoring hiv tat-cocaine-mediated impairment of neuronal differentiation,Yang L,10.1007/s12035-015-9536-0,2016,NR,,0,,,,,
nationwide trends in molecular epidemiology of hiv-1 in china,Li X,10.1089/aid.2016.0029,2016,NR,,0,,,,,
minimal contribution of apobec3-induced g-to-a hypermutation to hiv-1 recombination and genetic variation,Delviks-Frankenberry KA,10.1371/journal.ppat.1005646,2016,NR,,0,,,,,
minimally mutated hiv-1 broadly neutralizing antibodies to guide reductionist vaccine design,Jardine JG,10.1371/journal.ppat.1005815,2016,NR,,0,,,,,
modern molecular genetic technologies in the supervision over hiv-1 subtypes circulation,Zaitseva NN,10.17691/stm2016.8.1.16,2016,NR,,0,,,,,
modular synthesis of n-glycans and arrays for the hetero-ligand binding analysis of hiv antibodies,Shivatare SS,10.1038/nchem.2463,2016,NR,,0,,,,,
no evidence of sexual transmission of minority hiv drug resistance mutations in msm,Chaillon A,,2016,NR,,0,,,,,
no selection of x4 viruses by maraviroc in cell reservoirs in r5x4 hiv infections,Raymond S,,2016,NR,,0,,,,,
"monitoring hiv-1 group m subtypes in yaounde, cameroon reveals broad genetic diversity and a novel crf02_ag/f2 infection",Courtney CR,10.1089/aid.2015.0286,2016,NR,,0,,,,,
"monitoring hiv-1 group m subtypes in yaounde, cameroon reveals broad genetic diversity and a novel crf02-ag/f2 infection",Courtney CR,10.1089/aid.2015.0286,2016,NR,,0,,,,,
novel mutant human immunodeficiency virus type 1 strains with high degree of resistance to cynomolgus macaque trimcyp generated by random mutagenesis,Sultana T,10.1099/jgv.0.000408,2016,NR,,0,,,,,
nuclear envelope expansion is crucial for proper chromosomal segregation during a closed mitosis,Takemoto A,10.1242/jcs.181560,2016,NR,,0,,,,,
multiple antibody lineages in one donor target the glycan-v3 supersite of the hiv-1 envelope glycoprotein and display a preference for quaternary binding,Longo NS,10.1128/JVI.01012-16,2016,NR,,0,,,,,
multiple introductions and onward transmission of non-pandemic hiv-1 subtype b strains in north america and europe,Cabello M,10.1038/srep33971,2016,NR,,0,,,,,
optimal combinations of bnabs for prevention and treatment of hiv-1 clade c infection,Seaman M,,2016,NR,,0,,,,,
optimal combinations of broadly neutralizing antibodies for prevention and treatment of hiv-1 clade c infection,Wagh K,10.1371/journal.ppat.1005520,2016,NR,,0,,,,,
multiplexed next-generation sequencing and de novo assembly to obtain near full-length hiv-1 genome from plasma virus,Aralaguppe SG,10.1016/j.jviromet.2016.07.010,2016,NR,,0,,,,,
release of soluble ligands for the activating nkg2d receptor: one more immune evasion strategy evolved by hiv-1?,Giuliani E,,2016,NR,,0,,,,,
"navigating opportunities, learning and potential threats: mentee perspectives on mentoring in hiv research",Brewer RA,10.1007/s10461-016-1488-5,2016,NR,,0,,,,,
origin of rebound plasma hiv includes cells with identical proviruses that are transcriptionally active before stopping of antiretroviral therapy,Kearney MF,10.1128/JVI.02139-15,2016,NR,,0,,,,,
near full length genome amplification and sequencing of acute hiv-1 infections in virologically-linked heterosexual transmissions in a rwandan cohort,Muok EMO,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
near full-length genome (nflg) characterisation of hiv-1 subtype b identified in south africa,Obasa A,10.1186/s12977-016-0294-5,2016,NR,,0,,,,,
oropharyngeal candidiasis and antifungal assessment of candida glabrata in patients with hiv infection,Sharifzadeh,,2016,NR,,0,,,,,
near real-time monitoring of hiv transmission hotspots from routine hiv genotyping: an implementation case study,Poon AFY,10.1016/S2352-3018%2816%2900046-1,2016,NR,,0,,,,,
neutralization differences between ccr5 and cxcr4 tropic viruses in hiv-1b infection,Registre L,,2016,NR,,0,,,,,
structure of an n276-dependent hiv-1 neutralizing antibody targeting a rare v5 glycan hole adjacent to the cd4 binding site,Wibmer CK,10.1128/JVI.01357-16,2016,NR,,0,,,,,
people living with hiv travel farther to access healthcare: a population-based geographic analysis from rural uganda,Akullian AN,10.7448/IAS.19.1.20171,2016,NR,,0,,,,,
nextgen sequencing defines response to h1n1 vaccination in hiv-infected individuals,Yin L,,2016,NR,,0,,,,,
persistence of transmitted antiretroviral drug resistance mutations in the iavi-early hiv infection cohort (protocol c),Harris D,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
nurses' involvement in hiv policy formulation in nigerian health care system,Asuquo,,2016,NR,,0,,,,,
phylogenetic analysis of ethiopian hiv-1 subtype c near full-length genomes reveals high intrasubtype diversity and a strong geographical cluster,Amogne W,10.1089/aid.2015.0380,2016,NR,,0,,,,,
paediatric non-progression following grandmother-to-child hiv transmission,Tsai MH,10.1186/s12977-016-0300-y,2016,NR,,0,,,,,
phylogenetic and molecular characterization of six full-length hiv-1 genomes from india reveals a monophyletic lineage of indian sub-subtype a1,Pandey,10.1089/aid.2015.0207,2016,NR,,0,,,,,
phylogenetic evidence for the persistence of contemporary pre-endemic hiv-1m viruses in cameroon,Passo AMT,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
performance-based incentives may be appropriate to address challenges to delivery of prevention of vertical transmission of hiv services in rural mozambique: a qualitative investigation,Schuster,,2016,NR,,0,,,,,
persistent hiv-1 in the cns during therapy: evidence of a viral reservoir in the cns,Joseph SB,,2016,NR,,0,,,,,
population-based surveillance of hiv-1 drug resistance in cameroonian adults initiating antiretroviral therapy according to the world health organization guidelines,Fokam,10.1089/aid.2015.0065,2016,NR,,0,,,,,
population-level immune-mediated adaptation in hiv-1 polymerase during the north american epidemic,Kinloch NN,10.1128/JVI.02353-15,2016,NR,,0,,,,,
possible involvement of distinct phylogenetic clusters of hiv-1 variants in the discrepancies between coreceptor tropism predictions based on viral rna and proviral dna,Kotani H,,2016,NR,,0,,,,,
potent hiv neutralizing antibodies elicited by bg505 sosip trimer immunization in rhesus macaques as a starting point for iterative vaccine design,Van Gils M,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
potential misclassification in standard hiv phylogenetic clusters association studies,Visseaux B,,2016,NR,,0,,,,,
potency and kinetics of autologous hiv-1 neutralizing antibody responses during ati,Salantes B,,2016,NR,,0,,,,,
predominance of crf06-cpx and transmitted hiv resistance in algeria: update 2013-2014,Abdellaziz A,10.1089/aid.2015.0292,2016,NR,,0,,,,,
prevalence and associated factors for hiv-1 transmitted drug resistance in voluntary clients for counseling and testing in southern taiwan,Weng YW,10.1016/j.jmii.2014.08.002,2016,NR,,0,,,,,
prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (art) among a diverse multicountry cohort of hiv-infected adults,Rupak Shivakoti,10.1016/j.clnu.2015.02.002,2016,NR,,0,,,,,
prevalence of drug resistance mutations in haart patients infected with hiv-1 crf06_cpx in estonia,Avi R,10.1002/jmv.24361,2016,NR,,0,,,,,
progress in harmonizing tiered hiv laboratory systems: challenges and opportunities in 8 african countries,Williams J,10.9745/GHSP-D-16-00004,2016,NR,,0,,,,,
projectheartforgirlscom: development of a web-based hiv/std prevention program for adolescent girls emphasizing sexual communication skills,Widman,10.1521/aeap.2016.28.5.365,2016,NR,,0,,,,,
probabilistic estimation of hiv-1 subtype b transmission rates from viral phylogenies,Hue S,,2016,NR,,0,,,,,
quantification of hiv-1 splicing using a primerid-tagged deep sequencing assay,Emery A,,2016,NR,,0,,,,,
quantifying next generation sequencing sample pre-processing bias in hiv-1 complete genome sequencing,Vrancken B,10.3390/v8010012,2016,NR,,0,,,,,
rapid hiv-1 disease progression in individuals infected with a virus adapted to its host population,Katoh J,10.1371/journal.pone.0150397,2016,NR,,0,,,,,
rapid sequencing of complete env genes from primary hiv-1 samples,Laird Smith M,10.1093/ve/vew018,2016,NR,,0,,,,,
rational design of bispecific antibodies targeting hiv-1 env to achieve enhanced anti-viral potency and breadth,Steinhardt J,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
"pyrazolo[1,5-a]pyrimidine-based macrocycles as novel hiv-1 inhibitors: a patent evaluation of wo2015123182",Sun L,10.1080/13543776.2016.1210127,2016,NR,,0,,,,,
"racial and ethnic differences in substance use diagnoses, comorbid psychiatric disorders, and treatment initiation among hiv-positive and hiv-negative women in an integrated health plan",Storholm ED,10.1080/02791072.2016.1242180,2016,NR,,0,,,,,
"rapid and sustained release combination drug-eluting fibers for vaginal hiv prevention result in high, lasting arv concentrations in pigtail macaques",Blakney A,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
rare hiv-1 subtype j genomes and a new h/u/crf02_ag recombinant genome suggests an ancient origin of hiv-1 in angola,Bartolo I,10.1089/AID.2016.0084,2016,NR,,0,,,,,
reassuring birth outcomes with tenofovir/emtricitabine/efavirenz used for prevention of mother-to-child transmission of hiv in botswana,Zash,10.1097/QAI.0000000000000847,2016,NR,,0,,,,,
rev-rre functional activity differs substantially among primary hiv-1 isolates,Jackson PE,10.1089/aid.2016.0047,2016,NR,,0,,,,,
role of hla adaptation in hiv evolution,Kloverpris HN,10.3389/fimmu.2015.00665,2016,NR,,0,,,,,
safety and efficacy of a dapivirine vaginal ring for hiv prevention in women,Nel A,10.1056/NEJMoa1602046,2016,NR,,0,,,,,
relative frequency of drug resistance mutations on individual hiv-1 genomes in hand,Evering T,,2016,NR,,0,,,,,
saturation mutagenesis of the hiv-1 envelope cd4 binding loop reveals residues controlling distinct trimer conformations,Duenas-Decamp M,10.1371/journal.ppat.1005988,2016,NR,,0,,,,,
repositioning hiv-based small molecule inhibitors of the stress oncoprotein ledgf/p75 to overcome prostate cancer resistance to taxane chemotherapy,Rios-Colon L,10.1158/1538-7755.DISP15-B06,2016,NR,,0,,,,,
the effects of killer cell immunoglobulin-like receptor (kir) genes on susceptibility to hiv-1 infection in the polish population,Zwolinska K,10.1007/s00251-016-0906-1,2016,NR,,0,,,,,
risk of major depressive disorder among older persons living in hiv-endemic central and southwestern uganda,Kinyanda,,2016,NR,,0,,,,,
the role genes encoding of killer cell immunoglobulin-like receptors (kirs) and their ligands in susceptibility to and progression of hiv infection,Blachowicz O,10.5604/17322693.1227771,2016,NR,,0,,,,,
selection of hiv-1 variants with higher transmission potential by 1% tenofovir gel microbicide,Ngandu N,10.7448/IAS.19.6.21264,2016,NR,,0,,,,,
sensitive sentinel mutation screening reveals differential underestimation of transmitted hiv drug resistance among demographic groups,Li JF,10.1097/QAD.0000000000001099,2016,NR,,0,,,,,
spatial association between population viral load and hiv incidence,Riche B,10.7448/IAS.19.6.21264,2016,NR,,0,,,,,
specific destruction of hiv proviral p17 gene in t lymphoid cells achieved by the genome editing technology,Kishida T,10.3389/fmicb.2016.01001,2016,NR,,0,,,,,
stability of hiv-1 subtype b and c tat is associated with variation in the carboxyl-terminal region,Zhao X,10.1007/s12250-016-3681-0,2016,NR,,0,,,,,
sequencing of gag/env association with hiv genotyping resolution and hiv-related epidemiologic studies of hiv in china,Ren L,10.4238/gmr15048870,2016,NR,,0,,,,,
sequential ccr5-tropic hiv-1 reactivation from distinct cellular reservoirs following perturbation of elite control,Watters SA,10.1371/journal.pone.0158854,2016,NR,,0,,,,,
the sooner the better: innate immunity as a path toward the hiv cure,Tomalka J,10.1016/j.coviro.2016.07.003,2016,NR,,0,,,,,
status of vaccine research and development of vaccines for hiv-1,Safrit JT,10.1016/j.vaccine.2016.02.074,2016,NR,,0,,,,,
streamlined quasispecies and subtype analysis of hiv-1 sequences generated by high-throughput sequencing using the high-performance integrated virtual environment (hive),Hora B,10.7448/IAS.19.6.21264,2016,NR,,0,,,,,
"striking hiv-1 entry by targeting hiv-1 gp41 but, where should we target?",Teixeira C,10.1371/journal.pone.0146743,2016,NR,,0,,,,,
"study of antibody repertoires to the cd4 binding site of gp120 of a chinese hiv-1-infected elite neutralizer, using 454 sequencing and single-cell sorting",Li D,10.1007/s00705-015-2710-x,2016,NR,,0,,,,,
sexual activity without condoms and risk of hiv transmission in serodifferent couples when the hiv-positive partner is using suppressive antiretroviral therapy,Rodger AJ,10.1001/jama.2016.5148,2016,NR,,0,,,,,
suicide risk and prevalence of major depressive disorder (mdd) among individuals infected with hiv-1 subtype c versus b in southern brazil,de Almeida SM,10.1007/s13365-016-0454-3,2016,NR,,0,,,,,
supranormal thymic output up to 2 decades after hiv-1 infection,Aguilera-Sandoval CR,10.1097/QAD.0000000000001010,2016,NR,,0,,,,,
sharp increase in rates of hiv transmitted drug resistance at antenatal clinics in botswana demonstrates the need for routine surveillance,Rowley CF,10.1093/jac/dkv500,2016,NR,,0,,,,,
"short communication: limited hiv pretreatment drug resistance among adults attending free antiretroviral therapy clinic of pune, india",Karade S,10.1089/aid.2015.0277,2016,NR,,0,,,,,
short communication: phylogenetic and molecular characterization of six full-length hiv-1 genomes from india reveals a monophyletic lineage of indian sub-subtype a1,Pandey SS,10.1089/AID.2015.0207,2016,NR,,0,,,,,
short communication: population-based surveillance of hiv-1 drug resistance in cameroonian adults initiating antiretroviral therapy according to the world health organization guidelines,Fokam J,10.1089/AID.2015.0065,2016,NR,,0,,,,,
short-term dynamic and local epidemiological trends in the south american hiv-1b epidemic,Junqueira DM,10.1371/journal.pone.0156712,2016,NR,,0,,,,,
social media use and hiv-related risk behaviors in young black and latino gay and bi men and transgender individuals in new york city: implications for online interventions,Patel,10.1007/s11524-016-0025-1,2016,NR,,0,,,,,
strategic partnerships for hiv prevention research in uganda,Wambuzi M,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
strengthening hiv surveillance: measurements to track the epidemic in real time,Buthelezi UE,10.2989/16085906.2016.1196223,2016,NR,,0,,,,,
"structural determinants of antiretroviral therapy use, hiv care attendance, and viral suppression among adolescents and young adults living with hiv",Kahana SY,10.1371/journal.pone.0151106,2016,NR,,0,,,,,
sub-epidemics explain localized high prevalence of reduced susceptibility to rilpivirine in treatment-naive hiv-1-infected patients: subtype and geographic compartmentalization of baseline resistance mutations,Theys K,10.1089/AID.2015.0095,2016,NR,,0,,,,,
the composition of the cell envelope affects conjugation in bacillus subtilis,Johnson CM,10.1128/JB.01044-15,2016,NR,,0,,,,,
"the complex interplay of social networks, geography and hiv risk among malaysian drug injectors: results from respondent-driven sampling",Zelenev A,10.1016/j.drugpo.2016.08.008,2016,NR,,0,,,,,
the early bird catches the worm - can evolution teach us lessons in fighting hiv?,Schaller T,10.2174/1570162X14999160224094914,2016,NR,,0,,,,,
the epidemic dynamics of four major lineages of hiv-1 crf01_ae strains after their introduction into china,Zeng HaiYan,10.1089/aid.2015.0212,2016,NR,,0,,,,,
the epidemic dynamics of four major lineages of hiv-1 crf01-ae strains after their introduction into china,Zeng H,10.1089/aid.2015.0212,2016,NR,,0,,,,,
the global response to hiv in men who have sex with men,Beyrer,10.1016/S0140-6736(16)30781-4,2016,NR,,0,,,,,
the hiv env signal peptide impacts the glycosylation and antigenicity of gp120,Yolitz J,,2016,NR,,0,,,,,
the glycosylphosphatidylinositol-anchored variable region of llama heavy chain-only antibody jm4 efficiently blocks both cell-free and t cell-t cell transmission of human immunodeficiency virus type 1,Liu L,10.1128/JVI.01559-16,2016,NR,,0,,,,,
the gut and oral microbiome in hiv disease: a workshop report,Moyes DL,10.1111/odi.12415,2016,NR,,0,,,,,
the majority of reactivatable latent hiv are genetically distinct,Ping Mok H,10.1186/s12977-016-0294-5,2016,NR,,0,,,,,
the menopause transition in women living with hiv: current evidence and future avenues of research,Tariq S,,2016,NR,,0,,,,,
"the limitations of 'black msm' as a category: why gender, sexuality, and desire still matter for social and biomedical hiv prevention methods",Garcia J,10.1080/17441692.2015.1134616,2016,NR,,0,,,,,
a recombinant variant with increased envelope entry efficiency emerged during early infection of an hiv-1 subtype c dual infected rapid progressor,Gordon,10.1089/aid.2014.0100,2016,NR,,0,,,,,
p21/cdkn1a expression shows broad interindividual diversity in a subset of hiv-1 elite controllers,Pablo,10.1089/aid.2015.0137,2016,NR,,0,,,,,
the role of the cdrh3 of germline vrc01-class antibodies in hiv-1 env interactions,Pancera M,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
three-dimensional structural characterization of hiv-1 tethered to human cells,Strauss JD,10.1128/JVI.01880-15,2016,NR,,0,,,,,
implementation and evaluation of the keep it up! online hiv prevention intervention in a community-based setting (special issue: hiv prevention among diverse young msm),Greene,10.1521/aeap.2016.28.3.231,2016,NR,,0,,,,,
"identification of a novel hiv-1 circulating recombinant form (crf85_bc) in sichuan, china",Su Ling,,2016,NR,,0,,,,,
the work of negotiating hiv as a chronic condition: a qualitative analysis,Thompson L,,2016,NR,,0,,,,,
the road less travelled: exploring gay and bisexual men's explanations of 'uncommon' routes of hiv transmission,Callander D,10.1007/s10461-016-1289-x,2016,NR,,0,,,,,
the role of sexual health professionals in developing a shared concept of risky sexual behavior as it relates to hiv transmission,Brawner,10.1111/phn.12216,2016,NR,,0,,,,,
the role of tenofovir alafenamide in future hiv management,Antela,,2016,NR,,0,,,,,
the social impact of hiv/aids in india,Solomon S,10.1111/odi.12449,2016,NR,,0,,,,,
toward innovation in hiv prevention: sustaining funding in a post-2015 landscape,Lazar LM,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
"the trouble with 'categories': rethinking men who have sex with men, transgender and their equivalents in hiv prevention and health promotion",Parker R,10.1080/17441692.2016.1185138,2016,NR,,0,,,,,
"three related hiv-1 cross-superinfected individuals exchange similar viral strains, but evolve different immunological responses",Duerr R,10.1089/aid.2016.5000.abstracts,2016,NR,,0,,,,,
tracing the origin of a singular hiv-1 crf45_cpx clade identified in brazil,Delatorre E,10.1016/j.meegid.2016.05.040,2016,NR,,0,,,,,
"transcription of novel hiv-1 rna species in the setting of ""undetectable"" virus",Imamichi H,,2016,NR,,0,,,,,
ultra-deep sequencing of hiv-1 near full-length and partial proviral genomes reveals high genetic diversity among brazilian blood donors,Pessoa R,10.1371/journal.pone.0152499,2016,NR,,0,,,,,
"ultrasensitive single-genome sequencing: accurate, targeted, next generation sequencing of hiv-1 rna",Boltz VF,10.1186/s12977-016-0321-6,2016,NR,,0,,,,,
"transmission dynamics of hiv-1 subtype b in the basque country, spain",Patino-Galindo JA,10.1016/j.meegid.2016.02.028,2016,NR,,0,,,,,
"unpacking the barriers to reproductive health services in ghana: hiv/sti testing, abortion and contraception",Thatte,,2016,NR,,0,,,,,
transmission patterns of hiv-1 subtype a resistant strains across greece: evidence for country and regional level transmission networks,Paraskevis D,10.7448/IAS.19.8.21487,2016,NR,,0,,,,,
utilization of hiv-1 envelope v3 to identify x4- and r5-specific tat and ltr sequence signatures,Antell GC,10.1186/s12977-016-0266-9,2016,NR,,0,,,,,
v1/v2 neutralizing epitope is conserved in divergent non-m groups of hiv-1,Morgand M,10.1097/QAI.0000000000000854,2016,NR,,0,,,,,
vaccine antigen design to maximize anti-hiv cd4+ t cell responses,Cunha-Neto E,10.1002/eji.201670200,2016,NR,,0,,,,,
viral and host characteristics of recent and established hiv-1 infections in kisumu based on a multiassay approach,Otecko N,10.1038/srep37964,2016,NR,,0,,,,,
viral load criteria and threshold optimization to improve hiv incidence assay characteristics,Kassanjee R,10.1097/QAD.0000000000001209,2016,NR,,0,,,,,
using nearly full-genome hiv sequence data improves phylogeny reconstruction in a simulated epidemic,Yebra G,10.1038/srep39489,2016,NR,,0,,,,,
using phylogenetics of hiv to inform prevention among young black men who have sex with men in chicago,Morgan E,10.7448/IAS.19.6.21264,2016,NR,,0,,,,,
vaginal bacteria associated with increased risk of hiv acquisition in african women,McClelland RS,10.7448/IAS.19.6.21264,2016,NR,,0,,,,,
viral decay dynamics and mathematical modeling of treatment response: evidence of lower in vivo fitness of hiv-1 subtype c,Shet A,,2016,NR,,0,,,,,
"washington state satellite human immunodeficiency virus (hiv) clinic program: delivering highly effective, decentralized care for patients in underserved communities",Wood B,10.1093/ofid/ofw172.362,2016,NR,,0,,,,,
"wecare: a social media-based intervention designed to increase hiv care linkage, retention, and health outcomes for racially and ethnically diverse young msm (special issue: hiv prevention among diverse young msm)",Tanner,10.1521/aeap.2016.28.3.216,2016,NR,,0,,,,,
"""communicating the complexities"": how service providers are meeting the challenge of integrating biomedical knowledge of hiv into their prevention efforts with gay men",Jackson E,,2015,NR,,0,,,,,
a cross-sectional assessment of metabolic syndrome in hiv-infected people of low socio-economic status receiving antiretroviral therapy,Tiozzo E,10.1186/s13098-015-0008-5,2015,NR,,0,,,,,
autonomic function is associated with fitness level in hiv-infected individuals,Kocher MH,,2015,NR,,0,,,,,
"a community empowerment approach to the hiv response among sex workers: effectiveness, challenges, and considerations for implementation and scale-up",Kerrigan D,10.1016/S0140-6736%2814%2960973-9,2015,NR,,0,,,,,
a human immune data-informed vaccine concept elicits strong and broad t-cell specificities associated with hiv-1 control in mice and macaques,Mothe B,10.1186/s12967-015-0392-5,2015,NR,,0,,,,,
a community-based assessment of correlates of facility delivery among hiv-infected women in western kenya,Kinuthia J,10.1186/s12884-015-0467-6,2015,NR,,0,,,,,
a phylotype-based analysis highlights the role of drug-naive hiv-positive individuals in the transmission of antiretroviral resistance in the uk,Mourad R,10.1097/QAD.0000000000000768,2015,NR,,0,,,,,
a population-structured hiv epidemic in israel: roles of risk and ethnicity,Grossman Z,10.1371/journal.pone.0135061,2015,NR,,0,,,,,
a subset of cd4/cd8 double-negative t cells expresses hiv proteins in patients on antiretroviral therapy,DeMaster LK,10.1128/JVI.01913-15,2015,NR,,0,,,,,
a tale of two epidemics: gender differences in socio-demographic characteristics and sexual behaviors among hiv positive individuals in mexico city,Bautista-Arredondo S,10.1186/s12939-015-0286-4,2015,NR,,0,,,,,
a molecular switch in immunodominant hiv-1-specific cd8 t-cell epitopes shapes differential hla-restricted escape,Kloverpris HN,10.1186/s12977-015-0149-5,2015,NR,,0,,,,,
"adolescents behaviorally and perinatally infected with hiv, the intersection of sexual and reproductive health services and transition of care: are their needs being met?",Moore KA,10.1016/j.jadohealth.2014.10.107,2015,NR,,0,,,,,
"a highly divergent gemycircularvirus genome identified in a hiv-positive plasma sample (french blood agency, national plasma bank): characterization and distribution",Biagini P,,2015,NR,,0,,,,,
"african american community leaders' policy recommendations for reducing racial disparities in hiv infection, treatment, and care: results from a community-based participatory research project in philadelphia, pennsylvania",Nunn,10.1177/1524839914534855,2015,NR,,0,,,,,
a multivalent clade c hiv-1 env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component,Bricault CA,10.1128/JVI.03331-14,2015,NR,,0,,,,,
analysis of a local hiv-1 epidemic in portugal highlights established transmission of non-b and non-g subtypes,Carvalho A,10.1128/JCM.03611-14,2015,NR,,0,,,,,
analysis of reverse transcriptase and protease genes of hiv for antiretroviral drug resistance in treatment-exposed jamaican pediatrics,Ramkissoon AP,10.1089/aid.2015.0122,2015,NR,,0,,,,,
antiretroviral drug resistance in pregnant women living with hiv in england and wales: preliminary results from the matching of three national hiv surveillance databases,Byrne L,10.1111/hiv.12264,2015,NR,,0,,,,,
adaptation of hiv-1 to rhtrim5 alpha -mediated restriction in vitro,Setiawan,10.1016/j.virol.2015.09.017,2015,NR,,0,,,,,
"antiretroviral treatment failure, drug resistance, and subtype diversity in the only pediatric hiv clinic in rhode island",Rogo T,10.1093/cid/civ058,2015,NR,,0,,,,,
antiretrovirals for primary hiv prevention: the current status of pre- and post-exposure prophylaxis,Krakower DS,10.1007/s11904-014-0253-5,2015,NR,,0,,,,,
assessing spatial patterns of hiv knowledge in rural mozambique using geographic information systems,Buehler CP,10.1111/tmi.12437,2015,NR,,0,,,,,
assessing the hiv-1 epidemic in brazilian drug users: a molecular epidemiology approach,Guimaraes ML,10.1371/journal.pone.0141372,2015,NR,,0,,,,,
assessing the paradox between transmitted and acquired hiv type 1 drug resistance mutations in the swiss hiv cohort study from 1998 to 2012,Yang WL,10.1093/infdis/jiv012,2015,NR,,0,,,,,
properties of human immunodeficiency virus type 1 reverse transcriptase recombination upon infection,Sakuragi S,10.1099/jgv.0.000265,2015,NR,,0,,,,,
aging with hiv vs hiv seroconversion at older age:a diverse population with distinct comorbidity profiles,Guaraldi G,10.1371/journal.pone.0118531,2015,NR,,0,,,,,
avian sarcoma and leukosis virus gag gene in the anser anser domesticus genome,Zhu F,10.4238/2015.November.18.1,2015,NR,,0,,,,,
avian sarcoma leukosis virus receptor-envelope system for simultaneous dissection of multiple neural circuits in mammalian brain,Matsuyama M,10.1073/pnas.1423963112,2015,NR,,0,,,,,
"awareness and knowledge of treatment as prevention (tasp) among hiv-positive and hiv-negative men who have sex with men in vancouver, canada",Carter A,,2015,NR,,0,,,,,
amsterdam's sti/hiv programme: an innovative strategy to achieve and enhance the participation of migrant community-based organisations,Wagemakers A,10.1177/0017896914542665,2015,NR,,0,,,,,
an integrated map of hiv genome-wide variation from a population perspective,Li G,10.1186/s12977-015-0148-6,2015,NR,,0,,,,,
analysis of hiv rna in single cells reveals clonal expansions and defective genomes,Wiegand A,,2015,NR,,0,,,,,
bms-986001: a promising candidate for hiv-2 treatment,Smith RA,,2015,NR,,0,,,,,
bridging epidemiology with population genetics in a low incidence msm-driven hiv-1 subtype b epidemic in central europe,Lunar MM,10.1186/s12879-015-0802-6,2015,NR,,0,,,,,
"anti-v3/glycan and anti-mper neutralizing antibodies, but not anti-v2/glycan site antibodies, are strongly associated with greater anti-hiv-1 neutralization breadth and potency",Jacob RA,10.1128/JVI.00129-15,2015,NR,,0,,,,,
can we rely on the antiretroviral treatment as the only means for human immunodeficiency virus prevention? a public health perspective,Mozalevskis A,10.1016/j.eimc.2014.07.014,2015,NR,,0,,,,,
assessing biases in the evaluation of classification assays for hiv infection recency,Patterson-Lomba O,10.1371/journal.pone.0139735,2015,NR,,0,,,,,
assessment of profile and level of awareness about hiv/aids among truck drivers passing through a state capital city of india,Chandra H,,2015,NR,,0,,,,,
association of hiv viral load and shorter telomere length,Gogia S,,2015,NR,,0,,,,,
changes in hiv reservoirs during long-term antiretroviral therapy,Hong,10.1097/COH.0000000000000119,2015,NR,,0,,,,,
"barriers to accessing hiv services for black african communities in cambridgeshire, the united kingdom",Shangase P,10.1007/s10900-014-9889-8,2015,NR,,0,,,,,
bayesian joint modelling of disease progression marker and time to death event of hiv/aids patients under art follow-up,Gemeda Bedaso Buta,10.9734/BJMMR/2015/12907,2015,NR,,0,,,,,
bispecific antibodies targeting different epitopes on the hiv-1 envelope exhibit broad and potent neutralization,Asokan M,10.1128/JVI.02097-15,2015,NR,,0,,,,,
breakthrough of preexisting x4-capable hiv after allogeneic stem-cell transplantation,Verheyen J,,2015,NR,,0,,,,,
characterizing the diverse mutational pathways associated with r5-tropic maraviroc resistance: hiv-1 that uses the drug-bound ccr5 coreceptor,Jiang X,10.1128/JVI.01384-15,2015,NR,,0,,,,,
broad-spectrum anti-hiv rt rna aptamers,Lange MJ,10.1038/mt.2015.74,2015,NR,,0,,,,,
chimeric porcine reproductive and respiratory syndrome virus containing shuffled multiple envelope genes confers cross-protection in pigs,Tian D,10.1016/j.virol.2015.08.021,2015,NR,,0,,,,,
cell walls and the convergent evolution of the viral envelope,Buchmann JP,10.1128/MMBR.00017-15,2015,NR,,0,,,,,
cell-to-cell infection by hiv contributes over half of virus infection,Iwami S,10.7554/eLife.08150,2015,NR,,0,,,,,
central memory cd4+ t cells are preferential targets of double infection by hiv-1,Haqqani AA,10.1186/s12985-015-0415-0,2015,NR,,0,,,,,
"centralized hiv program oversight: an investigation of a case series of new hiv infections among us army soldiers, 2012 to 2013",Pacha LA,10.1097/MD.0000000000002093,2015,NR,,0,,,,,
comparison of 454 ultra-deep sequencing and allele-specific real-time pcr with regard to the detection of emerging drug-resistant minor hiv-1 variants after antiretroviral prophylaxis for vertical transmission,Hauser A,10.1371/journal.pone.0140809,2015,NR,,0,,,,,
longitudinal antigenic sequences and sites from intra-host evolution (lassie) identifies immune-selected hiv variants,Hraber P,10.3390/v7102881,2015,NR,,0,,,,,
the utility of protein structure as a predictor of site-wise dn/ds varies widely among hiv-1 proteins,Meyer AG,10.1098/rsif.2015.0579,2015,NR,,0,,,,,
viral variants that initiate and drive maturation of v1v2-directed hiv-1 broadly neutralizing antibodies,Bhiman JN,10.1038/nm.3963,2015,NR,,0,,,,,
"comparison of immunogenicity in rhesus macaques of transmitted-founder, hiv-1 group m consensus, and trivalent mosaic envelope vaccines formulated as a dna prime, nyvac, and envelope protein boost",Hulot SL,10.1128/JVI.00383-15,2015,NR,,0,,,,,
changing demographics of hiv+ liver transplant candidates,Durand C,,2015,NR,,0,,,,,
characteristics and spread to the native population of hiv-1 non-b subtypes in two european countries with high migration rate,Dauwe K,10.1186/s12879-015-1217-0,2015,NR,,0,,,,,
beliefs about anal cancer among hiv-infected women: barriers and motivators to participation in research,Battaglia TA,10.1016/j.whi.2015.06.008,2015,NR,,0,,,,,
murine antibody responses to cleaved soluble hiv-1 envelope trimers are highly restricted in specificity,Hu JK,10.1128/JVI.01653-15,2015,NR,,0,,,,,
association of vh4-59 antibody variable gene usage with recognition of an immunodominant epitope on the hiv-1 gag protein,Chukwuma VU,10.1371/journal.pone.0133509,2015,NR,,0,,,,,
hiv-1 vpu utilizes both cullin-ring ligase (crl) dependent and independent mechanisms to downmodulate host proteins,Ramirez PW,10.1186/s12977-015-0192-2,2015,NR,,0,,,,,
crf19_cpx is an evolutionary fit hiv-1 variant strongly associated with rapid progression to aids in cuba,Kouri V,10.1016/j.ebiom.2015.01.015,2015,NR,,0,,,,,
diverse mutants of hiv rre iib recognize wild-type rev arm or rev arm r35g-n40v,Abdallah EY,10.1002/jmr.2485,2015,NR,,0,,,,,
genome-wide transcriptional profiling reveals that hiv-1 vpr differentially regulates interferon-stimulated genes in human monocyte-derived dendritic cells,Zahoor MA,10.1016/j.virusres.2015.06.017,2015,NR,,0,,,,,
compensatory substitutions in the hiv-1 capsid reduce the fitness cost associated with resistance to a capsid-targeting small-molecule inhibitor,Shi J,10.1128/JVI.01411-14,2015,NR,,0,,,,,
cocirculation of several similar but unique hiv-1 recombinant forms in guinea-bissau revealed by near full-length genomic sequencing,Palm AA,10.1089/AID.2015.0073,2015,NR,,0,,,,,
"genomic characterization of two novel hiv-1 unique (crf01_ae/b) recombinant forms among men who have sex with men in beijing, china",Li Z,10.1089/AID.2015.0076,2015,NR,,0,,,,,
incomplete apobec3g/f neutralization by hiv-1 vif mutants facilitates the genetic evolution from ccr5 to cxcr4 usage,Alteri C,10.1128/AAC.00137-15,2015,NR,,0,,,,,
gene target specificity of the super elongation complex (sec) family: how hiv-1 tat employs selected sec members to activate viral transcription,Lu H,10.1093/nar/gkv541,2015,NR,,0,,,,,
complex drug use patterns and associated hiv transmission risk behaviors in an internet sample of us men who have sex with men,Yu G,10.1007/s10508-014-0337-8,2015,NR,,0,,,,,
composite sequence-structure stability models as screening tools for identifying vulnerable targets for hiv drug and vaccine development,Manocheewa S,10.3390/v7112901,2015,NR,,0,,,,,
sirna-induced mutation in hiv-1 polypurine tract region and its influence on viral fitness,Rausch JW,10.1371/journal.pone.0122953,2015,NR,,0,,,,,
near full-length characterization and population dynamics of the human immunodeficiency virus type i circulating recombinant form 42 (crf42_bf) in luxembourg,Struck D,10.1089/AID.2014.0364,2015,NR,,0,,,,,
viral envelope is a major determinant of enhanced fitness of a multidrug-resistant hiv-1 variant,Mohri H,10.1097/QAI.0000000000000524,2015,NR,,0,,,,,
"conflicting and conflicted: how gay men in canada are making sense of and applying new biomedical knowledge of hiv risk, transmission and prevention",Adam B,,2015,NR,,0,,,,,
identification and genetic characterization of unique hiv-1 a1/c recombinant strain in south africa,Musyoki AM,10.1089/AID.2014.0212,2015,NR,,0,,,,,
deep sequencing of ryr3 gene identifies rare and common variants associated with increased carotid intima-media thickness (cimt) in hiv-infected individuals,Zhi D,10.1038/jhg.2014.104,2015,NR,,0,,,,,
pilot testing an internet-based sti and hiv prevention intervention with chilean women,Villegas N,10.1111/jnu.12114,2015,NR,,0,,,,,
risk of breast cancer with cxcr4-using hiv defined by v3 loop sequencing,Goedert JJ,10.1097/QAI.0000000000000400,2015,NR,,0,,,,,
role of tnf block genetic variants in hiv-associated sensory neuropathy in black southern africans,Wadley AL,10.1038/ejhg.2014.104,2015,NR,,0,,,,,
"crf07_bc strain dominates the hiv-1 epidemic in injection drug users in liangshan prefecture of sichuan, china",Li L,10.1089/AID.2014.0120,2015,NR,,0,,,,,
client change language and hiv risk reduction in justice-involved youth,Houck JM,10.1111/acer.12742,2015,NR,,0,,,,,
clustering of swiss hiv patients not enrolled in the swiss hiv cohort study (shcs),Shilaih M,,2015,NR,,0,,,,,
clusters of hiv transmission among high-risk populations in pakistan,Thompson LH,10.7448/IAS.18.5.20450,2015,NR,,0,,,,,
demographic and hiv-specific characteristics of participants enrolled in the insight strategic timing of antiretroviral treatment (start) trial (special issue: the start trial characteristics at study entry),Sharma,10.1111/hiv.12231,2015,NR,,0,,,,,
design and structure of two hiv-1 clade c sosip664 trimers that increase the arsenal of native-like env immunogens,Julien J-P,10.1073/pnas.1507793112,2015,NR,,0,,,,,
design of a highly potent hiv-1 fusion inhibitor targeting the gp41 pocket,Chong H,10.1097/QAD.0000000000000498,2015,NR,,0,,,,,
"community perceptions of childbearing and use of safer conception strategies among hiv-discordant couples in kisumu, kenya",Breitnauer BT,10.7448/IAS.18.1.19972,2015,NR,,0,,,,,
"dietary patterns and maternal anthropometry in hiv-infected, pregnant malawian women",Ramlal RT,10.3390/nu7010584,2015,NR,,0,,,,,
"differing identities but comparably high hiv and bacterial sexually transmitted disease burdens among married and unmarried men who have sex with men in mumbai, india",Mayer KH,10.1097/OLQ.0000000000000344,2015,NR,,0,,,,,
compartmentalized replication of r5 t cell-tropic hiv-1 in the central nervous system early in the course of infection,Sturdevant CB,10.1371/journal.ppat.1004720,2015,NR,,0,,,,,
competitive exclusion by autologous antibodies can prevent broad hiv-1 antibodies from arising,Luo S,10.1073/pnas.1505207112,2015,NR,,0,,,,,
disease progression despite protective hla expression in an hiv-infected transmission pair,Brener J,10.1186/s12977-015-0179-z,2015,NR,,0,,,,,
complementary feeding practices and associated factors among hiv positive mothers in southern ethiopia,Haile D,10.1186/s41043-015-0006-0,2015,NR,,0,,,,,
complex t-cell receptor repertoire dynamics underlie the cd8+ t-cell response to hiv-1,Costa AI,10.1128/JVI.01765-14,2015,NR,,0,,,,,
dispersion of the hiv-1 epidemic in men who have sex with men in the netherlands: a combined mathematical model and phylogenetic analysis,Bezemer D,10.1371/journal.pmed.1001898,2015,NR,,0,,,,,
diverse hiv epidemics among people who inject drugs in thailand: evidence from respondent-driven sampling surveys in bangkok and chiang mai,Prybylski D,10.1016/j.drugalcdep.2014.12.034,2015,NR,,0,,,,,
consequences of hla-b*13-associated escape mutations on hiv-1 replication and nef function,Shahid A,10.1128/JVI.01955-15,2015,NR,,0,,,,,
"diversity and antifungal resistance patterns of prevalent opportunistic pathogenic yeasts colonizing the oral cavities of asymptomatic human immunodeficiency virus-infected individuals, and their relation to cd4 + counts",Kumar DA,10.4103/0253-7184.156724,2015,NR,,0,,,,,
dynamics of immunoglobulin sequence diversity in hiv-1 infected individuals,Hoehn KB,10.1098/rstb.2014.0241,2015,NR,,0,,,,,
effect of different types of exercise in hiv + mozambican women using antiretroviral therapy,Mangona L,10.2174/1874613601509010089,2015,NR,,0,,,,,
effect of different types of exercise in hiv+mozambican women using antiretroviral therapy (special issue: physical activity and hiv in africa),Mangona,,2015,NR,,0,,,,,
deep sequencing of hiv-1 in cerebrospinal fluid,Tong CY,10.1093/cid/civ417,2015,NR,,0,,,,,
defective hiv-1 proviruses can be transcribed upon activation,Ho Y-C,,2015,NR,,0,,,,,
effects of cyp2b6 and cyp1a2 genetic variation on nevirapine plasma concentration and pharmacodynamics as measured by cd4 cell count in zimbabwean hiv-infected patients,Mhandire D,10.1089/omi.2015.0104,2015,NR,,0,,,,,
depression predicts survival in a 17 year longitudinal study of people with hiv,Ironson GH,,2015,NR,,0,,,,,
"determinants and processes of hiv status disclosure to hiv - infected children aged 4 to 17 years receiving hiv care services at baylor college of medicine children's foundation tanzania, centre of excellence (coe) in mbeya: a cross-sectional study",Nzota MS,10.1186/s12887-015-0399-3,2015,NR,,0,,,,,
emergence of clusters of crf02_ag and b human immunodeficiency viral strains among men having sex with men exhibiting hiv primary infection in southeastern france,Tamalet C,10.1002/jmv.24184,2015,NR,,0,,,,,
emergent hiv-1 drug resistance mutations were not present at low-frequency at baseline in non-nucleoside reverse transcriptase inhibitor-treated subjects in the star study,Porter DP,10.3390/v7122943,2015,NR,,0,,,,,
enhanced hiv-1 surveillance using molecular epidemiology to study and monitor hiv-1 outbreaks among intravenous drug users (idus) in athens and bucharest,Paraskevis D,10.1016/j.meegid.2015.08.004,2015,NR,,0,,,,,
enhanced trapping of hiv-1 by human cervicovaginal mucus is associated with lactobacillus crispatus-dominant microbiota,Nunn KL,10.1128/mBio.01084-15,2015,NR,,0,,,,,
development of an in-house multiplex nested rt-pcr method for detecting acute hiv-1 infection in high risk populations,Liu Z,10.2174/1570162X13666150424154657,2015,NR,,0,,,,,
epigenetic control of transcriptional changes implicated in defective learning and memory in hiv-infected mice and prevention by valproic acid treatment,Borjabad A,10.1007/s13365-015-0345-z,2015,NR,,0,,,,,
discovery of cd8+ t cell epitopes encoded by the hiv 5' leader sequence,Kreider E,,2015,NR,,0,,,,,
evaluation of an in-house hiv-1 drug resistance genotypic testing for using dried blood spot specimens in china,Zhao H,10.2174/1570162X13666141210154647,2015,NR,,0,,,,,
discrepancy between years of education and reading level affects neuropsychological performance in an urban hiv infected cohort,Minniti N,10.1007/s13365-015-0345-z,2015,NR,,0,,,,,
distance from household to clinic and its association with the uptake of prevention of mother-to-child hiv transmission regimens in rural zambia,Escamilla V,,2015,NR,,0,,,,,
evidence of self-sustaining drug resistant hiv-1 lineages among untreated patients in the united kingdom,Mbisa JL,10.1093/cid/civ393,2015,NR,,0,,,,,
ex vivo analysis identifies effective hiv-1 latency-reversing drug combinations,Laird GM,10.1172/JCI80142,2015,NR,,0,,,,,
exosomes in human semen restrict hiv-1 transmission by vaginal cells and block intravaginal replication of lp-bm5 murine aids virus complex,Madison MN,10.1016/j.virol.2015.03.040,2015,NR,,0,,,,,
"exploring the roles of community-based organizations (cbos) in the rollout of hiv pre-exposure prophylaxis (prep) among toronto gay, bisexual & other msm (gbmsm)",Wilton J,,2015,NR,,0,,,,,
"exploring transmission dynamics of hiv in rural kwazulu-natal, using phylogenetics",Wilkinson E,,2015,NR,,0,,,,,
dose-response curve slope helps predict therapeutic potency and breadth of hiv broadly neutralizing antibodies,Webb NE,10.1038/ncomms9443,2015,NR,,0,,,,,
"feasible, efficient and necessary, without exception - working with sex workers interrupts hiv/sti transmission and brings treatment to many in need",Steen R,10.1371/journal.pone.0121145,2015,NR,,0,,,,,
frequency of transmitted drug resistance mutations among treatment-naive hiv-1-infected individuals at a tertiary care centre in south india,Kannangai R,10.1007/s40291-015-0160-5,2015,NR,,0,,,,,
frequent dapivirine cross-resistance of hiv from 1st-line art failures in s africa,Penrose KJ,,2015,NR,,0,,,,,
from the traditional chinese medicine plant schisandra chinensis new scaffolds effective on hiv-1 reverse transcriptase resistant to non-nucleoside inhibitors,Xu L,10.1007/s12275-015-4652-0,2015,NR,,0,,,,,
hiv-1 adaptation to hla: a window into virus-host immune interactions,Carlson JM,10.1016/j.tim.2014.12.008,2015,NR,,0,,,,,
hiv-1 nef: a master manipulator of the membrane trafficking machinery mediating immune evasion,Pawlak EN,10.1016/j.bbagen.2015.01.003,2015,NR,,0,,,,,
efforts to characterize community hiv transmission dynamics may be critically dependent on provision of both partner services and genetic sequence analysis,Green NL,,2015,NR,,0,,,,,
genetic characterization of a novel hiv-1 circulating recombinant form (crf74-01b) identified among intravenous drug users in malaysia: recombination history and phylogenetic linkage with previously defined recombinant lineages,Cheong HT,10.1371/journal.pone.0133883,2015,NR,,0,,,,,
"genetic diversity and antiretroviral drug resistance among drug-naive hiv type 1 infected patients attending clinics in kinshasa, democratic republic of congo",Kamangu EN,10.1111/tmi.12574,2015,NR,,0,,,,,
environmental influences on hiv medication adherence: the role of neighborhood disorder,Surratt HL,10.2105/AJPH.2015.302612,2015,NR,,0,,,,,
genetic diversity in the feline leukemia virus gag gene,Kawamura M,10.1016/j.virusres.2015.04.008,2015,NR,,0,,,,,
"genetic diversity of hiv-1 and transmitted drug resistance among newly diagnosed individuals with hiv infection in hangzhou, china",Zhang J,10.1002/jmv.24223,2015,NR,,0,,,,,
genome-wide association studies of hiv-1 host control in ethnically diverse chinese populations,Wei Z,10.1038/srep10879,2015,NR,,0,,,,,
genomic non-b dna is a new factor that influences retroviral integration: implications for hiv latency and cure-focused antiretrovirals,Ajoge H,,2015,NR,,0,,,,,
genotyping of pneumocystis jirovecii isolates from human immunodeficiency virus-negative patients in china,Sun L,10.1016/j.meegid.2015.01.021,2015,NR,,0,,,,,
"growth and geographic spread of hiv transmission clusters, united states, 2007-2012",Oster AM,,2015,NR,,0,,,,,
high prevalence of hiv-1 drug-resistance mutations in subtype c transmitting mothers detected using 454 ultra-deep sequencing,Ledwaba J,,2015,NR,,0,,,,,
estimation of hiv-1 transmission during recent infection in switzerland,Marzel A,,2015,NR,,0,,,,,
histone deacetylase (hdac) and histone acetyltransferase (hat) inhibitors have opposing effects on cellular susceptibility to hiv infection,Lucera MB,,2015,NR,,0,,,,,
hiv and aids programming for people with disabilities on antiretroviral therapy (art) in zambia,Chibuye D,10.1136/sextrans-2015-052270.619,2015,NR,,0,,,,,
hiv drug resistance surveillance among jamaican men who have sex with men should be prioritized for reducing hiv transmission,Collins-Fairclough AM,10.1089/aid.2015.0040,2015,NR,,0,,,,,
hiv epidemic in asia: implications for hiv vaccine and other prevention trials,Phanuphak N,10.1089/aid.2015.0049,2015,NR,,0,,,,,
hiv inhibitory activity from papua new guinean medicinal plants,Pond CD,10.1055/s00351556333,2015,NR,,0,,,,,
hiv networks; regional experience of developing new models of care,Rutland E,10.1111/hiv.12265,2015,NR,,0,,,,,
"hiv persistence in the setting of antiretroviral therapy: when, where and how does hiv hide?",Kulpa DA,,2015,NR,,0,,,,,
hiv phylogenetics: lessons for hiv prevention,Fraser C,,2015,NR,,0,,,,,
human leucocyte antigen class i diversity among human immunodeficiency virus exposed negative and positive children in cameroon,Nkenfou,,2015,NR,,0,,,,,
"hiv stigma among substance-abusing plwh: implications for hiv treatment, arv adherence and diversion",Levi Minzi MA,10.1016/j.drugalcdep.2014.09.392,2015,NR,,0,,,,,
evaluation of gs junior and miseq next-generation sequencing technologies as an alternative to trugene population sequencing in the clinical hiv laboratory,Ram,10.1016/j.jviromet.2014.11.003,2015,NR,,0,,,,,
hiv transmission risk behaviors among people living with hiv/aids: the need to integrate hiv prevention interventions and public health strategies into hiv care,Du P,10.1097/PHH.0000000000000038,2015,NR,,0,,,,,
evaluation of the cepheid xpert hiv-1 viral load assay,McHugh M,10.1111/hiv.12265,2015,NR,,0,,,,,
"hiv-1 and hcv molecular epidemiology of a large community outbreak of hiv-1 infection linked to injection drug use of oxymorphone-indiana, 2015",Galang RR,10.7448/IAS.18.5.20489,2015,NR,,0,,,,,
"immune-mediated adaptation of hiv-1 polymerase sequences in north america, 1979-present",Kinloch NN,,2015,NR,,0,,,,,
hiv-1 coreceptor usage assessment by ultra-deep pyrosequencing and response to maraviroc,Rodriguez C,10.1371/journal.pone.0127816,2015,NR,,0,,,,,
"hiv-1 diversity in an antiretroviral treatment naive cohort from bushbuckridge, mpumalanga province, south africa",Msimanga,,2015,NR,,0,,,,,
immunogenic display of purified chemically cross-linked hiv-1 spikes,Leaman DP,10.1128/JVI.03738-14,2015,NR,,0,,,,,
hiv-1 epidemiology and circulating subtypes in the countryside of south brazil,Librelotto CS,10.1590/0037-8682-0083-2015,2015,NR,,0,,,,,
factors affecting the uptake of hiv testing among men: a mixed-methods study in rural burkina faso,De Allegri M,10.1371/journal.pone.0130216,2015,NR,,0,,,,,
"hiv-1 genetic diversity and transmitted drug resistance among recently infected individuals at men who have sex with men sentinel surveillance points in hebei province, china",Lu X,10.1089/AID.2015.0160,2015,NR,,0,,,,,
factors associated with inspiratory muscle weakness in patients with hiv-1,Jeronimo,10.1016/j.bjid.2014.07.003,2015,NR,,0,,,,,
"hiv-1 genotypic drug resistance testing: digging deep, reaching wide?",Van Laethem K,10.1016/j.coviro.2015.06.001,2015,NR,,0,,,,,
"factors influencing the uptake of voluntary hiv counseling and testing among secondary school students in arusha city, tanzania: a cross sectional study",Sanga,,2015,NR,,0,,,,,
fifteen year trends in hiv diagnoses among men who have sex with men in the united kingdom: 1999-2013,Desai S,10.1136/sextrans-2015-052126.106,2015,NR,,0,,,,,
"hiv-1 pol genetic diversity and antiretroviral resistance mutations in illicit drug users from piaui, northeast brazil",Oliveira-Filho A,10.7448/IAS.18.3.20139,2015,NR,,0,,,,,
fogging the issue of hiv - barriers for hiv testing in a migrated population from ethiopia and eritrea,Lindkvist P,10.1186/s12889-014-1333-6,2015,NR,,0,,,,,
full-length env deep sequencing in a donor with broadly neutralizing v1/v2 antibodies,Murrell B,,2015,NR,,0,,,,,
"hiv-1 sequence diversity and transmission networks in western australia from 2000-2014, and their impact on baseline clinical characteristics",Castley A,10.1136/sextrans-2015-052270.188,2015,NR,,0,,,,,
functional and molecular characteristics of novel and conserved cross-clade hiv envelope specific human monoclonal antibodies,Kobie JJ,10.1089/mab.2014.0064,2015,NR,,0,,,,,
g-quadruplex forming oligonucleotides as anti-hiv agents,Musumeci D,10.3390/molecules200917511,2015,NR,,0,,,,,
hiv-1 subtype diversity among clinical specimens submitted for routine antiviral drug resistance testing in the united states,Germer JJ,10.1016/j.diagmicrobio.2015.07.014,2015,NR,,0,,,,,
hiv-1 subtype diversity based on envelope c2v3 sequences from kenyan patients on highly active antiretroviral therapy,Kitawi,10.1089/aid.2014.0306,2015,NR,,0,,,,,
genetic ancestry component proportions are correlated with hiv disease progression,Garrido-Rodriguez D,10.7448/IAS.18.5.20421,2015,NR,,0,,,,,
hiv-1 transmission risk persists during the first 6 months of antiretroviral therapy,Mujugira A,,2015,NR,,0,,,,,
"hiv-1 transmitted drug resistance and genetic diversity among patients from piaui state, northeast brazil",Moura ME,10.1002/jmv.24087,2015,NR,,0,,,,,
genetic diversity and proviral dna load in different neural compartments of hiv-1 subtype c infection,Mishra M,10.1007/s13365-015-0328-0,2015,NR,,0,,,,,
"hiv-exposure, gut microbiome, and vaccine responses in south african infants",Viljoen K,10.7448/IAS.18.5.20327,2015,NR,,0,,,,,
hiv/aids epidemic in the state of amazonas: characteristics and trends from 2001 to 2012,Oliveira RDSMD,10.1590/0037-8682-0121-2013,2015,NR,,0,,,,,
heterogeneous evolution of hiv-1 crf01_ae in men who have sex with men (msm) and other populations in china,Peng XiaoRong,10.1371/journal.pone.0143699,2015,NR,,0,,,,,
sequence and structural determinants of human apobec3h deaminase and anti-hiv-1 activities,Mitra M,10.1186/s12977-014-0130-8,2015,NR,,0,,,,,
high heritability is compatible with the broad distribution of set point viral load in hiv carriers,Bonhoeffer S,10.1371/journal.ppat.1004634,2015,NR,,0,,,,,
high hiv prevalence and incidence among msm across 12 cities in india,Solomon,10.1097/QAD.0000000000000602,2015,NR,,0,,,,,
human rhinovirus displaying hiv-1 4e10 epitope elicits broad neutralization in hicam-1 tg mice,Yi G,,2015,NR,,0,,,,,
high prevalence of hiv infection among patients with sti syndromes in zimbabwe: implications for prevention,Mungati M,10.1136/sextrans-2015-052270.407,2015,NR,,0,,,,,
high recombination potential of subtype a hiv-1,Nikolaitchik O,10.1016/j.virol.2015.06.025,2015,NR,,0,,,,,
identification of owl monkey cd4 receptors broadly compatible with early-stage hiv-1 isolates,Meyerson NR,10.1128/JVI.00890-15,2015,NR,,0,,,,,
hiv and smoking: associated risks and prevention strategies,Kariuki W,10.2147/HIV.S56952,2015,NR,,0,,,,,
hiv infection in male adolescents: a qualitative study,Taquette,,2015,NR,,0,,,,,
impact of hiv-1 infection on herpes simplex virus type 2 genetic variability among co-infected individuals,Abrao EP,10.1002/jmv.24061,2015,NR,,0,,,,,
hiv infection leads to the presentation of unexpectedly long peptides by hla-a*11:01,Yaciuk JC,,2015,NR,,0,,,,,
hiv neutralizing antibodies induced by native-like envelope trimers,Sanders R,,2015,NR,,0,,,,,
impact of sexual violence on hiv epidemic in highlands of papua new guinea: results from a cohort of sex workers,Wand H,,2015,NR,,0,,,,,
hiv rebound and meningoencephalitis following art interruption after allogeneic hematopoietic stem cell transplant: an investigation of the source of hiv rebound,Capoferri A,10.7448/IAS.18.5.20424,2015,NR,,0,,,,,
"implementation research for the prevention of mother-to-child hiv transmission in sub-saharan africa: existing evidence, current gaps, and new opportunities (the global epidemic)",Bhardwaj,10.1007/s11904-015-0260-1,2015,NR,,0,,,,,
hiv transmission among seattle adolescents,Herbeck J,,2015,NR,,0,,,,,
hiv type 1 subtype a1 dominates in armenia,Laga V,10.2174/1570162X13666150407142834,2015,NR,,0,,,,,
increase of rt-related transmitted drug resistance in non-crf01-ae among hiv type 1 infected men who have sex with men in the 7 cities of china,Zhao B,10.1097/QAI.0000000000000467,2015,NR,,0,,,,,
hiv-1 adaptation to humans involved interactions of vpr with the dna damage response,Fregoso OI,,2015,NR,,0,,,,,
individual and community factors associated with geographic clusters of poor hiv care retention and poor viral suppression,Eberhart MG,10.1097/QAI.0000000000000587,2015,NR,,0,,,,,
individual and community factors associated with geographic clusters of poor hiv care retention and poor viral suppression (special issue: addressing the challenges of the hiv continuum of care in high prevalence cities in the united states),Eberhart,10.1097/QAI.0000000000000587,2015,NR,,0,,,,,
hiv-1 dual infected ltnp-ec patients developed an unexpected antibody cross-neutralizing activity,Pernas M,10.1371/journal.pone.0134054,2015,NR,,0,,,,,
"hiv-1 genetic diversity and its impact on baseline cd4+t cells and viral loads among recently infected men who have sex with men in shanghai, china",Li X,10.1371/journal.pone.0129559,2015,NR,,0,,,,,
inhibitory effect of individual or combinations of broadly neutralizing antibodies and antiviral reagents against cell-free and cell-to-cell hiv-1 transmission,Gombos RB,10.1128/JVI.00783-15,2015,NR,,0,,,,,
hiv-1 genetic variability in cuba and implications for transmission and clinical progression,Blanco M,,2015,NR,,0,,,,,
hiv-1 gp120 as a therapeutic target: navigating a moving labyrinth,Acharya P,10.1517/14728222.2015.1010513,2015,NR,,0,,,,,
"hiv-1 group o infection in cameroon from 2006 to 2013: prevalence, genetic diversity, evolution and public health challenges",Villabona-Arenas CJ,10.1016/j.meegid.2015.09.006,2015,NR,,0,,,,,
hiv-1 replication in the cns is associated with increased neurocognitive impairment,Joseph SB,,2015,NR,,0,,,,,
"hiv-1 rnas: sense and antisense, large mrnas and small sirnas and mirnas",Harwig A,10.1097/COH.0000000000000135,2015,NR,,0,,,,,
hiv-1 subtype characteristics of infected persons living in southwestern greece,Davanos N,10.2147/HIV.S90755,2015,NR,,0,,,,,
hiv-1 tat genetic polymorphisms associated with neurocognitive impairment impact nmda receptor docking,Antell G,10.1007/s13365-015-0345-z,2015,NR,,0,,,,,
hiv-1 tropism determines different mutation profiles in proviral dna,Nascimento-Brito S,10.1371/journal.pone.0139037,2015,NR,,0,,,,,
intrapatient evolutionary dynamics of human immunodeficiency virus type 1 in individuals undergoing alternative treatment strategies with reverse transcriptase inhibitors,Kayondo JK,10.1089/AID.2015.0035,2015,NR,,0,,,,,
hiv/aids in mid-sized cities in senegal: from individual to place-based vulnerability,Drame FM,10.1016/j.socscimed.2014.11.038,2015,NR,,0,,,,,
hla class ii diversity in hiv-1 uninfected individuals from the placebo arm of the rv144 thai vaccine efficacy trial,Baldwin KM,10.1111/tan.12507,2015,NR,,0,,,,,
"large phylogenetically linked hiv cluster in king county, washington, 2008 to 2014",Buskin SE,,2015,NR,,0,,,,,
hormonal contraception and the risk of hiv acquisition: an individual participant data meta-analysis,Morrison CS,10.1371/journal.pmed.1001778,2015,NR,,0,,,,,
human polyomavirus 6 dna in the cerebrospinal fluid of an hiv-positive patient with leukoencephalopathy,Delbue S,10.1016/j.jcv.2015.04.016,2015,NR,,0,,,,,
long-range hiv genotyping using viral rna and proviral dna for analysis of hiv drug resistance and hiv clustering,Novitsky V,10.1128/JCM.00756-15,2015,NR,,0,,,,,
low hiv-1 transmitted drug resistance in bulgaria against a background of high clade diversity,Alexiev I,10.1093/jac/dkv011,2015,NR,,0,,,,,
identification of hiv-1 genitourinary tract compartmentalization by analyzing the env gene sequences in urine,Blasi M,10.1097/QAD.0000000000000757,2015,NR,,0,,,,,
low-level hiv viremias originate in part from infected proliferating cells,Bull ME,,2015,NR,,0,,,,,
pass,Bagaya BS,10.1186/s12977-015-0170-8,2015,NR,,0,,,,,
strain-specific v3 and cd4 binding site autologous hiv-1 neutralizing antibodies select neutralization-resistant viruses,Moody MA,10.1016/j.chom.2015.08.006,2015,NR,,0,,,,,
recovery of the wild type atomic flexibility in the hiv-1 protease double mutants,De Conto V,10.1016/j.jmgm.2015.04.006,2015,NR,,0,,,,,
anti-apobec3g activity of hiv-1 vif protein is attenuated in elite controllers,Kikuchi T,10.1128/JVI.03464-14,2015,NR,,0,,,,,
structured observations reveal slow hiv-1 ctl escape,Roberts HE,10.1371/journal.pgen.1004914,2015,NR,,0,,,,,
"pre-exposure prophylaxis to prevent hiv infection: current status, future opportunities and challenges",Krakower DS,10.1007/s40265-015-0355-4,2015,NR,,0,,,,,
high interest in preexposure prophylaxis among men who have sex with men at risk for hiv infection: baseline data from the us prep demonstration project,Cohen SE,10.1097/QAI.0000000000000479,2015,NR,,0,,,,,
majority of xdr tb cases are due to transmission in a high-hiv-prevalence setting,Shah NS,,2015,NR,,0,,,,,
near full-length identification of a novel hiv-1 crf01-ae/b/c recombinant in northern myanmar,Zhou Y-H,10.1089/aid.2015.0021,2015,NR,,0,,,,,
"genomic characterization of two novel hiv-1 unique (crf01-ae/b) recombinant forms among men who have sex with men in beijing, china",Li Z,10.1089/aid.2015.0076,2015,NR,,0,,,,,
deciphering how hiv-1 intersubtype recombination shapes viral fitness and disease progression,Turk G,10.1016/j.ebiom.2015.02.011,2015,NR,,0,,,,,
implementation and operational research: distance from household to clinic and its association with the uptake of prevention of mother-to-child hiv transmission regimens in rural zambia,Escamilla,,2015,NR,,0,,,,,
"knowledge, attitudes, and likelihood of pre-exposure prophylaxis (prep) use among us women at risk of acquiring hiv",Auerbach JD,10.1089/apc.2014.0142,2015,NR,,0,,,,,
importance of viral sequence length and number of variable and informative sites in analysis of hiv clustering,Novitsky V,10.1089/aid.2014.0211,2015,NR,,0,,,,,
improved antibody cross-neutralizing activity in hiv-1 dual-infected ltnp patients,Pernas M,,2015,NR,,0,,,,,
evaluation of the xpert hiv-1 viral load assay on a wide panel of hiv-1 variants,Gueudin M,10.1016/j.jcv.2015.07.194,2015,NR,,0,,,,,
hiv-1 infection induces dynamic reorganization of cytoplasmic rna surveillance complexes,Becker JT,10.1091/mbc.E15-09-0674,2015,NR,,0,,,,,
crf19-cpx is an evolutionary fit hiv-1 variant exclusively associated with rapid progression to aids in cuba,Kouri V,,2015,NR,,0,,,,,
translating anti-hiv-1 immune mechanisms into clinical interventions,Permar SR,,2015,NR,,0,,,,,
functional differences in the viral accessory protein nef between major hiv-1 subtypes,Johnson A,10.7448/IAS.18.5.20463,2015,NR,,0,,,,,
an hiv pre-exposure prophylaxis demonstration project and safety study for young men who have sex with men in the united states (atn 110),Hosek S,10.7448/IAS.18.5.20549,2015,NR,,0,,,,,
evaluating the use and reporting of minority variants in hiv genotypic testing using ultra-deep sequencing,Chanqueo L,10.7448/IAS.18.3.20155,2015,NR,,0,,,,,
hiv-1 subtype distribution and circulating recombinant forms in colombia 2011-2014,Gonzalez A,10.7448/IAS.18.3.20146,2015,NR,,0,,,,,
exosomes from hiv-1 infected cells stimulate production of pro-inflammatory cytokines through tar rna,Kashanchi F,10.1007/s11481-015-9596-y,2015,NR,,0,,,,,
"culture, stigma, and agency: telling and re-telling the stories about hiv/aids",Zhou YR,,2015,NR,,0,,,,,
dna target specificity for deamination by the apobec3 proteins influences their potency for hiv-1 gene inactivation,Belanger K,,2015,NR,,0,,,,,
phylodynamics analysis of the human immunodeficiency virus type 1 envelope gene in mother and child pairs,Santos,10.1089/aid.2014.0352,2015,NR,,0,,,,,
genome-wide dna copy number imbalances associated with hiv positive plasmablastic lymphomas,Willem P,,2015,NR,,0,,,,,
intersubtype genetic variation of hiv-1 tat exon 1,Roy CN,10.1089/AID.2014.0346,2015,NR,,0,,,,,
invaluable lessons: compensating peer research associates in hiv community-based research in canada,Langlois A,,2015,NR,,0,,,,,
investigation of the association of gag-protease dependent replication capacities with clinical outcomes of hiv-1 infection,Sakai K,,2015,NR,,0,,,,,
keeping confidence: hiv and the criminal law from hiv service providers' perspectives (special section: hiv criminalisation and public health),Dodds,10.1080/09581596.2015.1019835,2015,NR,,0,,,,,
la isla bonita - designing services to meet the increasing needs of spanish-speaking hiv patients in london,Hart MM,10.1177/0956462415601768,2015,NR,,0,,,,,
legal and human rights dimensions of hiv and sti: historical background and policy implications,Caceres C,10.1136/sextrans-2015-052270.16,2015,NR,,0,,,,,
"prospects for a globally effective hiv-1 vaccine (special issue: advancing vaccines and immunization issues, insights and innovations)",Excler,10.1016/j.amepre.2015.09.004,2015,NR,,0,,,,,
lower self-reported quality of life in hiv-infected patients on cart and with low comorbidity compared with healthy controls,Pedersen KK,10.1097/QAI.0000000000000697,2015,NR,,0,,,,,
multicenter comparison of lung and oral microbiomes of hiv-infected and hiv-uninfected individuals,Beck JM,10.1164/rccm.201501-0128OC,2015,NR,,0,,,,,
"male sex workers: practices, contexts, and vulnerabilities for hiv acquisition and transmission",Baral SD,10.1016/S0140-6736%2814%2960801-1,2015,NR,,0,,,,,
mapping the dna and rna binding domains of the hiv restriction factor apobec3g,Smith H,,2015,NR,,0,,,,,
"multiple roles for enterococcus faecalis glycosyltransferases in biofilm-associated antibiotic resistance, cell envelope integrity, and conjugative transfer",Dale JL,10.1128/AAC.00344-15,2015,NR,,0,,,,,
maturation and diversity of the vrc01-antibody lineage over 15 years of chronic hiv-1 infection,Wu X,10.1016/j.cell.2015.03.004,2015,NR,,0,,,,,
"medical hiv prevention: science, public health and medical ethics",Lundgren JD,10.1111/tmi.12575,2015,NR,,0,,,,,
medication adherence challenges among hiv positive substance abusers: the role of food and housing insecurity,Surratt,10.1080/09540121.2014.967656,2015,NR,,0,,,,,
"neighborhood disorder, hiv treatment access and arv diversion: a mediation study of drug-involved hiv positive individuals in south florida",O'Grady CL,10.1016/j.drugalcdep.2014.09.521,2015,NR,,0,,,,,
molecular analysis allows inference into hiv transmission among young men who have sex with men in the united states,Whiteside YO,10.1097/QAD.0000000000000852,2015,NR,,0,,,,,
molecular characterization of full-length tat in hiv-1 subtypes b and c,Roy CN,10.6026/97320630011151,2015,NR,,0,,,,,
molecular characterization of hiv-1 infection in northwest spain (2009-2013): investigation of the subtype f outbreak,Paraskevis D,10.1016/j.meegid.2014.12.012,2015,NR,,0,,,,,
molecular tracing of heterosexual hiv-1 transmission in georgia,Dvali N,,2015,NR,,0,,,,,
not until i'm absolutely half-dead and have to:' accounting for non-use of antiretroviral therapy in semi-structured interviews with people living with hiv in australia,Newman,,2015,NR,,0,,,,,
moving mountains to address hiv/aids in northern bc through community based research,Daniels T,,2015,NR,,0,,,,,
multidimensional clusters of cd4+ t cell dysfunction are primarily associated with the cd4/cd8 ratio in chronic hiv infection,Frederiksen J,10.1371/journal.pone.0137635,2015,NR,,0,,,,,
multiple co-circulating hiv-1 subtypes in the middle east and north africa,Rolland M,10.1097/QAD.0000000000000764,2015,NR,,0,,,,,
multiplexing seven mirna-based shrnas to suppress hiv replication,Choi JG,10.1038/mt.2014.205,2015,NR,,0,,,,,
relationship between human immunodeficiency virus neuroretinal disorder and vision-specific quality of life among people with aids,Ashraf DC,10.1016/j.ophtha.2015.07.037,2015,NR,,0,,,,,
origin and population dynamics of a novel hiv-1 subtype g clade circulating in cape verde and portugal,de Pina-Araujo II,10.1371/journal.pone.0127384,2015,NR,,0,,,,,
near full length hiv-1 sequencing to understand hiv phylodynamics in africa in real time,Danaviah S,,2015,NR,,0,,,,,
near full-length hiv type 1m genomic sequences from cameroon,Tongo M,10.1093/emph/eov022,2015,NR,,0,,,,,
new prospects for a preventive hiv-1 vaccine,Brown J,,2015,NR,,0,,,,,
"perceived barriers to accessing and adhering to antiretroviral therapy by people living with hiv/aids (plwhas) in akwa ibom state, nigeria",Okoye,,2015,NR,,0,,,,,
perceived family support and antiretroviral adherence in hiv-positive individuals: results from a community-based positive living with hiv study,Poudel,,2015,NR,,0,,,,,
novel cd4-based bispecific chimeric antigen receptor designed for enhanced anti-hiv potency and absence of hiv entry receptor activity,Liu L,10.1128/JVI.00474-15,2015,NR,,0,,,,,
persistence of transmitted hiv-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds,Yang WL,10.1371/journal.ppat.1004722,2015,NR,,0,,,,,
perspectives of health care provider regarding tb-hiv referral strategy and non-uptake of hiv testing in delhi - a qualitative study,Soyam,10.1016/j.ijtb.2015.09.001,2015,NR,,0,,,,,
ongoing hiv transmission and the hiv care continuum in north carolina,Cope AB,10.1371/journal.pone.0127950,2015,NR,,0,,,,,
phylodynamic analysis of the hiv epidemic within canada,Joy JB,,2015,NR,,0,,,,,
phylodynamic inference with kernel abc and its application to hiv epidemiology,Poon AF,10.1093/molbev/msv123,2015,NR,,0,,,,,
phylogenetic analysis of hiv-1 crf65-cpx reveals yunnan province is still a source contributing to the spread of hiv-1 in china,Liu Y,10.1097/QAI.0000000000000775,2015,NR,,0,,,,,
pan-hiv next-gen sequencing strategy for viral surveillance,Berg MG,,2015,NR,,0,,,,,
paternal involvement and fetal morbidity outcomes in hiv/aids: a population-based study,Alio AP,10.1177/1557988313498890,2015,NR,,0,,,,,
patient and provider priorities for self-reported domains of hiv clinical care,Fredericksen,10.1080/09540121.2015.1050983,2015,NR,,0,,,,,
short communication: phylodynamics analysis of the human immunodeficiency virus type 1 envelope gene in mother and child pairs,Santos LA,10.1089/AID.2014.0352,2015,NR,,0,,,,,
phylogenetically estimated hiv diversification rates reveal prevention of hiv-1 by antiretroviral therapy,Joy J,10.7448/IAS.18.5.20349,2015,NR,,0,,,,,
short conserved sequences of hiv-1 are highly immunogenic and shift immunodominance,Yang OO,10.1128/JVI.02370-14,2015,NR,,0,,,,,
performance of the viroseq hiv-1 genotyping system v20 in central africa,Mekue Mouafo LC,10.2174/1874613601509010009,2015,NR,,0,,,,,
physical impairment in hiv infections and aids: responses to resistance and aerobic training,Shephard,,2015,NR,,0,,,,,
"phylodynamic analysis of hiv sub-epidemics in mochudi, botswana",Novitsky V,10.1016/j.epidem.2015.07.002,2015,NR,,0,,,,,
pilot study of immediate antiretrovirals and behavioural intervention for persons with acute hiv infection: opportunity for interrupting transmission,Rutstein SE,10.1136/sextrans-2015-052270.207,2015,NR,,0,,,,,
phylodynamics of major hiv-1 subtype b pandemic clades circulating in latin america,Mir D,10.1097/QAD.0000000000000770,2015,NR,,0,,,,,
physical training improves oxidative stress status in people living with hiv-aids: a pilot study,Karsten M,10.1177/2047487315586749,2015,NR,,0,,,,,
positive charge: filling the gaps in the us hiv continuum of care,Maulsby C,10.1007/s10461-015-1015-0,2015,NR,,0,,,,,
predictors of the existence of congregational hiv programs: similarities and differences compared with other health programs,Williams MV,10.4278/ajhp.130531-QUAN-280,2015,NR,,0,,,,,
structure-guided redesign increases the propensity of hiv env to generate highly stable soluble trimers,Guenaga J,10.1128/JVI.02652-15,2015,NR,,0,,,,,
prevalence and clinical impacts of hiv-1 intersubtype recombinants in uganda,Lee GQ,,2015,NR,,0,,,,,
preterm birth and fetal growth restriction in hiv-infected brazilian pregnant women,dos Reis HLB,10.1590/S0036-46652015000200003,2015,NR,,0,,,,,
prevalence of and risk factors for low bone mineral density in untreated hiv infection: a substudy of the insight strategic timing of antiretroviral treatment (start) trial,Carr A,10.1111/hiv.12242,2015,NR,,0,,,,,
prospects for a globally effective hiv-1 vaccine,Excler J-L,10.1016/j.amepre.2015.09.004,2015,NR,,0,,,,,
quality and implementation barriers of prevention of mother to child transmission of hiv program in ethiopia: a cross sectional study,Legesse B,,2015,NR,,0,,,,,
quasispecies analyses of the hiv-1 near-full-length genome with illumina miseq,Ode H,10.3389/fmicb.2015.01258,2015,NR,,0,,,,,
proximate context of hiv-related stigma and utilization of skilled childbirth services in uganda,Ng C,,2015,NR,,0,,,,,
rapid screening and identification of active ingredients in licorice extract interacting with v3 loop region of hiv-1 gp120 using ace and ce-ms,Li Z,10.1016/j.jpba.2015.02.021,2015,NR,,0,,,,,
reactivation of neutralized hiv-1 by dendritic cells is dependent on the epitope bound by the antibody,van Montfort T,10.4049/jimmunol.1402344,2015,NR,,0,,,,,
recalibration of the limiting antigen avidity eia to determine mean duration of recent infection in divergent hiv-1 subtypes,Duong YT,10.1371/journal.pone.0114947,2015,NR,,0,,,,,
recombination elevates the effective evolutionary rate and facilitates the establishment of hiv-1 infection in infants after mother-to-child transmission,Sanborn KB,10.1186/s12977-015-0222-0,2015,NR,,0,,,,,
recombination enhances hiv-1 envelope diversity by facilitating the survival of latent genomic fragments in the plasma virus population,Immonen TT,10.1371/journal.pcbi.1004625,2015,NR,,0,,,,,
racial/ethnic differences in hiv-related knowledge among young men who have sex with men and their association with condom errors,Garofalo R,10.1177/0017896914549485,2015,NR,,0,,,,,
redesigned hiv antibodies exhibit enhanced neutralizing potency and breadth,Willis JR,10.1172/JCI80693,2015,NR,,0,,,,,
"relationship power, sexual decision making, and hiv risk among midlife and older women",Altschuler J,10.1080/08952841.2014.954499,2015,NR,,0,,,,,
relationships between hiv-related neuroretinal disorder and measures of vision-specific quality of life among people with aids,Ashraf D,,2015,NR,,0,,,,,
"recent infection, sexually transmitted infections, and transmission clusters frequently observed among persons newly diagnosed with hiv in san francisco",Truong,,2015,NR,,0,,,,,
"reducing the overall hiv-burden in south africa: is 'reviving abc' an appropriate fit for a complex, adaptive epidemiological hiv landscape?",Burman,10.2989/16085906.2015.1016988,2015,NR,,0,,,,,
"safety, pharmacokinetics and neutralization of the broadly neutralizing hiv-1 human monoclonal antibody vrc01 in healthy adults",Ledgerwood JE,10.1111/cei.12692,2015,NR,,0,,,,,
searching for rare hiv strains in rural democratic republic of congo (2001-2003),Vallari AS,,2015,NR,,0,,,,,
"replicative fitness of transmitted hiv-1 drives acute immune activation, proviral load in memory cd4+ t cells, and disease progression",Claiborne DT,10.1073/pnas.1421607112,2015,NR,,0,,,,,
replicative fitness of transmitted hiv-1 drives disease progression,Harper KN,10.1097/QAD.0000000000000858,2015,NR,,0,,,,,
rhesus macaque b-cell responses to an hiv-1 trimer vaccine revealed by unbiased longitudinal repertoire analysis,Dai K,10.1128/mBio.01375-15,2015,NR,,0,,,,,
risk-taking behaviours and hiv infection among sex workers in portugal: results from a cross-sectional survey,Dias,,2015,NR,,0,,,,,
short communication: investigating a chain of hiv transmission events due to homosexual exposure and blood transfusion based on a next generation sequencing method,Zhao Q,10.1089/aid.2015.0178,2015,NR,,0,,,,,
"sequencing and phylogenetic analysis of near full-length hiv-1 subtypes a, b, g and unique recombinant ac and ad viral strains identified in south africa",Wilkinson,10.1089/aid.2014.0230,2015,NR,,0,,,,,
"sexual and prevention practices in men who have sex with men in the era of combination hiv prevention: results from the presse gays et lesbiennes survey, france, 2011",Velter,,2015,NR,,0,,,,,
subtype associations with hiv-associated neurocognitive dysfunction,Day TR,,2015,NR,,0,,,,,
sexual networks across risk groups persistently contribute to local spread of hiv,Hofstra M,,2015,NR,,0,,,,,
suppressive art is key to reduce neurocognitive impairment in aging hiv+ individuals,Yek CC,,2015,NR,,0,,,,,
symptom clusters in people living with hiv attending five palliative care facilities in two sub-saharan african countries: a hierarchical cluster analysis,Moens K,10.1371/journal.pone.0126554,2015,NR,,0,,,,,
single genome analysis for the detection of linked multiclass drug resistance mutations in hiv-1-infected children after failure of protease inhibitor-based first-line therapy,Lange,10.1097/QAI.0000000000000568,2015,NR,,0,,,,,
single nucleotide polymorphisms (snps) in the hiv-1 ltr correlate with clinical disease parameters,Sullivan N,10.1007/s13365-015-0345-z,2015,NR,,0,,,,,
social media use and hiv transmission risk behavior among ethnically diverse hiv-positive gay men: results of an online study in three us states (special section: sexual health in gay and bisexual men),Hirshfield,10.1007/s10508-015-0513-5,2015,NR,,0,,,,,
spastin and escrt-iii coordinate mitotic spindle disassembly and nuclear envelope sealing,Vietri M,10.1038/nature14408,2015,NR,,0,,,,,
special issue: fostering hiv program quality to achieve epidemic impact (special issue: fostering hiv program quality to achieve epidemic impact),El-Sadr,,2015,NR,,0,,,,,
srsf1 rna recognition motifs are strong inhibitors of hiv-1 replication,Paz S,10.1128/JVI.00693-15,2015,NR,,0,,,,,
the 2 phases of hiv-1 group o diversification,Leoz M,,2015,NR,,0,,,,,
subtype-independent near full-length hiv-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management,Grossmann S,10.7448/IAS.18.1.20035,2015,NR,,0,,,,,
targeting hiv prevention based on molecular epidemiology among deeply sampled subnetworks of men who have sex with men,Wang X,10.1093/cid/civ526,2015,NR,,0,,,,,
the biological characteristics of predominant strains of hiv-1 genotype: modeling of hiv-1 infection among men who have sex with men,Dai D,10.1002/jmv.24116,2015,NR,,0,,,,,
the association between sexual behavior and disclosure of hiv test results in central kenya,Kingori C,,2015,NR,,0,,,,,
"the canadian perinatal hiv surveillance programme (cphsp): programme description and trends in demographics, treatment and transmission",Singer J,10.7448/IAS.18.5.20471,2015,NR,,0,,,,,
the contribution of advanced nursing practice to hiv care: preliminary findings of a national study,Piercy H,10.1111/hiv.12265,2015,NR,,0,,,,,
the conceptual framework of quality of sexual life in hiv and hcv,Dara AF,,2015,NR,,0,,,,,
the current status of the use of oral medication to prevent hiv transmission,Mayer KH,10.1097/COH.0000000000000170,2015,NR,,0,,,,,
the effect of interference on the cd8+ t cell escape rates in hiv,Garcia V,10.3389/fimmu.2014.00661,2015,NR,,0,,,,,
"trends of subtype variation of human immunodeficiency virus type 1 in zhejiang province, china",Yao Y,10.1007/s11262-014-1136-y,2015,NR,,0,,,,,
the evolution of hiv-1 interactions with coreceptors and mannose c-type lectin receptors,Borggren M,10.1016/bs.pmbts.2014.10.004,2015,NR,,0,,,,,
the hiv-1 entry process: a stoichiometric view,Brandenberg OF,10.1016/j.tim.2015.09.003,2015,NR,,0,,,,,
the impact of hiv-1 genetic diversity on the efficacy of a combinatorial rnai-based gene therapy,Herrera-Carrillo E,10.1038/gt.2015.11,2015,NR,,0,,,,,
the gap procedure: for the identification of phylogenetic clusters in hiv-1 sequence data,Vrbik I,10.1186/s12859-015-0791-x,2015,NR,,0,,,,,
the genetic diversity and evolution of hiv-1 subtype b epidemic in puerto rico,Lopez P,10.3390/ijerph13010055,2015,NR,,0,,,,,
"the impact of clinical, demographic and risk factors on rates of hiv transmission: a population-based phylogenetic analysis in british columbia, canada",Poon AF,10.1093/infdis/jiu560,2015,NR,,0,,,,,
the importance of quality over in quantity in the social sharing of emotions (sse) in people living with hiv/aids,Cantisano,10.1080/13548506.2014.901544,2015,NR,,0,,,,,
the new hiv/aids program in peru: the role of prioritizing and budgeting for results,Vargas,,2015,NR,,0,,,,,
"the predominant cluster of crf01-ae circulating among newly diagnosed hiv-1-positive people in anhui province, china",Wu J,10.1089/aid.2015.0107,2015,NR,,0,,,,,
the primer rna packaging complex of hiv-1: understanding its assembly and disassembly,Agha FK,,2015,NR,,0,,,,,
the role of fc receptors in hiv prevention and therapy,Boesch AW,10.1111/imr.12339,2015,NR,,0,,,,,
the role of kir and hla polymorphism in hiv acquisition: association and in vitro functional studies (vir1p1159),Erlich H,,2015,NR,,0,,,,,
"the number and complexity of pure and recombinant hiv-1 strains observed within incident infections during the hiv and malaria cohort study conducted in kericho, kenya, from 2003 to 2006",Billings E,10.1371/journal.pone.0135124,2015,NR,,0,,,,,
the oral bacterial communities of children with well-controlled hiv infection and without hiv infection,Goldberg,10.1371/journal.pone.0131615,2015,NR,,0,,,,,
the temporal increase in hiv-1 non-r5 tropism frequency among newly diagnosed patients from northern poland is associated with clustered transmissions,Parczewski M,10.7448/IAS.18.1.19993,2015,NR,,0,,,,,
the v1v2 region of hiv-1 gp120 forms a five-stranded beta barrel,Pan R,10.1128/JVI.00754-15,2015,NR,,0,,,,,
high interest in pre-exposure prophylaxis among men who have sex with men at risk for hiv infection: baseline data from the us prep demonstration project,Cohen,10.1097/QAI.0000000000000479,2015,NR,,0,,,,,
the relevance of timing of illness and death events in the household life cycle for coping outcomes in rural uganda in the era of hiv,Amurwon J,10.1186/s12939-015-0253-0,2015,NR,,0,,,,,
"how setswana cultural beliefs and practices on sexuality affect teachers' and adolescents' sexual decisions, practices, and experiences as well as hiv/aids and sti prevention in select botswanan secondary schools",Nleya,10.1177/2325957413488174,2015,NR,,0,,,,,
incomplete apobec3 g/f neutralization by hiv-1 vif mutants facilitates the genetic evolution from ccr5 to cxcr4 usage,Alteri,10.1128/AAC.00137-15,2015,NR,,0,,,,,
the structure of immature virus-like rous sarcoma virus gag particles reveals a structural role for the p10 domain in assembly,Schur FK,10.1128/JVI.01502-15,2015,NR,,0,,,,,
towards a science of community stakeholder engagement in biomedical hiv prevention trials: an embedded four-country case study,Newman PA,10.1371/journal.pone.0135937,2015,NR,,0,,,,,
"transmission clustering among newly diagnosed hiv patients in chicago, 2008 to 2011: using phylogenetics to expand knowledge of regional hiv transmission patterns",Lubelchek RJ,10.1097/QAI.0000000000000404,2015,NR,,0,,,,,
uneven genetic robustness of hiv-1 integrase,Rihn SJ,10.1128/JVI.02451-14,2015,NR,,0,,,,,
transmission networks of hiv-1 among men who have sex with men in east and southeast asia,Tee KK,10.7448/IAS.18.5.20451,2015,NR,,0,,,,,
transmission of hiv drug resistance: lessons from sensitive screening assays,Geretti AM,10.1097/QCO.0000000000000136,2015,NR,,0,,,,,
using molecular hiv surveillance data to understand transmission between subpopulations in the united states,Oster AM,10.1097/QAI.0000000000000809,2015,NR,,0,,,,,
transmitted virus fitness and host t cell responses collectively define divergent infection outcomes in two hiv-1 recipients,Yue L,10.1371/journal.ppat.1004565,2015,NR,,0,,,,,
"views of hiv positive pregnant women on accessibility of the prevention of mother-to-child transmission programme in north west province, south africa",Habedi,,2015,NR,,0,,,,,
trends in web-based hiv behavioural surveillance among gay and bisexual men in new zealand: complementing location-based surveillance,Saxton PJ,10.1080/09540121.2014.998615,2015,NR,,0,,,,,
"two independent hiv epidemics in saint petersburg, russia revealed by molecular epidemiology",Dukhovlinova E,10.1089/AID.2014.0150,2015,NR,,0,,,,,
understanding drivers of phylogenetic clustering in molecular epidemiological studies of hiv,Frost SDW,10.1093/infdis/jiu563,2015,NR,,0,,,,,
viremic hiv controllers exhibit high plasmacytoid dendritic cell-reactive opsonophagocytic igg antibody responses against hiv-1 p24 associated with greater antibody isotype diversification,Tjiam MC,10.4049/jimmunol.1402918,2015,NR,,0,,,,,
use of amplification refractory mutation system pcr assay as a simple and effective tool to detect hiv-1 drug resistance mutations,Nanfack,10.1128/JCM.00114-15,2015,NR,,0,,,,,
variability and signatures of rnase-h amino acid domain and central polypurine tract of hiv-1 b-subtype from drug-naive individuals,Dimonte S,10.2174/1570162X13666150623144706,2015,NR,,0,,,,,
variability of human immunodeficiency virus-1 in the female genital reservoir during genital reactivation of herpes simplex virus type 2,LeGoff J,10.1016/j.cmi.2015.05.014,2015,NR,,0,,,,,
venue-mediated weak ties in multiplex hiv transmission risk networks among drug-using male sex workers and associates,Fujimoto K,10.2105/AJPH.2014.302474,2015,NR,,0,,,,,
virome analysis of antiretroviral-treated hiv patients shows no correlation between t-cell activation and anelloviruses levels,Li L,10.1016/j.jcv.2015.09.004,2015,NR,,0,,,,,
worldwide genetic features of hiv-1 env alpha4beta7 binding motif: the local dissemination impact of the ldi tripeptide,Hait SH,10.1097/QAI.0000000000000802,2015,NR,,0,,,,,
weighted brain networks in disease: centrality and entropy in human immunodeficiency virus and aging,Thomas JB,10.1016/j.neurobiolaging.2014.06.019,2015,NR,,0,,,,,
where you live matters: structural correlates of hiv risk behavior among young men who have sex with men in metro detroit,Bauermeister JA,10.1007/s10461-015-1180-1,2015,NR,,0,,,,,
"""deep"" sequencing accuracy and reproducibility using roche/454 technology for inferring co-receptor usage in hiv-1",Knapp DJ,10.1371/journal.pone.0099508,2014,NR,,0,,,,,
"""we are not saying that gay men shouldn't have services"": experiences of heterosexual black men in accessing hiv and health services in ontario",Luyombya H,,2014,NR,,0,,,,,
a cell-intrinsic inhibitor of hiv-1 reverse transcription in cd4 + t cells from elite controllers,Leng J,10.1016/j.chom.2014.05.011,2014,NR,,0,,,,,
a case cluster demonstrating the relationship between hla concordance and virologic and disease outcomes in human immunodeficiency virus infection,Chaillon A,10.1016/j.virol.2013.11.012,2014,NR,,0,,,,,
"an outdated notion of antibody specificity is one of the major detrimental assumptions of the structure-based reverse vaccinology paradigm, which prevented it from helping to develop an effective hiv-1 vaccine",van Regenmortel MHV,10.3389/fimmu.2014.00593,2014,NR,,0,,,,,
a newly emerging hiv-1 recombinant lineage (crf58_01b) disseminating among people who inject drugs in malaysia,Chow WeiZhen,10.1371/journal.pone.0085250,2014,NR,,0,,,,,
associations between physical activity and sedentary time on components of metabolic syndrome among adults with hiv,Jaggers JR,10.1080/09540121.2014.920075,2014,NR,,0,,,,,
a single-tube real-time rt-pcr assay for rna detection and quantification of genetically diverse hiv including rare hiv-1 non-m groups and hiv-2,Prasolova MA,10.3103/S0891416814040089,2014,NR,,0,,,,,
a uniquely prevalent nonnucleoside reverse transcriptase inhibitor resistance mutation in russian subtype a hiv-1 viruses,Kolomeets AN,10.1097/QAD.0000000000000485,2014,NR,,0,,,,,
accelerated viral load increase and cd4 decline in hiv-1 superinfected women,Ronen K,,2014,NR,,0,,,,,
accessing hiv testing and treatment among men who have sex with men in china: a qualitative study,Wei C,10.1080/09540121.2013.824538,2014,NR,,0,,,,,
adjudicated morbidity and mortality outcomes by age among individuals with hiv infection on suppressive antiretroviral therapy,Miller CJ,10.1371/journal.pone.0095061,2014,NR,,0,,,,,
a gene-specific role for the ssu72 rnapii ctd phosphatase in hiv-1 tat transactivation,Chen Y,10.1101/gad.250449.114,2014,NR,,0,,,,,
ahi detection among people who inject drugs in russia reveals the hiv-1 transmission bottleneck,Dukhovlinova E,,2014,NR,,0,,,,,
altered response hierarchy and increased t-cell breadth upon hiv-1 conserved element dna vaccination in macaques,Kulkarni V,10.1371/journal.pone.0086254,2014,NR,,0,,,,,
a novel hiv-1-encoded microrna enhances its viral replication by targeting the tata box region,Zhang Y,10.1186/1742-4690-11-23,2014,NR,,0,,,,,
an in silico study on hiv-1 protease wild-type and mutant with inhibitors from annona squamosa,Lisina KV,10.13040/IJPSR.0975-8232.5%285%29.1811-18,2014,NR,,0,,,,,
an international multicenter study on hiv-1 drug resistance testing by 454 ultra-deep pyrosequencing,Simen BB,10.1016/j.jviromet.2014.04.007,2014,NR,,0,,,,,
an online study of the hiv/aids transmission prevention strategies of sexually active young adults: what are adaptive coping strategies in the ongoing era of hiv/aids?,Vasquez-Iscan E,,2014,NR,,0,,,,,
a proposed hiv reference sample characterized by three next-generation sequencing platforms,Gonzalez-Serna A,,2014,NR,,0,,,,,
anal microbiota profiles in hiv-positive and hiv-negative msm,Yu,10.1097/QAD.0000000000000154,2014,NR,,0,,,,,
analysis of hiv transmission in the russian federation,Kireev DE,,2014,NR,,0,,,,,
"analysis of hiv-1 protease gene reveals frequent multiple infections followed by recombination among drug treated individuals living in sao paulo and santos, brazil",Nunes ER,10.1371/journal.pone.0084066,2014,NR,,0,,,,,
acute coronary thrombosis and multiple coronary aneurysms in a 22-year-old man with the human immunodeficiency virus,Ayers J,10.14503/THIJ-13-3160,2014,NR,,0,,,,,
analysis of transmitted hiv-1 drug resistance using 454 ultra-deep-sequencing and the deepchek( r)-hiv system,Garcia-Diaz A,10.7448/IAS.17.4.19752,2014,NR,,0,,,,,
"antiretroviral therapy, immune suppression and renal impairment in hiv-positive persons",Ryom,10.1097/COH.0000000000000023,2014,NR,,0,,,,,
apobec3d and apobec3f potently promote hiv-1 diversification and evolution in humanized mouse model,Sato K,10.1371/journal.ppat.1004453,2014,NR,,0,,,,,
association between hiv-1 coreceptor usage and resistance to broadly neutralizing antibodies,Pfeifer N,10.1097/QAI.0000000000000283,2014,NR,,0,,,,,
association between latent proviral characteristics and immune activation in antiretrovirus-treated human immunodeficiency virus type 1-infected adults,Liang EC,10.1128/JVI.01257-14,2014,NR,,0,,,,,
"membrane binding and subcellular localization of retroviral gag proteins are differentially regulated by ma interactions with phosphatidylinositol-(4,5)-bisphosphate and rna",Inlora J,10.1128/mBio.02202-14,2014,NR,,0,,,,,
alterations in hiv-1 gp120 v3 region are necessary but not sufficient for coreceptor switching in crf07_bc in china,Zhang L,10.1371/journal.pone.0093426,2014,NR,,0,,,,,
baseline and dynamic expression of activating nk cell receptors in the control of chronic viral infections: the paradigm of hiv-1 and hcv,Marras F,10.3389/fimmu.2014.00305,2014,NR,,0,,,,,
an innovative approach to reducing pain in patients with peripheral neuropathy related to hiv: a single case study,Benjamin NA,10.4102/ajod.v3i1.118,2014,NR,,0,,,,,
binding mode characterization of nbd series cd4-mimetic hiv-1 entry inhibitors by x-ray structure and resistance study,Curreli F,10.1128/AAC.03339-14,2014,NR,,0,,,,,
an open debate about the object and purpose of global health knowledge in the context of an interdisciplinary research partnership on hiv/sti prevention priorities in peru,Suarez EB,10.1186/1744-8603-10-40,2014,NR,,0,,,,,
analysis of the volatile fraction of a brazilian propolis from ubatuba (sp) shows unusual chemical composition and anti-hiv properties,Fernandes-Silva CC,10.1055/s-0034-1394978,2014,NR,,0,,,,,
"analyzing spatial clustering and the spatiotemporal nature and trends of hiv/aids prevalence using gis: the case of malawi, 1994-2010",Zulu LC,10.1186/1471-2334-14-285,2014,NR,,0,,,,,
catalytic activity of apobec3f is required for efficient restriction of vif-deficient human immunodeficiency virus,Albin,10.1016/j.virol.2013.11.041,2014,NR,,0,,,,,
antibody b cell responses in hiv-1 infection,Mouquet H,10.1016/j.it.2014.08.007,2014,NR,,0,,,,,
application of ambiguous analysis for determining recent infections of hiv-1 in a china men who had sex with men population,Bai XiaoYan,,2014,NR,,0,,,,,
apri and fib-4 scores are not associated with neurocognitive impairment in hiv-infected persons,Libertone R,10.7448/IAS.17.4.19658,2014,NR,,0,,,,,
"assessing the relevance, efficiency, and sustainability of hiv/aids in-service training in nigeria",Burlew R,10.1186/1478-4491-12-20_old,2014,NR,,0,,,,,
assessment of viral diversity during viral rebound in a hiv-1 elite controller,Watters S,10.1111/hiv.12147,2014,NR,,0,,,,,
characterization and immunogenicity of a novel mosaic m hiv-1 gp140 trimer,Nkolola JP,10.1128/JVI.01739-14,2014,NR,,0,,,,,
association between hiv-1 tropism and ccr5 human haplotype e in a caucasian population,Huik K,10.1097/QAI.0000000000000127,2014,NR,,0,,,,,
characterising the complex mutational pathways associated with maraviroc-resistant hiv-1,Jiang X,,2014,NR,,0,,,,,
baseline cd4+ t cell counts correlates with hiv-1 synonymous rate in hla-b*5701 subjects with different risk of disease progression,Norstrom MM,10.1371/journal.pcbi.1003830,2014,NR,,0,,,,,
characterization of t-cell responses to conserved regions of the hiv-1 proteome in balb/c mice,Ondondo B,10.1128/CVI.00587-14,2014,NR,,0,,,,,
comparison of multiple adjuvants on the stability and immunogenicity of a clade c hiv-1 gp140 trimer,Nkolola JP,10.1016/j.vaccine.2014.02.001,2014,NR,,0,,,,,
clade homogeneity and pol gene polymorphisms in chronically hiv-1 infected antiretroviral treatment naive patients after the roll out of art in ethiopia,Mulu A,10.1186/1471-2334-14-158,2014,NR,,0,,,,,
can molecular hiv surveillance identify groups to prioritize for prevention?,Oster AM,,2014,NR,,0,,,,,
co-evolution of compensatory mutation k43e with mutation m41l in long-term hiv antiretroviral treatment,Wang Y,10.2174/1570162X12666140617154400,2014,NR,,0,,,,,
identification of a novel hiv-1 circulating recombinant form (crf72_bf1) in deep sequencing data from blood donors in southeastern brazil,Pessoa R,10.1128/genomeA.00386-14,2014,NR,,0,,,,,
causes and investigation of anaemia in patients with hiv,Jones T,10.1111/hiv.12147,2014,NR,,0,,,,,
cd8 and cd4 epitope predictions in rv144: no strong evidence of a t-cell driven sieve effect in hiv-1 breakthrough sequences from trial participants,Dommaraju K,10.1371/journal.pone.0111334,2014,NR,,0,,,,,
central memory and effector memory cd4 t cells from hiv controllers harbor distinct hiv strains,Boritz E,,2014,NR,,0,,,,,
cervical screening uptake and abnormalities among women attending sexual health clinics for hiv care,Tilley,10.1071/SH14063,2014,NR,,0,,,,,
comparison between an in-house method and the viroseqtm method for determining mutations for drug resistance in the hiv-1 crf01_ae subtype circulating in china,Li H,10.1016/j.jviromet.2014.04.020,2014,NR,,0,,,,,
challenges in the design of a t cell vaccine in the context of hiv-1 diversity,Tongo M,10.3390/v6103968,2014,NR,,0,,,,,
comparison of lower genital tract microbiota in hiv-infected and uninfected women from rwanda and the us,Benning L,10.1371/journal.pone.0096844,2014,NR,,0,,,,,
comparison of ultra-deep versus sanger sequencing detection of minority mutations on the hiv-1 drug resistance interpretations after virological failure,Mohamed S,10.1097/QAD.0000000000000267,2014,NR,,0,,,,,
competitive fitness assays indicate that the e138a substitution in hiv-1 reverse transcriptase decreases in vitro susceptibility to emtricitabine,Sluis-Cremer N,10.1128/AAC.02114-13,2014,NR,,0,,,,,
characteristics of patients recently infected with hiv-1 non-b subtypes in france: a nested study within the mandatory notification system for new hiv diagnoses,Brand D,10.1128/JCM.01141-14,2014,NR,,0,,,,,
concordance between allele-specific pcr and ultra-deep pyrosequencing for the detection of hiv-1 non-nucleoside reverse transcriptase inhibitor resistance mutations,Hunt GM,10.1016/j.jviromet.2014.07.010,2014,NR,,0,,,,,
contagiousness under antiretroviral therapy and stigmatization toward people with hiv,Drewes J,10.1080/09540121.2014.913768,2014,NR,,0,,,,,
preexisting compensatory amino acids compromise fitness costs of a hiv-1 t cell escape mutation,Liu D,10.1186/s12977-014-0101-0,2014,NR,,0,,,,,
cytoplasmic hiv-1 rna is mainly transported by diffusion in the presence or absence of gag protein,Chen J,10.1073/pnas.1413169111,2014,NR,,0,,,,,
"deep sequencing of hiv-1 near full-length proviral genomes identifies high rates of bf1 recombinants including two novel circulating recombinant forms (crf) 70_bf1 and a disseminating 71_bf1 among blood donors in pernambuco, brazil",Pessoa R,10.1371/journal.pone.0112674,2014,NR,,0,,,,,
the captured retroviral envelope syncytin-a and syncytin-b genes are conserved in the spalacidae together with hemotrichorial placentation,Vernochet C,10.1095/biolreprod.114.124818,2014,NR,,0,,,,,
three amino acid residues in the envelope of human immunodeficiency virus type 1 crf07_bc regulate viral neutralization susceptibility to the human monoclonal neutralizing antibody igg1b12,Nie J,10.1007/s12250-014-3485-z,2014,NR,,0,,,,,
contribution of human immunodeficiency virus type 1 minority variants to reduced drug susceptibility in patients on an integrase strand transfer inhibitor-based therapy,Gibson,10.1371/journal.pone.0104512,2014,NR,,0,,,,,
eef2 and ras-gap sh3 domain-binding protein (g3bp1) modulate stress granule assembly during hiv-1 infection,Valiente-Echeverria F,10.1038/ncomms5819,2014,NR,,0,,,,,
"coreceptor usage, diversity, and divergence in drug-naive and drug-exposed individuals from malawi, infected with hiv-1 subtype c for more than 20 years",Seager I,10.1089/aid.2013.0240,2014,NR,,0,,,,,
temporal and spatial organization of escrt protein recruitment during hiv-1 budding,Bleck M,10.1073/pnas.1321655111,2014,NR,,0,,,,,
impact of hla selection pressure on hiv fitness at a population level in mexico and barbados,Juarez-Molina CI,10.1128/JVI.01162-14,2014,NR,,0,,,,,
reliable reconstruction of hiv-1 whole genome haplotypes reveals clonal interference and genetic hitchhiking among immune escape variants,Pandit A,10.1186/1742-4690-11-56,2014,NR,,0,,,,,
critical amino acids within the human immunodeficiency virus type 1 envelope glycoprotein v4 n- and c-terminals contribute to virus entry,Li Y,10.1371/journal.pone.0086083,2014,NR,,0,,,,,
"characterization of the envelope glycoprotein of a novel filovirus, lloviu virus",Maruyama J,10.1128/JVI.02265-13,2014,NR,,0,,,,,
patterns of recombination in hiv-1m are influenced by selection disfavouring the survival of recombinants with disrupted genomic rna and protein structures,Golden M,10.1371/journal.pone.0100400,2014,NR,,0,,,,,
"a cluster analysis on the structural diversity of protein crystals, exemplified by human immunodeficiency virus type 1 protease",Qi F,,2014,NR,,0,,,,,
deep sequencing of hiv-infected cells: insights into nascent transcription and host-directed therapy,Peng X,10.1128/JVI.00768-14,2014,NR,,0,,,,,
co-expression of foreign proteins tethered to hiv-1 envelope glycoprotein on the cell surface by introducing an intervening second membrane-spanning domain,Wang H,10.1371/journal.pone.0096790,2014,NR,,0,,,,,
impact of mutations in highly conserved amino acids of the hiv-1 gag-p24 and env-gp120 proteins on viral replication in different genetic backgrounds,Liu Y,10.1371/journal.pone.0094240,2014,NR,,0,,,,,
"a truncated hnrnp a1 isoform, lacking the rgg-box rna binding domain, can efficiently regulate hiv-1 splicing and replication",Jean-Philippe J,10.1016/j.bbagrm.2014.02.002,2014,NR,,0,,,,,
cutting edge: an antibody recognizing ancestral endogenous virus glycoproteins mediates antibody-dependent cellular cytotoxicity on hiv-1-infected cells,Michaud HA,10.4049/jimmunol.1302108,2014,NR,,0,,,,,
the complex and specific pmhc interactions with diverse hiv-1 tcr clonotypes reveal a structural basis for alterations in ctl function,Xia Z,10.1038/srep04087,2014,NR,,0,,,,,
"new findings in cleavage sites variability across groups, subtypes and recombinants of human immunodeficiency virus type 1",Torrecilla E,10.1371/journal.pone.0088099,2014,NR,,0,,,,,
"near full-length genome identification of a novel hiv-1 recombinant form (crf01_ae/b'/c) among heterosexuals in jilin, china",Li X,10.1089/AID.2013.0278,2014,NR,,0,,,,,
cytotoxic and hiv-1 enzyme inhibitory activities of red sea marine organisms,Ellithey MS,10.1186/1472-6882-14-77,2014,NR,,0,,,,,
diverse recombinant hiv-1 envs fail to activate b cells expressing the germline b cell receptors of the broadly neutralizing anti-hiv-1 antibodies pg9 and 447-52d,McGuire AT,10.1128/JVI.03228-13,2014,NR,,0,,,,,
"identification of a novel hiv type 1 circulating recombinant form (crf65_cpx) composed of crf01_ae and subtypes b and c in western yunnan, china",Feng Y,10.1089/AID.2013.0233,2014,NR,,0,,,,,
vaccine-elicited human t cells recognizing conserved protein regions inhibit hiv-1,Borthwick N,10.1038/mt.2013.248,2014,NR,,0,,,,,
significant impact of non-b hiv-1 variants genetic diversity in gabon on plasma hiv-1 rna quantitation,Mouinga-Ondeme A,10.1002/jmv.23770,2014,NR,,0,,,,,
design challenges for hiv-1 vaccines based on humoral immunity,Greenspan NS,10.3389/fimmu.2014.00335,2014,NR,,0,,,,,
detection of hiv drug resistance by real-time pcr based method,Ulenga N,10.1515/cclm-2014-4001,2014,NR,,0,,,,,
detection of protein homolougs with hiv-1 antigens in bacteria of positive patients - phase ii,Hainova K,,2014,NR,,0,,,,,
development and validation of a high-content bimolecular fluorescence complementation assay for small-molecule inhibitors of hiv-1 nef dimerization,Poe JA,10.1177/1087057113513640,2014,NR,,0,,,,,
"development, calibration and performance of an hiv transmission model incorporating natural history and behavioral patterns: application in south africa",McCormick AW,10.1371/journal.pone.0098272,2014,NR,,0,,,,,
differentially expressed drug-resistant hiv subpopulations identiied by surface marker immunocapture,Malik S,,2014,NR,,0,,,,,
discovery of novel inhibitors of hiv-1 reverse transcriptase through virtual screening of experimental and theoretical ensembles,Ivetac A,10.1111/cbdd.12277,2014,NR,,0,,,,,
"distinct hiv-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies",Chikere K,10.1186/1742-4690-11-48,2014,NR,,0,,,,,
diversity of hiv/aids epidemic in china: a result from hierarchical clustering analysis and spatial autocorrelation analysis,Qian ShaSha,10.1097/QAD.0000000000000323,2014,NR,,0,,,,,
"correlates and outcomes of preterm birth, low birth weight, and small for gestational age in hiv-exposed uninfected infants",Slyker JA,10.1186/1471-2393-14-7,2014,NR,,0,,,,,
cost-effectiveness of community vegetable gardens for people living with hiv in zimbabwe,Puett C,10.1186/1478-7547-12-11,2014,NR,,0,,,,,
drug resistance mutations and genetic diversity in adults treated for hiv type 1 infection in mauritania,Fall-Malick FZ,10.1002/jmv.23860,2014,NR,,0,,,,,
diverse viral glycoproteins as well as cd4 co-package into the same human immunodeficiency virus (hiv-1) particles,Gregory DA,10.1186/1742-4690-11-28,2014,NR,,0,,,,,
cross-border sexual transmission of the newly emerging hiv-1 clade crf51_01b,Cheong HT,10.1371/journal.pone.0111236,2014,NR,,0,,,,,
cross-clade inhibition of hiv on primary cells by cxcr4 or ccr5 fused to the c34 peptide from gp41 hr2,Leslie GJ,,2014,NR,,0,,,,,
cross-clade ultrasensitive pcr-based assays to measure hiv persistence in large-cohort studies,Vandergeeten C,10.1128/JVI.00609-14,2014,NR,,0,,,,,
cross-neutralizing antibody profile of chinese hiv-1-infected individuals and the viral envelope features from elite neutralizers,Ren C,10.1097/QAI.0000000000000345,2014,NR,,0,,,,,
cross-reactive potential of human t-lymphocyte responses in hiv-1 infection,Giorgi EE,10.1016/j.vaccine.2014.04.040,2014,NR,,0,,,,,
dearth of full-length hiv-1 sequences obscures the true hiv-1 genetic subtypes distribution in sub-saharan africa,Pondei,,2014,NR,,0,,,,,
decline in locomotor functions over time in hiv-infected patients,Richert L,10.1097/QAD.0000000000000246,2014,NR,,0,,,,,
effect of early antiretroviral therapy on sexual behaviors and hiv-1 transmission risk among adults with diverse heterosexual partnership statuses in cote d'ivoire,Jean K,10.1093/infdis/jit470,2014,NR,,0,,,,,
deep sequencing of hiv: clinical and research applications,Chabria SB,10.1146/annurev-genom-091212-153406,2014,NR,,0,,,,,
effect of mobile telephone reminders on treatment outcome in hiv: evidence from a randomised controlled trial in india,Shet A,10.1136/bmj.g5978,2014,NR,,0,,,,,
early immune adaptation in hiv-1 revealed by population-level approaches,Martin E,10.1186/s12977-014-0064-1,2014,NR,,0,,,,,
defining differential genetic signatures in cxcr4- and the ccr5-utilizing hiv-1 co-linear sequences,Aiamkitsumrit B,10.1371/journal.pone.0107389,2014,NR,,0,,,,,
effects of the w153l substitution in hiv reverse transcriptase on viral replication and drug resistance to multiple categories of reverse transcriptase inhibitors,Xu HT,10.1128/AAC.02729-14,2014,NR,,0,,,,,
efficient phagocytosis and laccase activity affect the outcome of hiv-associated cryptococcosis,Sabiiti W,10.1172/JCI72950,2014,NR,,0,,,,,
"detection of the newly characterized hiv crf56_cpx in marseille, southeastern france",Colson P,10.1016/j.ijid.2014.10.020,2014,NR,,0,,,,,
enhanced immunogenicity of an hiv-1 dna vaccine delivered with electroporation via combined intramuscular and intradermal routes,Mann JFS,10.1128/JVI.00183-14,2014,NR,,0,,,,,
determination of viral tropism by genotyping and phenotyping assays in brazilian hiv-1-infected patients,Arruda LB,,2014,NR,,0,,,,,
developing high-throughput hiv incidence assay with pyrosequencing platform,Park SY,10.1128/JVI.03128-13,2014,NR,,0,,,,,
development and implementation of a workshop to enhance the effectiveness of mentors working with diverse mentees in hiv research,Gandhi M,10.1089/aid.2014.0018,2014,NR,,0,,,,,
development of a contemporary globally diverse hiv viral panel by the eqapol program,Sanchez AM,10.1016/j.jim.2014.01.004,2014,NR,,0,,,,,
development of broadly neutralizing antibodies from autologous neutralizing antibody responses in hiv infection,Derdeyn CA,10.1097/COH.0000000000000057,2014,NR,,0,,,,,
differential impact of apobec3-driven mutagenesis on hiv evolution in diverse anatomical compartments,Fourati,10.1097/QAD.0000000000000182,2014,NR,,0,,,,,
"discordances with hiv-1 rna quantitative determinations by three commercial assays in pointe noire, republic of congo",Bruzzone B,10.1016/j.jviromet.2014.02.030,2014,NR,,0,,,,,
discordant patterns of tissue-specific genetic characteristics in the hiv-1 env gene from hiv-associated neurocognitive disorder (hand) and non-hand patients,Ouyang Y,10.1007/s13365-014-0247-5,2014,NR,,0,,,,,
etravirine and rilpivirine-specific mutations selected by efavirenz and nevirapine exposure in patients infected with hiv-1 non-b subtypes,Crawford KW,10.1097/QAD.0000000000000350,2014,NR,,0,,,,,
evolution of hiv-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure,Rozera,10.1093/jac/dku255,2014,NR,,0,,,,,
genetic relatedness of human immunodeficiency virus-1 (hiv-1) strains in a 12-year-old daughter and her father in a household setting,Shao J,10.1007/s00705-013-1963-5,2014,NR,,0,,,,,
evolving molecular epidemiological profile of human immunodeficiency virus 1 in the southwest border of china,Chen Y,10.1371/journal.pone.0107578,2014,NR,,0,,,,,
"expansion of hiv care and treatment in yunnan province, china: treatment outcomes with scale up of combination antiretroviral therapy",Chen J,10.1080/09540121.2013.845281,2014,NR,,0,,,,,
exploring the hidden interrelationship of hiv-1 epidemics in asia and beyond,Takebe Y,,2014,NR,,0,,,,,
exposure of hiv-1 to a combination of two carbohydrate-binding agents markedly delays drug resistance development and selects for virus strains with compromised fitness,Mathys L,10.1093/jac/dkt414,2014,NR,,0,,,,,
expression analysis of immune-related genes in brain regions of the hiv-1 transgenic rat,Yang Z,10.1007/s11481-014-9535-3,2014,NR,,0,,,,,
factors informing hiv providers' decisions to start antiretroviral therapy for young people living with behaviorally acquired hiv,Lee L,10.1016/j.jadohealth.2014.03.006,2014,NR,,0,,,,,
"families matter: social relationships and adolescent hiv testing behaviors in ndola, zambia",Denison,10.1080/17450128.2013.808781,2014,NR,,0,,,,,
fitness impaired drug resistant hiv-1 is not compromised in cell-to-cell transmission or establishment of and reactivation from latency,Bastarache SM,10.3390/v6093487,2014,NR,,0,,,,,
high rates of human immunodeficiency virus type 1 mutational profiles by single-genome amplification after 48-hour propagation in peripheral blood mononuclear cells at different levels of cell activation,Russo CT,10.1159/000362415,2014,NR,,0,,,,,
french hiv experts on early antiretroviral treatment for prevention: uncertainty and heterogeneity,Lebouche B,10.1177/2325957413488196,2014,NR,,0,,,,,
early development of broadly neutralizing antibodies in hiv-1-infected infants,Goo L,10.1038/nm.3565,2014,NR,,0,,,,,
hiv-1 adaptation to antigen processing results in population-level immune evasion and affects subtype diversification,Tenzer S,10.1016/j.celrep.2014.03.031,2014,NR,,0,,,,,
effect of mood disorders and the predictive value of simple screening questions on screening for hiv-related neurocognitive impairment,Nally E,10.1111/hiv.12147,2014,NR,,0,,,,,
functional and structural characterization of 2-amino-4-phenylthiazole inhibitors of the hiv-1 nucleocapsid protein with antiviral activity,Mori M,10.1021/cb500316h,2014,NR,,0,,,,,
functional avidity and il-2/perforin production is linked to the emergence of mutations within hla-b*5701-restricted epitopes and hiv-1 disease progression,Buggert M,10.4049/jimmunol.1302253,2014,NR,,0,,,,,
human apobec3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection,Kim EY,10.1371/journal.ppat.1004281,2014,NR,,0,,,,,
engineered tcr-redirected clearance of gag-positive reservoir cells from art-treated subjects,Yang H,,2014,NR,,0,,,,,
genetic diversity and susceptibility study of single cryptococcal isolates from hiv-infected patients in indonesia,Adawiyah R,10.1111/myc.12196,2014,NR,,0,,,,,
estimating the fraction of progeny virions that must incorporate apobec3g for suppression of productive hiv-1 infection,Thangavelu PU,10.1016/j.virol.2013.11.026,2014,NR,,0,,,,,
genome-wide association study of human immunodeficiency virus (hiv)-1 coreceptor usage in treatment-naive patients from an aids clinical trials group study,Henrich TJ,10.1093/ofid/ofu018,2014,NR,,0,,,,,
"genotypes and transmitted drug resistance among treatment-naive hiv-1-infected patients in a northwestern province, china: trends from 2003 to 2013",Zhao K,10.1371/journal.pone.0109821,2014,NR,,0,,,,,
genotypic and functional impact of hiv-1 adaptation to its host population during the north american epidemic,Cotton LA,10.1371/journal.pgen.1004295,2014,NR,,0,,,,,
health behavior change models for hiv prevention and aids care: practical recommendations for a multi-level approach,Kaufman MR,10.1097/QAI.0000000000000236,2014,NR,,0,,,,,
"health care utilization and access to human immunodeficiency virus (hiv) testing and care and treatment services in a rural area with high hiv prevalence, nyanza province, kenya, 2007",Ackers M-L,10.4269/ajtmh.13-0181,2014,NR,,0,,,,,
higher risk of sexually acquired hcv coinfection in msm with wide hiv transmission bottleneck,Kouyos RD,,2014,NR,,0,,,,,
hiv diversity and drug resistance from plasma and non-plasma analytes in a large treatment program in western kenya,Kantor R,,2014,NR,,0,,,,,
hiv reverse-transcriptase drug resistance mutations during early infection reveal greater transmission diversity than in envelope sequences,Lipscomb JT,10.1093/infdis/jiu333,2014,NR,,0,,,,,
ethical considerations in hiv prevention and vaccine research in resource-limited settings,Garner SA,10.1097/QAI.0000000000000248,2014,NR,,0,,,,,
"hiv transmission in the united states: the roles of risk group, race/ethnicity, and geography",Oster AM,,2014,NR,,0,,,,,
"evidence that hiv-1 crf01-ae is associated with low cd4+t cell count and cxcr4 co-receptor usage in recently infected young men who have sex with men (msm) in shanghai, china",Li X,10.1371/journal.pone.0089462,2014,NR,,0,,,,,
hiv-1 antiretroviral drug resistance in pregnant women in jamaica: a preliminary report,Amarakoon II,10.7727/wimj.2014.016,2014,NR,,0,,,,,
hiv-1 conserved elements p24ce dna vaccine induces humoral immune responses with broad epitope recognition in macaques,Kulkarni V,10.1371/journal.pone.0111085,2014,NR,,0,,,,,
"hiv-1 diversity and drug resistance mutations among people seeking hiv diagnosis in voluntary counseling and testing sites in rio de janeiro, brazil",Velasco-de-Castro,10.1371/journal.pone.0087622,2014,NR,,0,,,,,
"hiv-1 diversity and drug-resistant mutations in infected individuals in changchun, china",Yan M,10.1371/journal.pone.0100540,2014,NR,,0,,,,,
"hiv-1 diversity, transmission dynamics and primary drug resistance in angola",Bartolo I,10.1371/journal.pone.0113626,2014,NR,,0,,,,,
examining the role of serostatus disclosure on unprotected sex among people living with hiv,Przybyla S,10.1089/apc.2014.0203,2014,NR,,0,,,,,
experiences and conceptualizations of sexual debut from the narratives of south african men and women in the context of hiv/aids,Stern,10.2989/16085906.2014.943252,2014,NR,,0,,,,,
"hiv-1 drug resistance mutations among infants born to hiv-positive mothers in busia, kenya",Lel R,10.1089/AID.2014.0158,2014,NR,,0,,,,,
exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy,Fong RH,10.1128/JVI.01943-14,2014,NR,,0,,,,,
"hiv-1 genetic characteristics and transmitted drug resistance among men who have sex with men in kunming, china",Chen M,10.1371/journal.pone.0087033,2014,NR,,0,,,,,
risk of breast cancer with hiv-using cxcr4 defined by v3-loop sequencing,Goedert JJ,10.1097/QAI.0000000000000400,2014,NR,,0,,,,,
hiv-1 near full-length genome analysis by nextgeneration sequencing: evaluation of quasispecies and minority drug resistance,Ode H,,2014,NR,,0,,,,,
full-length hiv-1 haplotype reconstruction from heterogeneous virus populations,Topfer A,,2014,NR,,0,,,,,
primer id deep sequencing of hiv-1 env region to reveal genetic structure of viral population,Zhou S,,2014,NR,,0,,,,,
hiv-1 subtype c is not associated with higher risk of heterosexual hiv-1 transmission: a multinational study among hiv-1 serodiscordant couples,Kahle E,10.1097/QAD.0000000000000024,2014,NR,,0,,,,,
impact of human leukocyte antigen polymorphisms in human immunodeficiency virus progression in a paediatric cohort infected with a mono-phyletic human immunodeficiency virus-1 strain,Montesano,,2014,NR,,0,,,,,
"hiv-1 subtypes b and c unique recombinant forms (urfs) and transmitted drug resistance identified in the western cape province, south africa",Jacobs GB,10.1371/journal.pone.0090845,2014,NR,,0,,,,,
hiv-1 transmission networks among men who have sex with men in asia,Ng KT,10.1093/cid/ciu480,2014,NR,,0,,,,,
hiv-1 transmission networks in a small world,Pennings PS,10.1093/infdis/jit525,2014,NR,,0,,,,,
hiv-1 vpr redirects host ubiquitination pathway,Arora S,10.1128/JVI.00619-14,2014,NR,,0,,,,,
genetic signatures of hiv-1 envelope-mediated bystander apoptosis,Joshi A,10.1074/jbc.M113.514018,2014,NR,,0,,,,,
hla-b*57 elite suppressor and chronic progressor hiv-1 isolates replicate vigorously and cause cd4+ t cell depletion in humanized blt mice,Salgado M,10.1128/JVI.03380-13,2014,NR,,0,,,,,
genotypic and phenotypic heterogeneity in the u3r region of hiv type 1 subtype c,Mates JM,10.1089/AID.2013.0026,2014,NR,,0,,,,,
genotypic prediction of tropism of highly diverse hiv-1 strains from cameroon,Mbondji-Wonje C,10.1371/journal.pone.0112434,2014,NR,,0,,,,,
"getting to zero the biomedical way in africa: outcomes of deliberation at the 2013 biomedical hiv prevention forum in abuja, nigeria",Folayan MO,10.1186/1753-6561-8-S3-S1,2014,NR,,0,,,,,
gfe blut hiv-1 triple target pcr for blood screening,Roth WK,10.1159/000368692,2014,NR,,0,,,,,
global panel of hiv-1 env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies,deCamp A,10.1128/JVI.02853-13,2014,NR,,0,,,,,
guavah: a compendium of host genetic data in hiv biology and disease,Bartha I,,2014,NR,,0,,,,,
human immunodeficiency virus type 1 (hiv-1) subtype b epidemic in panama is mainly driven by dissemination of country-specific clades,Mendoza Y,10.1371/journal.pone.0095360,2014,NR,,0,,,,,
innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following hiv infection,Nguyen PV,10.1038/cmi.2014.41,2014,NR,,0,,,,,
heterogeneous hiv testing preferences in an urban setting in tanzania: results from a discrete choice experiment,Ostermann J,10.1371/journal.pone.0092100,2014,NR,,0,,,,,
high-accuracy identification of incident hiv-1 infections using a sequence clustering based diversity measure,Xia XY,10.1371/journal.pone.0100081,2014,NR,,0,,,,,
high-throughput analysis of full-length proviral hiv-1 genomes from pbmcs,Imamichi H,,2014,NR,,0,,,,,
high-throughput profiling of point mutations across the hiv-1 genome,Al-Mawsawi LQ,10.1186/s12977-014-0124-6,2014,NR,,0,,,,,
identification of cryptosporidium subtype isolates from hiv-seropositive patients in equatorial guinea,Blanco MA,10.1093/trstmh/tru108,2014,NR,,0,,,,,
killer-cell immunoglobulin-like receptor (kir) genetic diversity in a unique hiv-1 cohort in china,Wang L,10.1111/imm.12406,2014,NR,,0,,,,,
immunity to hiv and influenza,Kent S,10.1111/imj.12432,2014,NR,,0,,,,,
"hiv infection among partners of hiv-infected black men who have sex with men - north carolina, 2011-2013",Peters PJ,,2014,NR,,0,,,,,
"impact of clade, geography, and age of the epidemic on hiv-1 neutralization by antibodies",Hraber P,10.1128/JVI.01705-14,2014,NR,,0,,,,,
impact of human immunodeficiency virus type-1 sequence diversity on antiretroviral therapy outcomes,Langs-Barlow A,10.3390/v6103855,2014,NR,,0,,,,,
"impact of immigration on hiv-1 molecular epidemiology in west africa, maghreb and southern europe",Miri L,,2014,NR,,0,,,,,
hiv prevalence and risk in long-distance truck drivers in south africa: a national cross-sectional survey,Delany-Moretlwe S,10.1177/0956462413512803,2014,NR,,0,,,,,
"hiv testing preferences in tanzania: a qualitative exploration of the importance of confidentiality, accessibility, and quality of service",Njau,,2014,NR,,0,,,,,
hiv transmission risk through condomless sex if hiv+ partner on suppressive art: partner study,Rodger A,,2014,NR,,0,,,,,
increased cxcr4 use of hiv-1 subtype c identified by population sequencing in patients failing antiretroviral treatment compared with treatment-naive patients in botswana,Sollerkvist LP,10.1089/AID.2013.0203,2014,NR,,0,,,,,
hiv-1 pol diversity among female bar and hotel workers in northern tanzania,Kiwelu IE,10.1371/journal.pone.0102258,2014,NR,,0,,,,,
hiv-1 quasispecies delineation by tag linkage deep sequencing,Wu NC,10.1371/journal.pone.0097505,2014,NR,,0,,,,,
"integration of prevention of mother-to-child transmission of hiv (pmtct) postpartum services with other hiv care and treatment services within the maternal and child health setting in zimbabwe, 2012",Wiegert K,10.1371/journal.pone.0098236,2014,NR,,0,,,,,
interferon-induced herc5 is evolving under positive selection and inhibits hiv-1 particle production by a novel mechanism targeting rev/rre-dependent rna nuclear export,Woods MW,10.1186/1742-4690-11-27,2014,NR,,0,,,,,
hiv-1 triple target nat for blood donation screening,Roth WK,10.1111/vox.12155,2014,NR,,0,,,,,
"investigation of hiv transmission dynamics reveals ""active"" clusters of men who have sex with men",Chan PA,,2014,NR,,0,,,,,
"investigation of hiv-1 drug-resistant variants in plasma bulk and cell-associated strains ultra-deep sequencing from blood donors in recife, brazil",Rodrigo P,10.7448/IAS.17.2.19170,2014,NR,,0,,,,,
"hiv/aids in older women: unique challenges, unmet needs (special issue: biopsychosocial challenges of older adults living with hiv)",Durvasula,10.1080/08964289.2014.893983,2014,NR,,0,,,,,
"lack of detectable hiv dna in a prep study participant treated during ""hyperacute"" hiv infection",Hatano H,,2014,NR,,0,,,,,
"hla class i, kir, and genome-wide snp diversity in the rv144 thai phase 3 hiv vaccine clinical trial",Prentice HA,10.1007/s00251-014-0765-6,2014,NR,,0,,,,,
lack of detectable hiv-1 molecular evolution during suppressive antiretroviral therapy,Kearney MF,10.1371/journal.ppat.1004010,2014,NR,,0,,,,,
homogeneous heparan sulfate oligomers for nmr studies of vacv b18 gag binding,Pederson K,10.1093/glycob/cwu087,2014,NR,,0,,,,,
host and viral determinants for mxb restriction of hiv-1 infection,Matreyek KA,10.1186/s12977-014-0090-z,2014,NR,,0,,,,,
host-specific adaptation of hiv-1 subtype b in the japanese population,Chikata T,10.1128/JVI.00147-14,2014,NR,,0,,,,,
human semen contains exosomes with potent anti-hiv-1 activity,Madison MN,10.1186/s12977-014-0102-z,2014,NR,,0,,,,,
"location-based hiv behavioural surveillance among msm in auckland, new zealand 2002-2011: condom use stable and more hiv testing",Saxton,10.1136/sextrans-2013-051160,2014,NR,,0,,,,,
"identifying factors associated with the uptake of prevention of mother to child hiv transmission programme in tigray region, ethiopia: a multilevel modeling approach",Lerebo,,2014,NR,,0,,,,,
impact of sampling density on the extent of hiv clustering,Novitsky V,10.1089/aid.2014.0173,2014,NR,,0,,,,,
independent assessment of candidate hiv incidence assays on specimens in the cephia repository,Kassanjee R,10.1097/QAD.0000000000000429,2014,NR,,0,,,,,
methodological challenges in collecting social and behavioural data regarding the hiv epidemic among gay and other men who have sex with men in australia,Zablotska IB,10.1371/journal.pone.0113167,2014,NR,,0,,,,,
"insight derived from molecular dynamics simulations into molecular motions, thermodynamics and kinetics of hiv-1 gp120",Sang P,10.1371/journal.pone.0104714,2014,NR,,0,,,,,
intercontinental dispersal of hiv-1 subtype b associated with transmission among men who have sex with men in japan,Takebe Y,10.1128/JVI.01354-14,2014,NR,,0,,,,,
"molecular diversity of hiv-1 and surveillance of transmitted drug resistance variants among treatment naive patients, 5 years after active introduction of haart in kuala lumpur, malaysia",Ong LY,10.1002/jmv.23772,2014,NR,,0,,,,,
intra-facility linkage of hiv-positive mothers and hiv-exposed babies into hiv chronic care: rural and urban experience in a resource limited setting,Mugasha C,10.1371/journal.pone.0115171,2014,NR,,0,,,,,
barriers to uptake and use of pre-exposure prophylaxis (prep) among communities most affected by hiv in the uk: findings from a qualitative study in scotland,Young I,10.1136/bmjopen-2014-005717,2014,NR,,0,,,,,
an intervention to reduce hiv-related stigma in partnership with african american and latino churches,Derose KP,10.1521/aeap.2014.26.1.28,2014,NR,,0,,,,,
alternative sigma factor rpoe is important for vibrio parahaemolyticus cell envelope stress response and intestinal colonization,Haines-Menges B,10.1128/IAI.01854-14,2014,NR,,0,,,,,
"near full-length genome sequence of a novel hiv-1 recombinant form (crf01-ae/b) detected among men who have sex with men in jilin province, china",Li X,10.1089/aid.2014.0008,2014,NR,,0,,,,,
"a novel hiv-1 crf01-ae/b recombinant among men who have sex with men in jiangsu province, china",Guo H,10.1089/aid.2014.0012,2014,NR,,0,,,,,
"near full-length genome identification of a novel hiv-1 recombinant form (crf01-ae/b'/c) among heterosexuals in jilin, china",Li X,10.1089/aid.2013.0278,2014,NR,,0,,,,,
"molecular epidemiology of hiv-1 strains in antalya, turkey",Inan D,10.7448/IAS.17.4.19684,2014,NR,,0,,,,,
just getting by': a cross-sectional study of male sex workers as a key population for hiv/stis among men who have sex with men in peru,Bayer,10.1136/sextrans-2013-051265,2014,NR,,0,,,,,
ifitm proteins incorporated into hiv-1 virions impair viral fusion and spread,Compton AA,10.1016/j.chom.2014.11.001,2014,NR,,0,,,,,
implementing a brief evidence-based hiv intervention: a mixed methods examination of compliance fidelity,Dolcini MM,10.1007/s13142-014-0268-x,2014,NR,,0,,,,,
"identification of a novel hiv-1 second-generation recombinant form (crf01-ae/crf07-bc) in jilin, china",Feng Y,10.1089/aid.2014.0071,2014,NR,,0,,,,,
recombination accelerates adaptation on a large-scale empirical fitness landscape in hiv-1,Moradigaravand D,10.1371/journal.pgen.1004439,2014,NR,,0,,,,,
evolution of hiv-related stigma in spain between 2008 and 2012,Fuster-Ruizdeapodaca MJ,10.1080/09540121.2014.906557,2014,NR,,0,,,,,
antigen modification regulates competition of broad and narrow neutralizing hiv antibodies,McGuire AT,10.1126/science.1259206,2014,NR,,0,,,,,
abcc protein function and genetic variability in hiv infection,Maciejewska K,10.1016/j.hivar.2014.03.001,2014,NR,,0,,,,,
molecular epidemiology of recent seroconverters and drug-resistant hiv-1 transmission networks in japan,Hattori J,,2014,NR,,0,,,,,
molecular evolution of broadly neutralizing llama antibodies to the cd4-binding site of hiv-1,McCoy LE,10.1371/journal.ppat.1004552,2014,NR,,0,,,,,
leishmania amastigotes in the ascites of a hiv-positive patient,Szeto,10.1002/dc.23082,2014,NR,,0,,,,,
identification of a novel hiv-1 circulating recombinant form (crf62-bc) in western yunnan of china,Wei H,10.1089/aid.2013.0235,2014,NR,,0,,,,,
"genome sequence of a novel hiv-1 circulating recombinant form (crf57-bc) identified from yunnan, china",Wei H,10.1089/aid.2013.0228,2014,NR,,0,,,,,
"deep sequencing of hiv-1 near full-length proviral genomes identifies high rates of bf1 recombinants including two novel circulating recombinant forms (crf) 70-bf1 and a disseminating 71-bf1 among blood donors in pernambuco, brazil",Pessoa R,10.1371/journal.pone.0112674,2014,NR,,0,,,,,
lessons learnt from sexual and reproductive health and hiv linkages for multipurpose prevention technology service delivery,Lusti-Narasimhan M,10.1111/1471-0528.12845,2014,NR,,0,,,,,
"identification of a novel hiv type 1 circulating recombinant form (crf65-cpx) composed of crf01-ae and subtypes b and c in western yunnan, china",Feng Y,10.1089/aid.2013.0233,2014,NR,,0,,,,,
"hiv-1 genetic diversity in russia: crf63-02a1, a new hiv type 1 genetic variant spreading in siberia",Baryshev PB,10.1089/aid.2013.0196,2014,NR,,0,,,,,
the fitness landscape of hiv-1 gag: advanced modeling approaches and validation of model predictions by in vitro testing,Mann JK,10.1371/journal.pcbi.1003776,2014,NR,,0,,,,,
programmed death-1 expression on cd4+ and cd8+ t cells in treated and untreated hiv disease,Cockerham LR,10.1097/QAD.0000000000000314,2014,NR,,0,,,,,
linkage of viral sequences among hiv-infected village residents in botswana: estimation of linkage rates in the presence of missing data,Carnegie NB,10.1371/journal.pcbi.1003430,2014,NR,,0,,,,,
community-based implementation and effectiveness in a randomized trial of a risk reduction intervention for hiv-serodiscordant couples: study protocol,Hamilton AB,10.1186/1748-5908-9-79,2014,NR,,0,,,,,
full-length genome sequences of estonian hiv-1 crf06 and eastern-european subtype a1 recombinant forms,Avi R,,2014,NR,,0,,,,,
baseline hiv-1 tropism prediction in advanced immune suppressed patients: evidence of cxcr4 viruses in idus infected with recombinant forms,Paraschiv S,,2014,NR,,0,,,,,
loss and recovery of genetic diversity in adapting populations of hiv,Pennings PS,10.1371/journal.pgen.1004000,2014,NR,,0,,,,,
hiv antibody characterization to quantify reservoir size during curative interventions,Burbelo PD,,2014,NR,,0,,,,,
complex impact of reversion mutations and cd8+ t cell escape mutations on hiv-1 fitness,Song H,,2014,NR,,0,,,,,
lower odds of hiv among circumcised msm in china and interaction with anal sexual role,Qian H-Z,,2014,NR,,0,,,,,
structure determination of vpu from hiv-1 by nmr,Zhang H,10.1002/pro.2504,2014,NR,,0,,,,,
silent mutations in hiv-1 subtype b reverse transcriptase selected by art restore viral fitness,Telwatte S,,2014,NR,,0,,,,,
multilocus sequence typing of serially collected isolates of cryptococcus from hiv-infected patients in south africa,Van Wyk M,10.1128/JCM.03177-13,2014,NR,,0,,,,,
"making the invisible, visible: a cross-sectional study of late presentation to hiv/aids services among men who have sex with men from a large urban center of brazil",MacCarthy,,2014,NR,,0,,,,,
attitudes and beliefs towards early art initiation in msm with primary hiv infection,Parsons V,10.7448/IAS.17.4.19732,2014,NR,,0,,,,,
primer id deep sequencing of hiv-1 env region to reveal the genetic structure of viral populations with x4 variants,Zhou S,,2014,NR,,0,,,,,
live cell imaging of cytoplasmic mrnp complexes in response to hiv-1 infection,Becker JT,,2014,NR,,0,,,,,
human cytomegalovirus gb genotype distribution among hiv infected patients from pretoria,Baloyi SS,10.1016/j.ijid.2014.03.1350,2014,NR,,0,,,,,
"midwives' perspectives on male participation in pmtct of hiv and how they can support it in lusaka, zambia",Auvinen J,10.1016/j.midw.2013.01.010,2014,NR,,0,,,,,
mobile men with money': hiv prevention and the erasure of difference,Aggleton P,10.1080/17441692.2014.889736,2014,NR,,0,,,,,
molecular diversity of hiv-1 in croatia,Grgic I,,2014,NR,,0,,,,,
molecular genetics of hiv-1 strains spreading in russia,Karamov E,10.4172/1948-5964.S1.020,2014,NR,,0,,,,,
"multi-level factors affecting entry into and engagement in the hiv continuum of care in iringa, tanzania",Layer EH,10.1371/journal.pone.0104961,2014,NR,,0,,,,,
ongoing hiv-1 subtype b transmission networks in the netherlands,Bezemer D,,2014,NR,,0,,,,,
multiple discriminations experienced by people living with hiv in france: results from the anrs-vespa2 study,Marsicano E,10.1080/09540121.2014.907385,2014,NR,,0,,,,,
optimized lentiviral vectors for hiv gene therapy: multiplexed expression of small rnas and inclusion of mgmt p140k drug resistance gene,Chung J,10.1038/mt.2014.32,2014,NR,,0,,,,,
natural polymorphisms in human apobec3h and hiv-1 vif combine in primary t lymphocytes to affect viral g-to-a mutation levels and infectivity,Refsland EW,10.1371/journal.pgen.1004761,2014,NR,,0,,,,,
pathways towards risk: syndemic conditions mediate the effect of adversity on hiv risk behaviors among young men who have sex with men (ymsm),Herrick,10.1007/s11524-014-9896-1,2014,NR,,0,,,,,
patterns of geographic mobility predict barriers to engagement in hiv care and antiretroviral treatment adherence,Taylor BS,10.1089/apc.2014.0028,2014,NR,,0,,,,,
next generation sequencing of full-length hiv-1 env during primary infection,Laird M E,,2014,NR,,0,,,,,
persistence of vrc01-resistant hiv-1 during antiretroviral therapy,Guo D,10.1007/s11427-013-4593-y,2014,NR,,0,,,,,
persistent hiv in plasma during cart can lead to rebound viremia after treatment interruption,Hattori J,,2014,NR,,0,,,,,
sequence heterogeneity in human immunodeficiency virus type 1 nef in patients presenting with rapid progression and delayed progression to aids,Gupta P,10.1007/s00705-014-2026-2,2014,NR,,0,,,,,
phylodynamic analysis of a regional hiv epidemic,Joy JB,,2014,NR,,0,,,,,
online detection of concerned hiv-related messages in web forums,Sung R-J,10.1080/09540121.2013.819408,2014,NR,,0,,,,,
phylogenetic analysis of hiv type 1 crf02-ag in multiple genes in italian and african patients living in italy,Paolucci S,10.1089/aid.2014.0002,2014,NR,,0,,,,,
oregon patients with hiv infection who experience delayed diagnosis,Schwartz SL,10.1080/09540121.2014.882494,2014,NR,,0,,,,,
phylogenetic analysis of hiv-1 pol gene: first subgenomic evidence of crf29-bf among iranian hiv-1 patients,Baesi K,10.1016/S2222-1808%2814%2960690-3,2014,NR,,0,,,,,
phylogenetic and geospatial evaluation of hiv-1 subtype diversity at the largest hiv center in rhode island,Chan PA,10.1016/j.meegid.2014.03.027,2014,NR,,0,,,,,
particle infectivity of hiv-1 full-length genome infectious molecular clones in a subtype c heterosexual transmission pair following high fidelity amplification and unbiased cloning,Deymier MJ,10.1016/j.virol.2014.08.018,2014,NR,,0,,,,,
pattern of the evolution of hiv-1 ennu gene in cote d'ivoire,Bi SG,10.6026/97320630010671,2014,NR,,0,,,,,
performance of hiv rapid tests to identify seroconverters in mtn 003 (voice),Parikh UM,,2014,NR,,0,,,,,
"perinatal hiv testing among african american, caucasian, hmong and latina women: exploring the role of health-care services, information sources and perceptions of hiv/aids",King,10.1093/her/cyt101,2014,NR,,0,,,,,
pharmacologic prevention of perinatal hiv infection,Rakhmanina,10.1016/S0378-3782(14)70005-2,2014,NR,,0,,,,,
physician communication behaviors from the perspective of adult hiv patients in kenya,Wachira J,10.1093/intqhc/mzu004,2014,NR,,0,,,,,
"polymorphisms in the hiv-1 gp41 env gene, natural resistance to enfuvirtide (t-20) and pol resistance among pregnant brazilian women",Reis MN,10.1002/jmv.23738,2014,NR,,0,,,,,
"pi mutations and polymorphisms in hiv subtype ae by deep sequencing in art-naive subjects from hunan province, china",Zou X,,2014,NR,,0,,,,,
"potential implications of cyp3a4, cyp3a5 and mdr-1 genetic variants on the efficacy of lopinavir/ritonavir (lpv/r) monotherapy in hiv-1 patients",Berno G,10.7448/IAS.17.4.19589,2014,NR,,0,,,,,
polypharmacy and physiologic frailty in hiv-infected veterans,Sung M,,2014,NR,,0,,,,,
predicting the impact of cd8+ t cell polyfunctionality on hiv disease progression,Graw F,10.1128/JVI.00647-14,2014,NR,,0,,,,,
predictors of adverse pregnancy outcomes in women infected with hiv in latin america and the caribbean: a cohort study,Kreitchmann R,10.1111/1471-0528.12680,2014,NR,,0,,,,,
preservation of tetherin and cd4 counter-activities in circulating vpu alleles despite extensive sequence variation within hiv-1 infected individuals,Pickering S,10.1371/journal.ppat.1003895,2014,NR,,0,,,,,
prevalence and evolution of low frequency hiv drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failure,Vandenhende MA,10.1371/journal.pone.0086771,2014,NR,,0,,,,,
proceedings of the 7th romanian national hiv/aids congress and the 2nd central european hiv forum,Anonymous,,2014,NR,,0,,,,,
progress in hiv-1 vaccine development,Haynes BF,10.1016/j.jaci.2014.04.025,2014,NR,,0,,,,,
prolonged and shorter aerobic exercise training in hiv,Birk,,2014,NR,,0,,,,,
promising antibody testing strategies for early infant hiv infection diagnosis in china,Su X,10.1371/journal.pone.0099935,2014,NR,,0,,,,,
profile of the hiv epidemic in cape verde: molecular epidemiology and drug resistance mutations among hiv-1 and hiv-2 infected patients from distinct islands of the archipelago,De Pina-Araujo IIM,10.1371/journal.pone.0096201,2014,NR,,0,,,,,
project style: a multisite rct for hiv prevention among youths in mental health treatment,Brown LK,10.1176/appi.ps.201300095,2014,NR,,0,,,,,
"rational design and characterization of the novel, broad and potent bispecific hiv-1 neutralizing antibody imabm36",Sun M,10.1097/QAI.0000000000000218,2014,NR,,0,,,,,
research into a functional cure for hiv in neonates: the need for ethical foresight,Shah SK,10.1016/S1473-3099%2814%2970766-2,2014,NR,,0,,,,,
recent progress in developing potent and broadly active hiv-1 maturation inhibitors,Urano E,,2014,NR,,0,,,,,
risk factors for delayed entrance into care after diagnosis among patients with late-stage hiv disease in southern vietnam,Rangarajan S,10.1371/journal.pone.0108939,2014,NR,,0,,,,,
role of semen in altering the balance between inflammation and tolerance in the female genital tract: does it contribute to hiv risk?,Rametse CL,10.1089/vim.2013.0136,2014,NR,,0,,,,,
rt-aptamer interactions govern antiviral specificity and viral encapsidation of anti-hiv rt aptamers,Lange MJ,10.1038/mt.2014.64,2014,NR,,0,,,,,
reliance on condoms for contraceptive protection among hiv care and treatment clients: a mixed methods study on contraceptive choice and motivation within a generalised epidemic,Church K,10.1136/sextrans-2013-051339,2014,NR,,0,,,,,
resilience processes demonstrated by young gay and bisexual men living with hiv: implications for intervention,Harper GW,10.1089/apc.2013.0330,2014,NR,,0,,,,,
reversal of the kynurenine pathway of tryptophan catabolism may improve depression in art-treated hiv-infected ugandans,Martinez,10.1097/QAI.0000000000000062,2014,NR,,0,,,,,
short communication: hiv-1 gag genetic variation in a single acutely infected participant defined by high-resolution deep sequencing,Al-Mawsawi LQ,10.1089/AID.2014.0097,2014,NR,,0,,,,,
single genome analysis reveals genetic characteristics of neuroadaptation across hiv-1 envelope,Evering TH,10.1186/s12977-014-0065-0,2014,NR,,0,,,,,
"safety and tolerability of conserved region vaccines vectored by plasmid dna, simian adenovirus and modified vaccinia virus ankara administered to human immunodeficiency virus type 1-uninfected adults in a randomized, single-blind phase i trial",Hayton EJ,10.1371/journal.pone.0101591,2014,NR,,0,,,,,
the role of serpin and cystatin antiproteases in mucosal innate immunity and their defense against hiv,Aboud L,10.1111/aji.12166,2014,NR,,0,,,,,
sensitive testing of plasma hiv-1 rna and sanger sequencing of cellular hiv-1 dna for the detection of drug resistance prior to starting first-line antiretroviral therapy with etravirine or efavirenz,Geretti AM,10.1093/jac/dkt474,2014,NR,,0,,,,,
south african hiv strains in india: did clade c follow the mandrax route?,Sehgal S,10.4103/0255-0857.129763,2014,NR,,0,,,,,
the route of hiv escape from immune response targeting multiple sites is determined by the cost-benefit tradeoff of escape mutations,Batorsky R,10.1371/journal.pcbi.1003878,2014,NR,,0,,,,,
sequences type analysis of candida albicans isolates from iranian human immunodeficiency virus infected patients with oral candidiasis,Katiraee F,,2014,NR,,0,,,,,
statin use in the atp iii guidelines compared to the 2013 acc/aha guidelines in hiv primary care patients,Cha A,10.1002/phar.1497,2014,NR,,0,,,,,
severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis,Nieto-Torres JL,10.1371/journal.ppat.1004077,2014,NR,,0,,,,,
sexual risk for hiv among gay male couples: a longitudinal study of the impact of relationship dynamics,Darbes LA,,2014,NR,,0,,,,,
superimposed epitopes restricted by the same hla molecule drive distinct hiv-specific cd8+ t cell repertoires,Sun X,10.4049/jimmunol.1400375,2014,NR,,0,,,,,
short communication: molecular epidemiology of hiv type 1 infection in northern greece (2009-2010): evidence of a transmission cluster of hiv type 1 subtype a1 drug-resistant strains among men who have sex with men,Antoniadou Z-A,10.1089/aid.2013.0166,2014,NR,,0,,,,,
targeted deep sequencing of hiv-1 using the iontorrentpgm platform,Kijak GH,10.1016/j.jviromet.2014.04.017,2014,NR,,0,,,,,
"spatial analysis of hiv positive injection drug users in san francisco, 1987 to 2005",Martinez AN,10.3390/ijerph110403937,2014,NR,,0,,,,,
spatial epidemiology of recently acquired hiv infections across rural and urban areas of north carolina,Carrel M,10.1371/journal.pone.0088512,2014,NR,,0,,,,,
testing for hiv-the first 3 decades,Busch MP,10.1111/vox.12153,2014,NR,,0,,,,,
striking lack of t cell immunodominance in both a multiclade and monoclade hiv-1 epidemic: implications for vaccine development,Tongo M,10.1016/j.vaccine.2014.02.063,2014,NR,,0,,,,,
sustained spread of hiv-1 drug resistance in treatment-naive patients in the united kingdom,Mbisa JL,,2014,NR,,0,,,,,
synthesis and biological evaluation of macrocyclized betulin derivatives as a novel class of anti-hiv-1 maturation inhibitors,Tang J,10.2174/1874104501408010023,2014,NR,,0,,,,,
temporal trends in the swedish hiv-1 epidemic: increase in non-b subtypes and recombinant forms over three decades,Neogi U,10.1371/journal.pone.0099390,2014,NR,,0,,,,,
the characteristics of the hiv subtype b epidemic in slovenia,Lunar MM,,2014,NR,,0,,,,,
the connection domain mutation n348i in hiv-1 reverse transcriptase enhances resistance to etravirine and rilpivirine but restricts the emergence of the e138k resistance mutation by diminishing viral replication capacity,Xu HT,10.1128/JVI.02904-13,2014,NR,,0,,,,,
the cost of antiretroviral treatment service for patients with hiv/aids in a central outpatient clinic in vietnam,Nguyen LT,10.2147/CEOR.S57028,2014,NR,,0,,,,,
the depth of water requires knowledge: listening to the voices of the hiv patient journey,Howard PA,,2014,NR,,0,,,,,
the difference between the numbers of lymphocyte expressing co-stimulatory molecules from hbv and hiv-infected individuals,Srisurapanon S,10.1111/ijlh.12265/abstract,2014,NR,,0,,,,,
the effective population size of hiv-1 is large in vivo,Jabara C,,2014,NR,,0,,,,,
the genealogical population dynamics of hiv-1 in a large transmission chain: bridging within and among host evolutionary rates,Vrancken B,10.1371/journal.pcbi.1003505,2014,NR,,0,,,,,
the evolution of hiv-1 group m genetic variability in southern cameroon is characterized by several emerging recombinant forms of crf02_ag and viruses with drug resistance mutations,Agyingi L,10.1002/jmv.23846,2014,NR,,0,,,,,
"the increasing genetic diversity of hiv-1 in the uk, 2002-2010",UK Collaborative Group on HIV Drug Resistance,10.1097/QAD.0000000000000119,2014,NR,,0,,,,,
the influence of delivery vectors on hiv vaccine efficacy,Ondondo BO,10.3389/fmicb.2014.00439,2014,NR,,0,,,,,
"the influence of hiv-1 subtypes c, crf31_bc and b on disease progression and initial virologic response to haart in a southern brazilian cohort",Nunes CC,10.1590/S0036-46652014000300005,2014,NR,,0,,,,,
"the impact of a food assistance program on nutritional status, disease progression, and food security among people living with hiv in uganda",Rawat R,10.1097/QAI.0000000000000079,2014,NR,,0,,,,,
"the relationship between sexual trauma, peritraumatic dissociation, posttraumatic stress disorder, and hiv-related health in hiv-positive men",Yiaslas TA,10.1080/15299732.2013.873376,2014,NR,,0,,,,,
the lower airway microbiome of hiv subjects with and without pneumonia is characterized by enrichment with psychrobacter and microbacterium,Danckers M,,2014,NR,,0,,,,,
the lung microbiome of hiv-infected pneumonia patients in uganda,Iwai S,,2014,NR,,0,,,,,
the role of fc receptors in hiv infection and vaccine efficacy,Cocklin SL,10.1097/COH.0000000000000051,2014,NR,,0,,,,,
"the prevalence of transmitted hiv drug resistance among msm in anhui province, china",Shen Y,10.1186/1742-6405-11-19,2014,NR,,0,,,,,
the r263k mutation in hiv integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compound,Wainberg M,10.7448/IAS.17.4.19518,2014,NR,,0,,,,,
the variable loop 3 in the envelope glycoprotein is critical for the atypical coreceptor usage of an hiv-1 strain,Xiang Y,10.1371/journal.pone.0098058,2014,NR,,0,,,,,
"the role of viral introductions in sustaining community-based hiv epidemics in rural uganda: evidence from spatial clustering, phylogenetics, and egocentric transmission models",Grabowski MK,10.1371/journal.pmed.1001610,2014,NR,,0,,,,,
the search for a t cell line for testing novel antiviral strategies against hiv-1 isolates of diverse receptor tropism and subtype origin,Herrera-Carrillo E,10.1016/j.jviromet.2014.03.021,2014,NR,,0,,,,,
the semen microbiome and its relationship with local immunology and viral load in hiv infection,Liu CM,10.1371/journal.ppat.1004262,2014,NR,,0,,,,,
tracking the luminal exposure and lymphatic drainage pathways of intravaginal and intrarectal inocula used in nonhuman primate models of hiv transmission,Smedley J,10.1371/journal.pone.0092830,2014,NR,,0,,,,,
cardiovascular disease in patients with chronic human immunodeficiency virus infection,Escarcega,10.1016/j.ijcard.2014.04.155,2014,NR,,0,,,,,
"transmission clustering among newly diagnosed hiv+ patients in chicago, 2008 to 2011",Hoehnen S,,2014,NR,,0,,,,,
"the identification of a novel hiv-1 crf01_ae/b recombinant using the near full length genome in jiangsu province, china",Guo HongXiong,10.1089/aid.2014.0187,2014,NR,,0,,,,,
towards elimination of mother-to-child transmission of hiv: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in malawi (option b+),Van Lettow M,10.7448/IAS.17.1.18994,2014,NR,,0,,,,,
transmission and persistence of antiretroviral resistance amongst drug naive hiv positive individuals in the united kingdom,Mourad R,,2014,NR,,0,,,,,
transmission and prevention of hiv among heterosexual populations in australia (special issue: australia's hiv-prevention response),Persson,10.1521/aeap.2014.26.3.245,2014,NR,,0,,,,,
"transmission networks of hiv-1 subtype b, crf01_ae and crf51_01b among msm in singapore",Ng K T,,2014,NR,,0,,,,,
using syndemic theory to understand vulnerability to hiv infection among black and latino men in new york city,Wilson PA,10.1007/s11524-014-9895-2,2014,NR,,0,,,,,
transmitted hiv-1 drug resistance between partner-pairs,Stekler J,,2014,NR,,0,,,,,
variations of hla-c gene among hiv-infections in chinese southwest han population,Ou G,10.1111/vox.12155,2014,NR,,0,,,,,
treatment-naive individuals are the major source of transmitted hiv-1 drug resistance in men who have sex with men in the swiss hiv cohort study,Drescher SM,10.1093/cid/cit694,2014,NR,,0,,,,,
virus particle release from glycosphingolipid-enriched microdomains is essential for dendritic cell-mediated capture and transfer of hiv-1 and henipavirus,Akiyama H,10.1128/JVI.00992-14,2014,NR,,0,,,,,
use of deep sequencing data for routine analysis of hiv resistance in newly diagnosed patients,Fernandez-Caballero JA,10.7448/IAS.17.4.19748,2014,NR,,0,,,,,
using hiv networks to inform real time prevention interventions,Little SJ,,2014,NR,,0,,,,,
what is health communication and how does it affect the hiv/aids continuum of care? a brief primer and case study from new york city (special issue: strategic roles for health communication in combination hiv prevention and care programs),Storey,10.1097/QAI.0000000000000243,2014,NR,,0,,,,,
using rnaseq to characterize viral genetic diversity in a cohort of hiv-2 monoinfected individuals,James KL,,2014,NR,,0,,,,,
validation of hiv-1 drug resistance testing by deep sequencing: insights from comparative sanger sequencing,Thielen A,,2014,NR,,0,,,,,
vectored immunoprophylaxis protects humanized mice from mucosal hiv transmission,Balazs AB,10.1038/nm.3471,2014,NR,,0,,,,,
"what should the ideal hiv self-test look like? a usability study of test prototypes in unsupervised hiv self-testing in kenya, malawi, and south africa",Peck RB,,2014,NR,,0,,,,,
who is caring for our hiv-infected youth? disparities on adolescent-oriented clinical training of providers caring for hiv-infected youth,Lee L,10.1016/j.jadohealth.2013.10.133,2014,NR,,0,,,,,
"zero prevalence of primary drug resistance-associated mutations to protease inhibitors in hiv-1 drug-naive patients in and around aligarh, india",Azam M,10.3855/jidc.3480,2014,NR,,0,,,,,
"""i thought we are safe"": southern african lesbians' experiences of living with hiv",Matebeni,10.1080/13691058.2013.764016,2013,NR,,0,,,,,
"""if it's not working, why would they be testing it?"": mental models of hiv vaccine trials and preventive misconception among men who have sex with men in india",Venkatesan Chakrapani,,2013,NR,,0,,,,,
"""sisters, mothers, daughters and aunties"": hiv vaccine acceptability among african, caribbean and other black women in toronto",Weaver J,,2013,NR,,0,,,,,
"""what could have been different"": a qualitative study of syndemic theory and hiv prevention among young men who have sex with men (special issue: hiv/aids in adolescents and emerging adults: domestic and international perspectives on intervention development, treatment, and prevention)",Lyons,10.1080/15381501.2013.816211,2013,NR,,0,,,,,
a compensatory mutation provides resistance to disparate hiv fusion inhibitor peptides and enhances membrane fusion,Wood MP,10.1371/journal.pone.0055478,2013,NR,,0,,,,,
a digital signal processing-based bioinformatics approach to identifying the origins of hiv-1 non b subtypes infecting us army personnel serving abroad,Nwankwo N,,2013,NR,,0,,,,,
a forgotten drug in the hiv epidemic: alcohol use and unprotected sexual behavior in high-risk african american men,Operario D,10.1111/acer.12163,2013,NR,,0,,,,,
a model of hiv drug resistance driven by heterogeneities in host immunity and adherence patterns,Bershteyn A,10.1186/1752-0509-7-11,2013,NR,,0,,,,,
a multi-targeted drug candidate with dual anti-hiv and anti-hsv activity,Balzarini J,10.1371/journal.ppat.1003456,2013,NR,,0,,,,,
"acceptability of serial hiv testing and partner testing during pregnancy and lactation in tororo, uganda",Kim L,10.1016/j.ajog.2012.10.075,2013,NR,,0,,,,,
a multinational study of self-compassion and human immunodeficiency virus-related anxiety,Kemppainen J,10.1111/inr.12056,2013,NR,,0,,,,,
"a genome-to-genome analysis of associations between human genetic variation, hiv-1 sequence diversity, and viral control",Bartha I,10.7554/eLife.01123,2013,NR,,0,,,,,
a naturally occurring single amino acid substitution in human trim5alpha linker region affects its anti-hiv type 1 activity and susceptibility to hiv type 1 infection,Nakayama EE,10.1089/aid.2012.0369,2013,NR,,0,,,,,
amplification of complete gag gene sequences from geographically distinct equine infectious anemia virus isolates,Boldbaatar B,10.1016/j.jviromet.2012.12.010,2013,NR,,0,,,,,
an increasing proportion of monotypic hiv-1 dna sequences during antiretroviral treatment suggests proliferation of hiv-infected cells,Wagner TA,10.1128/JVI.01985-12,2013,NR,,0,,,,,
a single hiv-1 cluster and a skewed immune homeostasis drive the early spread of hiv among resting cd4+ cell subsets within one month post-infection,Bacchus C,10.1371/journal.pone.0064219,2013,NR,,0,,,,,
molecular mechanisms of hiv type 1 prophylaxis failure revealed by single-genome sequencing,Li H,10.1093/infdis/jit485,2013,NR,,0,,,,,
a single early introduction of hiv-1 subtype b into central america accounts for most current cases,Murillo W,10.1128/JVI.01602-12,2013,NR,,0,,,,,
a stochastic model for expected time to cross the antigenic diversity threshold of hiv infected under correlated intercontact times,Kannan,,2013,NR,,0,,,,,
ability of hiv-1 nef to downregulate cd4 and hla class i differs among viral subtypes,Mann JK,10.1186/1742-4690-10-100,2013,NR,,0,,,,,
"anti-cd4 monoclonal antibody ibalizumab exhibits breadth and potency against hiv-1, with natural resistance mediated by the loss of a v5 glycan in envelope",Pace CS,10.1097/QAI.0b013e3182732746,2013,NR,,0,,,,,
access to services for hiv prevention in men in long-distance drivers guatemala 2012 - 2013,Arambu NJ,10.1136/sextrans-2013-051184.0891,2013,NR,,0,,,,,
antibody responses to human immunodeficiency virus envelope from infections with multiple subtypes utilize the 1f7-idiotypic repertoire,Parsons,10.1089/aid.2012.0094,2013,NR,,0,,,,,
assisted evolution enables hiv-1 to overcome a high trim5alpha-imposed genetic barrier to rhesus macaque tropism,Soll SJ,10.1371/journal.ppat.1003667,2013,NR,,0,,,,,
association of pol diversity with antiretroviral treatment outcomes among hiv-infected african children,Chen I,10.1371/journal.pone.0081213,2013,NR,,0,,,,,
astrocyte-tissue inhibitor of metalloproteinases-1: the timp-ed balance of neuroinflammation: relevance to hiv-1-associated neurocognitive disorders,Ghorpade A,10.1002/glia.22530,2013,NR,,0,,,,,
attenuation of porcine reproductive and respiratory syndrome virus by molecular breeding of virus envelope genes from genetically divergent strains,Ni Y-Y,10.1128/JVI.01789-12,2013,NR,,0,,,,,
baseline clinical hiv genotypes are a valid measure of transmitted drug resistance within the treatment-naive population,Ragonnet-Cronin M,10.1097/QAI.0b013e3182a4b991,2013,NR,,0,,,,,
an evaluation of distance and its impact on long-term follow up outcomes in a rural hiv clinic in northern haiti,Sowah LA,,2013,NR,,0,,,,,
breast milk and gut microbiota in african mothers and infants from an area of high hiv prevalence,Gonzalez R,10.1371/journal.pone.0080299,2013,NR,,0,,,,,
broadening of the t-cell repertoire to hiv-1 gag p24 by vaccination of hla-a2/dr transgenic mice with overlapping peptides in the caf05 adjuvant,Korsholm KS,10.1371/journal.pone.0063575,2013,NR,,0,,,,,
antibody maturation and viral diversification in hiv-infected women,James MM,10.1371/journal.pone.0057350,2013,NR,,0,,,,,
antiviral stratagems against hiv-1 using rna interference (rnai) technology,Vlachakis D,10.4137/EBO.S11412,2013,NR,,0,,,,,
architect r hiv ag/ab combo assay: correlation of hiv-1 p24 antigen sensitivity and rna viral load using genetically diverse virus isolates,Brennan CA,10.1016/j.jcv.2013.01.017,2013,NR,,0,,,,,
architectreg hiv ag/ab combo assay: correlation of hiv-1 p24 antigen sensitivity and rna viral load using genetically diverse virus isolates,Brennan,10.1016/j.jcv.2013.01.017,2013,NR,,0,,,,,
assays for monitoring hiv therapy in low-middle income countries,Agneskog,,2013,NR,,0,,,,,
assessing contraceptive needs of women attending for hiv care in routine practice: using epr to augment performance,Malhotra YP,10.3109/13625187.2013.793038,2013,NR,,0,,,,,
changes in developmental contexts as predictors of transitions in hiv-risk behaviors among young men who have sex with men (ymsm),Wong CF,10.1007/s10464-012-9562-2,2013,NR,,0,,,,,
barriers to retention in care as perceived by persons living with hiv in rural ethiopia: focus group results and recommended strategies,Lifson AR,10.1177/1545109712456428,2013,NR,,0,,,,,
characterization of hiv-1 gag and nef in cameroon: further evidence of extreme diversity at the origin of the hiv-1 group m epidemic,Tongo M,10.1186/1743-422X-10-29,2013,NR,,0,,,,,
characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 hiv-1 env vaccine in healthy adults (ipcavd 001),Barouch DH,10.1093/infdis/jis671,2013,NR,,0,,,,,
comparative immunogenicity of evolved v1v2-deleted hiv-1 envelope glycoprotein trimers,Bontjer I,10.1371/journal.pone.0067484,2013,NR,,0,,,,,
characterizing the emergence and persistence of drug resistant mutations in hiv-1 subtype c infections using 454 ultra deep pyrosequencing,Bansode V,10.1186/1471-2334-13-52,2013,NR,,0,,,,,
circulation of hiv-1 crf02_ag among msm population in central italy: a molecular epidemiology-based study,Giuliani,,2013,NR,,0,,,,,
clonal amplification and maternal-infant transmission of nevirapine-resistant hiv-1 variants in breast milk following single-dose nevirapine prophylaxis,Permar SR,10.1186/1742-4690-10-88,2013,NR,,0,,,,,
calabash at george house trust: innovating to support hiv-positive african men in the north west,Armstead C,10.1111/hiv.12027,2013,NR,,0,,,,,
catching hiv 'in the act' with 3d electron microscopy,Earl LA,10.1016/j.tim.2013.06.004,2013,NR,,0,,,,,
collinearity of protease mutations in hiv-1 samples with high-level protease inhibitor class resistance,Babrzadeh F,10.1093/jac/dks409,2013,NR,,0,,,,,
challenges in hiv infection diagnosis,Laperche S,,2013,NR,,0,,,,,
challenges in virological diagnosis of hiv -1 transmission from sexual abuse - hiv-1 genetic links are mandatory,Ehrnst A,10.1111/aji.12057,2013,NR,,0,,,,,
characteristics of viremic controllers in southern hiv ambulatory clinic,Lynch MA,10.231/JIM.0b013e3182820c55,2013,NR,,0,,,,,
computer-aided design of novel hiv-1 entry inhibitors based on glycosphingolipids,Andrianov AM,10.1080/07391102.2013.786435,2013,NR,,0,,,,,
connection subdomain mutations in hiv-1 subtype-c treatment-experienced patients enhance nrti and nnrti drug resistance,Delviks-Frankenberry KA,10.1016/j.virol.2012.09.021,2013,NR,,0,,,,,
deciphering the complex distribution of human immunodeficiency virus type 1 subtypes among different cohorts in northern tanzania,Njai HF,10.1371/journal.pone.0081848,2013,NR,,0,,,,,
dc-sign as potential target for early intervention and transmission of hiv-1,Park M,10.1007/s13365-013-0211-9,2013,NR,,0,,,,,
deep sequencing does not reveal additional transmitted mutations in patients diagnosed with hiv-1 variants with single nucleoside reverse transcriptase inhibitor resistance mutations,Pingen M,10.1111/j.1468-1293.2012.01037.x,2013,NR,,0,,,,,
hiv-1 replication fitness of hla-b*57/58:01 ctl escape variants is restored by the accumulation of compensatory mutations in gag,Gijsbers EF,10.1371/journal.pone.0081235,2013,NR,,0,,,,,
combination implementation for hiv prevention: moving from clinical trial evidence to population-level effects,Chang LW,10.1016/S1473-3099%2812%2970273-6,2013,NR,,0,,,,,
a polymorphism at position 400 in the connection subdomain of hiv-1 reverse transcriptase affects sensitivity to nnrtis and rnaseh activity,Wright DW,10.1371/journal.pone.0074078,2013,NR,,0,,,,,
an immunomodulating motif of the hiv-1 fusion protein is chirality-independent: implications for its mode of action,Faingold O,10.1074/jbc.M113.512038,2013,NR,,0,,,,,
hiv-1 nef sequence and functional compartmentalization in the gut is not due to differential cytotoxic t lymphocyte selective pressure,Lewis MJ,10.1371/journal.pone.0075620,2013,NR,,0,,,,,
identification of cross-clade ctl epitopes in hiv-1 clade a/e-infected individuals by using the clade b overlapping peptides,Watanabe K,10.1016/j.micinf.2013.08.002,2013,NR,,0,,,,,
detection of a new variant of herpes simplex virus type 2 among hiv-1-infected individuals,Burrel,10.1016/j.jcv.2013.03.008,2013,NR,,0,,,,,
hiv gp120 induced gene expression signatures in vaginal epithelial cells,Fanibunda SE,10.1016/j.micinf.2013.07.003,2013,NR,,0,,,,,
comparative evaluation of the artus hiv-1 qs-rgq assay and the abbott realtime hiv-1 assay for the quantification of hiv-1 rna in plasma,Garcia-Diaz A,10.1016/j.jcv.2013.01.006,2013,NR,,0,,,,,
fitness costs of mutations at the hiv-1 capsid hexamerization interface,Manocheewa S,10.1371/journal.pone.0066065,2013,NR,,0,,,,,
"detection of the b""-gwgr variant in the southernmost region of brazil: unveiling the complexity of the human immunodeficiency virus-1 subtype b epidemic",Junqueira DM,10.1590/0074-0276108062013010,2013,NR,,0,,,,,
a naturally occurring vif mutant (i107t) attenuates anti-apobec3g activity and hiv-1 replication,Peng J,10.1016/j.jmb.2013.05.015,2013,NR,,0,,,,,
dissecting the dynamics of hiv-1 protein sequence diversity,Hu Y,10.1371/journal.pone.0059994,2013,NR,,0,,,,,
inhibition of hiv-1 transcription and replication by a newly identified cyclin t1 splice variant,Gao G,10.1074/jbc.M112.438465,2013,NR,,0,,,,,
engineering hiv envelope protein to activate germline b cell receptors of broadly neutralizing anti-cd4 binding site antibodies,McGuire AT,10.1084/jem.20122824,2013,NR,,0,,,,,
identification of human microrna-like sequences embedded within the protein-encoding genes of the human immunodeficiency virus,Holland B,10.1371/journal.pone.0058586,2013,NR,,0,,,,,
development of an hiv-1 microbicide based on caulobacter crescentus: blocking infection by high-density display of virus entry inhibitors,Farr C,10.1371/journal.pone.0065965,2013,NR,,0,,,,,
the conserved set of host proteins incorporated into hiv-1 virions suggests a common egress pathway in multiple cell types,Linde ME,10.1021/pr300918r,2013,NR,,0,,,,,
recombinant hiv envelope proteins fail to engage germline versions of anti-cd4bs bnabs,Hoot S,10.1371/journal.ppat.1003106,2013,NR,,0,,,,,
"development, validation and comparison of a reference equation for the distance walked during the six-minute walk in patients with the human immunodeficiency virus",Silva CS,,2013,NR,,0,,,,,
"different distribution of hiv-1 subtype and drug resistance were found among treatment naive individuals in henan, guangxi, and yunnan province of china",Li L,10.1371/journal.pone.0075777,2013,NR,,0,,,,,
interrelationship between hiv-1 fitness and mutation rate,Dapp MJ,10.1016/j.jmb.2012.10.009,2013,NR,,0,,,,,
differential association of toll-like receptor gene variants with bacterial vaginosis among hiv-1 infected and uninfected african women,MacKelprang R,10.1111/aji.12124,2013,NR,,0,,,,,
discordant genotypic resistance and hiv-1 genetic diversity from paired plasma and cerebrospinal fluid samples in chinese settings,Liu L,10.1007/s13365-013-0148-z,2013,NR,,0,,,,,
distance and geographic factors on hiv treatment outcomes in a kenyan cohort of hiv patients enrolled in an sms program (weltel kenya1),Luft LA,,2013,NR,,0,,,,,
distinct geographical clustering of hiv-1 and a signature amino acid at position 41 of the p24 unveiled by gag variability in india,Acharya A,,2013,NR,,0,,,,,
distinct hiv type 1 strains in different risk groups and the absence of new infections by drug-resistant strains in lithuania,Caplinskas S,10.1089/aid.2012.0312,2013,NR,,0,,,,,
diversity of hiv type 1 and drug resistance mutations among injecting drug users in kenya,Osman S,10.1089/AID.2012.0182,2013,NR,,0,,,,,
contribution of vh replacement products to the generation of anti-hiv antibodies,Liao H,10.1016/j.clim.2012.11.003,2013,NR,,0,,,,,
current trends of hiv recombination worldwide,Lau KA,10.4081/idr.2013.s1.e4,2013,NR,,0,,,,,
current trends of hiv recombination worldwide (special issue on hiv/aids: infectious disease reports),Lau,,2013,NR,,0,,,,,
efavirenz stimulates hiv-1 reverse transcriptase rnase h activity by a mechanism involving increased substrate binding and secondary cleavage activity,Muchiri JM,10.1021/bi400618q,2013,NR,,0,,,,,
effect of mutations at position e138 in hiv-1 reverse transcriptase and their interactions with the m184i mutation on defining patterns of resistance to nonnucleoside reverse transcriptase inhibitors rilpivirine and etravirine,Xu HT,10.1128/AAC.00348-13,2013,NR,,0,,,,,
"effect of progressive resistance training on cardio vascular fitness, quality of life and cd4 count in people with hiv/aids",Anandh V,,2013,NR,,0,,,,,
detectable signals of episodic risk effects on acute hiv transmission: strategies for analyzing transmission systems using genetic data,Alam,10.1016/j.epidem.2012.11.003,2013,NR,,0,,,,,
efficient bst2 antagonism by vpu is critical for early hiv-1 dissemination in humanized mice,Dave VP,10.1186/1742-4690-10-128,2013,NR,,0,,,,,
elucidating a relationship between conformational sampling and drug resistance in hiv-1 protease,De Vera IMS,10.1021/bi400109d,2013,NR,,0,,,,,
emergence in japan of an hiv-1 variant associated with transmission among men who have sex with men (msm) in china: first indication of the international dissemination of the chinese msm lineage,Kondo M,10.1128/JVI.02370-12,2013,NR,,0,,,,,
developing and using a partnership covenant to guide a study of late hiv diagnosis,Udoh IC,10.1353/cpr.2013.0053,2013,NR,,0,,,,,
enacting and imagining gay men: the looping effects of behavioural hiv surveillance in australia,Holt M,10.1080/09581596.2013.796038,2013,NR,,0,,,,,
factors influencing the sensitivity and specificity of conventional sequencing in human immunodeficiency virus type 1 tropism testing,Knapp DJ,10.1128/JCM.00739-12,2013,NR,,0,,,,,
forensic immunology: assessment of the source of hiv-1 infection in transmission pairs,Harrer T,10.1016/j.ijmm.2013.08.004,2013,NR,,0,,,,,
epidemiological correlates of hiv-1 b subtype transmission and tdr in italy according to a nationwide large-scale phylogeny,Lai A,,2013,NR,,0,,,,,
"disabling sexualities: exploring the impact of the intersection of hiv, disability and gender on the sexualities of women in zambia",Wickenden,,2013,NR,,0,,,,,
"ethnicity, socioeconomic characteristics and knowledge, beliefs and attitudes about hiv among yunnanese chinese, hmong, lahu and northern thai in a north-western thailand border district (special issue: sexual and reproductive health issues among indigenous and minority ethnic peoples in asia, africa and latin america)",Kunstadtera,10.1080/13691058.2013.814807,2013,NR,,0,,,,,
evaluation of sequence ambiguities of the hiv-1 pol gene as a method to identify recent hiv-1 infection in transmitted drug resistance surveys,Andersson E,10.1016/j.meegid.2013.03.050,2013,NR,,0,,,,,
evaluation of three next-generation sequencing platforms on low frequency hiv drug resistant variants detection,Liang D,,2013,NR,,0,,,,,
genetic diversity of the highly variable v1 region interferes with human immunodeficiency virus type 1 envelope functionality,Hamoudi M,10.1186/1742-4690-10-114,2013,NR,,0,,,,,
evolution of primary hiv drug resistance in a subtype c dominated epidemic in mozambique,Bila DCA,10.1371/journal.pone.0068213,2013,NR,,0,,,,,
diversity of antibody germline gene and hiv-1 infection: implication for hiv-1 vaccine,Guan Y,,2013,NR,,0,,,,,
does hiv increase the risk of spousal violence in sub-saharan africa?,Chin YM,10.1016/j.jhealeco.2013.07.005,2013,NR,,0,,,,,
factors associated with men in hiv-negative gay couples who practiced uai within and outside of their relationship,Mitchell JW,10.1007/s10461-012-0255-5,2013,NR,,0,,,,,
"factors associated with timely initiation of antiretroviral therapy in two hiv clinics in lilongwe, malawi",Johnson,10.1177/0956462412472312,2013,NR,,0,,,,,
"multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for hiv-1 neutralization by vrc01-class antibodies",Zhou T,10.1016/j.immuni.2013.04.012,2013,NR,,0,,,,,
hiv impairment of immune responses in dendritic cells,Ahmed Z,10.1007/978-1-4614-4433-6-8,2013,NR,,0,,,,,
frequent viral introductions sustain local hiv epidemics in rural africa,Grabowski MK,10.1136/sextrans-2013-051184.0070,2013,NR,,0,,,,,
future of phylogeny in hiv prevention,Brenner BG,10.1097/QAI.0b013e3182986f96,2013,NR,,0,,,,,
gag sequence variation in a human immunodeficiency virus type 1 transmission cluster influences viral replication fitness,Gijsbers EF,10.1099/vir.0.048371-0,2013,NR,,0,,,,,
"emerging variability in hiv-1 genetics among recently infected individuals in yunnan, china",Chen M,10.1371/journal.pone.0060101,2013,NR,,0,,,,,
"genetic characterization and transmitted drug resistance of the hiv type 1 epidemic in men who have sex with men in beijing, china",Li L,10.1089/aid.2012.0281,2013,NR,,0,,,,,
"estimating population size, hiv prevalence and hiv incidence among men who have sex with men: a case example of synthesising multiple empirical data sources and methods in san francisco",Raymond HF,10.1136/sextrans-2012-050675,2013,NR,,0,,,,,
estimating the rate of intersubtype recombination in early hiv-1 group m strains,Ward MJ,10.1128/JVI.02478-12,2013,NR,,0,,,,,
genotyping and antifungal susceptibility testing of cryptococcus neoformans isolates from cameroonian hiv-positive adult patients,Bertout S,10.1111/1469-0691.12019,2013,NR,,0,,,,,
genotyping of pneumocystis jirovecii isolates from chinese hiv-infected patients based on nucleotide sequence variations in the internal transcribed spacer regions of rrna genes,Li K,10.3109/13693786.2012.695458,2013,NR,,0,,,,,
geographically structured populations of cryptococcus neoformans variety grubii in asia correlate with hiv status and show a clonal population structure,Khayhan K,10.1371/journal.pone.0072222,2013,NR,,0,,,,,
girls' education and hiv risk: evidence from uganda,Alsan MM,10.1016/j.jhealeco.2013.06.002,2013,NR,,0,,,,,
"gps-measured distance to clinic, but not self-reported transportation factors, are associated with missed hiv clinic visits in rural uganda",Siedner MJ,10.1097/QAD.0b013e32835fd873,2013,NR,,0,,,,,
greater ethnic diversity correlates with lower hiv prevalence in africa: justification for an alloimmunity vaccine,Zamani C,10.2147/HIV.S38922,2013,NR,,0,,,,,
hcv envelope gene promiscuous prediction of epitopes using local and global genotypic variants and its utility in anti-hcv drug development employing in-silico methods,Saha K,,2013,NR,,0,,,,,
heavy marijuana use among gay and bisexual male emerging adults living with hiv/aids,Bruce,10.1080/15381501.2012.735171,2013,NR,,0,,,,,
"high prevalence of hiv-1 intersubtype b'/c recombinants among injecting drug users in dehong, china",Han X,10.1371/journal.pone.0065337,2013,NR,,0,,,,,
high rate of mrsa respiratory tract colonisation in hiv-positive children in cambodia during 2004-2012,Sokolova J,,2013,NR,,0,,,,,
"hiv among female sex workers in the central asian republics, afghanistan, and mongolia: contexts and convergence with drug use (special issue: hiv and people who use drugs in central asia: confronting the perfect storm)",Baral,10.1016/j.drugalcdep.2013.07.004,2013,NR,,0,,,,,
hiv infection reveals widespread expansion of novel centromeric human endogenous retroviruses,Contreras-Galindo R,10.1101/gr.144303.112,2013,NR,,0,,,,,
hiv patients with protease inhibitor mutations: identification of novel gag mutations and changes in utr rna structure using ultra-deep sequencing,Chanqueo L,10.1111/hiv.12027,2013,NR,,0,,,,,
ethical considerations in determining standard of prevention packages for hiv prevention trials: examining prep,Haire B,10.1111/dewb.12032,2013,NR,,0,,,,,
hiv sexual risk behavior among black men who meet other men on the internet for sex,White JM,,2013,NR,,0,,,,,
"evaluating the mcdonald's business model for hiv prevention among truckers to improve program coverage and service utilization in india, 2004-2010",Rao VT,10.2147/HIV.S38816,2013,NR,,0,,,,,
hiv type 1 origin and transmission dynamics among different risk groups in sardinia: molecular epidemiology within the close boundaries of an italian island,Ciccozzi M,10.1089/AID.2012.0209,2013,NR,,0,,,,,
hiv type-1 group o infection in gabon: low prevalence rate but circulation of genetically diverse and drug-resistant hiv type-1 group o strains,Liegeois F,10.1089/AID.2012.0375,2013,NR,,0,,,,,
evolution of locomotor performances in hiv-1 infected adults included in the anrs co3 aquitaine cohort,Richert L,10.1016/j.rehab.2013.07.470,2013,NR,,0,,,,,
"evolutionary history of hiv-1 subtype b and crf01_ae transmission clusters among men who have sex with men (msm) in kuala lumpur, malaysia",Ng KT,10.1371/journal.pone.0067286,2013,NR,,0,,,,,
"hiv-1 diversity, drug-resistant mutations, and viral evolution among high-risk individuals in phase ii hiv vaccine trial sites in southern china",Qi H,10.1371/journal.pone.0068656,2013,NR,,0,,,,,
exosomes derived from hiv-1-infected cells contain trans-activation response element rna,Narayanan A,10.1074/jbc.M112.438895,2013,NR,,0,,,,,
exploring experiences with community based promotion of exclusive breastfeeding in the context of hiv in the rural malawi,Bula AK,10.1136/sextrans-2013-051184.1169,2013,NR,,0,,,,,
"hiv-1 evolution in patients undergoing immunotherapy with tat, rev, and nef expressing dendritic cells followed by treatment interruption",Goede ALD,10.1097/01.aids.0000433813.67662.92,2013,NR,,0,,,,,
hiv-1 genetic diversity and drug resistance among senegalese patients in the public health system,Thiam M,10.1128/JCM.02452-12,2013,NR,,0,,,,,
extreme genetic fragility of the hiv-1 capsid,Rihn SJ,10.1371/journal.ppat.1003461,2013,NR,,0,,,,,
factors associated with hiv/aids in sudan,Mohamed BA,10.1155/2013/971203,2013,NR,,0,,,,,
"fertility intentions among hiv-infected, sero-concordant couples in nyanza province, kenya",Withers M,10.1080/13691058.2013.811289,2013,NR,,0,,,,,
first steps toward a globally effective hiv/aids vaccine,Palesch D,10.1016/j.cell.2013.10.012,2013,NR,,0,,,,,
food diversity and adequacy of foods consumed by hiv/aids infected women in mumias district-kenya,Shikuri R,10.1159/000354245,2013,NR,,0,,,,,
frequent intra-subtype recombination among hiv-1 circulating in tanzania,Kiwelu IE,10.1371/journal.pone.0071131,2013,NR,,0,,,,,
hiv-1 subtype distribution and its demographic determinants in newly diagnosed patients in europe suggest highly compartmentalized epidemics,Abecasis AB,10.1186/1742-4690-10-7,2013,NR,,0,,,,,
"hiv-1 subtype distribution trends and evidence of transmission clusters among incident cases in a rural clinical cohort in southwest uganda, 2004-2010",Kapaata A,10.1089/AID.2012.0170,2013,NR,,0,,,,,
hiv-1 transmission during early antiretroviral therapy: evaluation of two hiv-1 transmission events in the hptn 052 prevention study,Ping L-H,10.1371/journal.pone.0071557,2013,NR,,0,,,,,
hiv-1 vpu and env mutations contribute to a novel mechanism of resistance to ccr5 entry inhibitors,Nedellec R,,2013,NR,,0,,,,,
hiv-2 surveillance amongst south african blood donors,Coleman CF,10.1111/vox.12048,2013,NR,,0,,,,,
hla footprints in hiv/hcv co-infected patients,Dold L,10.1016/S0168-8278%2813%2960361-X,2013,NR,,0,,,,,
human apobec3g-mediated hypermutation is associated with antiretroviral therapy failure in hiv-1 subtype c-infected individuals,Neogi U,10.7448/IAS.16.1.18472,2013,NR,,0,,,,,
human endogenous retrovirus k(hml-2) gag and env specific t-cell responses are not detected in htlv-i-infected subjects using standard peptide screening methods,Jones RB,10.1186/1477-5751-12-3,2013,NR,,0,,,,,
human immunodeficiency virus transfusion transmission despite nucleic acid testing,Salles NA,10.1111/trf.12316,2013,NR,,0,,,,,
"human immunodeficiency virus type-1 (hiv-1) genetic diversity and prevalence of antiretroviral drug resistance mutations in treatment-naive adults in jos, north central nigeria",Anejo-Okopi,,2013,NR,,0,,,,,
human t cell lymphotropic virus type 2a strains among hiv type 1-coinfected patients from brazil have originated mostly from brazilian amerindians,Magri MC,10.1089/AID.2013.0014,2013,NR,,0,,,,,
identification of 3 distinct hiv-1 founding strains responsible for expanding epidemic among men who have sex with men in 9 chinese cities,Han X,10.1097/QAI.0b013e3182932210,2013,NR,,0,,,,,
identification of low molecular weight nuclear complexes containing integrase during the early stages of hiv-1 infection,Gerard A,10.1186/1742-4690-10-13,2013,NR,,0,,,,,
identification of potential hiv-1 integrase strand transfer inhibitors: in silico virtual screening and qm/mm docking studies,Reddy KK,10.1080/1062936X.2013.772919,2013,NR,,0,,,,,
identification of trim22 single nucleotide polymorphisms associated with loss of inhibition of hiv-1 transcription and advanced hiv-1 disease,Ghezzi S,10.1097/01.aids.0000432474.76873.5f,2013,NR,,0,,,,,
hiv among msm in a large middle-income country,Kerr LRFS,10.1097/QAD.0b013e32835ad504,2013,NR,,0,,,,,
hiv and adherence-a matter of health literacy,Rodkjaer Lo,10.1111/tmi.12161,2013,NR,,0,,,,,
stabilizing exposure of conserved epitopes by structure guided insertion of disulfide bond in hiv-1 envelope glycoprotein,Kassa A,10.1371/journal.pone.0076139,2013,NR,,0,,,,,
hiv infection and its impact on fetal outcomes among women of advanced maternal age: a propensity score weighted matching approach,Salihu HM,10.1089/aid.2012.0242,2013,NR,,0,,,,,
hiv n-linked glycosylation site analyzer and its further usage in anchored alignment,Shaw TI,10.1093/nar/gkt472,2013,NR,,0,,,,,
impact of primary elvitegravir resistance-associated mutations in hiv-1 integrase on drug susceptibility and viral replication fitness,Abram ME,10.1128/AAC.02568-12,2013,NR,,0,,,,,
hiv populations are large and accumulate high genetic diversity in a nonlinear fashion,Maldarelli F,10.1128/JVI.01225-12,2013,NR,,0,,,,,
hiv testing patterns among black men who have sex with men: a qualitative typology,Hussen,10.1371/journal.pone.0075382,2013,NR,,0,,,,,
in vitro hiv-1 evolution in response to triple reverse transcriptase inhibitors & in silico phenotypic analysis,Rath BA,10.1371/journal.pone.0061102,2013,NR,,0,,,,,
hiv type 1 subtype c remains the predominant subtype in men having sex with men in senegal,Ndiaye HD,10.1089/AID.2013.0140,2013,NR,,0,,,,,
increasing hiv-1 non-b subtype primary infections in patients in france and effect of hiv subtypes on virological and immunological responses to combined antiretroviral therapy,Chaix,10.1093/cid/cis999,2013,NR,,0,,,,,
hiv-1 associated topoisomerase iibeta kinase: a potential pharmacological target for viral replication,Ponraj K,10.2174/1381612811319260008,2013,NR,,0,,,,,
hiv-1 circulating among blood donors in japan: present and past,Matsumoto C,10.1111/vox.12100-2,2013,NR,,0,,,,,
hiv-1 conserved-element vaccines: relationship between sequence conservation and replicative capacity,Rolland M,10.1128/JVI.03033-12,2013,NR,,0,,,,,
hiv-1 envelope replication and alpha4beta7 utilization among newly infected subjects and their corresponding heterosexual partners,Pena-Cruz V,10.1186/1742-4690-10-162,2013,NR,,0,,,,,
molecular characterization of long terminal repeat sequences from brazilian human immunodeficiency virus type 1 isolates,Ferraro GA,10.1089/AID.2012.0326,2013,NR,,0,,,,,
inhibitory slopes show minimal variation within and across mechanistic classes of hiv-1 antiretroviral agents,Grobler JA,,2013,NR,,0,,,,,
hiv-1 genetic variability and clinical implications,Santoro MM,10.1155/2013/481314,2013,NR,,0,,,,,
insight into the evolution of nuclear envelope proteins from diverse eukaryotes,Koreny L,10.1091/mbc.E13-10-0584,2013,NR,,0,,,,,
"integrating behavioral hiv interventions into biomedical prevention trials with youth: lessons from chicago's project prepare (special issue: hiv/aids in adolescents and emerging adults: domestic and international perspectives on intervention development, treatment, and prevention)",Hosek,10.1080/15381501.2013.773575,2013,NR,,0,,,,,
"intention to use internet-based testing for hiv and sexually transmitted infections is high and wide-ranging among gay, bisexual and other men who have sex with men in canada",Gilbert M,,2013,NR,,0,,,,,
interleukin-27 is a potent inhibitor of cis hiv-1 replication in monocyte-derived dendritic cells via a type i interferon-independent pathway,Chen Q,10.1371/journal.pone.0059194,2013,NR,,0,,,,,
hiv-1 variable loop 2 and its importance in hiv-1 infection and vaccine development,Rao M,,2013,NR,,0,,,,,
hiv-1 variable loop 2 and its importance in hiv-1 infection and vaccine development (special issue: fc receptor-mediated effector functions in the humoral control of hiv-1 infection),Rao,10.2174/1570162X113116660064,2013,NR,,0,,,,,
hiv-untested men who have sex with men in south africa: the perception of not being at risk and fear of being tested,Nel JA,,2013,NR,,0,,,,,
"kpnef, a new member of the klebsiella pneumoniae cell envelope stress response regulon, is an smr-type efflux pump involved in broad-spectrum antimicrobial resistance",Srinivasan VB,10.1128/AAC.02284-12,2013,NR,,0,,,,,
"l74v increases the reverse transcriptase content of hiv-1 virions with non-nucleoside reverse transcriptase drug-resistant mutations l100i+k103n and k101e+g190s, which results in increased fitness",Wang J,10.1099/vir.0.050914-0,2013,NR,,0,,,,,
large-scale analysis of the prevalence and geographic distribution of hiv-1 non-b variants in the united states,Pyne MT,10.1128/JCM.00880-13,2013,NR,,0,,,,,
limited nucleotide changes in the rev response element (rre) during hiv-1 infection alter overall rev-rre activity and rev multimerization,Sloan EA,10.1128/JVI.01392-13,2013,NR,,0,,,,,
local phylogenetic analysis identifies distinct trends in transmitted hiv drug resistance: implications for public health interventions,Brooks,,2013,NR,,0,,,,,
identification of an hiv-1 clade a envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting three distinct epitopes,Hoffenberg S,10.1128/JVI.02827-12,2013,NR,,0,,,,,
low prevalence of transmitted k65r and other tenofovir resistance mutations across different hiv-1 subtypes: implications for pre-exposure prophylaxis,Chan PA,10.7448/IAS.15.2.17701,2013,NR,,0,,,,,
identifying biomarkers of increased hiv transmission in african populations,Kyongo JK,10.1111/aji.12124,2013,NR,,0,,,,,
management of hiv patients on a failing drug regimen: clinical audit and the reanalysis of data by ultra-deep sequencing,De Sario V,10.1111/hiv.12027,2013,NR,,0,,,,,
igm repertoire biodiversity is reduced in hiv-1 infection and systemic lupus erythematosus,Yin L,10.3389/fimmu.2013.00373,2013,NR,,0,,,,,
marketing the hiv test to msm: ethnic differences in preferred venues and sources,Lechuga J,,2013,NR,,0,,,,,
illuminating hiv-1 virological synapses,Chen BK,10.1007/s11481-013-9441-0,2013,NR,,0,,,,,
impact of apobec3-driven editing on hiv evolution in diverse anatomical compartments,Fourati S,,2013,NR,,0,,,,,
impact of hiv-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype c and crf01_ae backbone,Chenine AL,10.1371/journal.pone.0076104,2013,NR,,0,,,,,
implementation science in hiv research,Altice F,,2013,NR,,0,,,,,
"mechanisms of hiv-1 subtype c resistance to grft, cv-n and svn",Alexandre KB,10.1016/j.virol.2013.07.019,2013,NR,,0,,,,,
increasing heterosexual transmission of hiv-1 subtype c in inland central western brazil,Alcantara KC,10.1002/jmv.23474,2013,NR,,0,,,,,
modified social ecological model: a tool to guide the assessment of the risks and risk contexts of hiv epidemics,Baral S,10.1186/1471-2458-13-482,2013,NR,,0,,,,,
inter-laboratory assessment of a prototype multiplex kit for determination of recent hiv-1 infection,Curtis KA,10.1371/journal.pone.0077765,2013,NR,,0,,,,,
"molecular diversity of hiv-1 among people who inject drugs in kuala lumpur, malaysia: massive expansion of circulating recombinant form (crf) 33_01b and emergence of multiple unique recombinant clusters",Chow WZ,10.1371/journal.pone.0062560,2013,NR,,0,,,,,
intersubtype variation in the ability of hiv-1 nef to modulate cd4 and hla class i,Mann J,,2013,NR,,0,,,,,
intra-host evolutionary rates in hiv-1c env and gag during primary infection,Novitsky V,10.1016/j.meegid.2013.02.023,2013,NR,,0,,,,,
molecular epidemiology of hiv type 1 subtypes in rwanda,Kemal KS,10.1089/AID.2012.0095,2013,NR,,0,,,,,
isolation of a rare nocardia wallacei from an hiv-positive patient with pulmonary infection in southern saudi arabia,Hamid ME,,2013,NR,,0,,,,,
structural determinants of hiv-1 vif susceptibility and dna binding in apobec3f,Siu KK,10.1038/ncomms3593,2013,NR,,0,,,,,
molecular phylodynamic analysis of drug resistance transmissions in hiv-1 subtype b in japan,Shiino T,,2013,NR,,0,,,,,
molecular typing of the local hiv-1 epidemic in serbia,Siljic M,10.1016/j.meegid.2013.06.015,2013,NR,,0,,,,,
mouse marginal zone b cells harbor specificities similar to human broadly neutralizing hiv antibodies,Pujanauski LM,10.1073/pnas.1213713110,2013,NR,,0,,,,,
"multilocus sequence typing of cryptococcus neoformans in non-hiv associated cryptococcosis in nagasaki, japan",Mihara T,10.3109/13693786.2012.708883,2013,NR,,0,,,,,
high-throughput virtual screening of phloroglucinol derivatives against hiv-reverse transcriptase,Belekar V,10.1007/s11030-012-9417-7,2013,NR,,0,,,,,
ethics and pre-exposure prophylaxis for hiv infection,Sugarman J,10.1097/QAI.0b013e3182987787,2013,NR,,0,,,,,
"researching male circumcision for hiv prevention in papua new guinea: a process that incorporates science, faith and culture",Tommbe R,10.1186/1478-4505-11-44,2013,NR,,0,,,,,
de novo identification of vrc01 class hiv-1-neutralizing antibodies by next-generation sequencing of b-cell transcripts,Zhu J,10.1073/pnas.1306262110,2013,NR,,0,,,,,
"near full-length genomic characterization of a novel hiv type 1 crf07- bc/01-ae recombinant in men who have sex with men from sichuan, china",Wei H,10.1089/aid.2013.0104,2013,NR,,0,,,,,
genetic diversity of trichomonas vaginalis reinfection in hiv-positive women,Conrad MD,10.1136/sextrans-2013-051053,2013,NR,,0,,,,,
micronutrient supplementation for children with hiv infection,Irlam JH,10.1002/14651858.CD010666,2013,NR,,0,,,,,
state of genomics and epigenomics research in the perspective of hiv cure,Ciuffi A,10.1097/COH.0b013e32835f7340,2013,NR,,0,,,,,
"a brief, standardized tool for measuring hiv-related stigma among health facility staff: results of field testing in china, dominica, egypt, kenya, puerto rico and st christopher & nevis",Nyblade L,,2013,NR,,0,,,,,
cultural expectations and reproductive desires: experiences of south african women living with hiv/aids (wlha),Sofolahan YA,10.1080/07399332.2012.721415,2013,NR,,0,,,,,
impact of an hiv prevention intervention on condom use among long distance truckers in india,Juneja S,,2013,NR,,0,,,,,
"unity in diversity: results of a randomized clinical culturally tailored pilot hiv prevention intervention trial in baltimore, maryland, for african american men who have sex with men",Tobin K,10.1177/1090198112452125,2013,NR,,0,,,,,
no evidence for selection of hiv-1 with enhanced gag-protease or nef function among breakthrough infections in the caprisa 004 tenofovir microbicide trial,Chopera DR,10.1371/journal.pone.0071758,2013,NR,,0,,,,,
unique molecular features of the hiv-1 subtype c enhancer and core promoter and their influence on the viral gene expression,Verma A,,2013,NR,,0,,,,,
env mutations conferring improved entry efficiency allow hiv to replicate in the presence of ifn,Rato S,,2013,NR,,0,,,,,
molecular dating of hiv-1 subtype c from bangladesh,Bontell I,10.1371/journal.pone.0079193,2013,NR,,0,,,,,
poor aerobic fitness may contribute to cognitive decline in hiv-infected older adults,Shah K,10.1111/cts.12047,2013,NR,,0,,,,,
hiv-1 protease double mutants analysis by nma indicates convergence to flexibility of the wild type,Braz ASK,10.1007/s00249-013-0917-x,2013,NR,,0,,,,,
low level of awareness leading to stigma towards persons with hiv/aids,Muhammad A,10.1136/sextrans-2013-051184.0950,2013,NR,,0,,,,,
exosomes from hiv-1 infected cells carry distinct protein and mirna components which control cell survival and apoptosis in recipient cells,Narayanan A,10.1007/s13365-013-0211-9,2013,NR,,0,,,,,
whole genome sequencing of sporadic burkitt lymphoma in hiv-infected and uninfected patients,Ritter D,,2013,NR,,0,,,,,
development of novel adeno-associated virus variants targeting hiv-infected t cells,Wooley DP,10.1038/mt.2013.82,2013,NR,,0,,,,,
nucleotide ambiguity in population sequencing is of low specificity to detect recent hiv infection,Euler P,10.1016/j.ijmm.2013.08.004,2013,NR,,0,,,,,
the effectiveness of a single intervention short film on adolescent perception of people living with hiv - a pilot study,Barnes A,10.1111/hiv.12027,2013,NR,,0,,,,,
"mucocutaneous manifestations of hiv-infected patients in the era of haart in guangxi zhuang autonomous region, china",Han,10.1111/j.1468-3083.2011.04429.x,2013,NR,,0,,,,,
multiple pathways of escape from hiv broadly cross-neutralizing v2-dependent antibodies,Moore PL,10.1128/JVI.03424-12,2013,NR,,0,,,,,
nautilus: a bioinformatics package for the analysis of hiv type 1 targeted deep sequencing data,Kijak GH,10.1089/AID.2013.0175,2013,NR,,0,,,,,
"overcoming biological, behavioral, and structural vulnerabilities: new directions in research to decrease hiv transmission in men who have sex with men",Mayer KH,10.1097/QAI.0b013e318298700e,2013,NR,,0,,,,,
oxytocin and its relationship to psychosocial factors in hiv,Ironson G,10.1097/01.psy.0000429452.16135.1b,2013,NR,,0,,,,,
perceptions and acceptability of mhealth interventions for improving patient care at a community-based hiv/aids clinic in uganda: a mixed methods study,Chang,10.1080/09540121.2013.774315,2013,NR,,0,,,,,
next-generation sequencing of hiv-1 rna genomes: determination of error rates and minimizing artificial recombination,Di Giallonardo F,10.1371/journal.pone.0074249,2013,NR,,0,,,,,
notes on the concepts of 'serodiscordance' and 'risk' in couples with mixed hiv status,Persson A,10.1080/17441692.2012.729219,2013,NR,,0,,,,,
phylodynamics of the hiv-1 epidemic in cuba,Delatorre E,10.1371/journal.pone.0072448,2013,NR,,0,,,,,
optimized and enhanced dna plasmid vector based in vivo construction of a neutralizing anti-hiv-1 envelope glycoprotein fab,Muthumani K,10.4161/hv.26498,2013,NR,,0,,,,,
optimizing the health of ontario women living with hiv (wlwh) through knowledge translation and exchange (kte),Morshed M,,2013,NR,,0,,,,,
oral and injectable contraception use and risk of hiv acquisition among women in sub-saharan africa,McCoy SI,10.1097/QAD.0b013e32835da401,2013,NR,,0,,,,,
organizing the hiv vaccine development effort,Voronin Y,10.1097/COH.0b013e328363f5b6,2013,NR,,0,,,,,
"paleovirology of 'syncytins', retroviral env genes exapted for a role in placentation",Lavialle C,10.1098/rstb.2012.0507,2013,NR,,0,,,,,
"phylogenetic and demographic characterization of hiv-1 transmission in madrid, spain",Yebra G,10.1016/j.meegid.2012.12.006,2013,NR,,0,,,,,
phylogenetic and structural diversity in the feline leukemia virus env gene,Watanabe S,10.1371/journal.pone.0061009,2013,NR,,0,,,,,
phylogenetic and temporal dynamics of human immunodeficiency virus type 1 crf01_ae in china,Ye J,10.1371/journal.pone.0054238,2013,NR,,0,,,,,
pathogenesis of hiv infection,Naif HM,10.4081/idr.2013.s1.e6,2013,NR,,0,,,,,
patient costs associated with accessing hiv/aids care in malawi,Pinto AD,10.7448/IAS.16.1.18055,2013,NR,,0,,,,,
short communication: antibody responses to human immunodeficiency virus envelope from infections with multiple subtypes utilize the 1f7-idiotypic repertoire,Parsons MS,10.1089/AID.2012.0094,2013,NR,,0,,,,,
persistent elevation in hiv viraemia during cart with identical wt sequences imply expansion of a clonal source,Anderson E,,2013,NR,,0,,,,,
"phylodynamic profile of hiv-1 subtype b, crf01-ae and the recently emerging crf51-01b among men who have sex with men (msm) in singapore",Ng KT,10.1371/journal.pone.0080884,2013,NR,,0,,,,,
pneumocystis jirovecii haplotypes at the internal transcribed spacers of the rrna operon in french hiv-negative patients with diverse clinical presentations of pneumocystis infections,Le Gal S,10.3109/13693786.2013.824123,2013,NR,,0,,,,,
physical exercises for people living with hiv and aids (plhiv): brazilian policy for positive prevention in the public health system,Abreu KC,10.1136/sextrans-2013-051184.1184,2013,NR,,0,,,,,
posttraumatic stress disorder symptom severity and hiv-risk behaviors among substance-dependent inpatients,Weiss NH,10.1080/09540121.2013.764381,2013,NR,,0,,,,,
"potent inhibition of hiv-1 reverse transcriptase and replication by nonpseudoknot, ""ucaa-motif"" rna aptamers",Whatley AS,10.1038/mtna.2012.62,2013,NR,,0,,,,,
"potential for internet-based testing to reach gay, bisexual and other men who have sex with men (msm) in canada facing current barriers to testing for hiv and sexually transmitted infections",Gilbert M,10.1136/sextrans-2013-051184.0876,2013,NR,,0,,,,,
"polymorphisms in il-1 gene cluster and its association with the risk of perinatal hiv transmission, in an indian cohort",Ahir S,10.1016/j.imlet.2013.05.008,2013,NR,,0,,,,,
preferred hiv testing services and programme characteristics among clients of a rapid hiv testing programme,Hoyos,,2013,NR,,0,,,,,
prevalence and predictors of drug use among adolescents with hiv infection acquired perinatally or later in life,Conner LC,,2013,NR,,0,,,,,
prevalence of drug resistance mutations and hiv type 1 subtypes in an hiv type 1-infected cohort in rural tanzania,Masimba P,10.1089/AID.2011.0367,2013,NR,,0,,,,,
"prevention of mother-to-child hiv transmission in resource-limited settings: assessment of 99 viramune donation programmes in 34 countries, 2000-2011",Ladner,,2013,NR,,0,,,,,
prevalence of hiv and syphilis infections among long-distance truck drivers in china: a data synthesis and meta-analysis,Zhang XiaoHu,10.1016/j.ijid.2012.07.018,2013,NR,,0,,,,,
prevalence of transmitted drug resistance and relation to mean population viral load of treatment failing patients: a 16-year analysis within the swiss hiv cohort study (shcs),Yang W-L,,2013,NR,,0,,,,,
protective antiviral antibodies that lack neutralizing activity: precedents and evolution of concepts (special issue: fc receptor-mediated effector functions in the humoral control of hiv-1 infection),Schmaljohn,10.2174/1570162X113116660057,2013,NR,,0,,,,,
public voice shapes hiv service planning at vancouver coastal health,Webster K,,2013,NR,,0,,,,,
pulmonary hypertension in hiv positive patients: western india experience,Kubal M,,2013,NR,,0,,,,,
rapid hiv self-testing: long in coming but opportunities beckon,Myers,10.1097/QAD.0b013e32835fd7a0,2013,NR,,0,,,,,
psychometric evaluation of a cross-culturally adapted felt stigma questionnaire among people living with hiv in kenya,Kingori C,10.1089/apc.2012.0403,2013,NR,,0,,,,,
supersite of immune vulnerability on the glycosylated face of hiv-1 envelope glycoprotein gp120,Kong L,10.1038/nsmb.2594,2013,NR,,0,,,,,
"rapid, complex adaptation of transmitted hiv-1 full-length genomes in subtype c-infected individuals with differing disease progression",Abrahams MR,10.1097/QAD.0b013e32835cab64,2013,NR,,0,,,,,
recent advances in research of hiv infection: implications of viral and host genetics on treatment and prevention,Haaland RE,10.1159/000345935,2013,NR,,0,,,,,
residue-level prediction of hiv-1 antibody epitopes based on neutralization of diverse viral strains,Chuang GY,10.1128/JVI.00984-13,2013,NR,,0,,,,,
retaining in care people living with hiv: a key to disease control in resource constrained settings,Ekouevi K,10.1111/tmi.12161,2013,NR,,0,,,,,
risk patterns preceding diagnosis among newly hiv-diagnosed men who have sex with men in new york city,Drabkin AS,10.1089/apc.2012.0313,2013,NR,,0,,,,,
role of glycosphingolipids in dendritic cell-mediated hiv-1 trans-infection,Puryear WB,10.1007/978-1-4614-4433-6-5,2013,NR,,0,,,,,
role of hla-b alpha -3 domain amino acid position 194 in hiv disease progression,Grifoni,10.1016/j.molimm.2012.09.009,2013,NR,,0,,,,,
role of hla-b alpha-3 domain amino acid position 194 in hiv disease progression,Grifoni A,10.1016/j.molimm.2012.09.009,2013,NR,,0,,,,,
reconstructing the timing and dispersion routes of hiv-1 subtype b epidemics in the caribbean and central america: a phylogenetic story,Pagan I,10.1371/journal.pone.0069218,2013,NR,,0,,,,,
replication fitness of multiple nonnucleoside reverse transcriptase-resistant hiv-1 variants in the presence of etravirine measured by 454 deep sequencing,Brumme CJ,10.1128/JVI.00335-13,2013,NR,,0,,,,,
second generation hiv surveillance in pakistan: policy challenges and opportunities,Munro M,10.1136/sextrans-2012-050773,2013,NR,,0,,,,,
resistance mutations and ctl epitopes in archived hiv-1 dna of patients on antiviral treatment: toward a new concept of vaccine,Papuchon J,10.1371/journal.pone.0069029,2013,NR,,0,,,,,
resistance mutations outside the integrase coding region have an effect on human immunodeficiency virus replicative fitness but do not affect its susceptibility to integrase strand transfer inhibitors,Weber,10.1371/journal.pone.0065631,2013,NR,,0,,,,,
sequences within rna coding for hiv-1 gag p17 are efficiently targeted to exosomes,Columba Cabezas S,10.1111/cmi.12046,2013,NR,,0,,,,,
restriction of v3 region sequence divergence in the hiv-1 envelope gene during antiretroviral treatment in a cohort of recent seroconverters,Gall A,10.1186/1742-4690-10-8,2013,NR,,0,,,,,
seroadaptation among men who have sex with men: emerging research themes (behavioral aspects of hiv management),Cassels,10.1007/s11904-013-0188-2,2013,NR,,0,,,,,
the potential of the human immune system to develop broadly neutralizing hiv-1 antibodies: implications for vaccine development,Zhang Y,10.1097/QAD.0000000000000015,2013,NR,,0,,,,,
rna deep sequencing analysis reveals that nicotine restores impaired gene expression by viral proteins in the brains of hiv-1 transgenic rats,Cao J,10.1371/journal.pone.0068517,2013,NR,,0,,,,,
share information on his status 'meteorological hiv in the context of polygamy se'ne' gal: hiv disclosure in polygamous settings in senegal,Sow K,10.1080/02664763.2012.755322,2013,NR,,0,,,,,
short communication: new hiv infections at southern new england academic institutions: implications for prevention,Chan PA,10.1089/aid.2012.0130,2013,NR,,0,,,,,
"side chain requirements for affinity and specificity in d5, an hiv-1 antibody derived from the vh1-69 germline segment",Stewart A,10.1186/1471-2091-14-9,2013,NR,,0,,,,,
single cell analysis of lymph node tissue from hiv-1 infected patients reveals that the majority of cd4+ t-cells contain one hiv-1 dna molecule,Josefsson L,10.1371/journal.ppat.1003432,2013,NR,,0,,,,,
second-generation surveillance for hiv/aids in pakistan: results from the 4th round of integrated behavior and biological survey 2011-2012,Emmanuel F,10.1136/sextrans-2013-051161,2013,NR,,0,,,,,
statin therapy and mortality in hiv-infected individuals; a danish nationwide population-based cohort study,Rasmussen,10.1371/journal.pone.0052828,2013,NR,,0,,,,,
straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved cd4 and coreceptor binding sites of hiv-1 gp120,Matz J,10.1128/JVI.00461-12,2013,NR,,0,,,,,
strategies for reinventing and reinforcing the disrupted biography of people with hiv in nepal,Jha,,2013,NR,,0,,,,,
"subtype b was the dominant strain among hiv type 1 infections except for the population of men who have sex with men in harbin city, china",Shao B,10.1089/AID.2013.0135,2013,NR,,0,,,,,
superior control of hiv-1 replication by cd8+ t cells targeting conserved epitopes: implications for hiv vaccine design,Kunwar P,10.1371/journal.pone.0064405,2013,NR,,0,,,,,
synonymous site conservation in the hiv-1 genome,Mayrose I,10.1186/1471-2148-13-164,2013,NR,,0,,,,,
significant reductions in gag-protease-mediated hiv-1 replication capacity during the course of the epidemic in japan,Nomura S,10.1128/JVI.02122-12,2013,NR,,0,,,,,
site-specific genome editing in pbmcs with plga nanoparticle-delivered pnas confers hiv-1 resistance in humanized mice,Schleifman EB,10.1038/mtna.2013.59,2013,NR,,0,,,,,
tat exon 1 exhibits functional diversity during hiv-1 subtype c primary infection,Rossenkhan R,10.1128/JVI.03297-12,2013,NR,,0,,,,,
social determinants of health and hiv: the experience of prisoners and other populations made vulnerable,Rodriguez-Diaz C,10.7448/IAS.16.2.18704,2013,NR,,0,,,,,
"strategies for recruiting injection drug users for hiv prevention services in delhi, india",Tun W,10.1186/1477-7517-10-16,2013,NR,,0,,,,,
structure and dynamics of the gp120 v3 loop that confers noncompetitive resistance in r5 hiv-1(jr-fl) to maraviroc,Yuan Y,10.1371/journal.pone.0065115,2013,NR,,0,,,,,
structure and dynamics of the gp120 v3 loop that confers noncompetitive resistance in r5 hiv-1jr-fl to maraviroc,Yuan Y,10.1371/journal.pone.0065115,2013,NR,,0,,,,,
"subtype crf01_ae dominate the sexually transmitted human immunodeficiency virus type 1 epidemic in guangxi, china",Li L,10.1002/jmv.23360,2013,NR,,0,,,,,
subtype-specific differences in the development of accessory mutations associated with high-level resistance to hiv-1 nucleoside reverse transcriptase inhibitors,Koning FA,10.1093/jac/dkt012,2013,NR,,0,,,,,
"temporal trends and molecular epidemiology of hiv type 1 infection in rio de janeiro, brazil",Pimentel VF,10.1089/AID.2013.0050,2013,NR,,0,,,,,
the diverse and rapidly growing hiv epidemic in the who eastern mediterranean region: will countries succeed in their control?,Riedner G,,2013,NR,,0,,,,,
the effects of somatic hypermutation on neutralization and binding in the pgt121 family of broadly neutralizing hiv antibodies,Sok D,10.1371/journal.ppat.1003754,2013,NR,,0,,,,,
the implications of viral reservoirs on the elite control of hiv-1 infection,Buckheit Iii RW,10.1007/s00018-012-1101-7,2013,NR,,0,,,,,
united states policy implications of generic substitution of branded human immunodeficiency virus medications,Hogue S,10.1016/j.jval.2013.08.244,2013,NR,,0,,,,,
the increasing prevalence of hiv-1 subtype c in southern brazil and its dispersion through the continent,Graf T,10.1016/j.virol.2012.08.048,2013,NR,,0,,,,,
"the role of trust in delayed hiv diagnosis in a diverse, urban population",Graham JL,10.1007/s10461-011-0114-9,2013,NR,,0,,,,,
the resistance of human apobec3h to hiv-1 nl4-3 molecular clone is determined by a single amino acid in vif,Ooms M,10.1371/journal.pone.0057744,2013,NR,,0,,,,,
thwarting hiv evasion of antibody avidity with novel antibody architectures (p4489),Galimidi R,,2013,NR,,0,,,,,
translating knowledge from pakistan's second generation surveillance system to other global contexts (special issue: hiv second generation surveillance - pakistan),Adrien,,2013,NR,,0,,,,,
"translational hiv-1 research: from routine diagnostics to new virology insights in amsterdam, the netherlands during 1983-2013",van der Kuyl AC,10.1186/1742-4690-10-93,2013,NR,,0,,,,,
translational research insights from completed hiv vaccine efficacy trials,Tieu H-V,10.1097/QAI.0b013e31829a3985,2013,NR,,0,,,,,
"trends in mortality and loss to follow-up in hiv care at the nkongsamba regional hospital, cameroon",Bekolo CE,10.1186/1756-0500-6-512,2013,NR,,0,,,,,
are hiv-negative men who have sex with men and who bareback concerned about hiv infection? implications for hiv risk reduction interventions,Balan,10.1007/s10508-011-9886-2,2013,NR,,0,,,,,
higher cross-subtype ifn- gamma elispot responses to gag and nef peptides in brazilian hiv-1 subtype b- and f1- than in c-infected subjects,Cortes,10.1016/j.vaccine.2012.12.023,2013,NR,,0,,,,,
tracing the origin and northward dissemination dynamics of hiv-1 subtype c in brazil,Delatorre E,10.1371/journal.pone.0074072,2013,NR,,0,,,,,
identification of new and unusual rev and nef transcripts expressed by an hiv type 1 primary isolate,Vega,10.1089/aid.2013.0053,2013,NR,,0,,,,,
update on diversity and distribution of hiv-1 subtypes in yunnan province,Su YZ,10.1017/S0950268812002713,2013,NR,,0,,,,,
uracil dna glycosylase initiates degradation of hiv-1 cdna containing misincorporated dutp and prevents viral integration,Weil AF,10.1073/pnas.1219702110,2013,NR,,0,,,,,
viral escape from hiv-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes,Wibmer CK,10.1371/journal.ppat.1003738,2013,NR,,0,,,,,
transmitted hiv type-1 drug resistance in newly diagnosed patients from havana city: 2009-2012,Machado L,10.7448/IAS.16.2.18657,2013,NR,,0,,,,,
"variability of hiv-1 genomes among children and adolescents from sao paulo, brazil",Sanabani SS,10.1371/journal.pone.0062552,2013,NR,,0,,,,,
"trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible hiv-infected individuals in north america, 2001-2009",Hanna DB,10.1093/cid/cit003,2013,NR,,0,,,,,
trim5 genotypes in cynomolgus monkeys primarily influence inter-individual diversity in susceptibility to monkey-tropic human immunodeficiency virus type 1,Saito A,10.1099/vir.0.050252-0,2013,NR,,0,,,,,
viral escape from neutralizing antibodies in early subtype a hiv-1 infection drives an increase in autologous neutralization breadth,Murphy MK,10.1371/journal.ppat.1003173,2013,NR,,0,,,,,
"undernutrition among hiv positive women in humera hospital, tigray, ethiopia, 2013: antiretroviral therapy alone is not enough, cross sectional study",Hadgu,,2013,NR,,0,,,,,
unseen risks: hiv-related risk behaviors among ethnically diverse sexual minority adolescent females,Thoma BC,,2013,NR,,0,,,,,
vaccination directed against the human endogenous retrovirus-k envelope protein inhibits tumor growth in a murine model system,Kraus B,10.1371/journal.pone.0072756,2013,NR,,0,,,,,
variable changes in gag and nef function in clinical sequences sampled over the course of the hiv-1 epidemic in north america,Cotton LA,,2013,NR,,0,,,,,
when talking or not talking becomes a risk: a grounded theory study exploring the impact of hiv on immigrant black african families in the uk,Owuor JOA,10.1136/sextrans-2013-051184.0943,2013,NR,,0,,,,,
xfirst steps toward a globally effective hiv/aids vaccine,Palesch D,10.1016/j.cell.2013.10.012,2013,NR,,0,,,,,
what constitutes the best sex life for gay and bisexual men? implications for hiv prevention,Bourne A,,2013,NR,,0,,,,,
what if hiv were unable to develop resistance against a new therapeutic agent?,Wainberg MA,10.1186/1741-7015-11-249,2013,NR,,0,,,,,
"""in my house"": laying the foundation for youth hiv prevention in the black church",Lightfoot AF,,2012,NR,,0,,,,,
"""we weren't using condoms because we were trying to conceive"": the need for reproductive counseling for hiv-positive women in clinical care",Finocchario-Kessler S,10.1089/apc.2012.0232,2012,NR,,0,,,,,
a collaborative approach to controlling an hiv outbreak among intravenous drug users,Bell G,10.1136/sextrans-2012-050601c.35,2012,NR,,0,,,,,
a comprehensive mapping of hiv-1 genotypes in various risk groups and regions across china based on a nationwide molecular epidemiologic survey,He X,10.1371/journal.pone.0047289,2012,NR,,0,,,,,
a case of hiv-associated multicentric castleman disease with pulmonary involvement,Lemay A-S,,2012,NR,,0,,,,,
a proposal for a new hiv-1 dls structural model,Sakuragi J,10.1093/nar/gks156,2012,NR,,0,,,,,
a strain-specific approach to hiv-1 vaccine design: a study of the saskatche wan epidemic and botswana acute infection cohort,Scott JK,,2012,NR,,0,,,,,
"a surveillance of hiv-1 drug resistance mutations among hiv-1 infected voluntary blood donors and clinical patients in chengdu, sichuan, china",Zeng PB,10.1111/j.1423-0410.2012.01615-2.x,2012,NR,,0,,,,,
accurate quantification of amplifiable viral templates is essential in order to determine the limit of detection of hiv drug resistance assays,Olson SC,,2012,NR,,0,,,,,
added value of ultra deep sequencing in patients with hiv-1 transmitted drug resistance mutations in the reverse transcriptase,Chueca N,,2012,NR,,0,,,,,
a hybrid stochastic-deterministic computational model accurately describes spatial dynamics and virus diffusion in hiv-1 growth competition assay,Immonen T,10.1016/j.jtbi.2012.07.005,2012,NR,,0,,,,,
a new pattern-based method for identifying recent hiv-1 infections from the viral env sequence,Yang J,10.1007/s11427-012-4312-0,2012,NR,,0,,,,,
a new real-time quantitative pcr for diagnosis and monitoring of hiv-1 group o infection,Gueudin M,10.1128/JCM.05669-11,2012,NR,,0,,,,,
a novel mutation in hiv-1 vif found in a long-term survivor from nairobi significantly attenuated a3g degradation and viral replication,Peng J,,2012,NR,,0,,,,,
a novel strategy for efficient production of anti-v3 human scfvs against hiv-1 clade c,Kumar R,10.1186/1472-6750-12-87,2012,NR,,0,,,,,
a patient-centered pharmacy services model of hiv patient care in community pharmacy settings: a theoretical and empirical framework,Kibicho J,10.1089/apc.2011.0212,2012,NR,,0,,,,,
a qualitative evaluation of men living with hiv: views on condom use,Fallahi H,,2012,NR,,0,,,,,
a quantitative study of michigan's criminal hiv exposure law,Galletly CL,10.1080/09540121.2011.603493,2012,NR,,0,,,,,
analysis of enfuvirtide resistance mutations prevalence among hiv-1 variants circulating in russia and cis countries,Vasilyev A,10.7448/IAS.15.6.18226,2012,NR,,0,,,,,
a prospective analysis of viral immune escape in the chronic phase of the subtype c hiv-1 infections of india,Sharma S,,2012,NR,,0,,,,,
a single residue within the v5 region of hiv-1 envelope facilitates viral escape from the broadly neutralizing monoclonal antibody vrc01,Guo D,10.1074/jbc.M112.399402,2012,NR,,0,,,,,
analysis of protease and reverse transcriptase genes of hiv for antiretroviral drug resistance in jamaican adults,Hamilton,10.1089/aid.2011.0312,2012,NR,,0,,,,,
absence of hiv-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection,Evering TH,10.1371/journal.ppat.1002506,2012,NR,,0,,,,,
active program participation and hiv risk reduction among urban youth: findings from the complementary strengths research partnership,Tiffany J,org/10.7448/IAS.15.5.18438,2012,NR,,0,,,,,
antiretroviral therapy reduces the magnitude and t cell receptor repertoire diversity of hiv-specific t cell responses without changing t cell clonotype dominance,Conrad JA,10.1128/JVI.06000-11,2012,NR,,0,,,,,
"apobec3g-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete ""all or nothing"" phenomenon",Armitage AE,10.1371/journal.pgen.1002550,2012,NR,,0,,,,,
assessing the impact of adherence to anti-retroviral therapy on treatment failure and resistance evolution in hiv,Cadosch D,10.1098/rsif.2012.0127,2012,NR,,0,,,,,
assessment of a microbicide candidate among a diverse cohort of urban southern us women and their male sexual partners (special issue: epidemiology and prevention: hiv),Frew,,2012,NR,,0,,,,,
assessment of t cell immune responses towards hiv-1 epitopes designed by reverse immunogenetic approach: proof-of-concept in hiv+ cameroonian children,Nemes E,,2012,NR,,0,,,,,
assessment of phylogenetic sensitivity for reconstructing hiv-1 epidemiological relationships,Beloukas A,10.1016/j.virusres.2012.03.002,2012,NR,,0,,,,,
"an assessment of cost, quality and outcomes for five hiv prevention youth peer education programs in zambia",Burke HM,10.1093/her/cyr103,2012,NR,,0,,,,,
"beneficial hla-mediated viral polymorphisms on the transmitted virus additively influence disease progression in hiv-1, subtype c infection",Ntale RS,,2012,NR,,0,,,,,
analysis of a stochastic predator-prey model with applications to intrahost hiv genetic diversity,Leviyang S,10.1007/s00285-011-0497-2,2012,NR,,0,,,,,
analysis of hiv using a high resolution melting (hrm) diversity assay: automation of hrm data analysis enhances the utility of the assay for analysis of hiv incidence,Cousins MM,10.1371/journal.pone.0051359,2012,NR,,0,,,,,
analysis of hiv-1 gp120 quasispecies suggests high prevalence of intra-subtype recombination,Kiwelu IE,,2012,NR,,0,,,,,
broad antiviral activity and crystal structure of hiv-1 fusion inhibitor sifuvirtide,Yao X,10.1074/jbc.M111.317883,2012,NR,,0,,,,,
antibodies to a superantigenic glycoprotein 120 epitope as the basis for developing an hiv vaccine,Planque SA,10.4049/jimmunol.1200981,2012,NR,,0,,,,,
can humanized mice reflect the complex pathobiology of hiv-associated neurocognitive disorders?,Gorantla S,10.1007/s11481-011-9335-y,2012,NR,,0,,,,,
apobec3-mediated editing in hiv type 1 from pediatric patients and its association with apobec3 g/cul5 polymorphisms and vif variability,Maio,10.1089/aid.2011.0291,2012,NR,,0,,,,,
caprisa 004 tenofovir microbicide trial: no impact of tenofovir gel on the hiv transmission bottleneck,Valley-Omar Z,10.1093/infdis/jis305,2012,NR,,0,,,,,
association of schistosomiasis and hiv infection in tanzania,Downs JA,10.4269/ajtmh.2012.12-0395,2012,NR,,0,,,,,
"characterization of drug resistance mutations in naive and art-treated patients infected with hiv-1 in yaounde, cameroon",Ceccarelli L,10.1002/jmv.23244,2012,NR,,0,,,,,
"bf integrase genes of hiv-1 circulating in sao paulo, brazil, with a recurrent recombination region",Iamarino A,10.1371/journal.pone.0034324,2012,NR,,0,,,,,
characterization of human endogenous retroviral elements in the blood of hiv-1-infected individuals,Contreras-Galindo R,10.1128/JVI.00602-11,2012,NR,,0,,,,,
"body composition changes in ageing hiv-infected patients: the complex interplay between low muscle mass, lipodystrophy and osteopenia",Guaraldi G,,2012,NR,,0,,,,,
broad and cross-clade cd4+ t-cell responses elicited by a dna vaccine encoding highly conserved and promiscuous hiv-1 m-group consensus peptides,Almeida RR,10.1371/journal.pone.0045267,2012,NR,,0,,,,,
characterizing hiv prevalence distribution across subpopulations at variable levels of sexual behavior,Awad S,10.1016/j.ijid.2012.05.737,2012,NR,,0,,,,,
characterizing hiv transmission networks across the united states,Aldous JL,,2012,NR,,0,,,,,
characterizing the hiv epidemic in the prairie provinces,Becker,,2012,NR,,0,,,,,
"circulation of hiv-1 subtype a within the subtype c hiv-1 epidemic in tamil nadu, india",Ragupathy V,10.1002/jmv.23383,2012,NR,,0,,,,,
burden of hiv disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use,Dray-Spira R,10.1097/QAD.0b013e32834dcf61,2012,NR,,0,,,,,
can we broaden the applicability of hiv transmission cluster analyses?,Lubelchek,10.1097/QAD.0b013e3283522d81,2012,NR,,0,,,,,
canadian hiv pregnancy planning guidelines,Loutfy MR,10.1016/S1701-2163%2816%2935274-4,2012,NR,,0,,,,,
candidate antibody-based therapeutics against hiv-1,Gong R,10.2165/11631400-000000000-00000,2012,NR,,0,,,,,
co-selected single nucleotide polymorphisms in the human immunodeficiency virus type 1 viral promoter precede the onset of neurocognitive impairment,Aiamkitsumrit B,10.1007/s13365-012-0101-6,2012,NR,,0,,,,,
characterization of staufen1 ribonucleoproteins by mass spectrometry and biochemical analyses reveal the presence of diverse host proteins associated with human immunodeficiency virus type 1,Milev MP,10.3389/fmicb.2012.00367,2012,NR,,0,,,,,
commentary on the role of treatment-related hiv compensatory mutations on increasing virulence: new discoveries twenty years since the clinical testing of protease inhibitors to block hiv-1 replication,Arts EJ,10.1186/1741-7015-10-114,2012,NR,,0,,,,,
conservation of hiv-1 t cell epitopes across time and clades: validation of immunogenic hla-a2 epitopes selected for the gaia hiv vaccine,Levitz L,10.1016/j.vaccine.2012.10.042,2012,NR,,0,,,,,
"common transcriptional signatures in hiv-1-associated neurocognitive disorder, alzheimer'sdisease andmultiple sclerosis comparison with a mouse model of hand",Borjabad A,10.1007/s13365-012-0101-6,2012,NR,,0,,,,,
community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an hiv prevention strategy: implications for implementation,Galindo GR,10.1186/1748-5908-7-116,2012,NR,,0,,,,,
comparative analysis of the fusion efficiency elicited by the envelope glycoprotein v1-v5 regions derived from human immunodeficiency virus type 1 transmitted perinatally,Guo H,10.1099/vir.0.046771-0,2012,NR,,0,,,,,
"high-resolution deep sequencing reveals biodiversity, population structure, and persistence of hiv-1 quasispecies within host ecosystems",Yin L,10.1186/1742-4690-9-108,2012,NR,,0,,,,,
"characteristics of hiv-1 gp120 molecules that bind ancestor, intermediate and mature forms of vrc01-like antibodies",Joyce M,,2012,NR,,0,,,,,
"characterization of hiv type 1 envelope sequence among viral isolates circulating in the northern region of colombia, south america",Villarreal,10.1089/aid.2011.0357,2012,NR,,0,,,,,
characterization of hiv-specific cd4+ t cell responses against peptides selected with broad population and pathogen coverage,Buggert M,10.1371/journal.pone.0039874,2012,NR,,0,,,,,
characterization of persistent hiv-1 in a broad spectrum of cd4+ t cells isolated from peripheral blood and gut associated lymphoid tissue from patients on long-term suppressive therapy,Josefsson L,org/10.7448/IAS.15.5.18438,2012,NR,,0,,,,,
cross clade reactive plasma anti-v3 antibodies in human immunodeficiency virus type-1 infected individuals develop with time,Andrabi R,,2012,NR,,0,,,,,
"climate envelope modelling reveals intraspecific relationships among flowering phenology, niche breadth and potential range size in arabidopsis thaliana",Banta JA,10.1111/j.1461-0248.2012.01796.x,2012,NR,,0,,,,,
depressive symptoms are increased in the early perimenopausal stage in ethnically diverse human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women,Maki,10.1097/gme.0b013e318255434d,2012,NR,,0,,,,,
"detailed characterization of hiv-1 mutants selected by 3-azido-2,3-dideoxypurine nucleosides in primary human lymphocytes",Nie T,,2012,NR,,0,,,,,
comparing different measures of retention in outpatient hiv care,Yehia BR,10.1097/QAD.0b013e3283528afa,2012,NR,,0,,,,,
comparison of a high-resolution melting assay to next-generation sequencing for analysis of hiv diversity,Cousins MM,10.1128/JCM.01460-12,2012,NR,,0,,,,,
determination of hiv-1 tropism from proviral hiv-1 dna in patients with suppressed plasma hiv-1 rna using population based-and deepsequencing: impact of x4-hiv variants on virologic responses to maraviroc?,Bellecave P,,2012,NR,,0,,,,,
comparison of the depth of vaccine-elicited hiv-1 env epitope-specific cd8+ t lymphocyte responses,Hulot SL,,2012,NR,,0,,,,,
multiple nf-kappab sites in hiv-1 subtype c long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance,Bachu M,10.1074/jbc.M112.397158,2012,NR,,0,,,,,
a combination of broadly neutralizing hiv-1 monoclonal antibodies targeting distinct epitopes effectively neutralizes variants found in early infection,Goo L,10.1128/JVI.01414-12,2012,NR,,0,,,,,
differential distribution of compound microsatellites in various human immunodeficiency virus type 1 complete genomes,Chen M,10.1016/j.meegid.2012.05.006,2012,NR,,0,,,,,
selected amino acid changes in hiv-1 subtype-c gp41 are associated with specific gp120(v3) signatures in the regulation of co-receptor usage,Dimonte S,10.1016/j.virusres.2012.06.019,2012,NR,,0,,,,,
subunit-selective mutational analysis and tissue culture evaluations of the interactions of the e138k and m184i mutations in hiv-1 reverse transcriptase,Xu HT,10.1128/JVI.00271-12,2012,NR,,0,,,,,
differential expression and hiv-1 regulation of mu-opioid receptor splice variants across human central nervous system cell types,Dever SM,10.1007/s13365-012-0096-z,2012,NR,,0,,,,,
chronic myeloid leukaemia and human immunodeficiency virus (hiv) infection,Webb MJ,10.1007/s12185-012-1073-2,2012,NR,,0,,,,,
diverse models for the prediction of hiv integrase inhibitory activity of substituted quinolone carboxylic acids,Gupta M,10.1002/ardp.201100316,2012,NR,,0,,,,,
motions on the millisecond time scale and multiple conformations of hiv-1 capsid protein: implications for structural polymorphism of ca assemblies,Byeon IJ,10.1021/ja300937v,2012,NR,,0,,,,,
independent evolution of macrophage-tropism and increased charge between hiv-1 r5 envelopes present in brain and immune tissue,Gonzalez-Perez MP,10.1186/1742-4690-9-20,2012,NR,,0,,,,,
envelope glycoproteins of human immunodeficiency virus type 1 variants issued from mother-infant pairs display a wide spectrum of biological properties,Thenin S,10.1016/j.virol.2012.01.017,2012,NR,,0,,,,,
mutual information analysis reveals coevolving residues in tat that compensate for two distinct functions in hiv-1 gene expression,Dey SS,10.1074/jbc.M111.302653,2012,NR,,0,,,,,
evidences for viral strain selection in late stages of hiv infection: an analysis of vpu alleles,Gondim MV,10.1007/s10930-011-9389-y,2012,NR,,0,,,,,
"characterization of primary isolates of hiv type 1 crf28_bf, crf29_bf, and unique bf recombinants circulating in sao paulo, brazil",Melo FL,10.1089/AID.2011.0123,2012,NR,,0,,,,,
continuous evolution of hiv-1 more than ten years after infection in an elite neutralizer,Chaillon A,,2012,NR,,0,,,,,
direct evidence for the importance and potency of cd8-mediated immunity in control of hiv viraemia,Gupta RK,,2012,NR,,0,,,,,
controlling the spread of hiv among long haulage workers in nigeria,Benjamin E,,2012,NR,,0,,,,,
functional analysis of hiv type 1 nef gene variants from adolescent and adult survivors of perinatal infection,Zuo J,10.1089/AID.2011.0172,2012,NR,,0,,,,,
controversies in hiv cure research,Johnston R,10.1186/1758-2652-15-16,2012,NR,,0,,,,,
less is more': assessing the effectiveness of a hiv prevention program for long distance trucker drivers in india after a re-designing in implementation structure,Tirumalasetti VR,org/10.7448/IAS.15.5.18438,2012,NR,,0,,,,,
coronary heart disease is associated with renal impairment in hiv positive patients,Desai M,10.1111/j.1468-1293.2011.01008.x,2012,NR,,0,,,,,
e138k and m184i mutations in hiv-1 reverse transcriptase coemerge as a result of apobec3 editing in the absence of drug exposure,Fourati S,10.1097/QAD.0b013e3283560703,2012,NR,,0,,,,,
"effect of hiv coinfection on genotypic distribution of hcv infected persons attending clinical immunology outpatient clinic (cioc), hotel dieu hospital (hdh), kingston , ontario",Medford R,,2012,NR,,0,,,,,
effect of synaptic transmission on viral fitness in hiv infection,Komarova NL,10.1371/journal.pone.0048361,2012,NR,,0,,,,,
early changes in the cd8 t cell immunodominance hierarchy in primary hiv infection prior to seroconversion,Keane N,,2012,NR,,0,,,,,
determinants of condom uptake among hiv voluntary counselling and testing clients: experiences from a hospital-based study in south india,Myerson R,,2012,NR,,0,,,,,
"eliminating vertically-transmitted hiv/aids while improving access to treatment and care for women, children and adolescents in jamaica",Christie CD,10.7727/wimj.2012.211,2012,NR,,0,,,,,
"emergence of a new hiv type 1 crf01-ae variant in guangxi, southern china",Zeng H,10.1089/aid.2011.0364,2012,NR,,0,,,,,
emergence of unique recombinant forms (urfs) in indian hiv-1 epidemic: data from nationwide clinical cohort between 2007 and 2011,Neogi U,,2012,NR,,0,,,,,
"endogenous or exogenous spreading of hiv-1 in nordrhein-westfalen, germany, investigated by phylodynamic analysis of the resina study cohort",Lawyer G,10.1007/s00430-011-0228-8,2012,NR,,0,,,,,
endogenous origins of hiv-1 g-to-a hypermutation and restriction in the nonpermissive t cell line cem2n,Refsland EW,10.1371/journal.ppat.1002800,2012,NR,,0,,,,,
eosinophilic panniculitis presenting with kaposi's sarcoma-like plaques in a patient who is human immunodeficiency virus positive: a case report,Ustuner P,10.1186/1752-1947-6-387,2012,NR,,0,,,,,
"development, implementation, and evaluation of a student-initiated undergraduate medical education elective in hiv care",Chew D,10.3109/0142159X.2012.668237,2012,NR,,0,,,,,
further progress on defining highly conserved immunogenic epitopes for a global hiv vaccine: hla-a3-restricted gaia vaccine epitopes,De Groot AS,10.4161/hv.20528,2012,NR,,0,,,,,
estimating the origin and evolution characteristics for korean hiv type 1 subtype b using bayesian phylogenetic analysis,Kim GJ,10.1089/AID.2011.0267,2012,NR,,0,,,,,
discordance in hiv-1 co-receptor use prediction by different genotypic algorithms and phenotype assay: intermediate profile in relation to concordant predictions,Trabaud MA,10.1002/jmv.23209,2012,NR,,0,,,,,
evaluation of cervical mucosa in transmission bottleneck during acute hiv-1 infection using a cervical tissue-based organ culture,Shen C,10.1371/journal.pone.0032539,2012,NR,,0,,,,,
evaluation of hiv-1 ambiguous nucleotide frequency during antiretroviral treatment interruption,Li,10.1097/QAI.0b013e318264460f,2012,NR,,0,,,,,
evaluation of hiv-1 resistance to antiretroviral drugs among 150 patients after six months of therapeutic interruption,Kalmar EM,10.1258/ijsa.2011.011124,2012,NR,,0,,,,,
evidence for env-v2 sieve effect in breakthrough sivmac251 infections in rhesus monkeys vaccinated with ad26/mva and mva/ad26 constructs,Sina S,,2012,NR,,0,,,,,
evidence for extended age dependent maternal immunity in infected children: mother to child transmission of hiv infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines,Bhargav H,jsc.2012.7.3.127,2012,NR,,0,,,,,
diverse hiv viruses are targeted by a conformationally dynamic antiviral,Caines ME,10.1038/nsmb.2253,2012,NR,,0,,,,,
diversification of specificity after maturation of the antibody response to the hiv gp41 epitope eldkwa,White HN,10.1371/journal.pone.0031555,2012,NR,,0,,,,,
diversity of hiv type 1 envelope (v3-v5) sequence in hiv type 1-infected indian children,Prakash SS,10.1089/AID.2011.0206,2012,NR,,0,,,,,
first report on hiv molecular epidemiology in a native community from argentina reveals transmission clades in the context of a unique hla background,Monaco D,,2012,NR,,0,,,,,
focus on increasing treatment self-efficacy to improve human immunodeficiency virus treatment adherence,Nokes K,10.1111/j.1547-5069.2012.01476.x,2012,NR,,0,,,,,
food insecurity and associated factors among hiv-infected individuals receiving highly active antiretroviral therapy in jimma zone southwest ethiopia,Ayele Tiyou,,2012,NR,,0,,,,,
early loss to follow-up of recently diagnosed hiv-infected adults from routine pre-art care in a rural district hospital in kenya: a cohort study,Hassan AS,10.1111/j.1365-3156.2011.02889.x,2012,NR,,0,,,,,
early low-titer neutralizing antibodies impede hiv-1 replication and select for virus escape,Bar KJ,10.1371/journal.ppat.1002721,2012,NR,,0,,,,,
full-length hiv-1 immunogens induce greater magnitude and comparable breadth of t lymphocyte responses to conserved hiv-1 regions compared with conserved-region-only hiv-1 immunogens in rhesus monkeys,Stephenson KE,10.1128/JVI.01779-12,2012,NR,,0,,,,,
efficacy of cell phone-delivered smoking cessation counseling for persons living with hiv/aids: 3-month outcomes,Vidrine DJ,10.1093/ntr/ntr121,2012,NR,,0,,,,,
"efficiency of ccr5 coreceptor utilization by the hiv quasispecies increases over time, but is not associated with disease progression",Redd AD,10.1089/AID.2011.0006,2012,NR,,0,,,,,
genetic diversity and drug resistance among newly diagnosed and antiretroviral treatment-naive hiv-infected individuals in western yunnan: a hot area of viral recombination in china,Chen Min,,2012,NR,,0,,,,,
"genetic variability and drug resistance mutations in hiv-1 infected individuals on haart or drug naive in limbe, cameroon",Agyingi L,,2012,NR,,0,,,,,
genetic variability at the trex1 locus is not associated with natural resistance to hiv-1 infection,Sironi M,10.1097/QAD.0b013e328354b3c2,2012,NR,,0,,,,,
genotyping and antifungal susceptibility profile of sequential candida albicans isolated from the oral cavity of hiv-infected individuals,Moris DV,10.1111/j.1439-0507.2012.02206.x,2012,NR,,0,,,,,
global analysis of sequence diversity within hiv-1 subtypes across geographic regions,Huang A,,2012,NR,,0,,,,,
health systems and hiv treatment in sub-saharan africa: matching intervention and programme evaluation strategies,Barnighausen,10.1136/sextrans-2011-050303,2012,NR,,0,,,,,
high diversity of cryptosporidium subgenotypes identified in malaysian hiv/aids individuals targeting gp60 gene,Iqbal A,10.1371/journal.pone.0031139,2012,NR,,0,,,,,
high viremia and low level of transmitted drug resistance in anti-retroviral therapy-naive perinatally-infected children and adolescents with hiv-1 subtype c infection,Neogi U,10.1186/1471-2334-12-317,2012,NR,,0,,,,,
highly active antiretroviral therapy and adverse birth outcomes among hiv-infected women in botswana,Chen,10.1093/infdis/jis553,2012,NR,,0,,,,,
hiv health center affiliation networks of black men who have sex with men: disentangling fragmented patterns of hiv prevention service utilization,Schneider JA,10.1097/OLQ.0b013e3182515cee,2012,NR,,0,,,,,
hiv infection among ethnic minority and migrant men who have sex with men in britain,Elford J,10.1097/OLQ.0b013e31825c8018,2012,NR,,0,,,,,
hiv risk among australian men travelling overseas: networks and context matter,Brown G,10.1080/13691058.2012.678015,2012,NR,,0,,,,,
hiv screening acceptance in an ethnically diverse urban emergency department,Cohen H,10.1111/j.1553-2712.2012.01332.x,2012,NR,,0,,,,,
"human immunodeficiency virus/human parvovirus b19 co-infection in blood donors and aids patients in sichuan, china",He M,10.2450/2012.0134-11,2012,NR,,0,,,,,
evaluation of genotypic prediction of hiv-1 tropism using population sequencing of replicates,Ferreira JL,10.1016/j.jviromet.2011.11.018,2012,NR,,0,,,,,
hiv type 1 genetic diversity and naturally occurring polymorphisms in hiv type 1 kenyan isolates: implications for integrase inhibitors,Nyamache,10.1089/aid.2011.0122,2012,NR,,0,,,,,
"hiv type 1 genetic variation in foreskin and blood from subjects in rakai, uganda",Galiwango RM,10.1089/AID.2011.0176,2012,NR,,0,,,,,
evidence of multiple introductions and autochthonous transmission of the hiv type 1 crf02-ag clade in brazil,Delatorre EO,10.1089/aid.2011.0381,2012,NR,,0,,,,,
immunodominance and viral ditness in gag may contribute to differential viral control in hla-b*7 supertype individuals acutely infected with hiv-1c,Gounder K,,2012,NR,,0,,,,,
immunogenetic surveillance of hiv/aids,Stephens HAF,10.1016/j.meegid.2012.04.011,2012,NR,,0,,,,,
"hiv-1 genetic diversity and transmitted drug resistance mutations among patients from the north, central and south regions of angola",Afonso JM,10.1371/journal.pone.0042996,2012,NR,,0,,,,,
family impact analysis of section 6 (sexual transmission) of the kenya hiv and aids prevention and control act no 14 of 2006,Rombo,10.1007/s10826-011-9515-7,2012,NR,,0,,,,,
immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virus,Lujan-Zilbermann J,10.1016/j.jpeds.2012.04.005,2012,NR,,0,,,,,
hiv-1 mother-to-child transmission and drug resistance among brazilian pregnant women with high access to diagnosis and prophylactic measures,Alcantara KC,10.1016/j.jcv.2012.01.011,2012,NR,,0,,,,,
"hiv-1 polymerase inhibition by nucleoside analogs: cellular- and kinetic parameters of efficacy, susceptibility and resistance selection",von Kleist M,10.1371/journal.pcbi.1002359,2012,NR,,0,,,,,
food insecurity and hiv: concepts and measurement tools in the haart era,Fielden S,org/10.7448/IAS.15.5.18438,2012,NR,,0,,,,,
"immunogenicity of a universal hiv-1 vaccine vectored by dna, mva and chadv-63 in a phase i/iia clinical trial",Hanke T,10.1111/imm.12002,2012,NR,,0,,,,,
from promoting to inhibiting: diverse roles of helicases in hiv-1 replication,Lorgeoux R-P,10.1186/1742-4690-9-79,2012,NR,,0,,,,,
hiv-1 subtype f1 epidemiological networks among italian heterosexual males are associated with introduction events from south america,Lai A,10.1371/journal.pone.0042223,2012,NR,,0,,,,,
increase of the hiv-1 non-b subtypes frequency in patients during primary infection in france and effect of hiv-1 subtypes on the virological and immunological response to cart,Chaix ML,,2012,NR,,0,,,,,
genetic diversity of ebv-encoded lmp1 in the swiss hiv cohort study and implication for nf- kappa b activation,Zuercher,10.1371/journal.pone.0032168,2012,NR,,0,,,,,
dna prime-protein boost using subtype consensus env was effective in eliciting neutralizing antibody responses against subtype bc hiv-1 viruses circulating in china,Zhang M,10.4161/hv.21648,2012,NR,,0,,,,,
"genetic diversity of hiv type 1 isolated from newly diagnosed subjects (2006-2007) in beijing, china",Ye JR,10.1089/AID.2011.0012,2012,NR,,0,,,,,
increasing diversity of human immunodeficiency virus type 1 subtypes circulating in australia,Chibo D,10.1089/AID.2011.0200,2012,NR,,0,,,,,
genome sequences of a novel hiv-1 crf53_01b identified in: malaysia,Chow WZ,10.1128/JVI.01932-12,2012,NR,,0,,,,,
global hiv-1 diversity surveillance,Aldrich C,10.1016/j.molmed.2012.06.004,2012,NR,,0,,,,,
human b-cell ontogeny in humanized nod/scid gammac(null) mice generates a diverse yet auto/poly- and hiv-1-reactive antibody repertoire,Chang H,10.1038/gene.2012.16,2012,NR,,0,,,,,
human immunodeficiency virus type 1 in ireland: phylogenetic evidence for risk group-specific subepidemics,De Gascun CF,10.1089/AID.2011.0301,2012,NR,,0,,,,,
heterogeneity in outcomes of treated hiv-positive patients in europe and north america: relation with patient and cohort characteristics,May MT,10.1093/ije/dys164,2012,NR,,0,,,,,
"human nucleoporins promote hiv-1 docking at the nuclear pore, nuclear import and integration",Di Nunzio F,10.1371/journal.pone.0046037,2012,NR,,0,,,,,
"innate, adaptive and intrinsic immunity in human immunodeficiency virus infection",Perera SS,10.3844/ajidsp.2012.132.148,2012,NR,,0,,,,,
"human t-cell lymphotropic virus in patients infected with hiv-1: molecular epidemiology and risk factors for transmission in piaui, northeastern brazil",de Oliveira EH,10.2174/157016212803901374,2012,NR,,0,,,,,
human tetherin exerts strong selection pressure on the hiv-1 group n vpu protein,Sauter D,10.1371/journal.ppat.1003093,2012,NR,,0,,,,,
humanized mice to assess the hiv-1 clade-specific differences: apropos of viral virulence and neuropathology,Gorantla S,10.1007/s11481-012-9349-0,2012,NR,,0,,,,,
iatrogenic mitochondrial disease emerging years after stopping anti-hiv treatment: the tip of the iceberg in 2012?,Payne B,10.1002/ana.23769,2012,NR,,0,,,,,
higher hiv-1 genetic diversity is associated with aids and neuropsychological impairment,Hightower GK,10.1016/j.virol.2012.08.028,2012,NR,,0,,,,,
identification of cellular proteins required for replication of human immunodeficiency virus type 1,Dziuba N,,2012,NR,,0,,,,,
hiv transmissions during seroconversion contribute significantly to new infections in men who have sex with men in australia,Chibo D,10.1089/aid.2011.0137,2012,NR,,0,,,,,
increased likelihood of bacterial pathogens in the coronal sulcus and urethra of uncircumcised men in a diverse group of hiv infected and uninfected patients in india,Schneider JA,10.4103/0974-777X.93750,2012,NR,,0,,,,,
increases in cd4 counts and effects on hiv in aviremic hiv-infected subjects infused with zinc finger nuclease (zfn) ccr5 modified autologous cd4 t-cells (sb-728-t),Tang W,10.1038/mt.2012.86,2012,NR,,0,,,,,
hiv-1 and autophagy,Chen S-H,10.1091/mbc.E12-10-0757,2012,NR,,0,,,,,
hiv-1 clade d is associated with increased rates of cd4 decline in a kenyan cohort,McKinnon,10.1371/journal.pone.0049797,2012,NR,,0,,,,,
hiv-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120,Kovacs JM,,2012,NR,,0,,,,,
hiv-1 subtype b- and f1-infected subjects display higher cross-clade t-cell response than subtype c-infected subjects,Cortes FH,,2012,NR,,0,,,,,
"interplay between single resistance-associated mutations in the hiv-1 protease and viral infectivity, protease activity, and inhibitor sensitivity",Henderson,10.1128/AAC.05549-11,2012,NR,,0,,,,,
isolation of older adults living with hiv: factors varying according to social networks,Wallach I,,2012,NR,,0,,,,,
structural definition for a new modality of broad and potent antibody neutralization at the cd4-binding site on hiv-1 gp120,Zhou T,,2012,NR,,0,,,,,
host genes important to hiv replication and evolution,Telenti A,10.1101/cshperspect.a007203,2012,NR,,0,,,,,
lignosulfonic acid exhibits broadly anti-hiv-1 activity--potential as a microbicide candidate for the prevention of hiv-1 sexual transmission,Qiu M,10.1371/journal.pone.0035906,2012,NR,,0,,,,,
identification of new crf51-01b in singapore using full genome analysis of three hiv type 1 isolates,Ng OT,10.1089/aid.2011.0177,2012,NR,,0,,,,,
impact of p38sj/ding on hiv-and ethanol-induced neuronal cell injury,Sarkissian N,10.1007/s13365-012-0101-6,2012,NR,,0,,,,,
impact of substance abuse on hiv-1 ltr polymorphisms and disease progression in subtype b and c clinical cohorts,Wigdahl B,10.1007/s11481-012-9349-0,2012,NR,,0,,,,,
improved outlook on hiv-1 prevention and vaccine development,Vasan S,10.1517/14712598.2012.688020,2012,NR,,0,,,,,
improvement in the health of hiv-infected persons in care: reducing disparities,Moore,10.1093/cid/cis654,2012,NR,,0,,,,,
in-depth characterization of viral isolates from plasma and cells compared with plasma circulating quasispecies in early hiv-1 infection,Dalmau J,10.1371/journal.pone.0032714,2012,NR,,0,,,,,
increased hiv-1 vaccine efficacy against viruses with genetic signatures in env v2,Rolland M,10.1038/nature11519,2012,NR,,0,,,,,
meta genomic characterization of the vaginal microbiome in hiv-infected women using culture independent methods,Mahal D,,2012,NR,,0,,,,,
influence of hormones and hiv infection on viral transport,Stieh DJ,,2012,NR,,0,,,,,
inhibition of 5'-utr rna conformational switching in hiv-1 using antisense pnas,Parkash B,10.1371/journal.pone.0049310,2012,NR,,0,,,,,
inhibition of hiv-1 subtype c by 2'f-rna aptamers isolated against enveloped pseudovirus,London GG,,2012,NR,,0,,,,,
molecular epidemiology of hiv-1 subtype b in the basque country (spain),Patino JA,,2012,NR,,0,,,,,
k65r in subtype c hiv-1 isolates from patients failing on a first-line regimen including d4t or azt: comparison of sanger and udp sequencing data,Recordon-Pinson,10.1371/journal.pone.0036549,2012,NR,,0,,,,,
learning from hiv: exploring migration and health in south africa,Vearey J,10.1080/17441692.2010.549494,2012,NR,,0,,,,,
"long-chain peer referral of men who have sex with men: a novel approach to establish and maintain a cohort to measure hiv incidence, nanjing, china",Yan HongJing,10.1097/QAI.0b013e318239c947,2012,NR,,0,,,,,
longitudinal analysis of early hiv-1-specific neutralizing activity in an elite neutralizer and in five patients who developed cross-reactive neutralizing activity,Euler Z,10.1128/JVI.06091-11,2012,NR,,0,,,,,
longitudinal analysis of intra-host hiv-1 envelope species during the course of hand,Vazquez-Santiago FJ,10.1007/s11481-012-9349-0,2012,NR,,0,,,,,
molecular typing of the recently expanding subtype b hiv-1 epidemic in romania: evidence for local spread among msms in bucharest area,Paraschiv S,10.1016/j.meegid.2012.03.003,2012,NR,,0,,,,,
losing the battle? time to focus the risk discussion with hiv-positive msm,Perera S,10.1136/sextrans-2012-050601c.40,2012,NR,,0,,,,,
monte carlo sampling and multivariate adaptive regression splines as tools for qsar modelling of hiv-1 reverse transcriptase inhibitors,Alamdari RF,10.1080/1062936X.2012.696552,2012,NR,,0,,,,,
"more than just a cut: a qualitative study of penile practices and their relationship to masculinity, sexuality and contagion and their implications for hiv prevention in papua new guinea",Kelly A,10.1186/1472-698X-12-10,2012,NR,,0,,,,,
naive t-cells remain a very stable reservoir of hiv after 5 years of suppressive combination antiretroviral therapy,Khoury G,,2012,NR,,0,,,,,
mind the gap: evaluating internal controls in hiv supply chains across sub-saharan africa,Kohler J,org/10.7448/IAS.15.5.18438,2012,NR,,0,,,,,
missed opportunities for hiv testing in the emergency department,O'Connell R,10.1111/j.1468-1293.2011.01009.x,2012,NR,,0,,,,,
needle exchange and the hiv epidemic in vancouver: lessons learned from 15 years of research,Hyshka E,10.1016/j.drugpo.2012.03.006,2012,NR,,0,,,,,
modelling the course of an hiv infection: insights from ecology and evolution,Alizon S,10.3390/v4101984,2012,NR,,0,,,,,
modern hiv prevention strategies: what are the implications for german populations? community perspectives,Langanke H,10.1111/j.1610-0387.2012.07967.x,2012,NR,,0,,,,,
new subtypes and genetic recombination in hiv type 1-infecting patients with highly active antiretroviral therapy in peru (2008-2010),Yabar,10.1089/aid.2012.0040,2012,NR,,0,,,,,
"molecular characterization of non-b hiv type 1 isolates from patients of a department of infectious diseases, university hospital of bordeaux, france, 1989-2009",Javaugue FC,10.1089/AID.2011.0321,2012,NR,,0,,,,,
nonrandom distribution of cryptic repeating triplets of purines and pyrimidines (rny)n in gp120 of hiv type1,De Crignis E,10.1089/aid.2011.0208,2012,NR,,0,,,,,
nucleocapsid protein annealing of a primer-template enhances (+)-strand dna synthesis and fidelity by hiv-1 reverse transcriptase,Kim J,10.1016/j.jmb.2011.12.034,2012,NR,,0,,,,,
sustained local delivery of structurally diverse hiv-1 microbicides released from sublimation enthalpy controlled matrices,Gunaseelan S,10.1007/s11095-012-0811-8,2012,NR,,0,,,,,
mrkad5 hiv-1 gag/pol/nef vaccine-induced t-cell responses inadequately predict distance of breakthrough hiv-1 sequences to the vaccine or viral load,Janes H,10.1371/journal.pone.0043396,2012,NR,,0,,,,,
multicohort genomewide association study reveals a new signal of protection against hiv-1 acquisition,Limou S,10.1093/infdis/jis028,2012,NR,,0,,,,,
high resolution human leukocyte antigen class i allele frequencies and hiv-1 infection associations in chinese han and uyghur cohorts,Liu Y,10.1371/journal.pone.0050656,2012,NR,,0,,,,,
ongoing sexually transmitted disease acquisition and risk-taking behavior among us hiv-infected patients in primary care: implications for prevention interventions,Mayer KH,10.1097/OLQ.0b013e31823b1922,2012,NR,,0,,,,,
selected amino acid changes in hiv-1 subtype-c gp41 are associated with specific gp120v3 signatures in the regulation of co-receptor usage,Dimonte S,10.1016/j.virusres.2012.06.019,2012,NR,,0,,,,,
mutations in hiv-1 gag and pol compensate for the loss of viral fitness caused by a highly mutated protease,Kozisek M,10.1128/AAC.00465-12,2012,NR,,0,,,,,
near full-length sequence analysis of two new hiv type 1 unique (crf01-ae/b) recombinant frms among men who have sex with men in china,Wang W,10.1089/aid.2011.0196,2012,NR,,0,,,,,
spatial accessibility and the spread of hiv-1 subtypes and recombinants,Tatem AJ,10.1097/QAD.0b013e328359a904,2012,NR,,0,,,,,
near full-length sequence analysis of hiv type 1 bf recombinants from italy,Saladini F,10.1089/aid.2011.0002,2012,NR,,0,,,,,
mechanisms and modifications of naturally occurring host defense peptides for anti-hiv microbicide development,Eade CR,10.2174/157016212799304580,2012,NR,,0,,,,,
role of beta-catenin and tcf/lef family members in transcriptional activity of hiv in astrocytes,Narasipura SD,10.1128/JVI.06266-11,2012,NR,,0,,,,,
two unique recombinant forms identified in incident hiv type 1 infections in thai blood donors,Rutvisuttinunt W,10.1089/aid.2011.0339,2012,NR,,0,,,,,
evolutionary pattern of asian hiv-1 subtype b from 1990 to 2007: in silico analysis based on envelop protein,Kanwal S,10.1100/2012/978917,2012,NR,,0,,,,,
francophones living with hiv/aids in ontario: the unknown reality of an invisible cultural minority,Samson AA,10.1080/09540121.2011.630350,2012,NR,,0,,,,,
oral and airway microbiota in hiv-infected pneumonia patients,Iwai S,10.1128/JCM.00278-12,2012,NR,,0,,,,,
modeling adaptive regulatory t-cell dynamics during early hiv infection,Simonov M,10.1371/journal.pone.0033924,2012,NR,,0,,,,,
knowledge and access are not enough: hiv risk and prevention among people from culturally and linguistically diverse backgrounds in sydney: to the editor,Asante AD,10.5694/mja11.11342,2012,NR,,0,,,,,
the impact of stigma on medication adherence among hiv-positive adolescent and young adult females and the moderating effects of coping and satisfaction with health care,Martinez J,10.1089/apc.2011.0178,2012,NR,,0,,,,,
origin of minority drug-resistant hiv-1 variants in primary hiv-1 infection,Metzner KJ,,2012,NR,,0,,,,,
"characterization of primary isolates of hiv type 1 crf28-bf, crf29-bf, and unique bf recombinants circulating in sao paulo, brazil",Melo FL,10.1089/aid.2011.0123,2012,NR,,0,,,,,
stability and neutralization capacity of a novel mosaic hiv-1 gp140 trimer in a guinea pig model,Nkolola JP,,2012,NR,,0,,,,,
hla-associated viral polymorphism in chronically hiv-1-infected japanese cohort: analysis of four-digit hla allele level,Chikata T,,2012,NR,,0,,,,,
neutralizing and non-neutralizing antibody responses in hiv-1 subtype c chronically infected patients with divergent rates of disease progression,Archary D,,2012,NR,,0,,,,,
neutralizing antibodies and control of hiv: moves and countermoves,Hessell AJ,10.1007/s11904-011-0105-5,2012,NR,,0,,,,,
isolation of broadly neutralizing hiv-1 antibodies from high-throughput single b cell culture,Longo NS,,2012,NR,,0,,,,,
new models for medical education: web-based conferencing to support hiv training in sub-saharan africa,Reid MJ,10.1089/tmj.2011.0200,2012,NR,,0,,,,,
influx of uncommon hiv-1 strains from eastern europe and identification of a new unique recombinant strain among young cypriot msm in cyprus,Kousiappa I,,2012,NR,,0,,,,,
physical activity particpation and cardiovascular fitness in people leaving with hiv a one-year longitudinal study,Fillipas S,,2012,NR,,0,,,,,
production and expression of recombinant anti-v3 scfvs from hiv-1 clade c infected indian patient,Kumar R,,2012,NR,,0,,,,,
gender and hiv/aids education in the multi-cultural context of schools at kakuma refugee camp in kenya,Ochieng RM,org/10.7448/IAS.15.5.18438,2012,NR,,0,,,,,
third generation long-read sequencing of hiv-1 transcripts discloses cell type specific and temporal regulation of rna splicing,Bushman F,org/10.7448/IAS.15.5.18438,2012,NR,,0,,,,,
hiv-1 genetic variants in kyrgyzstan,Laga V,10.7448/IAS.15.6.18229,2012,NR,,0,,,,,
rapid broadening of the ctl responses retards the evolution of immune escapes of hiv,Van Deutekom HWM,10.1111/imm.12002,2012,NR,,0,,,,,
nutritional status of hiv-positive individuals in a sanitary district of southern spain usefulness of modified version of sga as a screening tool of malnutrition,Cayon M,10.1016/S1744-1161%2812%2970469-6,2012,NR,,0,,,,,
"elevated prevalence of the e138a mutation in reverse transcriptase of hiv-1 subtypes a and c from recently infected, untreated subjects",Jordan M,,2012,NR,,0,,,,,
on hiv diversity,Ndung'U T,10.1097/QAD.0b013e32835461b5,2012,NR,,0,,,,,
one pot efficient diversity oriented synthesis of polyfunctional styryl thiazolopyrimidines and their bio-evaluation as antimalarial and anti-hiv agents,Fatima S,10.1016/j.ejmech.2012.07.018,2012,NR,,0,,,,,
chest ct scan findings and implications for lung cancer screening in hiv infected patients,Sigel KM,10.1111/j.1752-8062.2012.00398.x,2012,NR,,0,,,,,
hiv-related stigma as a mediator of the relation between multiple-minority status and mental health burden in an aging hiv-positive population,Storholm ED,10.1111/j.1752-8062.2012.00398.x,2012,NR,,0,,,,,
phylodynamics of hiv-1 subtype c epidemic in east africa,Delatorre EO,10.1371/journal.pone.0041904,2012,NR,,0,,,,,
opioids in the management of hiv-related pain,Krashin DL,,2012,NR,,0,,,,,
phylogenetic analysis of the latvian hiv-1 epidemic,Balode D,10.1089/aid.2011.0310,2012,NR,,0,,,,,
participation of hiv prevention programs among men who have sex with men in two cities of china--a mixed method study,Ma W,10.1186/1471-2458-12-847,2012,NR,,0,,,,,
phylogenetic characterization of hiv type 1 crf01_ae v3 envelope sequences in pregnant women in northern vietnam,Caridha,10.1089/aid.2011.0033,2012,NR,,0,,,,,
phylogenetic insights into regional hiv transmission,Dennis,10.1097/QAD.0b013e3283573244,2012,NR,,0,,,,,
"perceptions regarding the ease of use and usefulness of health information exchange systems among medical providers, case managers and non-clinical staff members working in hiv care and community settings",Myers JJ,10.1016/j.ijmedinf.2012.07.005,2012,NR,,0,,,,,
"phylodynamics of hiv-1 subtype f1 in angola, brazil and romania",Bello G,10.1016/j.meegid.2012.03.014,2012,NR,,0,,,,,
polymorphisms of hiv rt gene among the art nave native drug exposed rural plha,Krishnan K M,10.4103/0974-777X.96775,2012,NR,,0,,,,,
pilot studies for development of an hiv subtype panel for surveillance of global diversity,Manak M,10.1089/aid.2011.0271,2012,NR,,0,,,,,
plasma antibodies that cross react to subtype-b and c third variable (v3) region develop in indian hiv-1 infected iindividuals with time,Andrabi R,,2012,NR,,0,,,,,
predictors of antiretroviral medication adherence among a diverse cohort of adolescents with hiv,Chandwani S,10.1016/j.jadohealth.2011.12.013,2012,NR,,0,,,,,
pregnancies among women seen for hiv-clinical care-predictors and trends over time,Huntington S,10.1111/j.1468-1293.2011.01009.x,2012,NR,,0,,,,,
prenatal hiv testing: the compartmentalization of women's sexual risk exposure and the return of the maternal fetal conflict,Kelly K,10.1080/03630242.2012.717594,2012,NR,,0,,,,,
previously transmitted hiv-1 strains are preferentially selected during subsequent sexual transmissions,Redd AD,10.1093/infdis/jis503,2012,NR,,0,,,,,
primary hiv-1 resistance - persistence of transmitted drug resistance mutations,Nikolic,10.2298/ABS1204301N,2012,NR,,0,,,,,
"rapid, efficient functional characterization and recovery of hiv-specific human cd8+ t cells using microengraving",Varadarajan N,10.1073/pnas.1111205109,2012,NR,,0,,,,,
qualitative comparison of barriers to antiretroviral medication adherence among perinatally and behaviorally hiv-infected youth,Fields EL,10.1016/j.jadohealth.2011.10.036,2012,NR,,0,,,,,
racial differences in same-race partnering and the effects of sexual partnership characteristics on hiv risk in msm: a prospective sexual diary study,Newcomb ME,10.1097/QAI.0b013e31827e5f8c,2012,NR,,0,,,,,
"reducing harm from hiv/aids misconceptions among female sex workers in tijuana and ciudad juarez, mexico: a cross sectional analysis",Robertson AM,10.1186/1477-7517-9-35,2012,NR,,0,,,,,
"relationship type, condom use and hiv/aids risks among men who have sex with men in six chinese cities",Kong TSK,10.1080/09540121.2011.617411,2012,NR,,0,,,,,
relaxation of adaptive evolution during the hiv-1 infection owing to reduction of cd4+ t cell counts,Leal E,10.1371/journal.pone.0039776,2012,NR,,0,,,,,
reproductive healthcare needs and desires in a cohort of hiv-positive women,Badell ML,10.1155/2012/107878,2012,NR,,0,,,,,
"recombination form and epidemiology of hiv-1 unique recombinant strains identified in yunnan, china",Li L,10.1371/journal.pone.0046777,2012,NR,,0,,,,,
routine prenatal hiv testing: women's concerns and their strategies for addressing concerns,Rothpletz-Puglia P,10.1007/s10995-011-0754-4,2012,NR,,0,,,,,
selection pressure on hiv-1 envelope by broadly neutralizing antibodies to the conserved cd4-binding site,Wu X,10.1128/JVI.07139-11,2012,NR,,0,,,,,
serum neutralizing activities from a beijing homosexual male cohort infected with different subtypes of hiv-1 in china,Zhang M,10.1371/journal.pone.0047548,2012,NR,,0,,,,,
"rising epidemic of hiv-1 infections among general populations in fujian, china",Yao X,10.1097/QAI.0b013e31824f19f5,2012,NR,,0,,,,,
sexual assault injuries and increased risk of hiv transmission,Draughon JE,10.1097/TME.0b013e3182439e1a,2012,NR,,0,,,,,
sexual health of people living with hiv,Nostlinger C,10.3109/13625187.2012.673960,2012,NR,,0,,,,,
role of transmitted gag ctl polymorphisms in defining replicative capacity and early hiv-1 pathogenesis,Prince JL,10.1371/journal.ppat.1003041,2012,NR,,0,,,,,
second-site suppressors of hiv-1 capsid mutations: restoration of intracellular activities without correction of intrinsic capsid stability defects,Yang R,10.1186/1742-4690-9-30,2012,NR,,0,,,,,
small for gestational age birth outcomes in pregnant women with perinatally acquired hiv,Jao,10.1097/QAD.0b013e328351f6ef,2012,NR,,0,,,,,
somatic populations of pgt135-137 hiv-1-neutralizing antibodies identified by 454 pyrosequencing and bioinformatics,Zhu J,,2012,NR,,0,,,,,
"sensitivity of the ultrio elite assay on the panther instrument to a diverse sample of hiv-1, hiv-2, hcv, and hbv",Deras M,10.1111/j.1537-2995.2012.03833-1.x,2012,NR,,0,,,,,
"spline-based modelling of trends in the force of hiv infection, with application to the unaids estimation and projection package (unaids report 2012)",Hogan,10.1136/sextrans-2012-050652,2012,NR,,0,,,,,
stochastic simulations suggest that hiv-1 survives close to its error threshold,Tripathi K,10.1371/journal.pcbi.1002684,2012,NR,,0,,,,,
"sexual health information seeking online: a mixed-methods study among lesbian, gay, bisexual, and transgender young people (special issue: sexuality relationships, & hiv prevention)",Magee,10.1177/1090198111401384,2012,NR,,0,,,,,
successes and challenges of hiv prevention in men who have sex with men,Sullivan PS,10.1016/S0140-6736%2812%2960955-6,2012,NR,,0,,,,,
"sexual life, options for contraception and intention for conception in hiv-positive people on successful antiretroviral therapy in thailand",Landolt NK,10.1080/09540121.2011.648161,2012,NR,,0,,,,,
t cell virological synapses and hiv-1 pathogenesis,Chen BK,10.1007/s12026-012-8320-8,2012,NR,,0,,,,,
short communication: phylogenetic characterization of hiv type 1 crf01-ae v3 envelope sequences in pregnant women in northern vietnam,Caridha R,10.1089/aid.2011.0033,2012,NR,,0,,,,,
significant hiv-1 subtype differences observed in the development of accessory mutations associated with high-level resistance to reverse transcriptase inhibitors,Koning FA,,2012,NR,,0,,,,,
"similar prevalence of baseline hiv-1 minority variants among responders and virologic failures, as well as increased detection of hiv-1 minority variants at treatment failure, in rilpivirine patients from the echo and thrive phase iii studies (post hoc resistance analysis)",Rimsky L,org/10.7448/IAS.15.5.18438,2012,NR,,0,,,,,
small for gestational age birth outcomes in pregnant women with perinatally acquired hiv [],Jao J,10.1097/QAD.0b013e328351f6ef,2012,NR,,0,,,,,
"small-for-gestational-age births in pregnant women with hiv, due to severity of hiv disease, not antiretroviral therapy",Aaron E,10.1155/2012/135030,2012,NR,,0,,,,,
temporal association of hla-b*81:01- and hla-b*39:10-mediated hiv-1 p24 sequence evolution with disease progression,Ntale RS,10.1128/JVI.00539-12,2012,NR,,0,,,,,
"sociosexuality, human immunodeficiency virus (hiv) susceptibility, and sexual behavior among african american women",Hall NM,,2012,NR,,0,,,,,
"spatial dynamics of hiv-1 infection in rakai, uganda",Grabowski M,10.1093/aje/kws258,2012,NR,,0,,,,,
standing genetic variation and the evolution of drug resistance in hiv,Pennings PS,10.1371/journal.pcbi.1002527,2012,NR,,0,,,,,
the antibody response against hiv-1,Overbaugh J,10.1101/cshperspect.a007039,2012,NR,,0,,,,,
structural modulation study of inhibitory compounds for ribonuclease h activity of human immunodeficiency virus type 1 reverse transcriptase,Yanagita H,,2012,NR,,0,,,,,
the association between adolescent entry into the trucking industry and risk of hiv among long-distance truck drivers in india,Mishra RM,10.2147/HIV.S35003,2012,NR,,0,,,,,
the breadth and titer of maternal hiv-1-specific heterologous neutralizing antibodies are not associated with a lower rate of mother-to-child transmission of hiv-1,Chaillon A,10.1128/JVI.00518-12,2012,NR,,0,,,,,
the complexity of negotiating hiv risk with clients and in private relationships: experiences of female sex workers in india,Panchanadeswaran S,org/10.7448/IAS.15.5.18438,2012,NR,,0,,,,,
the conserved polarity factor podj1 impacts multiple cell envelope-associated functions in sinorhizobium meliloti,Fields AT,10.1111/j.1365-2958.2012.08064.x,2012,NR,,0,,,,,
the development and psychometric properties of the hiv and abuse related shame inventory (harsi),Neufeld SA,10.1007/s10461-011-0086-9,2012,NR,,0,,,,,
the future of hiv care in the usa,Sherer,10.1136/sextrans-2011-050160,2012,NR,,0,,,,,
the evolution of hiv: inferences using phylogenetics,Castro-Nallar E,10.1016/j.ympev.2011.11.019,2012,NR,,0,,,,,
the human neuroinflammasome is activated by hiv-1 infection: microglia contain requisite inflammasome components,Walsh JG,10.1016/j.jneuroim.2012.10.001,2012,NR,,0,,,,,
the impact of hiv-1 infection in naive cd4+ t-cell homeostasis,Lu I,10.1111/imm.12001,2012,NR,,0,,,,,
the hiv-1 epidemic: low- to middle-income countries,Shao Y,10.1101/cshperspect.a007187,2012,NR,,0,,,,,
the hiv-1 reverse transcriptase m184i mutation enhances the e138k-associated resistance to rilpivirine and decreases viral fitness,Kulkarni R,10.1097/QAI.0b013e31823aca74,2012,NR,,0,,,,,
the molecular basis of hiv entry,Klasse PJ,10.1111/j.1462-5822.2012.01812.x,2012,NR,,0,,,,,
the personal cost of early and late stage diagnosis of hiv and factors contributing to delayed diagnosis: a qualitative study,Samuel M,10.1111/j.1468-1293.2011.01009.x,2012,NR,,0,,,,,
the realities of rapid hiv testing in primary care: initial qualitative findings from the rhiva 2 trial,McMullen H,10.1111/j.1468-1293.2011.01009.x,2012,NR,,0,,,,,
the role of vif oligomerization and rna chaperone activity in hiv-1 replication,Batisse J,10.1016/j.virusres.2012.06.018,2012,NR,,0,,,,,
the recognition of hiv-1 consensus group m gag and nef peptide reagents in mono-and multi-clade epidemics: implications for hiv vaccine design,Zembe L,,2012,NR,,0,,,,,
transmembrane domain membrane proximal external region but not surface unit-directed broadly neutralizing hiv-1 antibodies can restrict dendritic cell-mediated hiv-1 trans-infection,Sagar M,10.1093/infdis/jis183,2012,NR,,0,,,,,
transmission of two distinct hiv type 1 strains to an individual that were harbored for many years by another,van Werkhoven MB,10.1089/aid.2011.0178,2012,NR,,0,,,,,
tracing the origin and history of hiv-1 subtype b' epidemic by near full-length genome analyses,Li Z,10.1097/QAD.0b013e328351430d,2012,NR,,0,,,,,
typical clinical presentation and broad spectrum of mri findings in general paresis due to neurosyphilis in a hiv-negative patient,Scalco RS,10.1007/s00415-012-6524-4,2012,NR,,0,,,,,
uncomfortable silences: narratives of four educators teaching about hiv/aids in a high school near montreal,Cobbler M-A,org/10.7448/IAS.15.5.18438,2012,NR,,0,,,,,
understanding the diversity of male clients of sex workers in china and the implications for hiv prevention programmes,Huang Y,10.1080/17441692.2012.657663,2012,NR,,0,,,,,
"universal amplification, next-generation sequencing, and assembly of hiv-1 genomes",Gall A,10.1128/JCM.01516-12,2012,NR,,0,,,,,
near full-length sequence analysis of two new hiv type 1 unique (crf01_ae/b) recombinant forms among men who have sex with men in china,Wang WanHai,10.1089/aid.2011.0196,2012,NR,,0,,,,,
early and long-lasting alteration of effector cd45ra-foxp3high regulatory t-cell homeostasis during hiv infection,Simonetta,10.1093/infdis/jis235,2012,NR,,0,,,,,
unusual substitutions in hiv-1 vif from children infected perinatally without progression to aids for more than 8 years without therapy,De Maio FA,10.1002/jmv.23261,2012,NR,,0,,,,,
knowledge and access are not enough: hiv risk and prevention among people from culturally and linguistically diverse backgrounds in sydney,Asante,10.5694/mja11.11342,2012,NR,,0,,,,,
differential expression and hiv-1 regulation of mu -opioid receptor splice variants across human central nervous system cell types,Dever,10.1007/s13365-012-0096-z,2012,NR,,0,,,,,
"structural stigma, sex work and hiv: contradictions and lessons learnt from a community-led structural intervention in southern india (special issue: assessing the role of community mobilisation in a scaled hiv prevention programme among marginalized populations in india - findings from avahan)",Biradavolu,10.1136/jech-2011-200508,2012,NR,,0,,,,,
"how effective is community mobilisation in hiv prevention among highly diverse sex workers in urban settings? the aastha intervention experience in mumbai and thane districts, india (special issue: assessing the role of community mobilisation in a scaled hiv prevention programme among marginalized populations in india - findings from avahan)",Gaikwad,10.1136/jech-2011-200514,2012,NR,,0,,,,,
use of a rapid hiv home test to screen potential sexual partners prevents hiv exposure in a high-risk sample of msm,Carballo-Dieguez A,org/10.7448/IAS.15.5.18438,2012,NR,,0,,,,,
transmitted drug resistance and phylogenetic analysis of hiv crf01_ae in northern vietnam,Bontell I,10.1016/j.meegid.2011.04.034,2012,NR,,0,,,,,
v5 region in the hiv-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody vrc01,Guo D,,2012,NR,,0,,,,,
transmitted hiv-1 variants in hiv infected mother-child pairs carrying different subtypes,Caridha R,,2012,NR,,0,,,,,
treatment acceptance and adherence in hiv disease: patient identity and the perceived impact of physician-patient communication,Laws MB,10.2147/PPA.S36912,2012,NR,,0,,,,,
treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower cd4 count in newly diagnosed drug-naive hiv-1 infected patients,Theys K,10.1186/1742-4690-9-81,2012,NR,,0,,,,,
understanding how adherence goals promote adherence behaviours: a repeated measure observational study with hiv seropositive patients,Jones G,,2012,NR,,0,,,,,
use of a high resolution melting assay to analyze hiv diversity in hiv-infected ugandan children,James MM,10.1097/INF.0b013e3182678c3f,2012,NR,,0,,,,,
what hiv/aids case management approaches bring about positive client outcomes? results from connecthiv,Rogers,10.1080/15381501.2012.652546,2012,NR,,0,,,,,
workshop summary: novel biomarkers for hiv incidence assay development,Sharma UK,10.1089/AID.2011.0332,2012,NR,,0,,,,,
"vpu downmodulates two distinct targets, tetherin and gibbon ape leukemia virus envelope, through shared features in the vpu cytoplasmic tail",Lucas TM,10.1371/journal.pone.0051741,2012,NR,,0,,,,,
worldwide variation in human drug-metabolism enzyme genes cyp2b6 and ugt2b7: implications for hiv/aids treatment,Li J,10.2217/pgs.11.160,2012,NR,,0,,,,,
zdv resistance mutations detected by pyrosequencing in women treated with singleagent zdv for prevention of mother-to-childtransmission of hiv-1,Olson SC,,2012,NR,,0,,,,,
"""aging out"": from pediatric to adult models of hiv care",Fernet M,,2011,NR,,0,,,,,
"a multimodal behavioral intervention to impact adherence and risk behavior among perinatally and behaviorally hiv-infected youth: description, delivery, and receptivity of adolescent impact",Chandwani S,10.1521/aeap.2011.23.3.222,2011,NR,,0,,,,,
a multinational study of neurological performance in antiretroviral therapy-naive hiv-1-infected persons in diverse resource-constrained settings,Robertson K,10.1007/s13365-011-0044-3,2011,NR,,0,,,,,
a positively selected apobec3h haplotype is associated with natural resistance to hiv-1 infection,Cagliani R,10.1111/j.1558-5646.2011.01368.x,2011,NR,,0,,,,,
"a wandering bus for the prevention of hiv and sexually transmitted diseases: the project ""parliamonetour"" (let's talk tour) of the cotugno hospital",Franco A,10.1007/s15010-011-0090-z,2011,NR,,0,,,,,
addressing men and gender diversity in education: a promising solution to the hiv/aids epidemic,Amir Biglar,10.1080/07399332.2010.532577,2011,NR,,0,,,,,
a description of an integrated model of hiv/aids care including supervised injection services,Baltzer Turje R,,2011,NR,,0,,,,,
a house is not a home: the housing experiences of african and caribbean mothers living with hiv,Greene S,,2011,NR,,0,,,,,
alcohol and antiretroviral therapy - a lethal cocktail (special issue: risk behaviors: hiv/aids - volume 1),Schneider,,2011,NR,,0,,,,,
ambiguous nucleotide calls from population-based sequencing of hiv-1 are a marker for viral diversity and the age of infection,Kouyos RD,10.1093/cid/ciq164,2011,NR,,0,,,,,
a signature in hiv-1 envelope leader peptide associated with transition from acute to chronic infection impacts envelope processing and infectivity,Asmal M,10.1371/journal.pone.0023673,2011,NR,,0,,,,,
a single mutation turns a non-binding germline-like predecessor of broadly neutralizing antibody into a binding antibody to hiv-1 envelope glycoproteins,Yuan T,,2011,NR,,0,,,,,
analysis of hiv type 1 bf recombinant sequences from south america dates the origin of crf12_bf to a recombination event in the 1970s,Dilernia,,2011,NR,,0,,,,,
analysis of the origin and evolutionary history of hiv-1 crf28_bf and crf29_bf reveals a decreasing prevalence in the aids epidemic of brazil,Ristic N,10.1371/journal.pone.0017485,2011,NR,,0,,,,,
antiretroviral drug resistance in a respondent-driven sample of hiv-infected men who have sex with men in brazil,Bermudez-Aza EH,10.1097/QAI.0b013e31821e9c36,2011,NR,,0,,,,,
accurate sampling and deep sequencing of the hiv-1 protease gene using a primer id,Jabara CB,10.1073/pnas.1110064108,2011,NR,,0,,,,,
antiretroviral drug resistance mutations among treated and treatment-naive patients in pakistan: diversity of the hiv type 1 pol gene in pakistan,Shah S,10.1089/aid.2010.0324,2011,NR,,0,,,,,
"are information, motivation, and behavioral skills linked with hiv-related sexual risk among young men who have sex with men?",Fisher,10.1080/15381501.2011.549064,2011,NR,,0,,,,,
apobec3h haplotypes and hiv-1 pro-viral vif dna sequence diversity in early untreated human immunodeficiency virus-1 infection,Gourraud PA,10.1016/j.humimm.2010.12.008,2011,NR,,0,,,,,
association of methicillin-resistant staphylococcus aureus (mrsa) colonization with high-risk sexual behaviors in persons infected with human immunodeficiency virus (hiv),Crum-Cianflone NF,10.1097/MD.0b013e318238dc2c,2011,NR,,0,,,,,
bayesian evidence synthesis for a transmission dynamic model for hiv among men who have sex with men,Presanis AM,10.1093/biostatistics/kxr006,2011,NR,,0,,,,,
amplifying and quantifying hiv-1 rna in hiv infected individuals with viral loads below the limit of detection by standard clinical assays,Mens H,10.3791/2960,2011,NR,,0,,,,,
can ethics help when choosing antiretroviral therapy for treatment naive hiv-infected adults?,Gilmore N,,2011,NR,,0,,,,,
"canadian perinatal hiv surveillance program (cphsp): perinatal hiv transmission, treatment in pregnancy and demographics in canada",Singer J,,2011,NR,,0,,,,,
"challenges in meeting the psycho-social needs of older youth living with hiv since childhood: sex, haart and disclosure",Compton M,,2011,NR,,0,,,,,
"characterisation of hiv-1 genetic diversity in established and recent infections among intravenous drug users from lisbon, portugal",Francisco AP,10.1111/j.1469-0691.2011.03557.x,2011,NR,,0,,,,,
beyond plasma membrane targeting: role of the ma domain of gag in retroviral genome encapsidation,Parent LJ,10.1016/j.jmb.2011.04.072,2011,NR,,0,,,,,
"characterization of hiv-1 subtype distribution among thai msm using mhabce, a high throughput approach for molecular epidemiology studies",Leelawiwat W,10.1089/aid.2011.1502,2011,NR,,0,,,,,
from population to hiv: the organizational and structural determinants of hiv outcomes in sub-saharan africa,Robinson R,10.1186/1758-2652-14-S2-S6,2011,NR,,0,,,,,
broad neutralization coverage of hiv by multiple highly potent antibodies,Walker LM,10.1038/nature10373,2011,NR,,0,,,,,
clonal sequences recovered from plasma from patients with residual hiv-1 viremia and on intensified antiretroviral therapy are identical to replicating viral rnas recovered from circulating resting cd4+ t cells,Anderson JA,10.1128/JVI.00284-11,2011,NR,,0,,,,,
"cahr 2011 - honouring our history, embracing our diversity: 20th annual canadian conference on hiv/aids research",Anonymous,,2011,NR,,0,,,,,
cd40l adjuvanted alvac-hiv vaccine elicits stronger cd8+ t cell responses than dna primealvac boost hiv-1 vaccine regimen,Liu J,,2011,NR,,0,,,,,
combined antiretroviral therapy and immune pressure lead to in vivo hiv-1 recombination with ancestral viral genomes,Buzon MJ,10.1097/QAI.0b013e318215ab0a,2011,NR,,0,,,,,
cell-to-cell transmission of hiv-1 is susceptible to entry inhibition and involves viral endocytosis,Sloan RD,,2011,NR,,0,,,,,
comparative evaluation of the viroseqtm hiv-1 genotyping system and an in-house method for analysis of hiv-1 drug-resistance mutations in china,Xu S,10.2165/11588860-000000000-00000,2011,NR,,0,,,,,
cervical th17 cells express multiple markers that suggest an important role in hiv acquisition,McKinnon L,,2011,NR,,0,,,,,
change of positive selection pressure on hiv-1 envelope gene inferred by early and recent samples,Yoshida I,10.1371/journal.pone.0018630,2011,NR,,0,,,,,
characteristics of hiv infected adolescents in latin america: results from the nisdi pediatric study,Cruz MLS,10.1093/tropej/fmq068,2011,NR,,0,,,,,
components of body image in gay men with hiv/aids,Blashill,10.1177/1557988309356942,2011,NR,,0,,,,,
contribution of magnitude and multifunctional hiv-specific cd8 + t cells to immune selective pressure,Riou C,10.1089/aid.2011.1502,2011,NR,,0,,,,,
coordinate linkage of hiv evolution reveals regions of immunological vulnerability,Dahirel V,10.1073/pnas.1105315108,2011,NR,,0,,,,,
"characterization of partial and near full-length genomes of hiv-1 strains sampled from recently infected individuals in sao paulo, brazil",Sanabani,10.1371/journal.pone.0025869,2011,NR,,0,,,,,
"correlation of hiv-specific immunity, viral control, and diversification following planned multiple exposures to autologous hiv in a pediatric population",Borkowsky W,10.1128/CVI.05176-11,2011,NR,,0,,,,,
"cross-sectional detection of acute hiv infection: timing of transmission, inflammation and antiretroviral therapy",Gay C,10.1371/journal.pone.0019617,2011,NR,,0,,,,,
current molecular epidemiology and recombination of hiv type 1 subtypes in northern thailand,Praparattanapan J,10.1089/AID.2010.0257,2011,NR,,0,,,,,
deep third variable sequencing for hiv type 1 tropism in treatment-naive patients: a reanalysis of the merit trial of maraviroc,Swenson LC,10.1093/cid/cir493,2011,NR,,0,,,,,
"combination hiv prevention: significance, challenges, and opportunities",Kurth AE,10.1007/s11904-010-0063-3,2011,NR,,0,,,,,
"community engagement in hiv vaccine research: a multiple embedded case study in canada, india, south africa and thailand",Newman PA,10.1089/aid.2011.1502,2011,NR,,0,,,,,
human anti-v3 hiv-1 monoclonal antibodies encoded by the vh5-51/vl lambda genes define a conserved antigenic structure,Gorny MK,10.1371/journal.pone.0027780,2011,NR,,0,,,,,
detection of minority resistance during early hiv-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants,Gianella S,10.1128/JVI.02582-10,2011,NR,,0,,,,,
"comparable antigenicity among subtype b, subtype f1 and group m nef consensus peptides in brazilians hiv-1-infected subjects",Cortes F,10.1089/aid.2011.1502,2011,NR,,0,,,,,
comparative rna quantification of hiv-1 group m and non-m with the roche cobas ampliprep/cobas taqman hiv-1 v20 and abbott real-time hiv-1 pcr assays,Sire J-M,10.1097/QAI.0b013e3182099891,2011,NR,,0,,,,,
comparison of bioinformatic algorithms to identify recent hiv-1 infection,Shao W,,2011,NR,,0,,,,,
development of a cross-european virtual sample repository and hiv resistance database,Kjaer J,,2011,NR,,0,,,,,
development of antimicrobial peptides as topical microbicides for the prevention of hiv,Watson KM,10.1016/j.antiviral.2011.03.082,2011,NR,,0,,,,,
development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment,Li L,10.1007/s13365-010-0014-1,2011,NR,,0,,,,,
comparisons of the genetic and neutralization properties of hiv-1 subtype c and crf07/08_bc env molecular clones isolated from infections in china,Wang S,10.1016/j.virusres.2010.09.012,2011,NR,,0,,,,,
differential persistence of transmitted hiv-1 drug resistance mutation classes,Jain V,10.1093/infdis/jiq167,2011,NR,,0,,,,,
computerized testing augments pencil-and-paper tasks in targeting hiv-associated mild cognitive impairment,Koski L,,2011,NR,,0,,,,,
distribution of surveillance drug resistance mutations in different hiv-1 subtypes in newly-diagnosed untreated hiv patients in croatia,Grgic I,,2011,NR,,0,,,,,
conservancy of the alpha4beta7 integrin mimotope in the v2 domain of hiv type 1 crf07-bc compared to subtype b' strains in china,He X,10.1089/aid.2011.0007,2011,NR,,0,,,,,
consultation on the canadian hiv vaccine initiative research and development alliance,Acquaah E,,2011,NR,,0,,,,,
contributions of hiv infection in the hypothalamus and substance abuse/use to hpt dysregulation,Langford D,10.1016/j.psyneuen.2010.10.005,2011,NR,,0,,,,,
mapping of positive selection sites in the hiv-1 genome in the context of rna and protein structural constraints,Snoeck J,10.1186/1742-4690-8-87,2011,NR,,0,,,,,
compensatory mutations rescue the virus replicative capacity of virip-resistant hiv-1,Gonzalez-Ortega E,10.1016/j.antiviral.2011.10.010,2011,NR,,0,,,,,
dramatic changes to t-cell nuclear envelope composition induced by human immunodeficiency virus type 1,Monette A,,2011,NR,,0,,,,,
attitudes and practices towards haart among people living with hiv/aids in a resource-limited setting in northern burkina faso,Guiro AK,10.1016/j.puhe.2011.09.015,2011,NR,,0,,,,,
drug development risk in hiv-1 clinical trials: the effect of drug class,Osborne B,,2011,NR,,0,,,,,
detection of distinct human immunodeficiency virus type 1 circulating recombinant forms in northeast brazil,Santos LA,10.1002/jmv.22170,2011,NR,,0,,,,,
correlates of hiv testing history among urban youth recruited through venue-based testing in 15 us cities,Straub DM,10.1097/OLQ.0b013e318214bb70,2011,NR,,0,,,,,
sentinel' mutations in standard population sequencing can predict the presence of hiv-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing,Alteri C,10.1093/jac/dkr354,2011,NR,,0,,,,,
viral suppression of multiple escape mutants by de novo cd8(+) t cell responses in a human immunodeficiency virus-1 infected elite suppressor,O'Connell KA,10.1186/1742-4690-8-63,2011,NR,,0,,,,,
dominant genetic aberrations and coexistent ebv infection in hiv-related oral plasmablastic lymphomas,Boy SC,10.1016/j.oraloncology.2011.06.506,2011,NR,,0,,,,,
criminal law and hiv non-disclosure: encouraging developments,Elliott R,,2011,NR,,0,,,,,
selected amino acid mutations in hiv-1 b subtype gp41 are associated with specific gp120v3 signatures in the regulation of co-receptor usage,Dimonte S,10.1186/1742-4690-8-33,2011,NR,,0,,,,,
drug-resistant hiv-1 in cuban children and their seropositive mothers,Perez L,,2011,NR,,0,,,,,
differential microrna regulation of hla-c expression and its association with hiv control,Kulkarni S,10.1038/nature09914,2011,NR,,0,,,,,
fitness ranking of individual mutants drives patterns of epistatic interactions in hiv-1,Martinez JP,10.1371/journal.pone.0018375,2011,NR,,0,,,,,
performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in cameroon,Fokam J,10.1007/s00705-011-0982-3,2011,NR,,0,,,,,
increased breadth and depth of cytotoxic t lymphocytes responses against hiv-1-b nef by inclusion of epitope variant sequences,Rolland M,10.1371/journal.pone.0017969,2011,NR,,0,,,,,
a systems analysis of mutational effects in hiv-1 protease and reverse transcriptase,Hinkley T,10.1038/ng.795,2011,NR,,0,,,,,
current and future assays for identifying recent hiv infections at the population level,Smolen-Dzirba J,10.12659/MSM.881757,2011,NR,,0,,,,,
dynamics of hiv-1 subtype c gag in the global epidemic,Novitsky V,10.1089/aid.2011.1502,2011,NR,,0,,,,,
"dynamics of two separate but linked hiv-1 crf01-ae outbreaks among injection drug users in stockholm, sweden, and helsinki, finland",Skar H,10.1128/JVI.01413-10,2011,NR,,0,,,,,
relationship between functional profile of hiv-1 specific cd8 t cells and epitope variability with the selection of escape mutants in acute hiv-1 infection,Ferrari G,10.1371/journal.ppat.1001273,2011,NR,,0,,,,,
multiple barriers to recombination between divergent hiv-1 variants revealed by a dual-marker recombination assay,Nikolaitchik OA,10.1016/j.jmb.2011.01.052,2011,NR,,0,,,,,
decolonizing hiv research using arts-based methods: what aboriginal youth in canada had to say,Flicker S,,2011,NR,,0,,,,,
simple and rapid determination of the enzyme kinetics of hiv-1 reverse transcriptase and anti-hiv-1 agents by a fluorescence based method,Silprasit K,10.1016/j.jviromet.2010.12.001,2011,NR,,0,,,,,
detection of quasispecies variants predicted to use cxcr4 by ultra-deep pyrosequencing during early hiv infection,Abbate I,10.1097/QAD.0b013e328343489e,2011,NR,,0,,,,,
longitudinal analysis of hiv-1 bf1 recombinant strains in vertically infected children from argentina reveals a decrease in crf12_bf pol gene mosaic patterns and high diversity of bf unique recombinant forms,Aulicino PC,10.1016/j.meegid.2010.11.008,2011,NR,,0,,,,,
deep molecular characterization of hiv-1 dynamics under suppressive haart,Buzon,10.1371/journal.ppat.1002314,2011,NR,,0,,,,,
defining epitope coverage requirements for t cell-based hiv vaccines: theoretical considerations and practical applications,Currier JR,10.1186/1479-5876-9-212,2011,NR,,0,,,,,
designing a genome-based hiv incidence assay with high sensitivity and specificity,Park SY,10.1097/QAD.0b013e328349f089,2011,NR,,0,,,,,
designing and implementing a communications strategy: lessons learnt from hiv and sexual and reproductive health research programme consortia,South,10.1186/1478-4505-9-S1-S15,2011,NR,,0,,,,,
detection of a rare hiv type 1 strain crf16_a2d in bangladesh,Safiullah Sarker M,10.1089/aid.2010.0209,2011,NR,,0,,,,,
development of an hiv/std screening index to measure hiv/std risk in adolescents,Jarama,10.1080/15381501.2011.596766,2011,NR,,0,,,,,
functional stability of unliganded envelope glycoprotein spikes among isolates of human immunodeficiency virus type 1 (hiv-1),Agrawal N,10.1371/journal.pone.0021339,2011,NR,,0,,,,,
generation of a collection of hiv-1 envelopes to be used as immunogens with increased affinity for broadly neutralizing antibodies,Sanchez-Merino V,10.1089/aid.2011.1502,2011,NR,,0,,,,,
different regions of hiv-1 subtype c env are associated with placental localization and in utero mother-to-child transmission,Kumar SB,10.1128/JVI.01955-10,2011,NR,,0,,,,,
"evaluating pmtct beyond ""progress indicators"" in an hiv-endemic setting: substantial discord between reported coverage rates and actual receipt of per-guideline antiretroviral regimens",Cescon AM,,2011,NR,,0,,,,,
disparate associations of hla class i markers with hiv-1 acquisition and control of viremia in an african population,Song W,10.1371/journal.pone.0023469,2011,NR,,0,,,,,
disparities in hiv testing based on testing location,Striley CLW,10.1016/j.comppsych.2011.04.047,2011,NR,,0,,,,,
diversity of hiv-1 subtype c strains isolated in romania,Paraschiv S,10.1016/j.meegid.2010.07.002,2011,NR,,0,,,,,
effectiveness of hiv self-management support group program for aboriginal and non-aboriginal peoples living in vancouver's downtown eastside,Tam T,,2011,NR,,0,,,,,
employability and hiv infection: can the military claim to be an exception?,London L,,2011,NR,,0,,,,,
"human immunodeficiency virus screening in a cosmopolitan, urban emergency department: is the yield worth the effort?",Heller MB,10.1111/j.1553-2712.2011.01073.x,2011,NR,,0,,,,,
epitope specificity and envelope diversity in an elite neutralizer from the san francisco bay area,O'Rourke SM,10.1089/aid.2011.1502,2011,NR,,0,,,,,
"genetic diversity and drug resistance mutations in hiv-1 from untreated patients in niamey, niger",Mamadou S,10.5402/2011/797463,2011,NR,,0,,,,,
estimate of effective recombination rate and average selection coefficient for hiv in chronic infection,Batorsky R,10.1073/pnas.1102036108,2011,NR,,0,,,,,
genetic diversity at endoplasmic reticulum aminopeptidases 2 (erap2) is coupled with innate resistance to hiv-1 infection,Borelli M,10.1007/s15010-011-0090-z,2011,NR,,0,,,,,
"genetic diversity of recently acquired and prevalent hiv, hbv, and hcv infections in us blood donors",Delwart E,10.1111/j.1537-2995.2011.03301_1.x,2011,NR,,0,,,,,
"high hiv risk behavior among men who have sex with men in kigali, rwanda: making the case for supportive prevention policy",Chapman J,10.1080/09540121.2010.507758,2011,NR,,0,,,,,
"high hiv type 1 group m pol diversity and low rate of antiretroviral resistance mutations among the uniformed services in kinshasa, democratic republic of the congo",Djoko CF,10.1089/aid.2010.0201,2011,NR,,0,,,,,
high proportion of hiv-1 subtype f1 transmission networks among italian heterosexual males associated with introduction events from south america,Lai A,10.1007/s15010-011-0090-z,2011,NR,,0,,,,,
high rates of adherence and treatment success in a public and public-private hiv clinic in india: potential benefits of standardized national care delivery systems,Shet A,,2011,NR,,0,,,,,
hiv envelop proteins immunization effect in hu-scid mice model,Bychenko A,10.1089/aid.2011.1502,2011,NR,,0,,,,,
hiv full-replication technology for identification of novel hiv inhibitors from multiple sources,Kremb S,10.1016/j.antiviral.2011.03.046,2011,NR,,0,,,,,
hiv heterosexual sexual risk from injecting drug users among hiv-seronegative noninjecting heroin users (special issue: the new york hiv-drug use epidemic: lessons learned and unresolved issues),Neaigus,10.3109/10826084.2011.521473,2011,NR,,0,,,,,
hiv risk and prevention among hispanic immigrants in new york: the salience of diversity (special issue: the new york hiv-drug use epidemic: lessons learned and unresolved issues),Deren,10.3109/10826084.2011.523215,2011,NR,,0,,,,,
"hiv transmission patterns among the netherlands, suriname, and the netherlands antilles: a molecular epidemiological study",Kramer MA,10.1089/aid.2010.0115,2011,NR,,0,,,,,
immediate and long-term immunogenicity and efficacy of adjuvanted pandemic h1n1 2009 vaccine (arepanrix) with or without booster: a randomized trial in hiv infected adults,Cooper C,,2011,NR,,0,,,,,
evidence of hiv coreceptor tropism switch during pregnancy,Ransy DG,,2011,NR,,0,,,,,
hiv- and hcv-related practices decline among people who smoke crack following implementation of controversial safer inhalation program,Leonard L,,2011,NR,,0,,,,,
immune-mediated attenuation of hiv-1,Chopera DR,,2011,NR,,0,,,,,
evolution of nigeria's two predominant hiv-1 subtypes,Ajoge HO,10.1089/aid.2011.1502,2011,NR,,0,,,,,
evolutionary gamut of in vivo gag substitutions during early hiv-1 subtype c infection,Novitsky V,10.1016/j.virol.2011.09.020,2011,NR,,0,,,,,
"hiv-1 drug resistance among newly hiv-1 infected individuals attending tertiary referral center in chennai, india",Iqbal HS,10.4103/0019-5359.109538,2011,NR,,0,,,,,
hiv-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro,Svicher V,10.1016/j.antiviral.2011.02.005,2011,NR,,0,,,,,
exploring the needs of experiences of people ageing with hiv in the london borough of newham: methodology and preliminary findings,Foster N,,2011,NR,,0,,,,,
hiv-1 genetic diversity and drug resistance among treatment naive patients from southern brazil: an association of hiv-1 subtypes with exposure categories,Graf,10.1016/j.jcv.2011.04.011,2011,NR,,0,,,,,
extensive hla-driven viral diversity following a narrow-source hiv-1 outbreak in rural china,Dong T,10.1182/blood-2010-06-291963,2011,NR,,0,,,,,
features and diversity of quaternary neutralizing epitopes (qnes) in hiv-1 env that mediate potent viral neutralization,Krachmarov C,10.1089/aid.2011.1502,2011,NR,,0,,,,,
using knowledge of protein structural constraints to predict the evolution of hiv-1,Williams SG,10.1016/j.jmb.2011.04.037,2011,NR,,0,,,,,
"hiv-1 outbreak among injecting drug users in greece, 2011: a preliminary report",Paraskevis D,10.2807/ese.16.36.19962-en,2011,NR,,0,,,,,
"food insecurity, bmi and dietary diversity in rwandan hiv + women",Sirotin N,10.1007/s11606-011-1730-9,2011,NR,,0,,,,,
fostering equity in hiv care with aboriginal people affected by systemic inequities in urban contexts,Tu D,,2011,NR,,0,,,,,
frequency of cxcr4-using viruses in primary hiv-1 infections using ultra-deep pyrosequencing,Raymond S,10.1097/QAD.0b013e3283498305,2011,NR,,0,,,,,
"promotion of the neutralization-competent structure of the hiv-1 gp41 membrane proximal external region when tethered to its native transmembrane domain, and expressed in the context of the plasma membrane: implications for vaccine design",Montero M,,2011,NR,,0,,,,,
gendered perceptions of hiv risk among young women and men in a high-hiv-prevalence setting,Casale M,10.2989/16085906.2011.637728,2011,NR,,0,,,,,
gendered perceptions of hiv risk among young women and men in a high-hiv-prevalence setting (special issue: hiv prevention and the world of work),Casale,10.2989/16085906.2011.637728,2011,NR,,0,,,,,
genes encoding kir2ds4 and kir3dl1 are found at higher frequencies in hiv-susceptible than in hiv-exposed seronegative individuals,Tallon BJ,,2011,NR,,0,,,,,
genetic and neutralization sensitivity of diverse hiv-1 env clones from chronically infected patients in china,Shang H,10.1074/jbc.M111.224527,2011,NR,,0,,,,,
"hiv-positive men who use the internet to meet other men in france: results from the french ""net gay barometre"" study",Leobon A,,2011,NR,,0,,,,,
genotypic characterization of hiv type 1 in jamaica,Roye ME,10.1089/aid.2010.0106,2011,NR,,0,,,,,
gp120 interaction with sgg and sgc may lead to hiv-1 infection of non-cd4 expressing cells,Young CD,,2011,NR,,0,,,,,
hammering out hiv-1 incidence with hamming distance,Allam O,10.1097/QAD.0b013e32834bac66,2011,NR,,0,,,,,
healing journeys: wellness retreats for aboriginal women living with hiv,Migwans S,,2011,NR,,0,,,,,
health-related use of the internet by men who have sex with men (msm) living with hiv (hiv+) in canada,Dumas J,,2011,NR,,0,,,,,
"human immunodeficiency virus type 1 induces lytic cycle replication of kaposi's-sarcoma-associated herpesvirus: role of ras/c-raf/mek1/2, pi3k/akt, and nf-kappab signaling pathways",Zhu X,10.1016/j.jmb.2011.03.055,2011,NR,,0,,,,,
human immunodeficiency virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides,Selhorst P,10.1128/AAC.01426-10,2011,NR,,0,,,,,
human monoclonal antibodies to hiv-1 gp140 from mice bearing yac-based human immunoglobulin transloci,Pruzina S,10.1093/protein/gzr038,2011,NR,,0,,,,,
"high genetic diversity of hiv-1 was found in men who have sex with men in shijiazhuang, china",Li L,10.1016/j.meegid.2011.05.017,2011,NR,,0,,,,,
human pluripotent stem cells produce natural killer cells that mediate anti-hiv-1 activity by utilizing diverse cellular mechanisms,Ni Z,10.1128/JVI.01774-10,2011,NR,,0,,,,,
high roads and low roads in hiv/aids programming: plea for a diversification of itinerary,Vanwesenbeeck I,10.1080/09581596.2010.539594,2011,NR,,0,,,,,
identification of a current hot spot of hiv type 1 transmission in mongolia by molecular epidemiological analysis,Davaalkham J,10.1089/AID.2010.0196,2011,NR,,0,,,,,
identification of a methylated oligoribonucleotide as a potent inhibitor of hiv-1 reverse transcription complex,Grigorov B,10.1093/nar/gkr117,2011,NR,,0,,,,,
"identification of new, emerging hiv-1 unique recombinant forms and drug resistant viruses circulating in cameroon",Ragupathy V,10.1186/1743-422X-8-185,2011,NR,,0,,,,,
"immunogenicity of a dna vaccine containing multiple hla- dr binding, conserved m group hiv-1 epitopes in balb/c mice",Almeida RR,10.1089/aid.2011.1502,2011,NR,,0,,,,,
immunogenicity of as03-adjuvanted h1n1 pandemic influenza vaccine in hiv-infected children,Brophy JC,,2011,NR,,0,,,,,
hiv infection in long-distance truck drivers in a low income setting in the niger delta of nigeria,Erhabor O,,2011,NR,,0,,,,,
impact of hiv type 1 subtype on drug resistance mutations in nigerian patients failing first-line therapy,Chaplin B,10.1089/aid.2010.0050,2011,NR,,0,,,,,
impact of nucleotide polymorphisms at drug resistance sites on genetic barrier in human immunodeficiency virus type 1 subtype c resistance evolution,Iweriebor BC,10.5897/AJB10.1580,2011,NR,,0,,,,,
"hiv prevalence and route of transmission in turkish immigrants living in north-rhine westphalia, germany",Schulter E,10.1007/s00430-011-0193-2,2011,NR,,0,,,,,
impact of the interactions of rilpivirine (e138k) and lamivudine/emtricitabine (m184v/i) resistance mutations on viral dna synthesis and fitness of hiv-1,Hu ZX,,2011,NR,,0,,,,,
in-depth analysis of g-to-a hypermutation rate in hiv-1 env dna induced by endogenous apobec3 proteins using massively parallel sequencing,Knoepfel SA,10.1016/j.jviromet.2010.11.016,2011,NR,,0,,,,,
structural basis for vrc01-like-antibody recognition of variable loops that surround the site of cd4 attachment on hiv-1 gp120,Zhou T,10.1089/aid.2011.1502,2011,NR,,0,,,,,
infectivity of homologous recombinant hiv-1 pseudo-virus with reverse transcriptase inhibitor-related mutations from highly active antiretroviral therapy experienced patients,Kwon OK,10.1016/j.phrp.2011.04.006,2011,NR,,0,,,,,
hiv-1 evolution in primary infection is affected by stochastic followed by selective processes,Herbeck JT,10.1097/01.qai.0000397358.45921.c4,2011,NR,,0,,,,,
hiv-1 replication in the central nervous system occurs in two distinct cell types,Schnell G,10.1371/journal.ppat.1002286,2011,NR,,0,,,,,
interaction of reverse transcriptase (rt) mutations conferring resistance to lamivudine and etravirine: effects on fitness and rt activity of human immunodeficiency virus type 1,Hu Z,10.1128/JVI.05578-11,2011,NR,,0,,,,,
intercompartmental recombination of hiv-1 contributes to env intrahost diversity and modulates viral tropism and sensitivity to entry inhibitors,Brown RJ,10.1128/JVI.00131-11,2011,NR,,0,,,,,
hla targeting efficiency and its applications in predictions of hiv viral load and hiv disease progression,Hertz T,10.1089/aid.2011.1502,2011,NR,,0,,,,,
"how can we measure what we know about african, caribbean and black (acb) women living with hiv in canada? critical approaches and research methods for identifying and using validated and reliable instruments to measure quality of life (qol) among acb women",James LL,,2011,NR,,0,,,,,
living with symptomatic herpes simplex virus type 2 (hsv-2) infections and quality of life: hiv-positive women's experiences,Ion A,,2011,NR,,0,,,,,
hysterectomy complications in hiv positive women,Duong TH,10.1097/SPV.0b013e31820e8a9a,2011,NR,,0,,,,,
"long-chain peer referral of men who have sex with men: a novel approach to establish and maintain a cohort to measure hiv incidence, nanjing, china []",Yan H,10.1097/QAI.0b013e318239c947,2011,NR,,0,,,,,
long-term follow-up of occult hbv quasispecies diversity and lymphotropism in hiv-1-infected patients reactive for antibody to hbv core antigen (anti-hbc),Coffin CS,10.1016/S0168-8278%2811%2961107-0,2011,NR,,0,,,,,
making sense of condoms: social representations in young people's hiv-related narratives from six african countries,Winskell,10.1016/j.socscimed.2011.01.014,2011,NR,,0,,,,,
identifying locus of control dimensions related to hiv/aids risk among south african students,Gwandure,10.1080/15381501.2011.596763,2011,NR,,0,,,,,
measuring enzymatic hiv-1 susceptibility to two reverse transcriptase inhibitors as a rapid and simple approach to hiv-1 drug-resistance testing,Hoffmann D,10.1371/journal.pone.0022019,2011,NR,,0,,,,,
medical and psychiatric comorbidities: the complexity of care in a sample of vulnerable patients with late-stage hiv disease,Halman M,,2011,NR,,0,,,,,
"increasing hiv subtype diversity in canadian-born patients living in southern alberta, canada",Luft LM,10.1097/QAI.0b013e31821438d9,2011,NR,,0,,,,,
minor hiv-1 variants with the k103n resistance mutation during intermittent efavirenz-containing antiretroviral therapy and virological failure,Delobel P,10.1371/journal.pone.0021655,2011,NR,,0,,,,,
"moderate prevalence of transmitted drug resistance and high hiv-1 genetic diversity in patients from mato grosso state, central western brazil",Ferreira AS,10.1002/jmv.22128,2011,NR,,0,,,,,
"moderate prevalence of transmitted drug resistance and interiorization of hiv type 1 subtype c in the inland north state of tocantins, brazil",Carvalho BC,10.1089/AID.2010.0334,2011,NR,,0,,,,,
"inspiration, hope, and silence: canadian reflections on zambian field worker involvement in international hiv research",Manning E,,2011,NR,,0,,,,,
molecular characterization of hiv type 1 strains from newly diagnosed patients in cyprus (2007-2009) recovers multiple clades including unique recombinant strains and lack of transmitted drug resistance,Kousiappa,10.1089/aid.2011.0060,2011,NR,,0,,,,,
interdisciplinary evaluation of broadly-reactive hla class ii restricted epitopes eliciting hiv-specific cd4 + t cell responses,Buggert M,10.1089/aid.2011.1502,2011,NR,,0,,,,,
is 80% a passing grade? meanings attached to condom use in an abstinence-plus hiv prevention programme in south africa,Nixon,10.1080/09540121.2010.498875,2011,NR,,0,,,,,
is the bone health of hiv-infected children and adolescents compromised?,Alimenti A,,2011,NR,,0,,,,,
molecular epidemiology of hiv type 1 crf02_ag in cameroon and african patients living in italy,Veras,10.1089/aid.2010.0333,2011,NR,,0,,,,,
it's not just who you are but where you live: an exploration of community influences on individual hiv status in rural malawi,Feldacker C,10.1016/j.socscimed.2011.01.003,2011,NR,,0,,,,,
"language choice and sexual communication among xhosa speakers in cape town, south africa: implications for hiv prevention message development",Cain,10.1093/her/cyq067,2011,NR,,0,,,,,
live-cell visualization of dynamics of hiv budding site interactions with an escrt component,Baumgartel V,10.1038/ncb2215,2011,NR,,0,,,,,
living with hiv at 50 years of age and over: what is the impact on one's love life and sexuality?,Wallach I,,2011,NR,,0,,,,,
loci polymorphisms of the apobec3g gene in hiv type 1-infected brazilians,Bizinoto MC,10.1089/aid.2010.0146,2011,NR,,0,,,,,
morphology and biochemical markers of people living with hiv/aids undergoing a resistance exercise program: clinical series,Soares,,2011,NR,,0,,,,,
moving beyond the discourse of 'individual risky behaviors': addressing social inequalities as risk conditions for hiv infections among marginalized young men,Wong JP,,2011,NR,,0,,,,,
"multi-nucleoside reverse transcriptase inhibitor resistant hiv type-1 in a patient from sierra leone failing stavudine, lamivudine and nevirapine",Hamers RL,10.3851/IMP1683,2011,NR,,0,,,,,
multiple cellular proteins contribute to pkr inhibition during hiv replication in lymphocytes,Clerzius G,,2011,NR,,0,,,,,
multiple hiv-1 infections with evidence of recombination in heterosexual partnerships in a low risk rural clinical cohort in uganda,Ssemwanga D,10.1016/j.virol.2010.12.025,2011,NR,,0,,,,,
male circumcision and risk of hiv acquisition among msm,Sanchez,10.1097/QAD.0b013e328340fd81,2011,NR,,0,,,,,
memory b cell antibodies to hiv-1 gp140 cloned from individuals infected with clade a and b viruses,Mouquet H,10.1371/journal.pone.0024078,2011,NR,,0,,,,,
national prevalence and trends of hiv transmitted drug resistance in mexico,Avila-Rios S,10.1371/journal.pone.0027812,2011,NR,,0,,,,,
modelling the impact of acute infection dynamics on the accumulation of hiv-1 mutations,Shiri T,10.1016/j.jtbi.2011.03.011,2011,NR,,0,,,,,
nevirapine plasma concentrations in premature infants exposed to single-dose nevirapine for prevention of mother-tochild transmission of hiv-1,Mugabo P,,2011,NR,,0,,,,,
new technology to detect low-level drug-resistant hiv variants,Gega A,10.2217/fvl.10.77,2011,NR,,0,,,,,
next-generation sequencing of dried blood spot specimens: a novel approach to hiv drug-resistance surveillance,Ji H,10.3851/IMP1839,2011,NR,,0,,,,,
non-random distribution of cryptic repeating triplets of purines and pyrimidines (rny)n and recombination in gp120 of hiv-1,De Crignis E,10.1089/aid.2011.1502,2011,NR,,0,,,,,
monitoring of hiv pandemic in hungary by molecular virological methods,Ay E,10.1556/AMicr.58.2011.Suppl.1,2011,NR,,0,,,,,
"more than just talk: the framing of transactional sex and its implications for vulnerability to hiv in lesotho, madagascar and south africa",Stoebenau K,10.1186/1744-8603-7-34,2011,NR,,0,,,,,
mycoplasma genitalium is associated with cervicitis and hiv infection in an urban australian sti clinic population,Lusk MJ,10.1136/sti.2010.045138,2011,NR,,0,,,,,
origin and dynamics of hiv-1 subtype c infection in india,Shen C,10.1371/journal.pone.0025956,2011,NR,,0,,,,,
origin and epidemiological history of hiv-1 crf14_bg,Bartolo I,10.1371/journal.pone.0024130,2011,NR,,0,,,,,
origin and evolution of hiv-1 in breast milk determined by single-genome amplification and sequencing,Salazar-Gonzalez JF,10.1128/JVI.02316-10,2011,NR,,0,,,,,
"natural polymorphisms of hiv-1 crf01_ae integrase coding region in arv-naive individuals in cambodia, thailand and vietnam: an anrs ac12 working group study",Nouhin,10.1016/j.meegid.2010.10.014,2011,NR,,0,,,,,
neutralization potential and epitope profiling of plasma antibodies from hiv-1 infected asian indians,Andrabi R,10.1089/aid.2011.1502,2011,NR,,0,,,,,
role of hypervariable loops in intersubunit associations of env: trimeric gp140 immunogen as a platform for novel epitope display,Cheng H,10.1089/aid.2011.1502,2011,NR,,0,,,,,
new directions in hiv healthcare,Potter M,10.1586/eri.11.60,2011,NR,,0,,,,,
peering ahead: the ontario hiv treatment network's (ohtn) harmonized peer research assistant training model,Mayoh M,,2011,NR,,0,,,,,
penile infection of rhesus macaques with sivmac251 recapitulates the extreme genetic bottleneck of mucosal hiv-1 transmission,Keele BF,10.1111/j.1600-0684.2011.00491.x,2011,NR,,0,,,,,
non-means-tested provision of formula feed to help prevent hiv transmission,Dawson M,10.1111/j.1468-1293.2011.00925.x,2011,NR,,0,,,,,
persistent airway microbiome in hiv-positive patients with acute pneumonia and on antibiotics,Huang D,,2011,NR,,0,,,,,
"pervasive developmental disorder in antiretroviral- and hiv-exposed, uninfected children",Bowes J,,2011,NR,,0,,,,,
viral suppression of multiple escape mutants by de novo cd8+ t cell responses in a human immunodeficiency virus-1 infected elite suppressor,O'Connell KA,10.1186/1742-4690-8-63,2011,NR,,0,,,,,
optimized methods for imaging membrane nanotubes between t cells and trafficking of hiv-1,Sowinski S,10.1016/j.ymeth.2010.04.002,2011,NR,,0,,,,,
age- and disease-dependent herv-w envelope allelic variation in brain: association with neuroimmune gene expression,Bhat RK,10.1371/journal.pone.0019176,2011,NR,,0,,,,,
overwhelming uncertainties and contested threats: a contextual understanding of the hiv risk faced by chinese immigrants in canada,Zhou YR,,2011,NR,,0,,,,,
diverse interactions of retroviral gag proteins with rnas,Rein A,10.1016/j.tibs.2011.04.001,2011,NR,,0,,,,,
mapping of positive selection sites in the hiv genome in the context of rna and protein structural constraints,Snoeck J,,2011,NR,,0,,,,,
"characterization of body composition, physical fitness and lipid profile among adults living with hiv who participate in a fitness program",Ortiz A,10.1016/j.physio.2011.04.002,2011,NR,,0,,,,,
a bifunctional anti-hiv protein: delivering a 1-2 punch based on the sequential dual receptor virus entry mechanism,Dey B,10.4172/1948-5964.S1.4,2011,NR,,0,,,,,
influence of the pi3k/akt signaling pathway on the regulation of hiv-1 alternative rna splicing,Hillebrand F,10.1091/mbc.E11-10-0886,2011,NR,,0,,,,,
colorectal cancer screening in patients with hiv,Momplaisir F,10.1007/s11606-011-1730-9,2011,NR,,0,,,,,
hiv infection induces the alteration of cytolytic effector molecule expression diversity in cd8 + t cell population,Onlamoon N,10.1089/aid.2011.1502,2011,NR,,0,,,,,
phylogenetic structure in african hiv-1 subtype c revealed by selective sequential pruning,Thomson MM,10.1016/j.virol.2011.03.021,2011,NR,,0,,,,,
control of hiv viral replication mediated by the synergistic effects of unique combinations of hla class i alleles,Wang YE,10.1089/aid.2011.1502,2011,NR,,0,,,,,
neutralisation activity of hiv-1 clade c- and crf02-ag-infected serum/plasma: some viruses are not as resistant as previously thought,Jacob RA,10.1089/aid.2011.1502,2011,NR,,0,,,,,
balance of ctl escape and viral fitness in acute and early hiv infection,Brown J,10.1089/aid.2011.1502,2011,NR,,0,,,,,
low-frequency nnrti-resistant hiv-1 variants and mutational load relationship in art-naive subjects,Kozal MJ,,2011,NR,,0,,,,,
performance of ultra-deep pyrosequencing in analysis of hiv-1 pol gene variation,Mild M,10.1371/journal.pone.0022741,2011,NR,,0,,,,,
a demonstration of a web-based intervention for hiv+ men having sex with men,Miranda J,,2011,NR,,0,,,,,
protective and risk factors associated with hiv stigma in a population of older adults living with hiv,Emlet CA,,2011,NR,,0,,,,,
"phylodynamics of hiv-1 from a phase iii aids vaccine trial in bangkok, thailand",Perez-Losada M,10.1371/journal.pone.0016902,2011,NR,,0,,,,,
phylodynamics of hiv-1 subtype b among the men-having-sex-with-men (msm) population in hong kong,Chen JH,10.1371/journal.pone.0025286,2011,NR,,0,,,,,
"depression, anxiety, and cardiovascular disease risk among people living with hiv/aids (phas) in the canadian hiv vascular study",Xu K,,2011,NR,,0,,,,,
"canadian physician attitudes regarding pregnancy, fertility care, and assisted reproductive technologies for hiv-positive individuals or couples",Yudin M,,2011,NR,,0,,,,,
hnrnp d/auf1 isoforms regulate hiv-1 replication,Lund N,,2011,NR,,0,,,,,
hiv exposed seronegative people express lower level of ifn-g inductible chemokine in their cervico-vaginal lavages,Lajoie J,,2011,NR,,0,,,,,
towards chimeric transcription factor repression of hiv-1: mutating a highly conserved cis-element ablates hiv-1 activation,Gill G,,2011,NR,,0,,,,,
silencing hiv-1 expression through manipulation of sr kinase function: use of small molecules to alter hiv-1 rna processing,Wong R,,2011,NR,,0,,,,,
"racism, sexism and hiv-related stigma: an intersectional approach to understanding predictors of depression among african caribbean women living with hiv in ontario, canada",Logie C,,2011,NR,,0,,,,,
"gp120 induces type i interferon and pro-inflammatory cytokine production by primary genital epithelial cells, independent of hiv-1 infection",Nazli A,,2011,NR,,0,,,,,
identification of new patterns of splice site usage by transcripts of hiv-1 primary isolates of diverse subtypes,Delgado E,10.1097/01.qai.0000397319.32460.a0,2011,NR,,0,,,,,
predictors of adherence for patients on highly active antiretroviral therapy in hiv treatment program,Adeyemi A,10.1097/01.qai.0000397388.36512.bf,2011,NR,,0,,,,,
preclinical evaluation of hiv-1 therapeutic ex vivo dendritic cell vaccines expressing consensus gag antigens and conserved gag epitopes,Niu L,10.1016/j.vaccine.2010.12.131,2011,NR,,0,,,,,
"predictors of successful early infant diagnosis of hiv in a rural district hospital in zambezia, mozambique",Cook RE,10.1097/QAI.0b013e318207a535,2011,NR,,0,,,,,
prevalence and patterns of hiv transmitted drug resistance in guatemala,Avila-Rios,10.1590/S1020-49892011001200024,2011,NR,,0,,,,,
"prevalence of genotypic resistance to antiretroviral drugs in treatment-naive youths infected with diverse hiv type 1 subtypes and recombinant forms in dar es salaam, tanzania",Mosha F,10.1089/aid.2010.0113,2011,NR,,0,,,,,
prevalence of hiv type 1 antiretroviral drug resistance mutations in vietnam: a multicenter study,Dean J,10.1089/aid.2011.0013,2011,NR,,0,,,,,
problems taking pills: understanding hiv medication adherence from a new perspective,Okonsky JG,10.1080/09540121.2011.579944,2011,NR,,0,,,,,
prevalence of low-level hiv-1 variants with reverse transcriptase mutation k65r and the effect of antiretroviral drug exposure on variant levels,Kozal MJ,10.3851/IMP1851,2011,NR,,0,,,,,
"prevalence of transmitted drug resistance mutations among persons undergoing treatment-naive hiv genotyping in ontario, canada, 2002-09",Burchell A,,2011,NR,,0,,,,,
quantitative assessment of masking of neutralization epitopes in hiv-1,Agarwal A,10.1016/j.vaccine.2010.12.052,2011,NR,,0,,,,,
protection against rectal transmission of an emtricitabine-resistant simian/human immunodeficiency virus shiv162p3m184v mutant by intermittent prophylaxis with truvada,Cong ME,10.1128/JVI.00843-11,2011,NR,,0,,,,,
t-cell immune responses against env from crf12_bf and subtype b hiv-1 show high clade-specificity that can be overridden by multiclade immunizations,Monaco DC,10.1371/journal.pone.0017185,2011,NR,,0,,,,,
recruitment of high risk women for hiv prevention trials: baseline hiv prevalence and sexual behavior in the caprisa 004 tenofovir gel trial,Karim QA,10.1186/1745-6215-12-67,2011,NR,,0,,,,,
the breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with the risk of infant infection,Lynch JB,10.1128/JVI.02216-10,2011,NR,,0,,,,,
replicative fitness costs of nonnucleoside reverse transcriptase inhibitor drug resistance mutations on hiv subtype c,Armstrong KL,10.1128/AAC.01505-10,2011,NR,,0,,,,,
rescue of hiv-1 long-time archived x4 strains to escape maraviroc,Baatz F,10.1016/j.antiviral.2011.10.003,2011,NR,,0,,,,,
sense of coherence (soc) and tobacco use among people living with hiv (plwhiv),Roy JL,,2011,NR,,0,,,,,
serpin induced antiviral activity of prostaglandin synthetase-2 against hiv-1 replication,Whitney JB,10.1371/journal.pone.0018589,2011,NR,,0,,,,,
revisiting hiv epidemic appraisals for the design of effective prevention programs,Mishra S,,2011,NR,,0,,,,,
sexual health matters: concerns of hiv+ youth,Landry TM,,2011,NR,,0,,,,,
"sexual risk taking, sti and hiv prevalence among men who have sex with men in six indonesian cities",Morineau G,10.1007/s10461-009-9590-6,2011,NR,,0,,,,,
signature mutations in v3 and bridging sheet domain of hiv-1 gp120 hiv-1 are specifically associated with dual tropism and modulate the interaction with ccr5 n-terminus,Alteri C,10.1007/s15010-011-0090-z,2011,NR,,0,,,,,
role of regional reference laboratories for sexually transmitted infections in improvement of second generation hiv surveillance experience from the central america region,Ye T,10.1136/sextrans-2011-050109.161,2011,NR,,0,,,,,
single mutation turns a non-binding germline-like predecessor of broadly neutralizing antibody into a binding antibody to hiv-1 envelope glycoproteins,Yuan T,10.1089/aid.2011.1502,2011,NR,,0,,,,,
site-specific hyperphosphorylation of prb in hiv-induced neurotoxicity,Akay C,10.1016/j.mcn.2011.04.001,2011,NR,,0,,,,,
the role of recombination for the coevolutionary dynamics of hiv and the immune response,Mostowy R,10.1371/journal.pone.0016052,2011,NR,,0,,,,,
"south african hiv/aids programming overlooks migration, urban livelihoods, and informal workplaces (special issue: hiv prevention and the world of work)",Vearey,10.2989/16085906.2011.637741,2011,NR,,0,,,,,
serologic response to syphilis treatment among hiv-infected adults,Tan DH,,2011,NR,,0,,,,,
status and demand on hiv/aids control among men who have sex with men in main districts of chongqing,Zeng H,10.3724/SP.J.1008.2011.00494,2011,NR,,0,,,,,
"stop-hiv/aids: the development of an integrated outreach team (vancouver, british columbia)",Bath M,,2011,NR,,0,,,,,
severity and impact of antiretroviral-associated lipodystrophy in hiv-positive women,Andany N,,2011,NR,,0,,,,,
sex-associated differences in pre-antiretroviral therapy plasma hiv-1 rna in diverse areas of the world vary by cd4+ t-cell count,Grinsztejn B,10.3851/IMP1872,2011,NR,,0,,,,,
"sex, drugs and structural interventions: unstable housing associated with increased hiv risk behaviour in a cohort of people on treatment in british columbia",Parashar S,,2011,NR,,0,,,,,
shared molecular strategies of the malaria parasite p falciparum and the human virus hiv-1,Wuchty S,10.1074/mcp.M111.009035,2011,NR,,0,,,,,
"synthesis, gp120 binding and anti-hiv activity of fatty acid esters of 1,1-linked disaccharides",Bachan S,10.1016/j.bmc.2011.06.078,2011,NR,,0,,,,,
synthetic fab fragments that bind the hiv-1 gp41 heptad repeat regions,Liu Y,10.1016/j.bbrc.2011.09.012,2011,NR,,0,,,,,
systematic analysis of population-based hiv-1 genetic and functional datasets illuminates potential regions of interest for vaccine design,Martin E,,2011,NR,,0,,,,,
taking multiple infections of cells and recombination into account leads to small within-host effective-population-size estimates of hiv-1,Balagam R,10.1371/journal.pone.0014531,2011,NR,,0,,,,,
socio-demographic and drug use factors associated with hiv-1 recombinants and dual infections in northern thai drug users: associations of risk with genetic complexity,Kijak GH,10.1016/j.drugalcdep.2010.11.013,2011,NR,,0,,,,,
standard of care for antiretroviral therapy adherence and retention in care from the perspective of care providers attending the 5th international conference on hiv treatment adherence,Amico,10.1177/1545109711406734,2011,NR,,0,,,,,
statin use does not influence immunogenicity of seasonal influenza vaccine in hiv infected adults,Cooper C,,2011,NR,,0,,,,,
subjective social inclusion and social exclusion as measures of well-being: new applications for hiv research,Allman D,,2011,NR,,0,,,,,
subtype diversity associated with the development of hiv-1 resistance to integrase inhibitors,Brenner,10.1002/jmv.22047,2011,NR,,0,,,,,
the antiviral efficacy of hiv-specific cd8+ t-cells to a conserved epitope is heavily dependent on the infecting hiv-1 isolate,Ranasinghe SR,10.1371/journal.ppat.1001341,2011,NR,,0,,,,,
"synergy against drug-resistant hiv-1 with the microbicide antiretrovirals, dapivirine and tenofovir, in combination",Schader SM,10.1097/QAD.0b013e3283491f89,2011,NR,,0,,,,,
"the base component of 3'-azido-2',3'-dideoxynucleosides influences resistance mutations selected in hiv-1 reverse transcriptase",Meteer JD,10.1128/AAC.00414-11,2011,NR,,0,,,,,
the cd8 + t cell antiviral inhibitory activity predicts the rate of cd4 + cell decline in early hiv-1 infection and is independent of viral subtype,Yang H,10.1089/aid.2011.1502,2011,NR,,0,,,,,
the effects of binge ethanol exposure on the locomotor activity of hiv-1transgenic and fischer 344 rats,Liu C,10.1111/j.1530-0277.2011.01497.x,2011,NR,,0,,,,,
the effect of spirulina platensis versus soybean on insulin resistance in hiv-infected patients: a randomized pilot study,Marcel,,2011,NR,,0,,,,,
the evolution of catalytic function in the hiv-1 protease,Singh MK,10.1016/j.jmb.2011.02.031,2011,NR,,0,,,,,
the gaia hiv vaccine progress report: further validation of broadly conserved class i epitopes in west africa,Moise L,10.1089/aid.2011.1502,2011,NR,,0,,,,,
the evolution of hiv-1 reverse transcriptase in route to acquisition of q151m multi-drug resistance is complex and involves mutations in multiple domains,Mbisa JL,10.1186/1742-4690-8-31,2011,NR,,0,,,,,
the high mannose-type glycan binding lectin actinohivin: dimerization greatly improves anti-hiv activity,Takahashi A,10.1038/ja.2011.51,2011,NR,,0,,,,,
the fitness deficits of m184i/v in hiv reverse transcriptase are compensated by e138k that confers broad cross-resistance to second-generation nnrtis,Xu H,,2011,NR,,0,,,,,
the host-pathogen interaction of human cyclophilin a and hiv-1 vpr requires specific n-terminal and novel c-terminal domains,Solbak SM,10.1186/1472-6807-11-49,2011,NR,,0,,,,,
the gut mucosal viral reservoir in hiv-infected patients is not the major source of rebound plasma viremia following interruption of highly active antiretroviral therapy,Lerner P,10.1128/JVI.02409-10,2011,NR,,0,,,,,
the hiv type 1 protease l10i minor mutation decreases replication capacity and confers resistance to protease inhibitors,Flor-Parra,10.1089/aid.2010.0072,2011,NR,,0,,,,,
the human immunodeficiency virus-1 genotype diversity and drug resistance mutations profile of blood donors from five chinese blood centers,Zeng P,10.1111/j.1537-2995.2011.03301_1.x,2011,NR,,0,,,,,
"the impact of integrating food supplementation, nutritional education and haart (highly active antiretroviral therapy) on the nutritional status of patients living with hiv/aids in mozambique: results from the dream programme",Scarcella P,,2011,NR,,0,,,,,
the removal of transmission-linked glycosylation sites in hiv gp120 promotes high a4b7 -reactivity,Cicala C,10.1089/aid.2011.1502,2011,NR,,0,,,,,
the role of migration and domestic transmission in the spread of hiv-1 non-b subtypes in switzerland,von Wyl V,10.1093/infdis/jir491,2011,NR,,0,,,,,
the neglected reproductive health needs of sex workers who use drugs: the need for integrated reproductive health and hiv services for women,Duff PK,,2011,NR,,0,,,,,
the polymorphisms of the apobec3h gene in the pumwani sex worker cohort and the associations with the susceptibility/resistance to hiv-1,Wong S,,2011,NR,,0,,,,,
the prevalence and determinants of transmitted drug resistance among newly diagnosed hiv cases in canada,Yang Q,,2011,NR,,0,,,,,
toward a critical biosocial model of ecohealth in southern africa: the hiv/aids and nutrition insecurity syndemic (special issue: hiv/aids and food insecurity in sub-saharan africa: challenges and solutions),Singer,,2011,NR,,0,,,,,
tracking a century of global expansion and evolution of hiv to drive understanding and to combat disease,Tebit DM,10.1016/S1473-3099%2810%2970186-9,2011,NR,,0,,,,,
thymic- and bone marrow-cellular reservoirs harbor phylogenetically distinct hiv strains and different resistance profiles,De Luca F,10.1007/s15010-011-0090-z,2011,NR,,0,,,,,
trends in advanced hiv disease at the time of hiv diagnosis in british columbia and associated characteristics,Gilbert M,,2011,NR,,0,,,,,
trends in factors associated with recent hiv testing among montreal men who have sex with men (msm): results from the argus 2005 and 2008 surveys,Gallant S,,2011,NR,,0,,,,,
"trends in unsafe sex and influence of viral load among patients followed since primary hiv infection, 2000-2009",Seng R,10.1097/QAD.0b013e328345ef12,2011,NR,,0,,,,,
trim5alpha associates with proteasomal subunits in cells while in complex with hiv-1 virions,Lukic Z,10.1186/1742-4690-8-93,2011,NR,,0,,,,,
"trait self-enhancement, immune markers, and risk-reduction behaviors in hiv-positive gay men",Stein,10.1080/15381501.2011.549067,2011,NR,,0,,,,,
translation of hla-hiv associations to the cellular level: hiv adapts to inflate cd8 t cell responses against nef and hla-adapted variant epitopes,Almeida CA,10.4049/jimmunol.1100691,2011,NR,,0,,,,,
transmission dynamics of the m184v drug resistance mutation in primary hiv infection,Wainberg MA,10.1093/jac/dkr291,2011,NR,,0,,,,,
"use of a high resolution melting (hrm) assay to compare gag, pol, and env diversity in adults with different stages of hiv infection",Cousins MM,10.1371/journal.pone.0027211,2011,NR,,0,,,,,
"traditional knowledge, use practices and conservation of medicinal plants for hiv/aids care in rural tanzania",Kisangau,,2011,NR,,0,,,,,
"using hiv notification data to identify priority migrant groups for hiv prevention, new south wales, 2000-2008",McPherson,,2011,NR,,0,,,,,
transmission of new crf07_bc strains with 7 amino acid deletion in gag p6,Zhefeng M,10.1186/1743-422X-8-60,2011,NR,,0,,,,,
"sequence analysis of the gag-pol gene of human immunodeficiency virus type 1 of intersubtype (b'/c) recombinant strain in beijing, china",Ye JingRong,10.1089/aid.2010.0186,2011,NR,,0,,,,,
v3 region of gp120 genetic diversity and co-receptor use among brazilian clade b hiv-1 strains from individuals in whom disease progressed,Cavalieri E,,2011,NR,,0,,,,,
clinical factors related to brain structure in hiv: the charter study,Jernigan,10.1007/s13365-011-0032-7,2011,NR,,0,,,,,
transmitted hiv drug resistance surveillance: is a duplication of efforts necessary?,Merks H,,2011,NR,,0,,,,,
"immune activation, cd4+ t cell counts, and viremia exhibit oscillatory patterns over time in patients with highly resistant hiv infection",Kitchen,10.1371/journal.pone.0021190,2011,NR,,0,,,,,
transmitted hiv-1 drug resistance among young men of color who have sex with men: a multicenter cohort analysis,Hightow-Weidman LB,10.1016/j.jadohealth.2010.05.011,2011,NR,,0,,,,,
validating a shortened depression scale (10 item ces-d) amongst hiv positive patients in british columbia,Zhang W,,2011,NR,,0,,,,,
efficacy of a health educator-delivered hiv prevention intervention for latina women: a randomized controlled trial,Wingood,10.2105/AJPH.2011.300340,2011,NR,,0,,,,,
trends in behaviours associated with sexually transmitted and blood-borne infections (stbbi) among hiv-positive men who have sex with men (msm) in montreal,Lambert G,,2011,NR,,0,,,,,
viral linkage in hiv-1 seroconverters and their partners in an hiv-1 prevention clinical trial,Campbell MS,10.1371/journal.pone.0016986,2011,NR,,0,,,,,
under representation of the inhibitory kir3dl1 molecule and the kir3dl1+/bw4+ complex in hiv exposed seronegative individuals,Guerini FR,10.1093/infdis/jir020,2011,NR,,0,,,,,
understanding the context of providing hiv prevention and treatment in papua new guinea,Clark G,10.1177/1043659610387151,2011,NR,,0,,,,,
were hiv tests routinely carried out in patients with lymphadenopathy or rash attending a london hospital between 2009 and 2010?,MacKenzie M,10.1111/j.1468-1293.2011.00925.x,2011,NR,,0,,,,,
what did we learn on host's genetics by studying large cohorts of hiv-1-infected patients in the genome-wide association era?,Guergnon J,10.1097/COH.0b013e3283478449,2011,NR,,0,,,,,
using the millon behavioral medicine diagnostic (mbmd) to evaluate the need for mental health services in association with biomarkers of disease status among hiv positive men and women,Burbridge C,10.1007/s10880-011-9231-x,2011,NR,,0,,,,,
"women's struggles to find safe, secure and non-exploitative housing in canada's poorest postal code: gendered hiv risk environments",Lazarus L,,2011,NR,,0,,,,,
working in the formal economy is associated with better mental health among people with hiv: the ontario cihr employment change and health outcomes (echo) study,Rueda S,,2011,NR,,0,,,,,
vitamin d deficiency among children living with hiv: understanding clinical significance and response to treatment,Brophy JC,,2011,NR,,0,,,,,
vitamin d supplementation does not increase immunogenicity of seasonal influenza vaccine in hiv infected adults,Cooper C,,2011,NR,,0,,,,,
wrestling with our imperialist do-gooder legacy: coming into critical hiv research in zambia-canada partnership as a new researcher,Manning E,,2011,NR,,0,,,,,
you are not alone: the power of peer support for women living with hiv,Medjuck M,,2011,NR,,0,,,,,
voluntary counseling and testing (vct) for couples: a high-leverage intervention for hiv/aids prevention in uganda - kammengo subcounty,Nabunje J,,2011,NR,,0,,,,,
"what's going on with the basic rights of people living with hiv in quebec? the hiv info rights line of the cocq-sida: an observatory that highlights issues of discrimination, privacy and access to health and social services, insurance and employment in quebec",Perras M,,2011,NR,,0,,,,,
who accepts a rapid hiv antibody test? the role of race/ethnicity and hiv risk behavior among community adolescents,Swenson RR,10.1016/j.jadohealth.2010.08.013,2011,NR,,0,,,,,
who is at higher risk of stis and hiv-brothel-based or street-based female sex workers? evidence from two rounds of bio-behavioural surveys,Gautam A,10.1136/sextrans-2011-050108.66,2011,NR,,0,,,,,
"""resistance"" to psc-rantes revisited: two mutations in human immunodeficiency virus type 1 hiv-1sf162 or simian-human immunodeficiency virus shivsf162-p3 do not confer resistance",Nedellec R,10.1128/JVI.01907-09,2010,NR,,0,,,,,
a comparison of specimens for transmitted hiv drug resistance surveillance: diagnostic serum versus first-time clinical specimen,Brooks J,,2010,NR,,0,,,,,
a diagnostic strategy for measuring emergent drug-resistant hiv-1 in global chemoprophylaxis trials,Liegler T,,2010,NR,,0,,,,,
a common apobec3h haplotype associates with decreased hiv-1 sequence editing and lower hiv-1 rna set-point in early untreated hiv-1 infection,Barbour JD,10.1002/20553,2010,NR,,0,,,,,
a maraviroc-resistant hiv-1 with narrow cross-resistance to other ccr5 antagonists depends on both n-terminal and extracellular loop domains of drug-bound ccr5,Tilton JC,10.1128/JVI.01109-10,2010,NR,,0,,,,,
a multicentre collaborative study on hiv drug resistance testing using 454 massively parallel pyrosequencing,Simen BB,,2010,NR,,0,,,,,
a vaccine encoding conserved promiscuous hiv cd4 epitopes induces broad t cell responses in mice transgenic to multiple common hla class ii molecules,Ribeiro SP,10.1371/journal.pone.0011072,2010,NR,,0,,,,,
adaptation of hiv-1 to cells expressing rhesus monkey trim5alpha,Pacheco B,10.1016/j.virol.2010.09.019,2010,NR,,0,,,,,
affordable in-house antiretroviral drug resistance assay with good performance in non-subtype b hiv-1,Wallis CL,10.1016/j.jviromet.2009.11.011,2010,NR,,0,,,,,
a predictive model of neutralization sensitivity from indel-rich variable loop regions in hiv-1 envelope sequences using a tree-based kernel method,Poon AF,,2010,NR,,0,,,,,
a randomized controlled trial of health information exchange between human immunodeficiency virus institutions,Proeschold-Bell RJ,10.1097/PHH.0b013e3181df78b9,2010,NR,,0,,,,,
analysis of the respiratory microbiome using bronchoalveolar lavage from hiv-infected and uninfected subjects,Twigg HL,,2010,NR,,0,,,,,
accurately measuring recombination between closely related hiv-1 genomes,Schlub TE,10.1371/journal.pcbi.1000766,2010,NR,,0,,,,,
crystal structure of the neutralizing llama v(hh) d7 and its mode of hiv-1 gp120 interaction,Hinz A,10.1371/journal.pone.0010482,2010,NR,,0,,,,,
adaptive interactions between hla and hiv-1: highly divergent selection imposed by hla class i molecules with common supertype motifs,John M,10.4049/jimmunol.0903745,2010,NR,,0,,,,,
assessing hiv/aids awareness and high risk behavior among long distance truckers in northern india,Punia MS,,2010,NR,,0,,,,,
"association of hiv transmission categories with sociodemographic, viroimmunological and clinical parameters of hiv-infected patients",Collazos,10.1017/S0950268809991282,2010,NR,,0,,,,,
atypical cutaneous lympoproliferative disorders and lack of immune response in a patient with acute hiv infection,Franceschini E,10.1007/s15010-010-1001-4,2010,NR,,0,,,,,
associations of marijuana use and sex-related marijuana expectancies with hiv/std risk behavior in high-risk adolescents,Hendershot CS,10.1037/a0019844,2010,NR,,0,,,,,
autologous saliva transfusion: treatment for hiv?,Arakeri G,10.1016/j.mehy.2009.12.016,2010,NR,,0,,,,,
amino-acid co-variation in hiv-1 gag subtype c: hla-mediated selection pressure and compensatory dynamics,Rolland M,10.1371/journal.pone.0012463,2010,NR,,0,,,,,
analysis of hiv diversity using a high-resolution melting assay,Towler,10.1089/aid.2009.0259,2010,NR,,0,,,,,
analysis of hiv dna molecules in paired peripheral blood and lymph node tissue samples from chronically infected patients,Josefsson L,,2010,NR,,0,,,,,
analysis of memory b cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from hiv-1-infected individuals,Corti D,10.1371/journal.pone.0008805,2010,NR,,0,,,,,
both cd31+and cd31- naive cd4+ t cells are persistent hiv type 1-infected reservoirs in individuals receiving antiretroviral therapy,Wightman F,10.1086/656721,2010,NR,,0,,,,,
analysis of v3 loop sequences using various bioinformatic tools designed for genotypic hiv-1 tropism testing,Parczewski M,10.1016/S1730-1270%2810%2960098-7,2010,NR,,0,,,,,
anti-v3 monoclonal antibodies display broad neutralizing activities against multiple hiv-1 subtypes,Hioe CE,10.1371/journal.pone.0010254,2010,NR,,0,,,,,
aspects of the italian legislation related to hiv testing,D'Amato,,2010,NR,,0,,,,,
augmented trauma writing effects hiv symptoms and vl in women with ptsd and hiv,Ironson G,10.1016/j.bbi.2010.07.206,2010,NR,,0,,,,,
clinical performance of a dermal filler containing natural glycolic acid and a polylactic acid polymer: results of a clinical trial in human immunodeficiency virus subjects with facial lipoatrophy,Tagle JM,,2010,NR,,0,,,,,
bayesian analysis of primary and chronic hiv infections among montreal msm,Pilon R,,2010,NR,,0,,,,,
beliefs about participating in research among a sample of minority persons living with hiv/aids in new york city,Floyd T,10.1089/apc.2009.0306,2010,NR,,0,,,,,
characterization of mutations associated with resistance to mpc-4326 and their effecy on hiv-1 replicative fitness,Weber J,,2010,NR,,0,,,,,
chronology and evolution of the hiv-1 subtype c epidemic in ethiopia,Tully,10.1097/QAD.0b013e32833999e1,2010,NR,,0,,,,,
"clonal resistance analyses of hiv type-1 after failure of therapy with didanosine, lamivudine and tenofovir",Barnas D,10.3851/IMP1539,2010,NR,,0,,,,,
co-lethality studied as an asset against viral drug escape: the hiv protease case,Brouillet S,10.1186/1745-6150-5-40,2010,NR,,0,,,,,
"comment on ""the origins of sexually transmitted hiv among men who have sex with men""",Heath L,10.1126/scitranslmed.3001416,2010,NR,,0,,,,,
comparative description of haplotype structure and genetic diversity of mdr1 (abcb1) in hiv-positive and hiv-negative populations,Benish RL,10.1016/j.meegid.2009.09.018,2010,NR,,0,,,,,
characterization of hiv type 1 genetic diversity among south african participants enrolled in the aids vaccine integrated project (avip) study,Papathanasopoulos,10.1089/aid.2009.0281,2010,NR,,0,,,,,
conserved elements vaccine for hiv-1 p24gag is immunogenic in mice and macaques,Kulkarni V,10.1089/aid.2010.9998,2010,NR,,0,,,,,
"cost analysis of centralized viral load testing for antiretroviral therapy monitoring in nicaragua, a low-hiv prevalence, low-resource setting",Gerlach J,10.1186/1758-2652-13-43,2010,NR,,0,,,,,
chemokine control of hiv-1 infection: beyond a binding competition,Wu Y,10.1186/1742-4690-7-86,2010,NR,,0,,,,,
crystal methamphetamine use and sexual risk behaviors among hiv-positive and hiv-negative men who have sex with men in south florida,Forrest DW,10.1007/s11524-009-9422-z,2010,NR,,0,,,,,
cyclic and acyclic defensins inhibit human immunodeficiency virus type-1 replication by different mechanisms,Seidel A,10.1371/journal.pone.0009737,2010,NR,,0,,,,,
deep sequencing of the vaginal microbiota of women with hiv,Hummelen R,10.1371/journal.pone.0012078,2010,NR,,0,,,,,
delineation of the preferences and requirements of the human immunodeficiency virus type 1 dimerization initiation signal by using an in vivo cell-based selection approach,Hussein IT,10.1128/JVI.01930-09,2010,NR,,0,,,,,
codon optimization of hiv-1 vaccines decreases the potential breadth of cd8+ t-cell responses,Bet A,10.1089/aid.2010.9998,2010,NR,,0,,,,,
development and application of a broadly sensitive dried-blood-spot-based genotyping assay for global surveillance of hiv-1 drug resistance,Yang C,10.1128/JCM.00564-10,2010,NR,,0,,,,,
computational design of centralized hiv-1 genes,Arenas M,10.2174/157016210794088263,2010,NR,,0,,,,,
correlating hiv-1 gp120 sequences with neutralization data using w-curve heuristics,Cork D,10.1089/aid.2010.9998,2010,NR,,0,,,,,
cross-neutralizing antibodies in hiv-1 infected individuals recognize novel epitopes on monomeric gp120,Gray E,10.1089/aid.2010.9998,2010,NR,,0,,,,,
drug treatment as hiv prevention: a research update (special issue: treatment of hiv/aids among drug-using populations: a global perspective),Metzger,10.1097/QAI.0b013e3181f9c10b,2010,NR,,0,,,,,
decreased hiv diversity after allogeneic stem cell transplantation of an hiv-1 infected patient: a case report,Kamp C,10.1186/1743-422X-7-55,2010,NR,,0,,,,,
modelling the evolution and spread of hiv immune escape mutants,Fryer HR,10.1371/journal.ppat.1001196,2010,NR,,0,,,,,
"pp2a1 binding, cell transducing and apoptotic properties of vpr(77-92): a new functional domain of hiv-1 vpr proteins",Godet AN,10.1371/journal.pone.0013760,2010,NR,,0,,,,,
hiv promoter integration site primarily modulates transcriptional burst size rather than frequency,Skupsky R,10.1371/journal.pcbi.1000952,2010,NR,,0,,,,,
"hiv-1 subtype distribution in the gambia and the significant presence of crf49_cpx, a novel circulating recombinant form",de Silva TI,10.1186/1742-4690-7-82,2010,NR,,0,,,,,
constraints on hiv-1 diversity from protein structure,Woo J,10.1128/JVI.00702-10,2010,NR,,0,,,,,
high viral fitness during acute hiv-1 infection,Arnott A,10.1371/journal.pone.0012631,2010,NR,,0,,,,,
human anti-hiv-neutralizing antibodies frequently target a conserved epitope essential for viral fitness,Pietzsch J,10.1084/jem.20101176,2010,NR,,0,,,,,
identification of unusual and novel hiv type 1 spliced transcripts generated in vivo,Carrera C,10.1089/aid.2010.0011,2010,NR,,0,,,,,
characterization of the alpha interferon-induced postentry block to hiv-1 infection in primary human macrophages and t cells,Goujon C,10.1128/JVI.00854-10,2010,NR,,0,,,,,
hla-associated immune pressure on gag protein in crf01_ae-infected individuals and its association with plasma viral load,Gesprasert G,10.1371/journal.pone.0011179,2010,NR,,0,,,,,
"hiv-1 neutralization profile and plant-based recombinant expression of actinohivin, an env glycan-specific lectin devoid of t-cell mitogenic activity",Matoba N,10.1371/journal.pone.0011143,2010,NR,,0,,,,,
"near full-length genomic characterization of a novel hiv type 1 subtype b/c recombinant strain from yunnan, china",Li L,10.1089/aid.2010.0001,2010,NR,,0,,,,,
"patterns of human immunodeficiency virus type 1 recombination ex vivo provide evidence for coadaptation of distant sites, resulting in purifying selection for intersubtype recombinants during replication",Galli A,10.1128/JVI.00276-10,2010,NR,,0,,,,,
characterization of a discontinuous epitope of the hiv envelope protein gp120 recognized by a human monoclonal antibody using chemical modification and mass spectrometric analysis,Hager-Braun C,10.1016/j.jasms.2010.03.031,2010,NR,,0,,,,,
"hiv-1 recombinants with multiple parental strains in low-prevalence, remote regions of cameroon: evolutionary relics?",Carr JK,10.1186/1742-4690-7-39,2010,NR,,0,,,,,
"characterization and frequency of a newly identified hiv-1 bf1 intersubtype circulating recombinant form in sao paulo, brazil",Sanabani SS,10.1186/1743-422X-7-74,2010,NR,,0,,,,,
interdisciplinary analysis of hiv-specific cd8+ t cell responses against variant epitopes reveals restricted tcr promiscuity,Hoof I,10.4049/jimmunol.0903516,2010,NR,,0,,,,,
scd4-17b bifunctional protein: extremely broad and potent neutralization of hiv-1 env pseudotyped viruses from genetically diverse primary isolates,Lagenaur LA,10.1186/1742-4690-7-11,2010,NR,,0,,,,,
fitness epistasis and constraints on adaptation in a human immunodeficiency virus type 1 protein region,da Silva J,10.1534/genetics.109.112458,2010,NR,,0,,,,,
determinants of the willingness-to-pay for hiv/aids prevention: the case of mother-to-child transmission in selected hospitals in ghana,Ayifah E,10.1186/1742-4690-7-S1-P137,2010,NR,,0,,,,,
silencing of nbcep1 encoding a chloroplast envelope protein containing 15 leucine-rich-repeats disrupts chloroplast biogenesis in nicotiana benthamiana,Jeon Y,10.1007/s10059-010-0011-5,2010,NR,,0,,,,,
compartmentalization and clonal amplification of hiv-1 variants in the cerebrospinal fluid during primary infection,Schnell G,10.1128/JVI.01863-09,2010,NR,,0,,,,,
adaptive changes in hiv-1 subtype c proteins during early infection are driven by changes in hla-associated immune pressure,Treurnicht FK,10.1016/j.virol.2009.10.002,2010,NR,,0,,,,,
improvement of an ultrasensitive human immunodeficiency virus type 1 real-time reverse transcriptase-polymerase chain reaction targeting the long terminal repeat region,Edelmann A,10.1111/j.1537-2995.2009.02477.x,2010,NR,,0,,,,,
emergent properties and structural patterns in sexually transmitted infection and hiv research (special issue: epidemiology and prevention of stds: the role of emergent properties and structural patterns),Blanchard,10.1136/sti.2010.046037,2010,NR,,0,,,,,
exploiting knowledge of immune selection in hiv-1 to detect hiv-specific cd8 t-cell responses,Almeida CA,10.1016/j.vaccine.2010.06.091,2010,NR,,0,,,,,
enhancing hiv vaccine trial consent preparedness among street drug users,Fisher CB,10.1525/jer.2010.5.2.65,2010,NR,,0,,,,,
epidemiological bridging by injection drug use drives an early hiv epidemic,Volz E,10.1016/j.epidem.2010.06.003,2010,NR,,0,,,,,
full genome analysis of an emerging cluster of human immunodeficiency virus type 1 subtype b infection in hong kong,Tsui SK,10.1089/aid.2009.0104,2010,NR,,0,,,,,
estimating frequencies of minority nevirapine-resistant strains in chronically hiv-1-infected individuals naive to nevirapine by using stochastic simulations and a mathematical model,Gadhamsetty S,10.1128/JVI.01010-10,2010,NR,,0,,,,,
ethnic diversity and patterns of infection of a uk hiv-positive patient population outwith major conurbations,Aiken,10.1258/ijsa.2010.010043,2010,NR,,0,,,,,
direct correlation between genome dimerization and recombination efficiency of hiv-1,Sakuragi J,10.1016/j.micinf.2010.06.012,2010,NR,,0,,,,,
evaluation of abbott realtime hiv-1 qualitative assay in detection of hiv-1 nucleic acids from dried blood spots and plasma,Huang S,,2010,NR,,0,,,,,
evolution of ccr5 antagonist resistance in an hiv-1 subtype c clinical isolate,Henrich TJ,10.1097/QAI.0b013e3181f25574,2010,NR,,0,,,,,
genetics of focal segmental glomerulosclerosis and human immunodeficiency virus-associated collapsing glomerulopathy: the role of myh9 genetic variation,Winkler CA,10.1016/j.semnephrol.2010.01.003,2010,NR,,0,,,,,
expanded evaluation of blood donors in the united states for human immunodeficiency virus type 1 non-b subtypes and antiretroviral drug-resistant strains: 2005 through 2007,Brennan CA,10.1111/j.1537-2995.2010.02767.x,2010,NR,,0,,,,,
explosive hiv-1 subtype b' epidemics in asia driven by geographic and risk group founder events,Li Y,10.1016/j.virol.2010.03.048,2010,NR,,0,,,,,
domestic violence screening: prevalence and outcomes in a canadian hiv population,Siemieniuk RAC,10.1089/apc.2010.0235,2010,NR,,0,,,,,
factors affecting the emergence of intersubtype recombinants in hiv-1 population,Galli A,,2010,NR,,0,,,,,
dynamics and timing of in vivo mutations at gag residue 242 during primary hiv-1 subtype c infection,Novitsky V,10.1016/j.virol.2010.04.001,2010,NR,,0,,,,,
effects of thymic selection of the t-cell repertoire on hla class i-associated control of hiv infection,Kosmrlj A,10.1038/nature08997,2010,NR,,0,,,,,
gay men: current challenges and emerging approaches in hiv prevention (special issue: hiv in nsw in 2010),Wit,10.1071/NB10008,2010,NR,,0,,,,,
gender issues and the hiv/aids epidemic: the kuwaiti women experience,Ashkanani HR,10.1007/s00198-010-1247-9,2010,NR,,0,,,,,
"genetic and epidemiologic characterization of hiv-1 infection in liaoning province, china",Han X,10.1097/QAI.0b013e3181c7d5bf,2010,NR,,0,,,,,
genetic diversity at endoplasmic reticulum aminopeptidases is maintained by balancing selection and is associated with natural resistance to hiv-1 infection,Cagliani R,10.1093/hmg/ddq401,2010,NR,,0,,,,,
hbv evolution and drug resistance emergence in hiv-hbv co-infected patients depends upon the synergistic interaction between immunological and pharmacological selective pressure,Cento V,10.1007/s15010-010-1001-4,2010,NR,,0,,,,,
hidden drug resistant hiv to emerge in the era of universal treatment access in southeast asia,Hoare A,10.1371/journal.pone.0010981,2010,NR,,0,,,,,
high frequency of man having sex with man with unknown duration of infection in epidemiological networks involving primary resistance in hiv-1 naive individuals,Lai A,10.1007/s15010-010-1001-4,2010,NR,,0,,,,,
estimating time since infection in early homogeneous hiv-1 samples using a poisson model,Giorgi EE,10.1186/1471-2105-11-532,2010,NR,,0,,,,,
high polymorphism rates in the hr1 and hr2 gp41 and presence of primary resistance-related mutations in hiv type 1 circulating in brazil: possible impact on enfuvirtide efficacy,Teixeira,10.1089/aid.2008.0297,2010,NR,,0,,,,,
higher levels of zidovudine resistant hiv in the colon compared to blood and other gastrointestinal compartments in hiv infection,van Marle G,10.1186/1742-4690-7-74,2010,NR,,0,,,,,
hiv infection among us army and air force military personnel: sociodemographic and genotyping analysis,Singer DE,10.1089/aid.2009.0289,2010,NR,,0,,,,,
evaluating the opinions of staff and health care service provision of an std/hiv clinic in africa: indications for recovery,Cooper RG,,2010,NR,,0,,,,,
hiv treatment optimism and unsafe anal intercourse among hiv-positive men who have sex with men: findings from the positive connections study,Brennan DJ,10.1521/aeap.2010.22.2.126,2010,NR,,0,,,,,
"hiv treatment, care and support in nsw: a work necessarily still in progress (special issue: hiv in nsw in 2010)",Garsia,10.1071/NB10014,2010,NR,,0,,,,,
"hiv type 1 pol gene diversity and genotypic antiretroviral drug resistance mutations in malabo, equatorial guinea",Djoko CF,10.1089/aid.2010.0046,2010,NR,,0,,,,,
hiv type-1 genotypic resistance profiles in vertically infected patients from argentina reveal an association between k103n+l100i and l74v mutations,Aulicino PC,10.3851/IMP1571,2010,NR,,0,,,,,
evolution of hiv-1 diversity in regions of high viral diversity and implications for vaccine design,Powell R,10.1089/aid.2010.9998,2010,NR,,0,,,,,
evolution of hiv-1 in india,Seth P,10.1007/s13337-010-0001-4,2010,NR,,0,,,,,
factors affecting adherence to highly active anti retroviral therapy in hiv positive patients - southern india,Akhila JS,,2010,NR,,0,,,,,
female disclosure of hiv-positive serostatus to sex partners: a two-city study,Kathleen S,10.1080/03630242.2010.516697,2010,NR,,0,,,,,
hiv-1 non-b subtypes: high transmitted nnrti-resistance in spain and impaired genotypic resistance interpretation due to variability,Yebra G,10.1016/j.antiviral.2009.11.010,2010,NR,,0,,,,,
fluidity of hiv-1-specific t-cell responses during acute and early subtype c hiv-1 infection and associations with early disease progression,Mlotshwa M,10.1128/JVI.01472-10,2010,NR,,0,,,,,
hiv-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naive to haart in cameroon,Burda ST,10.1002/jmv.21677,2010,NR,,0,,,,,
hiv-1 subtype c phylodynamics in the global epidemic,Novitsky V,10.3390/v2010033,2010,NR,,0,,,,,
gender differences in hiv-related coping and depression,Vosvick M,10.1007/s10461-008-9490-1,2010,NR,,0,,,,,
generation of a family-specific phage library of llama single chain antibody fragments that neutralize hiv-1,Koh WW,10.1074/jbc.M110.116699,2010,NR,,0,,,,,
genetic analyses of hiv-1 env sequences demonstrate limited compartmentalization in breast milk and suggest viral replication within the breast that increases with mastitis,Gantt S,10.1128/JVI.00543-10,2010,NR,,0,,,,,
genetic analyses suggest functional differences in the nature of persistent viraemia between hiv-1 elite controllers and therapy exposed controllers,Mens H,,2010,NR,,0,,,,,
genetic characteristics of hiv-1 envelope associated with broadly cross-reactive neutralizing antibody responses,Thebus R,10.1089/aid.2010.9998,2010,NR,,0,,,,,
hiv-1 transmission after cessation of early antiretroviral therapy among men having sex with men,Rieder P,10.1097/QAD.0b013e328338e4de,2010,NR,,0,,,,,
hiv-2 antiretroviral drug resistance and genetic diversity in cote d'ivoire: presence of key resistance mutations in hiv-2 naive patients from abidjan,Toni TA,,2010,NR,,0,,,,,
"hiv/aids and the long-distance truck drivers in south-west nigeria: a cross-sectional survey on the knowledge, attitude, risk behaviour and beliefs of truckers",Atilola GO,10.1016/j.jiph.2010.08.002,2010,NR,,0,,,,,
genetic variation within the gene encoding the hiv-1 ccr5 coreceptor in two south african populations,Picton AC,10.1016/j.meegid.2010.02.012,2010,NR,,0,,,,,
"hla-b alleles associate consistently with hiv heterosexual transmission, viral load, and progression to aids, but not susceptibility to infection",Gao X,10.1097/QAD.0b013e32833c3219,2010,NR,,0,,,,,
genotypic and phenotypic characteristics of crf01-ae hiv-1 virus env genes from early infected individuals,Zhao C,10.1089/aid.2010.9998,2010,NR,,0,,,,,
genotypic characterization of hiv type 1 env gp160 sequences from three regions in thailand,de Silva UC,10.1089/aid.2009.0213,2010,NR,,0,,,,,
strategies in designing multigene expression units to downregulate hiv-1,Zhang J,10.1007/978-1-60761-588-0_8,2010,NR,,0,,,,,
"human immunodeficiency virus (hiv) and migrant ""risk environments"": the case of the ethiopian and eritrean immigrant community in the west midlands of the uk",Barrett HR,10.1080/13548501003653192,2010,NR,,0,,,,,
human immunodeficiency virus type 1 protease inhibitor drug-resistant mutants give discordant results when compared in single-cycle and multiple-cycle fitness assays,Dykes C,10.1128/JCM.00605-10,2010,NR,,0,,,,,
heterogeneity and penetration of hiv-1 non-subtype b viruses in an italian province: public health implications,Torti C,10.1017/S0950268810000166,2010,NR,,0,,,,,
heterologous prime-boost hiv-1 vaccination regimens in pre-clinical and clinical trials,Brown,,2010,NR,,0,,,,,
"high genetic diversity of hiv-1 viruses in macao, china",Tan Y,10.1016/j.jinf.2010.04.012,2010,NR,,0,,,,,
is there a genetic basis for health disparities in human immunodeficiency virus disease?,Winkler C,10.1002/msj.20172,2010,NR,,0,,,,,
"identification of the phenotypic, genotypic and fitness correlates of non-b subtype hiv-1 nrti resistance through longitudinal analysis of children with virological failure in the developing world",Mbisa JL,,2010,NR,,0,,,,,
"hiv among plasma donors and other high-risk groups in henan, china",Li N,10.1097/QAI.0b013e3181c7d717,2010,NR,,0,,,,,
hiv patient characteristics that affect adherence to exercise programmes: an observational study,Petroczi,10.2174/1874613601004010148,2010,NR,,0,,,,,
hiv prevention and care in the digital age,Chiasson MA,10.1097/QAI.0b013e3181fcb878,2010,NR,,0,,,,,
in vitro hiv-1 cross-resistance against reverse transcriptase inhibitor-based microbicides,Selhorst P,,2010,NR,,0,,,,,
lower prevalence of human immunodeficiency virus type 1 brazilian subtype b found in northeastern brazil with slower progression to aids,Araujo AF,10.1089/aid.2010.0068,2010,NR,,0,,,,,
"hiv type 1 genetic diversity in silesia, poland: a retrospective analysis",Smolen J,10.1089/aid.2009.0172,2010,NR,,0,,,,,
hiv vaccines: lessons learned and the way forward,Kim JH,10.1097/COH.0b013e32833d17ac,2010,NR,,0,,,,,
hiv with contact tracing: a case study in approximate bayesian computation,Blum MGB,10.1093/biostatistics/kxq022,2010,NR,,0,,,,,
hiv-1 continues to replicate and evolve in patients with natural control of hiv infection,Mens H,10.1128/JVI.00387-10,2010,NR,,0,,,,,
hiv-1 diversity after a class switch failure,Kolber MA,10.1089/aid.2010.0069,2010,NR,,0,,,,,
hiv-1 genetic diversity in bulgaria 2008-2009,Ake J,10.1089/aid.2010.9998,2010,NR,,0,,,,,
hiv-1 subtype c envelope characteristics associated with divergent rates of chronic disease progression,Archary D,10.1186/1742-4690-7-92,2010,NR,,0,,,,,
hiv-1 subtype g strains play a major role in hiv-1 genetic complexity in nigeria,Heipertz RA,10.1089/aid.2010.9998,2010,NR,,0,,,,,
hiv-mir-h1 evolvability during hiv pathogenesis,Lamers SL,10.1016/j.biosystems.2010.05.001,2010,NR,,0,,,,,
"hiv-positive men who have sex with men: biography, diversity in lifestyles, common experience of living with hiv anrs-en12 vespa study, 2003",Lert,10.1080/09540120903012544,2010,NR,,0,,,,,
hiv-specific t cells: strategies for fighting a moving target,Mckinnon LR,10.2174/157016210794088245,2010,NR,,0,,,,,
lead expansion and virtual screening of indinavir derivate hiv-1 protease inhibitors using pharmacophoric - shape similarity scoring function,Shityakov S,,2010,NR,,0,,,,,
host genes associated with hiv/aids: advances in gene discovery,An P,10.1016/j.tig.2010.01.002,2010,NR,,0,,,,,
long peptides induce polyfunctional t cells against conserved regions of hiv-1 with superior breadth to single-gene vaccines in macaques,Rosario M,10.1002/eji.201040344,2010,NR,,0,,,,,
"lowering hiv fitness and replication rate by administration of lamivudine alone, in extensively resistant hiv-infected patients, as a ""bridging"" strategy towards optimized salvage regimens",Manfredi R,10.1186/1742-4690-7-S1-P58,2010,NR,,0,,,,,
novel subtype c human immunodeficiency virus type 1 envelopes cloned directly from plasma: coreceptor usage and neutralization phenotypes,Koh WW,10.1099/vir.0.022228-0,2010,NR,,0,,,,,
impaired replication capacity of acute/early viruses in persons who become hiv controllers,Miura T,10.1128/JVI.00286-10,2010,NR,,0,,,,,
"improved hiv-1 rna quantitation by cobas ampliprep/cobas taqman hiv-1 test, v20 using a novel dual-target approach",Sizmann D,10.1016/j.jcv.2010.06.004,2010,NR,,0,,,,,
in vivo validation of a bioinformatics based tool to identify reduced replication capacity in hiv-1,Kitchen CM,10.2174/1874431101004010225,2010,NR,,0,,,,,
increase in frequency of hiv-1 non-b subtypes in patients enrolled at the time of primary infection,Chaix ML,,2010,NR,,0,,,,,
increased genetic diversity of hiv-1 circulating in hong kong,Chen JH,10.1371/journal.pone.0012198,2010,NR,,0,,,,,
increased sensitivity to neutralizing antibodies of end-stage disease r5 hiv-1 is concomitant with reduced gp120 glyco-sylation and increased+charge,Fenyo E,10.1089/aid.2010.9998,2010,NR,,0,,,,,
"increasing hiv-related knowledge, communication, and testing intentions among latinos: protege tu familia: hazte la prueba",Rios-Ellis B,10.1353/hpu.0.0360,2010,NR,,0,,,,,
infection by discordant strains of hiv-1 markedly enhances the neutralizing antibody response against heterologous virus,Powell RL,10.1128/JVI.02732-09,2010,NR,,0,,,,,
inter-clade dual hiv-1 infection in the uk - an emerging phenomenon,Deayton J,10.1111/j.1468-1293.2010.00841-2.xP54,2010,NR,,0,,,,,
molecular diversity and polymerase gene genotypes of hiv-1 among treatment-naive cameroonian subjects with advanced disease,Soares EA,10.1016/j.jcv.2010.04.008,2010,NR,,0,,,,,
molecular epidemiology of hiv type 1 in mexico: emergence of bg and bf intersubtype recombinants,Vazquez-Valls E,10.1089/aid.2009.0195,2010,NR,,0,,,,,
molecular epidemiology of human immunodeficiency virus type 1 (hiv-1) in north-central nigeria and the evolution of crf02-ag and subtype g in nigeria,Ajoge HO,10.1089/aid.2010.9998,2010,NR,,0,,,,,
limited introductions and genetic variation of hiv-1 in a msm cohort in china,Chen Y,10.1089/aid.2010.9998,2010,NR,,0,,,,,
molecular targets and potency of hiv-1 neutralization revealed by dynamic assessment of transmitted/founder virus antibody recognition and escape,Bar KJ,10.1089/aid.2010.9998,2010,NR,,0,,,,,
lymphopenia on routine full blood count as an indicator of undiagnosed hiv infection,Hogan S,10.1111/j.1468-1293.2010.00841-2.xP54,2010,NR,,0,,,,,
macrophages and cell-cell spread of hiv-1,Waki,,2010,NR,,0,,,,,
multiple nucleotide preferences determine cleavage-site recognition by the hiv-1 and m-mulv rnases h,Schultz SJ,10.1016/j.jmb.2010.01.059,2010,NR,,0,,,,,
mental health in hiv seronegative and seropositive idus in south florida,Jones DL,10.1080/09540120903039851,2010,NR,,0,,,,,
modeling the impact of hiv/aids upon food security of diverse rural households in western kenya,Gill,10.1016/j.agsy.2010.01.007,2010,NR,,0,,,,,
modelling the between-host evolution of set-point viral load in hiv infection,Shirreff G,10.1016/j.ijid.2010.02.1665,2010,NR,,0,,,,,
"neither molecular diversity of the envelope, immunosuppression status, nor proviral load causes indeterminate htlv western blot profiles in samples from human t-cell lymphotropic virus type 2 (htlv-2)-infected individuals",Olah I,10.1002/jmv.21718,2010,NR,,0,,,,,
neutralization activity in a geographically diverse east london cohort of human immunodeficiency virus type 1-infected patients: clade c infection results in a stronger and broader humoral immune response than clade b infection,Dreja H,10.1099/vir.0.024224-0,2010,NR,,0,,,,,
modulation of hiv-1 virulence via the host glucocorticoid receptor: towards further understanding the molecular mechanisms of hiv-1 pathogenesis,Hapgood JP,10.1007/s00705-010-0678-0,2010,NR,,0,,,,,
"novel monocyclam derivatives as hiv entry inhibitors: design, synthesis, anti-hiv evaluation, and their interaction with the cxcr4 co-receptor",Pettersson S,10.1002/cmdc.201000124,2010,NR,,0,,,,,
nucleic acid template and the risk of a pcr-induced hiv-1 drug resistance mutation,Varghese V,10.1371/journal.pone.0010992,2010,NR,,0,,,,,
mosaic hiv-1 gag antigens can accurately present major hiv-specific epitopes in human cells,Ndhlovu ZM,10.1089/aid.2010.9998,2010,NR,,0,,,,,
multistage genomewide association study identifies a locus at 1q41 associated with rate of hiv-1 disease progression to clinical aids,Herbeck JT,10.1086/649842,2010,NR,,0,,,,,
national response to hiv/aids in india,Damodar Bachani,10.4103/0970-0218.74341,2010,NR,,0,,,,,
"partner age discordance, sexual relationship power, and hiv risk behavior in adolescent girls",Volpe E,10.1016/j.jadohealth.2009.11.089,2010,NR,,0,,,,,
overcoming challenges to accessing and adhering to care in minority patients living with hiv,Ojikutu B,,2010,NR,,0,,,,,
"pathways to sex-work in nagaland, india: implications for hiv prevention and community mobilisation",Devine,10.1080/09540120903039869,2010,NR,,0,,,,,
perceptions of condom fit and feel among men living with hiv,Reece M,10.1089/apc.2010.0021,2010,NR,,0,,,,,
perceptions of hiv-related websites among persons recently diagnosed with hiv,Courtenay-Quirk C,10.1089/apc.2009.0228,2010,NR,,0,,,,,
phylogeny and analysis of sequence motifs associated with biological activities of hiv-1 subtype c structural and accessory genes from south africa,Mothapo KM,10.1089/aid.2010.9998,2010,NR,,0,,,,,
"performance of the automated cobas ampliprep/cobas taqman hiv-1 test on a genetically diverse panel of specimens from china: comparison to the cobas amplicor hiv-1 monitor test, v15",Xu S,10.1159/000299064,2010,NR,,0,,,,,
phenotypic characterization of a panel of hiv-1 subtype g functional envelope clones,Thomson MM,10.1089/aid.2010.9998,2010,NR,,0,,,,,
phenotypic susceptibility to bevirimat in isolates from hiv-1-infected patients without prior exposure to bevirimat,Margot NA,10.1128/AAC.01784-09,2010,NR,,0,,,,,
skin disorders in korean patients infected with human immunodeficiency virus and their association with a cd4 lymphocyte count: a preliminary study,Kim T-G,10.1111/j.1468-3083.2010.03675.x,2010,NR,,0,,,,,
"pp2a1 binding, cell transducing and apoptotic properties of vpr77-92: a new functional domain of hiv-1 vpr proteins",Godet AN,10.1371/journal.pone.0013760,2010,NR,,0,,,,,
potent and broad neutralization of hiv-1 subtype c viruses by an antibody targeting a quaternary epitope including residues in the v2 loop,Moore PL,10.1089/aid.2010.9998,2010,NR,,0,,,,,
priming immunization with dna augments immunogenicity of recombinant adenoviral vectors for both hiv-1 specific antibody and t-cell responses,Koup RA,10.1371/journal.pone.0009015,2010,NR,,0,,,,,
identification of a new hiv type 1 bf intersubtype circulating recombinant form (crf44-bf) in chile,Delgado E,10.1089/aid.2010.0006,2010,NR,,0,,,,,
the rna binding protein hur does not interact directly with hiv-1 reverse transcriptase and does not affect reverse transcription in vitro,Ahn J,10.1186/1742-4690-7-40,2010,NR,,0,,,,,
phylodynamics of hiv-1 circulating recombinant forms 12_bf and 38_bf in argentina and uruguay,Bello G,10.1186/1742-4690-7-22,2010,NR,,0,,,,,
sub-attomolar hiv-1 dna detection using surface-enhanced raman spectroscopy,Hu J,10.1039/b920358c,2010,NR,,0,,,,,
presence of low abundance drug-resistant mutations in recently infected hiv-1 subtype c patients from south africa,Wallis CL,,2010,NR,,0,,,,,
"pregnancy intentions and family planning preferences among hiv-infected women in nyanza province, kenya",Harrington E,10.1016/j.contraception.2010.04.039,2010,NR,,0,,,,,
preliminary report of hiv and toxoplasma gondii occurrence in pregnant women from mozambique,Sitoe,,2010,NR,,0,,,,,
evidence for adaptive evolution at the divergence between lymphoid and brain hiv-1 nef genes,Olivieri KC,10.1089/aid.2009.0257,2010,NR,,0,,,,,
prevalence and correlates of sexual behavior and risk management among hiv-positive adults over 50,Golub SA,10.1097/OLQ.0b013e3181e15f20,2010,NR,,0,,,,,
"prevalence, estimated hiv-1 incidence and viral diversity among people seeking voluntary counseling and testing services in rio de janeiro, brazil",de Castro CA,10.1186/1471-2334-10-224,2010,NR,,0,,,,,
"viral tropism, fitness and pathogenicity of hiv-1 subtype c",Jakobsen MR,10.2217/fvl.09.77,2010,NR,,0,,,,,
alternative splicing: regulation of hiv-1 multiplication as a target for therapeutic action: minireview,Tazi J,10.1111/j.1742-4658.2009.07522.x,2010,NR,,0,,,,,
hla-b molecules target more conserved regions of the hiv-1 proteome,Fontaine Costa AI,10.1097/QAD.0b013e328334442e,2010,NR,,0,,,,,
apobec3g expression is dysregulated in primary hiv-1 infection and polymorphic variants influence cd4+ t-cell counts and plasma viral load,Reddy K,10.1097/QAD.0b013e3283353bba,2010,NR,,0,,,,,
"genetic composition of replication competent clonal hiv-1 variants isolated from peripheral blood mononuclear cells (pbmc), hiv-1 proviral dna from pbmc and hiv-1 rna in serum in the course of hiv-1 infection",Edo-Matas D,10.1016/j.virol.2010.06.029,2010,NR,,0,,,,,
germline antecedents of an anti-hiv murine antibody,Feng W,10.1111/j.1532-5415.2010.02850.x,2010,NR,,0,,,,,
relocalization of hiv-gag+cd81+ vesicles to the macrophage surface after exposure to chlorpromazine,Weaver C,10.1091/mbc.E10-10-0839,2010,NR,,0,,,,,
"evidence-based hiv disclosure intervention for african and caribbean women in canada: when to tell, to whom, why and how",Tharao WE,,2010,NR,,0,,,,,
apobec1 editing of hiv1 rna often leads to the destruction of linear b-cell epitopes: case study of env gene region coding for gp120 protein,Khrustalev VV,10.1016/j.nbt.2010.01.008,2010,NR,,0,,,,,
"prevalence of transmitted drug resistance associated mutations and hiv-1 subtypes in new hiv-1 diagnoses, us-2006",Wheeler WH,10.1097/QAD.0b013e3283388742,2010,NR,,0,,,,,
underestimation of viremia of hiv-1 variants by commercial real time pcr assays,Foglieni B,10.1007/s15010-010-1001-4,2010,NR,,0,,,,,
"specific genetic signatures in v3 base can modulate co-receptor usage in vivo, the interaction with neutralizing antibodies, and hiv-1 cytopathic effect",Alteri C,10.1007/s15010-010-1001-4,2010,NR,,0,,,,,
"local production of hiv variants in breast milk of chronically hiv-infected, lactating women",Salazar-Gonzalez JF,10.1089/aid.2010.9998,2010,NR,,0,,,,,
promoting new hiv testing options to msm in montreal: spot's communications campaign,Haig TA,,2010,NR,,0,,,,,
a bifunctional designer protein with potential for hiv prevention: concepts and implications,Dey B,10.1089/aid.2010.9998,2010,NR,,0,,,,,
high prevalence of ctl escape mutations on hiv strains circulating in a native population with limited hla diversity,Monaco D,10.1089/aid.2010.9998,2010,NR,,0,,,,,
impact of b*57/b*5801 associated ctl escape and compensatory mutations on hiv-1 subtype c viral fitness,Chopera DR,10.1089/aid.2010.9998,2010,NR,,0,,,,,
characterization of hiv-1 envelope variants from slow pro-gressors who developed broadly neutralizing cd4-binding site antibodies against hiv-1,Wu X,10.1089/aid.2010.9998,2010,NR,,0,,,,,
generation of broadly neutralizing monoclonal antibodies to hiv-1 envelope protein and characterization of the epitopes,Jacob RA,10.1089/aid.2010.9998,2010,NR,,0,,,,,
prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for hiv-1,Paris RM,10.1586/erv.10.106,2010,NR,,0,,,,,
principal component analysis of general patterns of hiv-1 replicative fitness in different drug environments,Martins JZ,10.1016/j.epidem.2010.03.003,2010,NR,,0,,,,,
"ctl escape and reversion in hiv-1 gag, pol and nef in an african subtype c cohort",Schaefer MR,10.1089/aid.2010.9998,2010,NR,,0,,,,,
site-specific genome cleavage by a vector-incorporated hiv-1 integrase fusion protein,Schenkwein D,10.1089/hum.2010.915,2010,NR,,0,,,,,
"the base component of 3'-azido-2',3'-dideoxynucleosides determines the mutation patterns selected in hiv-1 reverse transcriptase",Meteer J,,2010,NR,,0,,,,,
prolonged control of an hiv type 1 escape variant following treatment interruption in an hla-b*27-positive patient,O'Connell KA,10.1089/aid.2010.0135,2010,NR,,0,,,,,
prevalence of low-level variants with rt k65r among different hiv subtypes and the effects of arv-exposure on variant levels,Kozal MJ,,2010,NR,,0,,,,,
"specific genetic signatures in v3 base can modulate coreceptor usage in vivo, the interaction with neutralizing antibodies and hiv-1 cytopathic effect",Svicher V,,2010,NR,,0,,,,,
physical performance among individuals with cancer and hiv-aids: a comparison with health cohorts,Lee JQ,,2010,NR,,0,,,,,
recombination rate and selection strength in hiv intra-patient evolution,Neher RA,10.1371/journal.pcbi.1000660,2010,NR,,0,,,,,
relationship between antibody 2f5 neutralization of hiv-1 and hydrophobicity of its heavy chain third complementarity-determining region,Ofek G,10.1128/JVI.02257-09,2010,NR,,0,,,,,
rebound hiv-1 viraemia after cessation of long-term suppressive antiretroviral therapy has low genetic diversity and little divergence from pre-therapy virus populations,Kearney M,,2010,NR,,0,,,,,
replication competent molecular clones of hiv-1 expressing renilla luciferase facilitate the analysis of antibody inhibition in pbmc,Edmonds TG,10.1016/j.virol.2010.08.028,2010,NR,,0,,,,,
"reproductive health services for populations at high risk of hiv: performance of a night clinic in tete province, mozambique",Lafort,,2010,NR,,0,,,,,
restriction of hiv-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission,Heath L,10.1371/journal.pone.0010213,2010,NR,,0,,,,,
"risk factors for transmission of hiv in a hospital environment of yaounde, cameroon",Mbanya,10.3390/ijerph7052085,2010,NR,,0,,,,,
role of service providers of needle syringe program in preventing hiv/aids,Tsai T-I,10.1521/aeap.2010.22.6.546,2010,NR,,0,,,,,
reduction of the risk of transfusion-transmitted hiv infection by using a hiv ag/ab combination assay in blood screening in cameroon,Laperche S,10.1111/j.1423-0410.2010.01343-2.x,2010,NR,,0,,,,,
remarkable lethal g-to-a mutations in vif-proficient hiv-1 provirus by individual apobec3 proteins in humanized mice,Sato K,10.1128/JVI.00823-10,2010,NR,,0,,,,,
resistance pathways of human immunodeficiency virus type 1 against the combination of zidovudine and lamivudine,Theys,10.1099/vir.0.022657-0,2010,NR,,0,,,,,
"response to comment on ""the origins of sexually transmitted hiv among men who have sex with men""",Smith D,10.1126/scitranslmed.3001473,2010,NR,,0,,,,,
role of gag in hiv resistance to protease inhibitors,Clavel F,10.3390/v2071411,2010,NR,,0,,,,,
small molecule mimetics of an hiv-1 gp41 fusion intermediate as vaccine leads,Caulfield MJ,10.1074/jbc.M110.172197,2010,NR,,0,,,,,
solution conformation and dynamics of the hiv-1 integrase core domain,Fitzkee NC,10.1074/jbc.M110.113407,2010,NR,,0,,,,,
"seroprevalence and molecular epidemiology of htlv-1 isolates from hiv-1 co-infected women in feira de santana, bahia, brazil",de Almeida Rego FF,10.1089/aid.2009.0298,2010,NR,,0,,,,,
sulfatide administration leads to inhibition of hiv-1 replication and enhanced hematopoeisis,Sundell IB,jsc.2010.5.1.33,2010,NR,,0,,,,,
shiv162p3 infection of macaques resulting from vaccine failure using fthi or gp120 shows less envelope evolution than infection of naive macaques,Srinivasan P,10.1089/aid.2010.9998,2010,NR,,0,,,,,
short communication: biological and genetic characterization of hiv type 1 subtype b and nonsubtype b transmitted viruses: usefulness for vaccine candidate assessment,Cuevas MT,10.1089/aid.2010.0018,2010,NR,,0,,,,,
short communication: high polymorphism rates in the hr1 and hr2 gp41 and presence of primary resistance-related mutations in hiv type 1 circulating in brazil: possible impact on enfuvirtide efficacy,Teixeira C,10.1089/aid.2008.0297,2010,NR,,0,,,,,
"short communication: molecular epidemiology of hiv type 1 in the republic of dagestan, russian federation: virtually uniform circulation of subtype a, former soviet union variant, with predominance of the v77ipr subvariant",Vinogradova A,10.1089/aid.2009.0205,2010,NR,,0,,,,,
socioeconomic position and hiv risk-relevant behavior among lower-income heterosexuals in san francisco,Arnold MP,10.1007/s10461-009-9665-4,2010,NR,,0,,,,,
sources of human immunodeficiency virus and sexually transmitted disease information and responses to prevention messages among massachusetts men who have sex with men,Mimiaga MJ,10.4278/ajhp.08042841,2010,NR,,0,,,,,
spatial and socio-behavioral patterns of hiv prevalence in the democratic republic of congo,Messina JP,10.1016/j.socscimed.2010.07.025,2010,NR,,0,,,,,
strategies for eliciting hiv-1 inhibitory antibodies,Tomaras GD,10.1097/COH.0b013e32833d2d45,2010,NR,,0,,,,,
the anti-hiv actions of 7- and 10-substituted camptothecins,Li YuYe,10.3390/molecules15010138,2010,NR,,0,,,,,
stratification by hiv-1 subtype does not eliminate systematic geographical variation,Huang A,,2010,NR,,0,,,,,
tetherin restricts direct cell-to-cell infection of hiv-1,Kuhl BD,10.1186/1742-4690-7-115,2010,NR,,0,,,,,
"the context and impact of hiv and aids in chiang rai, thailand: a study of youth and young adults",Jongsthapongpanth,10.1080/00045600903364176,2010,NR,,0,,,,,
the dominance of hiv epitope-specific t cell clonotypes is not altered by anti-retroviral therapy,Ramalingam RK,10.1089/aid.2010.9998,2010,NR,,0,,,,,
the development of antiretroviral therapy and its impact on the hiv-1/aids pandemic (special issue: twenty-five years of antiretroviral drug development: progress and prospects),Broder,10.1016/j.antiviral.2009.10.002,2010,NR,,0,,,,,
the effect of transmitted hiv-1 drug resistance on pre-therapy viral load,Harrison L,10.1097/QAD.0b013e32833c1d93,2010,NR,,0,,,,,
the effects of national and international hiv/aids funding and governance mechanisms on the development of civil-society responses to hiv/aids in east and southern africa (special issue: the social context of community mobilization: foundations for success or failure),Kelly,10.1080/09540121.2010.524191,2010,NR,,0,,,,,
"the entry efficiency of transmitted hiv-1 variants from mbeya, tanzania plays a role in disease progression",Nofemela A,10.1089/aid.2010.9998,2010,NR,,0,,,,,
the evolution of hiv-1 diversity in rural cameroon and its implications in vaccine design and trials,Powell R,,2010,NR,,0,,,,,
"the epidemic of hiv infection and aids promotion of testing, and innovative strategies",Suligoi,,2010,NR,,0,,,,,
"the epidemic of hiv infection and aids, promotion of testing, and innovative strategies",Suligoi B,10.4415/ANN-10-01-03,2010,NR,,0,,,,,
the frequency of hiv-1 specific cellular immune responses in seronegative individuals with parenteral or heterosexual hiv-1 exposure,Murashev BV,10.1089/aid.2010.9998,2010,NR,,0,,,,,
the hiv-infected adolescent,Ross,10.1007/s11908-009-0077-4,2010,NR,,0,,,,,
the genetics of hiv resistance in exposed uninfected haemophilia a patients: an update on the chavi 014 protocol,Dorrell L,10.1111/j.1365-2516.2010.02201.x,2010,NR,,0,,,,,
the in vivo evolution of gag mutations during the early phase of hiv-1 subtype c infection,Novitsky V,10.1089/aid.2010.9998,2010,NR,,0,,,,,
the hiv-1 subtype c epidemic in south america is linked to the united kingdom,de Oliveira T,10.1371/journal.pone.0009311,2010,NR,,0,,,,,
the multiple facets of hiv attachment to dendritic cell lectins,Tsegaye TS,10.1111/j.1462-5822.2010.01519.x,2010,NR,,0,,,,,
the potential global market size and public health value of an hiv-1 vaccine in a complex global market,Marzetta CA,10.1016/j.vaccine.2010.04.098,2010,NR,,0,,,,,
the non-nucleoside reverse transcriptase inhibitor efavirenz stimulates replication of human immunodeficiency virus type 1 harboring certain non-nucleoside resistance mutations,Wang J,10.1016/j.virol.2010.03.018,2010,NR,,0,,,,,
the origins of sexually transmitted hiv among men who have sex with men,Butler DM,10.1126/scitranslmed.3000447,2010,NR,,0,,,,,
the predictive role of circulating serum free light chains (sflc) in hiv-associated non hodgkin's lymphoma (nhl) and hodgkin's disease (hd) and its correlation with effective combined antiretroviral treatment (cart),Bibas M,,2010,NR,,0,,,,,
the ring-ch ligase k5 antagonizes restriction of kshv and hiv-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin,Pardieu C,10.1371/journal.ppat.1000843,2010,NR,,0,,,,,
thermodynamic examination of conserved sequences of tar rna in hiv-1,Hannan PL,,2010,NR,,0,,,,,
tiered categorization of a diverse panel of hiv-1 env pseudoviruses for assessment of neutralizing antibodies,Seaman MS,10.1128/JVI.02108-09,2010,NR,,0,,,,,
the role of transmitted hla associated gag polymorphisms in defining hiv-1 set-point viral load and in vitro replicative fitness,Prince JL,10.1089/aid.2010.9998,2010,NR,,0,,,,,
to tell or not to tell: managing hiv/aids disclosure in a low-prevalence context,Adedimeji A,10.1080/17290376.2010.9724951,2010,NR,,0,,,,,
toward an antibody-based hiv-1 vaccine,Hoxie JA,10.1146/annurev.med.60.042507.164323,2010,NR,,0,,,,,
"two clusters of hiv-1 infection, rural idaho, usa, 2008",Nett RJ,10.3201/eid1611.100857,2010,NR,,0,,,,,
unique aspects of the care of hiv-positive latino patients living in the united states,Garland,10.1007/s11904-010-0049-1,2010,NR,,0,,,,,
transmission networks of hiv-1 among men having sex with men in the netherlands,Bezemer D,10.1097/QAD.0b013e328333ddee,2010,NR,,0,,,,,
"uptake of prenatal hiv testing in hai phong province, vietnam",Nguyen LT,,2010,NR,,0,,,,,
"transmission of hiv-1 drug-resistant mutations among treatment-naive infected patients in tel-aviv, israel: emergence of a cluster harbouring the major protease l90m mutation",Turner D,,2010,NR,,0,,,,,
using genomic signatures for hiv-1 sub-typing,Pandit A,10.1186/1471-2105-11-S1-S26,2010,NR,,0,,,,,
"near full-length sequence analysis of a novel hiv-1 c/crf01_ae recombinant variant from yunnan, china",Li Lin,10.1089/aid.2010.0116,2010,NR,,0,,,,,
"hiv and culture confluence: cross-cultural experiences on hiv, gender and education from johannesburg conference",Wangulu,,2010,NR,,0,,,,,
varied sensitivity to therapy of hiv-1 strains in cd4+ lymphocyte sub-populations upon art initiation,Heeregrave EJ,10.1186/1742-6405-7-42,2010,NR,,0,,,,,
treatment-mediated alterations in hiv fitness preserve cd4+ t cell counts but have minimal effects on viral load,Vaidya NK,10.1371/journal.pcbi.1001012,2010,NR,,0,,,,,
tribal ethnicity and cyp2b6 genetics in ugandan and zimbabwean populations in the uk: implications for efavirenz dosing in hiv infection,Jamshidi Y,10.1093/jac/dkq369,2010,NR,,0,,,,,
viral evolution and escape during acute hiv-1 infection,Boutwell CL,10.1086/655653,2010,NR,,0,,,,,
attitude of intending couple toward compulsory hiv screening test: a means to control the spread of hiv infection,Momoh,,2010,NR,,0,,,,,
two independent epidemics of hiv in maryland,Carr JK,10.1097/QAI.0b013e3181e0c3b3,2010,NR,,0,,,,,
w-curve alignments for hiv-1 genomic comparisons,Cork DJ,10.1371/journal.pone.0010829,2010,NR,,0,,,,,
variations in autologous neutralization and cd4 dependence of b12 resistant hiv-1 clade c env clones obtained at different time points from antiretroviral naive indian patients with recent infection,Ringe R,10.1186/1742-4690-7-76,2010,NR,,0,,,,,
"violence, abuse, alcohol and drug use, and sexual behaviors in street children of greater cairo and alexandria, egypt (special issue: progress in hiv research in the middle east and north africa: new study methods, results, and implications for prevention and care)",Nada,10.1097/01.aids.0000386732.02425.d1,2010,NR,,0,,,,,
viro-immunological dynamics in hiv-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: a pilot randomised trial,Soria A,10.1016/j.jcv.2009.12.007,2010,NR,,0,,,,,
"""keep holy distance and abstain till he comes"": interrogating a pentecostal church's engagements with hiv/aids and the youth in kenya (special issue: christianity and hiv/aids in east and southern africa)",Parsitau,10.2979/AFT.2009.56.1.44,2009,NR,,0,,,,,
a case of undetected hiv-1 rna by nat testing in an anti-hiv positive donor,Foglieni B,,2009,NR,,0,,,,,
"a public health model for the molecular surveillance of hiv transmission in san diego, california",Smith DM,10.1097/QAD.0b013e32831d2a81,2009,NR,,0,,,,,
"a study of knowledge, sexual behaviour and practices regarding hiv/aids among long distance truck drivers",Sanjeev K,,2009,NR,,0,,,,,
adaptations across clinical sites of an integrated treatment model for persons with hiv and substance abuse,Lombard F,10.1089/apc.2008.0260,2009,NR,,0,,,,,
a framework of sexual partnerships: risks and implications for hiv prevention in africa,Green EC,10.1111/j.1728-4465.2009.00187.x,2009,NR,,0,,,,,
"an analysis of hiv-related risk behaviors of men having sex with men (msm), using respondent driven sampling (rds), in albania",Sharra,,2009,NR,,0,,,,,
an exploratory study on the social and genotypic clustering of hiv infection in men having sex with men,Lee SS,10.1097/QAD.0b013e32832dc025,2009,NR,,0,,,,,
analysis of the diversity of the hiv-1 pol gene and drug resistance associated changes among drug-naive patients in burkina faso,Tebit DM,10.1002/jmv.21600,2009,NR,,0,,,,,
an african perspective on mucosal immunity and hiv-1,Pala P,10.1038/mi.2009.23,2009,NR,,0,,,,,
analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals,Li Y,10.1128/JVI.01992-08,2009,NR,,0,,,,,
antiretroviral therapy restores diversity in the t-cell receptor v beta repertoire of cd4 t-cell subpopulations among human immunodeficiency virus type 1-infected children and adolescents,Yin,10.1128/CVI.00074-09,2009,NR,,0,,,,,
"adherence to anti-retroviral therapy among hiv patients in bangalore, india",Cauldbeck MB,10.1186/1742-6405-6-7,2009,NR,,0,,,,,
association between mutations affects drug resistance selection by single-dose nevirapine in hiv-1 subtype c,Kantor R,,2009,NR,,0,,,,,
barriers and opportunities for recruitment for nonintervention studies on hiv risk: perspectives of street drug users,Oransky,10.3109/10826080802543671,2009,NR,,0,,,,,
biological signature characteristics of primary isolates from human immunodeficiency virus type 1 group o in ex vivo human tonsil histocultures,Geuenich S,10.1128/JVI.00928-09,2009,NR,,0,,,,,
an evaluation of performance-arts based hiv-prevention events in london with 13-16 year olds,Campbell T,10.1177/1757913909341615,2009,NR,,0,,,,,
an ssdna virus infecting archaea: a new lineage of viruses with a membrane envelope,Pietila MK,10.1111/j.1365-2958.2009.06642.x,2009,NR,,0,,,,,
analysis of hiv dna molecules in single infected cells from recently and chronically infected patients,Palmer S,,2009,NR,,0,,,,,
black men who have sex with men and the association of down-low identity with hiv risk behavior (special issue: mentoring for diversity in the mental health of hiv/aids),Bond,10.2105/AJPH.2007.127217,2009,NR,,0,,,,,
carriage of candida species in oral cavities of hiv infected patients in south india,Girish Kumar CP,10.1111/j.1439-0507.2008.01534.x,2009,NR,,0,,,,,
ccr5- and cxcr4-tropic subtype c human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group m subtypes: implications for the epidemic,Abraha A,10.1128/JVI.02051-08,2009,NR,,0,,,,,
"assessing motivations to engage in intentional condomless anal intercourse in hiv risk contexts (""bareback sex"") among men who have sex with men",Bauermeister JA,10.1521/aeap.2009.21.2.156,2009,NR,,0,,,,,
broad diversity of neutralizing antibodies isolated from memory b cells in hiv-infected individuals,Scheid JF,10.1038/nature07930,2009,NR,,0,,,,,
characterizing social support: global and specific social support experiences of hiv-infected youth,Abramowitz S,10.1089/apc.2008.0194,2009,NR,,0,,,,,
cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy,Everall I,10.3109/13550280903131915,2009,NR,,0,,,,,
building infrastructure for hiv/aids and mental health research at institutions serving minorities,Yanagihara R,10.2105/AJPH.2008.136903,2009,NR,,0,,,,,
close phylogenetic relationship between angolan and romanian hiv-1 subtype f1 isolates,Guimaraes ML,10.1186/1742-4690-6-39,2009,NR,,0,,,,,
cluster of acute hcv genotype 4 infections among hiv-positive men who have sex with men (msm),Vogel M,10.1002/hep.23303,2009,NR,,0,,,,,
cd3zeta down-modulation may explain vgamma9vdelta2 t lymphocytes anergy in hiv-infected patients,Sacchi A,10.1007/s15010-009-1002-3,2009,NR,,0,,,,,
non-random pre-transcriptional evolution in hiv-1 a refutation of the foundational conditions for neutral evolution,Valenzuela CY,10.1590/S1415-47572009005000025,2009,NR,,0,,,,,
"comparison of substance use and risky sexual behavior among a diverse sample of urban, hiv-positive men who have sex with men",Hatfield LA,10.1080/10550880903014726,2009,NR,,0,,,,,
"cost of treatment: the single biggest obstacle to hiv/aids treatment adherence in lower-middle class patients in mumbai, india",Naik E,10.4103/0253-7184.55476,2009,NR,,0,,,,,
"cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype a, c, and d envelope variants of human immunodeficiency virus type 1",Blish CA,10.1128/JVI.00673-09,2009,NR,,0,,,,,
current and novel inhibitors of hiv protease,Pokorna,,2009,NR,,0,,,,,
common genetic variation and the control of hiv-1 in humans,Fellay J,10.1371/journal.pgen.1000791,2009,NR,,0,,,,,
design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to t-20,Izumi K,10.1074/jbc.M807169200,2009,NR,,0,,,,,
detection of the protease codon 35 amino acid insertion in sequences from treatment-naive hiv-1 subtype c infected individuals in the central region of portugal,Pereira-Vaz J,10.1016/j.jcv.2009.06.019,2009,NR,,0,,,,,
comparison of commonly used real-time pcr methods to detect and quantify hiv-1 proviral dna in infected patients,Rozera G,10.1111/j.1469-0691.2009.02858.x,2009,NR,,0,,,,,
"comparison of hiv type 1 sequences from plasma, cell-free breast milk, and cell-associated breast milk viral populations in treated and untreated women in mozambique",Andreotti M,10.1089/aid.2008.0276,2009,NR,,0,,,,,
development of a panel of well-characterized human immunodeficiency virus type 1 isolates from newly diagnosed patients including acute and recent infections,Fernandez-Garcia A,10.1089/aid.2008.0174,2009,NR,,0,,,,,
"diffusion of effective behavioral interventions and hispanic/latino populations (special issue: hispanics/latinos and hiv/aids: epidemiologic, behavioral and ecological influences of risk and best practices for prevention)",Stallworth,10.1521/aeap.2009.21.5_supp.152,2009,NR,,0,,,,,
disparities in reported reasons for not initiating or stopping antiretroviral treatment among a diverse sample of persons living with hiv,Johnson MO,10.1007/s11606-008-0854-z,2009,NR,,0,,,,,
condom use and high-risk sexual acts in adult films: a comparison of heterosexual and homosexual films (special issue: mentoring for diversity in the mental health of hiv/aids),Grudzen,10.2105/AJPH.2007.127035,2009,NR,,0,,,,,
diversity of hiv-1 in bulgaria phylogenetic analisis,Alexiev I,,2009,NR,,0,,,,,
continuing clinical trials for hiv vaccine research,Gray G,,2009,NR,,0,,,,,
docudramas and public health: their role in access to hiv/sida prevention and treatment programs in southern mozambique,Degregori MCA,10.1111/j.1365-3156.2009.02354-1.x,2009,NR,,0,,,,,
drug pressure selected mutations in hiv-1 protease alter flap conformations,Galiano L,10.1021/ja807531v,2009,NR,,0,,,,,
"costs and effectiveness of partner counseling and referral services with rapid testing for hiv in colorado and louisiana, united states",Shrestha RK,10.1097/OLQ.0b013e3181a96d3d,2009,NR,,0,,,,,
dual hiv infection uncommon in patients on antiretroviral therapy in a region with high hiv prevalence,Naidoo AF,10.1089/aid.2009.0095,2009,NR,,0,,,,,
dynamics of emergence and linkage of hiv reverse transcriptase q151m mdr complex in children within first-line antiretroviral rollout uncovered by single-genome sequencing,Mbisa JL,,2009,NR,,0,,,,,
detection of low-frequency pretherapy chemokine (cxc motif) receptor 4 (cxcr4)-using hiv-1 with ultra-deep pyrosequencing,Archer J,10.1097/QAD.0b013e32832b4399,2009,NR,,0,,,,,
determinants of recent hiv infection among seattle-area men who have sex with men (special issue: mentoring for diversity in the mental health of hiv/aids),Thiede,10.2105/AJPH.2006.098582,2009,NR,,0,,,,,
differential evolution of human immunodeficiency virus type 1 protease and reverse transcriptase genes between haart-failing and naive-treated individuals,Varella RB,,2009,NR,,0,,,,,
characterization of the molecular determinants of primary hiv-1 vpr proteins: impact of the q65r and r77q substitutions on vpr functions,Jacquot G,10.1371/journal.pone.0007514,2009,NR,,0,,,,,
mutations in the thumb allow human immunodeficiency virus type 1 reverse transcriptase to be cleaved by protease in virions,Dunn LL,10.1128/JVI.00676-09,2009,NR,,0,,,,,
96 shrnas designed for maximal coverage of hiv-1 variants,McIntyre GJ,10.1186/1742-4690-6-55,2009,NR,,0,,,,,
"molecular characterization of non-subtype c and recombinant hiv-1 viruses from cape town, south africa",Wilkinson E,10.1016/j.meegid.2009.05.001,2009,NR,,0,,,,,
susceptibility loci for murine hiv-associated nephropathy encode trans-regulators of podocyte gene expression,Papeta N,10.1172/JCI37131,2009,NR,,0,,,,,
viral fitness implications of variation within an immunodominant cd8+ t-cell epitope of hiv-1,Christie NM,10.1016/j.virol.2009.03.003,2009,NR,,0,,,,,
variable fitness impact of hiv-1 escape mutations to cytotoxic t lymphocyte (ctl) response,Troyer RM,10.1371/journal.ppat.1000365,2009,NR,,0,,,,,
frequency and phenotype of human immunodeficiency virus envelope-specific b cells from patients with broadly cross-neutralizing antibodies,Doria-Rose NA,10.1128/JVI.01583-08,2009,NR,,0,,,,,
hiv diversity in venezuela: predominance of hiv type 1 subtype b and genomic characterization of non-b variants,Rangel HR,10.1089/aid.2008.0241,2009,NR,,0,,,,,
rare hla drive additional hiv evolution compared to more frequent alleles,Rousseau CM,10.1089/aid.2008.0208,2009,NR,,0,,,,,
single nef proteins from hiv type 1 subtypes c and f fail to upregulate invariant chain cell surface expression but are active for other functions,Turk G,10.1089/aid.2008.0132,2009,NR,,0,,,,,
"envelope coreceptor tropism, drug resistance, and viral evolution among subtype c hiv-1-infected individuals receiving nonsuppressive antiretroviral therapy",Kassaye S,10.1097/QAI.0b013e31818ffdff,2009,NR,,0,,,,,
hiv-1 reverse transcriptase can simultaneously engage its dna/rna substrate at both dna polymerase and rnase h active sites: implications for rnase h inhibition,Beilhartz GL,10.1016/j.jmb.2009.03.025,2009,NR,,0,,,,,
development of multi-turnover metallopeptides for efficient cleavage of hiv-1 mrna rev response element,Joyner JC,,2009,NR,,0,,,,,
amino acid covariation in a functionally important human immunodeficiency virus type 1 protein region is associated with population subdivision,da Silva J,10.1534/genetics.108.099853,2009,NR,,0,,,,,
massively parallel pyrosequencing highlights minority variants in the hiv-1 env quasispecies deriving from lymphomonocyte sub-populations,Rozera G,10.1186/1742-4690-6-15,2009,NR,,0,,,,,
epidemiologically linked transmission of hiv-1 illustrates the impact of host genetics on virological outcome,Streeck,10.1097/QAD.0b013e328315a78b,2009,NR,,0,,,,,
protective hla class i alleles that restrict acute-phase cd8+ t-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1,Wang YE,10.1128/JVI.01061-08,2009,NR,,0,,,,,
"genetic and temporal dynamics of human immunodeficiency virus type 1 crf07_bc in xinjiang, china",Xin R,10.1099/vir.0.009290-0,2009,NR,,0,,,,,
genetic determinants of hiv-1 infection and progression to aids: immune response genes,Kaur,10.1111/j.1399-0039.2009.01337.x,2009,NR,,0,,,,,
"evaluation of the impact of news coverage of an hiv multiclass drug-resistant cluster in seattle, washington (special issue: mentoring for diversity in the mental health of hiv/aids)",Kahle,10.2105/AJPH.2007.126656,2009,NR,,0,,,,,
evidence of hiv-1 adaptation to host hla alleles following chimp-to-human transmission,Ngandu NK,10.1186/1743-422X-6-164,2009,NR,,0,,,,,
evolution and molecular epidemiology of subtype c hiv-1 in zimbabwe,Dalai SC,10.1097/QAD.0b013e3283320ef3,2009,NR,,0,,,,,
"diverse blood exposures associated with incident hiv infection in calabar, nigeria",Peters EJ,10.1258/ijsa.2009.009272,2009,NR,,0,,,,,
evolution of hiv-1 in a patient population failing multiple-drug therapy,Hong S,10.1111/j.1348-0421.2009.00153.x,2009,NR,,0,,,,,
"genetic variability of human immunodeficiency virus-1 in bahia state, northeast, brazil: high diversity of hiv genotypes",Monteiro JP,10.1002/jmv.21414,2009,NR,,0,,,,,
experience of managing hiv in pregnancy in a cohort of intravenous drug users (ivdu) from a large ethnically diverse inner city hiv european centre,Surah S,10.1111/j.1468-1293.2009.00706.x,2009,NR,,0,,,,,
diversity of pol iv function is defined by mutations at the maize rmr7 locus,Stonaker JL,10.1371/journal.pgen.1000706,2009,NR,,0,,,,,
exploring the nuclear envelope of herpes simplex virus 1-infected cells by high-resolution microscopy,Wild P,10.1128/JVI.01568-08,2009,NR,,0,,,,,
"genotypic analysis of human immunodeficiency virus type 1 in blood monocytes, cd4 t cells and plasma from naive and treated individuals",Boni A,10.1007/s15010-009-1002-3,2009,NR,,0,,,,,
exposure to abacavir and biomarkers associated with cardiovascular disease (cvd) in hiv-1-infected patients on suppressive antiretroviral therapy: a longitudinal study,De Luca A,10.1111/j.1468-1293.2009.00792.x,2009,NR,,0,,,,,
factors associated with psychotherapy longevity among hiv-positive patients,Bottonari KA,10.1089/apc.2008.0081,2009,NR,,0,,,,,
high genetic diversity in human immunodeficiency virus-type 1 in jamaica,Heslop OD,,2009,NR,,0,,,,,
hiv-1 clade a infection and viral control: an immunological perspective on a case of under-quantification,Westrop SJ,10.1111/j.1468-1293.2009.00706.x,2009,NR,,0,,,,,
gag mutations strongly contribute to hiv-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss,Dam E,10.1371/journal.ppat.1000345,2009,NR,,0,,,,,
nmr second site screening for structure determination of ligands bound in the hydrophobic pocket of hiv-1 gp41,Balogh E,10.1021/ja8094558,2009,NR,,0,,,,,
hla-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection,Duda A,10.1128/JVI.01545-08,2009,NR,,0,,,,,
genetic analysis of hiv type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance,Kousiappa I,10.1089/aid.2008.0168,2009,NR,,0,,,,,
hla-associated viral mutations are common in human immunodeficiency virus type 1 elite controllers,Miura T,10.1128/JVI.02459-08,2009,NR,,0,,,,,
human immunodeficiency virus infection and associated factors among specific population subgroups in cameroon,Mosoko JJ,,2009,NR,,0,,,,,
escape from autologous neutralizing antibodies in acute/early subtype c hiv-1 infection requires multiple pathways,Rong R,10.1371/journal.ppat.1000594,2009,NR,,0,,,,,
genetic diversity and drug resistance of hiv type 1 circulating recombinant form_bc among drug users in guangdong province,Yu G,10.1089/aid.2008.0312,2009,NR,,0,,,,,
human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm,Simek MD,10.1128/JVI.00110-09,2009,NR,,0,,,,,
human immunodeficiency virus type 1 subtypes prevalence in central china,Zhao F,10.3349/ymj.2009.50.5.644,2009,NR,,0,,,,,
genetic profiles of hiv-1 populations in patients on failing abacavir/lamivudine/zidovudine,Hong S,10.1111/j.1469-0691.2009.02858.x,2009,NR,,0,,,,,
health care access and sexually transmitted infection screening frequency among at-risk massachusetts men who have sex with men (special issue: mentoring for diversity in the mental health of hiv/aids),Johnson,10.2105/AJPH.2007.127464,2009,NR,,0,,,,,
"high hiv type 1 prevalence and wide genetic diversity with dominance of recombinant strains but low level of antiretroviral drug-resistance mutations in untreated patients in northeast gabon, central africa",Mintsa-Ndong A,10.1089/aid.2008.0223,2009,NR,,0,,,,,
high level of multidrug resistance mutations in hiv type 1 pol gene and resistance-associated mutations to enfuvirtide (t-20) among antiretroviral-experienced patients from central brazil,Cardoso LP,10.1089/aid.2009.0060,2009,NR,,0,,,,,
"high prevalence and association of hiv-1 non-b subtype with specific sexual transmission risk among antiretroviral naive patients in porto alegre, rs, brazil",Dias CF,,2009,NR,,0,,,,,
"high prevalence of hiv infection among injection drug users (idus) in hyderabad and sukkur, pakistan",Altaf A,,2009,NR,,0,,,,,
"high prevalence of risk behaviour concurrent with links to other high-risk populations: a potentially explosive hiv epidemic among men who have sex with men in guangzhou, china",He Q,10.1136/sti.2009.035808,2009,NR,,0,,,,,
high replication fitness and transmission efficiency of hiv-1 subtype c from india: implications for subtype c predominance,Rodriguez MA,10.1016/j.virol.2008.12.025,2009,NR,,0,,,,,
highly divergent subtypes and new recombinant forms prevail in the hiv/aids epidemic in angola: new insights into the origins of the aids pandemic,Bartolo I,10.1016/j.meegid.2008.05.003,2009,NR,,0,,,,,
hiv and sti behavioural surveillance among men who have sex with men in europe,Elford J,10.2807/ese.14.47.19414-en,2009,NR,,0,,,,,
hiv resistance to antiretroviral drugs in treated and treatment-naive patients in clinics using national guidelines for art in the democratic republic of congo,Muwonga J,,2009,NR,,0,,,,,
hiv risk associated with gay bathhouses and sex clubs: findings from 2 seattle surveys of factors related to hiv and sexually transmitted infections (special issue: mentoring for diversity in the mental health of hiv/aids),Reidy,10.2105/AJPH.2007.130773,2009,NR,,0,,,,,
evaluating hiv-1 co-receptor tropism in a diverse clinic population,Rogers M,10.1111/j.1468-1293.2009.00706.x,2009,NR,,0,,,,,
human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent env vaccines,McBurney SP,10.1016/j.vaccine.2009.04.032,2009,NR,,0,,,,,
identification of specific small molecule ligands for stem loop 3 ribonucleic acid of the packaging signal psi of human immunodeficiency virus-1,Warui DM,10.1021/jm900599v,2009,NR,,0,,,,,
hiv type 1 subtype diversity and drug resistance among hiv type 1-infected kenyan patients initiating antiretroviral therapy,Lihana RW,10.1089/aid.2009.0007,2009,NR,,0,,,,,
evidence for limited genetic compartmentalization of hiv-1 between lung and blood,Heath L,10.1371/journal.pone.0006949,2009,NR,,0,,,,,
immune impairment thresholds in hiv infection,Iwami S,10.1016/j.imlet.2009.03.007,2009,NR,,0,,,,,
evolution of hiv-1 envelope sequences and coreceptor tropism during pregnancy,Ransy D,10.1186/1742-4690-6-S1-P2,2009,NR,,0,,,,,
"explosive expansion of hiv and associated risk factors among male and hijra sex workers in sindh, pakistan",Altaf A,,2009,NR,,0,,,,,
extended il10 haplotypes and their association with hiv progression to aids,Oleksyk TK,10.1038/gene.2009.9,2009,NR,,0,,,,,
"hiv-1 genetic diversity and transmitted drug resistance in health care settings in maputo, mozambique",Bartolo I,,2009,NR,,0,,,,,
factors that determine the efficiency of hiv-1 strand transfer initiated at a specific site,Rigby ST,10.1016/j.jmb.2009.10.036,2009,NR,,0,,,,,
epistasis among deleterious mutations in the hiv-1 protease,Parera M,10.1016/j.jmb.2009.07.015,2009,NR,,0,,,,,
hiv-1 plasma virus diversity persists despite suppression with antiretroviral therapy,Kearney M,,2009,NR,,0,,,,,
"five-factor model personality traits, spirituality/religiousness, and mental health among people living with hiv",Lockenhoff CE,10.1111/j.1467-6494.2009.00587.x,2009,NR,,0,,,,,
hiv-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naive patients from central west brazil,Cardoso LP,10.1016/j.jcv.2009.07.009,2009,NR,,0,,,,,
hiv-1 primary drug resistance in protease and reverse transcriptase polymerase and rnase h domains from viruses infecting cameroonian subjects,Soares EA,,2009,NR,,0,,,,,
impact of hla in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection,Thobakgale CF,10.1128/JVI.00921-09,2009,NR,,0,,,,,
hiv-1 subtype and viral tropism determination for evaluating antiretroviral therapy options: an analysis of archived kenyan blood samples,Lihana RW,10.1186/1471-2334-9-215,2009,NR,,0,,,,,
hiv/aids related high risk behaviour among long distance truckers in india,Punia M,,2009,NR,,0,,,,,
genotypic and demographic characterization of invasive isolates of salmonella typhimurium in hiv co-infected patients in south africa,Keddy KH,,2009,NR,,0,,,,,
"human immunodeficiency virus-1 genotypic drug resistance among volunteer blood donors in yunnan, china",Tu YuanQuan,10.1111/j.1537-2995.2009.02219.x,2009,NR,,0,,,,,
identification of human immunodeficiency virus type 1 non-b subtypes and antiretroviral drug-resistant strains in united states blood donors,Brennan CA,10.1111/j.1537-2995.2008.01935.x,2009,NR,,0,,,,,
hiv education in south african schools: the dilemma and conflicts of educators (special issue: school-based hiv/aids prevention in sub-saharan africa),Ahmed,10.1177/1403494808097190,2009,NR,,0,,,,,
"hiv evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of apobec",Wood N,10.1371/journal.ppat.1000414,2009,NR,,0,,,,,
hiv infection and associated risk factors among long-distance truck drivers travelling through azerbaijan,Botros BA,10.1258/ijsa.2008.008396,2009,NR,,0,,,,,
impact of newly hiv diagnosed individuals on the transmission of drug resistance,Yerly S,,2009,NR,,0,,,,,
an improved strategy for efficient expression and purification of soluble hiv-1 tat protein in ecoli,Zhang S-M,10.1007/s12250-009-3068-6,2009,NR,,0,,,,,
hiv prevention technology transfer: challenges and strategies in the real world (special issue: mentoring for diversity in the mental health of hiv/aids),Veniegas,10.2105/AJPH.2007.124263,2009,NR,,0,,,,,
"implementation of a multiregion hybridization assay to characterize hiv-1 strains detected among injecting drug users in manipur, india",Sarkar R,10.1159/000224645,2009,NR,,0,,,,,
"hiv testing factors associated with delayed entry into hiv medical care among hiv-infected persons from eighteen states, united states, 2000-2004",Reed,10.1089/apc.2008.0213,2009,NR,,0,,,,,
hiv type 1 diversity from newly diagnosed patients in santos metropolitan area/brazil,de Sa-Filho DJ,10.1089/aid.2009.0073,2009,NR,,0,,,,,
in vivo fitness cost of the m184v mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine,Paredes R,10.1128/JVI.02154-08,2009,NR,,0,,,,,
in-depth analysis of the origins of hiv type 1 subtype c in south america,Jones LR,10.1089/aid.2008.0293,2009,NR,,0,,,,,
structural and functional studies on hiv nef-peptide presented by hla-a*2402,Shi Y,10.1002/eji.200990224,2009,NR,,0,,,,,
"incidence of non-b subtypes of hiv-1 in galicia, spain: high frequency and diversity of hiv-1 among men who have sex with men (special issue: hiv/aids and other sexually transmitted infections (sti) in men who have sex with men (msm) - trends and behavioural surveillance)",Cuevas,,2009,NR,,0,,,,,
major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization,Ince WL,10.1128/JVI.02486-08,2009,NR,,0,,,,,
maternal transmission of human immunodeficiency virus escape mutations subverts hla-b57 immunodominance but facilitates viral control in the haploidentical infant,Schneidewind A,10.1128/JVI.00730-09,2009,NR,,0,,,,,
influence of socio-demographic factors on distances travelled to access hiv services: enhanced surveillance of hiv patients in north west england,Cook PA,10.1186/1471-2458-9-78,2009,NR,,0,,,,,
hiv-1 nef dimerization is required for nef-mediated receptor downregulation and viral replication,Poe JA,10.1016/j.jmb.2009.09.047,2009,NR,,0,,,,,
hiv-1 nonsubtype b distribution across certain resource-rich countries,Brindicci,10.2217/hiv.09.25,2009,NR,,0,,,,,
molecular immune signatures of hiv-1 vaccines in human pbmcs,Monaco A,10.1016/j.febslet.2009.07.060,2009,NR,,0,,,,,
monotypic human immunodeficiency virus type 1 genotypes across the uterine cervix and in blood suggest proliferation of cells with provirus,Bull ME,10.1128/JVI.02664-08,2009,NR,,0,,,,,
mother to child transmission of hiv-1 in a thai population: role of virus characteristics and maternal humoral immune response,Kittinunvorakoon C,10.1002/jmv.21465,2009,NR,,0,,,,,
hiv/aids and sexuality: concerns of youths in rural zimbabwe,Chikovore J,10.2989/AJAR.2009.8.4.14.1051,2009,NR,,0,,,,,
lack of duffy antigen receptor for chemokines: no influence on hiv disease progression in an african treatment-naive population,Julg B,10.1016/j.chom.2009.04.009,2009,NR,,0,,,,,
"low-abundance drug-resistant viral variants in chronically hiv-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes",Simen,10.1086/596736,2009,NR,,0,,,,,
"near full-length genome analysis of low prevalent human immunodeficiency virus type 1 subclade f1 in sao paulo, brazil",Sanabani SS,10.1186/1743-422X-6-78,2009,NR,,0,,,,,
mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody b12 that effectively targets the site of cd4 attachment,Wu X,10.1128/JVI.01142-09,2009,NR,,0,,,,,
"incidence of non-b subtypes of hiv-1 in galicia, spain: high frequency and diversity of hiv-1 among men who have sex with men",Cuevas M,,2009,NR,,0,,,,,
increased mutations in env and pol suggest greater hiv-1 replication in sputum-derived viruses compared with blood-derived viruses,Wagner TA,10.1097/QAD.0b013e328329f964,2009,NR,,0,,,,,
methamphetamine initiation among hiv-positive gay and bisexual men,Nakamura N,10.1080/09540120902729999,2009,NR,,0,,,,,
minority drug-resistant hiv-1 variants: transmission and response to antiretroviral therapy,Masquelier B,10.2217/17584310.3.1.55,2009,NR,,0,,,,,
initial evaluation of the roche cobas taqman hiv-1 v20 assay for determining viral load in hiv-infected individuals,Taylor N,10.3851/IMP1427,2009,NR,,0,,,,,
molecular and phylogenetic analysis of hiv type 1 non-b subtypes in emilia romagna,Bon I,10.1007/s15010-009-1002-3,2009,NR,,0,,,,,
intrahost and interhost variability of the hiv type 1 nef gene in brazilian children,Cavalieri E,10.1089/aid.2009.0061,2009,NR,,0,,,,,
"is 'bareback' a useful construct in primary hiv-prevention? definitions, identity and research",Carballo-Dieguez,10.1080/13691050802419467,2009,NR,,0,,,,,
molecular phylodynamics of the heterosexual hiv epidemic in the united kingdom,Hughes GJ,10.1371/journal.ppat.1000590,2009,NR,,0,,,,,
limited neutralizing antibody specificities drive neutralization escape in early hiv-1 subtype c infection,Moore PL,10.1371/journal.ppat.1000598,2009,NR,,0,,,,,
"monitoring hiv drug resistance in treatment-naive individuals: molecular indicators, epidemiology and clinical implications",Magiorkinis E,10.2217/hiv.09.23,2009,NR,,0,,,,,
quantifying differences in the tempo of human immunodeficiency virus type 1 subtype evolution,Abecasis AB,10.1128/JVI.01022-09,2009,NR,,0,,,,,
measuring hiv neutralization in a luciferase reporter gene assay,Montefiori DC,10.1007/978-1-59745-170-3_26,2009,NR,,0,,,,,
mechanical unfolding of two dis rna kissing complexes from hiv-1,Li PT,,2009,NR,,0,,,,,
"mechanism analysis indicates that recombination events in hiv-1 initiate and complete over short distances, explaining why recombination frequencies are similar in different sections of the genome",Rigby ST,10.1016/j.jmb.2009.02.029,2009,NR,,0,,,,,
natural products for the treatment of hiv/aids,Klimkait T,10.1055/s-0029-1234241,2009,NR,,0,,,,,
mindfulness meditation training effects on cd4+ t lymphocytes in hiv-1 infected adults: a small randomized controlled trial,Creswell JD,10.1016/j.bbi.2008.07.004,2009,NR,,0,,,,,
"rapid, point-of-care extraction of human immunodeficiency virus type 1 proviral dna from whole blood for detection by real-time pcr",Jangam SR,10.1128/JCM.r00092-09,2009,NR,,0,,,,,
new small-molecule inhibitor class targeting human immunodeficiency virus type 1 virion maturation,Blair WS,10.1128/AAC.00759-09,2009,NR,,0,,,,,
modulation of hiv-1 infectivity and cyclophilin a-dependence by gag sequence and target cell type,Matsuoka S,10.1186/1742-4690-6-21,2009,NR,,0,,,,,
nmr structural characterization of hiv-1 virus protein u cytoplasmic domain in the presence of dodecylphosphatidylcholine micelles,Wittlich M,10.1111/j.1742-4658.2009.07363.x,2009,NR,,0,,,,,
molecular characterization of hiv-1 in nicaragua,Carrion G,,2009,NR,,0,,,,,
molecular pathology of neuro-aids (cns-hiv),Crews L,10.3390/ijms10031045,2009,NR,,0,,,,,
natural killer cells derived from human pluripotent stem cells provide a novel method to treat hiv-1 infection,Ni Z,,2009,NR,,0,,,,,
selective expansion of hiv-1 envelope glycoprotein-specific b cell subsets recognizing distinct structural elements following immunization,Dosenovic P,10.4049/jimmunol.0900407,2009,NR,,0,,,,,
"perceived everyday racism, residential segregation, and hiv testing among patients at a sexually transmitted disease clinic (special issue: mentoring for diversity in the mental health of hiv/aids)",Ford,10.2105/AJPH.2007.120865,2009,NR,,0,,,,,
"non-b hiv type 1 subtypes among men who have sex with men in rome, italy",Giuliani M,10.1089/aid.2008.0175,2009,NR,,0,,,,,
pharmacogenetics-based population pharmacokinetic analysis of efavirenz in hiv-1-infected individuals,Arab-Alameddine M,10.1038/clpt.2008.271,2009,NR,,0,,,,,
"nutritional status, quality of life and cd4 cell count of adults living with hiv/aids in the ga-rankuwa area (south africa)",Venter ME,10.1080/16070658.2009.11734233,2009,NR,,0,,,,,
oral candidiasis of hiv-infected children undergoing sequential hiv therapies,Melo NR,10.1080/13693780802195315,2009,NR,,0,,,,,
"patient perspectives with abbreviated versus standard pre-test hiv counseling in the prenatal setting: a randomized-controlled, non-inferiority trial",Cohan D,10.1371/journal.pone.0005166,2009,NR,,0,,,,,
personal values and meaning in the use of methamphetamine among hiv-positive men who have sex with men,Chartier,10.1177/1049732309333018,2009,NR,,0,,,,,
simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses,Rudnicka D,10.1128/JVI.00282-09,2009,NR,,0,,,,,
prediction of hiv-1 protease inhibitors using machine learning approaches,Rao H,10.1002/qsar.200960021,2009,NR,,0,,,,,
practice of feeding premasticated food to infants: a potential risk factor for hiv transmission,Gaur AH,10.1542/peds.2008-3614,2009,NR,,0,,,,,
predicted co-receptor tropism and sequence characteristics of china hiv-1 v3 loops: implications for the future usage of ccr5 antagonists and aids vaccine development,Zhang C,10.1016/j.ijid.2008.12.010,2009,NR,,0,,,,,
predicting anti-hiv activity of dimethylaminopyridin-2-ones: computational approach using topochemical descriptors,Dureja H,10.1111/j.1747-0285.2008.00766.x,2009,NR,,0,,,,,
hiv risk among bisexually and homosexually active racially diverse young men,Flores SA,10.1097/OLQ.0b013e3181924201,2009,NR,,0,,,,,
preventing human immunodeficiency virus (hiv) and other sexually transmitted infections and reducing hiv-stigmatizing attitudes in high-risk youth: evaluation of a comprehensive community-based and peer-facilitated curriculum,Zuniga,10.1080/17450120802613179,2009,NR,,0,,,,,
preventing transfusion-transmitted hiv infection in latin america and the caribbean: issues associated with blood donor interviews and sex between men,Alonso M,10.1097/QAI.0b013e3181a268ed,2009,NR,,0,,,,,
qsar modeling of hiv-1 protease inhibition on six- and seven-membered cyclic ureas,Takkis K,10.1002/qsar.200860006,2009,NR,,0,,,,,
"genetic characterization of eight full-length hiv type 1 genomes from the democratic republic of congo (drc) reveal a new subsubtype, a5, in the a radiation that predominates in the recombinant structure of crf26-a5u",Vidal N,10.1089/aid.2008.0283,2009,NR,,0,,,,,
effects of an internet-based intervention for hiv prevention: the youthnet trials,Bull S,10.1007/s10461-008-9487-9,2009,NR,,0,,,,,
psychosocial predictors of sexual hiv transmission risk behavior among hiv-positive adults with a sexual abuse history in childhood,Sikkema,10.1007/s10508-007-9238-4,2009,NR,,0,,,,,
the capsid protein of human immunodeficiency virus: intersubunit interactions during virus assembly,Mateu MG,10.1111/j.1742-4658.2009.07313.x,2009,NR,,0,,,,,
genetic variability of blastocystis sp isolates obtained from cancer and hiv/aids patients,Tan TC,10.1007/s00436-009-1551-5,2009,NR,,0,,,,,
use of massive parallel pyrosequencing for near full-length characterization of a unique hiv type 1 bf recombinant associated with a fatal primary infection,Bruselles A,10.1089/aid.2009.0083,2009,NR,,0,,,,,
"short communication: hiv type 1 genetic diversity among tea plantation workers in kericho, kenya",Arroyo MA,10.1089/aid.2009.0092,2009,NR,,0,,,,,
defining the fitness of hiv-1 ltr quasispecies containing specific core/enhancer region binding site polymorphisms,Li L,10.1080/13550280903016074,2009,NR,,0,,,,,
"neuronal subtype specific responses to hiv transactivator protein, tat",DeFazio RA,10.1080/13550280903016074,2009,NR,,0,,,,,
randomized controlled trial of a cognitive-behavioral intervention for hiv-positive persons: an investigation of treatment effects on psychosocial adjustment,Carrico AW,10.1007/s10461-008-9429-6,2009,NR,,0,,,,,
expression of natural killer cell receptor genes in hiv-infected patients lacking cd4 recovery on long-term haart,Bandera A,10.1007/s15010-009-1002-3,2009,NR,,0,,,,,
hiv-1 subtypes and circulating recombinant forms among immigrants in apulia,Altamura M,10.1111/j.1365-3156.2009.02354-3.x,2009,NR,,0,,,,,
hiv-1 reverse transcriptase fidelity variants alter levels of mutation during replication,Nissley DV,,2009,NR,,0,,,,,
hiv-associated peripheral t-cell lymphoma,Milani C,,2009,NR,,0,,,,,
hiv-1 genetic variants in the asian part of russia,Bobkova M,10.1111/j.1468-1293.2009.00792.x,2009,NR,,0,,,,,
reduction of the hiv-1 reservoir in resting cd4+ t-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept study,Lindkvist A,10.1186/1742-6405-6-15,2009,NR,,0,,,,,
"relationship of injection drug use, antiretroviral therapy resistance, and genetic diversity in the hiv-1 pol gene",Kowalski J,10.1097/QAI.0b013e318198a619,2009,NR,,0,,,,,
secondary prevention of hiv infection: the current state of prevention for positives,Fisher JD,10.1097/COH.0b013e32832c7ce5,2009,NR,,0,,,,,
the expanding range of cutaneous conditions causing immune reconstitution inflammatory syndrome (iris) in hiv infection,Preda VA,10.1111/j.1440-0960.2009.00524.x,2009,NR,,0,,,,,
self-silencing and age as risk factors for sexually acquired hiv in midlife and older women,Jacobs,10.1177/0898264308328646,2009,NR,,0,,,,,
rural black women's agency within intimate partnerships amid the south african hiv epidemic,Thege B,10.2989/AJAR.2009.8.4.9.1046,2009,NR,,0,,,,,
secondary prevention of hiv infection: the current state of prevention for positives (special issue: epidemiology),Fisher,10.1097/COH.0b013e32832c7ce5,2009,NR,,0,,,,,
smoking motivations and quitting motivations among hiv-infected smokers,Peretti-Watel P,10.3851/IMP1292,2009,NR,,0,,,,,
solute effects on spin labels at an aqueous-exposed site in the flap region of hiv-1 protease,Galiano L,10.1021/jp8057788,2009,NR,,0,,,,,
"seroprevalence study of human t-lymphotropic virus type 1, human immunodeficiency virus, tripanosoma cruzi and treponema pallidum infections in kollas and guarani natives from argentina",Eirin ME,10.1089/aid.2009.9992,2009,NR,,0,,,,,
"sexual orientation, drug use preference during sex, and hiv risk practices and preferences among men who specifically seek unprotected sex partners via the internet",Klein,10.3390/ijerph6051620,2009,NR,,0,,,,,
surprisingly high prevalence of subtype c and specific hiv-1 subtype/crf distribution in men having sex with men in senegal,Ndiaye HD,10.1097/QAI.0b013e3181af70a4,2009,NR,,0,,,,,
tracking the culprit: hiv-1 evolution and immune selection revealed by single-genome amplification,Brumme ZL,10.1084/jem.20091094,2009,NR,,0,,,,,
"social context, sexual risk perceptions and stigma: hiv vulnerability among male sex workers in mombasa, kenya",Okal J,10.1080/13691050902906488,2009,NR,,0,,,,,
"standardization of hiv-2 viral load quantification assays - results from achiev2e, an international collaboration on hiv-2",Damond F,10.1111/j.1468-1293.2009.00792.x,2009,NR,,0,,,,,
"stigma, identity and resistance among people living with hiv in south africa",Goudge J,,2009,NR,,0,,,,,
successful identification of sources of transmitted drug-resistant hiv-1 via a crosssectional phylogenetic analysis,Von Wyl V,,2009,NR,,0,,,,,
the differential binding and activity of pro 2000 against diverse hiv-1 envelopes,Sachdev DD,10.1097/QAI.0b013e31819f9e31,2009,NR,,0,,,,,
the effects of environmental factors on persons living with hiv/aids,Nichols L,10.3390/ijerph6072041,2009,NR,,0,,,,,
the frequency of hiv-i drug resistance mutations among treatment-naive individuals at a tertiary care centre in south india,Kandathil AJ,10.1258/ijsa.2008.008403,2009,NR,,0,,,,,
the impact of pharmacogenetics on hiv therapy,Mahungu,10.1258/ijsa.2008.008369,2009,NR,,0,,,,,
the impact of transmission clusters on primary drug resistance in newly diagnosed hiv-1 infection,Yerly S,10.1097/QAD.0b013e32832d40ad,2009,NR,,0,,,,,
the risk of developing malnutrition in people living with hiv/aids: observations from six support groups in botswana,Nnyepi,,2009,NR,,0,,,,,
"the moral emotions, alcohol dependence, and hiv risk behavior in an incarcerated sample",Stuewig J,10.1080/10826080802421274,2009,NR,,0,,,,,
the set complex acts as a barrier to autointegration of hiv-1,Yan N,,2009,NR,,0,,,,,
timing constraints of in vivo gag mutations during primary hiv-1 subtype c infection,Novitsky V,10.1371/journal.pone.0007727,2009,NR,,0,,,,,
"tnf, lta, hspa1l and hla-dr gene polymorphisms in hiv-positive patients with hypersensitivity to cotrimoxazole",Alfirevic A,10.2217/pgs.09.6,2009,NR,,0,,,,,
toxoplasma gondii infection and cerebral toxoplasmosis in hiv-infected patients,Pereira-Chioccola VL,10.2217/fmb.09.89,2009,NR,,0,,,,,
transmission events in newly hiv-1 subtype b-infected patients diagnosed in italy between 2004 and 2008,Callegaro A,10.1111/j.1468-1293.2009.00792.x,2009,NR,,0,,,,,
unprotected sex among men who have sex with men in canada: exploring rationales and expanding hiv prevention,Gastaldo D,10.1080/09581590802566453,2009,NR,,0,,,,,
unsafe sex among hiv positive individuals: cross-sectional and prospective predictors,Reilly T,10.1007/s10900-009-9203-3,2009,NR,,0,,,,,
use of gp120-v3 rna and dna genotype to predict tropism in hiv-infected patients,Prosperi MCF,10.1111/j.1468-1293.2009.00792.x,2009,NR,,0,,,,,
transmitted drug resistance in nonsubtype b hiv-1 infection,Chan PA,,2009,NR,,0,,,,,
preinfection human immunodeficiency virus (hiv)-specific cytotoxic t lymphocytes failed to prevent hiv type 1 infection from strains genetically unrelated to viruses in long-term exposed partners,Liu,10.1128/JVI.00839-09,2009,NR,,0,,,,,
"trends and correlates of hiv testing during pregnancy in racially/ ethnically diverse insured population, 1997-2006",Lawrence JM,10.1007/s10995-008-0403-8,2009,NR,,0,,,,,
validation of the worry about sexual outcomes scale for use in sti/hiv prevention interventions for adolescent females,Sales,10.1093/her/cyn006,2009,NR,,0,,,,,
what do people with hiv really think clinics and hiv organizations are good for?,Power L,10.1111/j.1468-1293.2009.00706.x,2009,NR,,0,,,,,
variations in the frequencies of torque teno virus subpopulations during haart treatment in hiv-1-coinfected patients,Devalle S,10.1007/s00705-009-0440-7,2009,NR,,0,,,,,
women's opinions about routine hiv testing during pregnancy: implications for the opt-out approach,Podhurst LS,10.1089/apc.2008.0186,2009,NR,,0,,,,,
znrd1 as a host cellular factor influencing hiv-1 replication,Ballana E,10.1016/j.antiviral.2009.02.099,2009,NR,,0,,,,,
2'-deoxy-4'-c-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants,Kawamoto A,10.1016/j.biocel.2008.04.007,2008,NR,,0,,,,,
a centralized gene-based hiv-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys,Santra S,10.1073/pnas.0803352105,2008,NR,,0,,,,,
a heteroduplex assay for the rapid detection of dual human immunodeficiency virus type 1 infections,Powell RL,10.1016/j.jviromet.2008.01.015,2008,NR,,0,,,,,
a radiolabeled oligonucleotide ligation assay demonstrates the high frequency of nevirapine resistance mutations in hiv type 1 quasispecies of nvp-treated and untreated mother-infant pairs from uganda,Troyer RM,10.1089/aid.2007.0138,2008,NR,,0,,,,,
analysis of hiv subtype and the phylogenetic tree in hiv-positive samples from saudi arabia,Alzahrani AJ,,2008,NR,,0,,,,,
a study of hiv-1 genetic diversity in the czech republic: 1986-2007,Linka M,,2008,NR,,0,,,,,
chemical library and structure-activity relationships of 11-demethyl-12-oxo calanolide a analogues as anti-hiv-1 agents,Ma T,10.1021/jm701405p,2008,NR,,0,,,,,
recombination analysis and structure prediction show correlation between breakpoint clusters and rna hairpins in the pol gene of human immunodeficiency virus type 1 unique recombinant forms,Galli A,10.1099/vir.0.2008/003418-0,2008,NR,,0,,,,,
"recombination increases human immunodeficiency virus fitness, but not necessarily diversity",Vijay NNV,10.1099/vir.0.83668-0,2008,NR,,0,,,,,
african-american clinicians providing hiv care: the experience of the national hiv/aids clinicians' consultation center,Mahoney MR,10.1016/s0027-9684%2815%2931371-7,2008,NR,,0,,,,,
associations between hiv-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes,Bruneau J,10.1136/jech.2007.064154,2008,NR,,0,,,,,
baseline integrated behavioural and biological assessment among most at-risk populations in six high-prevalence states of india: design and implementation challenges (special issue: characterizing the indian hiv epidemic and assessing large-scale prevention efforts - avahan),Tobi Saidel,10.1097/01.aids.0000343761.77702.04,2008,NR,,0,,,,,
an online needs assessment of a virtual community: what men who use the internet to seek sex with men want in internet-based hiv prevention,Hooper S,10.1007/s10461-008-9373-5,2008,NR,,0,,,,,
analysis of the eiav rev-responsive element (rre) reveals a conserved rna motif required for high affinity rev binding in both hiv-1 and eiav,Lee JH,10.1371/journal.pone.0002272,2008,NR,,0,,,,,
antigen load and viral sequence diversification determine the functional profile of hiv-1-specific cd8+ t cells,Streeck H,10.1371/journal.pmed.0050100,2008,NR,,0,,,,,
central role of reverting mutations in hla associations with human immunodeficiency virus set point,Matthews PC,10.1128/JVI.00580-08,2008,NR,,0,,,,,
cerebrospinal fluid viral load and intrathecal immune activation in individuals infected with different hiv-1 genetic subtypes,Abdulle S,10.1371/journal.pone.0001971,2008,NR,,0,,,,,
characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1,Keele BF,10.1128/JVI.00124-08,2008,NR,,0,,,,,
characterization of b/c recombinants of near full-length hiv type 1 from northeastern india with mosaics identical to are195fl but with a different ancestral origin,Lakhashe S,10.1089/aid.2007.0214,2008,NR,,0,,,,,
blood monocytes harbor hiv type 1 strains with diversified phenotypes including macrophage-specific ccr5 virus,Xu Y,10.1086/524847,2008,NR,,0,,,,,
conflicting evidence in a bayesian synthesis of surveillance data to estimate human immunodeficiency virus prevalence,Presanis,10.1111/j.1467-985X.2008.00543.x,2008,NR,,0,,,,,
clustering and classifying diverse hiv entry inhibitors using a novel consensus shape-based virtual screening approach: further evidence for multiple binding sites within the ccr5 extracellular pocket,Perez-Nueno VI,10.1021/ci800257x,2008,NR,,0,,,,,
comparison of the diversity of the vaginal microbiota in hiv-infected and hiv-uninfected women with or without bacterial vaginosis,Spear GT,10.1086/591942,2008,NR,,0,,,,,
characteristics of the env genes of hiv type 1 quasispecies in long-term nonprogressors with broadly neutralizing antibodies,Braibant M,10.1097/QAI.0b013e318162cac2,2008,NR,,0,,,,,
critical issues in mucosal immunity for hiv-1 vaccine development,Haynes BF,10.1016/j.jaci.2008.03.036,2008,NR,,0,,,,,
circuit assemblages derived from net dinucleotide values provide a succinct identity for the hiv-1 genome and each of its genes,Lang DM,,2008,NR,,0,,,,,
cross-subtype antibody and cellular immune responses induced by a polyvalent dna prime-protein boost hiv-1 vaccine in healthy human volunteers (doi:101016/jvaccine200712024),Wang S,10.1016/j.vaccine.2007.12.060,2008,NR,,0,,,,,
clinical presentation and diagnosis of primary hiv-1 infection,Daar ES,10.1097/COH.0b013e3282f2e295,2008,NR,,0,,,,,
coming and going: some aspects of care for migrants with hiv in the uk (special issue: focus on hiv/aids),Anderson,10.1016/j.jinf.2008.05.002,2008,NR,,0,,,,,
detection of drug-resistant hiv minorities in clinical specimens and therapy failure,Louvel S,10.1111/j.1468-1293.2007.00529.x,2008,NR,,0,,,,,
continuous crossover (s) events of hiv-1 crf01ae and b subtype strain in malaysia: evidence of rapid and extensive hiv -1 evolution in the region,Lau KA,10.2174/157016208783885010,2008,NR,,0,,,,,
corruption and oil exploration: expert agreement about the prevention of hiv/aids in the niger delta of nigeria,Udoh IA,10.1093/her/cym042,2008,NR,,0,,,,,
drug resistance profiles for the hiv integrase gene in patients failing raltegravir salvage therapy,Charpentier,10.1111/j.1468-1293.2008.00628.x,2008,NR,,0,,,,,
drug resistance-associated genotypic alterations in the pol gene of hiv type 1 isolates in art-naive individuals in north india,Arora SK,10.1089/aid.2007.0156,2008,NR,,0,,,,,
"drug-associated changes in amino acid residues in gag p2, p7nc, and p6gag/p6pol in human immunodeficiency virus type 1 (hiv-1) display a dominant effect on replicative fitness and drug response",Ho,10.1016/j.virol.2008.05.029,2008,NR,,0,,,,,
"dynamic analysis of genetic diversity of gag and env regions of hiv-1 crf07_bc recombinant in intravenous drug users in xinjiang uvghur autonomous region, china",Liu S,10.1007/s00705-008-0107-9,2008,NR,,0,,,,,
effects of a coping intervention on transmission risk behavior among people living with hiv/aids and a history of childhood sexual abuse,Sikkema KJ,10.1097/QAI.0b013e318160d727,2008,NR,,0,,,,,
early infant human immunodeficiency virus type 1 detection suitable for resource-limited settings with multiple circulating subtypes by use of nested three-monoplex dna pcr and dried blood spots,Zhang Q,,2008,NR,,0,,,,,
"focusing the immune response on the v3 loop, a neutralizing epitope of the hiv-1 gp120 envelope",Zolla-Pazner S,10.1016/j.virol.2007.09.024,2008,NR,,0,,,,,
differences in hiv vaccine acceptability between genders,Kakinami,10.1080/09540120701867180,2008,NR,,0,,,,,
"short communication: molecular characterization of hiv type 1 bf pol recombinants from sao paulo, brazil",de Souza AC,10.1089/aid.2008.0089,2008,NR,,0,,,,,
different sliding window sizes and inappropriate subtype references result in discordant mosaic maps and breakpoint locations of hiv-1 crfs,Zhang C,10.1016/j.meegid.2008.04.001,2008,NR,,0,,,,,
"high human cytomegalovirus loads and diverse linked variable genotypes in both hiv-1 infected and exposed, but uninfected, children in africa",Bates M,10.1016/j.virol.2008.09.001,2008,NR,,0,,,,,
global analysis of host-pathogen interactions that regulate early-stage hiv-1 replication,Konig R,10.1016/j.cell.2008.07.032,2008,NR,,0,,,,,
"identification of subtype b, multiple circulating recombinant forms and unique recombinants of hiv type 1 in an msm cohort in china",Wang W,10.1089/aid.2008.0095,2008,NR,,0,,,,,
a comprehensive analysis of the naturally occurring polymorphisms in hiv-1 vpr: potential impact on ctl epitopes,Srinivasan A,10.1186/1743-422X-5-99,2008,NR,,0,,,,,
molecular and structural characterization of hiv-1 subtype b brazilian isolates with gwgr tetramer at the tip of the v3-loop,Leal E,10.1016/j.virol.2008.08.029,2008,NR,,0,,,,,
increase of non-b subtypes and recombinants among newly diagnosed hiv-1 native spaniards and immigrants in spain,Holguin A,,2008,NR,,0,,,,,
new and old complex recombinant hiv-1 strains among patients with primary infection in 1996-2006 in france: the french anrs co06 primo cohort study,Frange P,10.1186/1742-4690-5-69,2008,NR,,0,,,,,
"marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (hiv-1) gag, pol, and nef cytotoxic t-lymphocyte epitopes in acute/early hiv-1 infection",Brumme ZL,10.1128/JVI.01041-08,2008,NR,,0,,,,,
temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08_bc and 07_bc in asia,Tee KK,10.1128/JVI.00399-08,2008,NR,,0,,,,,
"full-length hiv type 1 proviral sequencing of 10 highly exposed women from nairobi, kenya reveals a high proportion of intersubtype recombinants",Land AM,10.1089/aid.2007.0200,2008,NR,,0,,,,,
the possible contribution of hiv-1-induced syncytia to the generation of intersubtype recombinants in vitro,Steain MC,10.1097/QAD.0b013e3282f82b6c,2008,NR,,0,,,,,
hla class i-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load,Rousseau CM,10.1128/JVI.02455-07,2008,NR,,0,,,,,
full-length characterization of a1/d intersubtype recombinant genomes from a therapy-induced hiv type 1 controller during acute infection and his noncontrolling partner,Fomsgaard A,10.1089/aid.2006.0294,2008,NR,,0,,,,,
evolution of dc-sign use revealed by fitness studies of r5 hiv-1 variants emerging during aids progression,Borggren M,10.1186/1742-4690-5-28,2008,NR,,0,,,,,
comparison of ligamp and an aspcr assay for detection and quantification of k103n-containing hiv variants,Church JD,10.1089/aid.2007.0224,2008,NR,,0,,,,,
a model for oligomeric regulation of apobec3g cytosine deaminase-dependent restriction of hiv,Chelico L,10.1074/jbc.M801004200,2008,NR,,0,,,,,
broadly immunogenic hla class i supertype-restricted elite ctl epitopes recognized in a diverse population infected with different hiv-1 subtypes,Perez CL,,2008,NR,,0,,,,,
a new strategy based on recombinant viruses for assessing the replication capacity of hiv-1,Garcia-Perez J,10.1111/j.1468-1293.2007.00540.x,2008,NR,,0,,,,,
identification and characterization of hiv-1 cd8+ t cell escape variants with impaired fitness,Sanchez-Merino V,10.1086/524845,2008,NR,,0,,,,,
human immunodeficiency virus type 1 vif functionally interacts with diverse apobec3 cytidine deaminases and moves with them between cytoplasmic sites of mrna metabolism,Marin M,,2008,NR,,0,,,,,
human immunodeficiency virus type 1 vpu protein interacts with cd74 and modulates major histocompatibility complex class ii presentation,Hussain A,,2008,NR,,0,,,,,
a diverse view of protein dynamics from nmr studies of hiv-1 protease flaps,Ishima R,,2008,NR,,0,,,,,
evolution of genetic diversity and drug resistance mutations in hiv-1 among untreated patients from mali between 2005 and 2006,Derache A,10.1093/jac/dkn234,2008,NR,,0,,,,,
factors associated with the emergence of k65r in patients with hiv-1 infection treated with combination antiretroviral therapy containing tenofovir,von Wyl V,10.1086/528863,2008,NR,,0,,,,,
ms3d structural elucidation of the hiv-1 packaging signal,Yu ET,10.1073/pnas.0800509105,2008,NR,,0,,,,,
frequent polymorphism at drug resistance sites in hiv-1 protease and reverse transcriptase,Kearney M,10.1097/QAD.0b013e3282f29478,2008,NR,,0,,,,,
effective suppression of hiv-1 by artificial bispecific mirna targeting conserved sequences with tolerance for wobble base-pairing,Son J,10.1016/j.bbrc.2008.06.125,2008,NR,,0,,,,,
"effects of training programme on hiv/aids prevention among primary health care workers in oyo state, nigeria",Ajuwon,10.1108/09654280810910872,2008,NR,,0,,,,,
emerging issues in the neuropsychology of hiv infection (behavioral aspects of hiv management),Foley,10.1007/s11904-008-0029-x,2008,NR,,0,,,,,
enhancing exposure of hiv-1 neutralization epitopes through mutations in gp41,Blish CA,10.1371/journal.pmed.0050009,2008,NR,,0,,,,,
episodic sexual transmission of hiv revealed by molecular phylodynamics,Lewis F,10.1371/journal.pmed.0050050,2008,NR,,0,,,,,
genotypic resistance profiles in antiretroviral-naive hiv-1 infections before and after initiation of first-line haart: impact of polymorphism on resistance to therapy,Sukasem C,10.1016/j.ijantimicag.2007.10.029,2008,NR,,0,,,,,
high divergence within the major hiv type 1 subtype b epidemic in panama,Ahumada-Ruiz S,10.1089/aid.2008.0153,2008,NR,,0,,,,,
higher homologous and lower cross-reactive gag-specific t-cell responses in human immunodeficiency virus type 2 (hiv-2) than in hiv-1 infection,Jennes W,10.1128/JVI.00027-08,2008,NR,,0,,,,,
highly diversified multiply drug-resistant hiv-1 quasispecies in pbmcs: a case report,Quan Y,10.1186/1742-4690-5-43,2008,NR,,0,,,,,
evidence for hiv-associated b cell exhaustion in a dysfunctional memory b cell compartment in hiv-infected viremic individuals,Moir S,10.1084/jem.20072683,2008,NR,,0,,,,,
evolutionary modeling of rate shifts reveals specificity determinants in hiv-1 subtypes,Penn O,10.1371/journal.pcbi.1000214,2008,NR,,0,,,,,
exploring diaphragm use as a potential hiv prevention strategy among women in the united states at risk,Harvey SM,10.1521/aeap.2008.20.2.135,2008,NR,,0,,,,,
exposure first-time hiv-positive offender denied pretrial diversion,Anonymous,,2008,NR,,0,,,,,
extensive purifying selection acting on synonymous sites in hiv-1 group m sequences,Ngandu NK,10.1186/1743-422X-5-160,2008,NR,,0,,,,,
field evaluation of a gag/env heteroduplex mobility assay for genetic subtyping of small-ruminant lentiviruses,Germain K,10.1099/vir.0.2008/000851-0,2008,NR,,0,,,,,
hiv-1 resistance to the anti-hiv activity of a shrna targeting a dual-coding region,Senserrich J,,2008,NR,,0,,,,,
"hiv-1 transmission, replication fitness and disease progression",Biesinger T,,2008,NR,,0,,,,,
quantitative structure-activity relationship studies on 1-aryl-tetrahydroisoquinoline analogs as active anti-hiv agents,Chen K-x,10.1016/j.bmcl.2008.09.056,2008,NR,,0,,,,,
genetic factors that confer sensitivity to haart in hiv-infected subjects: implication of a benefit of an earlier initiation of haart,Nakajima T,10.2217/14622416.9.9.1347,2008,NR,,0,,,,,
"high frequency of bf mosaic genomes among hiv-1-infected children from sao paulo, brazil",de Oliveira CM,10.1007/s00705-008-0178-7,2008,NR,,0,,,,,
innate immune responses in primary hiv-1 infection,Borrow P,10.1097/COH.0b013e3282f2bce7,2008,NR,,0,,,,,
high hiv incidence in a community with high hiv prevalence in rural south africa: findings from a prospective population-based study,Barnighausen T,10.1097/QAD.0b013e3282f2ef43,2008,NR,,0,,,,,
identifying host targets for drug development with knowledge from genome-wide studies: lessons from hiv-aids,Winkler CA,10.1016/j.chom.2008.04.001,2008,NR,,0,,,,,
hiv genes diversify in b cells,Balin SJ,,2008,NR,,0,,,,,
"hiv rebounds from latently infected cells, rather than from continuing low-level replication",Joos B,10.1073/pnas.0804192105,2008,NR,,0,,,,,
implications for hiv/aids research and education among ethnic minority older adults,Altschuler,10.1080/15381500802307476,2008,NR,,0,,,,,
"hiv type 1 genetic diversity in moyale, mandera, and turkana based on env-c2-v3 sequences",Khamadi SA,10.1089/aid.2008.0085,2008,NR,,0,,,,,
hiv-1 diversity among inmates of italian prisons,Longo B,10.1002/jmv.21275,2008,NR,,0,,,,,
hiv-1 gp120 n-linked glycosylation differs between plasma and leukocyte compartments,Ho YS,10.1186/1743-422X-5-14,2008,NR,,0,,,,,
hiv-1 sequence diversity as a window into hiv-1 biology (infectious disease),Patel,,2008,NR,,0,,,,,
hiv-1 seroconversion during pregnancy resulting in vertical transmission,Moses,10.1016/j.jcv.2007.10.013,2008,NR,,0,,,,,
"interactive ""video doctor"" counseling reduces drug and sexual risk behaviors among hiv-positive patients in diverse outpatient settings",Gilbert P,10.1371/journal.pone.0001988,2008,NR,,0,,,,,
distinct determinants in hiv-1 vif and human apobec3 proteins are required for the suppression of diverse host anti-viral proteins,Zhang W,10.1371/journal.pone.0003963,2008,NR,,0,,,,,
hiv-1 vaccine development: tackling virus diversity with a multi-envelope cocktail,Hurwitz JL,10.2741/2706,2008,NR,,0,,,,,
it's like the treasure': beliefs associated with semen among young hiv-positive and hiv-negative gay men,Schilder,10.1080/13691050802183899,2008,NR,,0,,,,,
long-distance interactive expert advice in highly treatment-experienced hiv-infected patients,Llibre,10.1093/jac/dkm438,2008,NR,,0,,,,,
identification of new crf43_02g and crf25_cpx in saudi arabia based on full genome sequence analysis of six hiv type 1 isolates,Yamaguchi J,10.1089/aid.2008.0101,2008,NR,,0,,,,,
identification of primary hiv-1c infection in botswana,Novitsky V,10.1080/09540120701694055,2008,NR,,0,,,,,
impact of hiv-1 genetic diversity in china on the measurement of viral load,Wang Y,10.1002/jmv.21048,2008,NR,,0,,,,,
increase coverage of hiv and aids services in myanmar,Williams,,2008,NR,,0,,,,,
men who have sex with transgender women: challenges to category-based hiv prevention,Operario D,10.1007/s10461-007-9303-y,2008,NR,,0,,,,,
molecular and phylogenetic analysis of hiv-1 variants circulating in italy,Buonaguro L,10.1186/1750-9378-3-13,2008,NR,,0,,,,,
integrase polymorphism and hiv-1 group o diversity,Leoz,10.1097/QAD.0b013e3283021c30,2008,NR,,0,,,,,
integrating professional and folk models of hiv risk: ymsm's perceptions of high-risk sex,Kubicek K,10.1521/aeap.2008.20.3.220,2008,NR,,0,,,,,
molecular epidemiology and divergence of hiv type 1 protease codon 35 inserted strains among treatment-naive patients in hong kong,Chen JH,10.1089/aid.2007.0231,2008,NR,,0,,,,,
isolation and propagation of hiv-1 on peripheral blood mononuclear cells,van 't Wout AB,10.1038/nprot.2008.3,2008,NR,,0,,,,,
lack of evidence for changing virulence of hiv-1 in north america,Herbeck JT,10.1371/journal.pone.0001525,2008,NR,,0,,,,,
primary human immunodeficiency virus type 1 (hiv-1) infection during hiv-1 gag vaccination,Balamurugan A,10.1128/JVI.01720-07,2008,NR,,0,,,,,
pseudodiploid genome organization aids full-length human immunodeficiency virus type 1 dna synthesis,King SR,,2008,NR,,0,,,,,
malignancies in hiv: the indian scenario,Dhir AA,10.1097/CCO.0b013e32830a4c87,2008,NR,,0,,,,,
mapping mental number line in physical space: vertical and horizontal visual number line orientation in asymptomatic individuals with hiv,Bogdanova Y,10.1016/j.neuropsychologia.2008.05.029,2008,NR,,0,,,,,
maternal hiv status and pregnancy outcomes in northeastern tanzania: a registry-based study,Habib NA,10.1111/j.1471-0528.2008.01672.x,2008,NR,,0,,,,,
maternal hla homozygosity and mother-child hla concordance increase the risk of vertical transmission of hiv-1,Mackelprang RD,10.1086/529528,2008,NR,,0,,,,,
rates of hiv immune escape and reversion: implications for vaccination,Davenport MP,10.1016/j.tim.2008.09.001,2008,NR,,0,,,,,
on the origin of hiv-1 subtype c in south america,Fontella R,10.1097/QAD.0b013e3283108f69,2008,NR,,0,,,,,
national survey of prevalent hiv strains: limited genetic variation of korean hiv-1 clade b within the population of korean men who have sex with men,Kim GabJung,10.1097/QAI.0b013e31816b6ae6,2008,NR,,0,,,,,
origin and evolutionary history of hiv-1 subtype c in brazil,Bello G,10.1097/QAD.0b013e328315e0aa,2008,NR,,0,,,,,
only five of 10 strictly conserved disulfide bonds are essential for folding and eight for function of the hiv-1 envelope glycoprotein,van Anken E,10.1091/mbc.E07-12-1282,2008,NR,,0,,,,,
parents know and parents matter; is it time to develop family-based hiv prevention programs for young men who have sex with men?,Garofalo,10.1016/j.jadohealth.2008.01.017,2008,NR,,0,,,,,
phylogenetic investigation of transmission pathways of drug-resistant hiv-1 utilizing pol sequences derived from resistance genotyping,Kaye M,10.1097/QAI.0b013e318180c8af,2008,NR,,0,,,,,
"polymorphism, recombination, and mutations in hiv type 1 gag-infecting peruvian male sex workers",Yabar CA,10.1089/aid.2008.0130,2008,NR,,0,,,,,
predicting anti-hiv-1 activity of 6-arylbenzonitriles: computational approach using superaugmented eccentric connectivity topochemical indices,Dureja H,,2008,NR,,0,,,,,
"prevalence of reverse transcriptase and protease mutations associated with antiretroviral drug resistance among drug-naive hiv-1 infected pregnant women in kagera and kilimanjaro regions, tanzania",Nyombi BM,10.1186/1742-6405-5-13,2008,NR,,0,,,,,
prevention of hiv/aids among injecting drug users in russia: opportunities and barriers to scaling-up of harm reduction programmes,Tkatchenko-Schmidt E,10.1016/j.healthpol.2007.07.005,2008,NR,,0,,,,,
protocol for nearly full-length sequencing of hiv-1 rna from plasma,Nadai Y,10.1371/journal.pone.0001420,2008,NR,,0,,,,,
profile of primary resistance in hiv-1-infected treatment-naive individuals from western india,Lall M,10.1089/aid.2008.0079,2008,NR,,0,,,,,
rapid spread and genetic diversification of hiv type 1 subtype c in a rural area of southern mozambique,Lahuerta M,10.1089/aid.2007.0134,2008,NR,,0,,,,,
psychosocial predictors of hiv-associated sexual behaviors and the efficacy of prevention interventions in adolescents at-risk for hiv infection: what works and what doesn't work?,Diclemente RJ,10.1097/PSY.0b013e3181775edb,2008,NR,,0,,,,,
reappearance of an 11-year-old sequence in an hiv-1 infected patient during treatment interruption,Madsen TV,,2008,NR,,0,,,,,
"molecular characterization of hiv type 1 bf pol recombinants from sao paulo, brazil",De Souza ACMF,10.1089/aid.2008.0089,2008,NR,,0,,,,,
"recent diversity of human immunodeficiency virus type 1 in individuals who visited sexually transmitted infection-related clinics in osaka, japan",Kojima Y,10.1007/s10156-007-0579-7,2008,NR,,0,,,,,
strand transfer events during hiv-1 reverse transcription,Basu VP,10.1016/j.virusres.2007.12.017,2008,NR,,0,,,,,
"patients' attitudes about rapid oral hiv screening in an urban, free dental clinic",Dietz CA,10.1089/apc.2007.0235,2008,NR,,0,,,,,
role of the 5' tar stem--loop and the u5-aug duplex in dimerization of hiv-1 genomic rna,Song R,10.1021/bi7023173,2008,NR,,0,,,,,
cytotoxic t lymphocyte responses in hiv-1-infected long-term nonprogressors: lessons for vaccine design,Navis M,10.2217/17469600.2.4.351,2008,NR,,0,,,,,
a phase 1 study to evaluate the safety and immunogenicity of a recombinant hiv type 1 subtype c adeno-associated virus vaccine,Mehendale S,10.1089/aid.2007.0292,2008,NR,,0,,,,,
"safety, pharmacokinetics, and antiviral activity of hgs004, a novel fully human igg4 monoclonal antibody against ccr5, in hiv-1-infected patients",Lalezari J,10.1086/527327,2008,NR,,0,,,,,
"risk behaviour, sexually transmitted infections and hiv among long-distance truck drivers: a cross-sectional survey along national highways in india",Pandey A,10.1097/01.aids.0000343766.00573.15,2008,NR,,0,,,,,
"risk behaviour, sexually transmitted infections and hiv among long-distance truck drivers: a cross-sectional survey along national highways in india (special issue: characterizing the indian hiv epidemic and assessing large-scale prevention efforts - avahan)",Arvind Pandey,10.1097/01.aids.0000343766.00573.15,2008,NR,,0,,,,,
service utilization and cognitive complaints in adults with hiv: results from a statewide survey,Okonkwo,10.1080/15381500802006771,2008,NR,,0,,,,,
risky sexual behaviour in context: qualitative results from an investigation into risk factors for seroconversion among gay men who test for hiv,Elam,10.1136/sti.2008.031468,2008,NR,,0,,,,,
situational predictors of sexual risk episodes among men with hiv who have sex with men,Wilson PA,10.1136/sti.2008.031583,2008,NR,,0,,,,,
the surrogate marker and its discontents: pluralism in immunity maintenance among hiv-infected persons in taiwan,Lew-Ting CY,10.1111/j.1467-9566.2008.01107.x,2008,NR,,0,,,,,
"sexual diversity, social inclusion and hiv/aids (taking the leap - leadership, equity, accountability and partnerships - in a world living with aids)",Caceres,,2008,NR,,0,,,,,
sexually transmitted infection/hiv risk reduction interventions in clinical practice settings,Jemmott LS,10.1111/j.1552-6909.2008.00221.x,2008,NR,,0,,,,,
short communication: the number of hiv major nrti mutations correlates directly with other antiretroviral-associated mutations and indirectly with replicative capacity and reduced drug susceptibility,Ross L,10.1089/aid.2007.0188,2008,NR,,0,,,,,
the achilles heel of the trojan horse model of hiv-1 trans-infection,Cavrois M,10.1371/journal.ppat.1000051,2008,NR,,0,,,,,
subtype assignment and phylogenetic analysis of hiv type 1 strains in patients from swaziland,Deho L,10.1089/aid.2007.0233,2008,NR,,0,,,,,
transmission of hiv-1 gag immune escape mutations is associated with reduced viral load in linked recipients,Goepfert PA,10.1084/jem.20072457,2008,NR,,0,,,,,
the challenge of hiv-1 subtype diversity,Taylor BS,10.1056/NEJMra0706737,2008,NR,,0,,,,,
transmission of human immunodeficiency virus type 1 from a patient who developed aids to an elite suppressor,Bailey JR,10.1128/JVI.00800-08,2008,NR,,0,,,,,
the hiv type 1 epidemic in bulgaria involves multiple subtypes and is sustained by continuous viral inflow from west and east european countries,Salemi M,10.1089/aid.2007.0181,2008,NR,,0,,,,,
the human immunodeficiency virus type 1 envelope confers higher rates of replicative fitness to perinatally transmitted viruses than to nontransmitted viruses,Kong X,10.1128/JVI.00952-08,2008,NR,,0,,,,,
the impact on orchid species abundance of gathering their edible tubers by hiv/aids orphans: a case of three villages in the southern highlands of tanzania (special issue: impacts of hiv/aids on agriculture and livelihood of rural households in sub-saharan africa),Challei,,2008,NR,,0,,,,,
the need for sociocultural awareness to maximize treatment acceptance and adherence in individuals initiating hiv therapy (special issue: the changing face of hiv),Willard,10.1177/1545109708315404,2008,NR,,0,,,,,
the number of hiv major nrti mutations correlates directly with other antiretroviral-associated mutations and indirectly with replicative capacity and reduced drug susceptibility,Ross L,10.1089/aid.2007.0188,2008,NR,,0,,,,,
the paradoxical effects of using antiretroviral-based microbicides to control hiv epidemics,Wilson DP,10.1073/pnas.0711813105,2008,NR,,0,,,,,
the specificity and polymorphism of the mhc class i prevents the global adaptation of hiv-1 to the monomorphic proteasome and tap,Schmid BV,10.1371/journal.pone.0003525,2008,NR,,0,,,,,
transmission of hiv-1 infection due to a fist fight,Emerson CR,10.1258/ijsa.2007.007156,2008,NR,,0,,,,,
"transmission cluster of multiclass highly drug-resistant hiv-1 among 9 men who have sex with men in seattle/king county, wa, 2005-2007",Buskin SE,10.1097/QAI.0b013e318185727e,2008,NR,,0,,,,,
transmission of hiv-1 ctl escape variants provides hla-mismatched recipients with a survival advantage,Chopera DR,10.1371/journal.ppat.1000033,2008,NR,,0,,,,,
viral evolution and escape during primary human immunodeficiency virus-1 infection: implications for vaccine design,Mullins JI,10.1097/COH.0b013e3282f233d9,2008,NR,,0,,,,,
using an online survey to assess knowledge of hiv in general and testing specifically among black and white college students,Hou S-I,10.1016/S0027-9684(15)31377-8,2008,NR,,0,,,,,
viral complementation allows hiv-1 replication without integration,Gelderblom HC,10.1186/1742-4690-5-60,2008,NR,,0,,,,,
"high prevalence of genetically similar hiv-1 recombinants among infected sex workers in nairobi, kenya",Land,10.1089/aid.2008.0179,2008,NR,,0,,,,,
understanding why gay men seek hiv-seroconcordant partners: intimacy and risk reduction motivations,Frost DM,10.1080/13691050801905631,2008,NR,,0,,,,,
viral evolution and escape during primary human immunodeficiency virus-1 infection: implications for vaccine design (special issue: primary hiv infection),Mullins,10.1097/COH.0b013e3282f233d9,2008,NR,,0,,,,,
"unique cryptosporidium population in hiv-infected persons, jamaica",Gatei W,10.3201/eid1405.071277,2008,NR,,0,,,,,
hiv postexposure prophylaxis use among ontario female adolescent sexual assault victims: a prospective analysis,Mont,,2008,NR,,0,,,,,
viral characteristics of transmitted hiv (special issue: primary hiv infection),Derdeyn,10.1097/COH.0b013e3282f2982c,2008,NR,,0,,,,,
"women's perceptions and experiences of hiv prevention trials in soweto, south africa",Stadler JJ,10.1016/j.socscimed.2007.08.021,2008,NR,,0,,,,,
"young people's sexual partnerships in kwazulu-natal, south africa: patterns, contextual influences, and hiv risk",Harrison A,10.1111/j.1728-4465.2008.00176.x,2008,NR,,0,,,,,
"vulnerability, gender and ""proxy negativity"": women in relationships with hiv-positive men in australia",Persson,10.1016/j.socscimed.2008.05.010,2008,NR,,0,,,,,
conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic hiv-1 subtype c infection,Bandawe GP,10.1186/1743-422X-5-141,2008,NR,,0,,,,,
"""it's hard to change something when you don't know where to start"": unpacking hiv vulnerability with aboriginal youth in canada",Flicker,,2007,NR,,0,,,,,
"""life is still going on"": reproductive intentions among hiv-positive women and men in south africa",Cooper D,10.1016/j.socscimed.2007.03.019,2007,NR,,0,,,,,
"""unconventional"" neutralizing activity of antibodies against hiv",Wen M,,2007,NR,,0,,,,,
a model of directional selection applied to the evolution of drug resistance in hiv-1,Seoighe C,,2007,NR,,0,,,,,
"acceptance of hiv-1 education & voluntary counselling/testing by & seroprevalence of hiv-1 among, pregnant women in rural south india",Samuel NM,,2007,NR,,0,,,,,
"a multi-vector, multi-envelope hiv-1 vaccine",Hurwitz JL,10.5863/1551-6776-12.2.68,2007,NR,,0,,,,,
amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across hiv-1 variants,Holguin A,,2007,NR,,0,,,,,
an outbreak of hiv-1 subtype g among italian injecting drug users,Ciccozzi M,10.1097/QAD.0b013e32813aee1a,2007,NR,,0,,,,,
aberrant life cycle of human immunodeficiency virus type 1 crf15_01b-like clinical isolates from thailand in human cd4+ t-cell lines,Warachit J,10.1016/j.micinf.2007.01.003,2007,NR,,0,,,,,
abstinence-only programs for hiv infection prevention in high-income countries,Underhill K,10.1002/14651858.CD005421.pub2,2007,NR,,0,,,,,
applying the transtheoretical model to ethnically diverse women at risk for hiv,Gazabon SA,10.1177/1090198105285328,2007,NR,,0,,,,,
an allosteric rheostat in hiv-1 gp120 reduces ccr5 stoichiometry required for membrane fusion and overcomes diverse entry limitations,Platt EJ,,2007,NR,,0,,,,,
analysis of hiv-1 crf07_bc gag p6 sequences indicating novel deletions in the central region of p6,Song YH,,2007,NR,,0,,,,,
capturing viral diversity for in-vitro test reagents and hiv vaccine immunogen design,Brander C,10.1097/COH.0b013e3280f3bfe2,2007,NR,,0,,,,,
centralized hiv-1 envelope immunogens and neutralizing antibodies,Gao F,10.2174/157016207782418498,2007,NR,,0,,,,,
"characterization of hiv type 1 reverse transcriptase mutations in infants infected by mothers who received peripartum nevirapine prophylaxis in jos, nigeria",Ojesina AI,,2007,NR,,0,,,,,
comparative study of methods for detecting sequence compartmentalization in human immunodeficiency virus type 1,Zarate S,,2007,NR,,0,,,,,
"buenos aires cohort of men who have sex with men: prevalence, incidence, risk factors, and molecular genotyping of hiv type 1",Segura M,10.1089/aid.2007.0063,2007,NR,,0,,,,,
clinical mitochondrial dysfunction in uninfected children born to hiv-infected mothers following perinatal exposure to nucleoside analogues,Benhammou V,10.1002/em.20279,2007,NR,,0,,,,,
clinical resistance to enfuvirtide does not affect susceptibility of human immunodeficiency virus type 1 to other classes of entry inhibitors,Ray N,,2007,NR,,0,,,,,
challenges and processes of selecting outcome measures for the nimh collaborative hiv/std prevention trial,Caceres CF,10.1097/01.aids.0000266455.03397.08,2007,NR,,0,,,,,
challenges and processes of selecting outcome measures for the nimh collaborative hiv/std prevention trial (special issue: nimh collaborative hiv/std prevention trial),Griensven,,2007,NR,,0,,,,,
characterization of near full-length genomes of hiv type 1 strains in denmark: basis for a universal therapeutic vaccine,Andresen BS,10.1089/aid.2007.0111,2007,NR,,0,,,,,
clade specific neutralising vaccines for hiv: an appropriate target?,McKnight A,10.2174/157016207782418524,2007,NR,,0,,,,,
cytidine deaminases apobec3g and apobec3f interact with human immunodeficiency virus type 1 integrase and inhibit proviral dna formation,Luo K,,2007,NR,,0,,,,,
"demographic correlates of hiv testing, high-risk behaviors, and condom/ std consultation among a multi-ethnic sample of women",Brown NC,10.1300/J013v46n02_05,2007,NR,,0,,,,,
description of the first full-length hiv type 1 subtype f1 strain in argentina: implications for the origin and dispersion of this subtype in south america,Aulicino PC,,2007,NR,,0,,,,,
design and characterization of an engineered gp41 protein from human immunodeficiency virus-1 as a tool for drug discovery,Stewart KD,,2007,NR,,0,,,,,
compartmentalization of the gut viral reservoir in hiv-1 infected patients,van Marle G,,2007,NR,,0,,,,,
"disentangling the stigma of hiv/aids from the stigmas of drugs use, commercial sex and commercial blood donation - a factorial survey of medical students in china",Chan KY,10.1186/1471-2458-7-280,2007,NR,,0,,,,,
conserved residue lys574 in the cavity of hiv-1 gp41 coiled-coil domain is critical for six-helix bundle stability and virus entry,He Y,,2007,NR,,0,,,,,
coping with viral diversity in hiv vaccine design,Nickle DC,,2007,NR,,0,,,,,
cornering hiv: taking advantage of interactions between selective pressures,Avila-Rios S,,2007,NR,,0,,,,,
correlates of suicidal ideation among hiv-positive persons,Carrico AW,10.1097/QAD.0b013e3281532c96,2007,NR,,0,,,,,
drug resistance in plasma and breast milk after single-dose nevirapine in subtype c hiv type 1: population and clonal sequence analysis,Kassaye S,,2007,NR,,0,,,,,
effects of a behavioral intervention to reduce risk of transmission among people living with hiv: the healthy living project randomized controlled study,Morin SF,10.1097/QAI.0b013e31802c0cae,2007,NR,,0,,,,,
emerging trends of hiv epidemiology in asia,Lau KA,,2007,NR,,0,,,,,
"genetic characterization of crf01_ae full-length human immunodeficiency virus type 1 sequences from fujian, china",Hai-Long H,,2007,NR,,0,,,,,
"complete genome sequencing of a non-syncytium-inducing hiv type 1 subtype d strain from cape town, south africa",Jacobs GB,,2007,NR,,0,,,,,
virion packaging determinants and reverse transcription of srp rna in hiv-1 particles,Tian C,,2007,NR,,0,,,,,
hla alleles associated with slow progression to aids truly prefer to present hiv-1 p24,Borghans JA,,2007,NR,,0,,,,,
regulated degradation of the hiv-1 vpu protein through a betatrcp-independent pathway limits the release of viral particles,Estrabaud E,,2007,NR,,0,,,,,
evidence of differential hla class i-mediated viral evolution in functional and accessory/regulatory genes of hiv-1,Brumme ZL,,2007,NR,,0,,,,,
"regulation of htlv-1 gag budding by vps4a, vps4b, and aip1/alix",Urata S,,2007,NR,,0,,,,,
compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant hla-b*5703-restricted gag epitope in chronic human immunodeficiency virus type 1 infection,Crawford H,,2007,NR,,0,,,,,
brain-derived human immunodeficiency virus-1 tat exerts differential effects on ltr transactivation and neuroimmune activation,Boven LA,,2007,NR,,0,,,,,
diversity of hiv-1 rna and dna in breast milk from hiv-1-infected mothers,Becquart P,10.1016/j.virol.2007.02.003,2007,NR,,0,,,,,
survey of the temporal changes in hiv-1 replicative fitness in the amsterdam cohort,Gali Y,,2007,NR,,0,,,,,
lentiviral vectors encoding hiv-1 polyepitopes induce broad ctl responses in vivo,Iglesias MC,,2007,NR,,0,,,,,
relative fitness and replication capacity of a multinucleoside analogue-resistant clinical human immunodeficiency virus type 1 isolate with a deletion of codon 69 in the reverse transcriptase coding region,Villena C,,2007,NR,,0,,,,,
dec-205 receptor on dendritic cells mediates presentation of hiv gag protein to cd8+ t cells in a spectrum of human mhc i haplotypes,Bozzacco L,,2007,NR,,0,,,,,
polyvalent vaccines for optimal coverage of potential t-cell epitopes in global hiv-1 variants,Fischer W,,2007,NR,,0,,,,,
precise identification of a human immunodeficiency virus type 1 antigen processing mutant,Zimbwa P,,2007,NR,,0,,,,,
extremely rapid spread of human immunodeficiency virus type 1 bf recombinants in argentina,Aulicino PC,,2007,NR,,0,,,,,
economic stress and hiv-associated health care utilization in a rural region of china: a qualitative study,Xu J,10.1089/apc.2007.0005,2007,NR,,0,,,,,
"genetic diversity and drug resistance mutations in hiv type 1 from untreated patients in bamako, mali",Derache A,,2007,NR,,0,,,,,
global epidemiology of hiv-aids,Abdool Karim SS,10.1016/j.idc.2007.01.010,2007,NR,,0,,,,,
hiv protease resistance and viral fitness,Nijhuis M,10.1097/COH.0b013e32801682f6,2007,NR,,0,,,,,
"hiv risk behavior among injection drug users in tehran, iran",Razani N,,2007,NR,,0,,,,,
hiv risk behaviors among rural stimulant users: variation by gender and race/ethnicity,Wright PB,10.1521/aeap.2007.19.2.137,2007,NR,,0,,,,,
evaluation of the effect of a health education campaign of hiv by using an analytical hierarchy process method,Tan X,10.3390/ijerph2007030010,2007,NR,,0,,,,,
hiv type 1 drug resistance among naive patients from venezuela,Bouchard M,10.1089/aid.2006.0219,2007,NR,,0,,,,,
hiv viral diversity and escape from cellular immunity,Frahm N,10.1007/s11908-007-0012-5,2007,NR,,0,,,,,
hiv-1 ctl-based vaccine immunogen selection: antigen diversity and cellular response features,Li F,10.2174/157016207779316260,2007,NR,,0,,,,,
"exposure to mtv's global hiv prevention campaign in kathmandu, nepal; sao paulo, brazil; and dakar, senegal",Geary CW,10.1521/aeap.2007.19.1.36,2007,NR,,0,,,,,
extensive cross-reactive neutralizing antibody response in indian patients with limited genetic diversity of hiv-1,Lakhashe SK,,2007,NR,,0,,,,,
feasibility of assessing autonomic dysregulation at a distance: the case of the hiv-positive patient,Malacarne,10.1089/tmj.2006.0092,2007,NR,,0,,,,,
hiv-1 subtype a envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry,Blish CA,,2007,NR,,0,,,,,
impact of human immunodeficiency virus (hiv) subtypes on hiv-associated neurological disease,Liner,10.1080/13550280701422383,2007,NR,,0,,,,,
genetic diversity of hiv type 1 subtype c env gene sequences from india,Khan IF,,2007,NR,,0,,,,,
"hiv/aids morbidity/mortality, access to social support and household utilization of natural resources in ngamiland, botswana",Ngwenya,,2007,NR,,0,,,,,
hla-b bw4 alleles and hiv-1 transmission in heterosexual couples,Welzel TM,10.1097/QAD.0b013e3280123840,2007,NR,,0,,,,,
"human immunodeficiency virus type 1 drug resistance mutations in peripheral blood mononuclear cell proviral dna among antiretroviral treatment-naive and treatment-experienced patients from pune, india",Sen S,,2007,NR,,0,,,,,
"heterogeneous response to haart across a diverse population of people living with hiv: results from the anrs-en12-vespa study (living with hiv: recent research from france and the french caribbean (vespa study), australia, canada and the united kingdom)",Dray-Spira,10.1097/01.aids.0000255079.39352.9b,2007,NR,,0,,,,,
high genetic variability of hiv-1 in female sex workers from argentina,Pando MA,10.1186/1742-4690-4-58,2007,NR,,0,,,,,
isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors,Blankson JN,,2007,NR,,0,,,,,
identification of 3 phylogenetically related hiv-1 bg intersubtype circulating recombinant forms in cuba,Sierra M,,2007,NR,,0,,,,,
hiv type 1 diversity in the seychelles,Razafindratsimandresy R,10.1089/aid.2007.0002,2007,NR,,0,,,,,
"hiv type 1 genetic diversity surveillance among newly diagnosed individuals from 2003 to 2005 in buenos aires, argentina",Dilernia DA,,2007,NR,,0,,,,,
hiv type 1 genetic variability in central brazil,Veras NM,,2007,NR,,0,,,,,
hiv type 1 subtype c gag and nef diversity in southern africa,Bredell H,10.1089/aid.2006.0232,2007,NR,,0,,,,,
macrophages transmit human immunodeficiency virus type 1 products to cd4-negative cells: involvement of matrix metalloproteinase 9,Muratori C,,2007,NR,,0,,,,,
increased genetic diversity and intersubtype recombinants of hiv-1 in blood donors from urban cameroon [2],Machuca A,10.1097/QAI.0b013e318053754c,2007,NR,,0,,,,,
maintenance of nef-mediated modulation of major histocompatibility complex class i and cd4 after sexual transmission of human immunodeficiency virus type 1,Noviello CM,,2007,NR,,0,,,,,
hiv-1 protease catalytic efficiency effects caused by random single amino acid substitutions,Parera M,,2007,NR,,0,,,,,
insights on the role of nucleic acid/protein interactions in chaperoned nucleic acid rearrangements of hiv-1 reverse transcription,Liu H-W,10.1073/pnas.0700166104,2007,NR,,0,,,,,
hiv-1 vpr potently induces programmed cell death in the cns in vivo,Cheng X,,2007,NR,,0,,,,,
introduction of hiv type 1 into an isolated population: molecular epidemiologic study from greenland,Madsen TV,,2007,NR,,0,,,,,
hiv/aids in pakistan: the battle begins,Rai MA,,2007,NR,,0,,,,,
"identification and characterization of previously described epitopes in hiv-1 subtypes b, c, f and bf in brazil",Queiroz,10.1590/S1413-86702007000100008,2007,NR,,0,,,,,
impaired reinnervation in hiv infection following experimental denervation,Hahn K,10.1212/01.wnl.0000261245.36884.7c,2007,NR,,0,,,,,
implementing a second-generation hiv surveillance system in romania: experiences and challenges,Lejars M,10.1007/s00508-007-0775-6,2007,NR,,0,,,,,
medication adherence and sexual risk behavior among hiv-infected adults: implications for transmission of resistant virus,Remien RH,,2007,NR,,0,,,,,
increasing hiv-1 genetic diversity in europe,Thomson MM,10.1086/521683,2007,NR,,0,,,,,
modeling within-host hiv-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibility,Rong L,,2007,NR,,0,,,,,
molecular basis of antagonism between k70e and k65r tenofovir-associated mutations in hiv-1 reverse transcriptase,Kagan RM,,2007,NR,,0,,,,,
molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed hiv-1 patients in portugal,Palma,10.1016/j.meegid.2007.01.009,2007,NR,,0,,,,,
investigation of finite-pulse radiofrequency-driven recoupling methods for measurement of intercarbonyl distances in polycrystalline and membrane-associated hiv fusion peptide samples,Zheng Z,10.1002/mrc.2160,2007,NR,,0,,,,,
is hiv-1 evolving to a less virulent form in humans?,Arien KK,10.1038/nrmicro1594,2007,NR,,0,,,,,
"molecular epidemiology of hiv type 1 in inner rio de janeiro state, brazil",Eyer-Silva WA,10.1089/aid.2006.0199,2007,NR,,0,,,,,
"living positively: narrative strategies of women living with hiv in cape town, south africa",Levy JM,10.1080/13648470601106343,2007,NR,,0,,,,,
longitudinal analysis of hiv type 1 subtype c envelope sequences from south africa,Coetzer M,10.1089/aid.2006.0207,2007,NR,,0,,,,,
"mtv's ""staying alive"" global campaign promoted interpersonal communication about hiv and positive beliefs about hiv prevention",Geary CW,10.1521/aeap.2007.19.1.51,2007,NR,,0,,,,,
rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution,Li B,,2007,NR,,0,,,,,
natural variation in the v3 crown of human immunodeficiency virus type 1 affects replicative fitness and entry inhibitor sensitivity,Lobritz MA,,2007,NR,,0,,,,,
"modeling within-host evolution of hiv: mutation, competition and strain replacement",Ball CL,10.1007/s11538-007-9223-z,2007,NR,,0,,,,,
negotiating cultures: disclosure of hiv-positive status among people from minority ethnic communities in sydney,Korner H,10.1080/13691050600975462,2007,NR,,0,,,,,
neutralizing and other antiviral antibodies in hiv-1 infection and vaccination,Montefiori DC,10.1097/COH.0b013e3280ef691e,2007,NR,,0,,,,,
selective pressures of human immunodeficiency virus type 1 (hiv-1) during pediatric infection,Leal E,,2007,NR,,0,,,,,
pasha: facilitating the replication and use of effective adolescent pregnancy and sti/hiv prevention programs,Card JJ,10.1016/j.jadohealth.2006.10.004,2007,NR,,0,,,,,
phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1,Gifford RJ,,2007,NR,,0,,,,,
phenotype and envelope gene diversity of nef-deleted hiv-1 isolated from long-term survivors infected from a single source,Gray L,,2007,NR,,0,,,,,
polymorphisms and resistance mutations in the protease and reverse transcriptase genes of hiv-1 f subtype romanian strains,Paraschiv S,10.1016/j.ijid.2005.11.006,2007,NR,,0,,,,,
potent activity of the hiv-1 maturation inhibitor bevirimat in scid-hu thy/liv mice,Stoddart CA,,2007,NR,,0,,,,,
plasma viral load threshold for sustaining intrahost hiv type 1 evolution,Bello,10.1089/aid.2007.0074,2007,NR,,0,,,,,
polymorphisms of cul5 are associated with cd4+ t cell loss in hiv-1 infected individuals,An P,10.1371/journal.pgen.0030019,2007,NR,,0,,,,,
prevalence and genetic diversity of hiv type 1 subtypes a and d in women attending antenatal clinics in uganda,Herbeck JT,10.1089/aid.2006.0237.A,2007,NR,,0,,,,,
"prevalence of drug-resistant and nonsubtype b hiv strains in antiretroviral-naive, hiv-infected individuals in new york state",Parker MM,10.1089/apc.2006.0172,2007,NR,,0,,,,,
"primary hiv infection, phylogenetics, and antiretroviral prevention",Pillay D,10.1086/512090,2007,NR,,0,,,,,
probing nonnucleoside inhibitor-induced active-site distortion in hiv-1 reverse transcriptase by transient kinetic analyses,Xia Q,,2007,NR,,0,,,,,
protein design of a bacterially expressed hiv-1 gp41 fusion inhibitor,Deng Y,,2007,NR,,0,,,,,
psychosocial health problems increase risk for hiv among urban young men who have sex with men: preliminary evidence of a syndemic in need of attention,Mustanski B,10.1007/BF02879919,2007,NR,,0,,,,,
the impact of viral and host elements on hiv fitness and disease progression,Henry KR,10.1007/s11904-007-0006-9,2007,NR,,0,,,,,
hiv-1 strains identified in brazilian blood donors: significant prevalence of b/f1 recombinants,Brennan CA,10.1089/aid.2007.0121,2007,NR,,0,,,,,
novel 2-chloro-8-arylthiomethyldipyridodiazepinone derivatives with activity against hiv-1 reverse transcriptase,Khunnawutmanotham N,10.3390/12020218,2007,NR,,0,,,,,
attitudes and perceptions of aids clinical trials group site coordinators on hiv clinical trial recruitment and retention: a descriptive study,King WD,10.1089/apc.2006.0173,2007,NR,,0,,,,,
hiv-1 over time: fitness loss or robustness gain?,Rolland M,10.1038/nrmicro1594-c1,2007,NR,,0,,,,,
roles of hiv-1 env variable regions in viral neutralization and vaccine development,Pinter A,10.2174/157016207782418470,2007,NR,,0,,,,,
outcomes from a group intervention for coping with hiv/aids and childhood sexual abuse: reductions in traumatic stress,Sikkema KJ,10.1007/s10461-006-9149-8,2007,NR,,0,,,,,
"detection of intersubtype recombinants with respect to env and nef genes of hiv-1 among female sex workers in calcutta, india",Bhanja P,10.1016/j.virusres.2007.06.013,2007,NR,,0,,,,,
clinical significance of human immunodeficiency virus type 1 replication fitness,Dykes C,10.1128/CMR.00017-07,2007,NR,,0,,,,,
"genetic diversity of hiv-1 non-b strains in sicily: evidence of intersubtype recombinants by sequence analysis of gag, pol, and env genes",Tramuto F,10.1089/aid.2007.0031,2007,NR,,0,,,,,
a novel internally controlled real-time reverse transcription-pcr assay for hiv-1 rna targeting the pol integrase genomic region,Muller J,10.1016/j.jviromet.2007.01.013,2007,NR,,0,,,,,
the community popular opinion leader hiv prevention programme: conceptual basis and intervention procedures,Caceres CF,10.1097/01.aids.0000266458.49138.fa,2007,NR,,0,,,,,
examining hiv/aids provider stigma: assessing regional concerns in the islands of the eastern caribbean,Abell N,10.1080/09540120600774297,2007,NR,,0,,,,,
ctl response to hiv type 1 subtype c is poorly predicted by known epitope motifs,Ngandu NG,10.1089/aid.2007.0024,2007,NR,,0,,,,,
new insights into the formation of hiv-1 reverse transcription initiation complex,Barraud P,10.1016/j.biochi.2007.01.016,2007,NR,,0,,,,,
rna and dna binding properties of hiv-1 vif protein: a fluorescence study,Bernacchi S,10.1074/jbc.M703122200,2007,NR,,0,,,,,
"affect regulation, stimulant use, and viral load among hiv-positive persons on anti-retroviral therapy",Carrico AW,10.1097/PSY.0b013e318157b142,2007,NR,,0,,,,,
sensitive oligonucleotide ligation assay for low-level detection of nevirapine resistance mutations in human immunodeficiency virus type 1 quasispecies,Lalonde MS,,2007,NR,,0,,,,,
start talking about risks: development of a motivational interviewing-based safer sex program for people living with hiv,Golin CE,10.1007/s10461-007-9256-1,2007,NR,,0,,,,,
"sexuality, vulnerability to hiv, and mental health: an ethnographic study of psychiatric institutions",Pinto,10.1590/S0102-311X2007000900030,2007,NR,,0,,,,,
"synthesis of novel derivatives of 4-amino-3-(2-furyl)-5-mercapto-1,2,4- triazole as potential hiv-1 nnrtis",Wu J,10.3390/12082003,2007,NR,,0,,,,,
systematic evaluation of allele-specific real-time pcr for the detection of minor hiv-1 variants with pol and env resistance mutations,Paredes R,,2007,NR,,0,,,,,
"the emergence of hiv transmitted resistance in botswana: ""when will the who detection threshold be exceeded?""",Vardavas R,10.1371/journal.pone.0000152,2007,NR,,0,,,,,
the emergence of hiv/aids in the americas and beyond,Gilbert MT,,2007,NR,,0,,,,,
the feasibility of hiv vaccine efficacy trials among russian injection drug users,Beyrer C,10.1016/j.vaccine.2007.07.028,2007,NR,,0,,,,,
the fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions,Cong ME,,2007,NR,,0,,,,,
the inner nuclear envelope as a transcription factor resting place,Heessen S,10.1038/sj.embor.7401075,2007,NR,,0,,,,,
the probable source of both the primary multidrug-resistant (mdr) hiv-1 strain found in a patient with rapid progression to aids and a second recombinant mdr strain found in a chronically hiv-1-infected patient,Blick G,,2007,NR,,0,,,,,
the stress moderating role of benefit finding on psychological distress and well-being among women living with hiv/aids,Siegel K,10.1007/s10461-006-9186-3,2007,NR,,0,,,,,
"trends in evaluation for sexually transmitted infections among hiv-infected people, king county, washington",Kahle E,,2007,NR,,0,,,,,
twenty years of prospective molecular epidemiology in senegal: changes in hiv diversity,Hamel DJ,10.1089/aid.2007.0037,2007,NR,,0,,,,,
unequal evolutionary rates in the human immunodeficiency virus type 1 (hiv-1) pandemic: the evolutionary rate of hiv-1 slows down when the epidemic rate increases,Berry IM,10.1128/JVI.00985-07,2007,NR,,0,,,,,
update: human papillomavirus infection remains highly prevalent and persistent among hiv-infected individuals,Kojic,10.1097/CCO.0b013e3282c8c84c,2007,NR,,0,,,,,
teens in the twenty-first century still prefer people over machines: importance of intervention delivery style in adolescent hiv/std prevention,Pendleton,10.1300/J499v08n02_06,2007,NR,,0,,,,,
short-term effects of a peer group intervention for hiv prevention among trainee teachers in malawi,Norr,10.2989/16085900709490420,2007,NR,,0,,,,,
what do young adults expect when they go online? lessons for development of an std/hiv and pregnancy prevention website,Bull SS,10.1007/s10916-006-9050-z,2007,NR,,0,,,,,
the community popular opinion leader hiv prevention programme: conceptual basis and intervention procedures (special issue: nimh collaborative hiv/std prevention trial),Griensven,,2007,NR,,0,,,,,
why are children still being infected with hiv? experiences in the prevention of mother-to-child transmission of hiv in south london,McDonald,10.1136/sti.2006.021535,2007,NR,,0,,,,,
willingness to participate in hiv vaccine trials: the impact of trial attributes,Newman PA,10.1016/j.ypmed.2006.12.007,2007,NR,,0,,,,,
wild mouse variants of envelope genes of xenotropic/polytropic mouse gammaretroviruses and their xpr1 receptors elucidate receptor determinants of virus entry,Yan Y,,2007,NR,,0,,,,,
a fuzzy discrete event system approach to determining optimal hiv/aids treatment regimens,Ying H,,2006,NR,,0,,,,,
a population-based approach to determine the prevalence of transmitted drug-resistant hiv among recent versus established hiv infections: results from the canadian hiv strain and drug resistance surveillance program,Jayaraman GC,,2006,NR,,0,,,,,
a randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant hiv: 48-week virologic results of actg a5086,Benson CA,,2006,NR,,0,,,,,
a sensitive in-house rt-pcr genotyping system for combined detection of plasma hiv-1 and assessment of drug resistance,Steegen K,,2006,NR,,0,,,,,
"a six-month, supervised, aerobic and resistance exercise program improves self-efficacy in people with human immunodeficiency virus: a randomised controlled trial",Fillipas S,,2006,NR,,0,,,,,
absence of detectable viremia in a perinatally hiv-1-infected teenager after discontinuation of antiretroviral therapy,Feeney,10.1016/j.jaci.2006.05.016,2006,NR,,0,,,,,
"adapting efficacious interventions: advancing translational research in hiv prevention (special issue: translation issues in prevention and treatment research, part 2)",Solomon,10.1177/0163278706287344,2006,NR,,0,,,,,
an adenovirus-based hiv subtype b prime/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype b hiv strains,Gomez-Roman VR,10.1097/01.qai.0000230318.40170.60,2006,NR,,0,,,,,
"a qualitative assessment of long distance truck drivers' vulnerability to hiv/aids in itajai, southern brazil",Malta M,10.1080/09540120500235241,2006,NR,,0,,,,,
"antiretroviral therapy and congenital abnormalities in infants born to hiv-1-infected women in the united kingdom and ireland, 1990 to 2003",Townsend CL,10.1097/01.qai.0000196667.24239.c2,2006,NR,,0,,,,,
adaptation to different human populations by hiv-1 revealed by codon-based analyses,Kosakovsky Pond SL,10.1371/journal.pcbi.0020062,2006,NR,,0,,,,,
alcohol use severity and hiv sexual risk among juvenile offenders,Malow RM,10.1080/10826080601006474,2006,NR,,0,,,,,
asymptomatic oral carriage of candida species in hiv-infected patients in the highly active antiretroviral therapy era,Costa CR,,2006,NR,,0,,,,,
behavioral risk exposure and host genetics of susceptibility to hiv-1 infection,Shrestha S,,2006,NR,,0,,,,,
analysis of hiv type 1 diversity in pregnant women from four latin american and caribbean countries,Gomez-Carrillo M,10.1089/aid.2006.22.1186,2006,NR,,0,,,,,
analysis of proxemic communication with hiv/aids patients,Galvao,10.1590/S0104-11692006000400004,2006,NR,,0,,,,,
buprenorphine use: the international experience (special issue: buprenorphine and hiv primary care: new opportunities for integrated treatment),Carrieri,10.1086/508184,2006,NR,,0,,,,,
assessment of the decision support needs of women from hiv endemic countries regarding voluntary hiv testing in canada,Mitra D,10.1016/j.pec.2006.04.005,2006,NR,,0,,,,,
"broad neutralization and complement-mediated lysis of hiv-1 by pehrg214, a novel caprine anti-hiv-1 polyclonal antibody",Verity EE,,2006,NR,,0,,,,,
genetic analyses reveal structured hiv-1 populations in serially sampled t lymphocytes of patients receiving haart,Potter SJ,,2006,NR,,0,,,,,
host polymorphism in steps of the hiv-1 lifecycle after entry and other genetic variants influencing hiv-1 pathogenesis,Telenti A,10.1097/01.COH.0000221598.79906.12,2006,NR,,0,,,,,
constraints on hiv-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus,Draenert R,10.1084/jem.20052116,2006,NR,,0,,,,,
continued evolution in gp41 after interruption of enfuvirtide in subjects with advanced hiv type 1 disease,Kitchen CM,,2006,NR,,0,,,,,
characterization of hiv-1 subtype c envelope glycoproteins from perinatally infected children with different courses of disease,Zhang H,,2006,NR,,0,,,,,
cross-subtype t-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen,Weaver EA,,2006,NR,,0,,,,,
comparison of the cobas taqmantm hiv-1 hps with versant hiv-1 rna 30 assay (bdna) for plasma rna quantitation in different hiv-1 subtypes,Gomes P,10.1016/j.jviromet.2006.03.018,2006,NR,,0,,,,,
compensatory mutations at the hiv cleavage sites p7/p1 and p1/p6-gag in therapy-naive and therapy-experienced patients,Verheyen J,,2006,NR,,0,,,,,
"complementary feeding adequacy in relation to nutritional status among early weaned breastfed children who are born to hiv-infected mothers: anrs 1201/1202 ditrame plus, abidjan, cote d'ivoire",Becquet R,10.1542/peds.2005-1911,2006,NR,,0,,,,,
dissecting hiv fusion: identifying novel targets for entry inhibitors,Finnegan C,10.2174/187152606779025851,2006,NR,,0,,,,,
core groups and the transmission of hiv: learning from male sex workers,Parker M,10.1017/S0021932005001136,2006,NR,,0,,,,,
editorial: hiv-1 reverse transcriptase inhibitors: drug resistance and drug development,Sluis-Cremer N,10.2174/138161206776873635,2006,NR,,0,,,,,
effects of human trim5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection,Javanbakht H,10.1016/j.virol.2006.06.031,2006,NR,,0,,,,,
emergence of antiretroviral theraphy resistance-associated primary mutations among drug-naive hiv-1-infected individuals in rural western cameroon,Koizumi Y,10.1097/01.qai.0000226793.16216.55,2006,NR,,0,,,,,
full-length genome analysis of human immunodeficiency virus type 1 subtype c in brazil,Sanabani S,,2006,NR,,0,,,,,
ethnic variations in the prevalence of metabolic bone disease among hiv-positive patients with lipodystrophy,Curtis JR,10.1089/aid.2006.22.125,2006,NR,,0,,,,,
"genetic characterization of human immunodeficiency virus type 1 from beira, mozambique",Parreira R,,2006,NR,,0,,,,,
distribution and heterogeneity of small ruminant lentivirus envelope subtypes in naturally infected french sheep,Germain K,,2006,NR,,0,,,,,
evolution of transmitted hiv-1 with drug-resistance mutations in the absence of therapy: effects on cd4+ t-cell count and hiv-1 rna load,Bezemer D,,2006,NR,,0,,,,,
diversity of hiv in rural burkina faso,Tebit DM,,2006,NR,,0,,,,,
"expression of the human endogenous retrovirus-k transmembrane envelope, rec and np9 proteins in melanomas and melanoma cell lines",Buscher K,,2006,NR,,0,,,,,
functional domains of the human immunodeficiency virus type 1 nef protein are conserved among different clades in cameroon,Ndjomou J,,2006,NR,,0,,,,,
conformational flexibility and strand arrangements of the membrane-associated hiv fusion peptide trimer probed by solid-state nmr spectroscopy,Zheng Z,,2006,NR,,0,,,,,
characterization of a new circulating recombinant form comprising hiv-1 subtypes c and b in southern brazil,Santos AF,,2006,NR,,0,,,,,
selection on the human immunodeficiency virus type 1 proteome following primary infection,Liu Y,,2006,NR,,0,,,,,
"first report of an hiv-1 triple recombinant of subtypes b, c and f in buenos aires, argentina",Pando MA,,2006,NR,,0,,,,,
antagonism between the hiv-1 reverse-transcriptase mutation k65r and thymidine-analogue mutations at the genomic level,Parikh UM,,2006,NR,,0,,,,,
the predominance of human immunodeficiency virus type 1 (hiv-1) circulating recombinant form 02 (crf02_ag) in west central africa may be related to its replicative fitness,Njai HF,,2006,NR,,0,,,,,
hypersusceptibility to substrate analogs conferred by mutations in human immunodeficiency virus type 1 reverse transcriptase,Smith RA,,2006,NR,,0,,,,,
the g490e mutation in reverse transcriptase does not impact trna primer selection by hiv-1 with altered pbs and a-loop,Xu W,,2006,NR,,0,,,,,
"evaluation of a multiple-cycle, recombinant virus, growth competition assay that uses flow cytometry to measure replication efficiency of human immunodeficiency virus type 1 in cell culture",Dykes C,,2006,NR,,0,,,,,
"gene expression profiling of the host response to hiv-1 b, c, or a/e infection in monocyte-derived dendritic cells",Solis M,,2006,NR,,0,,,,,
use of a novel assay based on intact recombinant viruses expressing green (egfp) or red (dsred2) fluorescent proteins to examine the contribution of pol and env genes to overall hiv-1 replicative fitness,Weber J,,2006,NR,,0,,,,,
adapting efficacious interventions: advancing translational research in hiv prevention,Solomon J,,2006,NR,,0,,,,,
expansion and diversification of virus-specific t cells following immunization of human immunodeficiency virus type 1 (hiv-1)-infected individuals with a recombinant modified vaccinia virus ankara/hiv-1 gag vaccine,Dorrell L,,2006,NR,,0,,,,,
genetic analysis of hiv-1 strains in rural eastern cameroon indicates the evolution of second-generation recombinants to circulating recombinant forms,Konings FA,,2006,NR,,0,,,,,
"polyvalent hiv-1 env vaccine formulations delivered by the dna priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes a, b, c, d and e",Wang S,,2006,NR,,0,,,,,
fitness comparison of thymidine analog resistance pathways in human immunodeficiency virus type 1,Hu Z,,2006,NR,,0,,,,,
"analysis of the near full length genomes of hiv-1 subtypes b, f and bf recombinant from a cohort of 14 patients in sao paulo, brazil",Sanabani S,,2006,NR,,0,,,,,
r5 and x4 hiv envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells,Cicala C,,2006,NR,,0,,,,,
higher transactivation activity associated with ltr and tat elements from hiv-1 bf intersubtype recombinant variants,Turk G,,2006,NR,,0,,,,,
modeling and estimation of replication fitness of human immunodeficiency virus type 1 in vitro experiments by using a growth competition assay,Wu H,,2006,NR,,0,,,,,
human immunodeficiency virus type 1 coreceptor switching: v1/v2 gain-of-fitness mutations compensate for v3 loss-of-fitness mutations,Pastore C,,2006,NR,,0,,,,,
altered hiv-1 gag protein interactions with cyclophilin a (cypa) on the acquisition of h219q and h219p substitutions in the cypa binding loop,Gatanaga H,,2006,NR,,0,,,,,
effects of quality of life and coping on depression among adults living with hiv/aids,Gore-Felton C,10.1177/1359105306066626,2006,NR,,0,,,,,
multiple antigenic mimotopes of hiv carbohydrate antigens: relating structure and antigenicity,Pashov AD,,2006,NR,,0,,,,,
functional correlation between a novel amino acid insertion at codon 19 in the protease of human immunodeficiency virus type 1 and polymorphism in the p1/p6 gag cleavage site in drug resistance and replication fitness,Brann TW,,2006,NR,,0,,,,,
human escrt-ii complex and its role in human immunodeficiency virus type 1 release,Langelier C,,2006,NR,,0,,,,,
genetic characterization of respiratory syncytial viruses isolated from consecutive acute respiratory infections in a hiv infected child,Arbiza J,,2006,NR,,0,,,,,
genetic variation in the ccl18-ccl3-ccl4 chemokine gene cluster influences hiv type 1 transmission and aids disease progression,Modi WS,,2006,NR,,0,,,,,
genotypic and phenotypic analyses of human immunodeficiency virus type 1 in antiretroviral drug-naive nigerian patients,Agwale SM,,2006,NR,,0,,,,,
hiv behavioral research online,Chiasson MA,10.1007/s11524-005-9008-3,2006,NR,,0,,,,,
"hiv in east london: ethnicity, gender and risk design and methods",Elford J,10.1186/1471-2458-6-150,2006,NR,,0,,,,,
hiv infection in injection drug users: an immunological paradox?,Bongertz V,,2006,NR,,0,,,,,
evaluation of fda licensed hiv assays using plasma from cameroonian blood donors,Lee S,,2006,NR,,0,,,,,
"hiv type 1 molecular epidemiology in cuba: high genetic diversity, frequent mosaicism, and recent expansion of bg intersubtype recombinant forms",Perez L,10.1089/aid.2006.22.724,2006,NR,,0,,,,,
evidence for onward transmission of hiv-1 non-b subtype strains in the united kingdom,Aggarwal I,10.1097/01.qai.0000179430.34660.11,2006,NR,,0,,,,,
evolution of intrahost hiv-1 genetic diversity during chronic infection,Shriner D,,2006,NR,,0,,,,,
evolutionary dynamics of hiv-1 and the control of aids,Mullins JI,10.1007/3-540-26397-7_6,2006,NR,,0,,,,,
hiv-1 genetic diversity and genotypic drug susceptibility in the republic of georgia,Zarandia M,,2006,NR,,0,,,,,
hiv-1 reverse transcriptase mutants resistant to nonnucleoside reverse transcriptase inhibitors do not adversely affect dna synthesis: pre-steady-state and steady-state kinetic studies,Domaoal RA,10.1097/01.qai.0000222288.90201.33,2006,NR,,0,,,,,
full-length genomic sequencing and analysis of four hiv type 1 subtype b isolates circulating in the territory of russia,Galkin AN,,2006,NR,,0,,,,,
hiv-1 subtype c viruses rapidly develop k65r resistance to tenofovir in cell culture,Brenner BG,,2006,NR,,0,,,,,
hiv-1 transmission cluster with m41l 'singleton' mutation and decreased transmission of resistance in newly diagnosed swedish homosexual men,Lindstrom A,,2006,NR,,0,,,,,
"genetic characterization of three crf01_ae full-length hiv type 1 sequences from fujian province, china",Huang HL,,2006,NR,,0,,,,,
"hiv/aids and injection drug use in the neighborhoods of dar es salaam, tanzania",McCurdy SA,10.1016/S0376-8716%2806%2980004-9,2006,NR,,0,,,,,
"hiv/aids epidemiology, pathogenesis, prevention, and treatment",Simon,10.1016/S0140-6736(06)69157-5,2006,NR,,0,,,,,
genetic variability of gag and env regions of hiv type 1 strains circulating in slovenia,Mezei M,10.1089/aid.2006.22.109,2006,NR,,0,,,,,
"growing up: perspectives of children, families and service providers regarding the needs of older children with perinatally-acquired hiv",Fielden SJ,10.1080/09540120600581460,2006,NR,,0,,,,,
hiv evolutionary dynamics within and among hosts,Lemey P,,2006,NR,,0,,,,,
hiv global surveillance: foundation for retroviral discovery and assay development,Brennan CA,10.1002/jmv.20603,2006,NR,,0,,,,,
hiv status of partners of hiv positive pregnant women in different regions of nigeria: matters arising,Sagay AS,,2006,NR,,0,,,,,
in vitro human immunodeficiency virus type 1 resistance selections with combinations of tenofovir and emtricitabine or abacavir and lamivudine,Margot NA,,2006,NR,,0,,,,,
"in vitro selection of mutations in human immunodeficiency virus type 1 reverse transcriptase that confer resistance to capravirine, a novel nonnucleoside reverse transcriptase inhibitor",Sato A,,2006,NR,,0,,,,,
hiv type 1 subtypes among sti patients in nairobi: a genotypic study based on partial pol gene sequencing,Lihana RW,,2006,NR,,0,,,,,
increasing hiv type 1 polymorphic diversity but no resistance to antiretroviral drugs in untreated patients from central african republic: a 2005 study,Marechal V,,2006,NR,,0,,,,,
hiv-1 genetic diversity in argentina and early diagnosis of perinatal infection,Aulicino PC,,2006,NR,,0,,,,,
hiv-1 group n: evidence of ongoing transmission in cameroon,Yamaguchi J,10.1089/aid.2006.22.453,2006,NR,,0,,,,,
inverse relationship between viral load and genotypic resistance mutations in korean patients with primary hiv type 1 infections,Chin BS,,2006,NR,,0,,,,,
multiple antigen concentrations in delayed-type hypersensitivity (dth) and response diversity during and after immunization with a peptide-based hiv-1 immunotherapy candidate (vacc-4x),Nyhus J,10.1016/j.vaccine.2005.10.012,2006,NR,,0,,,,,
human genetic polymorphisms affecting hiv-1 diseases,Shioda T,10.1532/IJH97.06100,2006,NR,,0,,,,,
influence of sequence identity and unique breakpoints on the frequency of intersubtype hiv-1 recombination,Baird HA,,2006,NR,,0,,,,,
molecular analysis and phylogenetic characterization of hiv in iran,Sarrami-Forooshani R,10.1002/jmv.20634,2006,NR,,0,,,,,
integrating hiv prevention activities into the hiv medical care setting: a report from the nyc hiv centers consortium,Wilson TE,10.1007/s11524-005-9004-7,2006,NR,,0,,,,,
molecular epidemiology of hiv type 1 in ukraine: birthplace of an epidemic,Saad MD,10.1089/aid.2006.22.709,2006,NR,,0,,,,,
molecular epidemiology of hiv type 1 subtypes in taiwan: outbreak of hiv type 1 crf07_bc infection in intravenous drug users,Chang SY,,2006,NR,,0,,,,,
"molecular epidemiology of hiv-1 subtypes based on analysis of pol sequences in slovenia, 1996-2005",Babic DZ,,2006,NR,,0,,,,,
"molecular epidemiology of human immunodeficiency virus-infected individuals in medellin, colombia",Sanchez GI,,2006,NR,,0,,,,,
mode of inhibition of hiv-1 integrase by a c-terminal domain-specific monoclonal antibody,Ramcharan J,10.1186/1742-4690-3-34,2006,NR,,0,,,,,
model for prediction of anti-hiv activity of 2-pyridinone derivatives using novel topological descriptor,Bajaj S,10.1002/qsar.200430918,2006,NR,,0,,,,,
novel broad-spectrum thiourea non-nucleoside inhibitors for the prevention of mucosal hiv transmission,D'Cruz OJ,10.2174/157016206777709519,2006,NR,,0,,,,,
"novel tight binding pett, hept and dabo-based non-nucleoside inhibitors of hiv-1 reverse transcriptase",D'Cruz OJ,10.1080/14756360600774413,2006,NR,,0,,,,,
nucleotide and amino acid mutations in human immunodeficiency virus corresponding to cd4+ decline,Hill MD,,2006,NR,,0,,,,,
opioid dependence: rationale for and efficacy of existing and new treatments (special issue: buprenorphine and hiv primary care: new opportunities for integrated treatment),Fiellin,10.1086/508180,2006,NR,,0,,,,,
nef gene sequence variation among hiv-1-infected african children,Chakraborty R,10.1111/j.1468-1293.2006.00341.x,2006,NR,,0,,,,,
novel approach for differential diagnosis of hiv infections in the face of vaccine-generated antibodies: utility for detection of diverse hiv-1 subtypes,Khurana S,,2006,NR,,0,,,,,
"novel, rapid assay for measuring entry of diverse enveloped viruses, including hiv and rabies",Saeed MF,,2006,NR,,0,,,,,
"phylogenetic analysis of env, gag, and tat genes of hiv type 1 detected among the injecting drug users in west bengal, india",Mullick R,10.1089/aid.2006.22.1293,2006,NR,,0,,,,,
sequential priming and boosting with heterologous hiv immunogens predominantly stimulated t cell immunity against conserved epitopes,Xu J,10.1097/QAD.0b013e328010ad0c,2006,NR,,0,,,,,
phylogenetic analysis of envelope glycoprotein (e1) gene of rubella viruses prevalent in japan in 2004,Saitoh M,,2006,NR,,0,,,,,
prevalence of drug-resistance mutations and non-subtype b strains among hiv-infected infants from new york state,Karchava M,,2006,NR,,0,,,,,
quality of life in hiv subtype c infection among asymptomatic subjects and its association with cd4 counts and viral loads - a study from south india,Chandra,10.1007/s11136-006-9001-7,2006,NR,,0,,,,,
real-time pcr quantitation of subtype c hiv dna in a zambian discordant couple cohort,Johnson RW,10.1089/aid.2006.22.438,2006,NR,,0,,,,,
rapid propagation of low-fitness drug-resistant mutants of human immunodeficiency virus type 1 by a streptococcal metabolite sparsomycin,Miyauchi K,,2006,NR,,0,,,,,
rationale and uses of a public hiv drug-resistance database,Shafer,10.1086/505356,2006,NR,,0,,,,,
repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on hiv-1 susceptibility,Liu H,10.1086/499820,2006,NR,,0,,,,,
"scanning the hiv genome for cd4+ t cell epitopes restricted to hla-dp4, the most prevalent hla class ii molecule",Cohen WM,,2006,NR,,0,,,,,
residual human immunodeficiency virus type 1 viraemia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating cd4+ t cells,Bailey,10.1128/JVI.00591-06,2006,NR,,0,,,,,
the predominance of human immunodeficiency virus type i (hiv-1) circulating recombinant form 02 (crf02_ag) in west central africa may be related to its replicative fitness,Njai HF,10.1186/1742-4690-3-40,2006,NR,,0,,,,,
higher transactivation activity associated with ltr and tat elements from hiv-i bf intersubtype recombinant variants,Turk G,10.1186/1742-4690-3-14,2006,NR,,0,,,,,
"serotyping and genotyping of hiv-1 infection in residents of khayelitsha, cape town, south africa",Jacobs GB,10.1002/jmv.20735,2006,NR,,0,,,,,
ctl epitope distribution patterns in the gag and nef proteins of hiv-i from subtype a infected subjects in kenya: use of multiple peptide sets increases the detectable breadth of the ctl response,Currier JR,10.1186/1471-2172-7-8,2006,NR,,0,,,,,
replicative fitness of ccr5-using and cxcr4-using human immunodeficiency virus type 1 biological clones,Arien KK,10.1016/j.virol.2005.11.045,2006,NR,,0,,,,,
bursts of nonsynonymous substitutions in hiv-1 evolution reveal instances of positive selection at conservative protein sites,Bazykin GA,10.1073/pnas.0609484103,2006,NR,,0,,,,,
"risk perception, knowledge and social distance of turkish high school students about hiv/aids",Turhan E,10.1093/pubmed/fdi085,2006,NR,,0,,,,,
"construction and characterization of soluble, cleaved, and stabilized trimeric env proteins based on hiv type 1 env subtype a",Beddows S,10.1089/aid.2006.22.569,2006,NR,,0,,,,,
fitness constraints on immune escape from hiv: implications of envelope as a target for both hiv-specific t cells and antibody,Peut V,10.2174/157016206776055110,2006,NR,,0,,,,,
differential selection pressure exerted on hiv by ctl targeting identical epitopes but restricted by distinct hla alleles from the same hla supertype,Leslie A,10.4049/jimmunol.177.7.4699,2006,NR,,0,,,,,
stigma and hiv infection in russia,Balabanova Y,10.1080/09540120600643641,2006,NR,,0,,,,,
"short report: molecular epidemiology of human immunodeficiency virus-infected individuals in medellin, colombia",Sanchez GI,,2006,NR,,0,,,,,
single dna molecule stretching measures the activity of chemicals that target the hiv-1 nucleocapsid protein,Cruceanu M,,2006,NR,,0,,,,,
synthesis and anti-hiv activity of new alkenyldiarylmethane (adam) non-nucleoside reverse transcriptase inhibitors (nnrtis) incorporating benzoxazolone and benzisoxazole rings,Deng B-L,10.1016/j.bmc.2005.11.014,2006,NR,,0,,,,,
the contribution of hiv fitness to the evolution pattern of reverse transcriptase inhibitor resistance,Paintsil E,10.1002/jmv.20557,2006,NR,,0,,,,,
the mpondombili project: preventing hiv/aids and unintended pregnancy among rural south african school-going adolescents,Mantell JE,10.1016/S0968-8080%2806%2928269-7,2006,NR,,0,,,,,
uncovering implicit theories of hiv prevention providers: it takes a community,Freedman B,10.1521/aeap.2006.18.3.216,2006,NR,,0,,,,,
transmission of human immunodeficiency virus type 1 nevirapine resistance mutation k103n from a treatment-naive mother to her child,Schmitz T,10.1097/01.inf.0000202142.34502.5e,2006,NR,,0,,,,,
transmitted multidrug resistant hiv-1: new and investigational therapeutic approaches,Shet,,2006,NR,,0,,,,,
treatment switch guided by hiv-1 genotyping in brazil,Tupinambas U,10.1590/S1413-86702006000200003,2006,NR,,0,,,,,
"vulnerability, unsafe sex and non-adherence to haart: evidence from a large sample of french hiv/aids outpatients",Peretti-Watel,10.1016/j.socscimed.2005.10.020,2006,NR,,0,,,,,
whole genome composition distance for hiv-1 genotyping,Wu X,,2006,NR,,0,,,,,
"wiring the hiv/aids system: building interorganizational infrastructure to link people, sites, and networks",Indyk D,10.1300/J010v42n03_03,2006,NR,,0,,,,,
a genetic-algorithm approach to simulating human immunodeficiency virus evolution reveals the strong impact of multiply infected cells and recombination,Bocharov G,10.1099/vir.0.81138-0,2005,NR,,0,,,,,
"a comparative analysis of communication about sex, health and sexual health in india and south africa: implications for hiv prevention",Lambert H,10.1080/13691050500245818,2005,NR,,0,,,,,
a kaleidoscope of care for hiv-infected substance users,Tobias,10.1300/J187v04n02_04,2005,NR,,0,,,,,
a novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting cd4+ t cells of viremic patients,Monie D,,2005,NR,,0,,,,,
a population-based study of hiv testing practices and perceptions in 4 us states,Takahashi TA,10.1111/j.1525-1497.2005.0112.x,2005,NR,,0,,,,,
a yeast recombination-based cloning system to produce chimeric hiv-1 viruses and express hiv-1 genes,Moore DM,,2005,NR,,0,,,,,
antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to t cells,VanCompernolle SE,,2005,NR,,0,,,,,
"adaptive evolution of primate trim5alpha, a gene restricting hiv-1 infection",Liu HL,,2005,NR,,0,,,,,
alterations of lymphocyte membranes during hiv-1 infection via multiple and simultaneous entry strategies,Fermin C,,2005,NR,,0,,,,,
"barriers and facilitators to antiretroviral medication adherence among patients with hiv in chennai, india: a qualitative study",Kumarasamy N,10.1089/apc.2005.19.526,2005,NR,,0,,,,,
application of the polyvalent approach to hiv-1 vaccine development,Hurwitz JL,10.2174/1568005054201517,2005,NR,,0,,,,,
cell-based and biochemical screening approaches for the discovery of novel hiv-1 inhibitors,Westby M,10.1016/j.antiviral.2005.06.006,2005,NR,,0,,,,,
characterization and hiv-1 fusion inhibitory properties of monoclonal fabs obtained from a human non-immune phage library selected against diverse epitopes of the ectodomain of hiv-1 gp41,Louis JM,,2005,NR,,0,,,,,
"building holistic hiv/aids responses in african american urban faith communities: a qualitative, multiple case study analysis",Hicks KE,10.1097/00003727-200504000-00010,2005,NR,,0,,,,,
clonal analysis of hiv-1 variants in proviral dna during treatment interruption in patients with multiple therapy failures,Boucher S,,2005,NR,,0,,,,,
clonal analysis of hiv-1 variants in proviral dna during treatment interruption in patients with multiple therapy failures (special issue: focus on hiv),Boucher,10.1016/j.jcv.2005.01.005,2005,NR,,0,,,,,
combination of a mutagenic agent with a reverse transcriptase inhibitor results in systematic inhibition of hiv-1 infection,Tapia N,,2005,NR,,0,,,,,
combinatorial design of nonsymmetrical cyclic urea inhibitors of aspartic protease of hiv-1,Frecer V,10.1016/j.bmc.2005.06.026,2005,NR,,0,,,,,
"circulation of novel hiv type 1 a, b/c, and f subtypes in argentina",Aulicino PC,,2005,NR,,0,,,,,
cross-reactivity of anti-hiv-1 t cell immune responses among the major hiv-1 clades in hiv-1-positive individuals from 4 continents,Coplan PM,,2005,NR,,0,,,,,
dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for hiv and sti prevention,McCarthy TD,10.1021/mp050023q,2005,NR,,0,,,,,
commentary: sifting through the maze of viral and host diversity and hiv/aids clinical progression,Miller V,10.1093/ije/dyi090,2005,NR,,0,,,,,
determinants of human immunodeficiency virus type 1 resistance to membrane-anchored gp41-derived peptides,Lohrengel S,,2005,NR,,0,,,,,
"diaspora, a large family of ty3-gypsy retrotransposons in glycine max, is an envelope-less member of an endogenous plant retrovirus lineage",Yano ST,,2005,NR,,0,,,,,
correlates of hiv vaccine trial participation: an indian perspective,Sahay S,10.1016/j.vaccine.2004.09.032,2005,NR,,0,,,,,
covariability of selected amino acid positions for hiv type 1 subtypes c and b,Gilbert PB,,2005,NR,,0,,,,,
"diversity, divergence, and evolution of cell-free human immunodeficiency virus type 1 in vaginal secretions and blood of chronically infected women: associations with immune status",Sullivan ST,,2005,NR,,0,,,,,
effect of the q207d mutation in hiv type 1 reverse transcriptase on zidovudine susceptibility and replicative fitness,Lu J,,2005,NR,,0,,,,,
"determination of gag subtypes of hiv type 1 detected among female sex workers in calcutta, india",Sengupta S,10.1089/aid.2005.21.806,2005,NR,,0,,,,,
evidence for heterogeneous selective pressures in the evolution of the env gene in different human immunodeficiency virus type 1 subtypes,Travers SA,,2005,NR,,0,,,,,
enhanced replicative capacity and pathogenicity of hiv-1 isolated from individuals infected with drug-resistant virus and declining cd4+ t-cell counts,Solomon A,,2005,NR,,0,,,,,
ethnic differences in stage of presentation of adults newly diagnosed with hiv-1 infection in south london,Boyd AE,10.1111/j.1468-1293.2005.00267.x,2005,NR,,0,,,,,
"genetic recombination of human immunodeficiency virus type 1 in one round of viral replication: effects of genetic distance, target cells, accessory genes, and lack of high negative interference in crossover events",Rhodes TD,,2005,NR,,0,,,,,
exploring full-genome sequences for phylogenetic support of hiv-1 transmission events [4],Lemey P,10.1097/01.aids.0000182519.92030.ce,2005,NR,,0,,,,,
factors influencing hiv-risk behaviors among hiv-positive urban african americans,Plowden KO,,2005,NR,,0,,,,,
high genetic diversity of human immunodeficiency virus type 1 in angola,Bartolo I,,2005,NR,,0,,,,,
fatigue among hiv-infected patients in the era of highly active antiretroviral therapy,Henderson,10.1111/j.1468-1293.2005.00319.x,2005,NR,,0,,,,,
dynamic model of hiv/aids population of agra region,Chaturvedi DK,10.3390/ijerph2005030006,2005,NR,,0,,,,,
frequency of drug-resistant variants of hiv-1 coexistent with wild-type in treatment-naive patients of india,Sachdeva N,10.1186/1758-2652-7-3-68,2005,NR,,0,,,,,
an empowerment intervention for women living with hiv and its adaptation for women with a diagnosis of breast cancer,Zorrilla CD,,2005,NR,,0,,,,,
replicative fitness of historical and recent hiv-1 isolates suggests hiv-1 attenuation over time,Arien KK,,2005,NR,,0,,,,,
efficient expansion of hiv-1-specific t cell responses by homologous immunization with recombinant semliki forest virus particles,Sundback M,,2005,NR,,0,,,,,
effect of contraceptive methods on natural history of hiv: studies from the mombasa cohort,Baeten,10.1097/01.qai.0000167030.18278.0e,2005,NR,,0,,,,,
"outbreak of a west african recombinant of hiv-1 in tashkent, uzbekistan",Carr JK,,2005,NR,,0,,,,,
the hiv-1 leader rna conformational switch regulates rna dimerization but does not regulate mrna translation,Abbink TE,,2005,NR,,0,,,,,
restricted variable residues in the c-terminal segment of hiv-1 v3 loop regulate the molecular anatomy of ccr5 utilization,Hu Q,,2005,NR,,0,,,,,
hemagglutinating virus of japan-artificial viral envelope liposome-mediated cotransfer of bag-1 and bcl-2 genes protects hepatic cells against ischemic injury through bag-1-assisted preferential enhancement of bcl-2 protein expression,Yanada S,,2005,NR,,0,,,,,
diminished replicative fitness of primary human immunodeficiency virus type 1 isolates harboring the k65r mutation,Weber J,,2005,NR,,0,,,,,
hiv-1 genetic variants circulation in the north of angola,Abecasis A,,2005,NR,,0,,,,,
"the analysis of near full-length genome sequences of human immunodeficiency virus type 1 bf intersubtype recombinant viruses from chile, venezuela and spain reveals their relationship to diverse lineages of recombinant viruses related to crf12_bf",Sierra M,,2005,NR,,0,,,,,
hiv-1 subtypes and circulating recombinant forms (crfs) from hiv-infected patients residing in two regions of central and southern italy,Monno L,,2005,NR,,0,,,,,
heterogeneous nature of hiv-1 recombinants spreading in spain,Holguin A,,2005,NR,,0,,,,,
effects of virion surface gp120 density on infection by hiv-1 and viral production by infected cells,Bachrach E,10.1016/j.virol.2004.11.031,2005,NR,,0,,,,,
human immunodeficiency virus (hiv)-specific gamma interferon secretion directed against all expressed hiv genes: relationship to rate of cd4 decline,Peretz Y,,2005,NR,,0,,,,,
human immunodeficiency virus type 1 env clones from acute and early subtype b infections for standardized assessments of vaccine-elicited neutralizing antibodies,Li M,10.1128/JVI.79.16.10108-10125.2005,2005,NR,,0,,,,,
human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant?,van Marle G,10.1080/13550280590922838,2005,NR,,0,,,,,
human immunodeficiency virus type 1 genomic rna sequences in the female genital tract and blood: compartmentalization and intrapatient recombination,Philpott S,,2005,NR,,0,,,,,
human immunodeficiency virus type-1 (hiv-1) subtypes in jamaica,Heslop OD,,2005,NR,,0,,,,,
hiv and smallpox [3] (multiple letters),Gruters RA,,2005,NR,,0,,,,,
hiv recombination: what is the impact on antiretroviral therapy?,Fraser C,,2005,NR,,0,,,,,
hiv type 1 fitness evolution in antiretroviral-experienced patients with sustained cd4+ t cell counts but persistent virologic failure,Prado JG,,2005,NR,,0,,,,,
evidence for host-driven selection of the hiv type 1 vpr gene in vivo during hiv disease progression in a transfusion-acquired cohort,Cali L,10.1089/aid.2005.21.728,2005,NR,,0,,,,,
evolution of subtype c hiv-1 env in a slowly progressing zambian infant,Zhang H,,2005,NR,,0,,,,,
full-length hiv type 1 genome analysis showing evidence for hiv type 1 transmission from a nonprogressor to two recipients who progressed to aids,Mikhail M,,2005,NR,,0,,,,,
gender difference in hiv-1 rna viral loads,Donnelly CA,10.1111/j.1468-1293.2005.00285.x,2005,NR,,0,,,,,
"in-depth, longitudinal analysis of viral quasispecies from an individual triply infected with late-stage human immunodeficiency virus type 1, using a multiple pcr primer approach",Gerhardt M,,2005,NR,,0,,,,,
"genetic characterization of full-length hiv type 1 genomes from 3 infected paid blood donors in henan, china",Liu Li,10.1097/01.qai.0000182228.00333.e1,2005,NR,,0,,,,,
"genetic diversification and recombination of hiv type 1 group m in kinshasa, democratic republic of congo",Yang C,,2005,NR,,0,,,,,
hiv-1 viral escape in infancy followed by emergence of a variant-specific ctl response,Feeney ME,10.4049/jimmunol.174.12.7524,2005,NR,,0,,,,,
haplotype analysis of the sdf-1 (cxcl12) gene in a longitudinal hiv-1/aids cohort study,Modi WS,10.1038/sj.gene.6364258,2005,NR,,0,,,,,
high degree of inter-clade cross-reactivity of hiv-1-specific t cell responses at the single peptide level,Yu XG,,2005,NR,,0,,,,,
identification of diverse microbial metabolites as potent inhibitors of hiv-1 tat transactivation,Jayasuriya H,10.1002/cbdv.200490162,2005,NR,,0,,,,,
hiv infection and protease genetic diversity in a rural area of the southern central african republic,Punzi G,10.1002/jmv.20476,2005,NR,,0,,,,,
impact of drug resistance genotypes on cd4+ counts and plasma viremia in heavily antiretroviral-experienced hiv-infected patients,Rodes B,,2005,NR,,0,,,,,
"impact of genetic diversity of hiv-1 on diagnosis, antiretroviral therapy & vaccine development (special issue: hiv/aids)",Lal,,2005,NR,,0,,,,,
impact of hiv type 1 genetic subtype on the outcome of antiretroviral therapy,Atlas,10.1089/aid.2005.21.221,2005,NR,,0,,,,,
impact of hiv-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration,Kantor R,,2005,NR,,0,,,,,
in vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the k65r mutation in reverse transcriptase,Parikh UM,,2005,NR,,0,,,,,
hiv type 1 crf13_cpx revisited: identification of a new sequence from cameroon and signal for subsubtype j2,Zhang M,10.1089/aid.2005.21.955,2005,NR,,0,,,,,
in vivo dynamics of the k103n mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected patients,Gianotti N,,2005,NR,,0,,,,,
"hiv type 1 strains common in europe, africa, and asia cocirculate in yemen",Saad MD,10.1089/aid.2005.21.644,2005,NR,,0,,,,,
hiv vaccine acceptability among women at risk: perceived barriers and facilitators to future hiv vaccine uptake,Rudy ET,10.1521/aeap.17.4.253.66529,2005,NR,,0,,,,,
induction of t-cell immunity to antiretroviral drug-resistant human immunodeficiency virus type 1,Stratov I,,2005,NR,,0,,,,,
hiv-1 diversity and prevalence differ between urban and rural areas in the mbeya region of tanzania,Arroyo MA,10.1097/01.aids.0000183515.14642.76,2005,NR,,0,,,,,
hiv-1 envelope evolution and vaccine efficacy,Mosier DE,10.2174/1568005054201553,2005,NR,,0,,,,,
structural characterization of an anti-gp120 rna aptamer that neutralizes r5 strains of hiv-1,Dey AK,,2005,NR,,0,,,,,
hiv-1 genetic diversity surveillance in the united states,Bennett,10.1086/430329,2005,NR,,0,,,,,
inpatient care of the hiv infected patient in the highly active antiretroviral therapy (haart) era,Pulvirenti,10.2174/1570162053506964,2005,NR,,0,,,,,
hiv-1 pol replication capacity predicts disease progression,Daar ES,10.1097/01.aids.0000171400.15619.e1,2005,NR,,0,,,,,
hiv-1 subtype diversity in minnesota,Sides TL,,2005,NR,,0,,,,,
interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant hiv-1 infection,Deeks,10.1086/496892,2005,NR,,0,,,,,
hiv-1 subtypes in spain: a retrospective analysis from 1995 to 2003,Lospitao E,,2005,NR,,0,,,,,
investigation by fluorescence correlation spectroscopy of the chaperoning interactions of hiv-1 nucleocapsid protein with the viral dna initiation sequences,Egele C,10.1016/j.crvi.2005.06.005,2005,NR,,0,,,,,
hiv/aids in rural india: context and health care needs,Pallikadavath S,10.1017/S0021932004006893,2005,NR,,0,,,,,
hiv/aids in the caribbean basin,Inciardi,10.1080/09540120500120955,2005,NR,,0,,,,,
homosexuality and hiv/aids prevention: the challenge of transferring lessons learned from western europe to central and eastern european countries,Wright MT,10.1093/heapro/dah511,2005,NR,,0,,,,,
identification of a major restriction in hiv-1 intersubtype recombination,Chin MP,,2005,NR,,0,,,,,
low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions,Joos B,,2005,NR,,0,,,,,
international non-governmental actors in hiv/aids prevention in china,Wu FS,10.1038/sj.cr.7290369,2005,NR,,0,,,,,
is hiv-1 evolving to a less virulent (pathogenic) virus?,Quinones-Mateu,10.1097/01.aids.0000186018.39673.1c,2005,NR,,0,,,,,
molecular footprint of drug-selective pressure in a human immunodeficiency virus transmission chain,Lemey P,,2005,NR,,0,,,,,
most dc-signr transcripts at mucosal hiv transmission sites are alternatively spliced isoforms,Liu H,10.1038/sj.ejhg.5201409,2005,NR,,0,,,,,
mouse serum factor(s) down-modulate the cd4 and cxcr4 molecules on human t cells conferring resistance to hiv infection in nog mice,Dewan MZ,,2005,NR,,0,,,,,
multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys,Seaman MS,,2005,NR,,0,,,,,
"multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis",Palmer S,,2005,NR,,0,,,,,
mental health differences between rural and urban men living with hiv infection in various age groups,Uphold CR,10.1007/s10900-005-5517-y,2005,NR,,0,,,,,
mitigating impacts of hiv/aids on rural livelihoods: ngo experiences in sub-saharan africa,White,10.1080/09614520500041757,2005,NR,,0,,,,,
negotiated safety relationships and sexual behavior among a diverse sample of hiv-negative men who have sex with men,Guzman R,10.1097/00126334-200501010-00015,2005,NR,,0,,,,,
molecular diversity of hiv in albania,Ciccozzi M,,2005,NR,,0,,,,,
molecular testing of multiple hiv-1 transmissions in a criminal case,Lemey P,10.1097/01.aids.0000187904.02261.1a,2005,NR,,0,,,,,
"novel antibiotic-resistant pneumococcal strains recovered from the upper respiratory tracts of hiv-infected adults and their children in kisumu, kenya",Medina MJ,,2005,NR,,0,,,,,
natural variation in vif: differential impact on apobec3g/3f and a potential role in hiv-1 diversification,Simon V,,2005,NR,,0,,,,,
neurologic anifestations of hiv infection: an indian hospital-based study,Teja VD,,2005,NR,,0,,,,,
selective escape from cd8+ t-cell responses represents a major driving force of human immunodeficiency virus type 1 (hiv-1) sequence diversity and reveals constraints on hiv-1 evolution,Allen TM,,2005,NR,,0,,,,,
semen-specific genetic characteristics of human immunodeficiency virus type 1 env,Pillai SK,,2005,NR,,0,,,,,
pathogenesis of macrophage tropic hiv-1,Gorry PR,10.2174/1570162052772951,2005,NR,,0,,,,,
"polymorphism of hiv-1 gag (p17) gene from female sex workers in calcutta, india",Sengupta S,,2005,NR,,0,,,,,
predicting hiv transmission risk among hiv-infected men who have sex with men: findings from the healthy living project,Morin SE,10.1097/01.qai.0000166375.16222.eb,2005,NR,,0,,,,,
predicting the potential public health impact by disease-modifying hiv vaccines in south africa: the problem of subtypes,Blower SM,10.2174/1568005054201616,2005,NR,,0,,,,,
promoter trapping reveals significant differences in integration site selection between mlv and hiv vectors in primary hematopoietic cells,De Palma M,,2005,NR,,0,,,,,
protein promiscuity: drug resistance and native functions - hiv-1 case,Fernandez A,10.1080/07391102.2005.10531228,2005,NR,,0,,,,,
risk for hiv-1 infection associated with a common cxcl12 (sdf1) polymorphism and cxcr4 variation in an african population,Petersen DC,10.1097/01.qai.0000186360.42834.28,2005,NR,,0,,,,,
"the c-terminal tail of the gp41 transmembrane envelope glycoprotein of hiv-1 clades a, b, c, and d may exist in two conformations: an analysis of sequence, structure, and function",Hollier MJ,,2005,NR,,0,,,,,
role of viral evolutionary rate in hiv-1 disease progression in a linked cohort,Mikhail M,,2005,NR,,0,,,,,
response of religious groups to hiv/aids as a sexually transmitted infection in trinidad,Genrich GL,10.1186/1471-2458-5-121,2005,NR,,0,,,,,
"spatial genetic structure of two hiv-i-resistant polymorphisms (ccr2-64 i and sdf1-3'a) alleles in population of shandong province, china",Xue F-Z,,2005,NR,,0,,,,,
risk perception and sexual risk behaviors among hiv-positive men on antiretroviral therapy,Remien RH,10.1007/s10461-005-3898-7,2005,NR,,0,,,,,
"variants of ccr5, which are permissive for hiv-1 infection, show distinct functional responses to ccl3, ccl4 and ccl5",Dong H-F,10.1038/sj.gene.6364247,2005,NR,,0,,,,,
"a university and community-based organization collaboration to build capacity to develop, implement, and evaluate an innovative hiv prevention intervention for an urban african american population",Oliva G,10.1521/aeap.2005.17.4.300,2005,NR,,0,,,,,
characterization of intersubtype recombinant hiv type 1 genomes using a nonradioactive heteroduplex tracking assay,Schroeder TL,10.1089/aid.2005.21.314,2005,NR,,0,,,,,
"hiv-1 genetic variants in silesia, poland",Smolen J,,2005,NR,,0,,,,,
the host environment drives hiv-1 fitness,Van Opijnen T,10.1002/rmv.472,2005,NR,,0,,,,,
std and hiv counseling practices of british columbia primary care physicians,Hansen L,10.1089/apc.2005.19.40,2005,NR,,0,,,,,
strategies to prevent hiv transmission among heterosexual african-american women,Essien EJ,10.1186/1475-9276-4-4,2005,NR,,0,,,,,
subtyping and sequence analysis of the c2-v3 region of gp120 genes among hiv-1 strains in hebei province,Zhao C-Y,,2005,NR,,0,,,,,
sexual risk behaviors and substance use among alcohol abusing hiv-positive men who have sex with men,Parsons JT,10.1080/02791072.2005.10399746,2005,NR,,0,,,,,
targeted infection of hiv-1 env expressing cells by hiv(cd4/cxcr4) ventors reveals a potential new rationale for hiv-1 mediated down-modulation of cd4,Ye Z,10.1186/1742-4690-2-80,2005,NR,,0,,,,,
social and geographic distance in hiv risk,Rothenberg R,10.1097/01.olq.0000161191.12026.ca,2005,NR,,0,,,,,
stalling hiv through social marketing: prospects in pakistan,Husain S,,2005,NR,,0,,,,,
structural analysis of reverse transcriptase mutations at codon 215 explains the predominance of t215y over t215f in hiv-1 variants selected under antiretroviral therapy,Yahi N,10.1007/s11373-005-9011-4,2005,NR,,0,,,,,
structure and dynamics of micelle-associated human immunodeficiency virus gp41 fusion domain,Jaroniec CP,,2005,NR,,0,,,,,
"syncytin-a and syncytin-b, two fusogenic placenta-specific murine envelope genes of retroviral origin conserved in muridae",Dupressoir A,10.1073/pnas.0406509102,2005,NR,,0,,,,,
the evolving role of hiv counseling and testing in resource-limited settings: hiv prevention and linkage to expanding hiv care access,Liechty,10.1007/s11908-005-0076-z,2005,NR,,0,,,,,
"the hiv epidemic in china: history, response, and challenge",Na HE,10.1038/sj.cr.7290354,2005,NR,,0,,,,,
the rationale behind a vaccine based on multiple hiv antigens,Rollman E,,2005,NR,,0,,,,,
the spread of hiv in africa,Mokili J,10.1080/13550280590901769,2005,NR,,0,,,,,
"the x4 phenotype of hiv type 1 evolves from r5 in two children of mothers, carrying x4, and is not linked to transmission",Clevestig P,,2005,NR,,0,,,,,
transmission of hiv-1 during primary infection: relationship to sexual risk and sexually transmitted infections,Pao D,,2005,NR,,0,,,,,
vertical transmission of hiv in ghanaian women diagnosed in cord blood and post-natal samples,Fischetti,10.1002/jmv.20463,2005,NR,,0,,,,,
webcasting: an innovative approach to hiv/aids professional training in a rural setting,Waddell,10.1300/J187v04n02_05,2005,NR,,0,,,,,
re-analysis of 34 full-length hiv-1 intersubtype recombinant sequences,Magiorkinis,10.1016/j.meegid.2004.05.010,2005,NR,,0,,,,,
"a university and community-based organization collaboration to build capacity to develop, implement, and evaluate an innovative hiv prevention intervention for an urban african american population (special issue: building hiv prevention capacity through community collaborative research)",Oliva,10.1521/aeap.2005.17.4.300,2005,NR,,0,,,,,
fisherfolk are among groups most at risk of hiv: cross-country analysis of prevalence and numbers infected,Kissling,10.1097/01.aids.0000191925.54679.94,2005,NR,,0,,,,,
what's new in hiv/aids - hiv genetic diversity: any implications for drug resistance?,Julg B,10.1007/s15010-005-6405-1,2005,NR,,0,,,,,
a loss of viral replicative capacity correlates with altered dna polymerization kinetics by the human immunodeficiency virus reverse transcriptase bearing the k65r and l74v dideoxynucleoside resistance substitutions,Deval J,,2004,NR,,0,,,,,
a novel assay to identify entry inhibitors that block binding of hiv-1 gp120 to ccr5,Zhao Q,,2004,NR,,0,,,,,
a retroviral promoter and a cellular enhancer define a bipartite element which controls env ervwe1 placental expression,Prudhomme S,10.1128/JVI.78.22.12157-12168.2004,2004,NR,,0,,,,,
alcohol use and stigmatized sexual practices of hiv seropositive gay and bisexual men,Parsons,10.1016/j.addbeh.2004.03.001,2004,NR,,0,,,,,
a model hiv/aids risk reduction program in the philippines: a comprehensive community-based approach through participatory action research,Morisky DE,10.1093/heapro/dah109,2004,NR,,0,,,,,
functional characterization and nmr spectroscopy on full-length vpu from hiv-1 prepared by total chemical synthesis,Kochendoerfer GG,,2004,NR,,0,,,,,
antiretroviral drug resistance mutations sustain or enhance ctl recognition of common hiv-1 pol epitopes,Mason RD,,2004,NR,,0,,,,,
antiretroviral resistance and high-risk transmission behavior among hiv-positive patients in clinical care,Kozal MJ,,2004,NR,,0,,,,,
"association of dc-sign promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection",Martin MP,10.1128/JVI.78.24.14053-14056.2004,2004,NR,,0,,,,,
biased g-to-a hypermutation in hiv-1 proviral dna from a long-term non-progressor,Wei Min,10.1097/00002030-200409030-00023,2004,NR,,0,,,,,
compartmentalization of human immunodeficiency virus type 1 between blood monocytes and cd4+ t cells during infection,Fulcher JA,,2004,NR,,0,,,,,
comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes,Choisy M,,2004,NR,,0,,,,,
challenges in the search for an hiv vaccine,Lemckert AAC,10.1023/B:EJEP.0000032423.87658.68,2004,NR,,0,,,,,
competitive fitness of nevirapine-resistant human immunodeficiency virus type 1 mutants,Collins JA,,2004,NR,,0,,,,,
conformational changes in hiv-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding,Sluis-Cremer N,10.2174/1570162043351093,2004,NR,,0,,,,,
cytokine and chemokine gene polymorphisms among ethnically diverse north americans with hiv-1 infection,Wang C,10.1097/00126334-200404150-00002,2004,NR,,0,,,,,
declining trend in transmission of drug-resistant hiv-1 in amsterdam,Bezemer D,,2004,NR,,0,,,,,
development of a homology model for clade a human immunodeficiency virus type 1 gp120 to localize temporal substitutions arising in recently infected women,Poss M,10.1099/vir.0.79974-0,2004,NR,,0,,,,,
determinants of human immunodeficiency virus type 1 baseline susceptibility to the fusion inhibitors enfuvirtide and t-649 reside outside the peptide interaction site,Heil ML,,2004,NR,,0,,,,,
diminished representation of hiv-1 variants containing select drug resistance-conferring mutations in primary hiv-1 infection,Turner D,,2004,NR,,0,,,,,
distinct human immunodeficiency virus type 1 subtype a virus circulating in west africa: sub-subtype a3,Meloni ST,,2004,NR,,0,,,,,
could disease-modifying hiv vaccines cause population-level perversity?,Smith RJ,10.1016/S1473-3099%2804%2901148-X,2004,NR,,0,,,,,
drug resistance testing provides evidence of the globalization of hiv type 1: a new circulating recombinant form,Gomez-Carrillo M,10.1089/0889222041725172,2004,NR,,0,,,,,
"drug resistance, virus fitness and hiv-1 mutagenesis",Chen R,10.2174/1381612043382404,2004,NR,,0,,,,,
engineering immunogenic consensus t helper epitopes for a cross-clade hiv vaccine,De Groot AS,,2004,NR,,0,,,,,
development and application of a high-throughput hiv type 1 genotyping assay to identify crf02_ag in west/west central africa,Kijak GH,,2004,NR,,0,,,,,
foundations for a phase iii human immunodeficiency virus vaccine trial: a decade of thai-us army collaborative research,Brown AE,10.7205/MILMED.169.8.588,2004,NR,,0,,,,,
differences in disease progression in a cohort of long-term non-progressors after more than 16 years of hiv-1 infection,Rodes B,10.1097/00002030-200405210-00004,2004,NR,,0,,,,,
disease progression in heterosexual patients infected with closely related subtype b strains of hiv type 1 with differing coreceptor usage properties,Hayman A,,2004,NR,,0,,,,,
evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated hiv-infected men,Ghosn J,10.1097/00002030-200402200-00011,2004,NR,,0,,,,,
evolution of human immunodeficiency virus type 1 (hiv-1) resistance mutations in nonnucleoside reverse transcriptase inhibitors (nnrtis) in hiv-1-infected patients switched to antiretroviral therapy without nnrtis,Joly V,,2004,NR,,0,,,,,
"documentation of subtype c hiv type 1 strains in argentina, paraguay, and uruguay",Carrion G,,2004,NR,,0,,,,,
dynamics of hiv-1 recombination in its natural target cells,Levy DN,,2004,NR,,0,,,,,
gag non-cleavage site mutations contribute to full recovery of viral fitness in protease inhibitor-resistant human immunodeficiency virus type 1,Myint L,10.1128/AAC.48.2.444-452.2004,2004,NR,,0,,,,,
a riboswitch regulates rna dimerization and packaging in human immunodeficiency virus type 1 virions,Ooms M,,2004,NR,,0,,,,,
the signal peptide of the junin arenavirus envelope glycoprotein is myristoylated and forms an essential subunit of the mature g1-g2 complex,York J,,2004,NR,,0,,,,,
hla class i serotypes and cytotoxic t-lymphocyte responses among human immunodeficiency virus-1-uninfected thai volunteers immunized with alvac-hiv in combination with monomeric gp120 or oligomeric gp160 protein boosting,Paris R,,2004,NR,,0,,,,,
"transcriptional regulation of apobec3g, a cytidine deaminase that hypermutates human immunodeficiency virus",Rose KM,,2004,NR,,0,,,,,
multiplicity of human immunodeficiency virus infections in lymphoid tissue,Dixit NM,,2004,NR,,0,,,,,
evidence for selection of more adapted human immunodeficiency virus type 1 recombinant strains in a dually infected transfusion recipient,Costa LJ,,2004,NR,,0,,,,,
purifying selection masks the mutational flexibility of hiv-1 reverse transcriptase,Smith RA,,2004,NR,,0,,,,,
lack of cd28 expression on hiv-specific cytotoxic t lymphocytes is associated with disease progression,Gamberg J,,2004,NR,,0,,,,,
human immunodeficiency virus - one of nature's greatest evolutionary machines,Martin,,2004,NR,,0,,,,,
establishment of a novel ccr5 and cxcr4 expressing cd4+ cell line which is highly sensitive to hiv and suitable for high-throughput evaluation of ccr5 and cxcr4 antagonist,Princen K,10.1186/1742-4690-1-2,2004,NR,,0,,,,,
heterologous envelope immunogens contribute to aids vaccine protection in rhesus monkeys,Letvin NL,,2004,NR,,0,,,,,
hiv evolution: ctl escape mutation and reversion after transmission,Leslie AJ,10.1038/nm992,2004,NR,,0,,,,,
hiv prevalence in pregnant women in an ethnically diverse population in the uk: 1998-2002,Cortina-Borja M,10.1097/00002030-200402200-00021,2004,NR,,0,,,,,
hiv serostatus disclosure to sexual partners among hiv-positive injection drug users,Parsons JT,10.1089/1087291041703683,2004,NR,,0,,,,,
hiv type 1 bf recombinant strains exhibit different pol gene mosaic patterns: descriptive analysis from 284 patients under treatment failure,Quarleri JF,,2004,NR,,0,,,,,
hiv type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in rwanda,Servais J,10.1089/088922204322996518,2004,NR,,0,,,,,
immune reconstitution following autologous transfers of cd3/cd28 stimulated cd4+ t cells to hiv-infected persons,Bernstein WB,10.1016/j.clim.2004.03.004,2004,NR,,0,,,,,
immune reconstitution inflammatory syndrome in hiv-infected patients with mycobacterial infections starting highly active anti-retroviral therapy,Buckingham SJ,10.1016/j.crad.2003.12.002,2004,NR,,0,,,,,
hiv-1 compartmentalization in diverse leukocyte populations during antiretroviral therapy,Potter SJ,,2004,NR,,0,,,,,
"hiv-1 infection among injection and ex-injection drug users from rio de janeiro, brazil: prevalence, estimated incidence and genetic diversity",Teixeira SL,,2004,NR,,0,,,,,
hiv-1 nucleocapsid protein binds to the viral dna initiation sequences and chaperones their kissing interactions,Egele C,,2004,NR,,0,,,,,
hiv-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy,Hue S,,2004,NR,,0,,,,,
genetic diversity of hiv type 1 in rural eastern cameroon,Ndembi N,,2004,NR,,0,,,,,
"resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-hiv activity",Wang LX,,2004,NR,,0,,,,,
high prevalence of human t-lymphotropic virus type 1 (htlv-1) in immigrant male-to-female transsexual sex workers with hiv-1 infection,Zehender G,10.1002/jmv.20165,2004,NR,,0,,,,,
hiv infections in northwestern cameroon: identification of hiv type 1 group o and dual hiv type 1 group m and group o infections,Yamaguchi J,10.1089/aid.2004.20.944,2004,NR,,0,,,,,
impact on genetic networks in human macrophages by a ccr5 strain of human immunodeficiency virus type 1,Coberley CR,,2004,NR,,0,,,,,
hiv type 1 subtypes among blood donors in the mbeya region of southwest tanzania,Arroyo MA,10.1089/0889222041725235,2004,NR,,0,,,,,
hiv type 1 transmission by human bite,Andreo SMS,10.1089/088922204323048087,2004,NR,,0,,,,,
hiv/aids education and prevention in myanmar,Thwe M,,2004,NR,,0,,,,,
hiv/aids in asia,Ruxrungtham K,10.1016/S0140-6736%2804%2916593-8,2004,NR,,0,,,,,
hiv/aids in sub-saharan africa,Lau C,,2004,NR,,0,,,,,
lack of evidence for protease evolution in hiv-1-infected patients after 2 years of successful highly active antiretroviral therapy,Parera,10.1086/382485,2004,NR,,0,,,,,
host-dependent serum specificity to the v3 domain of hiv-1,Nabatov AA,10.1111/j.0300-9475.2004.01506.x,2004,NR,,0,,,,,
identifying diverse hiv risk groups among american indian young adults: the utility of cluster analysis,Mitchell CM,10.1023/B:AIBE.0000044074.46636.c2,2004,NR,,0,,,,,
improved breadth and potency of an hiv-1-neutralizing human single-chain antibody by random mutagenesis and sequential antigen panning,Zhang MY,,2004,NR,,0,,,,,
influence of cd4+ t cell counts on viral evolution in hiv-infected individuals undergoing suppressive haart,Lorenzo E,10.1016/j.virol.2004.09.015,2004,NR,,0,,,,,
minpd: distance-based phylogenetic analysis and recombination detection of serially-sampled hiv quasispecies,Buendia P,,2004,NR,,0,,,,,
interaction of sulfonated anionic porphyrins with hiv glycoprotein gp120: photodamages revealed by inhibition of antibody binding to v3 and c5 domains,Dairou J,10.1016/S0166-3542%2803%2900176-1,2004,NR,,0,,,,,
molecular epidemiology of hiv in ghana: dominance of crf02_ag,Fischetti L,10.1002/jmv.20070,2004,NR,,0,,,,,
molecular epidemiology of human immunodeficiency virus type 1 sub-subtype a3 in senegal from 1988 to 2001,Meloni ST,,2004,NR,,0,,,,,
pulmonary nocardiosis with multiple cavitary nodules in a hiv-negative immunocompromised patient,Hwang JH,10.2169/internalmedicine.43.852,2004,NR,,0,,,,,
multiple mutations in human immunodeficiency virus-1 integrase confer resistance to the clinical trial drug s-1360,Fikkert V,,2004,NR,,0,,,,,
mutations conferring drug resistance affect eukaryotic expression of hiv type 1 reverse transcriptase,Isaguliants MG,10.1089/088922204773004914,2004,NR,,0,,,,,
minor components of a multi-envelope hiv vaccine are recognized by type-specific t-helper cells,Zhan X,10.1016/j.vaccine.2003.09.028,2004,NR,,0,,,,,
obstacles to successful antiretroviral treatment of hiv-1 infection: problems & perspectives,Potter,,2004,NR,,0,,,,,
oral candida flora from brazilian human immunodeficiency virus-infected patients in the highly active antiretroviral therapy era,Melo NR,,2004,NR,,0,,,,,
selective modification of variable loops alters tropism and enhances immunogenicity of human immunodeficiency virus type 1 envelope,Yang ZY,,2004,NR,,0,,,,,
optimizing the care of minority patients with hiv/aids,Stone VE,,2004,NR,,0,,,,,
phylogenetic analysis of hiv-1 transmission: pol gene sequences are insufficient to clarify true relationships between patient isolates,Sturmer M,10.1097/00002030-200411050-00002,2004,NR,,0,,,,,
phylogenetic characteristics of three new hiv-1 n strains and implications for the origin of group n,Roques P,,2004,NR,,0,,,,,
phylogenetic internal control for hiv-1 genotypic antiretroviral testing,Boeri E,,2004,NR,,0,,,,,
positive and negative consequences of hiv disclosure among seropositive injection drug users,Parsons,10.1521/aeap.16.5.459.48741,2004,NR,,0,,,,,
primary hiv infection,Stekler J,10.1007/s11904-004-0010-2,2004,NR,,0,,,,,
probing alternative foldings of the hiv-1 leader rna by antisense oligonucleotide scanning arrays,Ooms M,,2004,NR,,0,,,,,
spliced human immunodeficiency virus type 1 rna is reverse transcribed into cdna within infected cells,Liang C,,2004,NR,,0,,,,,
"retrospective study to time the introduction of hiv type 1 non-b subtypes in lyon, france, using env genes obtained from primary infection samples",Vachot L,10.1089/0889222041524607,2004,NR,,0,,,,,
recombinant viruses and early global hiv-1 epidemic,Kalish ML,,2004,NR,,0,,,,,
rna interactions in the 5' region of the hiv-1 genome,Damgaard CK,10.1016/j.jmb.2003.12.010,2004,NR,,0,,,,,
relative replication fitness of multi-nucleoside analogue-resistant hiv-1 strains bearing a dipeptide insertion in the fingers subdomain of the reverse transcriptase and mutations at codons 67 and 215,Prado JG,,2004,NR,,0,,,,,
"the raft-promoting property of virion-associated cholesterol, but not the presence of virion-associated brij 98 rafts, is a determinant of human immunodeficiency virus type 1 infectivity",Campbell S,,2004,NR,,0,,,,,
"short communication: retrospective study to time the introduction of hiv type 1 non-b subtypes in lyon, france, using env genes obtained from primary infection samples",Vachot L,,2004,NR,,0,,,,,
prevention with hiv-seropositive men who have sex with men: lessons from the seropositive urban men's study (sums) and the seropositive urban men's intervention trial (sumit),Wolitski RJ,,2004,NR,,0,,,,,
can modulation of viral fitness represent a target for anti-hiv-1 strategies?,Clementi M,,2004,NR,,0,,,,,
a call for replicating vector prime-protein boost strategies in hiv vaccine design,Malkevitch NV,10.1586/14760584.3.4.S105,2004,NR,,0,,,,,
"hiv type 1 circulating recombinant form crf09_cpx from west africa combines subtypes a, f, g, and may share ancestors with crf02_ag and z321",McCutchan FE,10.1089/0889222041725163,2004,NR,,0,,,,,
requirement of diverse t-helper responses elicited by hiv vaccines: induction of highly targeted humoral and ctl responses,Heeney JL,10.1586/14760584.3.4.S53,2004,NR,,0,,,,,
clinical development of microbicides for the prevention of hiv infection,D'Cruz OJ,10.2174/1381612043386374,2004,NR,,0,,,,,
the efficacy of an integrated risk reduction intervention for hiv-positive women with child sexual abuse histories,Wyatt GE,10.1007/s10461-004-7329-y,2004,NR,,0,,,,,
"mutation, fitness, viral diversity, and predictive markers of disease progression in a computational model of hiv type 1 infection",Castiglione F,10.1089/aid.2004.20.1314,2004,NR,,0,,,,,
tryptophan scanning mutagenesis of aromatic residues within the polymerase domain of hiv-1 reverse transcriptase: critical role of phe-130 for p51 function and second-site revertant restoring viral replication capacity,Olivares I,10.1016/j.virol.2004.04.010,2004,NR,,0,,,,,
the subtypes of human immunodeficiency virus in australia and asia,Oelrichs,10.1071/SH03002,2004,NR,,0,,,,,
tc1 effector diversity shows dissociated expression of granzyme b and interferon-gamma in hiv infection,Kleen TO,10.1097/00002030-200402200-00003,2004,NR,,0,,,,,
"surveillance of hiv-1 subtypes among heterosexuals in england and wales, 1997-2000",Tatt ID,,2004,NR,,0,,,,,
smoking behavior in a low-income multiethnic hiv/aids population,Gritz ER,10.1080/14622200310001656885,2004,NR,,0,,,,,
temporal trends in the hiv-1 epidemic in russia: predominance of subtype a,Bobkov AF,,2004,NR,,0,,,,,
the challenge of antiretroviral-drug-resistant hiv: is there any possible clinical advantage?,Zaccarelli,10.2174/1570162043351192,2004,NR,,0,,,,,
"the changing molecular epidemiology of hiv type 1 among northern thai drug users, 1999 to 2002",Tovanabutra S,10.1089/088922204323087705,2004,NR,,0,,,,,
the genetic cohorts: facing the new challenges in infectious diseases the hiv model,Telenti A,10.1157/13063046,2004,NR,,0,,,,,
the lymphocyte hiv reservoir in patients on long-term haart is a memory of virus evolution,Lambotte O,,2004,NR,,0,,,,,
"the molecular epidemiology of hiv type 1 among vietnamese australian injecting drug users in melbourne, australia",Ryan CE,,2004,NR,,0,,,,,
thirteen years hiv-1 sentinel surveillance and indicators for behavioural change suggest impact of programme activities in south-west tanzania,Jordan-Harder B,10.1097/00002030-200401230-00019,2004,NR,,0,,,,,
vaccines and vaccine strategies against hiv,Stratov I,10.2174/1389450043490686,2004,NR,,0,,,,,
weight loss during pregnancy is associated with adverse pregnancy outcomes among hiv-1 infected women,Villamor E,,2004,NR,,0,,,,,
whoqol-hiv for quality of life assessment among people living with hiv and aids: results from the field test,Saxena S,10.1080/09540120412331290194,2004,NR,,0,,,,,
exclusion of hiv epitopes shared with human proteins is prerequisite for designing safer aids vaccines (special issue on hiv),Maksyutov,10.1016/j.jcv.2004.09.007,2004,NR,,0,,,,,
tc1 effector diversity shows dissociated expression of granzyme b and interferon- gamma in hiv infection,Kleen,10.1097/00002030-200402200-00003,2004,NR,,0,,,,,
window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor,Phelps R,10.1111/j.1537-2995.2004.03364.x,2004,NR,,0,,,,,
workshop report: the effects of psychological variables on the progression of hiv-1 disease,Kopnisky KL,10.1016/j.bbi.2003.08.003,2004,NR,,0,,,,,
recognition of variant hiv-1 epitopes from diverse viral subtypes by vaccine-induced ctl,McKinney DM,10.4049/jimmunol.173.3.1941,2004,NR,,0,,,,,
"a cluster of hiv type 1 subtype c sequences from ethiopia, observed in full genome analysis, is not sustained in subgenomic regions",Harris ME,10.1089/088922203771881220,2003,NR,,0,,,,,
"a molecular biologic study of enterocytozoon bieneusi in hiv-infected patients in lima, peru",Sulaiman IM,10.1111/j.1550-7408.2003.tb00642.x,2003,NR,,0,,,,,
a novel taqman real-time pcr assay to estimate ex vivo human immunodeficiency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral therapy,Weber J,10.1099/vir.0.19123-0,2003,NR,,0,,,,,
adherence to medication treatment: a qualitative study of facilitators and barriers among a diverse sample of hiv + men and women in four us cities,Remien RH,10.1023/A:1022513507669,2003,NR,,0,,,,,
a novel approach to perinatal hiv/aids training for doctors and nurses in south africa,Woods DL,,2003,NR,,0,,,,,
a novel long distance base-pairing interaction in human immunodeficiency virus type 1 rna occludes the gag start codon,Abbink TE,,2003,NR,,0,,,,,
a specific subtype c of human immunodeficiency virus type 1 circulates in brazil,Soares MA,,2003,NR,,0,,,,,
advantage of rare hla supertype in hiv disease progression,Trachtenberg E,10.1038/nm893,2003,NR,,0,,,,,
changing transmission fitness of drug-resistant human immunodeficiency virus against a background of evolving antiretroviral therapy [1] (multiple letters),Murray JM,10.1086/378679,2003,NR,,0,,,,,
classification of hiv protease inhibitors on the basis of their antiviral potency using radial basis function neural networks,Patankar SJ,10.1023/A:1025317806473,2003,NR,,0,,,,,
combination antiretroviral therapy results in a rapid increase in t cell receptor variable region beta repertoire diversity within cd45ra cd8 t cells in human immunodeficiency virus-infected children,Kou,10.1086/367674,2003,NR,,0,,,,,
correlates of depressive symptoms among hiv-positive injection drug users: the role of social support,Mizuno Y,10.1080/09540120310001595177,2003,NR,,0,,,,,
correlates of sexual risk behaviors among hiv-positive men who have sex with men,Parsons JT,10.1521/aeap.15.6.383.24043,2003,NR,,0,,,,,
"cryptosporidium species and genotypes in hiv-positive patients in lima, peru",Cama VA,10.1111/j.1550-7408.2003.tb00620.x,2003,NR,,0,,,,,
concerns and coping with hiv: comparisons across groups,Jenkins SR,10.1080/0954012031000105469,2003,NR,,0,,,,,
"diverse repertoire of hiv-1 p24-specific, ifn- gamma -producing cd4+ t cell clones following immune reconstitution on highly active antiretroviral therapy",Boritz,,2003,NR,,0,,,,,
detection of high frequencies of hiv-1 cross-subtype reactive cd8 t lymphocytes in the peripheral blood of hiv-1-infected kenyans,Currier JR,,2003,NR,,0,,,,,
"emergence of complex and diverse crf02-ag/crf06-cpx recombinant hiv type 1 strains in niger, west africa",Mamadou S,,2003,NR,,0,,,,,
hidden messages in the nef gene of human immunodeficiency virus type 1 suggest a novel rna secondary structure,Peleg O,,2003,NR,,0,,,,,
high rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication,Rhodes T,,2003,NR,,0,,,,,
generation of predictive pharmacophore models for ccr5 antagonists: study with piperidine- and piperazine-based compounds as a new class of hiv-1 entry inhibitors,Debnath AK,10.1021/jm030265z,2003,NR,,0,,,,,
nmr studies of the phosphorylation motif of the hiv-1 protein vpu bound to the f-box protein beta-trcp,Coadou G,,2003,NR,,0,,,,,
the human polycomb group eed protein interacts with the integrase of human immunodeficiency virus type 1,Violot S,,2003,NR,,0,,,,,
enhancement of gp120-specific immune responses by genetic vaccination with the human immunodeficiency virus type 1 envelope gene fused to the gene coding for soluble ctla4,Nayak BP,,2003,NR,,0,,,,,
pro-apoptotic activity of hiv-1 auxiliary regulatory protein vpr is subtype-dependent and potently enhanced by nonconservative changes of the leucine residue at position 64,Jian H,,2003,NR,,0,,,,,
"envelope diversity, coreceptor usage and syncytium-inducing phenotype of hiv-1 variants in saliva and blood during primary infection",Freel SA,,2003,NR,,0,,,,,
genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy,Dybul M,,2003,NR,,0,,,,,
role of the human immunodeficiency virus type 1 envelope gene in viral fitness,Rangel HR,,2003,NR,,0,,,,,
diminished rna primer usage associated with the l74v and m184v mutations in the reverse transcriptase of human immunodeficiency virus type 1 provides a possible mechanism for diminished viral replication capacity,Diallo K,,2003,NR,,0,,,,,
a non-replicating adenoviral vector as a potential hiv vaccine,Shiver J,,2003,NR,,0,,,,,
limited breadth of a t-helper cell response to a human immunodeficiency virus envelope protein,Zhan X,,2003,NR,,0,,,,,
human immunodeficiency virus type 1 (hiv-1) induces activation of multiple stats in cd4+ cells of lymphocyte or monocyte/macrophage lineages,Kohler JJ,,2003,NR,,0,,,,,
comparing the ex vivo fitness of ccr5-tropic human immunodeficiency virus type 1 isolates of subtypes b and c,Ball SC,,2003,NR,,0,,,,,
genotypic shuffling' of sequential clones of candida albicans in hiv-infected individuals with and without symptomatic oral candidiasis,Samaranayake YH,10.1099/jmm.0.04972-0,2003,NR,,0,,,,,
haplotype diversity in the interleukin-4 gene is not associated with hiv-1 transmission and aids progression,Modi,10.1007/s00251-003-0541-5,2003,NR,,0,,,,,
has the hiv/aids epidemic changed sexual behaviour of high risk groups in uganda?,Ntozi JP,,2003,NR,,0,,,,,
high prevalence of diverse forms of hiv-1 intersubtype recombinants in central myanmar: geographical hot spot of extensive recombination,Takebe Y,,2003,NR,,0,,,,,
hiv type 1 diversity in northeastern romania in 2000-2001 based on phylogenetic analysis of pol sequences from patients failing antiretroviral therapy,Apetrei C,10.1089/088922203771881266,2003,NR,,0,,,,,
evidence for gag p24-specific cd4 t cells with reduced susceptibility to r5 hiv-1 infection in a uk cohort of hiv-exposed-seronegative subjects,Eyeson J,,2003,NR,,0,,,,,
immunogenicity of multiple gene and clade human immunodeficiency virus type 1 dna vaccines,Kong WP,,2003,NR,,0,,,,,
functional evolution of the hiv-1 envelope glycoprotein 120 association site of glycoprotein 41,Poumbourios P,10.1074/jbc.M305223200,2003,NR,,0,,,,,
functional status and overall quality of life in a multiethnic hiv-positive population,Vidrine DJ,10.1089/108729103321619791,2003,NR,,0,,,,,
genetic diversity of hiv-1 in western kenya: subtype-specific differences in mother-to-child transmission,Yang,10.1097/00002030-200307250-00011,2003,NR,,0,,,,,
genetic therapy for hiv/aids,Poluri,10.1517/14712598.3.6.951,2003,NR,,0,,,,,
"high genetic diversity of hiv-1 strains in chad, west central africa",Vidal N,,2003,NR,,0,,,,,
"identification and distribution of hiv type 1 genetic diversity and protease inhibitor resistance-associated mutations in shanghai, p r china",Zhong P,10.1097/00126334-200309010-00014,2003,NR,,0,,,,,
identification of a cell envelope protein (mtrf) involved in hydrophobic antimicrobial resistance in neisseria gonorrhoeae,Veal WL,,2003,NR,,0,,,,,
"highly divergent hiv type 1 group m sequences evident in karonga district, malawi in the early 1980s",McCormack GP,10.1089/088922203765551782,2003,NR,,0,,,,,
hiv and aids: looking ahead,Weiss RA,10.1038/nm0703-887,2003,NR,,0,,,,,
immunological recovery despite virological failure is independent of human immunodeficiency virus-type 1 resistant mutants in children receiving highly active antiretroviral therapy,Chiappini E,,2003,NR,,0,,,,,
hiv type 1 infection in pygmy hunter gatherers is from contact with bantu rather than from nonhuman primates,Ndembi N,10.1089/088922203765551773,2003,NR,,0,,,,,
"hiv-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation",Kemal KS,,2003,NR,,0,,,,,
integrating qualitative and quantitative methods: comparing hiv-related risk behaviors among puerto rican drug users in puerto rico and new york,Deren S,10.1081/JA-120016563,2003,NR,,0,,,,,
intrafamilial transmission of hiv-1 [1],Casado C,10.1097/00002030-200312050-00018,2003,NR,,0,,,,,
hiv-associated pruritus: etiology and management,Singh F,10.2165/00128071-200304030-00004,2003,NR,,0,,,,,
hiv-mediated gammadelta t cell depletion is specific for vgamma2+ cells expressing the jgamma12 segment,Enders PJ,10.1089/08892220360473934,2003,NR,,0,,,,,
"hiv-positive immigrants in the canary islands, spain: implications for public health in eurpoe",Holguin A,10.1310/9X1G-MJ6L-PBJN-1PVE,2003,NR,,0,,,,,
lamivudine can exert a modest antiviral effect against human immunodeficiency virus type 1 containing the m184v mutation,Quan Y,,2003,NR,,0,,,,,
"lessons learned from hiv treatment interruption: safety, correlates of immune control, and drug sparing",Azzoni L,10.2174/1570162033485212,2003,NR,,0,,,,,
hydrolysis of rna/dna hybrids containing nonpolar pyrimidine isosteres defines regions essential for hiv type 1 polypurine tract selection,Rausch JW,10.1073/pnas.1932546100,2003,NR,,0,,,,,
neutralization of infectivity of diverse r5 clinical isolates of human immunodeficiency virus type 1 by gp120-binding 2'f-rna aptamers,Khati M,,2003,NR,,0,,,,,
mannose-binding lectin in hiv infection: relation to disease progression and highly active antiretroviral therapy,Heggelund,10.1097/00126334-200304010-00002,2003,NR,,0,,,,,
"molecular characteristics of human immunodeficiency virus type 1 subtype c viruses from kwazulu-natal, south africa: implications for vaccine and antiretroviral control strategies",Gordon M,,2003,NR,,0,,,,,
interests in hiv prevention topics of hiv-seropositive men who have sex with men,Courtenay-Quirk C,10.1521/aeap.15.6.401.24040,2003,NR,,0,,,,,
introduction of hiv type 1 non-b subtypes into eastern andalusia through immigration,Alvarez M,10.1002/jmv.10368,2003,NR,,0,,,,,
molecular epidemiology of hiv-1 in venezuela: high prevalence of hiv-1 subtype b and identification of a b/f recombinant infection,Castro E,10.1097/00126334-200303010-00015,2003,NR,,0,,,,,
"mother-to-child transmission of hiv: developing integration of healthcare programmes with clinical, social and basic research studies: report of the international workshop held at chobe marina lodge, kasane, botswana, 21-25 january 2003",Menu E,10.1080/08035250310006025,2003,NR,,0,,,,,
multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy,Frenkel LM,,2003,NR,,0,,,,,
mcp-1-mcp-3-eotaxin gene cluster influences hiv-1 transmission,Modi WS,,2003,NR,,0,,,,,
negative affect and hiv risk in alcohol and other drug (aod) abusing adolescent offenders,Lucenko,10.1300/J029v13n01_01,2003,NR,,0,,,,,
new hiv type 1 crf01_ae/b recombinants displaying unique distribution of breakpoints from incident infections among injecting drug users in thailand,Ramos A,,2003,NR,,0,,,,,
modernization in gum/hiv services: what does it mean?,Robinson AJ,10.1258/095646203321156845,2003,NR,,0,,,,,
molecular investigation of two possible cases of accidental hiv-1 transmission in south africa,Bredell H,,2003,NR,,0,,,,,
monophyletic clade of hiv-1 subtype b in korea: evolutionary pressure or single introduction?,Kim YB,10.1089/088922203322230996,2003,NR,,0,,,,,
on hiv genetic diversity in cuba [2],Ruibal I,10.1097/00002030-200310170-00022,2003,NR,,0,,,,,
mutational patterns of paired blood and rectal biopsies in hiv-infected patients on haart,Monno L,,2003,NR,,0,,,,,
mutations at the cxcr4 interaction sites for amd3100 influence anti-cxcr4 antibody binding and hiv-1 entry,Hatse S,,2003,NR,,0,,,,,
near full-length genomes of 15 hiv type 1 group o isolates,Yamaguchi J,10.1089/088922203322588332,2003,NR,,0,,,,,
pathways for the emergence of multi-dideoxynucleoside-resistant hiv-1 variants,Matsumi S,,2003,NR,,0,,,,,
nuances and shifts in lesbian women's constructions of sti and hiv vulnerability,Dolan KA,10.1016/S0277-9536%2802%2900305-2,2003,NR,,0,,,,,
structure-based prediction of potential binding and nonbinding peptides to hiv-1 protease,Kurt N,,2003,NR,,0,,,,,
prevalence and correlates of hiv serostatus disclosure,O'Brien ME,10.1097/01.OLQ.0000079049.73800.C2,2003,NR,,0,,,,,
progress in the development of an hiv vaccine,Tramont EC,10.1517/14728214.8.1.37,2003,NR,,0,,,,,
progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus,Gandhi RT,,2003,NR,,0,,,,,
quote-hiv: an instrument for assessing quality of hiv care from the patients' perspective,Hekkink CF,10.1136/qhc.12.3.188,2003,NR,,0,,,,,
recent evolutionary history of hiv-1 subtype b - rebuttal,Lukashov VV,10.1007/s00239-002-2439-5,2003,NR,,0,,,,,
recombination of hiv type 1c (c'/c) in ethiopia: possible link of ethhiv-1c' to subtype c sequences from the high-prevalence epidemics in india and southern africa,Pollakis G,10.1089/088922203322588350,2003,NR,,0,,,,,
salivary agglutinin inhibits hiv type 1 infectivity through interaction with viral glycoprotein 120,Wu Z,,2003,NR,,0,,,,,
relationship-specific unsupportive social interactions and depressive symptoms among women living with hiv/aids: direct and moderating effects,Schrimshaw EW,10.1023/A:1024200910092,2003,NR,,0,,,,,
"replication capacity, biological phenotype, and drug resistance of hiv strains isolated from patients failing antiretroviral therapy",Nicastri,10.1002/jmv.10269,2003,NR,,0,,,,,
replication of chimeric human immunodeficiency virus type 1 (hiv-1) containing hiv-2 integrase (in): naturally selected mutations in in augment dna synthesis,Padow M,,2003,NR,,0,,,,,
the ccr5 and cxcr4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype c,Cilliers T,10.1128/JVI.77.7.4449-4456.2003,2003,NR,,0,,,,,
selective recognition of configurational substates of zinc cyclam by carboxylates: implications for the design and mechanism of action of anti-hiv agents,Liang X,10.1002/chem.200304808,2003,NR,,0,,,,,
sexual behavior among injection drug users in 3 indonesian cities carries a high potential for hiv spread to noninjectors,Pisani E,10.1097/00126334-200312010-00007,2003,NR,,0,,,,,
markov modelling of changes in hiv-specific cytotoxic t-lymphocyte responses with time in untreated hiv-1 infected patients,Kousignian I,10.1002/sim.1404,2003,NR,,0,,,,,
"purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the v2 loop derived from sf162, an r5-tropic human immunodeficiency virus type 1 isolate",Srivastava IK,10.1128/JVI.77.20.11244-11259.2003,2003,NR,,0,,,,,
cost-effectiveness analysis of recruitment strategies in a community-based intervention study of hiv-infected persons,Baigis J,10.1080/09540120310001595203,2003,NR,,0,,,,,
regulation of hiv-1 gene transcription: from lymphocytes to microglial cells,Rohr O,10.1189/jlb.0403180,2003,NR,,0,,,,,
hiv-1 fitness and macrophages,Goodenow MM,10.1189/jlb.0403186,2003,NR,,0,,,,,
an hiv type 1 subtype b founder effect in korea: gp160 signature patterns infer circulation of ctl-escape strains at the population level,Daniels RS,10.1089/088922203322280847,2003,NR,,0,,,,,
social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for hiv intervention among adolescent and young adult injection drug users,Fuller CM,10.1097/00126334-200301010-00013,2003,NR,,0,,,,,
sorting out the complexities of hiv-1 fitness [2],Arts EJ,10.1097/00002030-200303280-00026,2003,NR,,0,,,,,
"spreading of hiv-1 subtype g and envb/gagg recombinant strains among injecting drug users in lisbon, portugal",Esteves A,,2003,NR,,0,,,,,
"the diverse older hiv-positive population: a national profile of economic circumstances, social support, and quality of life",Crystal S,,2003,NR,,0,,,,,
the effect of driving distance from medical treatment facility and short-term management outcomes in department of defense beneficiaries newly diagnosed with human immunodeficiency virus,Riddle MS,,2003,NR,,0,,,,,
turnover of env variable region 1 and 2 genotypes in subjects with late-stage human immunodeficiency virus type 1 infection,Kitrinos KM,,2003,NR,,0,,,,,
the influence of the expanding hiv genetic diversity on molecular diagnosis in the philippines,Espantaleon A,10.1258/095646203321156908,2003,NR,,0,,,,,
the molecular epidemiology and drug resistance determination of hiv type 1 subtype b infection in barbados,Gittens MV,,2003,NR,,0,,,,,
translational recoding signals between gag and pol in diverse ltr retrotransposons,Gao X,,2003,NR,,0,,,,,
transmission of hiv type 1 through blood transfusion from an antibody-negative/p24 antigen-negative donor,Toro C,,2003,NR,,0,,,,,
urban women's gender scripts: implications for hiv prevention,Ortiz-Torres B,10.1080/713804639,2003,NR,,0,,,,,
travel and the spread of hiv-1 genetic variants,Perrin,10.1016/S1473-3099(03)00484-5,2003,NR,,0,,,,,
human immunodeficiency virus type-1 (hiv-1) tat protein: mechanisms for activation of host factors and viral pathogenesis,Devadas,,2003,NR,,0,,,,,
widespread adaptive evolution in the human immunodeficiency virus type 1 genome,Yang W,,2003,NR,,0,,,,,
role of baseline pol genotype in hiv-1 fitness evolution,Weber,10.1097/00126334-200308010-00005,2003,NR,,0,,,,,
a human immunodeficiency virus type 1 isolate from an infected person homozygous for ccr5delta32 exhibits dual tropism by infecting macrophages and mt2 cells via cxcr4,Naif HM,,2002,NR,,0,,,,,
a division of labor: dc subsets and hiv receptor diversity,Kavanagh DG,10.1038/ni1002-891,2002,NR,,0,,,,,
altered substrate specificity of drug-resistant human immunodeficiency virus type 1 protease,Dauber DS,,2002,NR,,0,,,,,
"among 46 near full length hiv type 1 genome sequences from rakai district, uganda, subtype d and ad recombinants predominate",Harris ME,10.1089/088922202320886325,2002,NR,,0,,,,,
a predefined epitope-specific monoclonal antibody recognizes eldewa-epitope just presenting on gp41 of hiv-1 o clade,Huang J,10.1016/S0165-2478%2802%2900174-8,2002,NR,,0,,,,,
analysis of length variation in the v1-v2 region of env in nonsubtype b hiv type 1 from uganda,Klevytska AM,10.1089/08892220260139530,2002,NR,,0,,,,,
analysis of sequence diversity at the highly polymorphic cpgp40/15 locus among cryptosporidium isolates from human immunodeficiency virus-infected children in south africa,Leav BA,,2002,NR,,0,,,,,
cd8+ t-cell immunity to hiv infection,Piazza P,10.1016/S0272-2712%2802%2900006-9,2002,NR,,0,,,,,
chemokines as natural hiv antagonists,Verani A,10.2174/1566524023361862,2002,NR,,0,,,,,
clinical trials of hiv vaccines,Graham BS,10.1146/annurev.med.53.082901.104035,2002,NR,,0,,,,,
community effects on the risk of hiv infection in rural tanzania,Bloom SS,10.1136/sti.78.4.261,2002,NR,,0,,,,,
"diverse realities: sexually transmitted infections and hiv in india (special issue: phase-specific strategies for the prevention, control, and elimination of sexually transmitted diseases)",Hawkes,10.1136/sti.78.suppl_1.i31,2002,NR,,0,,,,,
effect of perinatal short-course zidovudine on the clinical and virological manifestations of hiv-1 subtype e infection in infants,Sutthent R,,2002,NR,,0,,,,,
determination of genetic subtypes of hiv type 1 isolated from korean aids patients,Myoung-Don OH,10.1089/08892220260387977,2002,NR,,0,,,,,
emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (t-20) monotherapy,Wei X,,2002,NR,,0,,,,,
diversity of receptors binding hiv on dendritic cell subsets,Turville SG,10.1038/ni841,2002,NR,,0,,,,,
genomic diversity of human immunodeficiency virus type-1 in india,Sahni AK,,2002,NR,,0,,,,,
factors affecting behaviours that address hiv risk among black and white south africans,Peltzer K,,2002,NR,,0,,,,,
"ecologically-minded reconstruction of experiments in hiv prevention: reduce, reuse, and recycle",Rapkin BD,10.1023/A:1019972416867,2002,NR,,0,,,,,
functionally-impaired hiv-1 nef alleles from a mother-child transmissionpair,Roth WW,10.3390/i3101058,2002,NR,,0,,,,,
eilatin ru(ii) complexes display anti-hiv activity and enantiomeric diversity in the binding of rna,Luedtke NW,10.1002/1439-7633%2820020802%293:8%3C766::AID-CBIC766%3E3.0.CO;2-X,2002,NR,,0,,,,,
reverse transcriptase and protease sequence evolution in two hiv-1-infected couples,Palmer S,,2002,NR,,0,,,,,
sequence variability of the integrase protein from a diverse collection of hiv type 1 isolates representing several subtypes,Burns CC,,2002,NR,,0,,,,,
analysis of partial pol and env sequences indicates a high prevalence of hiv type 1 recombinant strains circulating in gabon,Pandrea I,,2002,NR,,0,,,,,
stable expression of primary human immunodeficiency virus type 1 structural gene products by use of a noncytopathic sindbis virus vector,Kong W,,2002,NR,,0,,,,,
selection for human immunodeficiency virus type 1 recombinants in a patient with rapid progression to aids,Liu SL,,2002,NR,,0,,,,,
genotypic and phenotypic analysis of a novel 15-base insertion occurring between codons 69 and 70 of hiv type 1 reverse transcriptase,Lobato RL,,2002,NR,,0,,,,,
on-going generation of multiple forms of hiv-1 intersubtype recombinants in the yunnan province of china,Yang R,,2002,NR,,0,,,,,
"subtypes a, c, g, and recombinant hiv type 1 are circulating in bangladesh",Ljungberg K,,2002,NR,,0,,,,,
hiv among gay and other men who have sex with men in latin america and the caribbean: a hidden epidemic?,Caceres CF,10.1097/00002030-200212003-00005,2002,NR,,0,,,,,
"hiv infection in men who have sex with men, new york city department of health sexually transmitted disease clinics, 1990-1999: a decade of serosurveillance finds that racial disparities and associations between hiv and gonorrhea persist",Torian LV,10.1097/00007435-200202000-00002,2002,NR,,0,,,,,
"hiv is hiv to me': the meanings of treatment, viral load and reinfection for gay men living with hiv",Davis MDM,10.1080/13698570210288,2002,NR,,0,,,,,
"characterization of the south african hiv type 1 subtype c complete 5' long terminal repeat, nef, and regulatory genes",Scriba TJ,,2002,NR,,0,,,,,
persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection,Brenner BG,,2002,NR,,0,,,,,
recombinant glycoprotein vaccines for human immunodeficiency virus-infected children and their effects on viral quasispecies,Essajee SM,,2002,NR,,0,,,,,
identification of a novel clade of human immunodeficiency virus type 1 in democratic republic of congo,Mokili JL,,2002,NR,,0,,,,,
evaluation of the lipa hiv-1 rt assay version 1: comparison of sequence and hybridization based genotyping systems,Sturmer M,,2002,NR,,0,,,,,
exploring the envelope: systematic alteration in the sex-determination system of the nematode caenorhabditis elegans,Hodgkin J,,2002,NR,,0,,,,,
hiv-1 entry and entry inhibitors as therapeutic agents,Starr-Spires LD,10.1016/S0272-2712%2802%2900011-2,2002,NR,,0,,,,,
functional reconstitution of the hiv receptors ccr5 and cd4 in liposomes,Devesa F,10.1046/j.1432-1033.2002.03213.x,2002,NR,,0,,,,,
"genetic diversity and hiv-1 incidence estimation among cocaine users in sao paulo, brazil",Turchi MD,10.1097/00126334-200208150-00009,2002,NR,,0,,,,,
genetic diversity in the human major histocompatibility complex: lessons for vaccination approaches to hiv infection,Mehra NK,10.1159/000066330,2002,NR,,0,,,,,
genetic subtypes of hiv type 1 based on the vpu/env sequences in the republic of congo,Taniguchi Y,,2002,NR,,0,,,,,
human immunodeficiency virus type 1 group m protease in cameroon: genetic diversity and protease inhibitor mutational features,Fonjungo,10.1128/JCM.40.3.837-845.2002,2002,NR,,0,,,,,
high hiv-1 genetic diversity in cuba,Cuevas MT,,2002,NR,,0,,,,,
human retroviruses (hiv and htlv) in brazilian indians: seroepidemiological study and molecular epidemiology of htlv type 2 isolates,Shindo N,,2002,NR,,0,,,,,
intrapatient diversity and its correlation with viral setpoint in human immunodeficiency virus type 1 crf02_a/g-ibng infection,Mani I,,2002,NR,,0,,,,,
"hiv - 1 subtypes, its implications and viral dynamics",Sahni AK,10.1016/S0377-1237(02)80017-X,2002,NR,,0,,,,,
immune reconstitution in hiv-1-infected children on antiretroviral therapy: role of thymic output and viral fitness,Ometto L,,2002,NR,,0,,,,,
hiv multidisciplinary teams work: support services improve access to and retention in hiv primary care (evaluating the contribution of ancillary services in improving access to primary care in the united states under the ryan white care act),Sherer,10.1080/09540120220149975,2002,NR,,0,,,,,
in vitro analysis of human immunodeficiency virus type 1 resistance to nevirapine and fitness determination of resistant variants,Iglesias-Ussel MD,10.1099/0022-1317-83-1-93,2002,NR,,0,,,,,
in vivo hiv-1 compartmentalisation: drug resistance-associated mutation distribution,Devereux HL,,2002,NR,,0,,,,,
hiv type 1 group m clades infecting subjects from rural villages in equatorial rain forests of cameroon,Zhong P,10.1097/00126334-200212150-00007,2002,NR,,0,,,,,
"hiv-1 genetic diversity in western brittany, france",Vallet S,10.1016/S0928-8244%2802%2900338-3,2002,NR,,0,,,,,
inter-and intra-genic intersubtype hiv-1 recombination in rural and semi-urban uganda,Yirrell DL,10.1097/00002030-200201250-00018,2002,NR,,0,,,,,
hiv-1 subtypes in yugoslavia,Stanojevic M,10.1089/088922202317406673,2002,NR,,0,,,,,
"hiv-1 subtypes, its implications and viral dynamics",Sahni AK,,2002,NR,,0,,,,,
maintaining low hiv type 1 env genetic diversity among injection drug users infected with a b/c recombinant and crf01_ae hiv type 1 in southern china,Yu X-F,10.1089/08892220252779719,2002,NR,,0,,,,,
mechanistic studies to understand the progressive development of resistance in human immunodeficiency virus type 1 reverse transcriptase to abacavir,Ray AS,,2002,NR,,0,,,,,
isolation and characterization of an infectious hiv type 1 molecular clone from a patient with primary infection,Takeuchi H,,2002,NR,,0,,,,,
molecular epidemiology of hiv type 1 infection in portugal: high prevalence of non-b subtypes,Esteves A,,2002,NR,,0,,,,,
molecular epidemiology of hiv-1 genetic forms and its significance for vaccine development and therapy,Thomson MM,10.1016/S1473-3099%2802%2900343-2,2002,NR,,0,,,,,
posttraumatic stress disorder in women attending human immunodeficiency virus outpatient clinics,Martinez A,,2002,NR,,0,,,,,
molecular analysis in support of an investigation of a cluster of hiv-1-infected women,Robbins KE,,2002,NR,,0,,,,,
no evidence for persistence of multidrug-resistant viral strains after a 7-month treatment interruption in an hiv-1-infected individual,Walter H,,2002,NR,,0,,,,,
molecular surveillance of hiv-1 field strains in nigeria in preparation for vaccine trials,Agwale SM,,2002,NR,,0,,,,,
reduction of fat accumulation and lipid disorders by individualized light aerobic training in human immunodeficiency virus infected patients with lipodystrophy and/or dyslipidemia,Thoni GJ,,2002,NR,,0,,,,,
regional clustering of shared neutralization determinants on primary isolates of clade c human immunodeficiency virus type 1 from south africa,Bures R,,2002,NR,,0,,,,,
origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure,Kijak GH,,2002,NR,,0,,,,,
rna secondary structure and squence conservation in c1 region of human immunodeficiency virus type 1 env gene,Peleg O,,2002,NR,,0,,,,,
prediction of activity for nonnucleoside inhibitors with hiv-1 reverse transcriptase based on monte carlo simulations,Rizzo RC,10.1021/jm010580q,2002,NR,,0,,,,,
predictors of psychological well-being in a diverse sample of hiv-positive patients receiving highly active antiretroviral therapy,Safren SA,10.1176/appi.psy.43.6.478,2002,NR,,0,,,,,
predicting anti-hiv activity of tibo derivatives: a computational approach using a novel topological descriptor,Sardana S,10.1007/s00894-002-0093-x,2002,NR,,0,,,,,
primary hiv-1 drug resistance in abidjan (cote d'ivoire): a genotypic and phenotypic study,D'Aquin Toni T,10.1097/00002030-200202150-00024,2002,NR,,0,,,,,
project bart: effectiveness of a behavioral intervention to reduce hiv risk in adolescents,Butts JB,,2002,NR,,0,,,,,
"relationship of hiv viral loads, cd4 counts, and haart use to health-related quality of life",Gill,10.1097/00126334-200208150-00004,2002,NR,,0,,,,,
"sex partner support, drug use and sex risk among hiv-negative non-injecting heroin users",Miller M,10.1080/0954012021000031877,2002,NR,,0,,,,,
sexual and drug-using practices of hiv-positive men who frequent public and commercial sex environments,Parsons JT,10.1080/0954012021000031886,2002,NR,,0,,,,,
synthetic aids vaccine by targeting hiv receptor,Wang CY,10.1016/S0264-410X%2802%2900432-2,2002,NR,,0,,,,,
skeletal muscle mitochondrial function and exercise capacity in hiv-infected patients with lipodystrophy and elevated p-lactate levels,Roge BT,10.1097/00002030-200205030-00003,2002,NR,,0,,,,,
hiv/aids prevention education: culturally sensitive and responsive strategies for asian pacific islander american adolescents and young adults,Sileo TW,10.1300/J129v05n01_05,2002,NR,,0,,,,,
in vitro evidence that the untranslated leader of the hiv-1 genome is an rna checkpoint that regulates multiple functions through conformational changes,Berkhout B,10.1074/jbc.M200950200,2002,NR,,0,,,,,
testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade b and other clades from children failing antiretroviral therapy,Brindeiro,10.1128/JCM.40.12.4512-4519.2002,2002,NR,,0,,,,,
modulating influence on hiv/aids by interacting rantes gene variants,An P,10.1073/pnas.142313799,2002,NR,,0,,,,,
the m184v mutation in hiv-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses,Wei X,10.1097/00002030-200212060-00003,2002,NR,,0,,,,,
the sequential introduction of hiv-1 subtype b and crf01_ae in singapore by sexual transmission: accelerated v3 region evolution in a subpopulation of asian crf01 viruses,Kalish ML,10.1006/viro.2002.1691,2002,NR,,0,,,,,
tnf- alpha promoter region gene polymorphisms in hiv-positive patients with lipodystrophy,Maher,10.1097/00002030-200210180-00005,2002,NR,,0,,,,,
to test or not to test: are hispanic men at highest risk for hiv getting tested?,Fernandez MI,10.1080/09540120220123757,2002,NR,,0,,,,,
viral dynamics of hiv-1 infection,Martin D,,2002,NR,,0,,,,,
"vulnerability to hiv and aids of short distance truck drivers stationed, brazil",Villarinho L,,2002,NR,,0,,,,,
viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals,Martinez-Picado J,10.1128/JVI.76.23.12344-12348.2002,2002,NR,,0,,,,,
micronutrient interventions and the hiv pandemic (crc series in modern nutrition),Friis,,2002,NR,,0,,,,,
acute hiv infection: impact on the spread of hiv and transmission of drug resistance,Yerly S,10.1097/00002030-200111230-00010,2001,NR,,0,,,,,
amino acid deletion at codon 67 and thr-to-gly change at codon 69 of human immunodeficiency virus type 1 reverse transcriptase confer novel drug resistance profiles,Imamichi T,,2001,NR,,0,,,,,
a new algorithm for analysis of within-host hiv-1 evolution,Ren F,,2001,NR,,0,,,,,
absence of genetic diversity reduction in the hiv-1 integrated proviral ltr sequence population during successful combination therapy,Ibanez,10.1006/viro.2000.0840,2001,NR,,0,,,,,
antiretroviral resistance mutations among pregnant human immunodeficiency virus type 1-infected women and their newborns in the united states: vertical transmission and clades,Palumbo P,,2001,NR,,0,,,,,
"molecular characterization of a complex, recombinant human immunodeficiency virus type 1 (hiv-1) isolate (a/g/j/k/?): evidence to support the existence of a novel hiv-1 subtype",Paraskevis D,10.1099/0022-1317-82-10-2509,2001,NR,,0,,,,,
changing epidemiology of hiv type 1 infections in india: evidence of subtype b introduction in bombay from a common source,Halani N,,2001,NR,,0,,,,,
bitter-sweet symphony: defining the role of dendritic cell gp120 receptors in hiv infection,Turville SG,10.1016/S1386-6532%2801%2900194-9,2001,NR,,0,,,,,
characterization of rous sarcoma virus gag particles assembled in vitro,Yu F,,2001,NR,,0,,,,,
closely related hiv-1 crf01_ae variant among injecting drug users in northern vietnam: evidence of hiv spread across the vietnam-china border,Kato K,,2001,NR,,0,,,,,
cultural factors influencing hiv risk behavior among dominicans in new york city,Shedlin MG,10.1300/J233v01n01_05,2001,NR,,0,,,,,
dendritic cells and hiv infection; immunity with viral transmission versus compromised cellular immunity?,Knight SC,10.1078/0171-2985-00100,2001,NR,,0,,,,,
different evolutionary patterns are found within human immunodeficiency virus type 1-infected patients,Casado C,10.1099/0022-1317-82-10-2495,2001,NR,,0,,,,,
functional correlates of insertion mutations in the protease gene of human immunodeficiency virus type 1 isolates from patients,Kim EY,,2001,NR,,0,,,,,
genetic and functional diversity of human immunodeficiency virus type 1 subtype b nef primary isolates,Foster JL,,2001,NR,,0,,,,,
establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus,de Ronde A,,2001,NR,,0,,,,,
diversity of hiv-1 subtype e in semen and cervicovaginal secretion,Sutthent R,,2001,NR,,0,,,,,
douching practices among hiv infected and uninfected adolescents in the united states,Vermund SH,10.1016/S1054-139X%2801%2900284-1,2001,NR,,0,,,,,
enhanced efficiency of female-to-male hiv transmission in core groups in developing countries: the need to target men,O'Farrell N,10.1097/00007435-200102000-00005,2001,NR,,0,,,,,
genetic diversity and phylogenetic analysis of human immunodeficiency virus type 1 subtypes circulating in french guiana,Kazanji M,,2001,NR,,0,,,,,
genetic diversity of pneumocystis carinii in hiv-positive and -negative patients as revealed by pcr-sscp typing,Hauser PM,10.1097/00002030-200103090-00004,2001,NR,,0,,,,,
"genetic diversity of pneumocystis carinii isolated from human immunodeficiency virus-positive patients in turin, italy",Volpe G,,2001,NR,,0,,,,,
hbv x protein targets hiv tat-binding protein 1,Barak O,,2001,NR,,0,,,,,
"high-risk behaviours in men from bogota, colombia and the spread of hiv",Miguez-Burbano MJ,10.1258/0956462011924245,2001,NR,,0,,,,,
"identification of human immunodeficiency virus type 1 subtype c gag-, tat-, rev-, and nef-specific elispot-based cytotoxic t-lymphocyte responses for aids vaccine design",Novitsky V,,2001,NR,,0,,,,,
"increasing prevalence of non-clade b hiv-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences",Balotta C,,2001,NR,,0,,,,,
use of patient-derived human immunodeficiency virus type 1 integrases to identify a protein residue that affects target site selection,Harper AL,,2001,NR,,0,,,,,
concordant utilization of macrophage entry coreceptors by related variants within an hiv type 1 primary isolate viral swarm,Singh A,,2001,NR,,0,,,,,
the potent anti-hiv protein cyanovirin-n contains two novel carbohydrate binding sites that selectively bind to man(8) d1d3 and man(9) with nanomolar affinity: implications for binding to the hiv envelope protein gp120,Bewley CA,,2001,NR,,0,,,,,
the ag recombinant ibng and novel strains of group m hiv-1 are common in cameroon,Carr JK,,2001,NR,,0,,,,,
"subtyping hiv-1 infections in taiwan using peptide-enzyme immunoassay, reverse transcription-polymerase chain reaction, and sequencing",Yang JY,,2001,NR,,0,,,,,
recombinant strains of hiv type 1 in the united kingdom,Barlow KL,,2001,NR,,0,,,,,
primary effusion lymphoma in hiv-infected patients with multicentric castleman's disease,Ascoli V,,2001,NR,,0,,,,,
identification of non-b human immunodeficiency virus type 1 subtypes in rural georgia,Womack C,,2001,NR,,0,,,,,
identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system,Wang TH,,2001,NR,,0,,,,,
hiv type 1 genetic diversity and genotypic drug susceptibility in the republic of moldova,Pandrea I,,2001,NR,,0,,,,,
evidence of two distinct subsubtypes within the hiv-1 subtype a radiation,Gao F,,2001,NR,,0,,,,,
"molecular characterization of complex, recombinant human immunodeficiency virus type 1 (hiv-1) isolate (a/g/j/k/?): evidence to support the existence of a novel hiv-1 subtype",Paraskevis D,10.1099/0022-1317-82-10-2509,2001,NR,,0,,,,,
factors affecting quality of life in patients with hiv infection,Douaihy A,,2001,NR,,0,,,,,
feasibility of hiv vaccine efficacy trials in developing countries,Excler,,2001,NR,,0,,,,,
genetic subtypes of hiv type 1 viruses circulating in the czech republic,Reinis M,,2001,NR,,0,,,,,
hiv gp120 v1/v2 and c2-v3 domains glycoprotein compatibility is required for viral replication,Chen M,10.1016/S0168-1702%2801%2900322-7,2001,NR,,0,,,,,
impact of baseline polymorphisms in rt and protease on outcome of highly active antiretroviral therapy in hiv-1-infected african patients,Frater,10.1097/00002030-200108170-00006,2001,NR,,0,,,,,
"individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1",Bleiber G,,2001,NR,,0,,,,,
hiv/aids in caribbean children and adolescents (hiv/aids and children in the english speaking caribbean),Jack,,2001,NR,,0,,,,,
hiv/aids knowledge and self-esteem among adolescents,Oxley GM,,2001,NR,,0,,,,,
kinetics of hiv-1 rna and resistance-associated mutations after cessation of antiretroviral combination therapy,Birk M,,2001,NR,,0,,,,,
"importation of multiple hiv type 1 strains into west papua, indonesia (irian jaya)",Foley B,,2001,NR,,0,,,,,
measuring stigma in people with hiv: psychometric assessment of the hiv stigma scale,Berger BE,,2001,NR,,0,,,,,
molecular characterization of a highly divergent hiv type 1 isolate obtained early in the aids epidemic from the democratic republic of congo,Gao F,,2001,NR,,0,,,,,
monitoring hiv-specific cd8+ t cell responses by intracellular cytokine production,Betts MR,,2001,NR,,0,,,,,
mother-to-child transmission of hiv infection and ctl escape through hla-a2-slyntvatl epitope sequence variation,Goulder PJ,,2001,NR,,0,,,,,
molecular determinants of the human antibody response to hiv-1: implications for disease control,Viau M,,2001,NR,,0,,,,,
naturally occurring sequence polymorphisms within hiv type 1 group o protease,Luk KC,,2001,NR,,0,,,,,
phylogenetic relationships of bovine immunodeficiency virus in cattle and buffaloes based on surface envelope gene sequences: brief report,Meas S,10.1007/s007050170134,2001,NR,,0,,,,,
phylogeny and the origin of hiv-1,Rambaut,10.1038/35074179,2001,NR,,0,,,,,
predicting the unpredictable: transmission of drug-resistant hiv,Blower SM,,2001,NR,,0,,,,,
predictors of high-risk sexual behavior among people living with hiv/aids,Reilly T,10.1023/A:1011384408761,2001,NR,,0,,,,,
replicative fitness in vivo of hiv-1 variants with multiple drug resistance-associated mutations,Devereux HL,,2001,NR,,0,,,,,
t cell expansions in lymph nodes and peripheral blood in hiv-1-infected individuals: effect of antiretroviral therapy,Kostense,10.1097/00002030-200106150-00004,2001,NR,,0,,,,,
the correlates of dietary intake among hiv-positive adults,Kim JH,,2001,NR,,0,,,,,
diverse bf recombinants have spread widely since the introduction of hiv-1 into south america,Carr JK,10.1097/00002030-200110190-00002,2001,NR,,0,,,,,
the potent anti-hiv protein cyanovirin-n contains two novel carbohydrate binding sites that selectively bind to man8 d1d3 and man9 with nanomolar affinity: implications for binding to the hiv envelope protein gp120,Bewley CA,10.1021/ja004040e,2001,NR,,0,,,,,
the role of mch and family planning services in hiv/std control: is integration the answer?,Lush L,,2001,NR,,0,,,,,
the social construction of male 'homosexuality' in india: implications for hiv transmission and prevention,Asthana,10.1016/S0277-9536(00)00167-2,2001,NR,,0,,,,,
timing of the introduction into ethiopia of subcluster c' of hiv type 1 subtype c,Abebe A,,2001,NR,,0,,,,,
toward a definition of hiv expertise: a survey of experienced hiv physicians,Gerbert B,,2001,NR,,0,,,,,
transmission of zidovudine resistant strains of hiv-1: the first wave,Blower,10.1097/00002030-200111230-00014,2001,NR,,0,,,,,
willingness to volunteer in future preventive hiv vaccine trials: issues and perspectives from three us communities,Strauss RP,,2001,NR,,0,,,,,
"molecular characterization of a complex, recombinant human immunodeficiency virus type 1 (hiv-1) isolate (a/g/j/k?): evidence to support the existence of a novel hiv-1 subtype",Paraskevis,,2001,NR,,0,,,,,
survey of nonoccupational hiv postexposure prophylaxis in hospital emergency departments,Kunches,10.1097/00126334-200103010-00008,2001,NR,,0,,,,,
"[molecular epidemiology analysis of hiv-1 subtype e strains found in shenzhen, china]",Feng T,,2000,NR,,0,,,,,
a chimpanzee rhadinovirus sequence related to kaposi's sarcoma-associated herpesvirus/human herpesvirus 8: increased detection after hiv-1 infection in the absence of disease,Greensill J,,2000,NR,,0,,,,,
"a recent outbreak of human immunodeficiency virus type 1 infection in southern china was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form ae and a novel bc recombinant",Piyasirisilp S,,2000,NR,,0,,,,,
advances in hiv treatment and prevention: should treatment optimism lead to prevention pessimism?,Lert F,10.1080/09540120020014291,2000,NR,,0,,,,,
an inhibitory monoclonal antibody binds at the turn of the helix-turn-helix motif in the n-terminal domain of hiv-1 integrase,Yi J,10.1074/jbc.M005499200,2000,NR,,0,,,,,
analysis of env sequence evolution in human immunodeficiency virus-infected patients receiving therapy with nonnucleoside reverse-transcriptase inhibitors,Dykes C,,2000,NR,,0,,,,,
anti-human immunodeficiency virus type 1 gene therapy in human central nervous system-based cells: an initial approach against a potential viral reservoir,Mukhtar M,,2000,NR,,0,,,,,
apparent founder effect during the early years of the san francisco hiv type 1 epidemic (1978-1979),Foley B,,2000,NR,,0,,,,,
challenges in research on drug and sexual risk practices of men who have sex with men: applications of ethnography in hiv epidemiology and prevention,Clatts MC,10.1023/A:1009564524602,2000,NR,,0,,,,,
changes in cellular proliferation rate of lymphocytes after long-distance flights as a possible risk for patients with hiv-infection,Rose DM,,2000,NR,,0,,,,,
comparative analysis of hiv type 1 genotypic resistance across antiretroviral trial treatment regimens,Gilbert PB,10.1089/08892220050140874,2000,NR,,0,,,,,
chemokine signaling and hiv-1 fusion mediated by macrophage cxcr4: implications for target cell tropism,Collman RG,,2000,NR,,0,,,,,
critical role of enhanced cd4 affinity in laboratory adaptation of human immunodeficiency virus type 1,Platt EJ,,2000,NR,,0,,,,,
circumcision in men and the prevention of hiv infection: a 'meta-analysis' revisited,O'Farrell N,10.1258/0956462001915480,2000,NR,,0,,,,,
comparative quantification of diverse serotypes of hiv-1 in plasma from a diverse population of patients,Clarke JR,,2000,NR,,0,,,,,
determination of human immunodeficiency virus type 1 subtypes in taiwan by vpu gene analysis,Lee CN,,2000,NR,,0,,,,,
coping strategies and emotional wellbeing among hiv-infected men and women experiencing aids-related bereavement,Sikkema KJ,10.1080/095401200750003798,2000,NR,,0,,,,,
"distribution and quantification of human immunodeficiency virus type 1, strain jc499, proviral dna in tissues from an infected chimpanzee",Wei Q,,2000,NR,,0,,,,,
diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in thailand,McCutchan FE,10.1089/088922200308792,2000,NR,,0,,,,,
"evaluation of performance of the gen-probe human immunodeficiency virus type 1 viral load assay using primary subtype a, c, and d isolates from kenya",Emery S,,2000,NR,,0,,,,,
evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and aids pathogenesis,Hu QX,,2000,NR,,0,,,,,
"distribution of hiv-1 subtypes in female sex workers of calcutta, india",Mandal D,,2000,NR,,0,,,,,
evolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection,Frost SD,,2000,NR,,0,,,,,
early changes in quasispecies repertoire in hiv-infected infants: correlation with disease progression,Essajee SM,,2000,NR,,0,,,,,
"hiv-1 diversity in brazil: genetic, biologic, and immunologic characterization of hiv-1 strains in three potential hiv vaccine evaluation sites",Bongertz V,10.1097/00126334-200002010-00011,2000,NR,,0,,,,,
emerging genetic diversity of hiv-1 in south america,Russell KL,10.1097/00002030-200008180-00014,2000,NR,,0,,,,,
genetic characterization and phylogenetic analysis of hiv-1 subtype c from uganda,Downing R,,2000,NR,,0,,,,,
"genetic characterization of incident hiv type 1 subtype e and b strains from a prospective cohort of injecting drug users in bangkok, thailand",Subbarao S,,2000,NR,,0,,,,,
genetic diversity of protease and reverse transcriptase sequences in non-subtype-b human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients,Vergne L,,2000,NR,,0,,,,,
hiv heterogeneity and proximity of homestead to roads in rural south africa: an exploration using a geographical information system,Tanser F,10.1046/j.1365-3156.2000.00513.x,2000,NR,,0,,,,,
human immunodeficiency virus vaccine development in developing countries: are efficacy trials feasible?,Excler JL,,2000,NR,,0,,,,,
characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (c/b') recombinant strain in china,Su L,,2000,NR,,0,,,,,
relative replication fitness of a high-level 3'-azido-3'-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (thr-->gly) at codon 69,Imamichi T,,2000,NR,,0,,,,,
heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodeficiency virus type 1 primary-isolate quasispecies,Singh A,,2000,NR,,0,,,,,
evidence of hiv-1 genetic diversity among pregnant women with aids or infected with hiv-1 in central brazil,Stefani,,2000,NR,,0,,,,,
immunogenicity of a novel dna vaccine cassette expressing multiple human immunodeficiency virus (hiv-1) accessory genes,Ayyavoo V,,2000,NR,,0,,,,,
functional association between the nef gene product and gag-pol region of hiv-1,Ono T,,2000,NR,,0,,,,,
genetic analysis of hiv-1 samples from spain,Casado C,,2000,NR,,0,,,,,
genetic diversity of hiv-1: the moving target,Peeters M,,2000,NR,,0,,,,,
genetic diversity of primary hiv-1 isolates and their sensitivity to antibody-mediated neutralization,Gordon CJ,,2000,NR,,0,,,,,
genetic heterogeneity of hiv-1 in greece,Adwan G,,2000,NR,,0,,,,,
genetic subtypes of hiv type 1 in hungary,Mezei M,,2000,NR,,0,,,,,
highly restricted spread of hiv-1 and multiply infected cells within splenic germinal centers,Gratton S,,2000,NR,,0,,,,,
identification of the lymantria dispar nucleopolyhedrovirus envelope fusion protein provides evidence for a phylogenetic division of the baculoviridae,Pearson MN,,2000,NR,,0,,,,,
hiv type 1 envelope subtype c sequences from recent seoconverters in zimbabwe,Batra M,10.1089/08892220050058399,2000,NR,,0,,,,,
hiv type 1 envelope subtype c sequences from recent seroconverters in zimbabwe,Batra M,,2000,NR,,0,,,,,
"hiv-1 diversity in france, 1996-1998",Couturier E,10.1097/00002030-200002180-00011,2000,NR,,0,,,,,
hiv-1 strains from a cohort of american subjects reveal the presence of a v2 region extension unique to slow progressors and non-progressors,Wang B,,2000,NR,,0,,,,,
"hiv-1 subtype c in commercial sex workers in addis ababa, ethiopia",Hussein M,,2000,NR,,0,,,,,
multi-envelope hiv vaccine safety and immunogenicity in small animals and chimpanzees,Lockey TD,,2000,NR,,0,,,,,
hiv/aids managed care program,Bartlett JG,,2000,NR,,0,,,,,
"molecular epidemiology analysis of hiv-1 subtype e strains found in shenzhen, china",Feng T,,2000,NR,,0,,,,,
introduction of hiv type 1 subtype e virus into south korea,Lee JS,,2000,NR,,0,,,,,
molecular epidemiology of hiv type 1 in a rural community in southwest uganda,Kaleebu P,,2000,NR,,0,,,,,
"presence of human immunodeficiency virus (hiv) type 1, group m, non-b subtypes, bronx, new york: a sentinel site for monitoring hiv genetic diversity in the united states",Weidle PJ,,2000,NR,,0,,,,,
molecular typing of streptococcus pneumoniae in northeastern romania: unique clones of s pneumoniae isolated from children hospitalized for infections and from healthy and human immunodeficiency virus-infected children in the community,Porat N,,2000,NR,,0,,,,,
management of acute and early hiv-1 infection,Little SJ,,2000,NR,,0,,,,,
mapping the b cell superantigen binding site for hiv-1 gp120 on a v(h)3 ig,Neshat MN,10.1093/intimm/12.3.305,2000,NR,,0,,,,,
modeling plasma virus concentration during primary hiv infection,Stafford MA,,2000,NR,,0,,,,,
"mololipids, a new series of anti-hiv bromotyramine-derived compounds from a sponge of the order verongida",Ross SA,10.1021/np980414u,2000,NR,,0,,,,,
mother-to-child hiv-1 transmission: state of the art and implications for public policy,Zorrilla CD,,2000,NR,,0,,,,,
no association of hiv-1 envelope (c2-v3-c3) sequence pattern with long-term nonprogression,Machuca R,,2000,NR,,0,,,,,
perceiving benefits in adversity: stress-related growth in women living with hiv/aids,Siegel K,10.1016/S0277-9536%2800%2900144-1,2000,NR,,0,,,,,
"predicting substance abuse among youth with, or at high risk for, hiv",Huba GJ,10.1037/0893-164X.14.2.197,2000,NR,,0,,,,,
prenatal transmission of subtype c hiv-1 in zimbabwe: hiv-1 rna and dna in maternal and cord blood,Guevara H,,2000,NR,,0,,,,,
recent studies on natural products as anti-hiv agents,Jung M,10.2174/0929867003374822,2000,NR,,0,,,,,
reconstruction of hiv-1 transmission chains for forensic purposes,Leitner T,,2000,NR,,0,,,,,
morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral core,Zhang H,,2000,NR,,0,,,,,
significance of hiv-1 genetic subtypes,Alaeus A,10.1080/003655400458695,2000,NR,,0,,,,,
sequential cd4-coreceptor interactions in human immunodeficiency virus type 1 env function: soluble cd4 activates env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120,Salzwedel K,,2000,NR,,0,,,,,
transient t cell receptor beta-chain variable region-specific expansions of cd4+ and cd8+ t cells during the early phase of pediatric human immunodeficiency virus infection: characterization of expanded cell populations by t cell receptor phenotyping,Soudeyns H,,2000,NR,,0,,,,,
structured antiretroviral treatment interruption in heavily-experienced hiv-infected patients,Katlama C,,2000,NR,,0,,,,,
study of full-length porcine endogenous retrovirus genomes with envelope gene polymorphism in a specific-pathogen-free large white swine herd,Bosch S,,2000,NR,,0,,,,,
testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype e,Anderson JP,,2000,NR,,0,,,,,
the detection of proviral dna by semi-nested polymerase chain reaction and phylogenetic analysis of czech maedi-visna isolates based on gag gene sequences,Celer V Jr,,2000,NR,,0,,,,,
relative replication fitness of a high-level 3'-azido-3'-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (thr->gly) at codon 69,Imamichi T,10.1128/JVI.74.23.10958-10964.2000,2000,NR,,0,,,,,
virtually full-length subtype f and f/d recombinant hiv-1 from africa and south america,Laukkanen T,10.1006/viro.2000.0214,2000,NR,,0,,,,,
evidence of the existence of a new circulating recombinant form of hiv type 1 subtype a/j in cameroon,Tscherning-Casper C,10.1089/08892220050117078,2000,NR,,0,,,,,
monoclonal antibodies to native hiv type 1 reverse transcriptase and their interaction with enzymes from different subtypes,Rytting A-S,10.1089/08892220050117041,2000,NR,,0,,,,,
genetic restriction of hiv-1 pathogenesis to aids by promoter alleles of il10,Shin HD,10.1073/pnas.97.26.14467,2000,NR,,0,,,,,
"presence of 2',5'-bis-o-(tert-butyldimethylsilyl)-3'-spiro-5''(4''- amino-1'',2''-oxathiole-2'',2''-dioxide) (tsao)-resistant virus strains in tsao-inexperienced hiv patients",Van Laethem K,10.1089/08892220050042765,2000,NR,,0,,,,,
hiv-1 subtype h near-full length genome reference strains and analysis of subtype-h-containing inter-subtype recombinants,Janssens W,10.1097/00002030-200007280-00009,2000,NR,,0,,,,,
mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during hiv-1-associated dementia,Persidsky Y,,2000,NR,,0,,,,,
"the explosive human immunodeficiency virus type 1 epidemic among injecting drug users of kathmandu, nepal, is caused by a subtype c virus of restricted genetic diversity",Oelrichs RB,,2000,NR,,0,,,,,
"the natural history, current status, and future trends of hiv infection",Lears MK,,2000,NR,,0,,,,,
unusual distribution of mutations associated with serial bottleneck passages of human immunodeficiency virus type 1,Yuste E,,2000,NR,,0,,,,,
unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection,Alexander L,,2000,NR,,0,,,,,
viral dynamics and mutations in the pol gene during primary hiv-1 infection,Cenci A,,2000,NR,,0,,,,,
unprecedented degree of human immunodeficiency virus type 1 (hiv-1) group m genetic diversity in the democratic republic of congo suggests that the hiv-1 pandemic originated in central africa,Vidal N,,2000,NR,,0,,,,,
virological and immunological characteristics of hiv treatment failure,Kaufmann,10.1097/00002030-200008180-00012,2000,NR,,0,,,,,
a family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance,Larder BA,,1999,NR,,0,,,,,
an abnormally long hiv-1 env dna pcr product due to altered sequences of primer binding sites,Boriskin YS,,1999,NR,,0,,,,,
an unusual hiv type 1 env sequence embedded in a mosaic virus from cameroon: identification of a new env clade,Roques P,10.1089/088922299309883,1999,NR,,0,,,,,
changing sexual attitudes and behaviour in china: implications for the spread of hiv and other sexually transmitted diseases,Zhang K,10.1080/09540129947730,1999,NR,,0,,,,,
characterization of subtype a hiv-1 from africa by full genome sequencing,Carr JK,,1999,NR,,0,,,,,
cross-subtype neutralizing antibodies induced in baboons by a subtype e gp120 immunogen based on an r5 primary human immunodeficiency virus type 1 envelope,VanCott TC,,1999,NR,,0,,,,,
diagnosis disclosure by family caregivers to children who have perinatally acquired hiv disease: when the time comes,Ledlie SW,,1999,NR,,0,,,,,
diversity analysis of 14 156 molecules tested by the national cancer institute for anti-hiv activity using the quantitative structure-activity relational expert system mcase,Klopman G,10.1021/jm980451i,1999,NR,,0,,,,,
"emerging hiv infections with distinct subtypes of hiv-1 infection among injection drug users from geographically separate locations in guangxi province, china",Yu X-F,,1999,NR,,0,,,,,
emerging recombinant human immunodeficiency viruses: uneven representation of the envelope v3 region,Renjifo B,,1999,NR,,0,,,,,
"full-length human immunodeficiency virus type 1 genomes from subtype c-infected seroconverters in india, with evidence of intersubtype recombination",Lole KS,,1999,NR,,0,,,,,
general population and hiv prevention: from risk to action,Paicheler G,,1999,NR,,0,,,,,
"genetic heterogeneity of hiv type 1 subtypes in kimpese, rural democratic republic of congo",Mokili JLK,10.1089/088922299310953,1999,NR,,0,,,,,
genetic similarity of hiv type 1 subtype e in a recent outbreak among injecting drug users in northern vietnam to strains in guangxi province of southern china,Kato K,10.1089/088922299310250,1999,NR,,0,,,,,
genetic variability in envelope-associated protein genes of closely related group a strains of respiratory syncytial virus,Zheng H,,1999,NR,,0,,,,,
genetics of hiv-1 infection: chemokine receptor ccr5 polymorphism and its consequences,Carrington M,10.1093/hmg/8.10.1939,1999,NR,,0,,,,,
higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in hiv-1 pol,Gunthard HF,10.1006/viro.1999.9774,1999,NR,,0,,,,,
hiv risk behaviours among gay men who use anabolic steroids,Bolding G,10.1046/j.1360-0443.1999.941218298.x,1999,NR,,0,,,,,
hiv type 1 genetic variability in the northern part of cameroon,Mboudjeka I,,1999,NR,,0,,,,,
"hiv type 1 v3 domain serotyping and genotyping in gauteng, mpumalanga, kwazulu-natal, and western cape provinces of south africa",Engelbrecht S,10.1089/088922299311286,1999,NR,,0,,,,,
hiv-1 dna vaccines,Fomsgaard A,10.1016/S0165-2478%2898%2900135-7,1999,NR,,0,,,,,
hiv-1 infectability of cd4+ lymphocytes with relation to beta-chemokines and the ccr5 coreceptor,Paxton WA,,1999,NR,,0,,,,,
"hiv-1 subtypes among blood donors from rio de janeiro, brazil",Tanuri A,,1999,NR,,0,,,,,
hiv-specific cytotoxic t lymphocyte precursors exist in a cd28-cd8+ t cell subset and increase with loss of cd4 t cells,Lewis DE,,1999,NR,,0,,,,,
hla class i homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection,Tang J,,1999,NR,,0,,,,,
host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution,Bagnarelli P,,1999,NR,,0,,,,,
human immunodeficiency virus type 1 intergroup (m/o) recombination in cameroon,Takehisa J,,1999,NR,,0,,,,,
in vitro immunization with a recombinant antigen carrying the hiv-1 rt248-262 determinant inserted at different locations results in altered tcrvb region usage,Prisco A,10.1016/S0198-8859%2899%2900055-5,1999,NR,,0,,,,,
increased cd4+ t-lymphocyte senescence fraction in advanced human immunodeficiency virus type 1 infection,Nichols WS,10.1046/j.1365-3083.1999.00505.x,1999,NR,,0,,,,,
long terminal repeat promoter/enhancer activity of different subtypes of hiv type 1,Naghavi MH,,1999,NR,,0,,,,,
mechanistic studies examining the efficiency and fidelity of dna synthesis by the 3tc-resistant mutant (184v) of hiv-1 reverse transcriptase,Feng JY,,1999,NR,,0,,,,,
molecular analysis of the full-length genome of hiv type 1 subtype i: evidence of a/g/i recombination,Nasioulas G,,1999,NR,,0,,,,,
molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype c: a set of 23 full-length clones from botswana,Novitsky VA,,1999,NR,,0,,,,,
naturally occurring ccr5 extracellular and transmembrane domain variants affect hiv-1 co-receptor and ligand binding function,Howard OMZ,10.1074/jbc.274.23.16228,1999,NR,,0,,,,,
neutralization of hiv-1 infection of human peripheral blood mononuclear cells (pbmc) : infectivity reduction method,Mascola JR,10.1385/0-89603-369-4:317,1999,NR,,0,,,,,
nmr structure of the chimeric hybrid duplex r(gcaguggc)r(gcca)d(ctgc) comprising the trna-dna junction formed during initiation of hiv-1 reverse transcription,Szyperski T,10.1023/A:1008350604637,1999,NR,,0,,,,,
nmr structure of the complex between the zinc finger protein ncp10 of moloney murine leukemia virus and the single-stranded pentanucleotide d(acgcc): comparison with hiv-ncp7 complexes,Schuler W,,1999,NR,,0,,,,,
origin of hiv-1 in the chimpanzee pan troglodytes troglodytes,Gao F,,1999,NR,,0,,,,,
parallel evolution of drug resistance in hiv: failure of nonsynonymous/synonymous substitution rate ratio to detect selection,Crandall KA,,1999,NR,,0,,,,,
patterns of chemokine receptor fusion cofactor utilization by human immunodeficiency virus type 1 variants from the lungs and blood,Singh A,,1999,NR,,0,,,,,
plasma glutathione concentrations in non-infected infants born from hiv-infected mothers: developmental profile,Chantry CJ,,1999,NR,,0,,,,,
population dynamics of hiv-1 inferred from gene sequences,Grassly NC,,1999,NR,,0,,,,,
presence of multiple hiv subtypes and a high frequency of subtype chimeric viruses in heterosexually infected women,Iversen AK,,1999,NR,,0,,,,,
primary isolate neutralization by hiv type 1-infected patient sera in the era of highly active antiretroviral therapy,Dreyer K,,1999,NR,,0,,,,,
probing interactions between hiv-1 reverse transcriptase and its dna substrate with backbone-modified nucleotides,Marx A,,1999,NR,,0,,,,,
search for the mechanism of genetic variation in the pro gene of human immunodeficiency virus,Rouzine IM,,1999,NR,,0,,,,,
significance of plasma and peripheral blood mononuclear cell derived hiv-1 sequences in establishing epidemiologic linkage between two individuals multiply exposed to hiv-1,Song JZ,10.1006/mpat.1999.0275,1999,NR,,0,,,,,
social support and unsupportive social interactions: their association with depression among people living with hiv,Ingram KM,10.1080/09540129947947,1999,NR,,0,,,,,
"subtypes of human immunodeficiency virus type 1 and disease stage among women in nairobi, kenya",Neilson JR,,1999,NR,,0,,,,,
"the distribution of hiv-1 subtypes in fukuoka, japan",Chijiwa K,,1999,NR,,0,,,,,
the effect of template rna structure on elongation by hiv-1 reverse transcriptase,Klasens BI,,1999,NR,,0,,,,,
the gag domains required for avian retroviral rna encapsidation determined by using two independent assays,Lee Eg,,1999,NR,,0,,,,,
the zimbabwe hiv prevention program for truck drivers and commercial sex workers: a behaviour change intervention,Mupemba,,1999,NR,,0,,,,,
using physical-chemistry-based substitution models in phylogenetic analyses of hiv-1 subtypes,Koshi JM,10.1093/oxfordjournals.molbev.a026100,1999,NR,,0,,,,,
a comprehensive panel of near-full-length clones and reference sequences for non-subtype b isolates of human immunodeficiency virus type 1,Gao F,,1998,NR,,0,,,,,
a molecular epidemiologic survey of hiv in uganda,Rayfield MA,10.1097/00002030-199805000-00014,1998,NR,,0,,,,,
"a sudden epidemic of hiv type 1 among injecting drug users in the former soviet union: identification of subtype a, subtype b, and novel gaga/envb recombinants",Bobkov A,,1998,NR,,0,,,,,
adapting an effective primary care provider std/hiv prevention training programme,Rabin DL,,1998,NR,,0,,,,,
"altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi- dideoxynucleoside resistance",Maeda Y,10.1086/515282,1998,NR,,0,,,,,
alveolar bone levels in aids and hiv seropositive patients and in control subjects,Persson RE,,1998,NR,,0,,,,,
an african hiv-1 sequence from 1959 and implications for the of the epidemic,Zhu T,10.1038/35400,1998,NR,,0,,,,,
"an isolate of human immunodeficiency virus type 1 originally classified as subtype i represents a complex mosaic comprising three different group m subtypes (a, g, and i)",Gao F,,1998,NR,,0,,,,,
antiviral activities of 9-r-2-phosphonomethoxypropyl adenine (pmpa) and bis(isopropyloxymethylcarbonyl)pmpa against various drug-resistant human immunodeficiency virus strains,Srinivas RV,,1998,NR,,0,,,,,
association of non-acquired immunodeficiency syndrome-defining cancers with human immunodeficiency virus infection,Rabkin CS,10.1093/oxfordjournals.jncimonographs.a024168,1998,NR,,0,,,,,
biochemical and immunological characterization of rice homologues of the human immunodeficiency virus-1 tat binding protein and subunit 4 of human 26s proteasome subunits,Suzuka I,,1998,NR,,0,,,,,
characterization of gag and pol sequences from long-term survivors of human immunodeficiency virus type 1 infection,Huang Y,,1998,NR,,0,,,,,
complete nef gene sequence of hiv type 1 subtype b' from professional plasma donors in the people's republic of china,Nerurkar VR,,1998,NR,,0,,,,,
cross-clade cytotoxic t cell response to human immunodeficiency virus type 1 proteins among hla disparate north americans and thais,Lynch JA,10.1086/515652,1998,NR,,0,,,,,
cross-clade envelope glycoprotein 160-specific cd8+ cytotoxic t lymphocyte responses in early hiv type 1 clade b infection,Wilson SE,,1998,NR,,0,,,,,
cross-clade recognition of p55 by cytotoxic t lymphocytes in hiv-1 infection,McAdam S,10.1097/00002030-199806000-00005,1998,NR,,0,,,,,
cxcr4 polymorphisms and hiv-1 pathogenesis [1],Martin MP,10.1097/00042560-199812010-00017,1998,NR,,0,,,,,
detecting undetected hiv-1 variants in african children using degenerate polymerase chain reaction and sequence analyses,Nanteza M,,1998,NR,,0,,,,,
determinations of levels of human immunodeficiency virus type 1 rna in plasma: reassessment of parameters affecting assay outcome,Lew J,,1998,NR,,0,,,,,
diversity of the t-cell receptor bv repertoire in hiv-1-infected patients reflects the biphasic cd4+ t-cell repopulation kinetics during highly active antiretroviral therapy,Kostense S,10.1097/00002030-199818000-00001,1998,NR,,0,,,,,
dual-method use among an ethnically diverse group of women at risk of hiv infection,Riehman KS,10.2307/2991606,1998,NR,,0,,,,,
early effects of a school-based human immunodeficiency virus infection and sexual risk prevention intervention,Siegel DM,,1998,NR,,0,,,,,
epidemiology of hiv-1 infection in opiate users in northern thailand,Celentano DD,10.1097/00042560-199801010-00011,1998,NR,,0,,,,,
evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade a human immunodeficiency virus type 1,Poss M,,1998,NR,,0,,,,,
exclusive and persistent use of the entry coreceptor cxcr4 by human immunodeficiency virus type 1 from a subject homozygous for ccr5 delta32,Michael NL,10.1128/jvi.72.7.6040-6047.1998,1998,NR,,0,,,,,
expression of african swine fever virus envelope protein j13l inhibits vaccinia virus morphogenesis,Jacobs SC,,1998,NR,,0,,,,,
extensive diversification of human immunodeficiency virus type 1 subtype b strains during dual infection of a chimpanzee that progressed to aids,Wei Qing,,1998,NR,,0,,,,,
"extent of antigenic diversity in the v3 region of the surface glycoprotein, gp120, of human immunodeficiency virus type 1 group m and consequences for serotyping",Plantier JC,,1998,NR,,0,,,,,
"extreme founder effect in an hiv type 1 subtype a epidemic among drug users in svetlogorsk, belarus",Lukashov,10.1089/aid.1998.14.1299,1998,NR,,0,,,,,
full genome sequences of human immunodeficiency virus type 1 subtypes g and a/g intersubtype recombinants,Carr JK,,1998,NR,,0,,,,,
further characterization of hiv rna synthesis early after cell-to-cell transmission infection,Kok TW,,1998,NR,,0,,,,,
gag protein epitopes recognized by ela-a-restricted cytotoxic t lymphocytes from horses with long-term equine infectious anemia virus infection,Zhang W,,1998,NR,,0,,,,,
genetic and serologic characterization of hiv type 1 prevailing in myanmar (burma),Kusagawa,10.1089/aid.1998.14.1379,1998,NR,,0,,,,,
genetic characterization of hiv type 1 from migrant workers in three south african gold mines,Bredell H,,1998,NR,,0,,,,,
genetic diversity among mycobacterium avium complex strains recovered from children with and without human immunodeficiency virus infection,Swanson DS,,1998,NR,,0,,,,,
genetic subtypes of hiv-1 in the philippines,Paladin FJ,,1998,NR,,0,,,,,
genotypic changes in human immunodeficiency virus type 1 associated with loss of suppression of plasma viral rna levels in subjects treated with ritonavir (norvir) monotherapy,Eastman,,1998,NR,,0,,,,,
genotypic characterization of human immunodeficiency virus type 1 in greece,Nasioulas G,10.1089/aid.1998.14.685,1998,NR,,0,,,,,
grossly defective nef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor,Salvi R,,1998,NR,,0,,,,,
hiv epidemic -- a global update excerpts from the un world aids day report,Anonymous,,1998,NR,,0,,,,,
"hiv type 1 in thailand, 1994-1995: persistence of two subtypes with low genetic diversity",Subbarao S,,1998,NR,,0,,,,,
hiv-1 diversity in romania,Apetrei C,,1998,NR,,0,,,,,
hiv-1 subtype e incidence and sexually transmitted diseases in a cohort of military conscripts in northern thailand,Nopkesorn,,1998,NR,,0,,,,,
hiv-associated nephropathy,Winston J,,1998,NR,,0,,,,,
identification of a cd36-related thrombospondin 1-binding domain in hiv- 1 envelope glycoprotein gp120: relationship to hiv-1-specific inhibitory factors in human saliva,Crombie R,10.1084/jem.187.1.25,1998,NR,,0,,,,,
identification of the cd36-related thrombospondin 1-binding domain in hiv-1 envelope glycoprotein gp120: relationship to hiv-1-specific inhibitory factors in human saliva,Crombie,10.1084/jem.187.1.25,1998,NR,,0,,,,,
insertions into the beta3-beta4 hairpin loop of hiv-1 reverse transcriptase reveal a role for fingers subdomain in processive polymerization,Kew Y,,1998,NR,,0,,,,,
loss of viral fitness associated with multiple gag and gag-pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivo,Zennou,,1998,NR,,0,,,,,
molecular characterization of five neutralizing anti-hiv type 1 antibodies: identification of nonconventional d segments in the human monoclonal antibodies 2g12 and 2f5,Kunert R,,1998,NR,,0,,,,,
molecular variants of hiv-1 and their impact on vaccine development,Quinn TC,,1998,NR,,0,,,,,
multiple residues contribute to the inability of murine ccr-5 to function as a coreceptor for macrophage-tropic human immunodeficiency virus type 1 isolates,Ross TM,,1998,NR,,0,,,,,
oligoclonal expansion of hiv-specific cytotoxic cd8 t lymphocytes in the skin of hiv-1-infected patients with cutaneous pseudolymphoma,Bachelez H,10.1172/JCI1450,1998,NR,,0,,,,,
pleiotropic effects of hiv-1 protein r (vpr) on morphogenesis and cell survival in fission yeast and antagonism by pentoxifylline,Zhao Y,,1998,NR,,0,,,,,
quantification of the variation due to lysing technique in immunophenotyping of healthy and hiv-infected individuals,Pacifici R,,1998,NR,,0,,,,,
"recombinant production of cyanovirin-n, a potent human immunodeficiency virus-inactivating protein derived from a cultured cyanobacterium",Mori T,,1998,NR,,0,,,,,
regulation of carboxyl-terminal domain phosphatase by hiv-1 tat protein,Marshall NF,,1998,NR,,0,,,,,
relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro,Harrigan PR,,1998,NR,,0,,,,,
resistance-associated loss of viral fitness in human immunodeficiency virus type 1: phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients,Mammano,,1998,NR,,0,,,,,
solution structures of human immunodeficiency virus type 1 (hiv-1) and moloney murine leukemia virus (momlv) capsid protein major-homology-region peptide analogs by nmr spectroscopy,Clish CB,,1998,NR,,0,,,,,
structural studies of synthetic peptide fragments derived from the hiv-1 vpr protein,Luo Z,,1998,NR,,0,,,,,
structure of the complex between the hiv-1 nucleocapsid protein ncp7 and the single-stranded pentanucleotide d(acgcc),Morellet N,,1998,NR,,0,,,,,
superinduction of il-8 in t cells by hiv-1 tat protein is mediated through nf-kappab factors,Ott M,,1998,NR,,0,,,,,
the prevention minimum evaluation data set (pmeds): a tool for evaluating teen pregnancy and std/hiv/aids prevention programs,Card JJ,10.1177/016327879802100305,1998,NR,,0,,,,,
the walden house young adult hiv project: meeting the needs of multidiagnosed youth,Hymel MS,,1998,NR,,0,,,,,
tolerance of diverse amino acid substitutions at conserved positions in the nuclear export signal (nes) of hiv-1 rev,Zhang MJ,10.1006/bbrc.1997.8070,1998,NR,,0,,,,,
"transmission of genetically diverse strains of hiv-1 in pune, india",Gadkari DA,,1998,NR,,0,,,,,
"truck crew and risk of contraction of stds, including hiv: encouraging the use of condoms by the method of applying theories",Bansal RK,,1998,NR,,0,,,,,
"two variants of hiv-1 b serotype are transmitted heterosexually in sao paulo, brazil",Casseb J,,1998,NR,,0,,,,,
unique hiv type 1 v3 region sequences derived from six different regions of brain: region-specific evolution within host-determined quasispecies,Chang J,,1998,NR,,0,,,,,
v3 sequence diversity of hiv-1 subtype e in infected mothers and their infants,Sutthent R,,1998,NR,,0,,,,,
"women hiv sexual risk takers: related behaviors, interpersonal issues, and attitudes",Harlow LL,,1998,NR,,0,,,,,
accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals,Sanchez G,,1997,NR,,0,,,,,
anti-human immunodeficiency virus (anti-hiv) natural products with special emphasis on hiv reverse transcriptase inhibitors,Ng TB,10.1016/S0024-3205%2897%2900245-2,1997,NR,,0,,,,,
applying a feminist analysis model to selected nursing studies of women with hiv,Bunting SM,,1997,NR,,0,,,,,
asymptomatic hiv infection is characterized by rapid turnover of hiv rna in plasma and lymph nodes but not of latently infected lymph-node cd4+ t cells,Stellbrink HJ,,1997,NR,,0,,,,,
attenuated replication of human immunodeficiency virus type 1 with a didanosine-selected reverse transcriptase mutation,Sharma PL,,1997,NR,,0,,,,,
broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215,Goudsmit J,,1997,NR,,0,,,,,
cd4+ t-cell recognition of diverse clade b hiv-1 isolates,Fernandez MH,10.1097/00002030-199703110-00004,1997,NR,,0,,,,,
cd8+ t cell-mediated suppression of hiv long terminal repeat-driven gene expression is not associated with improved clinical status,Copeland KFT,10.1097/00002030-199705000-00005,1997,NR,,0,,,,,
"characterization of pseudorabies virus mutants expressing carboxy-terminal truncations of ge: evidence for envelope incorporation, virulence, and neurotropism domains",Tirabassi RS,,1997,NR,,0,,,,,
chemokines and hiv infection,Gallo RC,10.1097/00001432-199702000-00004,1997,NR,,0,,,,,
clade b-based hiv-1 vaccines elicit cross-clade cytotoxic t lymphocyte reactivities in uninfected volunteers,Ferrari G,,1997,NR,,0,,,,,
coinfection and genetic recombination between hiv-1 strains: possible biological implications in australia and south east asia,Saksena NK,,1997,NR,,0,,,,,
communicating hiv prevention messages in sub-saharan africa: the role of commercial sex workers lessons learned,Blair C,,1997,NR,,0,,,,,
"community capacity to prevent, manage and survive hiv / aids in rural zambia",Bond G,,1997,NR,,0,,,,,
contrasting genetic influence of ccr2 and ccr5 variants on hiv-1 infection and disease progression,Smith,10.1126/science.277.5328.959,1997,NR,,0,,,,,
coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype,Bjorndal A,,1997,NR,,0,,,,,
"correlation between hiv sequence evolution, specific immune response and clinical outcome in vertically infected infants",Halapi E,,1997,NR,,0,,,,,
determination of the minimal amount of tat activity required for human immunodeficiency virus type 1 replication,Verhoef K,,1997,NR,,0,,,,,
divergence of hiv-1 quasispecies in an epidemiologic cluster,Diaz RS,,1997,NR,,0,,,,,
divergent patterns of progression to aids after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses,Liu SL,,1997,NR,,0,,,,,
diversity and distribution of gag and env subtypes among 146 hiv type 1 isolates in taiwan,Chang KSS,10.1089/aid.1997.13.1539,1997,NR,,0,,,,,
diversity of the immunodominant epitope of gp41 of hiv-1 subtype o and its validity for antibody detection,Eberle J,,1997,NR,,0,,,,,
diversity of the vif gene of human immunodeficiency virus type 1 in uganda,Wieland U,,1997,NR,,0,,,,,
editorial: janus considers the hiv pandemic-harnessing recent advances to enhance aids prevention,St Louis,10.2105/AJPH.87.1.10,1997,NR,,0,,,,,
effect of rna secondary structure on rna cleavage catalyzed by hiv-1 reverse transcriptase,Suo Z,10.1021/bi971218+,1997,NR,,0,,,,,
efficient long-term coexpression of a hammerhead ribozyme targeted to the u5 region of hiv-1 ltr by linkage to the multidrug-resistance gene,Lee CG,,1997,NR,,0,,,,,
eliciting hiv-1 envelope-specific antibodies with mixed vaccinia virus recombinants,Rencher SD,,1997,NR,,0,,,,,
establishing a successful hiv counseling and testing service: a blueprint for preventing pediatric hiv infections and translating research into clinical practice,Rips J,10.1016/S0889-8545%2805%2970349-1,1997,NR,,0,,,,,
evaluation of a knowledge- and cognitive-behavioural skills-building intervention to prevent stds and hiv infection in high school students,Boyer,,1997,NR,,0,,,,,
evaluation of a quantitative double elisa strategy for confirmation and differentiation of hiv infection,Rehle TM,10.1016/S0166-0934%2897%2900058-X,1997,NR,,0,,,,,
evaluation of a system using oral mucosal transudate for hiv-1 antibody screening and confirmatory testing,Gallo D,,1997,NR,,0,,,,,
evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease,Salvatori F,,1997,NR,,0,,,,,
exploring attitudes of white dental students regarding willingness to treat people with hiv,Driscoll JM,,1997,NR,,0,,,,,
"frequency of the ccr5 delta 32 mutant allele in hiv-1-positive patients, female sex workers, and a normal population in taiwan",Li C,,1997,NR,,0,,,,,
"genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection",Zhang L,,1997,NR,,0,,,,,
genetic diversity of hiv,Diaz,,1997,NR,,0,,,,,
genetic diversity of human immunodeficiency virus type 1 (hiv-1) in russia,Bobkov,,1997,NR,,0,,,,,
genetic selection in escherichia coli for active human immunodeficiency virus reverse transcriptase mutants,Kim B,,1997,NR,,0,,,,,
genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection,Zhang L,,1997,NR,,0,,,,,
hiv type 1 env gene diversity detected in taiwan,Chang,10.1089/aid.1997.13.201,1997,NR,,0,,,,,
"hiv type 1 isolate z321, the strain used to make a therapeutic hiv type 1 immunogen is intersubtype recombinant",Choi,10.1089/aid.1997.13.357,1997,NR,,0,,,,,
"hiv type 1 subtypes, coreceptor usage, and ccr5 polymorphism",Zhang L,,1997,NR,,0,,,,,
hiv type 1 v3 variation dynamics in vivo: long-term persistence of non- syncytium-inducing genotypes and transient presence of syncytium-inducing genotypes during the course of progressive aids,Ida S,10.1089/aid.1997.13.1597,1997,NR,,0,,,,,
hiv-positive women living in the metropolitan toronto area: their experiences and perceptions related to hiv testing,Jackson LA,,1997,NR,,0,,,,,
"hiv/aids epidemics in sub-saharan africa: dynamism, diversity and discrete declines?",Tarantola D,,1997,NR,,0,,,,,
human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease,Ganeshan S,,1997,NR,,0,,,,,
impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors,Croteau,,1997,NR,,0,,,,,
"in vitro and ex vivo anti-human immunodeficiency virus (hiv) activities of a new water-soluble hiv protease inhibitor, r-87366, containing (2s,3s)- 3-amino-2-hydroxy-4-phenylbutanoic acid",Komai T,10.1248/bpb.20.175,1997,NR,,0,,,,,
in vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues,Wong JK,,1997,NR,,0,,,,,
increasing diversity of hiv-1(m) serotypes in french blood donors over a 10-year period (1985-1995),Barin F,10.1097/00002030-199712000-00015,1997,NR,,0,,,,,
inhibition of human immunodeficiency virus replication by the sulfonated stilbene dye resobene,Halliday,10.1016/S0166-3542(96)00994-1,1997,NR,,0,,,,,
intracellular inhibition of hiv-i replication using a dual protein- and rna-based strategy,Duan L,10.1038/sj.gt.3300422,1997,NR,,0,,,,,
investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17(gag) and env genes,Hughes ES,10.1128/jvi.71.2.1272-1280.1997,1997,NR,,0,,,,,
investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gag and env genes,Hughes ES,,1997,NR,,0,,,,,
lysis of hiv-1-infected cells and inhibition of viral replication by universal receptor t cells,Yang,10.1073/pnas.94.21.11478,1997,NR,,0,,,,,
mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries,Ditzel HJ,,1997,NR,,0,,,,,
molecular epidemiology of hiv in israel,Gehring S,10.1097/00042560-199708010-00008,1997,NR,,0,,,,,
molecular subtyping of the hiv-1 v3 loop sequences detected in hiv-1-positive patients in southern taiwan,Shieh B,,1997,NR,,0,,,,,
most hiv-1 genetic subtypes have entered sweden,Alaeus A,10.1097/00002030-199702000-00010,1997,NR,,0,,,,,
multigene antiviral vectors inhibit diverse human immunodeficiency virus type 1 clades,Gervaix A,,1997,NR,,0,,,,,
multiple human endogenous retrovirus (herv-k) loci with gag open reading frames in the human genome,Mayer J,,1997,NR,,0,,,,,
mutations of the hiv type 1 v3 loop under selection pressure with neutralizing monoclonal antibody nm-01,Yoshida K,,1997,NR,,0,,,,,
neutralization of hiv-1 primary isolates by polyclonal and monoclonal human antibodies,Hioe CE,,1997,NR,,0,,,,,
new mechanisms of viral persistence in primary human immunodeficiency virus (hiv) infection,Soudeyns H,,1997,NR,,0,,,,,
oral transmission of candida albicans between partners in hiv-infected couples could contribute to dissemination of fluconazole-resistant isolates,Dromer F,,1997,NR,,0,,,,,
oral ulcers in hiv-infected patients: an update on epidemiology and diagnosis,Ficarra G,,1997,NR,,0,,,,,
pathogenesis of hiv infection in children,Aldrovandi GM,10.1016/S1058-9813%2897%2900198-7,1997,NR,,0,,,,,
presence of human herpesvirus 8 variants in the oral tissues of human immunodeficiency virus-infected persons,Di Alberti L,,1997,NR,,0,,,,,
presence of human immunodeficiency virus (hiv) type 1 subtype a infection in a new york community with high hiv prevalence: a sentinel site for monitoring hiv genetic diversity in north america,Irwin,10.1086/517343,1997,NR,,0,,,,,
presence of multiple non-b subtypes and divergent subtype b strains of hiv-1 in individuals infected after overseas deployment,Lasky M,,1997,NR,,0,,,,,
production of tnfalpha and il-6 by activated whole blood from hiv-1 infected patients detected by a one-stage procedure: relationship with the phenotype of hiv-1 isolates,Benyoucef S,,1997,NR,,0,,,,,
recognition of a small number of diverse epitopes dominates the cytotoxic t lymphocyte response to hiv type 1 in an infected individual,Lieberman J,10.1089/aid.1997.13.383,1997,NR,,0,,,,,
"relationship of national highway with injecting drug abuse and hiv in rural manipur, india",Sarkar K,,1997,NR,,0,,,,,
safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (hiv) immunoglobulin administered to hiv-infected pregnant women and their newborns,Lambert,10.1093/infdis/175.2.283,1997,NR,,0,,,,,
sequence analysis of hiv-1 group o from norwegian patients infected in the 1960s,Jonassen TO,10.1006/viro.1997.8510,1997,NR,,0,,,,,
sequence note: hiv type 1 env gene diversity detected in taiwan,Chang KSS,10.1089/aid.1997.13.201,1997,NR,,0,,,,,
the flg motif in the n-terminal region of glucoprotein 41 of human immunodeficiency virus type 1 adopts a type-i beta turn in aqueous solution and serves as the initiation site for helix formation,Chang DK,,1997,NR,,0,,,,,
the molecular epidemiology of human immunodeficiency virus type 1 in six cities in britain and ireland,Brown AJ,,1997,NR,,0,,,,,
the rapid spread of recombinants during a natural in vitro infection with two human immunodeficiency virus type 1 strains,Kuwata T,,1997,NR,,0,,,,,
trauma of discovery: women's narratives of being informed they are hiv-infected,Stevens PE,10.1080/713613201,1997,NR,,0,,,,,
ultrastructure of hiv-1 genomic rna,Hoglund S,10.1006/viro.1997.8585,1997,NR,,0,,,,,
update: transmission of hiv-1 from mother to child,Fowler MG,10.1097/00001703-199712000-00001,1997,NR,,0,,,,,
"what women worry about: the place of hiv/aids and stds in health concerns among turkish, second-generation greek, chilean, vietnamese and anglo-australian women",Gifford SM,,1997,NR,,0,,,,,
a critical role for the tar element in promoting efficient human immunodeficiency virus type 1 reverse transcription,Harrich D,,1996,NR,,0,,,,,
activation of coagulation and fibrinolysis in hiv-infected patients,Toulon P,10.1016/S0268-9499(96)80051-8,1996,NR,,0,,,,,
adolescents' perceived risk for stds and hiv infection,Ellen JM,10.1016/1054-139X%2894%2900103-L,1996,NR,,0,,,,,
affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity,Thompson J,,1996,NR,,0,,,,,
an in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high- level resistance to 3'-azido-3'-deoxythymidine,Hooker DJ,10.1128/jvi.70.11.8010-8018.1996,1996,NR,,0,,,,,
"analysis of genetic heterogeneity, antigenicity, and biological characteristics of hiv-1 in a maternal transmitter and nontransmitter patient pair",Ayyavoo V,,1996,NR,,0,,,,,
antibodies reactive with hiv-1 antigens in systemic lupus erythematosus,Gul A,,1996,NR,,0,,,,,
antigenicity of hiv-derived t helper determinants in the context of carrier recombinant proteins: effect on t helper cell repertoire selection,Manca F,10.1002/eji.1830261029,1996,NR,,0,,,,,
cause of oral ulcers in hiv-infected patients: a study of 19 cases,Piluso S,,1996,NR,,0,,,,,
cellular reservoirs of hiv-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry,Bagasra O,,1996,NR,,0,,,,,
complexes of hiv-1 reverse transcriptase with inhibitors of the hept series reveal conformational changes relevant to the design of potent non- nucleoside inhibitors,Hopkins AL,10.1021/jm960056x,1996,NR,,0,,,,,
developing and implementing a group skill training intervention to reduce hiv/aids risk among sexually active adolescents in detention,Richey CA,10.1300/J129v01n01_06,1996,NR,,0,,,,,
development of the hairpin ribozyme as a gene therapy approach to human immunodeficiency virus type-1 infection,Gilles,,1996,NR,,0,,,,,
discovery and optimization of nonpeptide hiv-1 protease inhibitors,Tummino PJ,10.1016/0968-0896%2896%2900134-4,1996,NR,,0,,,,,
diversity of hiv type 1 envelope v3 loop region in saliva,Kakizawa J,10.1089/aid.1996.12.561,1996,NR,,0,,,,,
extensive polymorphisms observed in hiv-1 clade b protease gene using high-density oligonucleotide arrays,Kozal MJ,10.1038/nm0796-753,1996,NR,,0,,,,,
full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from thailand,Carr JK,,1996,NR,,0,,,,,
functional impairment trajectories among persons with hiv disease: a hierarchical linear models approach,Crystal S,,1996,NR,,0,,,,,
genetic variability and function of the long terminal repeat from syncytium-inducing and non-syncytium-inducing human immunodeficiency virus type 1,Simm M,,1996,NR,,0,,,,,
genetic variability of human immunodeficiency virus type 1 in rural northwest tanzania,Robbins,10.1089/aid.1996.12.1389,1996,NR,,0,,,,,
"hiv type 1 diversity in northern paris, france",Simon F,,1996,NR,,0,,,,,
hiv type 1 subtype e in commercial sex workers and injection drug users in southern vietnam,Nerurkar VR,,1996,NR,,0,,,,,
hiv-1 d subtype viruses in finland,Laukkanen T,,1996,NR,,0,,,,,
human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase,Goudsmit J,,1996,NR,,0,,,,,
human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay,Mascola JR,10.1089/aid.1996.12.1319,1996,NR,,0,,,,,
impact of hiv risk and infection and the role of prevention services,Watters JK,10.1016/S0740-5472%2896%2900115-8,1996,NR,,0,,,,,
independent evolution of the env and pol genes of hiv-1 during zidovudine therapy,Brown AJ,,1996,NR,,0,,,,,
lack of screening test sensitivity during hiv-1 non-subtype b seroconversions,Apetrei C,10.1097/00002030-199612000-00002,1996,NR,,0,,,,,
molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes a through g,Gao F,10.1128/jvi.70.3.1651-1667.1996,1996,NR,,0,,,,,
neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype,Weber J,10.1128/jvi.70.11.7827-7832.1996,1996,NR,,0,,,,,
nucleotide substitution patterns can predict the requirements for drug-resistance of hiv-1 proteins,Keulen W,,1996,NR,,0,,,,,
phylogenetic analysis of the env gene of hiv-1 isolates taking into account individual nucleotide substitution rates,Van De Peer Y,10.1097/00002030-199611000-00005,1996,NR,,0,,,,,
predominance of defective proviral sequences in an hiv+ long-term non-progressor,Schwartz DH,10.1016/0165-2478%2896%2902547-3,1996,NR,,0,,,,,
presence of a hypervariable region within the hr2 domain of the host range determining sequences of the envelope protein gp85 (su) of subgroup-a avian sarcoma-leukosis viruses,Hara H,,1996,NR,,0,,,,,
quantification of hiv-1 proviral dna and analysis of genomic diversity by polymerase chain reaction and temperature gradient gel electrophoresis,Wieland U,10.1016/0166-0934%2895%2901977-4,1996,NR,,0,,,,,
requirements for rna polymerase ii carboxyl-terminal domain for activated transcription of human retroviruses human t-cell lymphotropic virus i and hiv-1,Chun RF,,1996,NR,,0,,,,,
risk factors for hiv-1 infection among women in the arusha region of tanzania,Mnyika KS,,1996,NR,,0,,,,,
second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors,Doyon L,,1996,NR,,0,,,,,
sequence analysis of a highly divergent hiv-1-related lentivirus isolated from a wild captured chimpanzee,Vanden Haesevelde,10.1006/viro.1996.0384,1996,NR,,0,,,,,
simultaneous carriage of candida albicans strains from hiv-infected patients with oral candidiasis: multilocus enzyme electrophoresis analysis,Reynes J,,1996,NR,,0,,,,,
"the emerging genetic diversity of hiv: the importance of global surveillance for diagnostics, research, and prevention",Hu DJ,10.1001/jama.275.3.210,1996,NR,,0,,,,,
the tat and c2-v3 envelope genes in the molecular epidemiology of human immunodeficiency virus-1,Lorenzo E,,1996,NR,,0,,,,,
therapeutic potential of nonnucleoside reverse transcriptase inhibitors in the treatment of hiv infection,Spence RA,10.1517/13543784.5.8.985,1996,NR,,0,,,,,
triterpenes as potential dimerization inhibitors of hiv-1 protease,Quere L,10.1006/bbrc.1996.1533,1996,NR,,0,,,,,
women's experiences with hiv/aids: an international perspective,Long,,1996,NR,,0,,,,,
"a genetic analysis of hiv-1 from punjab, india reveals the presence of multiple variants",Jameel S,,1995,NR,,0,,,,,
a mutation in the rcc1-related protein pim1 results in nuclear envelope fragmentation in fission yeast,Demeter J,,1995,NR,,0,,,,,
adaptation to persistent growth in the h9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera,Wrin T,,1995,NR,,0,,,,,
"anthropology, hiv and contingent identities",Gatter PN,10.1016/0277-9536%2895%2900027-5,1995,NR,,0,,,,,
biotypes of oral candida albicans isolates in human immunodeficiency virus-infected patients from diverse geographic locations,Tsang PC,,1995,NR,,0,,,,,
cdr3-independent gammadelta vdelta1+ t cell expansion in the peripheral blood of hiv-infected persons,Boullier S,,1995,NR,,0,,,,,
conservation of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo,Sova P,,1995,NR,,0,,,,,
considering individual differences in the design of preventive interventions: hiv primary prevention as an example,Wagner EF,,1995,NR,,0,,,,,
detection of diverse hiv-1 genetic subtypes in the usa,Brodine SK,,1995,NR,,0,,,,,
distribution of linear antigenic epitopes on gp120 encoded in sibling clones of novel new york hiv-1 subtype b isolates,Riley JP,,1995,NR,,0,,,,,
electron spin echo envelope modulation spectroscopic analysis of altered nitrogenase mofe proteins from azotobacter vinelandii,DeRose VJ,,1995,NR,,0,,,,,
genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of african origin,Louwagie J,,1995,NR,,0,,,,,
high resolution analysis of hiv-1 quasispecies in the brain,Monken CE,,1995,NR,,0,,,,,
"hiv risk characteristics of young adult, adult, and older adult women who live in inner-city housing developments: implications for prevention",Heckman TG,10.1089/jwh.1995.4.397,1995,NR,,0,,,,,
hiv-1 reverse transcriptase-associated rnase h cleaves rna/rna in arrested complexes: implications for the mechanism by which rnase h discriminates beween rna/rna and rna/dna,Gotte M,,1995,NR,,0,,,,,
hiv-1 variants in south and south-east asia,Tsuchie H,,1995,NR,,0,,,,,
hiv/aids surveillance system and reported cases of human immunodeficiency virus infection and acquired immunodeficiency syndrome in japan (1983-1993),Miyazaki M,,1995,NR,,0,,,,,
in vitro interaction of the human immunodeficiency virus type 1 tat transactivator and the general transcription factor tfiib with the cellular protein tap,Yu L,,1995,NR,,0,,,,,
in vivo emergence of hiv-1 variants resistant to multiple protease inhibitors,Condra,10.1038/374569a0,1995,NR,,0,,,,,
"lack of induction of antibodies specific for conserved, discontinuous epitopes of hiv-1 envelope glycoprotein by candidate aids vaccines",VanCott TC,,1995,NR,,0,,,,,
low copy number and limited variability of proviral dna in alveolar macrophages from hiv-1-infected patients: evidence for genetic differences in hiv-1 between lung and blood macrophage populations,Nakata K,,1995,NR,,0,,,,,
molecular cloning and characterization of a cellular protein that interacts with the human immunodeficiency virus type 1 tat transactivator and encodes a strong transcriptional activation domain,Yu L,,1995,NR,,0,,,,,
optimal scaling of hiv-related sexual risk behaviors in ethnically diverse homosexually active men,Cochran SD,10.1037/0022-006X.63.2.270,1995,NR,,0,,,,,
persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual,Iversen AK,,1995,NR,,0,,,,,
phylogenetic analyses of 55 retroelements on the basis of the nucleotide and product amino acid sequences of the pol gene,Li MD,,1995,NR,,0,,,,,
phylogenetic analysis of primate foamy viruses by comparison of pol sequences,Schweizer M,10.1006/viro.1995.1120,1995,NR,,0,,,,,
sexual repertoires of heterosexuals: implications for hiv/sexually transmitted disease risk and prevention,Messiah A,,1995,NR,,0,,,,,
solution structure of the hydrophilic region of hiv-1 encoded virus protein u (vpu) by cd and 1h nmr spectroscopy,Wray V,,1995,NR,,0,,,,,
structure of hiv-1 rt/tibo r 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors,Ding J,10.1038/nsb0595-407,1995,NR,,0,,,,,
the detection of hiv-1 proviral dna by pcr in clotted blood specimens,Boriskin YuS,,1995,NR,,0,,,,,
"the evolving molecular epidemiology of hiv-1 envelope subtypes in injecting drug users in bangkok, thailand: implications for hiv vaccine trials",Kalish ML,,1995,NR,,0,,,,,
the social dynamics of hiv transmission as reflected through discordant couples in rural uganda,Serwadda D,,1995,NR,,0,,,,,
use of ethnography in the evaluation and targeting of hiv/aids education among latino farm workers,Bletzer KV,,1995,NR,,0,,,,,
v3 peptide binding pattern and hiv-1 transmission route in rio de janeiro,Pinto ME,,1995,NR,,0,,,,,
vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1,Girard M,,1995,NR,,0,,,,,
variable region light chain genes encoding human antibodies to hiv-1,David D,10.1016/0161-5890%2894%2900109-E,1995,NR,,0,,,,,
"""but i know my man!"" hiv/aids risk appraisals and heuristical reasoning patterns among childbearing women",Kinsey KK,,1994,NR,,0,,,,,
a new anti-hiv gene therapy strategy diversion of gp160 to lysosomes,Tang J,,1994,NR,,0,,,,,
"alkaloidal glycosidase inhibitors (agis) as the cause of sporadic scrapie, and the potential treatment of both transmissible spongiform encephalopathies (tses) and human immunodeficiency virus (hiv) infection",Dealler S,,1994,NR,,0,,,,,
analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes,Albert J,,1994,NR,,0,,,,,
assessment and psychotherapeutic intervention for an hiv-infected preschool child,Trad PV,,1994,NR,,0,,,,,
certain hla-dr5 and -dr6 major histocompatibility complex class ii alleles are associated with a cd8 lymphocytic host response to human immunodeficiency virus type 1 characterized by low lymphocyte viral strain heterogeneity and slow disease progression,Itescu S,,1994,NR,,0,,,,,
characteristics of individuals using different hiv/aids counseling and testing programs,Hong BA,10.1097/00002030-199402000-00015,1994,NR,,0,,,,,
characterization and molecular basis of heterogeneity of the african swine fever virus envelope protein p54,Rodriguez F,,1994,NR,,0,,,,,
characterization of human immunodeficiency virus type 1 dimeric rna from wild-type and protease-defective virions,Fu W,,1994,NR,,0,,,,,
cloning and biological characterization of human single-chain fv fragments that mediate neutralization of hiv-1,Srikantan V,10.1097/00002030-199411000-00002,1994,NR,,0,,,,,
dissociation rate of antibody-gp120 binding interactions is predictive of v3-mediated neutralization of hiv-1,VanCott TC,,1994,NR,,0,,,,,
efficient neutralization of primary isolates of hiv-1 by a recombinant human monoclonal antibody,Burton DR,,1994,NR,,0,,,,,
"female adolescents at high, moderate, and low risk of exposure to hiv: differences in knowledge, beliefs, and behavior",Millstein SG,10.1016/1054-139X%2894%2990540-1,1994,NR,,0,,,,,
genetic variability of hiv type 1 in kenya,Janssens W,,1994,NR,,0,,,,,
helper-cytotoxic t lymphocyte (ctl) determinant linkage required for priming of anti-hiv cd8+ ctl in vivo with peptide vaccine constructs,Shirai M,,1994,NR,,0,,,,,
hiv-1 nef leads to inhibition or activation of t cells depending on its intracellular localization,Baur AS,,1994,NR,,0,,,,,
human immunodeficiency virus infection in long-distance truck drivers in east africa,Bwayo J,,1994,NR,,0,,,,,
human immunodeficiency virus type 1 strains in the lungs of infected individuals evolve independently from those in peripheral blood and are highly conserved in the c-terminal region of the envelope v3 loop,Itescu S,10.1073/pnas.91.24.11378,1994,NR,,0,,,,,
identification of an env g subtype and heterogeneity of hiv-1 strains in the russian federation and belarus,Bobkov A,,1994,NR,,0,,,,,
identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes b and f in two epidemiologically linked individuals from brazil,Sabino EC,,1994,NR,,0,,,,,
lack of hiv transmission in the practice of a dentist with aids,Jaffe HW,,1994,NR,,0,,,,,
long distance truck drivers in india: hiv infection and their possible role in disseminating hiv into rural areas,Singh YN,,1994,NR,,0,,,,,
longitudinal analysis of t cell receptor (tcr) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic t lymphocyte clones reveals a limited tcr repertoire,Kalams SA,,1994,NR,,0,,,,,
macrogolgin - a new 376 kd golgi complex outer membrane protein as target of antibodies in patients with rheumatic diseases and hiv infections,Seelig HP,10.1006/jaut.1994.1006,1994,NR,,0,,,,,
molecular and virological effects of intracellular anti-rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strains,Duan L,,1994,NR,,0,,,,,
molecular epidemiology of hiv-1 in the former soviet union: analysis of env v3 sequences and their correlation with epidemiologic data,Bobkov A,,1994,NR,,0,,,,,
mutational trends in v3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1,Korber BT,,1994,NR,,0,,,,,
presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in uganda,Bruce C,,1994,NR,,0,,,,,
sensitivity of hiv-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate,Carroll SS,,1994,NR,,0,,,,,
serological and nucleic acid analyses for hiv and htlv infection on archival human plasma samples from zaire,Dube DK,,1994,NR,,0,,,,,
"socio-geographical patterns of hiv-1 transmission in kagera region, tanzania",Killewo J,10.1016/0277-9536%2894%2990307-7,1994,NR,,0,,,,,
"solution structure of rp 71955, a new 21 amino acid tricyclic peptide active against hiv-1 virus",Frechet D,,1994,NR,,0,,,,,
spatial proximity of the hiv-1 nucleocapsid protein zinc fingers investigated by time-resolved fluorescence and fluorescence resonance energy transfer,Mely Y,,1994,NR,,0,,,,,
substance abuse and hiv infection,Ostrow DG,,1994,NR,,0,,,,,
systemic lymphadenopathic histology in human immunodeficiency virus-1- seropositive drug addicts without apparent acquired immunodeficiency syndrome,Burke AP,10.1016/0046-8177%2894%2990196-1,1994,NR,,0,,,,,
systemic lymphadenopathic histology in human immunodeficiency virus-1-seropositive drug addicts without apparent acquired immunodeficiency syndrome,Burke AP,,1994,NR,,0,,,,,
t cell receptor gammadelta repertoire in hiv-1-infected individuals,Hinz T,10.1002/eji.1830241219,1994,NR,,0,,,,,
the risk of hiv infection in a national sample of women with injection drug-using partners,Tortu S,,1994,NR,,0,,,,,
two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype,Mascola JR,,1994,NR,,0,,,,,
viral variability and serum antibody response in a laboratory worker infected with hiv type 1 (htlv type iiib),Reitz MS Jr,,1994,NR,,0,,,,,
vpu and env sequence variability of hiv-1 isolates from tanzania,Siwka W,,1994,NR,,0,,,,,
"a comparative study of the solution structures of tachyplesin i and a novel anti-hiv synthetic peptide, t22 ([tyr5,12, lys7]-polyphemusin ii), determined by nuclear magnetic resonance",Tamamura H,,1993,NR,,0,,,,,
a fractal model of hiv transmission on complex sociogeographic networks: towards analysis of large data sets,Wallace R,,1993,NR,,0,,,,,
a hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1,Yu M,,1993,NR,,0,,,,,
age-adjusted cd4+ lymphocyte parameters in healthy children at risk for infection with the human immunodeficiency virus,Waecker Jr NJ,,1993,NR,,0,,,,,
"alternative splicing of human immunodeficiency virus type 1 mrna modulates viral protein expression, replication, and infectivity",Purcell DF,,1993,NR,,0,,,,,
analysis of a new subtype of hiv-1 gag sequence from a case of vertical transmission in taiwan,Chang KS,,1993,NR,,0,,,,,
analysis of gammadelta+ t cells in peripheral blood of children with perinatal human immunodeficiency virus (hiv) infection,Kozbor D,10.1007/BF00919972,1993,NR,,0,,,,,
anthropology and hiv /aids prevention in kenya new ways of cooperation,Nyamwaya DO,,1993,NR,,0,,,,,
comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors,Byrnes VW,,1993,NR,,0,,,,,
endoscopic characterization of idiopathic esophageal ulceration associated with human immunodeficiency virus infection,Wilcox CM,,1993,NR,,0,,,,,
further characterization of an antigenic site of hiv-1 gp120 recognized by virus neutralizing human monoclonal antibodies,Schutten M,,1993,NR,,0,,,,,
glycoprotein of human immunodeficiency virus type 1 synthesized in chronically infected molt3 cells acquires heterogeneous oligosaccharide structures,Pal R,,1993,NR,,0,,,,,
greater diversity of the hiv-1 v3 neutralization domain in tanzania compared with the netherlands: serological and genetic analysis,Zwart G,,1993,NR,,0,,,,,
hiv antibody testing in the antenatal clinic: the views of the consumers,Meadows J,,1993,NR,,0,,,,,
hiv infection,Britton CB,,1993,NR,,0,,,,,
"hiv infection among long-distance truck drivers in delhi, india",Singh,,1993,NR,,0,,,,,
hiv transmission through social and geographical networks in uganda,Obbo C,10.1016/0277-9536%2893%2990086-J,1993,NR,,0,,,,,
hiv-1 reverse transcriptase: a diversity generator and quasispecies regulator,Munoz JL,10.1111/j.1749-6632.1993.tb26257.x,1993,NR,,0,,,,,
"hiv-1 strains from india are highly divergent from prototypic african and us/european strains, but are linked to a south african isolate",Dietrich U,,1993,NR,,0,,,,,
increasing antigenic and genetic diversity of the v3 variable domain of the human immunodeficiency virus envelope protein in the course of the aids epidemic,Kuiken CL,,1993,NR,,0,,,,,
independent divergences in the cd4 binding site and v3 loop encoded in two seroprevalent ugandan hiv-1 clinical isolates,Pestano G,,1993,NR,,0,,,,,
independent variation and positive selection in env v1 and v2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo,Lamers SL,,1993,NR,,0,,,,,
intracellular diversion of glycoprotein gp160 of human immunodeficiency virus to lysosomes as a strategy of aids gene therapy,Lin X,,1993,NR,,0,,,,,
kinetic analysis of templateprimer interactions with recombinant forms of hiv-1 reverse transcriptase,Beard WA,,1993,NR,,0,,,,,
making hiv prevention work in the north,Crown M,,1993,NR,,0,,,,,
mechanism of hiv-1 reverse transcriptase termination of processive synthesis on a natural dna template is influenced by the sequence of the template-primer stem,Abbotts J,,1993,NR,,0,,,,,
methionyl-trna synthetase zinc binding domain three-dimensional structure and homology with rubredoxin and gag retroviral proteins,Fourmy D,,1993,NR,,0,,,,,
molecular epidemiology of hiv-1 based on phylogenetic analysis of in vivo gag p7/p9 direct sequences,Salminen M,,1993,NR,,0,,,,,
phylogenetic analysis of gag genes from 70 international hiv-1 isolates provides evidence for multiple genotypes,Louwagie J,,1993,NR,,0,,,,,
preferential vbeta usage by cytotoxic t cells cross-reactive between two epitopes of hiv-1 gp160 and degenerate in class i mhc restriction,Shirai M,,1993,NR,,0,,,,,
prostitution and risk of hiv: female prostitutes in london,Ward H,,1993,NR,,0,,,,,
risks of human immunodeficiency virus infection among adolescents attending three diverse clinics,Moscicki AB,,1993,NR,,0,,,,,
technical challenges and scientific issues: genetic subtypes of hiv-1,Louwagie J,,1993,NR,,0,,,,,
the origin of hiv-1 isolate htlv-iiib,Chang SY,,1993,NR,,0,,,,,
transcriptional and post-transcriptional mechanisms are involved in the absence of cd4 surface expression in two hiv-1 chronically infected t cell lines,Serpente N,,1993,NR,,0,,,,,
v3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1,Kliks SC,,1993,NR,,0,,,,,
virus excretion in the cervicovaginal secretions of pregnant and nonpregnant hiv-infected women,Henin Y,,1993,NR,,0,,,,,
"women and hiv: an eap professional's concerns with prevention, identification and assistance",Mason S,10.1300/J022v09n03_09,1993,NR,,0,,,,,
"a potential gene target in hiv-1: rationale, selection of a conserved sequence, and determination of nmr distance and torsion angle constraints",Mujeeb A,10.1021/bi00154a002,1992,NR,,0,,,,,
a vertically transmitted hiv-1 gag-subtype variant detected in taiwan,Guo HG,,1992,NR,,0,,,,,
antibodies of hiv-1 positive subjects and experimentally immunized primates and rodents bind to sequence divergent regions of the third variable domain (v3) of gp120,Boudet F,,1992,NR,,0,,,,,
assessment of hiv-1 antigenic diversification using serum as sample source,Goudsmit J,,1992,NR,,0,,,,,
comparison of antibody reactivity to human immunodeficiency virus type 1 (hiv-1) gp160 epitopes in sera from hiv-1-infected individuals from tanzania and from the united states,Warren RQ,,1992,NR,,0,,,,,
"complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation",Li Y,,1992,NR,,0,,,,,
content and design of laboratory report forms for human immunodeficiency virus type 1 antibody testing,Hewitt DJ,,1992,NR,,0,,,,,
convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient,Holmes EC,,1992,NR,,0,,,,,
determination of the structure of the nucleocapsid protein ncp7 from the human immunodeficiency virus type 1 by 1h nmr,Morellet N,,1992,NR,,0,,,,,
distinct populations of human immunodeficiency virus type 1 in blood and cerebrospinal fluid,Steuler H,,1992,NR,,0,,,,,
evaluation of viral-lysate enzyme-linked immunosorbent assay kits for detecting human immunodeficiency virus (type 1) infections using human sera standardized by quantitative western blotting,Hardy CT,,1992,NR,,0,,,,,
generation and characterization of a human monoclonal antibody that neutralizes diverse hiv-1 isolates in vitro,Lake DF,,1992,NR,,0,,,,,
"genetic comparison of hiv-1 isolates from africa, europe, and north america",Louwagie J,,1992,NR,,0,,,,,
geographic diversity of human immunodeficiency virus type 1: serologic reactivity to env epitopes and relationship to neutralization,Cheingsong-Popov,10.1093/infdis/165.2.256,1992,NR,,0,,,,,
hiv-1 sequence variation between isolates from mother-infant transmission pairs,Wike CM,,1992,NR,,0,,,,,
human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro,Kusumi K,,1992,NR,,0,,,,,
identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors,Condra JH,,1992,NR,,0,,,,,
idiotypic expression of anti-gp120 antibodies in unrelated human immunodeficiency virus-infected individuals,Fevrier M,,1992,NR,,0,,,,,
macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual v3 envelope sequence homogeneity in comparison with t-cell-tropic isolates: definition of critical amino acids involved in cell tropism,Chesebro B,,1992,NR,,0,,,,,
mechanism and fidelity of hiv reverse transcriptase,Kati WM,,1992,NR,,0,,,,,
molecular epidemiology of hiv transmission in a dental practice,Ou CY,,1992,NR,,0,,,,,
"molecular structures of two new anti-hiv nucleoside analogs: 9-(2,3-dideoxy-2-fluoro-beta- d-threo-pentofuranosyl)adenine and 9-(2,3-dideoxy-2-fluoro-beta-d-threo-pentofuranosyl) hypoxanthine",Liaw Y-C,,1992,NR,,0,,,,,
perinatal transmission of human immunodeficiency virus-1 infection and maternal immunization strategies for prevention,Ukwu HN,,1992,NR,,0,,,,,
rapid and simple characterization of in vivo hiv-1 sequences using solid-phase direct sequencing,Salminen M,,1992,NR,,0,,,,,
"status and trend of hiv-1 infection and aids in taiwan, december, 1991",Chang PY,,1992,NR,,0,,,,,
substance use among women at risk for hiv infection,Wambach KG,10.2190/36BW-GNR7-Y55K-2JMJ,1992,NR,,0,,,,,
synthesis and conformational studies of n-glycosylated analogues of the hiv-1 principal neutralizing determinant,Laczko I,10.1021/bi00132a019,1992,NR,,0,,,,,
synthetic peptides from a conserved region of gp120 induce broadly reactive anti-hiv responses,Morrow WJ,,1992,NR,,0,,,,,
testing renal patients for hiv: guidelines,Anonymous,10.7748/ns.6.46.32.s43,1992,NR,,0,,,,,
two major groups of neutralizing anti-gp120 antibodies exist in hiv- infected individuals: evidence for epitope diversity around the cd4 attachment site,Chamat S,,1992,NR,,0,,,,,
varied potential risks of hiv infection among prostitutes,Jackson L,10.1016/0277-9536%2892%2990024-K,1992,NR,,0,,,,,
wide distribution of two subtypes of hiv-1 in thailand,Ou CY,,1992,NR,,0,,,,,
aids epidemiology: inconsistencies with human immunodeficiency virus and with infectious disease,Duesberg,10.1073/pnas.88.4.1575,1991,NR,,0,,,,,
american academy of pediatrics committee on sports medicine and fitness: human immunodeficiency virus [acquired immunodeficiency syndrome (aids) virus] in the athletic setting,Anonymous,,1991,NR,,0,,,,,
c-terminal retroviral-type zinc finger domain from the hiv-1 nucleocapsid protein is structurally similar to the n-terminal zinc finger domain,South TL,,1991,NR,,0,,,,,
dextrin sulphate and fucoidan are potent inhibitors of hiv infection in vitro,McClure MO,10.1177/095632029100200304,1991,NR,,0,,,,,
evolution of human immunodeficiency virus type 1 nucleotide sequence diversity among close contacts,Burger H,,1991,NR,,0,,,,,
generation of hybrid human immunodeficiency virus utilizing the contransfection method and analysis of cellular tropism,Velpandi A,10.1128/jvi.65.9.4847-4852.1991,1991,NR,,0,,,,,
human immunodeficiency virus reverse transcriptase ribonuclease h: specificity of trna(lys3)-primer excision,Furfine ES,,1991,NR,,0,,,,,
human immunodeficiency virus type 1-infected blood donors: behavioral characteristics and reasons for donation,Doll LS,,1991,NR,,0,,,,,
in vivo sequence variation of the human immunodeficiency virus type 1 env gene: evidence for recombination among variants found in a single individual,Howell RM,,1991,NR,,0,,,,,
lack of hiv-1 v3 region sequence diversity in two haemophiliac patients infected with a putative biologic clone of hiv-1,Cichutek K,,1991,NR,,0,,,,,
mechanisms associated with the generation of biologically active human immunodeficiency virus type 1 particles from defective proviruses,Inoue M,,1991,NR,,0,,,,,
molecular characterization of biologically diverse envelope variants of human immunodeficiency virus type 1 derived from an individual,Daniels RS,,1991,NR,,0,,,,,
molecular characterization of five human anti-human immunodeficiency virus type 1 antibody heavy chains reveals extensive somatic mutation typical of an antigen-driven immune response,Andris JS,,1991,NR,,0,,,,,
naturally occurring mutations within hiv-1 v3 genomic rna lead to antigenic variation dependent on a single amino acid substitution,Wolfs TF,,1991,NR,,0,,,,,
"the naive repertoire of human t helper cells specific for gp120, the envelope glycoprotein of hiv",Manca F,,1991,NR,,0,,,,,
the oral manifestations of hiv infection,Jordan RC,,1991,NR,,0,,,,,
why woman partners of drug users will continue to be at high risk for hiv infection,Cohen JB,,1991,NR,,0,,,,,
analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1,Simmonds P,,1990,NR,,0,,,,,
"biological activity of diethyldithiocarbamate (ditiocarb, imuthiol) in an animal model of retrovirus-induced immunodeficiency disease and in clinical trials in patients with hiv infection the ditiocarb study group",Hersh EM,,1990,NR,,0,,,,,
"cd4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro",Cao YZ,,1990,NR,,0,,,,,
comparative analysis of the retroviral pol and env protein sequences reveal different evolutionary trees,Lewe G,,1990,NR,,0,,,,,
concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations,Balfe P,,1990,NR,,0,,,,,
diversity of oligosaccharide structures on the envelope glycoprotein gp 120 of human immunodeficiency virus 1 from the lymphoblastoid cell line h9 presence of complex-type oligosaccharides with bisecting n-acetylglucosamine residues,Mizuochi T,,1990,NR,,0,,,,,
dynamics of hiv infection and aids in central african cities,Auvert,10.1093/ije/19.2.417,1990,NR,,0,,,,,
exposure factors for hiv-1 infection among heterosexual drug abusers in new jersey treatment programs,Caussy D,,1990,NR,,0,,,,,
generation of hybrid genes and proteins by vaccinia virus-mediated recombination: application to human immunodeficiency virus type 1 env,Gritz L,,1990,NR,,0,,,,,
major histocompatibility complex genes influence the outcome of hiv infection: ancestral haplotypes with c4 null alleles explain diverse hla associations,Cameron PU,10.1016/0198-8859%2890%2990042-N,1990,NR,,0,,,,,
nucleotide sequence of a ugandan hiv-1 provirus reveals genetic diversity from other hiv-1 isolates,Oram JD,,1990,NR,,0,,,,,
prevalence of hiv-1 infection in the kagera region of tanzania: a population-based study,Killewo,10.1097/00002030-199011000-00005,1990,NR,,0,,,,,
"psychiatric aspects of aids and hiv infection legal, ethical, and public policy issues",Krajeski JP,,1990,NR,,0,,,,,
secondary structure is the major determinant for interaction of hiv rev protein with rna,Olsen HS,,1990,NR,,0,,,,,
sequence variability of bovine leukemia virus env gene and its relevance to the structure and antigenicity of the glycoproteins,Mamoun RZ,,1990,NR,,0,,,,,
spectrum of biological properties of human immunodeficiency virus (hiv-1) isolates,Cloyd MW,,1990,NR,,0,,,,,
the evolutionary dynamics of hiv-1 quasispecies and the development of immunodeficiency disease,Nowak MA,,1990,NR,,0,,,,,
"the putative cytoplasmic domain of the pseudorabies virus envelope protein giii, the herpes simplex virus type 1 glycoprotein c homolog, is not required for normal export and localization",Solomon KA,,1990,NR,,0,,,,,
the social context of the emergence of hiv in thailand,Ford N,,1990,NR,,0,,,,,
attitudes and beliefs related to hiv/aids in urban religious congregations: barriers and opportunities for hiv-related interventions,Bluthenthal RN,10.1016/j.socscimed.2012.01.020,NA,NR,,,,,,,
characterization of full-length hiv-1 crf17_bf genomes and comparison to the prototype crf12_bf strains,Aulicino PC,10.1016/j.meegid.2012.01.003,NA,NR,,,,,,,
"factors influencing the normalization of cd4+ t-cell count, percentage and cd4+/cd8+ t-cell ratio in hiv-infected patients on long-term suppressive antiretroviral therapy",Torti C,10.1111/j.1469-0691.2011.03650.x,NA,NR,,,,,,,
"high-risk sexual practices contribute to hiv-1 double infection among msm in madrid""",Casado C,10.1089/AID.2020.0068,2020,duplicate,,0,,,,,
"structure, function, and inhibitor targeting of hiv-1 nef-effector kinase complexes",Staudt RP,10.1074/jbc.REV120.012317,2020,duplicate,,0,,,,,
subordinate effect of -21m hla-b dimorphism on nk cell repertoire diversity and function in hiv-1 infected individuals of african origin,Cubero EM,10.3389/fimmu.2020.00156,2020,duplicate,,0,,,,,
the role of torsin aaa+ proteins in preserving nuclear envelope integrity and safeguarding against disease,Rampello AJ,10.3390/biom10030468,2020,duplicate,,0,,,,,
bridging of neisseria gonorrhoeae across diverse sexual networks in the hiv prep era,Williamson D,10.1136/sextrans-2019-sti.211,2019,duplicate,,0,,,,,
cd4/cd8 ratio is a better indicator of acute phase inflammation than absolute cd4 count during virallysuppressed hiv infection,Rousseau R,10.1111/hiv.12815,2019,duplicate,,0,,,,,
"hiv vertical transmission in rio de janeiro, brazil-does the distance matter?",Hofer CB,10.1080/09540121.2018.1515466,2019,duplicate,,0,,,,,
hiv-1 antibodies in prevention of transmission,Barin F,10.1097/COH.0000000000000553,2019,duplicate,,0,,,,,
genotypic characterization of hiv-1 subtype c in the central region of nepal,Oka T,10.1089/AID.2019.0105,2019,duplicate,,0,,,,,
hiv-positives men as superheros,Ohayon M,10.1016/j.sexol.2019.05.007,2019,duplicate,,0,,,,,
"onward transmission of multiple hiv-1 unique recombinant forms among men who have sex with men in beijing, china",Liu YongJian,,2019,duplicate,,0,,,,,
phylogenetic inference for the study of within-host hiv-1 dynamics and persistence on antiretroviral therapy,Capoferri AA,10.1016/S2352-3018%2819%2930051-7,2019,duplicate,,0,,,,,
phylogenetics in hiv transmission: taking within-host diversity into account,Leitner T,10.1097/COH.0000000000000536,2019,duplicate,,0,,,,,
prediction of pd-l1 inhibition effects for hiv-infected individuals,Zheltkova V,10.1371/journal.pcbi.1007401,2019,duplicate,,0,,,,,
"presence, persistence and effects of pretreatment hiv-1 drug resistance variants detected using next generation sequencing: a retrospective longitudinal study from rural coastal kenya",Hassan AS,10.1371/journal.pone.0210559,2019,duplicate,,0,,,,,
"pretreatment human immunodeficiency virus type 1 (hiv-1) drug resistance in transmission clusters of the cologne-bonn region, germany",Stecher M,10.1016/j.cmi.2018.09.025,2019,duplicate,,0,,,,,
rapid cd4+ t-cell decline is associated with coreceptor switch among msm primarily infected with hiv-1 crf01_ae in northeast china,Cui H,10.1097/QAD.0000000000001981,2019,duplicate,,0,,,,,
"risk of hiv transmission through condomless sex in serodifferent gay couples with the hiv-positive partner taking suppressive antiretroviral therapy (partner): final results of a multicentre, prospective, observational study",Rodger AJ,10.1016/S0140-6736(19)30418-0,2019,duplicate,,0,,,,,
rites of resistance: sex workers' fight to maintain rights and pleasure in the centre of the response to hiv in brazil (special issue: social inequities and contemporary struggles for collective health in latin america),Murray,10.1080/17441692.2018.1510020,2019,duplicate,,0,,,,,
"spatial clusters of hiv-1 genotypes in a recently infected population in yunnan, china",Chen M,10.1186/s12879-019-4276-9,2019,duplicate,,0,,,,,
accidental father-to-son hiv-1 transmission during the seroconversion period (special issue on hiv prevention science),Ezeonwumelu,10.1089/aid.2018.0060,2018,duplicate,,0,,,,,
"antiretroviral potency of 40-ethnyl-20-fluoro-20-deoxyadenosine, tenofovir alafenamide and second-generation nnrtis across diverse hiv-1 subtypes",Njenda DT,10.1093/jac/dky256,2018,duplicate,,0,,,,,
assessment of transmitted hiv-1 drug resistance mutations using ultra-deep pyrosequencing in a turkish cohort,Sili,10.2174/1570162X16666180910130112,2018,duplicate,,0,,,,,
characterization of the transmitted virus in an ongoing hiv-1 epidemic driven by injecting drug use (special issue on hiv prevention science),Dukhovlinova,10.1089/aid.2017.0313,2018,duplicate,,0,,,,,
"cytomegalovirus retinitis in hiv-negative patients - associated conditions, clinical presentation, diagnostic methods and treatment strategy",Shapira Y,10.1111/aos.13553,2018,duplicate,,0,,,,,
comparison of the genotypic and phenotypic properties of hiv-1 standard subtype b and subtype b/b' env molecular clones derived from infections in china article,Xie H,10.1038/s41426-018-0087-0,2018,duplicate,,0,,,,,
heterogeneous hiv reactivation patterns of dsf and combined dsf + romidepsin treatments,Kula A,10.1186/s12977-018-0436-z,2018,duplicate,,0,,,,,
hiv-1 transmission clustering and phylodynamics highlight the important role of young men who have sex with men,Dennis AM,10.1089/AID.2018.0039,2018,duplicate,,0,,,,,
hematopoietic stem and progenitor cells are a unique functional hiv reservoir,Zaikos TD,,2018,duplicate,,0,,,,,
infant t/f hiv-1 from peripartum transmission are resistant to maternal plasma,Kumar A,,2018,duplicate,,0,,,,,
identification of near-pan-neutralizing antibodies against hiv-1 by deconvolution of plasma humoral responses,Sajadi MM,10.1016/j.cell.2018.03.061,2018,duplicate,,0,,,,,
induction and relationship of hiv envelope-specific b cells in the peripheral blood and bone marrow following vaccination in humans,Kobie J,,2018,duplicate,,0,,,,,
loss of t-cell multifunctionality and tcr-v beta repertoire against epstein-barr virus is associated with worse prognosis and clinical parameters in hiv+ patients,Hernandez,,2018,duplicate,,0,,,,,
loss of t-cell multifunctionality and tcr-vbeta repertoire against epstein- barr virus is associated with worse prognosis and clinical parameters in hiv+patients,Hernandez DM,10.3389/fimmu.2018.02291,2018,duplicate,,0,,,,,
naturally occurring mutations in hiv-1 crf01_ae capsid affect viral sensitivity to restriction factors,Nakayama EE,10.1089/AID.2017.0212,2018,duplicate,,0,,,,,
no evidence for hiv replication in lymph nodes during art,McManus W,,2018,duplicate,,0,,,,,
phylogenetic analysis as a forensic tool in hiv transmission investigations,Abecasis AB,10.1097/QAD.0000000000001728,2018,duplicate,,0,,,,,
pairwise diversity and tmrca as potential markers of hiv infection recency,Moyo S,,2018,duplicate,,0,,,,,
rational design of a trispecific antibody targeting the hiv-1 env with elevated anti-viral activity,Steinhardt JJ,10.1038/s41467-018-03335-4,2018,duplicate,,0,,,,,
"regional transmission pattern of hiv-1 non-crf01_ae strains circulating in hebei province, china",Lu XinLi,10.1089/aid.2017.0166,2018,duplicate,,0,,,,,
the hiv/aids epidemic in grenada: a cross-sectional approach used to measure response variation regarding sexual behavior and health depending on the method of data collection,Chaudhry,10.1097/md.0000000000010869,2018,duplicate,,0,,,,,
the impact of hiv-1 within-host evolution on transmission dynamics,Theys K,10.1016/j.coviro.2017.12.001,2018,duplicate,,0,,,,,
a highly efficient and gmp-compliant protocol to manufacture ccr5-edited cells to treat hiv infection,Romito M,10.1089/hum.2017.29055.abstracts,2017,duplicate,,0,,,,,
clonal expansion of genome-intact hiv-1 in functionally polarized t-cell subsets,Lee GQ,,2017,duplicate,,0,,,,,
defining hiv-1 transmission clusters based on sequence data,Hassan AS,10.1097/QAD.0000000000001470,2017,duplicate,,0,,,,,
genomic epidemiology of cryptococcus yeasts identifies adaptation to environmental niches underpinning infection across an african hiv/aids cohort (special issue: microbial local adaptation),Vanhove,,2017,duplicate,,0,,,,,
hiv genetic diversity to infer prep adherence at the estimated time of infection,Council O,,2017,duplicate,,0,,,,,
interventions and approaches to integrating hiv and mental health services: a systematic review (special issue: achieving integration for stronger health systems: lessons from integrating sexual & reproductive health and hiv services),Chuah LehHoon [Chuah,,2017,duplicate,,0,,,,,
"induction of a tier-1-like phenotype in diverse tier-2 isolates by agents that guide hiv- 1 env to perturbation-sensitive, nonnative states",Johnson J,10.1128/JVI.00174-17,2017,duplicate,,0,,,,,
molecular characteristics of the envelope of vertically transmitted hiv-1 strains from infants with hiv infection (special issue on hiv prevention science),Manickam Ashokkumar,10.1089/aid.2016.0260,2017,duplicate,,0,,,,,
preferential targeting of conserved gag regions after vaccination with a heterologous dna prime-modified vaccinia virus ankara boost hiv-1 vaccine regimen,Bauer A,10.1128/JVI.00730-17,2017,duplicate,,0,,,,,
resistance to type i interferons is a major determinant of hiv-1 transmission fitness,Iyer SS,,2017,duplicate,,0,,,,,
temporal changes in hiv transmission patterns among young men who have sex with men,Panneer N,,2017,duplicate,,0,,,,,
the strategies of heterosexuals from large metropolitan areas for assessing the risks of exposure to hiv or other sexually transmitted infections from partners met online,Siegel K,10.1089/apc.2016.0299,2017,duplicate,,0,,,,,
"hiv surveillance combining an assay for identification of very recent infections and phylogenetic analyses on dried serum spots, france 2012-2014",Brand D,10.1089/aid.2016.5000.abstracts,2016,duplicate,,0,,,,,
"a global research synthesis of hiv and sti biobehavioural risks in female-to-male transgender adults (special issue: the trouble with 'categories': rethinking men who have sex with men, transgender and their equivalents in hiv prevention and health promotion)",Reisner,,2016,duplicate,,0,,,,,
characterizing the multiplicity of hiv founder variants during sexual transmission,Chaillon A,,2016,duplicate,,0,,,,,
buffering deleterious polymorphisms in highly constrained parts of hiv-1 envelope by flexible regions,Gasser R,10.1186/s12977-016-0285-6,2016,duplicate,,0,,,,,
community perceptions of repeat hiv-testing: experiences of the anrs 12249 treatment as prevention trial in rural south africa (special issue: social science and universal test and treat in africa),Orne-Gliemann,,2016,duplicate,,0,,,,,
defective hiv-1 proviruses produce novel proteincoding rna species in hiv-infected patients on combination antiretroviral therapy,Imamichia H,10.1073/pnas.1609057113,2016,duplicate,,0,,,,,
composition and antigenic effects of individual glycan sites of the hiv-1 glycan shield,Behrens A-J,10.1089/aid.2016.5000.abstracts,2016,duplicate,,0,,,,,
effects of patient load and travel distance on hiv transmission in a cohort of serodiscordant couples in rural china: a longitudinal analysis,Smith MK,,2016,duplicate,,0,,,,,
equity in adherence to antiretroviral therapy among economically vulnerable adolescents living with hiv in uganda (special issue: equity supplement (sponsored by the coalition for children affected by aids)),Bermudez,,2016,duplicate,,0,,,,,
equity in adherence to antiretroviral therapy among economically-vulnerable adolescents living with hiv in uganda,Gauer Bermudez L,10.7448/IAS.19.6.21264,2016,duplicate,,0,,,,,
distance to testing sites and its association with timing of hiv diagnosis*,Cope AB,10.1080/09540121.2016.1191599,2016,duplicate,,0,,,,,
"genetic diversity and transmission networks of hiv-1 strains among men having sex with men (msm) in lome, togo (special issue: evolution of hiv)",Konou,,2016,duplicate,,0,,,,,
genetic variants in cyp2b6 and cyp2a6 explain interindividual variation in efavirenz plasma concentrations in routine care of hiv-infected children with diverse ethnic origin,Soeria-Atmadja S,10.7448/IAS.19.8.21487,2016,duplicate,,0,,,,,
"genomic characterization of a novel hiv-1 second-generation recombinant form originated from crf01_ae and crf08_bc in dali prefecture of yunnan province, china",Li JianJian,,2016,duplicate,,0,,,,,
hiv integration sites in cellular models of viral persistence,Sunshine S,,2016,duplicate,,0,,,,,
evaluating the contribution of apobec3g haplotypes on influencing hiv infection in a zimbabwean paediatric population (special issue: a festschrift in honour of professor peter beighton),Mhandire,10.7196/SAMJ.2016.v106i6.11013,2016,duplicate,,0,,,,,
"evaluating the contribution of apobec3g haplotypes, on influencing hiv infection in a zimbabwean paediatric population",Mhandire K,10.7196/SAMJ.2016.v106i6.11013,2016,duplicate,,0,,,,,
hiv-1 drug resistance and resistance testing (special issue: evolution of hiv),Clutter,,2016,duplicate,,0,,,,,
"interventions to prevent sexually transmitted infections, including hiv, among young people in low- and middle-income countries: a systematic review of the published and gray literature",Kalamar AM,10.1016/j.jadohealth.2016.05.020,2016,duplicate,,0,,,,,
longitudinal trends in western australian hiv-1 sequence diversity and viral transmission networks and their influence on clinical parameters: 2000-2014,Castley AS,10.1089/AID.2015.0206,2016,duplicate,,0,,,,,
molecular epidemiology of hiv-1 infection in europe: an overview,Beloukas A,10.1016/j.meegid.2016.06.033,2016,duplicate,,0,,,,,
molecular epidemiology of hiv-1 infection in europe: an overview (special issue: evolution of hiv),Beloukas,10.1016/j.meegid.2016.06.033,2016,duplicate,,0,,,,,
predominance of crf06_cpx and transmitted hiv resistance in algeria: update 2013 2014,Abdellaziz,10.1089/aid.2015.0292,2016,duplicate,,0,,,,,
rare hiv-1 subtype j genomes and a new h/u/crf02-ag recombinant genome suggests an ancient origin of hiv-1 in angola,Bartolo I,10.1089/aid.2016.0084,2016,duplicate,,0,,,,,
safety and efficacy of dapivirine vaginal ring for hiv-1 prevention in african women,Nel A,,2016,duplicate,,0,,,,,
mode of sexual transmission can exert an impact on shaping the hiv-1 founder virus,Tully DC,,2016,duplicate,,0,,,,,
spatial distributions of hiv infection in an endemic area of western kenya: guiding information for localized hiv control and prevention,Hoshi T,10.1371/journal.pone.0148636,2016,duplicate,,0,,,,,
special issue: hiv prevention among diverse young msm (special issue: hiv prevention among diverse young msm),Rhodes,10.1521/aeap.2016.28.3.191,2016,duplicate,,0,,,,,
status of vaccine research and development of vaccines for hiv-1 (special issue: who product development for vaccines advisory committee (pdvac) pipeline analyses for 25 pathogens),Safrit,10.1016/j.vaccine.2016.02.074,2016,duplicate,,0,,,,,
the early bird catches the worm - can evolution teach us lessons in fighting hiv? (thematic issue: strategies to defeat hiv),Schaller,10.2174/1570162X14999160224094914,2016,duplicate,,0,,,,,
tracing the origin of a singular hiv-1 crf45_cpx clade identified in brazil (special issue: evolution of hiv),Delatorre,,2016,duplicate,,0,,,,,
"transmitted/founder hiv-1 subtype c viruses show distinctive signature patterns in vif, vpr, and vpu that are under subsequent immune pressure during early infection (special issue: hiv prevention science)",Rossenkhan,,2016,duplicate,,0,,,,,
a direct comparison of two densely sampled western european hiv epidemics: the uk and switzerland,Ragonnet-Cronin ML,,2015,duplicate,,0,,,,,
adaptation of hiv-1 to rhtrim5alpha-mediated restriction in vitro,Setiawan LC,10.1016/j.virol.2015.09.017,2015,duplicate,,0,,,,,
aging with hiv vs hiv seroconversion at older age: a diverse population with distinct comorbidity profiles,Guaraldi,10.1371/journal.pone.0118531,2015,duplicate,,0,,,,,
"anti-v3/glycan and anti-mper neutralizing antibodies, but not anti-v2/glycan-site antibodies are strongly associated with higher anti-hiv-1 neutralization breadth and potency",Jacob RA,10.7448/IAS.18.5.20394,2015,duplicate,,0,,,,,
cd4+ t cell counts in initiation of antiretroviral therapy in hiv infected asymptomatic individuals; controversies and inconsistencies,Maina EK,10.1016/j.imlet.2015.10.005,2015,duplicate,,0,,,,,
central memory cd4+ t cells are preferential targets of double infection by hiv-1 retroviruses,Haqqani AA,10.1186/s12985-015-0415-0,2015,duplicate,,0,,,,,
mucosal hiv-1 transmission specifically selects for type 1 interferon-resistant viruses,Iyer S,,2015,duplicate,,0,,,,,
hiv-1 infections with multiple founders are associated with higher viral loads,Janes H,,2015,duplicate,,0,,,,,
"diversity and antifungal resistance patterns of prevalent opportunistic pathogenic yeasts colonizing the oral cavities of asymptomatic human immunodeficiency virus-infected individuals, and their relation to cd4(+) counts",Kumar DA,10.4103/0253-7184.156724,2015,duplicate,,0,,,,,
"diversity and antifungal resistance patterns of prevalent opportunistic pathogenic yeasts colonizing the oral cavities of asymptomatic human immunodeficiency virus-infected individuals, and their relation to cd4+ counts",Kumar,,2015,duplicate,,0,,,,,
genetic characterization of a novel hiv-1 circulating recombinant form (crf74_01b) identified among intravenous drug users in malaysia: recombination history and phylogenetic linkage with previously defined recombinant lineages,Cheong HuiTing,10.1371/journal.pone.0133883,2015,duplicate,,0,,,,,
heterosexual transmission of subtype c hiv-1 selects consensus-like variants without increased replicative capacity or interferon- alpha resistance,Deymier,10.1371/journal.ppat.1005154,2015,duplicate,,0,,,,,
hiv and sti testing in older adults: an integrative review,Tillman JL,10.1111/jocn.12797,2015,duplicate,,0,,,,,
"hiv-1 group o origin, evolution, pathogenesis, and treatment: unraveling the complexity of an outlier 25 years later",Bush S,,2015,duplicate,,0,,,,,
hiv/aids epidemic in the state of amazonas: characteristics and trends from 2001 to 2012 (special issue: epidemiological transition of tropical diseases in the brazilian amazon),Oliveira,,2015,duplicate,,0,,,,,
heterogeneous evolution of hiv-1 crf01-ae in men who have sex with men (msm) and other populations in china,Wu H,10.1371/journal.pone.0143699,2015,duplicate,,0,,,,,
"implementation research for the prevention of mother-to-child hiv transmission in sub-saharan africa: existing evidence, current gaps, and new opportunities",Bhardwaj S,10.1007/s11904-015-0260-1,2015,duplicate,,0,,,,,
increase of rt-related transmitted drug resistance in non-crf01_ae among hiv type 1-infected men who have sex with men in the 7 cities of china,Zhao B,10.1097/QAI.0000000000000467,2015,duplicate,,0,,,,,
keeping confidence: hiv and the criminal law from hiv service providers' perspectives,Dodds C,10.1080/09581596.2015.1019835,2015,duplicate,,0,,,,,
molecular investigation for hiv-1 cross-group transmissions during the outbreak period (2011-2014) in athens metropolitan area: introduction of subtype a from eastern europe,Paraskevis D,10.7448/IAS.18.5.20449,2015,duplicate,,0,,,,,
"prospects for a globally effective hiv-1 vaccine (special issue: advancing vaccines and immunization issues, insights, and innovations)",Excler,,2015,duplicate,,0,,,,,
near full-length hiv type 1m genomic sequences from cameroon : evidence of early diverging under-sampled lineages in the country,Tongo M,10.1093/emph/eov022,2015,duplicate,,0,,,,,
near full-length hiv type 1m genomic sequences from cameroon: evidence of early diverging under-sampled lineages in the country,Tongo,,2015,duplicate,,0,,,,,
population-level spread of immune-driven mutations in hiv-1 polymerase during the north american epidemic,Kinloch NN,10.7448/IAS.18.5.20351,2015,duplicate,,0,,,,,
prevalence of and risk factors for low bone mineral density in untreated hiv infection: a substudy of the insight strategic timing of antiretroviral treatment (start) trial (special issue: the start trial characteristics at study entry),Carr,10.1111/hiv.12242,2015,duplicate,,0,,,,,
"recent infection, sexually transmitted infections, and transmission clusters frequently observed among persons newly diagnosed with hiv in san francisco",Truong H-HM,10.1097/QAI.0000000000000681,2015,duplicate,,0,,,,,
"reducing the overall hiv-burden in south africa: is reviving abc an appropriate fit for a complex, adaptive epidemiological hiv landscape?",Burman CJ,10.2989/16085906.2015.1016988,2015,duplicate,,0,,,,,
special issue: physical activity and hiv in africa (special issue: physical activity and hiv in africa),,,2015,duplicate,,0,,,,,
social media and hiv: a systematic review of uses of social media in hiv communication [review],Taggart T,10.2196/jmir.4387,2015,duplicate,,0,,,,,
worldwide genetic features of hiv-1 env alpha 4 beta 7 binding motif: the local dissemination impact of the ldi tripeptide,Hait,,2015,duplicate,,0,,,,,
hiv transmission selection bias at the heterosexual hiv-1 transmission bottleneck,Carlson JM,10.1126/science.1254031,2014,duplicate,,0,,,,,
antiretroviral therapy for initial human immunodeficiency virus/aids treatment: critical appraisal of the evidence from over 100 randomized trials and 400 systematic reviews and meta-analyses (themed section: systematic review or meta-analysis? their place in the evidence hierarchy),Kanters,10.1111/1469-0691.12475,2014,duplicate,,0,,,,,
alterations in hiv-1 gp120 v3 region are necessary but not sufficient for coreceptor switching in crf07-bc in china,Zhang L,10.1371/journal.pone.0093426,2014,duplicate,,0,,,,,
comparison of multiple adjuvants on the stability and immunogenicity of a clade c hiv-1 gp 140 trimer,Nkolola JP,10.1016/j.vaccine.2014.02.001,2014,duplicate,,0,,,,,
cross-border sexual transmission of the newly emerging hiv-1 clade crf51-01b,Cheong HT,10.1371/journal.pone.0111236,2014,duplicate,,0,,,,,
drug resistance in non-b subtype hiv-1: impact of hiv-1 reverse transcriptase inhibitors,Singh,10.3390/v6093535,2014,duplicate,,0,,,,,
health behavior change models for hiv prevention and aids care: practical recommendations for a multi-level approach (special issue: strategic roles for health communication in combination hiv prevention and care programs),Kaufman,10.1097/QAI.0000000000000236,2014,duplicate,,0,,,,,
hiv diversity and drug resistance from plasma and non-plasma analytes in a large treatment programme in western kenya,Kantor R,10.7448/IAS.17.1.19262,2014,duplicate,,0,,,,,
"how does mother-to-child transmission of hiv differ among african populations? lessons from mbl2 genetic variation in zimbabweans (special issue: ""omics in africa"": power to the people - moving 21st century integrative biology from lab to village to innovation ecosystems)",Mhandire,10.1089/omi.2013.0131,2014,duplicate,,0,,,,,
impact of human immunodeficiency virus type-1 sequence diversity on antiretroviral therapy outcomes [review],Langs-Barlow A,10.3390/v6103855,2014,duplicate,,0,,,,,
lessons learnt from sexual and reproductive health and hiv linkages for multipurpose prevention technology service delivery (special issue: multipurpose prevention technologies: maximising positive synergies),Lusti-Narasimhan,10.1111/1471-0528.12845,2014,duplicate,,0,,,,,
molecular tools for studying hiv transmission in sexual networks,Grabowski MK,10.1097/COH.0000000000000040,2014,duplicate,,0,,,,,
determinants of pd-1 expression on cd4+ and cd8+ t cells in treated and untreated hiv disease,Cockerham LR,,2014,duplicate,,0,,,,,
optimized lentiviral vectors for hiv gene therapy: multiplexed expression of small rnas and inclusion of mgmt(p140k) drug resistance gene,Chung J,10.1038/mt.2014.32,2014,duplicate,,0,,,,,
optimized lentiviral vectors for hiv gene therapy: multiplexed expression of small rnas and inclusion of mgmtp140k drug resistance gene,Chung J,10.1038/mt.2014.64,2014,duplicate,,0,,,,,
phylogenetic analysis of hiv type 1 crf02_ag in multiple genes in italian and african patients living in italy,Paolucci S,10.1089/AID.2014.0002,2014,duplicate,,0,,,,,
single genome analysis for detecting multi-class drug resistance in hiv-1 infected children on pi-based art,Lange CM,,2014,duplicate,,0,,,,,
structural and community-level interventions for increasing condom use to prevent the transmission of hiv and other sexually transmitted infections,Moreno R,10.1002/14651858.CD003363.pub3,2014,duplicate,,0,,,,,
the effect of interference on the cd8(+) t cell escape rates in hiv,Garcia V,10.3389/fimmu.2014.00661,2014,duplicate,,0,,,,,
ultra-deep sequencing of hiv-1 near full-length and partial proviral genomes among chronically infected blood donors at four blood centers in brazil,Pessoa R,,2014,duplicate,,0,,,,,
ultra-deep sequencing of hiv-1 near full-length and partial proviral genomes from recently infected blood donors at four blood centers in brazil,Pessoa R,,2014,duplicate,,0,,,,,
transmission and prevention of hiv among heterosexual populations in australia,Persson A,10.1521/aeap.2014.26.3.245,2014,duplicate,,0,,,,,
"transmission networks of hiv-1 subtype b, crf01-ae and crf51-01b among msm in singapore",Ng KT,,2014,duplicate,,0,,,,,
what is health communication and how does it affect the hiv/aids continuum of care? a brief primer and case study from new york city,Storey D,10.1097/QAI.0000000000000243,2014,duplicate,,0,,,,,
"willingness to participate in hiv vaccine trials among men who have sex with men in chennai and mumbai, india",Newman,10.1016/j.vaccine.2014.08.043,2014,duplicate,,0,,,,,
architect hiv ag/ab combo assay: correlation of hiv-1 p24 antigen sensitivity and rna viral load using genetically diverse virus isolates,Brennan CA,10.1016/j.jcv.2013.01.017,2013,duplicate,,0,,,,,
challenges in virological diagnosis of hiv-1 transmission from sexual abuse - hiv-1 genetic links are mandatory,Ehrnst,,2013,duplicate,,0,,,,,
higher cross-subtype ifn-gamma elispot responses to gag and nef peptides in brazilian hiv-1 subtype b- and f1- than in c-infected subjects,Cortes FH,10.1016/j.vaccine.2012.12.023,2013,duplicate,,0,,,,,
electrospun fibers for vaginal anti-hiv drug delivery,Blakney AK,10.1016/j.antiviral.2013.09.022,2013,duplicate,,0,,,,,
"ethnicity, socioeconomic characteristics and knowledge, beliefs and attitudes about hiv among yunnanese chinese, hmong, lahu and northern thai in a north-western thailand border district",Kunstadter P,,2013,duplicate,,0,,,,,
"hiv among female sex workers in the central asian republics, afghanistan, and mongolia: contexts and convergence with drug use",Baral S,10.1016/j.drugalcdep.2013.07.004,2013,duplicate,,0,,,,,
hiv-1 envelope replication and alpha 4 beta 7 utilization among newly infected subjects and their corresponding heterosexual partners,Pena-Cruz,,2013,duplicate,,0,,,,,
impact of hiv-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype c and crf01-ae backbone,Chenine A-L,10.1371/journal.pone.0076104,2013,duplicate,,0,,,,,
"overcoming biological, behavioral, and structural vulnerabilities: new directions in research to decrease hiv transmission in men who have sex with men (special issue: state of the art hiv prevention)",Mayer,10.1097/QAI.0b013e318298700e,2013,duplicate,,0,,,,,
pathogenesis of hiv infection (special issue on hiv/aids: infectious disease reports),Naif,,2013,duplicate,,0,,,,,
"phylodynamic profile of hiv-1 subtype b, crf01_ae and the recently emerging crf51_01b among men who have sex with men (msm) in singapore",Ng KT,10.1371/journal.pone.0080884,2013,duplicate,,0,,,,,
recent advances in research of hiv infection: implications of viral and host genetics on treatment and prevention [review],Haaland RE,10.1159/000345935,2013,duplicate,,0,,,,,
second generation hiv surveillance in pakistan: policy challenges and opportunities (special issue: hiv second generation surveillance - pakistan),Munro,,2013,duplicate,,0,,,,,
second-generation surveillance for hiv/aids in pakistan: results from the 4th round of integrated behavior and biological survey 2011-2012 (special issue: hiv/sti research in mena),Emmanuel,,2013,duplicate,,0,,,,,
sexually transmitted/founder hiv-1 cannot be directly predicted from plasma or pbmc-derived viral quasispecies in the transmitting partner,Frange P,,2013,duplicate,,0,,,,,
the role of neutralizing antibodies in prevention of hiv-1 infection: what can we learn from the mother-to-child transmission context?,Braibant M,10.1186/1742-4690-10-103,2013,duplicate,,0,,,,,
genetic diversity of trichomonas vaginalis reinfection in hiv-positive women (special issue: trichomonas vaginalis),Conrad,10.1136/sextrans-2013-051053,2013,duplicate,,0,,,,,
apobec3-mediated editing in hiv type 1 from pediatric patients and its association with apobec3g/cul5 polymorphisms and vif variability,De Maio FA,10.1089/AID.2011.0291,2012,duplicate,,0,,,,,
"canadian hiv pregnancy planning guidelines: no 278, june 2012",Loutfy MR,10.1016/j.ijgo.2012.06.004,2012,duplicate,,0,,,,,
cocaine and hiv-1 interplay in cns: cellular and molecular mechanisms,Buch S,10.2174/157016212802138823,2012,duplicate,,0,,,,,
characterization of persistent hiv-1 in a broad spectrum of cd4+ t-cells isolated from peripheral blood and gut associated lymphoid tissue from patients on long-term suppressive therapy,Josefsson L,,2012,duplicate,,0,,,,,
"emergence of a new hiv type 1 crf01_ae variant in guangxi, southern china",Zeng H,,2012,duplicate,,0,,,,,
evidence of multiple introductions and autochthonous transmission of the hiv type 1 crf02_ag clade in brazil,Delatorre EO,,2012,duplicate,,0,,,,,
hiv compartmentalization: a review on a clinically important phenomenon [review],Blackard JT,,2012,duplicate,,0,,,,,
hiv-1 subtype c is not associated with higher risk of heterosexual transmission: a multinational study among african hiv-1 serodiscordant couples,Kahle E,org/10.7448/IAS.15.5.18438,2012,duplicate,,0,,,,,
genetic diversity of ebv-encoded lmp1 in the swiss hiv cohort study and implication for nf-kappab activation,Zuercher E,10.1371/journal.pone.0032168,2012,duplicate,,0,,,,,
human b-cell ontogeny in humanized nod/scid gammacnull mice generates a diverse yet auto/poly-and hiv-1-reactive antibody repertoire,Chang H,10.1038/gene.2012.16,2012,duplicate,,0,,,,,
lignosulfonic acid exhibits broadly anti-hiv-1 activity - potential as a microbicide candidate for the prevention of hiv-1 sexual transmission,Qiu M,10.1371/journal.pone.0035906,2012,duplicate,,0,,,,,
mechanism of hiv antiretroviral drugs progress toward drug resistance,Ammaranond,10.1111/j.1472-8206.2011.01009.x,2012,duplicate,,0,,,,,
nonrandom distribution of cryptic repeating triplets of purines and pyrimidines (rny)n in gp120 of hiv type 1,Crignis,,2012,duplicate,,0,,,,,
neutralizing antibodies and control of hiv: moves and countermoves (the science of hiv),Hessell,10.1007/s11904-011-0105-5,2012,duplicate,,0,,,,,
participation of hiv prevention programs among men who have sex with men in two cities of china - a mixed method study,Ma Wei,,2012,duplicate,,0,,,,,
"spatial modeling of hiv prevalence among the clients of female sex workers in tamil nadu, south india",Joshua,,2012,duplicate,,0,,,,,
special issue: assessing the role of community mobilisation in a scaled hiv prevention programme among marginalized populations in india - findings from avahan (special issue: assessing the role of community mobilisation in a scaled hiv prevention programme among marginalized populations in india - findings from avahan),,,2012,duplicate,,0,,,,,
the breadth of maternal hiv-1 specific neutralizing antibodies is not associated with a lower risk of mother-to-infant transmission,Chaillon A,,2012,duplicate,,0,,,,,
the hiv epidemic: high-income countries,Vermund SH,10.1101/cshperspect.a007195,2012,duplicate,,0,,,,,
use of a rapid hiv home test prevents hiv exposure in a high risk sample of men who have sex with men,Carballo-Dieguez A,,2012,duplicate,,0,,,,,
hiv-1 dual infection is associated with faster cd4+ t cell decline in a cohort of men with primary hiv infection,Cornelissen M,,2011,duplicate,,0,,,,,
antiretroviral drug resistance in a respondent-driven sample of hiv-infected men who have sex with men in brazil (aids research in brazil),Bermudez-Aza,10.1097/QAI.0b013e31821e9c36,2011,duplicate,,0,,,,,
cellular kinases incorporated into hiv-1 particles: passive or active passengers?,Giroud C,10.1186/1742-4690-8-71,2011,duplicate,,0,,,,,
"cahr 2011, honouring our history, embracing our diversity, 20th annual canadian conference on hiv/aids research, toronto, ontario, canada, 14-17 april 2011",,,2011,duplicate,,0,,,,,
comparative evaluation of the viroseq tm hiv-1 genotyping system and an in-house method for analysis of hiv-1 drug-resistance mutations in china,Xu S,10.2165/11588860-000000000-00000,2011,duplicate,,0,,,,,
fitness costs and diversity of ctl response determine the rate of ctl escape during the acute and chronic phases of hiv infection,Ganusov V,,2011,duplicate,,0,,,,,
deep v3 sequencing for hiv type 1 tropism in treatment-naive patients: a reanalysis of the merit trial of maraviroc,Swenson LC,10.1093/cid/cir493,2011,duplicate,,0,,,,,
conservancy of the alpha 4 beta 7 integrin mimotope in the v2 domain of hiv type 1 crf07_bc compared to subtype b' strains in china,He Xiang,10.1089/aid.2011.0007,2011,duplicate,,0,,,,,
conservancy of the alpha4beta7 integrin mimotope in the v2 domain of hiv type 1 crf07_bc compared to subtype b' strains in china,He X,10.1089/AID.2011.0007,2011,duplicate,,0,,,,,
"dynamics of two separate but linked hiv-1 crf01_ae outbreaks among injection drug users in stockholm, sweden, and helsinki, finland",Skar H,10.1128/JVI.01413-10,2011,duplicate,,0,,,,,
epidemiology of hiv infection in the united states: implications for linkage to care,Moore RD,10.1093/cid/ciq044,2011,duplicate,,0,,,,,
"epidemiology of hiv infection in the united states: implications for linkage to care (special issue: linkage, engagement, and retention in hiv care)",Moore,10.1093/cid/ciq044,2011,duplicate,,0,,,,,
hiv-1 clade a infection and viral control: an immunological perspective on a case of underquantification,Westrop SJ,10.1258/ijsa.2009.009045,2011,duplicate,,0,,,,,
high proportion of hiv-1 subtype f1 epidemiological networks among italian heterosexual males associated with introduction events from south america and high proportion of resistance within clusters,Lai A,,2011,duplicate,,0,,,,,
hiv envelope: challenges and opportunities for development of entry inhibitors,Caffrey M,10.1016/j.tim.2011.02.001,2011,duplicate,,0,,,,,
hiv heterosexual sexual risk from injecting drug users among hiv-seronegative noninjecting heroin users,Neaigus A,,2011,duplicate,,0,,,,,
"hiv-1 envelope, integrins and co-receptor use in mucosal transmission of hiv",Cicala C,10.1186/1479-5876-9-S1-S2,2011,duplicate,,0,,,,,
hiv-1 molecular epidemiology evidence and transmission patterns in the middle east and north africa,Mumtaz G,10.1136/sti.2010.043711,2011,duplicate,,0,,,,,
hiv-1 molecular epidemiology in the middle east and north africa,Mumtaz G,10.1136/sextrans-2011-050108.17,2011,duplicate,,0,,,,,
hiv/sti prevention interventions targeting fsws in china: a systematic literature review (special issue: women and hiv in china),Hong,10.1080/09540121.2011.554526,2011,duplicate,,0,,,,,
nevirapine plasma concentrations in premature infants exposed to single-dose nevirapine for prevention of mother-to-child transmission of hiv-1,Mugabo,,2011,duplicate,,0,,,,,
reviewing the history of hiv-1: spread of subtype b in the americas [review],Junqueira DM,10.1371/journal.pone.0027489,2011,duplicate,,0,,,,,
special issue: hiv/aids research (special issue: hiv/aids research),Mayer,10.4103/0971-5916.92618,2011,duplicate,,0,,,,,
the antiviral efficacy of hiv-specific cd8+ t-cells to a conserved epitope is heavilydependent on the infecting hiv-1 isolate,Ranasinghe SRF,10.1371/journal.ppat.1001341,2011,duplicate,,0,,,,,
the role of hiv replicative fitness in perinatal transmission of hiv,Chen X-Q,10.1007/s12250-011-3180-2,2011,duplicate,,0,,,,,
"time-measured phylogenies of gag, pol and env sequence data reveal the direction and time interval of hiv-1 transmission []",Rachinger A,10.1097/QAD.0b013e3283467020,2011,duplicate,,0,,,,,
transmission of new crf07-bc strains with 7 amino acid deletion in gag p6,Zhefeng M,10.1186/1743-422X-8-60,2011,duplicate,,0,,,,,
adaptation of hiv-1 to cells expressing rhesus monkey trim5 alpha,Pacheco,10.1016/j.virol.2010.09.019,2010,duplicate,,0,,,,,
crystal structure of the neutralizing llama vhh d7 and its mode of hiv-1 gp120 interaction,Hinz A,10.1371/journal.pone.0010482,2010,duplicate,,0,,,,,
behavioural interventions for hiv positive prevention in developing countries: a systematic review and meta-analysis [review],Kennedy CE,10.2471/BLT.09.068213,2010,duplicate,,0,,,,,
behavioural interventions for hiv positive prevention in developing countries: a systematic review and meta-analysis [spanish],Kennedy CE,10.2471/BLT.09.068213,2010,duplicate,,0,,,,,
both cd31(+) and cd31- naive cd4(+) t cells are persistent hiv type 1-infected reservoirs in individuals receiving antiretroviral therapy,Wightman F,10.1086/656721,2010,duplicate,,0,,,,,
both cd31+ and cd31- naive cd4+ t cells are persistent hiv type 1-infected reservoirs in individuals receiving antiretroviral therapy,Wightman,10.1086/656721,2010,duplicate,,0,,,,,
drug treatment as hiv prevention: a research update,Metzger DS,10.1097/QAI.0b013e3181f9c10b,2010,duplicate,,0,,,,,
expanded evaluation of blood donors in the united states for hiv-1 non-b subtypes and antiretroviral drug resistant strains: 2005-2007,Brennan A,10.1111/j.1423-0410.2010.01343-1.x,2010,duplicate,,0,,,,,
gay men: current challenges and emerging approaches in hiv prevention,de Wit JB,,2010,duplicate,,0,,,,,
"hiv treatment, care and support in nsw: a work necessarily still in progress",Garsia R,,2010,duplicate,,0,,,,,
hiv-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central brazil,Cardoso LP,10.1002/jmv.21722,2010,duplicate,,0,,,,,
"hiv among plasma donors and other high-risk groups in henan, china (special issue: china meets new aids challenges)",Li Ning,,2010,duplicate,,0,,,,,
"improved hiv-1 rna quantitation by cobasreg ampliprep/cobasreg taqmanreg hiv-1 test, v20 using a novel dual-target approach",Sizmann,10.1016/j.jcv.2010.06.004,2010,duplicate,,0,,,,,
"non-nucleoside reverse transcriptase inhibitors (nnrtis), their discovery, development, and use in the treatment of hiv-1 infection: a review of the last 20 years (1989-2009) (special issue: twenty-five years of antiretroviral drug development: progress and prospects)",Bethune,10.1016/j.antiviral.2009.09.008,2010,duplicate,,0,,,,,
"non-nucleoside reverse transcriptase inhibitors (nnrtis), their discovery, development, and use in the treatment of hiv-1 infection: a review of the last 20 years (1989-2009) [review] [218 refs]",de Bethune MP,10.1016/j.antiviral.2009.09.008,2010,duplicate,,0,,,,,
recombination rate and selection strength in hiv intrapatient evolution,Neher RA,10.1371/journal.pcbi.1000660,2010,duplicate,,0,,,,,
sources of human immunodeficiency virus and sexually transmitted disease information and responses to prevention messages among massachusetts men who have sex with men (the science of health promotion),Mimiaga,,2010,duplicate,,0,,,,,
strategies for eliciting hiv-1 inhibitory antibodies (special issue: hiv vaccines after step),Tomaras,10.1097/COH.0b013e32833d2d45,2010,duplicate,,0,,,,,
tetherin restricts direct cell-cell viral transfer and transmission of hiv-1,Kuhl BD,10.1186/1758-2652-13-S3-O8,2010,duplicate,,0,,,,,
the expanding epidemics of hiv type 1 among men who have sex with men in low- and middle-income countries: diversity and consistency (special issue: epidemiologic approaches to global health),Beyrer,10.1093/epirev/mxq011,2010,duplicate,,0,,,,,
the expanding epidemics of hiv type 1 among men who have sex with men in low- and middle-income countries: diversity and consistency [review],Beyrer C,10.1093/epirev/mxq011,2010,duplicate,,0,,,,,
viral evolution and escape during acute hiv-1 infection (special issue: primary hiv-1 infection),Boutwell,10.1086/655653,2010,duplicate,,0,,,,,
"viral sequence analysis from hiv-infected mothers and infants: molecular evolution, diversity, and risk factors for mother-to-child transmission (special issue: perinatal hiv infection)",Bulterys,10.1016/j.clp.2010.08.003,2010,duplicate,,0,,,,,
building infrastructure for hiv/aids and mental health research at institutions serving minorities (special issue: mentoring for diversity in the mental health of hiv/aids),Yanagihara,10.2105/AJPH.2008.136903,2009,duplicate,,0,,,,,
"cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype a, c, and d envelope variants of human immunodeficiency virus type",Blish CA,10.1128/JVI.00673-09,2009,duplicate,,0,,,,,
high genetic diversity in human immunodeficiency virus - type 1 in jamaica,Heslop OD,,2009,duplicate,,0,,,,,
nmr second site screening for structure determination of ligands bound inthe hydrophobie pocket of hiv-1 gp41,Balogh E,10.1021/ja8094558,2009,duplicate,,0,,,,,
escape from neutralizing antibody in early subtype c hiv-1 infection,Rong R,,2009,duplicate,,0,,,,,
genetic diversity and drug resistance of hiv type 1 circulating recombinant form-bc among drug users in guangdong province,Yu G,10.1089/aid.2008.0312,2009,duplicate,,0,,,,,
global hiv-1 molecular epidemiology with special reference to genetic analysis of hiv-1 subtypes circulating in north india: functional and pathogenic implications of genetic variation,Neogi U,,2009,duplicate,,0,,,,,
high level of multidrug resistance mutations in hiv type 1 pol gene and resistance-associated mutations to enfuvirtide (t-20) among antiretroviral- experienced patients from central brazil,Cardoso LPV,10.1089/aid.2009.0060,2009,duplicate,,0,,,,,
hiv and sti behavioural surveillance among men who have sex with men in europe (special issue: hiv/aids and other sexually transmitted infections (sti) in men who have sex with men (msm) - trends and behavioural surveillance),Elford,,2009,duplicate,,0,,,,,
hiv molecular epidemiology: transmission and adaptation to human populations,Woodman Z,10.1097/COH.0b013e32832c0672,2009,duplicate,,0,,,,,
hiv molecular epidemiology: transmission and adaptation to human populations (special issue: epidemiology),Woodman,10.1097/COH.0b013e32832c0672,2009,duplicate,,0,,,,,
hiv-1 resistance to first- and second-generation non-nucleoside reverse transcriptase inhibitors,Ghosn J,,2009,duplicate,,0,,,,,
preventing transfusion-transmitted hiv infection in latin america and the caribbean: issues associated with blood donor interviews and sex between men (special issue: hiv infection in the americas: improving strategic information to improve response),Alonso,10.1097/QAI.0b013e3181a268ed,2009,duplicate,,0,,,,,
special issue: sexual acquisition and transmission of hiv cooperative agreement program (sathcap) (special issue: sexual acquisition and transmission of hiv cooperative agreement program (sathcap)),Compton,,2009,duplicate,,0,,,,,
"social context, sexual risk perceptions and stigma: hiv vulnerability among male sex workers in mombasa, kenya (special issue: recent research on sexuality in africa)",Okal,10.1080/13691050902906488,2009,duplicate,,0,,,,,
"unprotected sex among men who have sex with men in canada: exploring rationales and expanding hiv prevention (special issue: men's health: practice, policy, research and theory)",Gastaldo,10.1080/09581590802566453,2009,duplicate,,0,,,,,
"trends and correlates of hiv testing during pregnancy in racially/ethnically diverse insured population, 1997-2006",Lawrence JM,10.1007/s10995-008-0403-8,2009,duplicate,,0,,,,,
advances in basic science understanding of mother-to-child hiv-1 transmission (special issue: prevention of mother-to-child transmission),Walter,10.1097/COH.0b013e3282f50bb2,2008,duplicate,,0,,,,,
analysis of hiv subtypes and the phylogenetic tree in hiv-positive samples from saudi arabia,Alzahrani AJ,,2008,duplicate,,0,,,,,
abstinence-plus programs for hiv infection prevention in high-income countries,Underhill K,10.1002/14651858.CD007006,2008,duplicate,,0,,,,,
cross-subtype antibody and cellular immune responses induced by a polyvalent dna prime-protein boost hiv-1 vaccine in healthy human volunteers,Wang S,,2008,duplicate,,0,,,,,
continuous crossover(s) events of hiv-1 crf01_ae and b subtype strains in malaysia: evidence of rapid and extensive hiv-1 evolution in the region,Lau KA,,2008,duplicate,,0,,,,,
global hiv epidemiology and current migration (vih e inmigracion) [spanish],Gascon Brustenga,10.1157/13123261,2008,duplicate,,0,,,,,
hiv-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo,Martinez-Picado J,10.1016/j.virusres.2007.12.021,2008,duplicate,,0,,,,,
psychosocial predictors of hiv-associated sexual behaviors and the efficacy of prevention interventions in adolescents at-risk for hiv infection: what works and what doesn't work? (special issue: psychosocial and psychoneuroimmunological factors in hiv infection),DiClemente,10.1097/PSY.0b013e3181775edb,2008,duplicate,,0,,,,,
role of the 5' tar stem-loop and the u5-aug duplex in dimerization of hiv-1 genomic rna,Song R,10.1021/bi7023173,2008,duplicate,,0,,,,,
"sexual diversity, social inclusion and hiv/aids",Caceres CF,,2008,duplicate,,0,,,,,
the epidemic origin and molecular properties of b?: a founder strain of the hiv-1 transmission in asia,Deng X,10.1097/QAD.0b013e32830f4c62,2008,duplicate,,0,,,,,
viral characteristics of transmitted hiv,Derdeyn CA,10.1097/COH.0b013e3282f2982c,2008,duplicate,,0,,,,,
"young people's sexual partnerships in kwazulu-natal, south africa: patterns, contextual influences, and hiv risk (special issue: adolescent sexual and reproductive health in sub-saharan africa)",Harrison,10.1111/j.1728-4465.2008.00176.x,2008,duplicate,,0,,,,,
cloning and characterization of functional subtype a hiv-1 envelope variants transmitted through breastfeeding,Rainwater SM,,2007,duplicate,,0,,,,,
"demographic correlates of hiv testing, high-risk behaviors, and condom/std consultation among a multi-ethnic sample of women (black women and hiv/aids; epidemiology, risk behaviors, and prevention)",Brown,10.1300/J013v46n02_05,2007,duplicate,,0,,,,,
genetic and phylogenetic evolution of hiv-1 in a low subtype heterogeneity epidemic: the italian example,Buonaguro L,10.1186/1742-4690-4-34,2007,duplicate,,0,,,,,
hiv epidemiology update and transmission factors: risks and risk contexts - 16th international aids conference epidemiology plenary,Beyrer C,10.1086/512371,2007,duplicate,,0,,,,,
potentials of phenolic molecules of natural origin and their derivatives as anti-hiv agents,Hassan Khan MT,10.1016/S1387-2656%2807%2913009-X,2007,duplicate,,0,,,,,
prevalence and determinants of transmitted antiretroviral drug resistance in hiv-1 infection,Booth,10.1093/jac/dkm082,2007,duplicate,,0,,,,,
review of status of hiv strain diversity in the united states,Brennan CA,10.1002/jmv.20971,2007,duplicate,,0,,,,,
subtype and sequence analysis of gag genes among hiv-1 strains circulating in beijing immigration during 2006 [chinese],Ye J-R,,2007,duplicate,,0,,,,,
"diversity, drug resistance, and the epidemic of subtype c hiv-1 in africa",Katzenstein D,10.1086/505353,2006,duplicate,,0,,,,,
hiv transmission and primary drug resistance,Turner D,,2006,duplicate,,0,,,,,
"genetic characterization of three crf01ae full-length hiv type 1 sequences from fujian province, china",Huang H-L,,2006,duplicate,,0,,,,,
"hiv/aids epidemiology, pathogenesis, prevention, and treatment [review] [208 refs]",Simon V,,2006,duplicate,,0,,,,,
impact of hiv-1 pol diversity on drug resistance and its clinical implications,Kantor R,10.1097/QCO.0b013e3280109122,2006,duplicate,,0,,,,,
insertions and deletions in hiv-1 reverse transcriptase: consequences for drug resistance and viral fitness,Menendez-Arias L,10.2174/138161206776873608,2006,duplicate,,0,,,,,
molecular characterization of the hiv-i gag nucleocapsid gene associated with vertical transmission,Wellensiek BP,10.1186/1742-4690-3-21,2006,duplicate,,0,,,,,
residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating cd4+ t cells,Bailey JR,,2006,duplicate,,0,,,,,
conservation of functional domains and limited heterogeneity of hiv-1 reverse transcriptase gene following vertical transmission,Sundaravaradan V,,2005,duplicate,,0,,,,,
diversity of thymidine analogue resistance genotypes among newly diagnosed hiv-1-infected persons,Garcia-Lerma JG,10.1093/jac/dki194,2005,duplicate,,0,,,,,
"enfuvirtide, the first fusion inhibitor to treat hiv infection",Poveda E,,2005,duplicate,,0,,,,,
hiv vaccines: brief review and discussion of future directions [review] [104 refs],Slobod KS,,2005,duplicate,,0,,,,,
molecular epidemiology of hiv,Kandathil AJ,,2005,duplicate,,0,,,,,
neurologic manifestations of hiv infection: an indian hospital-based study,Teja VD,,2005,duplicate,,0,,,,,
reversion of immune escape hiv variants upon transmission: insights into effective viral immunity,Kent SJ,10.1016/j.tim.2005.03.011,2005,duplicate,,0,,,,,
targeted infection of hiv-1 env expressing cells by hiv(cd4/cxcr4) vectors reveals a potential new rationale for hiv-1 mediated down-modulation of cd4,Ye Z,,2005,duplicate,,0,,,,,
a model hiv/aids risk reduction programme in the philippines: a comprehensive community-based approach through participatory action research,Morisky,10.1093/heapro/dah109,2004,duplicate,,0,,,,,
establishment of a novel ccr5 and cxcr4 expressing cd4+ cell line which is highly sensitive to hiv and suitable for high-throughput evaluation of ccr5 and cxcr4 antagonists,Princen K,,2004,duplicate,,0,,,,,
hiv-resistance to viral entry inhibitors,Menendez-Arias,10.2174/1381612043384574,2004,duplicate,,0,,,,,
in vivo dynamics of the 103n mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in hiv-infected patients: preliminary results,Gianotti N,,2004,duplicate,,0,,,,,
molecular epidemiology of hiv: tracking aids pandemic,Takebe Y,10.1046/j.1442-200x.2004.01869.x,2004,duplicate,,0,,,,,
plasma rna viral load is not associated with intrapatient quasispecies heterogeneity in hiv-1 infection,Bello G,,2004,duplicate,,0,,,,,
changing transmission fitness of drug-resistant human immunodeficiency virus against a background of evolving antiretroviral therapy,Murray JM,,2003,duplicate,,0,,,,,
"diverse repertoire of hiv-1 p24-specific, ifn-gamma-producing cd4+ t cell clones following immune reconstitution on highly active antiretroviral therapy",Boritz E,,2003,duplicate,,0,,,,,
evolution and diversity of hiv-1 in africa--a review [review] [174 refs],Papathanasopoulos MA,,2003,duplicate,,0,,,,,
haplotype diversity in the interleukin-4 gene is not associated with hiv-1 -transmission and aids progression,Modi WS,10.1007/s00251-003-0541-5,2003,duplicate,,0,,,,,
"highly divergent hiv type 1 group m sequences evident in karonga district, malawi in early 1980s",McCormack GP,,2003,duplicate,,0,,,,,
"hiv-positive immigrants in the canary islands, spain: implications for public health in europe",Holguin A,,2003,duplicate,,0,,,,,
"mother-to-child transmission of hiv: developing integration of healthcare programmes with clinical, social and basic research studies",Menu,10.1080/08035250310006025,2003,duplicate,,0,,,,,
"the diverse older hiv-positive population: a national profile of economic circumstances, social support, and quality of life (special issue: the graying of the aids epidemic: hiv/aids and people age 50 and older)",Crystal,10.1097/00126334-200306012-00004,2003,duplicate,,0,,,,,
diverse realities: sexually transmitted infections and hiv in india,Hawkes S,,2002,duplicate,,0,,,,,
fitness of drug resistant hiv-1: methodology and clinical implications,Quinones-Mateu ME,10.1016/S1368-7646%2802%2900123-1,2002,duplicate,,0,,,,,
hiv among gay and other men who have sex with men in latin america and the caribbean: a hidden epidemic? (the hiv epidemic in latin america and the caribbean: impact and response a multidisciplinary view),Caceres,10.1097/00002030-200212003-00005,2002,duplicate,,0,,,,,
hiv and drug misuse in the edinburgh cohort,Bell JE,10.1097/00126334-200210012-00003,2002,duplicate,,0,,,,,
exploring the envelope systematic alteration in the sex-determination system of the nematode caenorhabditis elegans,Hodgkin J,,2002,duplicate,,0,,,,,
hiv multidisciplinary teams work: support services improve access to and retention in hiv primary care,Sherer R,,2002,duplicate,,0,,,,,
inter- and intra-genic intersubtype hiv-1 recombination in rural and semi-urban uganda,Yirrell DL,,2002,duplicate,,0,,,,,
mathematical models of hiv pathogenesis and treatment,Wodarz D,10.1002/bies.10196,2002,duplicate,,0,,,,,
rna secondary structure and sequence conservation in c1 region of human immunodeficiency virus type 1 env gene,Peleg O,10.1089/08892220260190353,2002,duplicate,,0,,,,,
tnf-alpha promoter region gene polymorphisms in hiv-positive patients with lipodystrophy,Maher B,,2002,duplicate,,0,,,,,
harm reduction theories and strategies for control of human immunodeficiency virus: a review of the literature,Hilton BA,,2001,duplicate,,0,,,,,
hiv gp120 v(1)/v(2) and c(2)-v(3) domains glycoprotein compatibility is required for viral replication,Chen M,,2001,duplicate,,0,,,,,
hiv/aids in caribbean children and adolescents,Jack N,10.1300/J129v04n02_03,2001,duplicate,,0,,,,,
mutational patterns in the hiv genome and cross-resistance following nucleoside and nucleotide analogue drug exposure,Miller V,,2001,duplicate,,0,,,,,
phylogenetic relationships of bovine immunodeficiency virus in cattle and buffaloes based on surface envelope gene sequences brief report,Meas S,,2001,duplicate,,0,,,,,
a chimpanzee rhadinovirus sequence related to kaposi's sarcoma-associated herpesvirus/human herpesvirus 8: increased detection after hiv-1 infection the absence of disease,Greensill J,10.1097/00002030-200012010-00001,2000,duplicate,,0,,,,,
genetic evidence of multiple transmissions of hiv type 1 subtype f within romania from adult blood donors to children,Op De Coul E,,2000,duplicate,,0,,,,,
the effect of genetic variation in chemokines and their receptors on hiv transmission and progression to aids,O'Brien SJ,10.1034/j.1600-065X.2000.17710.x,2000,duplicate,,0,,,,,
transmission and prevalence of hiv resistance among treatment-naive subjects,Little SJ,,2000,duplicate,,0,,,,,
"full-length human immunodeficiency virus type 1 genomes from subtype c- infected seroconverters in india, with evidence of intersubtype recombination",Lole KS,,1999,duplicate,,0,,,,,
genetic determinants of hiv-1 infection and its manifestations,Kaslow RA,10.1046/j.1525-1381.1999.99238.x,1999,duplicate,,0,,,,,
human immunodeficiency virus-associated pericardial effusion: report of 40 cases and review of the literature [review] [49 refs],Chen Y,,1999,duplicate,,0,,,,,
studies of human immunodeficiency virus type 1 mucosal viral shedding and transmission in kenya [review] [11 refs],Overbaugh J,,1999,duplicate,,0,,,,,
a molecular epidemiologic survey of hiv in uganda hiv variant working group,Rayfield MA,,1998,duplicate,,0,,,,,
"altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi-dideoxynucleoside resistance",Maeda Y,,1998,duplicate,,0,,,,,
an african hiv-1 sequence from 1959 and implications for the origin of the epidemic,Zhu T,,1998,duplicate,,0,,,,,
genotypic characterization of human immunodeficiency virus type 1 in greece multicentre study on hiv-1 heterogeneity,Nasioulas G,,1998,duplicate,,0,,,,,
hiv vaccine development: a subtype e-specific strategy,Brown AE,,1998,duplicate,,0,,,,,
host and viral factors influencing heterosexual hiv transmission,Miller CJ,10.1530/ror.0.0030042,1998,duplicate,,0,,,,,
multiple residues contribute to the inability of murine ccr5 to function as a coreceptor for macrophage-tropic human immunodeficiency virus type 1 isolates,Ross,,1998,duplicate,,0,,,,,
structural constraints in the hiv-1 reverse trancriptase - primer/template complex for the initiation of dna synthesis from primer trna(lys3),Zakharova OD,10.1021/bi980239g,1998,duplicate,,0,,,,,
superinduction of il-8 in t cells by hiv-1 tat protein is mediated through nf- kappa b factors,Ott,,1998,duplicate,,0,,,,,
testing for hiv infection in time: scientific reasons,Koblet H,,1998,duplicate,,0,,,,,
"the hiv epidemic in burkina faso: current status and level of aids knowledge in population, 1994-1995 [french]",Meda N,,1998,duplicate,,0,,,,,
virtues of being faithful: can we limit the genetic variation in human immunodeficiency virus?,Drosopoulos WC,10.1007/s001090050257,1998,duplicate,,0,,,,,
"characterization of pseudorabies virus mutants expressing carboxy- terminal truncations of ge: evidence for envelope incorporation, virulence, and neurotropism domains",Tirabassi RS,,1997,duplicate,,0,,,,,
comparison of four molecular typing methods for evaluating genetic diversity among candida albicans isolates from human immunodeficiency virus- positive patients with oral candidiasis,Diaz-Guerra TM,,1997,duplicate,,0,,,,,
evaluation of a knowledge- and cognitive-behavioral skills-building intervention to prevent stds and hiv infection in high school students,Boyer CB,,1997,duplicate,,0,,,,,
evaluation of a system using oral mucosal transudate for hiv-1 antibody screening and confirmatory testing orasure hiv clinical trials group,Gallo D,,1997,duplicate,,0,,,,,
"frequency of the ccr5 delta32 mutant allele in hiv-1-positive patients, female sex workers, and a normal population in taiwan",Li C,,1997,duplicate,,0,,,,,
hiv type 1 v3 variation dynamics in vivo: long-term persistence of non-syncytium-inducing genotypes and transient presence of syncytium-inducing genotypes during the course of progressive aids,Ida S,,1997,duplicate,,0,,,,,
increasing diversity of hiv-1m serotypes in french blood donors over a 10-year period (1985-1995),Barin,10.1097/00002030-199712000-00015,1997,duplicate,,0,,,,,
increasing diversity of hiv-1m serotypes in french blood donors over a 10-year period (1985-1995) retrovirus study group of the french society of blood transfusion,Barin F,,1997,duplicate,,0,,,,,
intracellular inhibition of hiv-1 replication using a dual protein- and rna-based strategy,Duan L,,1997,duplicate,,0,,,,,
investigation of population diversity of human immunodeficiency virus type 1 in vivo by nucleotide sequencing and length polymorphism analysis of the v1/v2 hypervariable region of env,Hughes ES,,1997,duplicate,,0,,,,,
"pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes b and d",Cornelissen M,,1997,duplicate,,0,,,,,
presence of human immunodeficiency virus (hiv) type 1 subtype a infection in a new york community with high hiv prevalence: a sentinel site for monitoring hiv genetic diversity in north america centers for disease control and prevention-bronx lebanon hiv serosurvey team,Irwin KL,,1997,duplicate,,0,,,,,
an in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine,Hooker DJ,,1996,duplicate,,0,,,,,
full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolated from thailand,Carr,,1996,duplicate,,0,,,,,
molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes a through g the who and niaid networks for hiv isolation and characterization,Gao F,,1996,duplicate,,0,,,,,
"a genetic analysis of hiv-1 from punjab, india, reveals the presence of multiple variants",Jameel S,,1995,duplicate,,0,,,,,
cdr3-independent gamma delta v delta 1+ t cell expansion in the peripheral blood of hiv-infected persons,Boullier S,,1995,duplicate,,0,,,,,
hiv-1 reverse transcriptase-associated rnase h cleaves rna/rna in arrested complexes: implications for the mechanism by which rnase h discriminates between rna/rna and rna/dna,Gotte M,,1995,duplicate,,0,,,,,
libraries of human rhinovirus-based hiv vaccines generated using random systematic mutagenesis,Resnick DA,,1994,duplicate,,0,,,,,
pathogenicity and diversity of hiv and implications for clinical management: a review [review] [36 refs],Saag MS,,1994,duplicate,,0,,,,,
the macrophage and hiv-1,Ho WZ,,1994,duplicate,,0,,,,,
age-adjusted cd4+ lymphocyte parameters in healthy children at risk for infection with the human immunodeficiency virus the military pediatric hiv consortium,Waecker NJ Jr,,1993,duplicate,,0,,,,,
hiv infection in children: a challenge to dental practice,Sote EO,,1993,duplicate,,0,,,,,
kinetic analysis of template-primer interactions with recombinant forms of hiv-1 reverse transcriptase,Beard WA,,1993,duplicate,,0,,,,,
preferential v beta usage by cytotoxic t cells cross-reactive between two epitopes of hiv-1 gp160 and degenerate in class i mhc restriction,Shirai M,,1993,duplicate,,0,,,,,
use of a rule based graph-theoretical system in evaluating the activity of a class of nucleoside analogues aginst human immunodeficiency virus,Raychaudhury C,,1993,duplicate,,0,,,,,
pulmonary hypertension and human immunodeficiency virus infection two reports and a review of the literature [review] [30 refs],Polos PG,,1992,duplicate,,0,,,,,
the host immune response may be responsible for selection of envelope and precore/core variants of hbv,Thomas HC,,1992,duplicate,,0,,,,,
two major groups of neutralizing anti-gp120 antibodies exist in hiv-infected individuals evidence for epitope diversity around the cd4 attachment site,Chamat S,,1992,duplicate,,0,,,,,
generation of hybrid human immunodeficiency virus utilizing the cotransfection method and analysis of cellular tropism,Velpandi A,,1991,duplicate,,0,,,,,
human immunodeficiency virus type 1-infected blood donors: behavioral characteristics and reasons for donation the hiv blood donor study group,Doll LS,,1991,duplicate,,0,,,,,
diversity of oligosaccharide structures on the envelope glycoprotein gp120 of human immunodeficiency virus 1 from the lymphoblastoid cell line h9 presence of complex-type oligosaccharidis with bisecting n-acetylglucosamine residues,Mizuochi T,,1990,duplicate,,0,,,,,
major histocompatibility complex genes influence the outcome of hiv infection ancestral haplotypes with c4 null alleles explain diverse hla associations,Cameron PU,,1990,duplicate,,0,,,,,
mechanisms of infectivity and replication of hiv-1 and implications for therapy,Terwilliger EF,,1990,duplicate,,0,,,,,
the neurobiology of human immunodeficiency virus infections,Johnson RT,,1988,duplicate,,0,,,,,
location of envelope-specific and sarcoma-specific oligonucleotides on rna of schmidt-ruppin rous sarcoma virus,Wang LH,,1976,duplicate,,0,,,,,
"hiv drug resistance abstracts of the 5th international workshop, held 3-6 july 1996, whistler, canada",1996,NR,,0,,,,,,,
"aids vaccine, microbicide and arv-based prevention science hiv research for prevention meeting, madrid, spain, 21-25 october 2018",2018,NR,,0,,,,,,,
[health care worker relationship with hiv infected patients or aids patients] [review] [41 refs] [spanish],Vallejo-Aguilar O,1992,review,,0,,,,,,
[sequence variation of hiv and bioinformatics] [review] [15 refs] [japanese],Yamaguchi-Kabata Y,2004,review,,0,,,,,,
[variability of human immunodeficiency virus type 1] [review] [10 refs] [french],Brun-Vezinet F,1999,review,,0,,,,,,
a call for replicating vector prime-protein boost strategies in hiv vaccine design [review] [107 refs],Malkevitch NV,2004,review,,0,,,,,,
a systematic review to quantitatively evaluate 'stepping stones': a participatory community-based hiv/aids prevention intervention,Skevington SM,2013,review,,0,,,,,,
current and future assays for identifying recent hiv infections at the population level [review],Smolen-Dzirba J,2011,review,,0,,,,,,
differential impact of genetic diversity on disease progression in treatment-naive hiv-1 infected adults: a systematic review of global evidence,Shivkumar S,2011,review,,0,,,,,,
diversity of thymidine analogue resistance genotypes among newly diagnosed hiv-1-infected persons [review] [33 refs],Garcia-Lerma JG,2005,review,,0,,,,,,
"diversity, drug resistance, and the epidemic of subtype c hiv-1 in africa [review] [29 refs]",Katzenstein D,2006,review,,0,,,,,,
exploring community-academic partnerships in hiv-related research: a systematic review of the literature,Globerman J,2014,review,,0,,,,,,
factors determining the vulnerability of women to sexually transmitted hiv: a literature review,Macleod-Downes,2008,review,,0,,,,,,
fitness of drug resistant hiv-1: methodology and clinical implications [review] [84 refs],Quinones-Mateu ME,2002,review,,0,,,,,,
genetic and phylogenetic evolution of hiv-1 in a low subtype heterogeneity epidemic: the italian example [review] [69 refs],Buonaguro L,2007,review,,0,,,,,,
"health promotion in the city: a structured review of the literature on interventions to prevent heart disease, substance abuse, violence and hiv infection in us metropolitan areas, 1980-1995",Freudenberg N,2000,review,,0,,,,,,
hiv-1 fitness and macrophages [review] [154 refs],Goodenow MM,2003,review,,0,,,,,,
hiv-resistance to viral entry inhibitors [review] [157 refs],Menendez-Arias L,2004,review,,0,,,,,,
hiv-specific t cells: strategies for fighting a moving target [review],McKinnon LR,2010,review,,0,,,,,,
identifying hiv-1 dual infections [review] [81 refs],van der Kuyl AC,2007,review,,0,,,,,,
insertions and deletions in hiv-1 reverse transcriptase: consequences for drug resistance and viral fitness [review] [154 refs],Menendez-Arias L,2006,review,,0,,,,,,
mechanisms of infectivity and replication of hiv-1 and implications for therapy [review] [76 refs],Terwilliger EF,1990,review,,0,,,,,,
potentials of phenolic molecules of natural origin and their derivatives as anti-hiv agents [review] [145 refs],Hassan Khan MT,2007,review,,0,,,,,,
"rna structures, genomic organization and selection of recombinant hiv [review]",Simon-Loriere E,2011,review,,0,,,,,,
role of genetic diversity amongst hiv-1 non-b subtypes in drug resistance: a systematic review of virologic and biochemical evidence [review] [56 refs],Martinez-Cajas JL,2008,review,,0,,,,,,
the host environment drives hiv-1 fitness [review] [151 refs],van Opijnen T,2005,review,,0,,,,,,
the non-clonal and transitory nature of hiv in vivo [review] [33 refs],Meyerhans A,2003,review,,0,,,,,,
travel and the introduction of human immunodeficiency virus type 1 non-b subtype genetic forms into western countries [review] [42 refs],Thomson MM,2001,review,,0,,,,,,
"understanding hiv resistance, fitness, replication capacity and compensation: targeting viral fitness as a therapeutic strategy [review] [221 refs]",Buckheit RW Jr,2004,review,,0,,,,,,
virtues of being faithful: can we limit the genetic variation in human immunodeficiency virus? [review] [83 refs],Drosopoulos WC,1998,review,,0,,,,,,
"virus fitness: concept, quantification, and application to hiv population dynamics [review] [303 refs]",Quinones-Mateu ME,2006,review,,0,,,,,,
[genetic diversity of human immunodeficiency virus type-1 (hiv-1) in infected women from a northeast city of brazil] [portuguese],Santos Ede S,2009,publication language,,0,,,,,,
[geographic inequalities in hiv infection and aids in sub-saharan africa] [french],Amat-Roze JM,1993,publication language,,0,,,,,,
[global hiv epidemiology and current migration] [spanish],Gascon Brustenga J,2008,publication language,,0,,,,,,
[hiv-1 genetic variants in the asian part of russia: a study (2005-2010)] [russian],Kazennova EV,2013,publication language,,0,,,,,,
[hiv-1 subtype distribution determined by phylogenetic analysis of pol gene sequences and automated subtyping tools among hiv-1 isolates from the aegian region of turkey] [turkish],Uluer Biceroglu S,2014,publication language,,0,,,,,,
[molecular analysis of the principal neutralization epitope (v3 loop) of human immunodeficiency virus type 1 in argentina] [spanish],Gomez Carrillo M,1992,publication language,,0,,,,,,
[molecular epidemiology of hiv-1 strains in the moscow region] [russian],Giliazova AV,2010,publication language,,0,,,,,,
[molecular-genetic characteristic of hiv-1 a and b subtypes variants isolated in novosibirsk region] [russian],Bogachev VV,2012,publication language,,0,,,,,,
[obstetrical management of a patient with hiv infection] [spanish],Figueroa Damian R,1994,publication language,,0,,,,,,
[prevalence of mutations responsible for resistance to antiretroviral preparations among hiv-1 variants circulating in novosibirsk region] [russian],Gashnikova NM,2012,publication language,,0,,,,,,
[protease and reverse transcriptase genetic polymorphism in hiv type 1 subtype a variants predominating in cis countries] [russian],Sukhanova AL,2005,publication language,,0,,,,,,
[psycho-pathological disturbance in hiv-aids patients] [spanish],Carballo Alvarez M,2008,publication language,,0,,,,,,
[rapid spread of the hiv-1 circular recombinant crf02-ag in russia and neighboring countries] [russian],Moskaleychik FF,2015,publication language,,0,,,,,,
[sequencing and their use in the study of fundamental hiv virus] [spanish],Maroto Vela Mdel C,2012,publication language,,0,,,,,,
a recombinant hiv-1 strain causing an epidemic among injection drug addicts in kaliningrad [russian],Korovina GI,1999,publication language,,0,,,,,,
analysis of the polymorphism of the genome region of hiv-1 encoding the fusion protein [russian],Vasil'Ev AV,2012,publication language,,0,,,,,,
application of heteroduplex mobility assay in molecular epidemiology study of hiv-1 in cuba [spanish],Blanco de Armas M,2001,publication language,,0,,,,,,
"contextual, spatial and time approach to the hiv/aids study [spanish]",Alegret Rodriguez,2008,publication language,,0,,,,,,
effect of breastfeeding protected by antiretroviral son mother-to-child hiv transmission in the pediatric unit of the university teaching hospital (cnhu-hkm) of cotonou [french],Zohoun Guidigbi,2017,publication language,,0,,,,,,
effect of hiv-1 crf01-ae in hiv transmission and epidemic [chinese],Sun XianGuang,2011,publication language,,0,,,,,,
effect on hiv-1 gene mutation strain for the aids epidemic situation in guizhou province [chinese],Sun XianGuang,2013,publication language,,0,,,,,,
evolution of hiv infection and its consequences on therapy [german],Jablonowski H,2007,publication language,,0,,,,,,
from risk to vulnerability methodological basis for understanding the relationship between sexual violence and hiv infection/aids among clandestine migrants [spanish],Martinez DH-R,2005,publication language,,0,,,,,,
"genotyping of hiv-1 detected in hiv infected men who have sex with men in shaoxing, zhejiang [chinese]",Cao DongQing,2015,publication language,,0,,,,,,
health care worker relationship with hiv infected patients or aids patients [spanish],Vallejo-Aguilar O,1992,publication language,,0,,,,,,
hiv epidemiology [french],Wandeler G,2008,publication language,,0,,,,,,
"hiv infection in the rijnmond region 1985-1993: more transmission by heterosexual contact and drugs abuse, and more female patients [dutch]",Van Der Ende ME,1995,publication language,,0,,,,,,
hiv-1 genetic variants in the asian part of russia: a study (2005-2010) [russian],Kazennova EV,2013,publication language,,0,,,,,,
hiv/aids infection the brazilian view aids in brazil [portuguese],Goncalves AP,1996,publication language,,0,,,,,,
identification and characterization of hiv-1 transmitted/founder viruses [chinese],Zhao JianYuan,2015,publication language,,0,,,,,,
influence of the clinical and biological variables cd4 and viral load on the neuropsychologic efficiency of patients with hiv-1 infection [spanish],Failde Garrido JM,2005,publication language,,0,,,,,,
interleukin 10 produced by hiv-1-infected pregnant women reduces viral replication: effect enhanced by anti-retroviral therapy [spanish],Bento CADM,2008,publication language,,0,,,,,,
molecular analysis of the principal neutralization epitope (v3 loop) of human immunodeficiency virus type 1 in argentina [spanish],Gomez Carrillo M,1992,publication language,,0,,,,,,
molecular epidemiological characteristics of 528 hiv-1 infected cases in shenzhen [chinese],Kong DongFeng,2015,publication language,,0,,,,,,
molecular epidemiological investigation on hiv-1 infection via mother-to-child transmission [chinese],Zhao HongRu,2011,publication language,,0,,,,,,
molecular epidemiological study of human immunodeficiency virus type 1 in minhang district of shanghai [chinese],Zhang XingCan,2015,publication language,,0,,,,,,
"molecular epidemiological survey among newly-diagnosed hiv-1 infected individuals in taizhou, zhejiang, 2011 [chinese]",Qiu DanHong,2013,publication language,,0,,,,,,
molecular epidemiology and the choice of the prototype strains of hiv-1 with the aim of designing a domestic candidate anti-hiv vaccines [russian],Moskaleychyuk FF,2015,publication language,,0,,,,,,
molecular epidemiology of hiv-1 strains in the moscow region [russian],Gilyazova AV,2010,publication language,,0,,,,,,
obstetrical management of a patient with hiv infection [spanish],Figueroa Damian R,1994,publication language,,0,,,,,,
periodontal disease in patients with hiv infection radiographic study [italian],Scutellari PN,1996,publication language,,0,,,,,,
protease and reverse transcriptase genetic polymorphism in hiv type 1 subtype a variants predominating in cis countries [russian],Sukhanova AL,2005,publication language,,0,,,,,,
psycho-pathological disturbance in hiv-aids patients [spanish],Carballo Alvarez M,2008,publication language,,0,,,,,,
rapid spread of the hiv-1 circular recombinant crf02-ag in russia and neighboring countries [russian],Moskaleychik FF,2015,publication language,,0,,,,,,
sequence analysis on envelope genes from human immunodeficiency virus type 1 samples with broadly neutralizing activities [chinese],Qi ZhongWei,2016,publication language,,0,,,,,,
subtype and sequence analysis of the gag genes for hiv-1 strains isolated in hubei province [chinese],Chu XiaoGang,2012,publication language,,0,,,,,,
"trend of genetic subtypes in people who living with hiv in liuzhou, guangxi, 1998-2018 [chinese]",Kang RuiHua,2019,publication language,,0,,,,,,
variability of human immunodeficiency virus type 1 [french],Brun-Vezinet F,1999,publication language,,0,,,,,,
characterization of cell envelope proteins and lipopolysaccharides of escherichia coli isolates from patients with neonatal meningitis,Van Alphen L,1983,pre 1990,,0,,,,,,
persistent coinfection of t lymphocytes with htlv-ii and hiv and the role of syncytium formation in hiv-induced cytopathic effect,Montefiori DC,1987,pre 1990,,0,,,,,,
risk factors for hiv infection in drug addicts from the northeast of italy,Franceschi S,1988,pre 1990,,0,,,,,,
act research day: communities of practice and community-based knowledge production in the response to hiv,Greenspan NR,2015,NR,,0,,,,,,
antiretroviral dynamics determines hiv evolution and predicts therapy outcome,Rosenbloom DI,2012,NR,,0,,,,,,
"antiretroviral resistance and genetic diversity of human immunodeficiency virus type 1 isolates from the federal district, central brazil",Cerqueira DM,2004,NR,,0,,,,,,
are we going to close social gaps in hiv? likely effects of behavioral hiv-prevention interventions on health disparities,Albarracin D,2010,NR,,0,,,,,,
admissible evidence: knowledge production for hiv programs and policy in community settings,Husbands WC,2011,NR,,0,,,,,,
"advocating for women's, transwomen's, and girls' hiv and aids issues: the 2012 report card from the coalition for a blueprint for action on women and girls and hiv/aids",Stephenson LM,2013,NR,,0,,,,,,
assessing the role of geographical hiv hot-spots in the spread of the epidemic,Cuadros DF,2018,NR,,0,,,,,,
role of common human trim5alpha variants in hiv-1 disease progression,Goldschmidt V,2006,NR,,0,,,,,,
"autochthonous horizontal transmission of a crf02_ag strain revealed by a human immunodeficiency virus type 1 diversity survey in a small city in inner state of rio de janeiro, southeast brazil",Eyer-Silva WA,2007,NR,,0,,,,,,
american and african adolescents' claim to hiv/aids invulnerability,Mwamwenda,2015,NR,,0,,,,,,
"beyond gay, bisexual, or dl: structural determinants of hiv sexual risk among black men in the united states",Malebranche,2013,NR,,0,,,,,,
"biological and biochemical anti-human immunodeficiency virus activity of uc 38, a new non-nucleoside reverse transcriptase inhibitor",McMahon JB,1996,NR,,0,,,,,,
broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of hiv-1,Javaherian K,1990,NR,,0,,,,,,
bystander effect of histone deacetylase inhibitors on hiv-1 infection,Campbell GR,2015,NR,,0,,,,,,
application of the geeniustm hiv1/2 supplemental assay for detection of recent hiv infections,Keating SM,2014,NR,,0,,,,,,
catastrophic health expenditure amongst people living with hiv/aids availing antiretroviral treatment services at two tertiary care health facilities in district of northern india,Mukesh Shukla,2015,NR,,0,,,,,,
autologous and heterologous neutralizing antibody responses in hiv-1 infection,Montefiori D,2012,NR,,0,,,,,,
availability of a diversely avid cd8+ t cell repertoire specific for the subdominant hla-a2-restricted hiv-1 gag p2419-27 epitope,Schaubert KL,2007,NR,,0,,,,,,
brazilian young adults vulnerability to hiv in rio de janeiro and toronto,Barbosa De Souza AC,2011,NR,,0,,,,,,
"circulation of subtype a and gaga/envb recombinant hiv type 1 strains among injecting drug users in st petersburg, russia, correlates with geographical origin of infections",Lukashov VV,1999,NR,,0,,,,,,
clinical analysis and parasite genetic diversity in human immunodeficiency virus/chagas' disease coinfections in brazil,Perez-Ramirez,1999,NR,,0,,,,,,
clinical impact of ultra deep versus sanger sequencing detection of minority mutations on hiv-1 drug resistance genotype interpretation after virological failure,Mohamed S,2014,NR,,0,,,,,,
building healthy online communities: ongoing successes and challenges in partnering with dating app owners to support hiv and std prevention online,Wohlfeiler D,2018,NR,,0,,,,,,
cluster analysis reveals important shift of drivers of the hiv epidemic in swiss msm,Bachmann N,2018,NR,,0,,,,,,
coalition building: a strategy for creating hiv/aids awareness on a college campus,Singleton EK,1996,NR,,0,,,,,,
college students' knowledge and attitudes about aids and changes in hiv-preventive behaviors,DiClemente RJ,1990,NR,,0,,,,,,
comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (hiv-1) in an in vitro competitive hiv-1 replication assay,Kosalaraksa P,1999,NR,,0,,,,,,
comparison of four molecular typing methods for evaluating genetic diversity among candida albicans isolates from human immunodeficiency virus-positive patients with oral candidiasis,Diaz-Guerra TM,1997,NR,,0,,,,,,
comparison of health-related quality of life in clinical trial and nonclinical trial human immunodeficiency virus-infected cohorts,Cunningham WE,1995,NR,,0,,,,,,
comparison of methods for assessing nutritional status in hiv-infected adults,Niyongabo T,1999,NR,,0,,,,,,
comparison of sentosareg sq deep sequencing-based hiv-1 genotyping coupled to integrated workflow with sanger sequencing method for detection of drug resistance mutations,Nimitsantiwong Pornpimon,2018,NR,,0,,,,,,
"comparison of vpu sequences from diverse geographical isolates of hiv type 1 identifies the presence of highly variable domains, additional invariant amino acids, and a signature sequence motif common to subtype c isolates",McCormick-Davis C,2000,NR,,0,,,,,,
comparison of whole gene and whole virus scrambled antigen approaches for dna prime and fowlpox virus boost hiv type 1 vaccine regimens in macaques,Pamungkas J,2005,NR,,0,,,,,,
consistent effects of tsg101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1,Bashirova AA,2006,NR,,0,,,,,,
characterization and selection of hiv-1 subtype c isolates for use in vaccine development,Williamson C,2003,NR,,0,,,,,,
characterization of complete hiv type 1 genomes from non-b subtype infections in us military personnel,Tovanabutra S,2005,NR,,0,,,,,,
continued high-risk sex among hiv seropositive gay and bisexual men seeking hiv prevention services,Kalichman SC,1997,NR,,0,,,,,,
characterization of the anti-hiv activity of trappin-2/elafin,Jasinghe VJ,2011,NR,,0,,,,,,
correlation between resistance profile and immunosuppression in heavily treated hiv-1 infected romanian patients,Manolescu L,2011,NR,,0,,,,,,
cospeciation and horizontal transmission of avian sarcoma and leukosis virus gag genes in galliform birds,Dimcheff DE,2000,NR,,0,,,,,,
circulating micrornas in hiv patients reveal specific signatures for liver damage,Martinez MA,2018,NR,,0,,,,,,
cross-reactive cytotoxic t lymphocytes induced by v3 loop synthetic peptides from different strains of human immunodeficiency virus type 1,Casement KS,1995,NR,,0,,,,,,
"cross-reactive hiv-1-specific ctl in recent seroconverters from pune, india",Paranjape RS,1998,NR,,0,,,,,,
"cultural, gender, and psychosocial influences on hiv-related behavior of african-american female adolescents: implications for the development of tailored prevention programs",Wingood GM,1992,NR,,0,,,,,,
cytotoxicity resulting from addition of hiv-1 nef n-terminal peptides to yeast and bacterial cells,Macreadie IG,1997,NR,,0,,,,,,
clonal proliferation of cd4 t cells encoding intact hiv-1,Lichterfeld M,2018,NR,,0,,,,,,
detecting changes in incidence using phylogenetic tools: simulation-based studies within the pangea-hiv initiative,Hodcroft EB,2015,NR,,0,,,,,,
design of immunogens that present the crown of the hiv-1 v3 loop in a conformation competent to generate 447-52d-like antibodies,Chakraborty K,2006,NR,,0,,,,,,
determinants of the rnase h cleavage specificity of human immunodeficiency virus reverse transcriptase,DeStefano JJ,1993,NR,,0,,,,,,
development of calibrated viral load standards for group m subtypes of human immunodeficiency virus type 1 and performance of an improved amplicor hiv-1 monitor test with isolates of diverse subtypes,Michael NL,1999,NR,,0,,,,,,
"diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase",McMahon JB,1993,NR,,0,,,,,,
dilute passage promotes expression of genetic and phenotypic variants of human immunodeficiency virus type 1 in cell culture,Sanchez-Palomino S,1993,NR,,0,,,,,,
"characterization of a novel hiv-1 crf01_ae/crf07_bc recombinant virus among men who have sex with men in tianjin, china",Ge ZhangWen,2019,NR,,0,,,,,,
complete genomes reveal complex hiv-1 diversity in the democratic republic of congo,Rodgers MA,2016,NR,,0,,,,,,
distinct features of large cluster viral variants lead to better transmission of hiv-1,Ibanescu R-I,2014,NR,,0,,,,,,
diversity and complexity of hiv-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype,Beerenwinkel N,2002,NR,,0,,,,,,
diversity of human immunodeficiency virus type 1 subtype a and crf03_ab protease in eastern europe: selection of the v77i variant and its rapid spread in injecting drug user populations,Roudinskii NI,2004,NR,,0,,,,,,
diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade e from asia and africa,McCutchan FE,1996,NR,,0,,,,,,
contraceptive challenges in adolescents living with or at risk of hiv,Kancheva Landolt N,2016,NR,,0,,,,,,
diversity of the human immunodeficiency virus type 1 envelope glycoprotein in san francisco men's health study participants,McCutchan FE,1998,NR,,0,,,,,,
dissection of the humoral immune response toward an immunodominant epitope of hiv: a model for the analysis of antibody diversity in hiv+ individuals,Enshell-Seijffers D,2001,NR,,0,,,,,,
correlation between trnalys3 aminoacylation and its incorporation into hiv-1,Javanbakht H,2002,NR,,0,,,,,,
dynamics of drug-resistant minor viral populations and phenotypic drug susceptibility in diverse hiv-1 subtypes,Ganeshappa Aralaguppe,2019,NR,,0,,,,,,
current status & future strategies in hiv/aids research - a botanical perspective,Shared Srivastava,2010,NR,,0,,,,,,
early evolution of the human immunodeficiency virus type 1 subtype c epidemic in rural malawi,McCormack GP,2002,NR,,0,,,,,,
defective hiv-1 proviral genomes in natural viral suppressors,Eyzaguirre LM,2009,NR,,0,,,,,,
effects of haart treatment on the microbiome of hiv-+ patients,Shorenstein J,2016,NR,,0,,,,,,
design and pre-clinical evaluation of a universal hiv-1 vaccine,Letourneau S,2007,NR,,0,,,,,,
determinants of hiv shedding in the lower genital tract of women,Anderson BL,2008,NR,,0,,,,,,
emergence of monotypic hiv-1 dna during art suggests proliferation of cells with integrated hiv dna provirus may sustain infection,Wagner TA,2010,NR,,0,,,,,,
emergence of recombinant forms of hiv: dynamics and scaling,Suryavanshi GW,2007,NR,,0,,,,,,
emergent properties and structural patterns in sexually transmitted infection and hiv research,Blanchard JF,2010,NR,,0,,,,,,
"erroneously low or undetectable plasma human immunodeficiency virus type 1 (hiv-1) ribonucleic acid load, determined by polymerase chain reaction, in west african and american patients with non-b subtype hiv-1 infection",Jenny-Avital ER,2001,NR,,0,,,,,,
enhanced nrti and nnrti resistance is associated with mutations in the hiv-1 reverse transcriptase connection subdomain of subtype c patients,Delviks-Frankenberry KA,2010,NR,,0,,,,,,
extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients,Charpentier C,2006,NR,,0,,,,,,
enhanced surveillance of hiv-1 transmitted drug resistance and transmission clusters in recently infected uk msm,Cunningham ES,2014,NR,,0,,,,,,
factors determining the breadth and potency of neutralization by v3-specific human monoclonal antibodies derived from subjects infected with clade a or clade b strains of human immunodeficiency virus type 1,Krachmarov CP,2006,NR,,0,,,,,,
development of an hiv-1 reference panel of subtype b envelope clones isolated from the plasma of recently infected individuals,Schweighardt B,2007,NR,,0,,,,,,
"partner notification after std and hiv exposures and infections: knowledge, attitudes, and experiences of massachusetts men who have sex with men",Mimiaga MJ,2009,NR,,0,,,,,,
epidemiology of hiv infection among long distance truck drivers in kenya,Mbugua GG,1995,NR,,0,,,,,,
evaluation of primary resistance in human immunodeficiency virus type-1 (hiv-1) circulating in angola and mozambique based on an hiv drug resistance threshold survey (hivdr-ts),Ferreira Da Silva RFC,2009,NR,,0,,,,,,
evaluation of the roche 454 hiv-1 drug resistance assay in a clinical laboratory,Garcia-Diaz A,2013,NR,,0,,,,,,
distinct chromosomal positions of intact hiv-1 proviruses,Lichterfeld M,2019,NR,,0,,,,,,
evidence of intra-familial transmission of an hiv-1 m/o intergroup recombinant virus,Ngoupo PAT,2015,NR,,0,,,,,,
evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a zambian couple,Salminen MO,1997,NR,,0,,,,,,
diversification and specialization of hiv protease function during in vitro evolution,O'Loughlin TL,2006,NR,,0,,,,,,
evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and t-cell function,McDonald RA,1997,NR,,0,,,,,,
escape and compensation from early hla-b57-mediated cytotoxic t-lymphocyte pressure on human immunodeficiency virus type 1 gag alter capsid interactions with cyclophilin a,Brockman MA,2007,NR,,0,,,,,,
evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection,van 't Wout AB,1998,NR,,0,,,,,,
"diversity of dis, sd and psi hairpins in hiv-1 isolates of group m: in silico study",Zarudnaya MI,2007,NR,,0,,,,,,
evolutionary mechanisms and population dynamics of the third variable envelope region of hiv within single hosts,Yamaguchi Y,1997,NR,,0,,,,,,
"examining the trait, desire, intention and behaviour (tdib) model for fertility planning in women living with hiv in ontario",Wagner AC,2011,NR,,0,,,,,,
fitness landscape of human immunodeficiency virus type 1 protease quasispecies,Fernandez G,2007,NR,,0,,,,,,
diversity of trypanosoma cruzi infection in patients co-infected with hiv and chagas disease,Bowman NM,2015,NR,,0,,,,,,
expression of human herpesvirus-8 oncogene and cytokine homologues in an hiv-seronegative patient with multicentric castleman's disease and primary effusion lymphoma,Teruya-Feldstein J,1998,NR,,0,,,,,,
expression of membrane drug efflux transporters in recto-sigmoid colon from hiv infected men who have sex with men (msm): potential role in microbicide permeability,De Rosa MF,2011,NR,,0,,,,,,
multicode-rtx real-time pcr system for detection of subpopulations of k65r human immunodeficiency virus type 1 reverse transcriptase mutant viruses in clinical samples,Svarovskaia ES,2006,NR,,0,,,,,,
dynamics of hiv neutralization by a microbicide formulation layer: biophysical fundamentals and transport theory,Geonnotti AR,2006,NR,,0,,,,,,
factors limiting the transmission of hiv mutations conferring drug resistance: fitness costs and genetic bottlenecks,Wagner BG,2012,NR,,0,,,,,,
factors that can negatively affect the daily life of patients on long term hiv treatment,Bouchaud O,2011,NR,,0,,,,,,
effects of random mutations in the human immunodeficiency virus type 1 transcriptional promoter on viral fitness in different host cell environments,van Opijnen T,2006,NR,,0,,,,,,
fecal microbiota of hiv controllers is similar to that of non-hiv-infected individuals,Alva Hernandez SN,2015,NR,,0,,,,,,
"purifying selection of ccr5-tropic human immunodeficiency virus type 1 variants in aids subjects that have developed syncytium-inducing, cxcr4-tropic viruses",Fernandez G,2006,NR,,0,,,,,,
fitness cost of escape mutations in p24 gag in association with control of human immunodeficiency virus type 1,Martinez-Picado J,2006,NR,,0,,,,,,
frequency and molecular epidemiology of panton-valentine leukocidin gene in staphylococcus aureus colonising hiv-infected patients,Mohd-Zain Z,2017,NR,,0,,,,,,
frequency of antiretroviral resistance mutations among art-naive hiv-1-infected populations in rural areas from cameroon,Aghokeng AF,2010,NR,,0,,,,,,
"hiv-1 mutants escaping neutralization by the human antibodies 2f5, 2g12, and 4e10: in vitro experiments versus clinical studies",Nakowitsch S,2005,NR,,0,,,,,,
stochastic gene expression in a lentiviral positive-feedback loop: hiv-1 tat fluctuations drive phenotypic diversity,Weinberger LS,2005,NR,,0,,,,,,
effects of antineoplastic chemotherapy on dynamics of hiv population genetics in vivo,Watters SA,2015,NR,,0,,,,,,
full-length sequence of an ethiopian human immunodeficiency virus type 1 (hiv-1) isolate of genetic subtype c,Salminen MO,1996,NR,,0,,,,,,
evaluation of a low cost reverse transcriptase assay for plasma hiv-1 viral load monitoring,Greengrass VL,2005,NR,,0,,,,,,
functional relevance of nonsynonymous mutations in the hiv-1 tat gene within an epidemiologically-linked transmission cohort,Sivakumaran H,2007,NR,,0,,,,,,
exclusion of hiv epitopes shared with human proteins is prerequisite for designing safer aids vaccines,Maksyutov AZ,2004,NR,,0,,,,,,
the human immunodeficiency virus type 1 promoter contains a cata box instead of a tata box for optimal transcription and replication,van Opijnen T,2004,NR,,0,,,,,,
"eliminating disparities in hiv disease: community mobilization to prevent hiv transmission among black and hispanic young adults in broward county, florida",Darrow WW,2004,NR,,0,,,,,,
genetic analysis of hiv-1 isolates from zambia and an expanded phylogenetic tree for hiv-1,McCutchan FE,1992,NR,,0,,,,,,
variability at human immunodeficiency virus type 1 subtype c protease cleavage sites: an indication of viral fitness?,de Oliveira T,2003,NR,,0,,,,,,
reduced fitness of hiv-1 resistant to cxcr4 antagonists,Armand-Ugon M,2003,NR,,0,,,,,,
"human immunodeficiency virus knowledge and attitudes among hospital-based healthcare professionals in guangxi zhuang autonomous region, people's republic of china",Anderson AF,2003,NR,,0,,,,,,
"genetic diversity and primary resistance among hiv-1-positive patients from maringa, parana, brazil",Gaspareto KV,2012,NR,,0,,,,,,
high frequency of recombinant genomes in hiv type 1 samples from brazilian southeastern and southern regions,Guimaraes ML,2002,NR,,0,,,,,,
precise mapping of recombination breakpoints suggests a common parent of two bc recombinant hiv type 1 strains circulating in china,McClutchan FE,2002,NR,,0,,,,,,
human immunodeficiency virus type 1 env sequences from calcutta in eastern india: identification of features that distinguish subtype c sequences in india from other subtype c sequences,Shankarappa R,2001,NR,,0,,,,,,
estimating the heritability of an hiv-1 trait in a clinical setting,Bachmann N,2017,NR,,0,,,,,,
genetic variability of the envelope gene of type d simian retrovirus-2 (srv-2) subtypes associated with saids-related retroperitoneal fibromatosis in different macaque species,Philipp-Staheli J,2006,NR,,0,,,,,,
genetic variants of hiv-1 in thailand,McCutchan FE,1992,NR,,0,,,,,,
human immunodeficiency virus type 1 variability and long-term non-progression,Visco-Comandini U,2001,NR,,0,,,,,,
genomic cloning and complete sequence analysis of a highly divergent african human immunodeficiency virus isolate,Vanden Haesevelde M,1994,NR,,0,,,,,,
genotyping of staphylococcus aureus colonizing hiv infected patients,Mohd-Zain Z,2015,NR,,0,,,,,,
guarding against emerging epidemics: addressing hiv and aids among culturally and linguistically diverse communities in nsw,McMahon T,2010,NR,,0,,,,,,
hcvns3 variants in hiv/hcv coinfected patients before-after pegifn/ribavirin,Abdel-Hameed E,2015,NR,,0,,,,,,
hellinger's classification of immunosuppression levels as a predictor of service usage among the hiv infected,Montoya ID,1996,NR,,0,,,,,,
herpes simplex virus type 2 (hsv-2) seroprevalence at the time of hiv-1 diagnosis and seroincidence after hiv-1 diagnosis in an ethnically diverse cohort of hiv-1-infected persons,Ramaswamy M,2006,NR,,0,,,,,,
heterogeneity in antifungal susceptibility of clones of candida albicans isolated on single and sequential visits from a hiv-infected southern chinese cohort,Samaranayake YH,2001,NR,,0,,,,,,
high frequency of identical lymphoma clones detected in pre-treatment tumor and plasma from untreated patients with hiv-associated lymphomas: prospective multicenter trial of the aids malignancy consortium (amc 064),Wagner-Johnston N,2014,NR,,0,,,,,,
high-resolution solution structure of siamycin ii: novel amphipathic character of a 21-residue peptide that inhibits hiv fusion,Constantine KL,1995,NR,,0,,,,,,
hiv / aids and the young: three studies in southern africa,Mutangadura G,1998,NR,,0,,,,,,
hiv and infant feeding in malawi: public health simplicity in complex social and cultural contexts,Chinkonde JR,2012,NR,,0,,,,,,
hiv drug resistance mutations: identifying variants most likely to generate large transmission clusters,Wagner BG,2011,NR,,0,,,,,,
hiv in nsw in 2010: sustaining success in an evolving epidemic,O'Donnell D,2010,NR,,0,,,,,,
hiv infection in the caribbean,Wheeler VW,1994,NR,,0,,,,,,
hiv inter-subtype recombination - consequences for the epidemic,Salminen M,2000,NR,,0,,,,,,
hiv molecular epidemiology and transmitted drug resistance in the mesoamerican region,Garcia-Morales C,2015,NR,,0,,,,,,
hiv prevention based on phylodynamics of the montreal msm epidemic,Brenner BG,2013,NR,,0,,,,,,
hiv resistance to antiviral drugs: public health implications,Wainberg MA,1998,NR,,0,,,,,,
ethical guidelines for hiv research: a contextual implementation process,Obermeyer CM,2004,NR,,0,,,,,,
hiv subtypes in new zealand,Schroeder B,1999,NR,,0,,,,,,
evaluating the services and resources of catie - a national hiv knowledge broker,Challacombe LA,2011,NR,,0,,,,,,
hiv transmission cluster dynamics that inform public health intervention in illinois,Ragonnet-Cronin M,2018,NR,,0,,,,,,
hiv transmission clusters among injecting drug users in romania,Temereanca A,2017,NR,,0,,,,,,
influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expression,Krummheuer J,2001,NR,,0,,,,,,
"hiv transmission networks among the usa, mexico, and central america",Avila-Rios S,2015,NR,,0,,,,,,
haart adherence in culturally diverse patients with hiv/aids: a study of male patients from a veteran's administration hospital in northern california,Kemppainen JK,2001,NR,,0,,,,,,
evaluations of hiv type 1 rev gene diversity and functional domains following perinatal transmission,Ramakrishnan R,2005,NR,,0,,,,,,
hiv type 1 subtype a epidemic in injecting drug user (idu) communities in iran,Tagliamonte M,2007,NR,,0,,,,,,
biochemical and structural analysis of the interaction between the uba(2) domain of the dna repair protein hhr23a and hiv-1 vpr,Withers-Ward ES,2000,NR,,0,,,,,,
immune correlates of hiv acquisition,Makamdop KN,2017,NR,,0,,,,,,
hiv type-1 transmission dynamics in recent seroconverters: relationship with transmission of drug resistance and viral diversity,Recordon-Pinson P,2009,NR,,0,,,,,,
evidence for within-host genetic recombination among the human pegiviral strains in hiv infected subjects,Wu HaoMing,2016,NR,,0,,,,,,
molecular characterization of a recombinant hiv type 1 isolate (a/g/e/?): unidentified regions may be derived from parental subtype e sequences,Paraskevis D,2000,NR,,0,,,,,,
"presence of 2',5'-bis-o-(tert-butyldimethylsilyl)-3'-spiro-5""-(4""-amino-1"",2""-oxath iole-2"",2""-dioxide) (tsao)-resistant virus strains in tsao-inexperienced hiv patients",Van Laethem K,2000,NR,,0,,,,,,
hiv virulence has not increased in the uk subtype b epidemic,Hodcroft EB,2014,NR,,0,,,,,,
hiv-1 diversity and tropism of rebound virus after treatment discontinuation,Bednar MM,2015,NR,,0,,,,,,
hiv-1 genetic diversity,McCutchan FE,1996,NR,,0,,,,,,
hiv-1 genetic diversity and drug resistance mutations among treatment-naive adult patients in suriname,Abdoel Wahid F,2016,NR,,0,,,,,,
immunogenic selection of hiv-1 mper epitopes for improved vaccine design,Wieczorek L,2012,NR,,0,,,,,,
factors associated with pmtct utilization among hiv-infected women,Hamahuwa M,2018,NR,,0,,,,,,
family of mirnas from hiv ltr elicits tlr signaling in alveolar macrophages,Bernard MA,2013,NR,,0,,,,,,
hiv-1 molecular epidemiology in the balkans - a melting pot for high genetic diversity,Stanojevic M,2012,NR,,0,,,,,,
fluctuations of functionally distinct cd8+ t-cell clonotypes demonstrate flexibility of the hiv-specific tcr repertoire,Meyer-Olson D,2006,NR,,0,,,,,,
foreskin cutting beliefs and practices and the acceptability of male circumcision for hiv prevention in papua new guinea,MacLaren D,2013,NR,,0,,,,,,
frontline practices with hiv prevention: a survey of us infectious disease physicians,Krakower DS,2015,NR,,0,,,,,,
immunologic and virologic analyses of an acutely hiv type 1-infected patient with extremely rapid disease progression,Demarest JF,2001,NR,,0,,,,,,
functional analyses of glycosylated gag molecules derived from different gammaretroviruses,Cuccurullo EC,2013,NR,,0,,,,,,
gene therapy using secreted scd4-17b and scab pro140 to inhibit hiv-1 entry in unmodified and modified target cells,Falkenhagen A,2011,NR,,0,,,,,,
genetic analysis of the complete gag and env genes of hiv type 1 subtype c primary isolates from south africa,Engelbrecht S,2001,NR,,0,,,,,,
"hiv-1 subtyping in salvador, bahia, brazil: a city with african sociodemographic characteristics",Couto-Fernandez JC,1999,NR,,0,,,,,,
hiv-1 transmission networks across south korea (special issue on hiv prevention science),Ahn MiYoung,2017,NR,,0,,,,,,
genetic characterization of hiv-1 strains circulating in kazakhstan,Eyzaguirre LM,2007,NR,,0,,,,,,
"genetic diversity in htlv-1 envelope (gp46), hbz and ltr region from assymptomatic and tsp/ham individuals",Mota-Miranda ACA,2011,NR,,0,,,,,,
hiv-related risk and antibody testing: an urban community survey,Kalichman SC,1993,NR,,0,,,,,,
independent evolution of human immunodeficiency virus type 1 env v1/v2 and v4/v5 hypervariable regions during chronic infection,Harrington PR,2007,NR,,0,,,,,,
"global challenges to achieving meaningful community engagement in biomedical hiv prevention research: a multiple embedded case study in canada , india, south africa and thailand",Newman PA,2014,NR,,0,,,,,,
human immunodeficiency virus type 1 cloning vectors for antiretroviral resistance testing,Martinez-Picado J,1999,NR,,0,,,,,,
human immunodeficiency virus type 1 genetic evolution in patients with prolonged suppression of plasma viremia,Martinez MA,1999,NR,,0,,,,,,
human immunodeficiency virus type 1 variants resistant to first- and second-version fusion inhibitors and cytopathic in ex vivo human lymphoid tissue,Chinnadurai R,2007,NR,,0,,,,,,
high incidence cohort of idus infected with hiv with low genetics diversity for hiv vaccine efficacy trials,Verevochkin S,2009,NR,,0,,,,,,
identification and characterization of multiple hla-a24-restricted hiv-1 ctl epitopes: strong epitopes are derived from v regions of hiv-1,Ikeda-Moore Y,1997,NR,,0,,,,,,
identification of a novel hiv-1 complex circulating recombinant form (crf18_cpx) of central african origin in cuba,Thomson MM,2005,NR,,0,,,,,,
identification of diverse hiv type 1 subtypes and dual hiv type 1 infection in pregnant ugandan women,Becker-Pergola G,2000,NR,,0,,,,,,
identification of hiv transmission networks in israel,Grossman Z,2012,NR,,0,,,,,,
identification of potential lead molecules for zika envelope protein from in silico perspective,Chellasamy SK,2019,NR,,0,,,,,,
assessing the contribution of myeloid cells to hiv-1 persistence under art,Stevenson M,2018,NR,,0,,,,,,
hiv cns compartmentalization among subjects with hiv-1 subtypes g and crf02-ag,Adewumi OM,2017,NR,,0,,,,,,
hiv compartmentalization in the cns is associated with neurocognitive impairment,Bowman NM,2016,NR,,0,,,,,,
identifying hiv variants that rebound after treatment interruption,Kearney MF,2015,NR,,0,,,,,,
the case for pre-exposure prophylaxis for hiv: why such conflict?,Grudgings P,2018,NR,,0,,,,,,
shape-directed discovery of a novel structure in the hiv-1 rna polyadenylation signal,Siegfried NA,2014,NR,,0,,,,,,
immunotyping of human immunodeficiency virus type 1 (hiv): an approach to immunologic classification of hiv,Zolla-Pazner S,1999,NR,,0,,,,,,
phosphorylated hiv-1 as potential cytotoxic t lymphocyte (ctl) targets,Chowdhury FZ,2018,NR,,0,,,,,,
hiv infection is associated with decreased dietary diversity in south african children,Mpontshane N,2008,NR,,0,,,,,,
the therapeutic vaccine vacc-4x targets gag ctl epitopes with preexisting mutations,Winckelmann A,2018,NR,,0,,,,,,
hiv pathogenesis: current understanding and future research,Gabuzda DH,2014,NR,,0,,,,,,
impaired fitness of foscarnet-resistant strains of human immunodeficiency virus type 1,Tachedjian G,1998,NR,,0,,,,,,
hiv recombination in the in vitro tcm latency model-reasons and solutions,Bonczkowski P,2015,NR,,0,,,,,,
in vitro and in vivo inhibition studies of human telomerase by hiv reverse transcriptase inhibitors,Hukezalie KR,2011,NR,,0,,,,,,
increased ability for selection of zidovudine resistance in a distinct class of wild-type hiv-1 from drug-naive persons,Garcia-Lerma JG,2001,NR,,0,,,,,,
hiv vaccine development,Johnston MI,2002,NR,,0,,,,,,
independent introduction of transmissible f/d recombinant hiv-1 from africa into belgium and the netherlands,Op de Coul E,2000,NR,,0,,,,,,
hiv-1 coreceptor usage prediction by 'ultra-deep pyrosequencing' increases the rate of patients treated with success by ccr5 antagonists,Rodriguez C,2011,NR,,0,,,,,,
influence of amino acid substitutions on antigenicity of immunodominant regions of the htlv type i envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides,Londos-Gagliardi D,1999,NR,,0,,,,,,
inhibition of human immunodeficiency virus-1 protease by a c2-symmetric phosphinate synthesis and crystallographic analysis,Abdel-Meguid SS,1993,NR,,0,,,,,,
insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation,Quinones-Mateu ME,2002,NR,,0,,,,,,
insight into the conformational features of the hiv-1 subtype a v3 loop for providing informational support to structure-based anti-aids drug projects,Anishchenko IV,2009,NR,,0,,,,,,
interaction kinetic characterization of hiv-1 reverse transcriptase non-nucleoside inhibitor resistance,Geitmann M,2006,NR,,0,,,,,,
interactions of different drug resistance mutations in hiv reverse transcriptase in defining patterns of drug resistance,Wainberg MA,2011,NR,,0,,,,,,
hiv-1-specific cd8+ t cell responses and viral evolution in women and infants,Sanchez-Merino V,2005,NR,,0,,,,,,
is pre-art intra-patient hiv-1 diversity associated with virologic failure and drug resistance on cart?,Kearney MF,2014,NR,,0,,,,,,
"hiv/aids risk factors and economic empowerment needs of female sex workers in enugu urban, nigeria",Onyeneho NG,2009,NR,,0,,,,,,
"hiv/aids-related knowledge, sexual practices and predictors of condom use among long-distance truck drivers in nigeria",Aniebue PN,2009,NR,,0,,,,,,
human tissue mast cells are an inducible reservoir of persistent hiv infection,Sundstrom JB,2007,NR,,0,,,,,,
long distance truck driving: its role in the dynamics of hiv/aids epidemic,McLigeyo SO,1997,NR,,0,,,,,,
identification and characterization of hiv type 1 subtypes present in the kingdom of saudi arabia: high level of genetic diversity found,Badreddine S,2007,NR,,0,,,,,,
longitudinal changes in cd4+ t cell antigen receptor diversity and naive/memory cell phenotype during 9 to 26 months of antiretroviral therapy of hiv-infected patients,Gea-Banacloche JC,2000,NR,,0,,,,,,
loss of t cell receptor vbeta repertoires in hiv type 1-infected scid-hu mice,Boldt-Houle DM,1997,NR,,0,,,,,,
sequencing technology comparison for detection of hiv-1 mutations in the protease and reverse transcriptase regions,Rakhmanaliev E,2016,NR,,0,,,,,,
identification of nk cell subsets correlating with hiv dna in hiv-infected subjects,Pohlmeyer C,2018,NR,,0,,,,,,
native envelope-based immunogens derived from critical timepoints in the development of breadth elicit rapid neutralizing antibodies in rabbits,Malherbe DC,2012,NR,,0,,,,,,
identification of the first nonhuman primate cd4 receptor for t/f hiv-1 isolates,Meyerson N,2015,NR,,0,,,,,,
performance characteristics of human immunodeficiency virus type 1 (hiv-1) genotyping systems in sequence-based analysis of subtypes other than hiv-1 subtype b,Jagodzinski LL,2003,NR,,0,,,,,,
"impact of dental care in hiv+ patients on haart, a pilot study",Fletcher SM,2011,NR,,0,,,,,,
"mcef is localized to the nucleus by protein sequences encoded within three distinct exons, where it represses hiv-1 tat-transactivation of ltr-directed transcription",Niedzielski MF,2007,NR,,0,,,,,,
the landscape of microrna expression in hiv and non-hiv associated classical hodgkin lymphoma through next generation sequencing,Rubinstein PG,2015,NR,,0,,,,,,
increasing hiv subtype diversity and its clinical implications in a sentinel north american population,Siemieniuk RA,2013,NR,,0,,,,,,
independent evaluation of predicate incidence assays for hiv surveillance,Kassanjee R,2014,NR,,0,,,,,,
molecular and biological diversity of hiv-1 in brazil,Couto-Fernandez JC,1992,NR,,0,,,,,,
molecular and phylogenetic characterization of hiv variants in italian primary hiv infections (phi): identification of non-b subtype variants,Buonaguro L,2002,NR,,0,,,,,,
prep for hiv prevention: what we know and what we still need to know for implementation,Landovitz RJ,,NR,,0,,,,,,
molecular characterization of variable heavy and light chain regions of five hiv type 1-specific human monoclonal antibodies,Van der Donk EMM,1994,NR,,0,,,,,,
molecular epidemiology and drug resistance prevalence of strains from newly diagnosed hiv-1 patients in northern greece during 2009-2010,Antoniadou Z,2012,NR,,0,,,,,,
molecular epidemiology of hiv-1 variants in the global aids pandemic: an update,Thomson MM,2005,NR,,0,,,,,,
key emotional issues for couples of mixed hiv status,Beckerman NL,2000,NR,,0,,,,,,
kir and hla play distinct roles in hiv infection and aids progression,Trachtenberg EA,2013,NR,,0,,,,,,
kir-hla footprints and nk cell-mediated recognition of hiv-1,Thobakgale CF,2012,NR,,0,,,,,,
knowledge of hiv/aids among the men sex with men (kothis) in puducherry,Ajeet Jaiswal,2017,NR,,0,,,,,,
molecular evidence that human immunodeficiency virus type 1 dissemination in a small brazilian city was already taking place in the early 1990s,Eyer-Silva WA,2007,NR,,0,,,,,,
letter to the editor performance of the viroseq hiv-1 genotyping system v20 in central africa,Mekue Mouafo LC,2015,NR,,0,,,,,,
molecular modeling of hiv-1 reverse transcriptase drug-resistant mutant strains: implications for the mechanism of polymerase action,Kroeger Smith MB,1997,NR,,0,,,,,,
listening to the voices of people living with hiv - the positive side/vision positive readership survey,Challacombe LA,2011,NR,,0,,,,,,
"dental students' hiv/aids-related knowledge, attitudes, and intentions: impact of the us health resources and services administration's community-based dental partnership program",Hamershock RA,2014,NR,,0,,,,,,
multiple identical proviral sequences with identical integration sites demonstrate proliferation of hiv-infected cells during suppressive antiretroviral treatment,Wagner TA,2013,NR,,0,,,,,,
multiple introductions of hiv-1 subtype e into the western hemisphere,Artenstein AW,1995,NR,,0,,,,,,
mapping the molecular characteristics of brazilian human t-cell lymphotropic virus type 1 env (gp46) and pol amino acid sequences for vaccine design,Mota-Miranda AC,2007,NR,,0,,,,,,
medical and non-medical expenses for treating babies born to hiv-infected and non-hiv-infected mothers,Pansatiankul B,2003,NR,,0,,,,,,
natural presence of resistance mutation y181c in hiv-1 group o variants is clade-dependent,Depatureaux A,2009,NR,,0,,,,,,
nef and ltr sequence variation from sequentially derived human immunodeficiency virus type 1 isolates,McNearney T,1995,NR,,0,,,,,,
new insights into the origin of the hiv type 1 subtype a epidemic in former soviet union's countries derived from sequence analyses of preepidemically transmitted viruses,Thomson MM,2007,NR,,0,,,,,,
modifications in senv dna detection and/or senv subtype determination over a prospective follow-up in a cohort of hiv-positive patients: is this a moving target?,Quiros-Roldan E,2004,NR,,0,,,,,,
next generation sequencing-based hiv-1 drug resistance monitoring system,Rakhmanaliev E,2016,NR,,0,,,,,,
molecular and phenotypic characteristics of neurotropic hiv-1 subtype e,Srisurapanon S,2001,NR,,0,,,,,,
transforming governance or reinforcing hierarchies and competition: examining the public and hidden transcripts of the global fund and hiv in india,Kapilashrami A,2013,NR,,0,,,,,,
no association of hiv type 1 long terminal repeat sequence pattern with long-term nonprogression and in vivo viral replication levels in european subjects,Visco-Comandini U,1999,NR,,0,,,,,,
no evidence for evolution of plasma hiv-1 rna or pbmc hiv-1 dna during long-term suppressive antiretroviral therapy,Kearney MF,2012,NR,,0,,,,,,
molecular characterization of hiv type 1 vpu genes from mothers and infants after perinatal transmission,Yedavalli VR,2001,NR,,0,,,,,,
molecular profile of hiv-1 reservoirs in early-treated infants from botswana,Broncano PG,2018,NR,,0,,,,,,
nondisclosed msm link together in hiv transmission networks,Ragonnet-Cronin M,2017,NR,,0,,,,,,
"monophyletic hiv type 1 crf02-ag in a nosocomial outbreak in benghazi, libya",Visco-Comandini U,2002,NR,,0,,,,,,
"multiple antibody specificities (gp41, v1v2, and v3) elicited in the phase ii multiclade (a, b, c) hiv-1 dna prime, rad5 boost vaccine trial",Williams WB,2012,NR,,0,,,,,,
opt-out hiv/hcv testing among jail inmates,De La Flor C,2017,NR,,0,,,,,,
mutations in hiv-1 env rescue replication defects despite poor cell-free infectivity,Van Duyne R,2017,NR,,0,,,,,,
origin and evolutionary history of hiv-1 subtype b in cuba,Machado-Zaldivar LY,2017,NR,,0,,,,,,
near full-length clones and reference sequences for subtype c isolates of hiv type 1 from three different continents,Rodenburg CM,2001,NR,,0,,,,,,
overview of hiv molecular epidemiology among people who inject drugs in europe and asia (special issue: evolution of hiv),Nikolopoulos,2016,NR,,0,,,,,,
"structural stigma, sex work and hiv: contradictions and lessons learnt from a community-led structural intervention in southern india",Biradavolu MR,2012,NR,,0,,,,,,
development of an allele-specific pcr method for rapid and sensitive detection of e138 mutations in hiv-1 reverse transcriptase,McCallum M,2012,NR,,0,,,,,,
role of human immunodeficiency virus type 1 group o in the aids pandemic,Quinones-Mateu ME,2000,NR,,0,,,,,,
"further confirmation of broadly conserved, highly immunogenic crossclade hiv ctl epitopes for inclusion in the gaia hiv vaccine",De Groot AS,2012,NR,,0,,,,,,
the roles of hiv-1 specific cd8+ t cell responses and hla class i alleles on viral control and viral escape in hiv-1 infected thai individuals,Buranapraditkun S,2012,NR,,0,,,,,,
evolutionary dynamics of hiv-1 subtype c accessory and regulatory genes in primary infection,Rossenkhan R,2012,NR,,0,,,,,,
new bioinformatic algorithm to identify recent hiv-1 infection,Maldarelli F,2010,NR,,0,,,,,,
patterns of hiv-1 evolution in individuals with differing rates of cd4 t cell decline,Markham RB,1998,NR,,0,,,,,,
patterns of knowledge and condom use among population groups: results from the 2005 ethiopian behavioral surveillance surveys on hiv,Getnet Mitike,2011,NR,,0,,,,,,
"genetic variability and high proportion of hiv-1 bf1 recombinant strains among vertically infected children in sao paulo, brazil",De Oliveira ACS,2012,NR,,0,,,,,,
no evidence for ongoing hiv replication in lymph nodes during suppressive art,McManus WR,2018,NR,,0,,,,,,
no evidence of ongoing hiv replication after 7 years on art,Katusiime MGK,2017,NR,,0,,,,,,
persistence of transmitted hiv-1 drug resistance mutations associated with fitness costs,Yang W-LY,2014,NR,,0,,,,,,
online and offline sexual health-seeking patterns of hiv-negative men who have sex with men,Wilkerson JM,2010,NR,,0,,,,,,
phylodynamic features of active large clusters fueling the hiv epidemic in quebec msm,Brenner BG,2018,NR,,0,,,,,,
knowledge and attitudes about hiv/aids of dental students from kuwait and sri lanka,Ellepola AN,2011,NR,,0,,,,,,
immune pressure analysis of protease and reverse transcriptase genes of primary hiv-1 subtype c isolates from south africa,Bessong PO,2011,NR,,0,,,,,,
impairment of viral replication capacity by nef alleles from hiv elite controllers,Mwimanzi P,2011,NR,,0,,,,,,
phylogenetic patterns of hiv transmission among transgender women in los angeles,Ragonnet-Cronin M,2018,NR,,0,,,,,,
pcr-free full genome characterization of diverse hiv-1 strains by nextgen sequencing,Ragupathy V,2015,NR,,0,,,,,,
perceptions of media coverage of hiv criminalization among phas in ontario,Globerman J,2011,NR,,0,,,,,,
perinatal exposure to aflatoxins is associated with a lower rate of weight gain among hiv-infected pregnant women and reduced linear growth of hiv-exposed infants,Natamba BK,2016,NR,,0,,,,,,
peripheral blood cells contribute to hiv-1 viremia induced by romidepsin,Winckelmann A,2017,NR,,0,,,,,,
phenotypic diversity of oral c albicans isolated on single and sequential visits in an hiv-infected chinese cohort,Samaranayake YH,2003,NR,,0,,,,,,
phylodynamic methods of identifying foci of hiv-1 transmission,McLaughlin A,2018,NR,,0,,,,,,
experiencing occupational violence is associated with inconsistent condom use among female sex workers in southern india: emphasizing the need for structural hiv interventions,Deering KN,2011,NR,,0,,,,,,
"pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns and common ancestry for subtypes b and d",Cornelissen M,1997,NR,,0,,,,,,
investigating the role of sr proteins in regulating hiv-1 rna processing,Calimano M,2011,NR,,0,,,,,,
biochemical characterization of staufen1 hiv-1-dependent rnps (shrnps) in hiv-1 expressing cells,Ravichandran M,2011,NR,,0,,,,,,
verotoxin/shiga toxin a subunit provides a prophylactic means to prevent primary lymphoid cell hiv infection in vitro,Lingwood CA,2011,NR,,0,,,,,,
pooled week 48 safety and efficacy results from echo and thrive phase iii trials comparing tmc278 vs efv in treatment-naive hiv-1-infected patients receiving ftc/tdf,Walmsley S,2011,NR,,0,,,,,,
population level analyses to examine comorbid hiv/aids infection in sub-saharan africa and transmission of drug resistant malaria parasites,Torrevillas BK,2017,NR,,0,,,,,,
pilot hiv prevention study for adolescent young women,Long-Middleton ER,2018,NR,,0,,,,,,
populations-specific hiv/aids status report: using the determinants of health as a lens to examine hiv vulnerability and resilience among women,Beausoleil KM,2011,NR,,0,,,,,,
community-level hiv/sti interventions and their impact on alcohol use in urban poor populations in india,Schensul SL,2010,NR,,0,,,,,,
"predisposing, enabling, and high risk behaviors associated with healthcare engagement among young, hiv-negative msm in new york city",Swanenberg I,2018,NR,,0,,,,,,
predicting hiv cluster growth using phylodynamic reconstruction in los angeles county,Ragonnet-Cronin M,2018,NR,,0,,,,,,
effects of a supervised exercise program on the physical fitness and immunological function of hiv-infected patients,Farinatti PTV,2010,NR,,0,,,,,,
preferences for rapid point-of-care hiv testing in a female primary care population,Schwandt M,2011,NR,,0,,,,,,
pretreatment hiv drug resistance spread within transmission clusters in mexico city,Matias-Florentino M,2018,NR,,0,,,,,,
"prevalence of paediatric hiv infection in federal capital territory, abuja",Okechukwu AA,2011,NR,,0,,,,,,
"prevalence of drug-resistant hiv-1 variants in first-line antiretroviral therapy failure: comparison between population-and ultra deep-sequencing, anrs co3 aquitaine cohort, 2000-2008",Vandenhende M-A,2010,NR,,0,,,,,,
prevalence of the k65r mutation in subtype c hiv-1-infected subjects failing tdf-containing irst-line antiretroviral therapy in south africa using deep sequencing,Casadella M,2014,NR,,0,,,,,,
"prevention of mother-to-child transmission of hiv infection: views and perceptions about swallowing nevirapine in rural lilongwe, malawi",O'Gorman DA,2010,NR,,0,,,,,,
promoting cultural competence in hiv/aids care,O'Connor BB,1996,NR,,0,,,,,,
protein methylation is required to maintain optimal hiv-1 infectivity,Willemsen NM,2006,NR,,0,,,,,,
proviral hiv-genome-wide and pol-gene specific zinc finger nucleases: usability for targeted hiv gene therapy,Wayengera M,2011,NR,,0,,,,,,
public health implications of antiretroviral therapy and hiv drug resistance,Wainberg MA,1998,NR,,0,,,,,,
recombination elevates hiv-1 evolution following mother-to-child transmission,Somasundaran M,2016,NR,,0,,,,,,
quantitative and phylogenetic analyses of persistent hiv in blood and galt during long-term cart,Simonetti FR,2014,NR,,0,,,,,,
rectal cell-associated hiv-1 rna as a marker for trials targeting the reservoir,Lafeuillade A,2009,NR,,0,,,,,,
"scd4-17b, an engineered bifunctional hiv-1 neutralizing protein: potent cross clade activity and potential microbicide use",Lagenaur LA,2009,NR,,0,,,,,,
rapid genetic characterization of hiv type 1 strains from four world health organization-sponsored vaccine evaluation sites using a heteroduplex mobility assay,Bachmann MH,1994,NR,,0,,,,,,
replication of hiv-1 in the central nervous system of adults early after infection,Sturdevant CB,2014,NR,,0,,,,,,
response to art and mortality in older hiv patients in a latin american cohort,Carriquiry G,2016,NR,,0,,,,,,
retention in care among hiv-infected pregnant women in haiti with pmtct option b,Dionne-Odom,2016,NR,,0,,,,,,
reconciling named partner and genetic partner hiv-1 transmission networks in new york city,Wertheim JO,2015,NR,,0,,,,,,
recovery of virtually full-length hiv-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction,Salminen MO,1995,NR,,0,,,,,,
romidepsin-induced hiv-1 viremia is oligoclonal with limited deleterious mutations,Winckelmann A,2017,NR,,0,,,,,,
regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (hiv-1)-infected monocytes: implications for hiv-associated neurological disease,Bukrinsky MI,1995,NR,,0,,,,,,
regulation of polyadenylation in human immunodeficiency virus (hiv): contributions of promoter proximity and upstream sequences,Cherrington J,1992,NR,,0,,,,,,
screening of hiv-1 isolates by reverse heteroduplex mobility assay and identification of non-b subtypes in italy,Buonaguro L,2004,NR,,0,,,,,,
religious and cultural traits in hiv/aids epidemics in sub-saharan africa,Velayati A-A,2007,NR,,0,,,,,,
restriction fragment length polymorphism analysis for rapid gag subtype determination of human immunodeficiency virus type 1 in south africa,van Harmelen J,1999,NR,,0,,,,,,
"senv infection in hiv-positive patients: prevalence, subtype characterization, and impact on hiv disease progression",Quiros-Roldan E,2003,NR,,0,,,,,,
risky sexual behavior and correlates of std prevalence among african american hiv serodiscordant couples,NIMH Multisite HIV STD Prevention Trial for African American Couples Group,2010,NR,,0,,,,,,
sexuality research in the era of hiv and aids: enhancing or damaging human sexuality?,Islam Khan S,2017,NR,,0,,,,,,
"virus fitness: concept, quantification, and application to hiv population dynamics",Quinones-Mateu ME,2006,NR,,0,,,,,,
"secondary defects of the mitochondrial respiratory chain: the examples of neuroleptic use, co toxicity, and hiv treatment",Casademont,2005,NR,,0,,,,,,
sequence analysis of human t cell lymphotropic virus type i (htlv-i) env genes amplified from central nervous system tissues of patients with htlv-i-associated myelopathy or leukemia,Maroushek SR,1995,NR,,0,,,,,,
serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry,Zolla-Pazner S,1995,NR,,0,,,,,,
surveillance of subtype and genetic variation of the circulating strains of hiv-1 in thailand,Wirachsilp P,2007,NR,,0,,,,,,
targeting gut dysbiosis with prebiotics and glutamine in hiv-infected subjects,Serrano-Villar S,2015,NR,,0,,,,,,
simplified multiplex mutation-specific pcr screening for hiv drug resistance,Lipscomb JT,2013,NR,,0,,,,,,
"simultaneous introduction of distinct hiv-1 subtypes into different risk groups in russia, byelorussia and lithuania",Lukashov VV,1995,NR,,0,,,,,,
single point mutations in the zinc finger motifs of the human immunodeficiency virus type 1 nucleocapsid alter rna binding specificities of the gag protein and enhance packaging and infectivity,Mark-Danieli M,2005,NR,,0,,,,,,
"single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (hiv) type 1 entry inhibitor pro 542 in hiv-infected adults",Jacobson JM,2000,NR,,0,,,,,,
tcr recognition is a mediator in the control of hiv infection by cd8 t cells,Nicodemos RAM,2017,NR,,0,,,,,,
sociocultural dimensions of hiv/aids among middle eastern immigrants in the us: bridging culture with hiv/aids programmes,Ehsanzadeh-Cheemeh P,2009,NR,,0,,,,,,
specific behaviors predict staphylococcus aureus colonization and skin and soft tissue infections among hiv-infected persons,Crum-Cianflone N,2015,NR,,0,,,,,,
strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the c4 domain of gp120 from human immunodeficiency virus type 1,Nakamura GR,1993,NR,,0,,,,,,
structural constraints in the hiv-1 reverse transcriptase-primer/template complex for the initiation of dna synthesis from primer trnalys3,Zakharova OD,1998,NR,,0,,,,,,
structural diversity of monoclonal cd4 antibodies and their capacity to block the hiv gp120/cd4 interaction,Weissenhorn W,1996,NR,,0,,,,,,
subtype analysis and mutations to antiviral drugs in hiv-1-infected patients from mozambique before initiation of antiretroviral therapy: results from the dream programme,Bellocchi MC,2005,NR,,0,,,,,,
subtype b hiv transmission groups in israel detected by bayesian phylogenetics are composed predominantly of men who have sex with men (msm) with recent hiv infection,Grossman Z,2013,NR,,0,,,,,,
subtype g and multiple forms of a/g intersubtype recombinant human immunodeficiency virus type 1 in nigeria,McCutchan FE,1999,NR,,0,,,,,,
survey of reverse transcriptase from the heterosexual epidemic of human immunodeficiency virus type 1 crf01_ae in thailand from 1990 to 2000,Sirivichayakul S,2001,NR,,0,,,,,,
"t cell responses to highly active antiretroviral therapy defined by chemokine receptors expression, cytokine production, t cell receptor repertoire and anti-hiv t-lymphocyte activity",Giovannetti A,2001,NR,,0,,,,,,
"the black, african and caribbean canadian health (blacch) study: laying the foundation for conducting hiv epidemiologic studies with ethno-racial minority communities in understudied urban-rural locales",Baidoobonso SM,2010,NR,,0,,,,,,
"the cedar project: gender differences in hiv vulnerabilities associated with unstable housing over time among young aboriginal people who use drugs in vancouver and prince george, bc",Jongbloed K,2011,NR,,0,,,,,,
the clinical course of human immunodeficiency virus infection in genetically identical children,Saulsbury FT,1997,NR,,0,,,,,,
the dynamics of drug resistance detected during acute hiv infection,Kanthula RM,2016,NR,,0,,,,,,
the effect of a single amino acid substitution within the v3 loop of hiv-1 gp120 on hla-dr1-restricted cd4 t-cell recognition,Fernandez MH,1995,NR,,0,,,,,,
the effect of zidovudine on skeletal muscle mtdna in hiv-1 infected patients with mild or no muscle dysfunction,Casademont J,1996,NR,,0,,,,,,
the evolution of hiv policy in vietnam: from punitive control measures to a more rights-based approach,Pham Nguyen Ha,2010,NR,,0,,,,,,
the genetic traits of full-length hiv sequenced from memory t cell subsets,Horsburgh BA,2018,NR,,0,,,,,,
syndemics and hiv-related sexual risk among men who have sex with men in india: influences of stigma and resilience,Venkatesan Chakrapani,2019,NR,,0,,,,,,
the importance of a local perspective in monitoring the success of hiv prevention,Anderson S-J,2017,NR,,0,,,,,,
the hiv epidemic in the amazon basin is driven by prototypic and recombinant hiv-1 subtypes b and f,Vicente ACP,2000,NR,,0,,,,,,
the influence of hla class i genes and hla-g on perinatal hiv-1 transmission: an update,Czarnecki CK,2011,NR,,0,,,,,,
the moment study: correlates of viral suppression at 6 months postpartum among hiv-positive women in rural nigeria,Ramadhani H,2018,NR,,0,,,,,,
the importance of core groups in the epidemiology and control of hiv-1 infection,Plummer FA,1991,NR,,0,,,,,,
the importance of treatment adherence in hiv,Schaecher KL,2013,NR,,0,,,,,,
the non-clonal and transitory nature of hiv in vivo,Meyerhans A,2003,NR,,0,,,,,,
the race between initial t-helper expansion and virus growth upon hiv infection influences polyclonality of the response and viral set-point,Korthals Altes H,2003,NR,,0,,,,,,
the molecular epidemiology of hiv type 1 of men in mexico,Rivera-Morales LG,2001,NR,,0,,,,,,
"the national consensus statement on women, trans people and girls and hiv research in canada : implications for epidemiology and public health",Wertheimer S,2014,NR,,0,,,,,,
the prediction of gag and env gene on epidemiology of hiv-1 infection in thailand,Sermsaksakul B,2014,NR,,0,,,,,,
the specificity of v3 antibodies in rv144 plasma implicated in reducing hiv infection,Zolla-Pazner S,2014,NR,,0,,,,,,
the role of multiple identities in adherence to medical appointments among gay/bisexual male adolescents living with hiv,Harper GW,2013,NR,,0,,,,,,
tim-3 is a marker of pdc dysfunction in hiv infection,Schwartz JA,2017,NR,,0,,,,,,
use of calibrated viral load standards for group m subtypes of human immunodeficiency virus type 1 to assess the performance of viral rna quantitation tests,Jagodzinski LL,2000,NR,,0,,,,,,
acceptability of hiv pre-exposure prophylaxis (prep) and implementation challenges among men who have sex with men in india: a qualitative investigation,Venkatesan Chakrapani,2015,NR,,0,,,,,,
tracking dynamic hiv-1 escape from ccr5 antagonist therapy in vivo by deep sequencing,Tsibris AMN,2009,NR,,0,,,,,,
vaccine-induced human antibodies specific for the third variable region of hiv-1 gp120 impose immune pressure on infecting viruses,Zolla-Pazner S,2014,NR,,0,,,,,,
"transmission clusters, recent infection and stis among new hiv cases: implications for prevention",Truong H-HM,2014,NR,,0,,,,,,
tls dependent and independent functions of dna polymerase eta (pol eta /rad30) from pathogenic yeast candida albicans,Kodavati Manohar,2018,NR,,0,,,,,,
triterpene constituents of euphorbia erythradenia bioss and their anti-hiv activity,Ayatollahi AM,2016,NR,,0,,,,,,
ultrasensitive p24 digital elisa can lead to an overestimate of hiv reservoir size,Simonetti FR,2018,NR,,0,,,,,,
understanding the genetic diversity of hiv-1,McCutchan FE,2000,NR,,0,,,,,,
transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population,Leigh Brown AJ,2003,NR,,0,,,,,,
transmission networks of drug resistance acquired in primary/early stage hiv infection,Brenner BG,2009,NR,,0,,,,,,
transmission of human immunodeficiency virus from monocytes to epithelia,Bourinbaiar AS,1991,NR,,0,,,,,,
use of propensity score matching to adjust for baseline imbalance in longitudinal hiv databases: association between male gender and progression of renal insufficiency among hiv patients,Odueyungbo A,2011,NR,,0,,,,,,
"using phylodynamic modelling to estimate the population attributable fraction of hiv spread due to key populations in dakar, senegal",Geidelberg E,2018,NR,,0,,,,,,
using underutilised food crops to strengthen the food and nutritional status of an hiv-impacted community in the uzumba-maramba-pfungwe district of zimbabwe,Nyamupingidza,2013,NR,,0,,,,,,
utility of metagenomic next-generation sequencing for characterization of hiv and human pegivirus diversity,Luk KaCheung,2015,NR,,0,,,,,,
"transmitted hiv drug resistance among early infected persons in san diego, california",Panichsillapakit T,2015,NR,,0,,,,,,
transmitted human immunodeficiency virus type 1 carrying the d67n or k219q/e mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine,Garcia-Lerma JG,2004,NR,,0,,,,,,
viral dynamics of hiv-1 rebound viremia,Scheinfeld B,2014,NR,,0,,,,,,
two viral strains and a possible novel recombinant are responsible for the explosive injecting drug use-associated hiv type 1 epidemic in estonia,Zetterberg V,2004,NR,,0,,,,,,
visceral leishmaniasis as influenced by hiv co-infection,Al-Ateeg FA,2004,NR,,0,,,,,,
voices from the fire: vision in truth a perspective of hiv/aids among aboriginal communities in central alberta,Konsmo EM,2010,NR,,0,,,,,,
use of a rule based graph-theoretical system in evaluating the activity of a class of nucleoside analogues against human immunodeficiency virus,Raychaudhury C,1993,NR,,0,,,,,,
wellness retreats for hiv+ women: moving beyond the cliche - why retreats are an effective tool for women-centred support,Medjuck MJ,2010,NR,,0,,,,,,
what makes someone a long-term survivor?: deciphering the multiple meanings of the long-term survivorship of hiv,Cattaneo JS,2012,NR,,0,,,,,,
where are the young men in hiv prevention efforts? comments on hiv prevention programs and research from young men who sex with men in los angeles county,Holloway IW,2012,NR,,0,,,,,,
womens constraint in access to prevention of mother to chidl transnmission of hiv/aids (pmtct) in enugu state nigeria,Ezumah NN,2017,NR,,0,,,,,,
virological and molecular demonstration of human immunodeficiency virus type 2 vertical transmission,Cavaco-Silva P,1998,NR,,0,,,,,,
"vulnerability and non-adherence to antiretroviral therapy among hiv patients, minas gerais state, brazil",De Fatima Bonolo P,2008,NR,,0,,,,,,
"what is in a label? multiple meanings of 'msm' among same-gender-loving black men in mississippi (special issue: the trouble with 'categories': rethinking men who have sex with men, transgender and their equivalents in hiv prevention and health promotion)",Nhan Truong,2016,NR,,0,,,,,,
predominance of defective proviral sequences in an hiv + long-term non-progressor,Schwartz DH,1996,duplicate,,0,,,,,,
rapid and simple characterization of in vivo hiv-1 sequences using solid- phase direct sequencing,Salminen M,1992,duplicate,,0,,,,,,
special issue on hiv prevention science (special issue on hiv prevention science),10.1089/aid.2019.0055,2019,duplicate,,0,,,,,,